Citrus Sinensis ID: 030203
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 181 | 2.2.26 [Sep-21-2011] | |||||||
| Q05609 | 821 | Serine/threonine-protein | yes | no | 0.972 | 0.214 | 0.892 | 2e-90 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.939 | 0.182 | 0.674 | 4e-63 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.861 | 0.121 | 0.459 | 8e-37 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.889 | 0.214 | 0.461 | 7e-36 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.872 | 0.246 | 0.45 | 2e-34 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.845 | 0.221 | 0.451 | 7e-34 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.823 | 0.162 | 0.467 | 8e-34 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.861 | 0.117 | 0.418 | 3e-33 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.878 | 0.314 | 0.456 | 7e-33 | |
| Q54U31 | 744 | Dual specificity protein | no | no | 0.878 | 0.213 | 0.447 | 1e-32 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 331 bits (848), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 157/176 (89%), Positives = 167/176 (94%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDERRRL+MAYDVAKGMNYLH RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA+TF
Sbjct: 646 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTF 705
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKSAAGTPEWMAPEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGF
Sbjct: 706 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 765
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
K KRLEIPRN+NP VA+IIE CW NEPWKRPSF+TIM+LLRPLIKS P P+ +D+
Sbjct: 766 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 821
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 116/172 (67%), Positives = 135/172 (78%), Gaps = 2/172 (1%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+DERRR+ MA DVA GMN LH P IVHRDLK+PNLLVD + VKV DFGLSRLK NTF
Sbjct: 762 IDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTF 821
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKS AGTPEWMAPEVLR+EPSNEK D+YSFGVILWELATL+ PW +NP QVV AVGF
Sbjct: 822 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGF 881
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL--IKSPTPQ 171
+ +RLEIP+ ++P V II CW +P RPSF+ + E+L+PL + PTPQ
Sbjct: 882 QNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVLPTPQ 933
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (385), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 73/159 (45%), Positives = 106/159 (66%), Gaps = 3/159 (1%)
Query: 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 66
RL + +D A+GM YLH RNP I+HRDLK+ NLLVD + VKV DFGL+ +K++TF +K+
Sbjct: 949 RLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKT 1006
Query: 67 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 126
GT W+APEVL +E EK+D+YS+ ++LWEL T P+ N QVV ++ +G+RL
Sbjct: 1007 MCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERL 1065
Query: 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
+P P A+++ CW +P RPSF I+ ++ +I
Sbjct: 1066 PMPAWCPPKYAALMNRCWETDPTHRPSFPEILPIMEGMI 1104
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 149 bits (377), Expect = 7e-36, Method: Compositional matrix adjust.
Identities = 77/167 (46%), Positives = 108/167 (64%), Gaps = 6/167 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANT 60
LD R +MA D+AKGMNYLH +P ++HRDLKS NLLVD+ Y VK+ DFGLS R K +
Sbjct: 585 LDWPRMKSMALDIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKH- 643
Query: 61 FLSSKSA---AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA 117
L K+A GTP W APEVLR++P EK+D++SF ++LWE+ T + P+ + Q+V
Sbjct: 644 -LDKKTAMTPVGTPCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVI 702
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164
+VG R +P V+ +I CW+ +P +RPSF I++ L +
Sbjct: 703 SVGQHKLRPIVPPQVSAPFTRLITECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (364), Expect = 2e-34, Method: Composition-based stats.
Identities = 72/160 (45%), Positives = 98/160 (61%), Gaps = 2/160 (1%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
+ M D AKG+ YLH P I+HRDLKS NLLVD+ + VKV DFGLS ++ ++ +A
Sbjct: 473 IKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTA 530
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
GTP W +PEVLR + EK+D+YSFG+ILWE AT Q P+ + P QV+ AVG +G R
Sbjct: 531 CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPP 590
Query: 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+P+N P ++ C P RP+ +E L + S
Sbjct: 591 VPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESIDSS 630
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 143 bits (360), Expect = 7e-34, Method: Composition-based stats.
Identities = 70/155 (45%), Positives = 97/155 (62%), Gaps = 2/155 (1%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
M D AKG+ YLH P I+HRDLKS NLLVD+ + VKV DFGLS ++ ++ +A G
Sbjct: 492 MMIDAAKGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACG 549
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 129
TP W +PEVLR + EK+D+YSFG+ILWE AT Q P+ + P QV+ AVG +G R P
Sbjct: 550 TPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTP 609
Query: 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164
+ P +++ C P +RP+ +E+L +
Sbjct: 610 KYGPPKYIQLLKDCLNENPSQRPTMEQCLEILESI 644
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (359), Expect = 8e-34, Method: Composition-based stats.
Identities = 71/152 (46%), Positives = 101/152 (66%), Gaps = 3/152 (1%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
+A +A+GMNYLH ++HRD+KS NLL+D+ VK+CDFGLS+LK+ + +KS G
Sbjct: 764 LAIQIAQGMNYLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSI-G 820
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 129
+P WM+PE+L E EK D+Y+FG+ILWEL T + P+ L+ Q+ AV K R IP
Sbjct: 821 SPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIP 880
Query: 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
++ +I+ACW +P KRPSF+ I+ LL
Sbjct: 881 NAWPYQLSHLIQACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 140 bits (354), Expect = 3e-33, Method: Composition-based stats.
Identities = 67/160 (41%), Positives = 101/160 (63%), Gaps = 4/160 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD L +A+D+A+GM +LH RN I+HRDLKS NLL+DK + +K+ D G++R +F
Sbjct: 1172 LDSTLILAIAFDIARGMQHLHTRN--IIHRDLKSSNLLMDKHFNIKIADLGIAR--ETSF 1227
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ + GT W APE+LR E N+K+D+YS+ ++L+EL T ++P+ + P V
Sbjct: 1228 TQTMTTIGTVAWTAPEILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVAS 1287
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
KG R E+P N +P+ ++ CW+ +P KRPSF I L
Sbjct: 1288 KGLRPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 140 bits (352), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 74/162 (45%), Positives = 99/162 (61%), Gaps = 3/162 (1%)
Query: 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SS 64
R+ MA D A G+N+LH NP VHRD+KS NLLVD+ VK+CDFGLS LK +
Sbjct: 122 RMRMARDAALGINWLHESNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQ 181
Query: 65 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV-AAVGFKG 123
SA GTP +MAPEV+ + NE SD+YSFG++LWE+ T ++P+ + + AV K
Sbjct: 182 SSAKGTPLYMAPEVMMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKH 241
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
+R IP + + +IE CW EP RPSF I+ L +I
Sbjct: 242 ERPPIPNDCLDSLRRLIEKCWDKEPISRPSFKEIISALDHVI 283
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54U31|SHKD_DICDI Dual specificity protein kinase shkD OS=Dictyostelium discoideum GN=shkD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 139 bits (350), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 72/161 (44%), Positives = 98/161 (60%), Gaps = 2/161 (1%)
Query: 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK 65
RR+ MA D A GMN+LH IVH DLK+ NLLVD VKV DFG S++K K
Sbjct: 375 RRMQMAKDAALGMNWLHGITR-IVHNDLKTANLLVDINLRVKVTDFGFSQIKEGEEFQDK 433
Query: 66 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV-VAAVGFKGK 124
+A GTP WMAPEV+ P NEK+D+YSFG+ILWE+ T + P+ + + A+ + +
Sbjct: 434 AAKGTPLWMAPEVMMGNPYNEKADVYSFGIILWEILTKEAPYSHHKDYDIFFNAICNEKE 493
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
R IP + P + +I+ CW + P RPSFS I+ L ++
Sbjct: 494 RPPIPADTLPSLRHLIQTCWDHNPQNRPSFSEILFRLNEIL 534
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 181 | ||||||
| 384979221 | 845 | CTR1 [Fragaria x ananassa] | 1.0 | 0.214 | 0.911 | 5e-95 | |
| 13936371 | 847 | CTR1-like protein kinase [Rosa hybrid cu | 1.0 | 0.213 | 0.917 | 7e-95 | |
| 255575367 | 871 | map3k delta-1 protein kinase, putative [ | 0.994 | 0.206 | 0.888 | 1e-92 | |
| 114229339 | 809 | ethylene control element [Malus x domest | 0.994 | 0.222 | 0.9 | 2e-92 | |
| 223413882 | 245 | CTR1-like protein kinase CTR1 [Eriobotry | 0.994 | 0.734 | 0.9 | 3e-92 | |
| 114229341 | 843 | ethylene control element variant [Malus | 0.994 | 0.213 | 0.9 | 4e-92 | |
| 114229343 | 843 | ethylene control element variant [Malus | 0.994 | 0.213 | 0.9 | 4e-92 | |
| 359481975 | 850 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.212 | 0.900 | 7e-92 | |
| 297740063 | 745 | unnamed protein product [Vitis vinifera] | 1.0 | 0.242 | 0.900 | 1e-91 | |
| 237857405 | 843 | serine/threonine protein kinase [Prunus | 0.994 | 0.213 | 0.9 | 4e-91 |
| >gi|384979221|gb|AFI38955.1| CTR1 [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 352 bits (902), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 165/181 (91%), Positives = 176/181 (97%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+LDERRRLNMA+DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT
Sbjct: 665 VLDERRRLNMAHDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 724
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
FLSSKSAAGTPEWMAPEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVG
Sbjct: 725 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 784
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLL 180
FK KRLEIPR++NP VASIIEACWANEPWKRPSF++IME L+PLIK+PTPQPS D+P+L
Sbjct: 785 FKNKRLEIPRDLNPQVASIIEACWANEPWKRPSFASIMESLKPLIKAPTPQPSHADLPIL 844
Query: 181 T 181
T
Sbjct: 845 T 845
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|13936371|gb|AAK40361.1| CTR1-like protein kinase [Rosa hybrid cultivar] | Back alignment and taxonomy information |
|---|
Score = 351 bits (901), Expect = 7e-95, Method: Compositional matrix adjust.
Identities = 166/181 (91%), Positives = 175/181 (96%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+LDERRRL MA+DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT
Sbjct: 667 ILDERRRLYMAHDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 726
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
FLSSKSAAGTPEWMAPEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVG
Sbjct: 727 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 786
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLL 180
FK KRLEIPR++NP VASIIEACWANEPWKRPSF++IME LRPLIK+PTPQPS DMP+L
Sbjct: 787 FKNKRLEIPRDLNPQVASIIEACWANEPWKRPSFASIMESLRPLIKAPTPQPSHADMPIL 846
Query: 181 T 181
T
Sbjct: 847 T 847
|
Source: Rosa hybrid cultivar Species: Rosa hybrid cultivar Genus: Rosa Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575367|ref|XP_002528586.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223531982|gb|EEF33794.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 343 bits (881), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 160/180 (88%), Positives = 172/180 (95%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDERRRL+MAYDVAKGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF
Sbjct: 692 LDERRRLSMAYDVAKGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 751
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKSAAGTPEWMAPEVLRDEPSNEKSD+YSFGVI+WELATLQQPWGNLNPAQVVAAVGF
Sbjct: 752 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIMWELATLQQPWGNLNPAQVVAAVGF 811
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 181
KG+RLEIPR++NP VA+IIEACWANEPWKRPSF+TIM+ LR LIK+P PQ D+PLLT
Sbjct: 812 KGRRLEIPRDLNPQVATIIEACWANEPWKRPSFATIMDSLRLLIKAPIPQTGHADVPLLT 871
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229339|gb|ABI58288.1| ethylene control element [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 343 bits (879), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 162/180 (90%), Positives = 172/180 (95%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDERRRL+MAYDVAKGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF
Sbjct: 630 LDERRRLSMAYDVAKGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 689
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT+QQPWGNLNPAQVVAAVGF
Sbjct: 690 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGF 749
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 181
K KRLEIPR++NP+VA+IIEACWANEPWKRPSF++IM+ L PLIK+P QPS DMPLLT
Sbjct: 750 KNKRLEIPRDLNPNVAAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRADMPLLT 809
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|223413882|gb|ACM89300.1| CTR1-like protein kinase CTR1 [Eriobotrya japonica] | Back alignment and taxonomy information |
|---|
Score = 342 bits (878), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 162/180 (90%), Positives = 173/180 (96%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDERRRL+MAYDVAKGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF
Sbjct: 66 LDERRRLSMAYDVAKGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 125
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKSAAGTPEWMAPEVLRDEPSNEKSD+YSFGVILWELAT+QQPWGNLNPAQVVAAVGF
Sbjct: 126 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATMQQPWGNLNPAQVVAAVGF 185
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 181
K KRLEIPR++NP+VA+IIEACWANEPWKRPSF++IM+ L PLIK+P QPSP DMPLLT
Sbjct: 186 KNKRLEIPRDLNPNVAAIIEACWANEPWKRPSFASIMDSLTPLIKAPLTQPSPADMPLLT 245
|
Source: Eriobotrya japonica Species: Eriobotrya japonica Genus: Eriobotrya Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229341|gb|ABI58289.1| ethylene control element variant [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 342 bits (876), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 162/180 (90%), Positives = 172/180 (95%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDERRRL+MAYDVAKGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF
Sbjct: 664 LDERRRLSMAYDVAKGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 723
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT+QQPWGNLNPAQVVAAVGF
Sbjct: 724 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGF 783
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 181
K KRLEIPR++NP+VA+IIEACWANEPWKRPSF++IM+ L PLIK+P QPS DMPLLT
Sbjct: 784 KNKRLEIPRDLNPNVAAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRADMPLLT 843
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229343|gb|ABI58290.1| ethylene control element variant [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 342 bits (876), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 162/180 (90%), Positives = 172/180 (95%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDERRRL+MAYDVAKGMNYLHRR PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF
Sbjct: 664 LDERRRLSMAYDVAKGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 723
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT+QQPWGNLNPAQVVAAVGF
Sbjct: 724 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGF 783
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 181
K KRLEIPR++NP+VA+IIEACWANEPWKRPSF++IM+ L PLIK+P QPS DMPLLT
Sbjct: 784 KNKRLEIPRDLNPNVAAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRADMPLLT 843
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481975|ref|XP_002277360.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 341 bits (875), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 163/181 (90%), Positives = 169/181 (93%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
MLDERRRL+MAYDVAKGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR KANT
Sbjct: 670 MLDERRRLSMAYDVAKGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRFKANT 729
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
FLSSKSAAGTPEWMAPEVLRDE SNEKSDIYSFG+ILWELATLQQPW NLNPAQVVAAVG
Sbjct: 730 FLSSKSAAGTPEWMAPEVLRDEASNEKSDIYSFGIILWELATLQQPWSNLNPAQVVAAVG 789
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLL 180
FKGKRLEIPR++NP VASIIEACWANEPWKRPSF IME L+PLIK PTPQP D PLL
Sbjct: 790 FKGKRLEIPRDLNPQVASIIEACWANEPWKRPSFFNIMESLKPLIKPPTPQPVRADRPLL 849
Query: 181 T 181
T
Sbjct: 850 T 850
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740063|emb|CBI30245.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 340 bits (872), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 163/181 (90%), Positives = 169/181 (93%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
MLDERRRL+MAYDVAKGMNYLH+RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR KANT
Sbjct: 565 MLDERRRLSMAYDVAKGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRFKANT 624
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
FLSSKSAAGTPEWMAPEVLRDE SNEKSDIYSFG+ILWELATLQQPW NLNPAQVVAAVG
Sbjct: 625 FLSSKSAAGTPEWMAPEVLRDEASNEKSDIYSFGIILWELATLQQPWSNLNPAQVVAAVG 684
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLL 180
FKGKRLEIPR++NP VASIIEACWANEPWKRPSF IME L+PLIK PTPQP D PLL
Sbjct: 685 FKGKRLEIPRDLNPQVASIIEACWANEPWKRPSFFNIMESLKPLIKPPTPQPVRADRPLL 744
Query: 181 T 181
T
Sbjct: 745 T 745
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|237857405|gb|ACR23642.1| serine/threonine protein kinase [Prunus persica] | Back alignment and taxonomy information |
|---|
Score = 338 bits (868), Expect = 4e-91, Method: Compositional matrix adjust.
Identities = 162/180 (90%), Positives = 170/180 (94%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDE+RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF
Sbjct: 664 LDEKRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 723
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKSAAGTPEWMAPEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGF
Sbjct: 724 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 783
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 181
K KRLEIPR++NP VASIIEACWANEPWKRPSF++IME L PLIK P QPS +PLL+
Sbjct: 784 KNKRLEIPRDLNPQVASIIEACWANEPWKRPSFASIMESLMPLIKPPATQPSRPGVPLLS 843
|
Source: Prunus persica Species: Prunus persica Genus: Prunus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 181 | ||||||
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.972 | 0.214 | 0.892 | 2.1e-84 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.994 | 0.181 | 0.644 | 8.4e-59 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.900 | 0.185 | 0.687 | 1.7e-58 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.994 | 0.174 | 0.635 | 2.8e-58 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.939 | 0.182 | 0.674 | 3.2e-58 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.922 | 0.226 | 0.640 | 3.3e-56 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.900 | 0.210 | 0.619 | 1.9e-53 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.933 | 0.220 | 0.588 | 1.3e-52 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.867 | 0.188 | 0.624 | 1.3e-50 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.790 | 0.213 | 0.671 | 1.3e-50 |
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 845 (302.5 bits), Expect = 2.1e-84, P = 2.1e-84
Identities = 157/176 (89%), Positives = 167/176 (94%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDERRRL+MAYDVAKGMNYLH RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA+TF
Sbjct: 646 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTF 705
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKSAAGTPEWMAPEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGF
Sbjct: 706 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 765
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
K KRLEIPRN+NP VA+IIE CW NEPWKRPSF+TIM+LLRPLIKS P P+ +D+
Sbjct: 766 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 821
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 610 (219.8 bits), Expect = 8.4e-59, P = 8.4e-59
Identities = 116/180 (64%), Positives = 137/180 (76%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDER+RL MA D A+GMNYLH NP IVHRDLKSPNLLVDK + VKVCDFGLSR+K +T+
Sbjct: 808 LDERKRLRMALDAARGMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTY 867
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKS AGT EWMAPEVLR+EP++EK D+YS+GVILWEL TLQQPWG +NP QVV AVGF
Sbjct: 868 LSSKSTAGTAEWMAPEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGF 927
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 181
+ +RL+IP V+P +A II CW +P RPSF IM+ L+ L K P+ L T
Sbjct: 928 QHRRLDIPEFVDPGIADIIRKCWQTDPRLRPSFGEIMDSLKQLQKPIQRAAVPSSSALTT 987
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 603 (217.3 bits), Expect = 1.7e-58, P = 1.7e-58
Identities = 112/163 (68%), Positives = 133/163 (81%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDE+RR+ MA DVAKGMNYLH +P +VHRDLKSPNLLVDK + VKVCDFGLSR+K +T+
Sbjct: 702 LDEKRRMRMALDVAKGMNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTY 761
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKS AGTPEWMAPEVLR+EP+NEK D+YSFGVILWELAT + PW LNP QVV AVGF
Sbjct: 762 LSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGF 821
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164
+ +RLEIP +++ VA II CW EP RPSF+ +M+ L+ L
Sbjct: 822 QNRRLEIPDDIDLTVAQIIRECWQTEPHLRPSFTQLMQSLKRL 864
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 2.8e-58, P = 2.8e-58
Identities = 117/184 (63%), Positives = 140/184 (76%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDERRRL MA D A+GMNYLH NP IVHRDLKSPNLLVDK + VKVCDFGLSR+K +T+
Sbjct: 841 LDERRRLRMALDAARGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTY 900
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKS AGT EWMAPEVLR+EP++EK D+YS+GVILWEL TLQQPWG +NP QVV AVGF
Sbjct: 901 LSSKSTAGTAEWMAPEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGF 960
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM----ELLRPLIKSPTPQPSPTDM 177
+ +RL+IP V+P +A +I CW + RPSF+ IM L +P+ S P+P P+
Sbjct: 961 QHRRLDIPDFVDPAIADLISKCWQTDSKLRPSFAEIMASLKRLQKPVTGSNIPRPVPSSS 1020
Query: 178 PLLT 181
L T
Sbjct: 1021 SLPT 1024
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 603 (217.3 bits), Expect = 3.2e-58, P = 3.2e-58
Identities = 116/172 (67%), Positives = 135/172 (78%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+DERRR+ MA DVA GMN LH P IVHRDLK+PNLLVD + VKV DFGLSRLK NTF
Sbjct: 762 IDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTF 821
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKS AGTPEWMAPEVLR+EPSNEK D+YSFGVILWELATL+ PW +NP QVV AVGF
Sbjct: 822 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGF 881
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL--IKSPTPQ 171
+ +RLEIP+ ++P V II CW +P RPSF+ + E+L+PL + PTPQ
Sbjct: 882 QNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVLPTPQ 933
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 3.3e-56, P = 3.3e-56
Identities = 107/167 (64%), Positives = 127/167 (76%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD++RRL MA DVA+GMNYLHRRNPPIVHRDLKS NLLVDK + VKV DFGLS+ K TF
Sbjct: 561 LDKKRRLRMALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATF 620
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LS+KS GTP+WMAPEVLR EPSNEK D++SFGVILWEL T PW LN QVV VGF
Sbjct: 621 LSTKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGF 680
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
+RL++P +NP +ASII+ CW +P KRPSF ++ + L + P
Sbjct: 681 MDRRLDLPEGLNPRIASIIQDCWQTDPAKRPSFEELISQMMSLFRKP 727
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 1.9e-53, P = 1.9e-53
Identities = 101/163 (61%), Positives = 131/163 (80%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD RRR++MA D+A+GMNYLH +PPI+HRDLKS NLLVDK +TVKV DFGLSR+K T+
Sbjct: 587 LDWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETY 646
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
L+SKS GTP+WMAPEVLR+E ++EKSDIYSFGV+LWELAT + PW LN QV+ AVGF
Sbjct: 647 LTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGF 706
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164
+RLEIP++++P S++E+CW ++ RP+F +M+ LR L
Sbjct: 707 MDQRLEIPKDIDPRWISLMESCWHSDTKLRPTFQELMDKLRDL 749
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 1.3e-52, P = 1.3e-52
Identities = 100/170 (58%), Positives = 134/170 (78%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD RRR++MA D+A+GMNYLH +PPI+HRDLKS NLLVD+ +TVKV DFGLSR+K T+
Sbjct: 580 LDLRRRIHMASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETY 639
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
L++ + GTP+WMAPEVLR+E ++EKSD+YSFGV+LWEL T + PW NLN QV+ AVGF
Sbjct: 640 LTT-NGRGTPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGF 698
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+RLE+P++V+P +++E+CW +EP RPSF +M+ LR L + T Q
Sbjct: 699 MNQRLEVPKDVDPQWIALMESCWHSEPQCRPSFQELMDKLRELQRKYTIQ 748
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 1.3e-50, P = 1.3e-50
Identities = 98/157 (62%), Positives = 123/157 (78%)
Query: 15 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 74
A+GMNYLH PPI+HRDLKS NLLVDK +TVKV DFGLSR+K T+L++K+ GTP+WM
Sbjct: 658 ARGMNYLHHCTPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTTKTGRGTPQWM 717
Query: 75 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 134
APEVLR+E ++EKSD+YSFGVILWEL T + PW +LN QV+ AVGF +RLE+P+NV+P
Sbjct: 718 APEVLRNEAADEKSDVYSFGVILWELVTEKIPWESLNAMQVIGAVGFMNQRLEVPKNVDP 777
Query: 135 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
S++E+CW +EP RPSF IME LR L + T Q
Sbjct: 778 QWISLMESCWHSEPQDRPSFQEIMEKLRELQRKYTIQ 814
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 526 (190.2 bits), Expect = 1.3e-50, P = 1.3e-50
Identities = 96/143 (67%), Positives = 119/143 (83%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD RRR+NMA D+A+GMNYLH +PPI+HRDLKS NLLVD+ +TVKV DFGLSR+K T+
Sbjct: 527 LDWRRRINMALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTY 586
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
L+SKS GTP+WMAPEVLR+E ++EKSDIYSFGV+LWELAT + PW NLN QV+ AVGF
Sbjct: 587 LTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGF 646
Query: 122 KGKRLEIPRNVNPHVASIIEACW 144
+RLEIP++ +P S+IE+CW
Sbjct: 647 MNQRLEIPKDTDPDWISLIESCW 669
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q05609 | CTR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8920 | 0.9723 | 0.2143 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00021674001 | SubName- Full=Chromosome chr8 scaffold_23, whole genome shotgun sequence; (777 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 181 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-56 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-55 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-37 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-37 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-33 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-32 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-31 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-31 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-30 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-30 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-30 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-29 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-29 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-29 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-28 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-28 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-28 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-28 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-28 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-27 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-27 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-27 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-27 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-27 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-27 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-25 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-25 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-25 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-24 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-24 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-24 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-24 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-23 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-23 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-23 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-23 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-23 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-21 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-20 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-19 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-17 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-56
Identities = 63/164 (38%), Positives = 94/164 (57%), Gaps = 9/164 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L L+ A +A+GM YL +N +HRDL + N LV + VK+ DFGLSR +
Sbjct: 100 LSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD- 156
Query: 62 LSSKSAAGTPE---WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVA 117
G WMAPE L++ KSD++SFGV+LWE+ TL ++P+ ++ A+V+
Sbjct: 157 -DYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE 215
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ KG RL P N P + ++ CWA +P RP+FS ++E+L
Sbjct: 216 YLK-KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-56
Identities = 62/164 (37%), Positives = 92/164 (56%), Gaps = 9/164 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L L+ A +A+GM YL +N +HRDL + N LV + VK+ DFGLSR +
Sbjct: 99 LSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD- 155
Query: 62 LSSKSAAGTPE---WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVA 117
G WMAPE L++ KSD++SFGV+LWE+ TL +QP+ ++ +V+
Sbjct: 156 -DYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE 214
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ G RL P N P + ++ CWA +P RP+FS ++E+L
Sbjct: 215 YLK-NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 5e-55
Identities = 62/165 (37%), Positives = 89/165 (53%), Gaps = 8/165 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L + L+ A +AKGM YL + VHRDL + N LV + VK+ DFGLSR +
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD- 158
Query: 62 LSSKSAAGTPE---WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVA 117
+ G WMAPE L+D KSD++SFGV+LWE+ TL P+ L+ +V+
Sbjct: 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE 218
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+ KG RL P + ++ +CW +P RP+FS ++E L
Sbjct: 219 YLR-KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-53
Identities = 65/163 (39%), Positives = 93/163 (57%), Gaps = 6/163 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT- 60
L + L MA +AKGM YL +N VHRDL + N LV + VK+ DFGLSR
Sbjct: 99 LTLKDLLQMALQIAKGMEYLESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ + P +WMAPE L+D KSD++SFGV+LWE+ TL +QP+ ++ +V+
Sbjct: 157 YYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL 216
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ G RL P N + ++ CWA +P RP+FS ++E L
Sbjct: 217 L-EDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-45
Identities = 51/160 (31%), Positives = 77/160 (48%), Gaps = 5/160 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E + + YLH + IVHRDLK N+L+D+ VK+ DFGL+R
Sbjct: 94 LSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE 151
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ GTPE+MAPEVL + + DI+S GVIL+EL T + P+ + +
Sbjct: 152 KL-TTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210
Query: 122 KGKRLEIPR--NVNPHVASIIEACWANEPWKRPSFSTIME 159
K K P +++P +I +P KR + ++
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-42
Identities = 57/155 (36%), Positives = 82/155 (52%), Gaps = 8/155 (5%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAA 68
+ +G+ YLH IVHRD+K N+LVD VK+ DFG ++ + + S
Sbjct: 107 TRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
Query: 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLE 127
GTP WMAPEV+R E +DI+S G + E+AT + PW L NP + +G G+ E
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE 224
Query: 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
IP +++ + C +P KRP T ELL+
Sbjct: 225 IPEHLSEEAKDFLRKCLRRDPKKRP---TADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 4e-42
Identities = 56/162 (34%), Positives = 76/162 (46%), Gaps = 37/162 (22%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANT 60
L E L + + +G+ YLH I+HRDLK N+L+D VK+ DFGLS+L +
Sbjct: 89 LSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
K+ GTP +MAPEVL + +EKSDI+S GVIL+EL L+
Sbjct: 147 KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKD-------------- 192
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+I +P KRPS I+E L
Sbjct: 193 -------------------LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-40
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 12/166 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E +A + +G+ YLH I+HRDLK N+L+D+ VK+ DFGL++ +
Sbjct: 95 LSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS 152
Query: 62 LSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPA---QVVA 117
S + GTP +MAPEVL K D++S GVIL+EL T + P+ N Q++
Sbjct: 153 SSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 118 AVGFKGKRLEIPR----NVNPHVASIIEACWANEPWKRPSFSTIME 159
+ G LE + + +I+ C +P KRP+ I++
Sbjct: 213 RI--LGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-37
Identities = 49/149 (32%), Positives = 89/149 (59%), Gaps = 5/149 (3%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 76
+ YLH R I+HRD+K N+ + VK+ DFG+S++ ++T +K+ GTP +++P
Sbjct: 115 ALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 136
E+ +++P N KSDI+S G +L+EL TL+ P+ N ++ + KG+ IP + +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-LKGQYPPIPSQYSSEL 231
Query: 137 ASIIEACWANEPWKRPSFSTIMELLRPLI 165
+++ + +P +RPS + I++ P I
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQS--PFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-37
Identities = 62/161 (38%), Positives = 91/161 (56%), Gaps = 6/161 (3%)
Query: 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK 65
+ + MA ++A GM YL + VHRDL + N +V + TVK+ DFG++R T K
Sbjct: 120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 66 SAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 122
G P WMAPE L+D KSD++SFGV+LWE+ATL +QP+ L+ +V+ V
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 163
G L++P N + ++ CW P RP+F I+ L+
Sbjct: 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-33
Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 5/156 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L+M DV + M YL +HRDL + N LV + VKV DFGL+R + +S
Sbjct: 103 LDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
P +W PEV + KSD++SFGV++WE+ + + P+ + ++VV +V G R
Sbjct: 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYR 219
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
L P+ V +I+ +CW +P RP+F ++ L
Sbjct: 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-32
Identities = 63/162 (38%), Positives = 93/162 (57%), Gaps = 11/162 (6%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSR-LKANTF 61
L++ DVAKG YL + + +HRDL + N LV +K VK+ DFGL+R + + +
Sbjct: 109 LDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 62 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 119
+ P WMAPE L D +SD++SFGV++WE+ TL QQP+ LN +V+ V
Sbjct: 167 YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
G RL+ P N + ++ CWA +P +RP+F I E+L
Sbjct: 227 T-AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-32
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 5/156 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++MA +A+GM YL RN +HRDL + N+LV + K+ DFGL+RL + +++
Sbjct: 106 VDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 125
A P +W APE KSD++SFG++L E+ T + P+ + +V+ V +G R
Sbjct: 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYR 222
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ P N + ++ CW +P +RP+F + L
Sbjct: 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-32
Identities = 60/158 (37%), Positives = 90/158 (56%), Gaps = 7/158 (4%)
Query: 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS 64
++L A DV +GM YL +N VHRDL + N+LV + KV DFGL++ + S
Sbjct: 102 AQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159
Query: 65 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
K +W APE LR++ + KSD++SFG++LWE+ + + P+ + VV V KG
Sbjct: 160 KLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KG 215
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
R+E P P V +++ CW +P KRP+F + E L
Sbjct: 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-32
Identities = 59/167 (35%), Positives = 98/167 (58%), Gaps = 12/167 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++ ++MA +A GM+YLH+R ++H+D+ + N ++D++ VK+ D LSR + F
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLF 168
Query: 62 LSSKSAAGTPE-----WMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQV 115
G E WMA E L ++ + SD++SFGV+LWEL TL Q P+ ++P ++
Sbjct: 169 PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228
Query: 116 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
A + G RL P N + +++ CWA +P +RPSFS +++ L
Sbjct: 229 AAYLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-32
Identities = 54/158 (34%), Positives = 86/158 (54%), Gaps = 6/158 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT--FLSS 64
+ A +A GM YL + +HRDL + N+L+ VK+ DFGL R L N ++
Sbjct: 100 CDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157
Query: 65 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
+ W APE LR + SD++ FGV LWE+ T ++PW L+ +Q++ + +G
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG 217
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+RLE P + +++ CWA+ P RP+F+ + E L
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-31
Identities = 56/159 (35%), Positives = 90/159 (56%), Gaps = 7/159 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKA-NTFLSSK 65
+A+ VA GM YL ++ VHRDL + N+L+ ++ K+ DFG+SR L A + + +
Sbjct: 98 KELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155
Query: 66 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
+A P +W APE + + KSD++S+GV LWE + +P+G + A+V+A + G
Sbjct: 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SG 214
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+RL P + SI+ +CW P RP+FS + R
Sbjct: 215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-31
Identities = 57/155 (36%), Positives = 82/155 (52%), Gaps = 4/155 (2%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++MA VA+GM YL +N +HRDL + N+LV + KV DFGL+RL S
Sbjct: 107 IDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK 164
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRL 126
+W APE + KSD++SFG++L+E+ T Q P+ +N +V + G R+
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRM 223
Query: 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
P + I+ CWA EP RPSF + E L
Sbjct: 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-31
Identities = 56/153 (36%), Positives = 87/153 (56%), Gaps = 5/153 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
L M DV +GM YL + +HRDL + N LVD + VKV DFGLSR + + + SS
Sbjct: 103 LEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160
Query: 67 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
+ W PEVL + KSD+++FGV++WE+ +L + P+ N ++ V V +G R
Sbjct: 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLR 219
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158
L P + V +I+ +CW + +RP+F ++
Sbjct: 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-30
Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR----- 55
L L+ +Y VAKGM +L +N +HRDL + N+L+ VK+CDFGL+R
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194
Query: 56 ----LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 111
+K N L K WMAPE + + +SD++S+G++LWE+ +L N
Sbjct: 195 SNYVVKGNARLPVK-------WMAPESIFNCVYTFESDVWSYGILLWEIFSLG---SNPY 244
Query: 112 PAQVVAAVGFK----GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
P V + +K G R+ P + + I++ CW +P KRP+F I++L+ +
Sbjct: 245 PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-30
Identities = 46/143 (32%), Positives = 79/143 (55%), Gaps = 3/143 (2%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y KG+ YLH +HRD+K+ N+L++++ K+ DFG+S +T + GTP
Sbjct: 106 YQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTP 163
Query: 72 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPR 130
WMAPEV+++ N K+DI+S G+ E+A + P+ +++P + + + K L P
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE 223
Query: 131 NVNPHVASIIEACWANEPWKRPS 153
+P ++ C +P +RPS
Sbjct: 224 KWSPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-30
Identities = 54/148 (36%), Positives = 77/148 (52%), Gaps = 7/148 (4%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 75
G+ YLH RN VHRD+K N+LVD VK+ DFG+++ + F +KS G+P WMA
Sbjct: 113 LGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMA 169
Query: 76 PEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 134
PEV+ + +DI+S G + E+AT + PW L V +G + IP +++
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229
Query: 135 HVASIIEACWANEPWKRPSFSTIMELLR 162
I C +P RP T ELL
Sbjct: 230 EAKDFILKCLQRDPSLRP---TAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-30
Identities = 61/161 (37%), Positives = 89/161 (55%), Gaps = 6/161 (3%)
Query: 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS 64
+ + MA ++A GM YL+ + VHRDL + N +V +TVK+ DFG++R T
Sbjct: 119 QEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176
Query: 65 KSAAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGF 121
K G WMAPE L+D SD++SFGV+LWE+ +L +QP+ L+ QV+ V
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-M 235
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
G L+ P N V ++ CW P RP+F I+ LL+
Sbjct: 236 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-30
Identities = 56/160 (35%), Positives = 91/160 (56%), Gaps = 5/160 (3%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 68
++ VA+GM +L R +HRDL + N+L+ + VK+CDFGL+R K ++ A
Sbjct: 179 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 127
+WMAPE + D+ +SD++SFGV+LWE+ +L P+ + + +G R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR 296
Query: 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
P P + SI+ CW N P RP+FS ++E+L L++
Sbjct: 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-30
Identities = 61/160 (38%), Positives = 90/160 (56%), Gaps = 5/160 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKS 66
L MA ++ M YL ++N +HRDL + N LV + + VKV DFGLSRL +T+ +
Sbjct: 107 LYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164
Query: 67 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A +W APE L + KSD+++FGV+LWE+AT P+ ++ +QV + KG R
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYR 223
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
+E P P V ++ ACW P RPSF+ I + +
Sbjct: 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-30
Identities = 54/155 (34%), Positives = 82/155 (52%), Gaps = 11/155 (7%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 70
++ KG+ YLH I+HRD+K+ N+L+ VK+ DFGLS ++T + + GT
Sbjct: 104 CKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGT 160
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV---VAAVGFKGKRLE 127
P WMAPEV+ +P + K+DI+S G+ ELA + P+ L P + +A G G L
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG--LR 218
Query: 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
P + ++ C P KRP T +LL+
Sbjct: 219 NPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-30
Identities = 54/169 (31%), Positives = 90/169 (53%), Gaps = 8/169 (4%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPP---IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 57
++E + + + H R+ P ++HRDLK N+ +D VK+ DFGL+++
Sbjct: 101 YIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160
Query: 58 ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA 117
+ +K+ GTP +M+PE L +EKSDI+S G +++EL L P+ N Q+ +
Sbjct: 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS 220
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLI 165
+ +GK IP + + +I++ +P KRPS ELL+ PLI
Sbjct: 221 KIK-EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-29
Identities = 59/155 (38%), Positives = 90/155 (58%), Gaps = 7/155 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L + DVA+GM YL + +VHRDL + N+LV + KV DFGL+R+ + +SK
Sbjct: 103 LQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRL 126
+W APE L+ + + KSD++S+GV+LWE+ + + P+ ++ +V V KG R+
Sbjct: 161 V---KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRM 216
Query: 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
E P V ++ +CW EP KRPSF + E L
Sbjct: 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-29
Identities = 55/156 (35%), Positives = 88/156 (56%), Gaps = 5/156 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L+M DV +GM YL R + +HRDL + N LV VKV DFG++R + +S S
Sbjct: 103 LSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A P +W PEV + KSD++SFGV++WE+ T + P+ + +VV + +G R
Sbjct: 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFR 219
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
L P+ + V ++ +CW +P RP+F+ ++ +
Sbjct: 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-29
Identities = 57/157 (36%), Positives = 89/157 (56%), Gaps = 6/157 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKS 66
+ M + A GM YL ++ +HRDL + N LV +K +K+ DFG+SR + + + S+
Sbjct: 97 IQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
P +W APE L + +SD++SFG++LWE +L P+ NL+ Q A+ +G
Sbjct: 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGV 213
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
RL P V ++E CW +P +RPSFST+ + L
Sbjct: 214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-29
Identities = 51/162 (31%), Positives = 86/162 (53%), Gaps = 4/162 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++++ + +A GM++L N VHRDL + N LV + VKV LS+ N+
Sbjct: 114 LSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171
Query: 62 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 119
A P W+APE ++++ + KSD++SFGV++WE+ T + P+ L+ +V+ +
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
L +P + ++ CWA P RPSFS ++ L
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-28
Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 6/163 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++ L M+ D A GM YL +N +HRDL + N LV + +K+ DFG+SR +
Sbjct: 90 LTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147
Query: 62 LSSKSAAG-TP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ P +W APE L +SD++S+G++LWE +L P+ ++ Q
Sbjct: 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER 207
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ G R+ P+ + ++ CWA +P RPSFS I L
Sbjct: 208 IE-SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-28
Identities = 53/155 (34%), Positives = 88/155 (56%), Gaps = 6/155 (3%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAA 68
AY VA+GM +L + +HRDL + N+LV + + +K+ DFGL+R + + +
Sbjct: 137 FAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 69 GTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGFKGKRL 126
P +WMAPE L D +SD++SFGV+LWE+ TL P+ + ++ + +G R+
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-EGYRM 253
Query: 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
E P+N + ++ CW P +RP+F ++E L
Sbjct: 254 EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-28
Identities = 59/177 (33%), Positives = 94/177 (53%), Gaps = 18/177 (10%)
Query: 10 MAY---DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG----LSRLKANTFL 62
+AY +V +G+ YLH +N ++HRD+KS N+L+ K +VK+ DFG L++ K+
Sbjct: 118 IAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--- 172
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
S GTP WMAPEV++ + K DI+S G++ E+A + P+ P + + + K
Sbjct: 173 -RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231
Query: 123 G-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 177
G L+ P +P + C +P KRPS ELL+ P +K P+ +
Sbjct: 232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAE---ELLQHPFLKKACPKEEFAPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-28
Identities = 63/165 (38%), Positives = 89/165 (53%), Gaps = 14/165 (8%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
L MA +A GM YL N VHRDL + N LV K YT+K+ DFG+SR L ++ + +
Sbjct: 133 LYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190
Query: 67 AAGTP-EWMAPE-VLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVV--AAVG 120
A P WMA E VL + + KSD+++FGV LWE+ TL +QP+ +L QV+ A
Sbjct: 191 RAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHF 249
Query: 121 FKGKRLEI----PRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
F+ +I P N + ++ CW + RP+F I L
Sbjct: 250 FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-28
Identities = 57/164 (34%), Positives = 96/164 (58%), Gaps = 7/164 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSK 65
++ A+ +++GM YL +VHRDL + N+LV + +K+ DFGLSR + ++++
Sbjct: 130 ISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 66 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
+WMA E L D +SD++SFGV+LWE+ TL P+ + P ++ + G
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK-TGY 246
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM-ELLRPLIKS 167
R+E P N + + +++ CW EP KRP+F+ I EL + ++KS
Sbjct: 247 RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-28
Identities = 53/161 (32%), Positives = 86/161 (53%), Gaps = 6/161 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
+ M +A GM YL N VHRDL + N+LV+ KV DFGLSR ++ + +
Sbjct: 109 VGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
Query: 68 AG-TP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
G P W APE + SD++SFG+++WE+ + ++P+ +++ V+ AV G
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGY 225
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
RL P + + ++ CW + +RP+FS I+ L +I
Sbjct: 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-28
Identities = 57/159 (35%), Positives = 93/159 (58%), Gaps = 5/159 (3%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 68
++ VA+GM +L R +HRDL + N+L+ + VK+CDFGL+R K ++ SA
Sbjct: 180 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 127
+WMAPE + D+ +SD++SFGV+LWE+ +L P+ + + G R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
P N P + I+ ACW +P +RP+FS ++E+L L++
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-28
Identities = 57/156 (36%), Positives = 88/156 (56%), Gaps = 5/156 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L M DV +GM YL N ++HRDL + N LV + VKV DFG++R + +S +
Sbjct: 103 LGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWEL-ATLQQPWGNLNPAQVVAAVGFKGKR 125
P +W +PEV + KSD++SFGV++WE+ + + P+ N + ++VV + G R
Sbjct: 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFR 219
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
L PR + V +++ CW P RPSFS ++ L
Sbjct: 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-28
Identities = 58/159 (36%), Positives = 91/159 (57%), Gaps = 7/159 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++ L+ A DVA+GM+YL ++ +HRDL + N+LV + Y K+ DFGLSR
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEV 176
Query: 62 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAV 119
K+ P WMA E L SD++S+GV+LWE+ +L P+ + A++ +
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158
+G RLE P N + V ++ CW +P++RPSF+ I+
Sbjct: 237 P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-28
Identities = 47/143 (32%), Positives = 78/143 (54%), Gaps = 5/143 (3%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGT 70
Y V +G+ YLH + ++HRD+K+ N+L K VK+ DFG++ +L + S GT
Sbjct: 106 YQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGT 162
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
P WMAPEV+ ++ SDI+S G + EL T P+ +LNP + + + +P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPE 221
Query: 131 NVNPHVASIIEACWANEPWKRPS 153
++P + + C+ +P RP+
Sbjct: 222 GISPELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-27
Identities = 53/161 (32%), Positives = 88/161 (54%), Gaps = 6/161 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
L D+A GM YL RN +HRDL + N ++ + TV V DFGLS+ + + +
Sbjct: 116 LKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
A P +W+A E L D KSD+++FGV +WE+AT Q P+ + ++ + G
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGN 232
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
RL+ P + + ++ +CW +P RP+F+ + E+L ++
Sbjct: 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-27
Identities = 58/158 (36%), Positives = 86/158 (54%), Gaps = 7/158 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++ L A DVA GM YL + +HRDL + N+LV + K+ DFGLSR
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSR--GEEV 171
Query: 62 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAV 119
K+ P WMA E L KSD++SFGV+LWE+ +L P+ + A++ +
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157
+G R+E PRN + V ++ CW + P++RP F+ I
Sbjct: 232 P-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 58/166 (34%), Positives = 93/166 (56%), Gaps = 11/166 (6%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSK 65
L+ Y VA+GM +L +N VHRDL + N+L+ + VK+CDFGL+R + + ++S
Sbjct: 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 66 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--- 122
S +WMAPE + D SD++S+G++LWE+ +L G P +V + +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG---GTPYPGMIVDSTFYNKIK 354
Query: 123 -GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
G R+ P + V I+ CW +EP KRPSF + +++ L+ S
Sbjct: 355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLPS 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-27
Identities = 55/149 (36%), Positives = 86/149 (57%), Gaps = 8/149 (5%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---LKANTFLSSKSAAGT 70
VAKGM YL + VHRDL + N ++D+ +TVKV DFGL+R K + + + A
Sbjct: 107 VAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 71 P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEI 128
P +WMA E L+ + KSD++SFGV+LWEL T P+ +++ + + +G+RL
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQ 223
Query: 129 PRNVNPHVASIIEACWANEPWKRPSFSTI 157
P + ++ +CW +P RP+FS +
Sbjct: 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-27
Identities = 42/163 (25%), Positives = 90/163 (55%), Gaps = 3/163 (1%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+ +E L + + ++Y+H+ I+HRD+K+ N+ + K +K+ DFG+S++ +
Sbjct: 97 LFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
+ +++ GTP +M+PE+ + N KSDI++ G +L+EL TL++ + NP +V +
Sbjct: 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI- 213
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 163
+G + + + S++ + +P KRP+ +++
Sbjct: 214 VQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-27
Identities = 55/179 (30%), Positives = 93/179 (51%), Gaps = 23/179 (12%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
++ +R L + + KGM+YL + +HRDL + N+LV+ + VK+ DFGL+++ +
Sbjct: 106 INLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
Query: 60 TFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVA 117
+ K +P W APE LR + SD++SFGV L+EL T P + +P A+ +
Sbjct: 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP--SQSPPAEFLR 221
Query: 118 AVGFK---------------GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+G G+RL P + V +++ CW EP RPSF+ ++ ++
Sbjct: 222 MIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-27
Identities = 62/191 (32%), Positives = 91/191 (47%), Gaps = 36/191 (18%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------R 55
LDE + +V G+ YLH +HRD+K+ N+L+ ++ VK+ DFG+S
Sbjct: 95 LDETYIAFILREVLLGLEYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152
Query: 56 LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 115
K NTF GTP WMAPEV++ +EK+DI+S G+ ELA + P +L+P +V
Sbjct: 153 SKRNTF------VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV 206
Query: 116 VAAVGFKGKRLEIPRNVNP----HVAS-----IIEACWANEPWKRPSFSTIMELLR-PLI 165
+ IP+N P + S + C +P +RPS ELL+ I
Sbjct: 207 L---------FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAK---ELLKHKFI 254
Query: 166 KSPTPQPSPTD 176
K T
Sbjct: 255 KKAKKTSYLTL 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-27
Identities = 59/161 (36%), Positives = 91/161 (56%), Gaps = 6/161 (3%)
Query: 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS 64
++ + MA ++A GM YL+ VHRDL + N +V + +TVK+ DFG++R T
Sbjct: 119 KKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 65 KSAAG--TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGF 121
K G WM+PE L+D SD++SFGV+LWE+ATL +QP+ ++ QV+ V
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-M 235
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+G L+ P N + ++ CW P RPSF I+ ++
Sbjct: 236 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-27
Identities = 56/163 (34%), Positives = 88/163 (53%), Gaps = 7/163 (4%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+L L + DV + M YL N VHRDL + N+LV + KV DFGL++ ++T
Sbjct: 98 VLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAV 119
+ K +W APE LR++ + KSD++SFG++LWE+ + + P+ + VV V
Sbjct: 156 QDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 212
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
KG +++ P P V +++ CW + RPSF + E L
Sbjct: 213 E-KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-27
Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 6/171 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ + LN +AKGM+YL + +VHRDL + N+LV VK+ DFGL++L
Sbjct: 106 IGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
Query: 62 LSSKSAAG-TP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ G P +WMA E + KSD++S+GV +WEL T +P+ + ++
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL 223
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169
+ KG+RL P V ++ CW + RP+F ++ + + P
Sbjct: 224 LE-KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-27
Identities = 58/158 (36%), Positives = 90/158 (56%), Gaps = 7/158 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++ L+ A DVA+GM+YL ++ +HRDL + N+LV + Y K+ DFGLSR
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEV 164
Query: 62 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAV 119
K+ P WMA E L SD++S+GV+LWE+ +L P+ + A++ +
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157
+G RLE P N + V ++ CW +P++RPSF+ I
Sbjct: 225 P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-27
Identities = 53/152 (34%), Positives = 83/152 (54%), Gaps = 5/152 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++MA VA GM YL +N +HRDL + N+LV + KV DFGL+R+ ++
Sbjct: 106 IDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A P +W APE + KSD++SFG++L E+ T + P+ + A+V+ V +G R
Sbjct: 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYR 222
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157
+ P + I+ CW +P RP+F T+
Sbjct: 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-27
Identities = 57/167 (34%), Positives = 96/167 (57%), Gaps = 13/167 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
LD L+ +Y VAKGM++L +N +HRDL + N+L+ K+CDFGL+R ++ ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
K A P +WMAPE + + +SD++S+G++LWE+ +L P+ P V +
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----PGMPVDS 324
Query: 119 VGFK----GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+K G R+ P + I+++CW +P KRP+F I++L+
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-26
Identities = 55/160 (34%), Positives = 89/160 (55%), Gaps = 5/160 (3%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAA 68
++ VAKGM +L R +HRDL + N+L+ + VK+CDFGL+R K ++ A
Sbjct: 185 SFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 127
+WMAPE + D +SD++SFGV+LWE+ +L P+ + + +G R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
P P + + CW EP +RP+FS ++E L L+++
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-26
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 9/156 (5%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSK-- 65
N + KG+NYLH R I+HRD+K N+LVD K +K+ DFG+S+ L+AN+ +
Sbjct: 110 NFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167
Query: 66 ---SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
S G+ WMAPEV++ K+DI+S G ++ E+ T + P+ + Q + +G
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN 227
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158
EIP N++ +E + + KRP+ + ++
Sbjct: 228 A-SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-26
Identities = 59/164 (35%), Positives = 96/164 (58%), Gaps = 15/164 (9%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKAN 59
+LDE L+ + ++++H + I+HRDLK+ N+L+DK V K+ DFG+S++
Sbjct: 97 LLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKI--- 151
Query: 60 TFLSSKSAA----GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQ 114
LSSKS A GTP +++PE+ +P N+KSDI++ G +L+ELA+L++ + N PA
Sbjct: 152 --LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL 209
Query: 115 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158
V+ + G I +P + +I + +P KRP S IM
Sbjct: 210 VLKIM--SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-26
Identities = 54/171 (31%), Positives = 86/171 (50%), Gaps = 26/171 (15%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
+ + +N+LH ++HRDLK+ N+L+ VK+ DFG+S +T + GTP
Sbjct: 110 RQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP 167
Query: 72 EWMAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 126
WMAPEV+ +D P + K+DI+S G+ L ELA ++ P LNP +V+ K +
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL----LKILKS 223
Query: 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
E P P W++ SF+ L L+K P +P+ ++
Sbjct: 224 EPPTLDQPSK-------WSS------SFNDF--LKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 4e-26
Identities = 42/144 (29%), Positives = 82/144 (56%), Gaps = 3/144 (2%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 76
G+ +LH + I+HRD+KS NL +D VK+ D G+++L ++ + + GTP +++P
Sbjct: 113 GLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
Query: 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 136
E+ D+P NEKSD+++ GV+L+E T + P+ N ++ + +G + + + +
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQL 229
Query: 137 ASIIEACWANEPWKRPSFSTIMEL 160
A +I+ C + +RP ++
Sbjct: 230 AQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-25
Identities = 40/132 (30%), Positives = 70/132 (53%), Gaps = 4/132 (3%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79
YLH I++RDLK N+L+D +K+ DFGL++ ++ + + GTPE++APEVL
Sbjct: 108 YLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165
Query: 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASI 139
+ + D +S GV+L+E+ T + P+ + ++ + L P ++P +
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDL 223
Query: 140 IEACWANEPWKR 151
I +P KR
Sbjct: 224 ISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-25
Identities = 61/166 (36%), Positives = 90/166 (54%), Gaps = 7/166 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
L++A +A GM YL ++ VHRDL + N LV VK+ DFG+SR + + +
Sbjct: 126 LHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
P WM PE + +SD++SFGVILWE+ T +QPW L+ +V+ + +G+
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-QGR 242
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170
LE PR V I+ CW EP +R + I ++L L K+ TP
Sbjct: 243 VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA-TP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-25
Identities = 56/164 (34%), Positives = 85/164 (51%), Gaps = 6/164 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L + L +A +A GM YL ++ VHRDL + N LV VK+ DFG+SR +
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ P WM PE + +SD++SFGV+LWE+ T +QPW L+ +V+
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+ +G+ L+ PR V I+ CW +P +R + I E L+
Sbjct: 237 IT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 3e-25
Identities = 54/162 (33%), Positives = 87/162 (53%), Gaps = 10/162 (6%)
Query: 10 MAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 68
+A + KG++YLH R+ I+HRD+K NLL++ K VK+ DFG+S++ NT +
Sbjct: 104 IARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV 161
Query: 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKR 125
GT +M+PE ++ E + +DI+S G+ L E A + P+ G + +++ A+
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIK 166
+P I AC +P KRP + ELL+ P IK
Sbjct: 222 SLPAEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-25
Identities = 51/149 (34%), Positives = 77/149 (51%), Gaps = 8/149 (5%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 75
KG+ YLH +HRD+K N+L+ + VK+ DFG+S T KS GTP WMA
Sbjct: 112 KGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMA 169
Query: 76 PEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKGKRLEIP 129
PEV R + K DI++ G+ ELA LQ P +L+P + + + F +L+
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229
Query: 130 RNVNPHVASIIEACWANEPWKRPSFSTIM 158
+P I+ C +P KRP+ + ++
Sbjct: 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 4e-25
Identities = 52/152 (34%), Positives = 85/152 (55%), Gaps = 6/152 (3%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP 71
D+A GM YL +N +HRDL + N ++++ TV V DFGLS+ + + + A+ P
Sbjct: 121 DIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 72 -EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 129
+W+A E L D SD+++FGV +WE+ T Q P+ + +++ + KG RL+ P
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQP 237
Query: 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ V ++ CW+ EP RPSF + + L
Sbjct: 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-25
Identities = 55/158 (34%), Positives = 81/158 (51%), Gaps = 14/158 (8%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA----NTFLSSKSAAG 69
V KG+ YLH +HRD+K+ N+L+ + +VK+ DFG+S A T K+ G
Sbjct: 111 VLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168
Query: 70 TPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLE 127
TP WMAPEV+ + + K+DI+SFG+ ELAT P+ P +V+ LE
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLE 228
Query: 128 IPRNVNPHVAS---IIEACWANEPWKRPSFSTIMELLR 162
+ + S +I C +P KRP+ ELL+
Sbjct: 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAE---ELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 5e-25
Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 6/160 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKS 66
L++A +A GM YL + VHRDL + N LV + TVK+ DFGLSR + + +S
Sbjct: 127 LHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
+ P WM PE + +SDI+SFGV+LWE+ + QP+ + +V+ + +
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR-SRQ 243
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164
L P + V +++ CW P +RP F I LR
Sbjct: 244 LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 7e-25
Identities = 56/153 (36%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
L +A +A GM YL + VHRDL + N LV + VK+ DFG+SR + + +
Sbjct: 125 LAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
P WM PE + +SDI+SFGV+LWE+ T +QPW L+ + + + +G+
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-QGR 241
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157
LE PR P V +I++ CW EP +R I
Sbjct: 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 7e-25
Identities = 49/156 (31%), Positives = 90/156 (57%), Gaps = 5/156 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++MA +A+GM ++ R+N +HRDL++ N+LV + K+ DFGL+RL + +++
Sbjct: 105 IDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 125
A P +W APE + KSD++SFG++L E+ T + P+ + +V+ + +G R
Sbjct: 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYR 221
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ P N + ++ CW +P +RP+F + +L
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 7e-25
Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 5/162 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD + +Y ++ + YL + VHRD+ + N+LV VK+ DFGLSR +
Sbjct: 104 LDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161
Query: 62 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 119
S P +WMAPE + SD++ FGV +WE+ L +P+ + V+ +
Sbjct: 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
G+RL +P N P + S++ CWA +P KRP F+ + L
Sbjct: 222 E-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 7e-25
Identities = 56/172 (32%), Positives = 95/172 (55%), Gaps = 6/172 (3%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG- 69
AY VA+GM YL R +HRDL + N+LV + +K+ DFGL+R + K++ G
Sbjct: 140 AYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGR 197
Query: 70 -TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 127
+WMAPE L D +SD++SFG+++WE+ TL P+ + P + + + +G R++
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREGHRMD 256
Query: 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 179
P N + ++ CW P +RP+F ++E L ++ + + + MP
Sbjct: 257 KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPF 308
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-24
Identities = 51/157 (32%), Positives = 84/157 (53%), Gaps = 13/157 (8%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAAGTP 71
V +G+ YLH + I+HRDLK+ NLLVD K+ DFG+S+ + + + + S G+
Sbjct: 117 VLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 72 EWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 129
WMAPEV+ + K DI+S G ++ E+ ++PW + + +G K IP
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234
Query: 130 RNVNPHVASI----IEACWANEPWKRPSFSTIMELLR 162
+V+ +++ + + AC+ P RP T ELL+
Sbjct: 235 PDVSMNLSPVALDFLNACFTINPDNRP---TARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-24
Identities = 53/161 (32%), Positives = 90/161 (55%), Gaps = 5/161 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSK 65
+ +Y VA GM +L +N VHRDL + N+L+ + VK+CDFGL+R ++ + ++S
Sbjct: 242 VGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG 299
Query: 66 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
S +WMAPE + + SD++SFG++LWE+ TL P+ L + +G
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY 359
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
R+ P + + + I++ CW + RP FS ++ L+ L+
Sbjct: 360 RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-24
Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKA----NTFLSSKS 66
+ +G+ YLH IVHRD+K N+L D VK+ DFG S RL+ T + KS
Sbjct: 111 RQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM--KS 166
Query: 67 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 126
GTP WM+PEV+ E K+D++S G + E+ T + PW + + +
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 226
Query: 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
++P +V+P + + + KRPS ELLR
Sbjct: 227 QLPSHVSPDARNFLRRTFVENAKKRPS---AEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-24
Identities = 47/158 (29%), Positives = 91/158 (57%), Gaps = 3/158 (1%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+L E + + +A + YLH ++ I+HRDLK+ N+ + + +KV D G++R+ N
Sbjct: 98 LLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
+ + GTP +M+PE+ ++P N KSD+++ G ++E+ATL+ + + +V +
Sbjct: 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI- 214
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158
+GK +P++ +P + +I + P KRPS +I+
Sbjct: 215 IEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-24
Identities = 47/158 (29%), Positives = 93/158 (58%), Gaps = 5/158 (3%)
Query: 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK 65
+ ++ + +A+GM Y+ R+N +HRDL++ N+LV + K+ DFGL+R+ + +++
Sbjct: 104 KLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161
Query: 66 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKG 123
A P +W APE + KSD++SFG++L+E+ T + P+ ++ + V++A+ +G
Sbjct: 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RG 220
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
R+ N + I++ CW + +RP+F + +L
Sbjct: 221 YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-24
Identities = 56/152 (36%), Positives = 86/152 (56%), Gaps = 6/152 (3%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG- 69
AY VA+GM YL + +HRDL + N+LV + +K+ DFGL+R N K+ G
Sbjct: 140 AYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197
Query: 70 -TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 127
+WMAPE L D +SD++SFGV+LWE+ TL P+ + P + + + +G R++
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGHRMD 256
Query: 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
P N + I+ CW P +RP+F ++E
Sbjct: 257 KPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-24
Identities = 58/178 (32%), Positives = 96/178 (53%), Gaps = 27/178 (15%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR------ 55
LD L + VA+GM++L +N +HRD+ + N+L+ K+CDFGL+R
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 56 ---LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 111
+K N L K WMAPE + D +SD++S+G++LWE+ +L + P+
Sbjct: 267 NYVVKGNARLPVK-------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY---- 315
Query: 112 PAQVVAAVGFK----GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
P +V + +K G ++ P P + SI++ CW EP +RP+FS I +L++ +
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-24
Identities = 54/156 (34%), Positives = 87/156 (55%), Gaps = 5/156 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++MA VA GM Y+ R N +HRDL+S N+LV K+ DFGL+RL + +++
Sbjct: 105 VDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 125
A P +W APE KSD++SFG++L EL T + P+ +N +V+ V +G R
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYR 221
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ P++ + ++ CW +P +RP+F + L
Sbjct: 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-23
Identities = 52/163 (31%), Positives = 90/163 (55%), Gaps = 7/163 (4%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKAN-TF 61
E+ + + V+ GM YL N VHRDL + N+L+ ++ K+ DFGLS+ L A+ +
Sbjct: 94 EKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151
Query: 62 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 119
+K+ P +W APE + + KSD++SFGV++WE + Q+P+ + +V +
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
G+R+E P+ P + +++ CW +RP F+ + LR
Sbjct: 212 E-SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-23
Identities = 48/145 (33%), Positives = 77/145 (53%), Gaps = 5/145 (3%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 73
+ +G+ LH + I+HRDLKS N+L+ VK+ D G+S++ K+ GTP +
Sbjct: 112 LLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHY 167
Query: 74 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 133
MAPEV + P + KSDI+S G +L+E+AT P+ Q + +GK IP +
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYS 226
Query: 134 PHVASIIEACWANEPWKRPSFSTIM 158
+ + I + +P RP+ I+
Sbjct: 227 QDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-23
Identities = 47/145 (32%), Positives = 93/145 (64%), Gaps = 5/145 (3%)
Query: 18 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMA 75
++++H ++ ++HRD+KS N+L+ VK+ DFG S++ A T ++ GTP ++A
Sbjct: 156 VHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 76 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPH 135
PE+ R +P ++K+D++S GV+L+EL TL++P+ N +V+ G+ +P +++P
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-LAGRYDPLPPSISPE 272
Query: 136 VASIIEACWANEPWKRPSFSTIMEL 160
+ I+ A +++P +RPS S ++ +
Sbjct: 273 MQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-23
Identities = 54/162 (33%), Positives = 85/162 (52%), Gaps = 5/162 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++ + A D A GM YL +N +HRDL + N LV + +K+ DFG+SR + +
Sbjct: 90 LKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147
Query: 62 LSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAV 119
SS P +W APE L + +SD++S+G++LWE +L P+ + Q V
Sbjct: 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
KG R+ P+ V +++ CW +P RP FS + + L
Sbjct: 208 E-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-23
Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 6/164 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKAN 59
L +L +A VA GM YL R VHRDL + N LV + VK+ DFGLSR A+
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ +S++ A WM PE + +SD++++GV+LWE+ + QP+ + +V+
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
V G L P N + +++ CW+ P RPSF++I +L+
Sbjct: 245 VR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-23
Identities = 57/169 (33%), Positives = 90/169 (53%), Gaps = 6/169 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L + + L++A +A GM YL ++ VHRDL + N LV + VK+ DFG+SR + +
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ P WM PE + +SD++S GV+LWE+ T +QPW L+ +V+
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+ +G+ L+ PR V ++ CW EP R + I LL+ L K+
Sbjct: 235 IT-QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-23
Identities = 47/147 (31%), Positives = 80/147 (54%), Gaps = 8/147 (5%)
Query: 18 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77
+ Y+H+ ++HRD+K+ N+LV VK+CDFG++ L + GTP WMAPE
Sbjct: 114 LKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171
Query: 78 VLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKGKRLEIPRNVNPH 135
V+ + + K+DI+S G+ ++E+AT P+ +++ + + + K RLE +
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKL 230
Query: 136 VASIIEACWANEPWKRPSFSTIMELLR 162
+ + AC EP +R S ELL+
Sbjct: 231 LREFVAACLDEEPKERLSAE---ELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-23
Identities = 55/154 (35%), Positives = 87/154 (56%), Gaps = 6/154 (3%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG- 69
AY VA+GM YL + +HRDL + N+LV + +K+ DFGL+R + K+ G
Sbjct: 146 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203
Query: 70 -TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLE 127
+WMAPE L D +SD++SFGV+LWE+ TL P+ + P + + + +G R++
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMD 262
Query: 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
P N + ++ CW P +RP+F ++E L
Sbjct: 263 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-23
Identities = 48/157 (30%), Positives = 93/157 (59%), Gaps = 7/157 (4%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSA 67
+ + V+ GM YL +N VHRDL + N+L+ ++ K+ DFGLS+ +++ ++SA
Sbjct: 100 LMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWE-LATLQQPWGNLNPAQVVAAVGFKGKR 125
P +W APE + + +SD++S+G+ +WE + Q+P+ + +V++ + +GKR
Sbjct: 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKR 216
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
L+ P P + ++++ CW + RP+F+ + E +R
Sbjct: 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-23
Identities = 52/166 (31%), Positives = 95/166 (57%), Gaps = 6/166 (3%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKAN 59
+ E + L+ ++ G+ ++H R I+HRD+KS N+ + K V K+ DFG++R +
Sbjct: 97 LFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
+ + + GTP +++PE+ ++ P N K+DI+S G +L+EL TL+ P+ N Q+V +
Sbjct: 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI 214
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
+G I N + + S+I + P RPS ++I++ RP +
Sbjct: 215 -CQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK--RPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-23
Identities = 56/165 (33%), Positives = 85/165 (51%), Gaps = 6/165 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
LN +AKGMNYL R +VHRDL + N+LV VK+ DFGL++ L A+
Sbjct: 112 LNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
P +WMA E + +SD++S+GV +WEL T +P+ + PA ++++ KG+
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGE 228
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169
RL P V I+ CW + RP F ++ + + P
Sbjct: 229 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-23
Identities = 60/165 (36%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
L MA +A GM YL N VHRDL + N LV YT+K+ DFG+SR L + + +
Sbjct: 132 LYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVVAAVG--F 121
A P WMA E + SD+++FGV LWE+ TL +QP+ L+ QV+ G F
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFF 249
Query: 122 KGKRLEIPRNVNP----HVASIIEACWANEPWKRPSFSTIMELLR 162
+ + +I + P V ++ CW+ + RP+F+ I LR
Sbjct: 250 RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 7e-23
Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS------KSA 67
+ G+ YLH +VHRD+K N+++ +K+ DFG +R A L KS
Sbjct: 111 ILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKGKRL 126
GTP WMAPEV+ + KSDI+S G ++E+AT + P +++ + +G +G
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP 228
Query: 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+P + + + +C + +RPS ++LLR
Sbjct: 229 RLPDSFSAAAIDFVTSCLTRDQHERPS---ALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-23
Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 6/153 (3%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG-- 69
Y VA+GM YL + +HRDL + N+LV + +K+ DFGL+R N K+ G
Sbjct: 144 YQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEI 128
+WMAPE L D +SD++SFGV++WE+ TL P+ + P + + + +G R++
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDK 260
Query: 129 PRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
P N + ++ CW P RP+F ++E L
Sbjct: 261 PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-22
Identities = 52/160 (32%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
M +A GM YL N VHRDL + N+LV+ KV DFGLSR+ + + + +G
Sbjct: 112 MLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG 169
Query: 70 TP---EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
W APE + SD++SFG+++WE+ + ++P+ +++ +V+ A+ G R
Sbjct: 170 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFR 228
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
L P + V ++ CW + +RP F I+ LL L+
Sbjct: 229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-22
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 24/166 (14%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----------KANTFLSSKS 66
+ YLH + I+HRDLK N+L+DK +K+ DFG +++ K +
Sbjct: 114 ALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 67 AA----------GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 116
GT E+++PE+L ++P+ + SD+++ G I++++ T + P+ N
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231
Query: 117 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+ P N P +IE +P R + + L+
Sbjct: 232 QKI--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-22
Identities = 45/162 (27%), Positives = 91/162 (56%), Gaps = 5/162 (3%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS 63
E + L+ + + ++H R I+HRD+KS N+ + K T+K+ DFG++R+ +T
Sbjct: 100 EDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 123
+++ GTP +++PE+ + P N KSDI++ G +L+E+ TL+ + N +V + +G
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-IRG 216
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
+ + + + +++ + P RPS ++I+E + I
Sbjct: 217 SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE--KNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-22
Identities = 59/163 (36%), Positives = 89/163 (54%), Gaps = 12/163 (7%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSA 67
MA +A GM YL N VHRDL + N LV K YT+K+ DFG+SR L + + +
Sbjct: 134 FMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGR 191
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVVAAVG--FK 122
A P WM+ E + SD+++FGV LWE+ TL +QP+ L+ QV+ G F+
Sbjct: 192 AVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR 251
Query: 123 --GKRLEIPR-NVNPH-VASIIEACWANEPWKRPSFSTIMELL 161
G+++ +P+ + P + ++ +CW +RPSF I L
Sbjct: 252 DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-22
Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 22/169 (13%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
DE + M ++ KG++YLH +HRD+K+ N+L+ ++ VK+ DFG++ +T
Sbjct: 98 FDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ + GTP WMAPEV++ + K+DI+S G+ ELA + P +++P +V+
Sbjct: 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----- 210
Query: 122 KGKRLEIPRNVNPHVA--------SIIEACWANEPWKRPSFSTIMELLR 162
IP+N P + I+AC +P RP T ELL+
Sbjct: 211 ----FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRP---TAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 5e-22
Identities = 54/161 (33%), Positives = 88/161 (54%), Gaps = 6/161 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDE + + ++ KG++YLH +HRD+K+ N+L+ + VK+ DFG++ +T
Sbjct: 98 LDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ + GTP WMAPEV++ + K+DI+S G+ ELA + P L+P +V+ +
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP- 214
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
K + N + + +EAC EP RP T ELL+
Sbjct: 215 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-22
Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 6/152 (3%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSKSAAGT 70
D+A GM YL ++ +HRDL + N ++++ V V DFGLS+ + + + A
Sbjct: 120 DIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIP 129
+W+A E L D KSD++SFGV +WE+AT Q P+ + +++ + +G RL+ P
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQP 236
Query: 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ + S++ +CW P RPSF T+ L
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 6e-22
Identities = 56/172 (32%), Positives = 87/172 (50%), Gaps = 20/172 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
LD R+ L A + KGM YL + VHRDL + N+LV+ + VK+ DFGL+++ +
Sbjct: 105 LDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
Query: 60 TFLSSKSAAGTPE-WMAPEVLRDEPSNEKSDIYSFGVILWELAT-----------LQQPW 107
+ + +P W APE L + + SD++SFGV+L+EL T +
Sbjct: 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM 222
Query: 108 GNLNPAQVV----AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155
GN Q++ + RL P + +I++ CW N+P +RPSFS
Sbjct: 223 GNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-22
Identities = 42/102 (41%), Positives = 63/102 (61%), Gaps = 3/102 (2%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
+A V KG+ YLH I+HRD+K N+LV+ + +K+CDFG+S N+ +K+ G
Sbjct: 105 IAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVG 161
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 111
T +MAPE ++ + KSDI+S G+ L ELAT + P+ N
Sbjct: 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 7e-22
Identities = 55/160 (34%), Positives = 84/160 (52%), Gaps = 9/160 (5%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR--LKANTFL 62
L A DVAKG YL + +HRD+ + N L+ K K+ DFG++R +A+ +
Sbjct: 119 LFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGF 121
A +WM PE D K+D++SFGV+LWE+ +L P+ +V+ V
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-T 235
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
G RL+ P+ V I+ CW + P RP+F+TI+E +
Sbjct: 236 GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 9e-22
Identities = 58/164 (35%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
L++A +A GM YL N VHRDL + N LV + T+K+ DFG+SR L A + +
Sbjct: 141 LHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQG 198
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--QQPWGNLNPAQVVAAVG--F 121
A P WMA E + SD+++FGV LWE+ L +QP+G L QV+ G F
Sbjct: 199 RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFF 258
Query: 122 KGKRLEI----PRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ + ++ P + ++ CW+ + +RPSFS I L
Sbjct: 259 RDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 9e-22
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 5/156 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++MA +A GM Y+ R N +HRDL++ N+LV K+ DFGL+RL + +++
Sbjct: 105 VDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 125
A P +W APE KSD++SFG++L EL T + P+ + +V+ V +G R
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYR 221
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ P+ + +++ CW +P +RP+F I L
Sbjct: 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 9e-22
Identities = 50/156 (32%), Positives = 91/156 (58%), Gaps = 5/156 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++ + +A+GM ++ +RN +HRDL++ N+LV K+ DFGL+R+ + +++
Sbjct: 105 IDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A P +W APE + KSD++SFG++L E+ T + P+ ++ +V+ A+ +G R
Sbjct: 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYR 221
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ P N + +I+ CW N P +RP+F I +L
Sbjct: 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-21
Identities = 54/156 (34%), Positives = 85/156 (54%), Gaps = 5/156 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++MA +A GM Y+ R N VHRDL++ N+LV + KV DFGL+RL + +++
Sbjct: 105 VDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKR 125
A P +W APE KSD++SFG++L EL T + P+ + +V+ V +G R
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 221
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ P + ++ CW EP +RP+F + L
Sbjct: 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-21
Identities = 57/156 (36%), Positives = 86/156 (55%), Gaps = 16/156 (10%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANT---FLSSKSAAGTP 71
+G+ YLH IVHRD+K N+ +D +K+ DFG + +LK NT +S AGTP
Sbjct: 110 EGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 72 EWMAPEVLRDEPSNEK---SDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLE 127
+MAPEV+ +DI+S G ++ E+AT ++PW L N Q++ VG G +
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP 226
Query: 128 IPRN--VNPHVASIIEACWANEPWKRPSFSTIMELL 161
IP + ++P ++ C ++P KRP T ELL
Sbjct: 227 IPDSLQLSPEGKDFLDRCLESDPKKRP---TASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-21
Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 22/169 (13%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L+E + ++ KG++YLH +HRD+K+ N+L+ ++ VK+ DFG++ +T
Sbjct: 98 LEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ + GTP WMAPEV++ + K+DI+S G+ ELA + P +L+P +V+
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL----- 210
Query: 122 KGKRLEIPRNVNPHV--------ASIIEACWANEPWKRPSFSTIMELLR 162
IP+N P + +EAC +P RP T ELL+
Sbjct: 211 ----FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP---TAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-21
Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 10/160 (6%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 75
+ + YLH I+HRDLK+ N+L+ +K+ DFG+S T S GTP WMA
Sbjct: 121 EALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMA 178
Query: 76 PEV-----LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKGKRLEIP 129
PEV ++D P + K+DI+S G+ L E+A ++ P LNP +V+ + + L P
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238
Query: 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169
+ ++ P RPS + ++E P + S T
Sbjct: 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLE--HPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-21
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
++ ER + + ++H + I+HRD+K N+ + VK+ D GL R
Sbjct: 102 LIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGR----- 154
Query: 61 FLSSKSAA-----GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW----GNLN 111
F SSK+ A GTP +M+PE + + N KSDI+S G +L+E+A LQ P+ NL
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL- 213
Query: 112 PAQVVAAVGFKGKRLEIPRNVNPHVA----SIIEACWANEPWKRPSFSTIME 159
++ K ++ + P H + ++ C +P KRP S +++
Sbjct: 214 -----YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-21
Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 5/160 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG-LSRLKANTFLSSKS 66
+ M +A GM YL VH+ L + +LV+ K+ F L K+ ++ S
Sbjct: 110 MGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMS 167
Query: 67 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
W APE ++ + SD++SFG+++WE+ + ++P+ +++ V+ AV G R
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFR 226
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
L PRN + ++ CW E +RP FS I +L ++
Sbjct: 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 5e-21
Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 30/170 (17%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
+ +G+ YLH ++HRD+K N+L+ K VK+ DFG+S +T + GTP
Sbjct: 120 RETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP 177
Query: 72 EWMAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 126
WMAPEV+ D + +SD++S G+ ELA + P +++P + + FK
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK---- 229
Query: 127 EIPRNVNPHVAS----------IIEACWANEPWKRPSFSTIMELLR-PLI 165
IPRN P + S I C +RP + ELL P I
Sbjct: 230 -IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRP---FMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 7e-21
Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 19/169 (11%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAA 68
A + +GM YLH ++ +HRDL + N+L+D VK+ DFGL++ + + + +
Sbjct: 113 AQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 69 GTPE-WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN--------LNPAQ----V 115
+P W A E L++ + SD++SFGV L+EL T + + P Q V
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 116 VAAVGF--KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
V + +G RL P+N V +++ CW E RP+F +++ +L+
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-21
Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 24/179 (13%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS 63
E+ +A V KG++YLH R I+HRD+K N+L+ +K VK+CDFG+S N+
Sbjct: 104 EKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-- 159
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-----GNLNPAQVVAA 118
+ + GT +MAPE ++ +P + SD++S G+ L E+A + P+ L P ++++
Sbjct: 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
+ VN + + W F ++ + L K PT +P+P DM
Sbjct: 220 I------------VNMPNPELKDEPGNGIKWSEE-FKDFIK--QCLEKDPTRRPTPWDM 263
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 9e-21
Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 6/164 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
LD L++A +A GM YL VH+DL + N+L+ ++ VK+ D GLSR + +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAA 118
+ + + P WM PE + + SDI+SFGV+LWE+ + QP+ + +V+
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
V K + L + P + S++ CW P +RP F I LR
Sbjct: 239 VR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-20
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----- 56
LDE ++ + YLH I+HRDLK N+L+D +K+ DFGLS++
Sbjct: 90 LDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147
Query: 57 ---KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 113
+ K GTP+++APEV+ + ++ D +S G IL+E P+ P
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 114 QVVAAVGFKGKRLEIPR--NVNPHVASIIEACWANEPWKRPSFSTIMEL 160
++ + ++E P V+ +I +P KR +I E+
Sbjct: 208 EIFQNI--LNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-20
Identities = 46/142 (32%), Positives = 82/142 (57%), Gaps = 3/142 (2%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 76
G+ ++H + ++HRD+KS N+ + + VK+ DFG +RL + + + GTP ++ P
Sbjct: 112 GVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169
Query: 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 136
E+ + P N KSDI+S G IL+EL TL+ P+ + ++ V +G +P + + +
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-CQGSYKPLPSHYSYEL 228
Query: 137 ASIIEACWANEPWKRPSFSTIM 158
S+I+ + P RPS +TI+
Sbjct: 229 RSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-20
Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 6/118 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E +V G+ LH+R I+HRD+K NLL+D+ +K+ DFGLSR
Sbjct: 94 LPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNG---- 147
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
L +K GTP+++APE + ++ SD +S G +++E P+ P V +
Sbjct: 148 LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-20
Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 21/179 (11%)
Query: 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT-FL 62
+++L A + KGM+YL R VHRDL + N+LV+ ++ VK+ DFGL++ ++ + +
Sbjct: 109 KQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 166
Query: 63 SSKSAAGTPE-WMAPEVLRDEPSNEKSDIYSFGVILWELAT---------------LQQP 106
+ K +P W APE L SD++SFGV L+EL T +
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT 226
Query: 107 WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
G + ++V + +GKRL P N V ++ CW +P KR +F ++E ++
Sbjct: 227 HGQMTVTRLVRVLE-EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-20
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLS-RLKAN---TFLSSKSAA 68
+ +G++YLH I+HRD+K NLL+D +++ DFG + RL A
Sbjct: 112 LLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKGKR 125
GT +MAPEVLR E D++S G ++ E+AT + PW N ++ +
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA 229
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
IP +++P + + C +P RP ELL+
Sbjct: 230 PSIPEHLSPGLRDVTLRCLELQPEDRPP---SRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-20
Identities = 48/143 (33%), Positives = 82/143 (57%), Gaps = 4/143 (2%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 76
G++Y+H+R I+HRDLK+ N+ + K +K+ DFG+SRL + + + GTP +M+P
Sbjct: 118 GVHYMHQRR--ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 136
E L+ + + KSDI+S G IL+E+ L + N VV + +G +P + +
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQL 233
Query: 137 ASIIEACWANEPWKRPSFSTIME 159
SI+++ +P RPS + I+
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-20
Identities = 54/171 (31%), Positives = 86/171 (50%), Gaps = 6/171 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--AN 59
+ + LN +AKGM+YL +VHRDL + N+LV VK+ DFGL+RL
Sbjct: 106 IGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
T + +WMA E + +SD++S+GV +WEL T +P+ + PA+ +
Sbjct: 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPD 222
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169
+ KG+RL P V I+ CW + RP F +++ + + P+
Sbjct: 223 LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 9e-20
Identities = 47/163 (28%), Positives = 86/163 (52%), Gaps = 8/163 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
L + +L+MA D KG+ L++ N P +++L S + LV + Y +K+ GL ++ ++
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP 176
Query: 61 FLSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
K+ + + ++L D K DIYS GV+LWE+ T + P+ NL ++
Sbjct: 177 --PFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ K L++P + + I+EAC +++ KRP+ I+ L
Sbjct: 234 IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-19
Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 7/160 (4%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
M +A GM YL + VHRDL + N+LV+ KV DFGLSR+ + ++ + G
Sbjct: 111 MLRGIASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168
Query: 70 TP---EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
W APE + SD++S+G+++WE+ + ++P+ ++ V+ A+ +G R
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYR 227
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
L P + + ++ CW + +RP F I+ +L LI
Sbjct: 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-19
Identities = 50/151 (33%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTP 71
+ +G+ YLH IVHRD+K N+LV+ Y+ VK+ DFG S+ A +++ GT
Sbjct: 117 ILEGLKYLHDNQ--IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTETFTGTL 173
Query: 72 EWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEI 128
++MAPEV+ P +DI+S G + E+AT + P+ L P + VG EI
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233
Query: 129 PRNVNPHVASIIEACWANEPWKRPSFSTIME 159
P +++ + I C+ +P KR S +++
Sbjct: 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-19
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 55/220 (25%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------ 56
DE R A ++ G+ +LH++ I++RDLK N+L+DK +K+ DFG+ +
Sbjct: 94 DEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151
Query: 57 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 116
KA+TF GTP+++APE+L+ + NE D +SFGV+L+E+ Q P+ + ++
Sbjct: 152 KASTF------CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL- 204
Query: 117 AAVGFKGKRLEI---PRNVNPHVASIIEACWANEPWKR----------PSFSTI-MELL- 161
F + PR ++ + + +P KR P F I E L
Sbjct: 205 ----FDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLE 260
Query: 162 --------RPLIKSPT-------------PQPSPTDMPLL 180
+P +KSP+ + SP D LL
Sbjct: 261 KREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDKKLL 300
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-19
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 16/160 (10%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RL---KANTFLSSK 65
M + K ++YL + ++HRD+K N+L+D VK+CDFG+S RL KA T
Sbjct: 119 MTVAIVKALHYL-KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT----- 172
Query: 66 SAAGTPEWMAPEVLRDEPSNEK----SDIYSFGVILWELATLQQPWGNLNPA-QVVAAV- 119
+AG +MAPE + N K +D++S G+ L ELAT Q P+ N +V+ +
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
+ L +P S ++ C + KRP + +++
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-19
Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 16/156 (10%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------R 55
DE R A ++ G+ +LH R I++RDLK N+L+D + +K+ DFG+
Sbjct: 93 FDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG 150
Query: 56 LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 115
+ +TF GTP+++APE+L +P D ++ GV+L+E+ Q P+ + ++
Sbjct: 151 VTTSTF------CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204
Query: 116 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 151
++ + PR ++ SI+++ P KR
Sbjct: 205 FQSI--LEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-19
Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 40/182 (21%)
Query: 10 MAYDVAKGMNYL---HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS----RLKANTFL 62
+A V +G+ YL HR I+HRD+K N+LV+ + +K+CDFG+S A+TF+
Sbjct: 108 IAVAVVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
GT +M+PE ++ KSD++S G+ + ELA + P+ N
Sbjct: 164 ------GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD---- 213
Query: 123 GKRLEIPRNVNPHVASIIE--ACWANEPWKR-PS--FSTIMELL--RPLIKSPTPQPSPT 175
I++ EP R PS F + L+K PT +P+P
Sbjct: 214 ------------DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQ 261
Query: 176 DM 177
+
Sbjct: 262 QL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-19
Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 17/142 (11%)
Query: 18 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL-----SRLKANTFLSSKSAAGTPE 72
YLH R I++RDLK NLL+D VK+ DFG S K TF GTPE
Sbjct: 106 FEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPE 157
Query: 73 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV---AAVGFKGKRLEIP 129
++APE++ ++ + D +S G++L+EL T + P+G + + + GK LE P
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-LEFP 216
Query: 130 RNVNPHVASIIEACWANEPWKR 151
++ +I+ P +R
Sbjct: 217 NYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-19
Identities = 45/151 (29%), Positives = 80/151 (52%), Gaps = 6/151 (3%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-NTFL 62
E R N+ + + YLH+ IVHRDL N+++ + V + DFGL++ K + L
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL 170
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
S GT + PE++++EP EK+D+++FG IL+++ TLQ P+ + N + + +
Sbjct: 171 --TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-VE 227
Query: 123 GKRLEIPRNV-NPHVASIIEACWANEPWKRP 152
+P + + V +I +C + RP
Sbjct: 228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-19
Identities = 58/181 (32%), Positives = 89/181 (49%), Gaps = 15/181 (8%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
DE+ ++A + G+ YLHRR+ IVHRD+K NLL++ VK+ DFG+SR+ A T
Sbjct: 166 DEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEK-----SDIYSFGVILWELATLQQPWG---NLNPAQ 114
S+ GT +M+PE + + ++ DI+S GV + E + P+G + A
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS 283
Query: 115 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPS 173
++ A+ + E P + I C EP KR S M+LL+ P I P
Sbjct: 284 LMCAICMS-QPPEAPATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRAQPGQG 339
Query: 174 P 174
Sbjct: 340 Q 340
|
Length = 353 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-19
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 7/166 (4%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 73
V K +++LH + ++HRD+KS ++L+ VK+ DFG + KS GTP W
Sbjct: 124 VLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 74 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKGKRLEIPRNV 132
MAPEV+ P + DI+S G+++ E+ + P+ N P Q + + +L+ V
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKV 241
Query: 133 NPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 177
+P + S ++ +P +R +T ELL P + P S +
Sbjct: 242 SPRLRSFLDRMLVRDPAQR---ATAAELLNHPFLAKAGPPSSIVPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-19
Identities = 45/149 (30%), Positives = 81/149 (54%), Gaps = 5/149 (3%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
+ER R A ++ + YLH R+ +V+RD+K NL++DK +K+ DFGL + +
Sbjct: 94 EERARFYGA-EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 150
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
+ K+ GTPE++APEVL D D + GV+++E+ + P+ N + ++ + +
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKR 151
R PR ++P S++ +P +R
Sbjct: 211 EIRF--PRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 82.9 bits (203), Expect = 5e-19
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 25/201 (12%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRLKANT 60
L E L + + + YLH + I+HRD+K N+L+D+ VK+ DFGL++L +
Sbjct: 98 LSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155
Query: 61 FLSS------KSAAGTPEWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPW---- 107
+S ++ GTP +MAPEVL ++ SDI+S G+ L+EL T P+
Sbjct: 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
Query: 108 GNLNPAQVVAAVGFKGKRL-------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160
+ +Q + + P ++ + +++ A +P R S+ +L
Sbjct: 216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL--SSSSDL 273
Query: 161 LRPLIKSPTPQPSPTDMPLLT 181
L+ + S L
Sbjct: 274 SHDLLAHLKLKESDLSDLLKP 294
|
Length = 384 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-19
Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 70
A K +NYL + I+HRD+K N+L+D+ +K+CDFG+S ++ ++ A
Sbjct: 113 AVATVKALNYL-KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCR 171
Query: 71 PEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-----AQVVAAVGFK 122
P +MAPE + + + +SD++S G+ L+E+AT + P+ N QVV K
Sbjct: 172 P-YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-----K 225
Query: 123 GK--RL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
G L R +P + I C + KRP + ++E
Sbjct: 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-19
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSS 64
M +A GM YL N VHRDL + N+LV+ KV DFGLSR + T+ SS
Sbjct: 111 MLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 65 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
W APE + SD++S+G+++WE+ + ++P+ +++ V+ A+ +
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QD 227
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
RL P + + ++ CW + RP F I+ L +I
Sbjct: 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-18
Identities = 42/110 (38%), Positives = 63/110 (57%), Gaps = 7/110 (6%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 75
+ +NYLH I+HRDLK+ N+L +K+ DFG+S T S GTP WMA
Sbjct: 114 EALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171
Query: 76 PEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
PEV+ +D P + K+D++S G+ L E+A ++ P LNP +V+ +
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-18
Identities = 52/152 (34%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGT 70
+ +G++YLH IVHRD+K N+L D VK+ DFG S+ LS KS GT
Sbjct: 115 ILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
P WM+PEV+ E K+DI+S G + E+ T + PW + + + +P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPP 232
Query: 131 NVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+V+ H ++ + E RPS ELLR
Sbjct: 233 HVSDHCRDFLKRIFV-EAKLRPSAD---ELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-18
Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGT 70
+ +GM+YLH IVHRD+K N+L D VK+ DFG S+ +S +S GT
Sbjct: 115 ILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
P WM+PEV+ E K+D++S G + E+ T + PW + + + ++P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232
Query: 131 NVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+++ H + C E RPS ELLR
Sbjct: 233 HISEHARDFL-GCIFVEARHRPSAE---ELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-18
Identities = 37/127 (29%), Positives = 67/127 (52%), Gaps = 17/127 (13%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEV 78
YLH + IV+RDLK NLL+D +K+ DFG + R+K T+ + GTPE++APE+
Sbjct: 116 YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPEYLAPEI 169
Query: 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFKGKRLEIPRNVNP 134
+ + + D ++ G++++E+ P+ + NP Q ++ ++ P +P
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG------KVRFPSFFSP 223
Query: 135 HVASIIE 141
+I
Sbjct: 224 DAKDLIR 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-18
Identities = 47/176 (26%), Positives = 90/176 (51%), Gaps = 19/176 (10%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL--SRLKA 58
M + MA +VA G+ +LH+ + +H DL N + +VK+ D+GL +
Sbjct: 96 MAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSN-------EKSDIYSFGVILWELATL-QQPWGNL 110
+ +++ A W+APE++ + +KS+I+S GV +WEL T QP+ +L
Sbjct: 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213
Query: 111 NPAQVVAAVGFKGKRLEIPR-NVNPHVA----SIIEACWANEPWKRPSFSTIMELL 161
+ QV+ V + + +++P+ ++ + +++ CW +P RP+ + ELL
Sbjct: 214 SDEQVLKQV-VREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-18
Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 6/164 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
LN +AKGM YL R +VHRDL + N+LV VK+ DFGL+RL +
Sbjct: 112 LNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 68 AGTP--EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
G +WMA E + +SD++S+GV +WEL T +P+ + P + + + KG+
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGE 228
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
RL P V ++ CW + RP F + + + P
Sbjct: 229 RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-18
Identities = 44/149 (29%), Positives = 79/149 (53%), Gaps = 4/149 (2%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
++R R A ++ ++YLH +V+RDLK NL++DK +K+ DFGL +
Sbjct: 94 EDRARFYGA-EIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
+ K+ GTPE++APEVL D D + GV+++E+ + P+ N + ++ + +
Sbjct: 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKR 151
R PR ++P S++ +P +R
Sbjct: 212 EIRF--PRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 1e-17
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
+G+ Y H I+HRDLK N+L+++ +K+ DFGL+R T E
Sbjct: 109 RGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVT 161
Query: 73 -WM-APEVLRDEPSNEKS-DIYSFGVILWELAT 102
W APE+L + DI+S G I E+ T
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-17
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 14/174 (8%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----- 56
LD +R LN +AKGM YL +VHR+L + N+L+ V++ DFG++ L
Sbjct: 106 LDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
Query: 57 KANTFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQ 114
K + S TP +WMA E + +SD++S+GV +WE+ + +P+ + P +
Sbjct: 164 KKYFY----SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
Query: 115 VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
V + KG+RL P+ V ++ CW + RP+F + + + P
Sbjct: 220 VPDLLE-KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-17
Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 8 LNMAY---DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS 64
L +AY + +G+ YLH + +HRD+K N+L+ VK+ DFG++ T
Sbjct: 106 LQIAYVCRETLQGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163
Query: 65 KSAAGTPEWMAPEVLRDEPS---NEKSDIYSFGVILWELATLQQPWGNLNPAQ---VVAA 118
KS GTP WMAPEV E + N+ DI++ G+ ELA LQ P +L+P + +++
Sbjct: 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK 223
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153
F+ +L+ + + ++ P KRP+
Sbjct: 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-17
Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 11/131 (8%)
Query: 19 NYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78
+ LH +HRDLK N L+D +K+ DFGLS + S G+P++MAPEV
Sbjct: 115 DALHELG--YIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANSVVGSPDYMAPEV 169
Query: 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVAS 138
LR + + D +S G +L+E P+ P + + + + L+ P +P
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP---- 225
Query: 139 IIEACWANEPW 149
++E W
Sbjct: 226 --RFNLSDEAW 234
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-17
Identities = 43/149 (28%), Positives = 80/149 (53%), Gaps = 5/149 (3%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
++R R A ++ + YLH + +V+RDLK NL++DK +K+ DFGL + +
Sbjct: 94 EDRARFYGA-EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA 150
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
+ K+ GTPE++APEVL D D + GV+++E+ + P+ N + ++ +
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM- 209
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKR 151
+ + PR ++P S++ +P +R
Sbjct: 210 -EEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-17
Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 28/180 (15%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDE + Y G+ +LH N I+HRD+K N+L+ + VK+ DFG+S +T
Sbjct: 125 LDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 62 LSSKSAAGTPEWMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 116
L ++ GTP WMAPEV+ D + + D++S G+ EL P +++P + +
Sbjct: 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242
Query: 117 AAVGFKGKRLEIPRNVNPHV----------ASIIEACWANEPWKRPSFSTIMELLRPLIK 166
+IPRN P + I C + RPS + ++E P IK
Sbjct: 243 ---------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE--HPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-17
Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 5/123 (4%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGT 70
+ +G++YLH IVHRD+K N+L D VK+ DFG S+ +S KS GT
Sbjct: 115 ILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
P WM+PEV+ E K+D++S + E+ T + PW + + + + +P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232
Query: 131 NVN 133
V+
Sbjct: 233 GVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-17
Identities = 43/156 (27%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
+A + K + YLH ++HRD+K N+L+++ VK+CDFG+S ++ ++ AG
Sbjct: 108 IAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAG 165
Query: 70 TPEWMAPEVLRDEPS----NEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGK 124
+MAPE + E + + KSD++S G+ + ELAT + P+ + P Q + V +
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VEEP 224
Query: 125 RLEIPRN-VNPHVASIIEACWANEPWKRPSFSTIME 159
++P +P + C +RP++ +++
Sbjct: 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 6e-17
Identities = 44/149 (29%), Positives = 80/149 (53%), Gaps = 5/149 (3%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
++R R A ++ ++YLH + IV+RDLK NL++DK +K+ DFGL +
Sbjct: 94 EDRTRFYGA-EIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA 150
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
+ K+ GTPE++APEVL D D + GV+++E+ + P+ N + ++ + +
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKR 151
++ PR ++ S++ +P KR
Sbjct: 211 D--IKFPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-17
Identities = 49/179 (27%), Positives = 85/179 (47%), Gaps = 5/179 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+DE + + + + + +LH ++HRD+KS N+L+ +VK+ DFG
Sbjct: 112 MDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ GTP WMAPEV+ + K DI+S G++ E+ + P+ N NP + + +
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229
Query: 122 KGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 179
G L+ P ++P + C + KR S +++ P +K P S T + L
Sbjct: 230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAKPLSSLTPLIL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-17
Identities = 33/105 (31%), Positives = 60/105 (57%), Gaps = 6/105 (5%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFL 62
E+ + + ++ + YLH + I+HRD+K N+L+D++ V + DF ++ + +T
Sbjct: 100 EQVKFWIC-EIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
+S S GTP +MAPEVL + + D +S GV +E ++P+
Sbjct: 157 TSTS--GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-16
Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 6/108 (5%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+ E R + A V G+ YLH IV+RDLK NLL+D + VK+ DFGL K
Sbjct: 97 VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLC--KEGM 152
Query: 61 FLSSKSAA--GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP 106
+++ GTPE++APEVL + D + GV+++E+ + P
Sbjct: 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-16
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
E R + G+ +LH+R I++RDLK N+L+D V++ D GL+ +
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+K AGTP +MAPE+L+ E + D ++ GV L+E+ + P+ A G
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF---------RARGE 202
Query: 122 KGKRLEIPRNV-----------NPHVASIIEACWANEPWKRPSF 154
K + E+ + + +P S EA A +P KR F
Sbjct: 203 KVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGF 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-16
Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 31/155 (20%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGT 70
+G+ YLH +HRD+K+ N+L+ + TVK+ DFG + L AN+F+ GT
Sbjct: 123 GALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GT 174
Query: 71 PEWMAPEVL--RDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
P WMAPEV+ DE + K D++S G+ ELA + P N+N +
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YH 225
Query: 128 IPRNVNPHVASI---------IEACWANEPWKRPS 153
I +N +P ++S +++C P RPS
Sbjct: 226 IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-16
Identities = 37/141 (26%), Positives = 82/141 (58%), Gaps = 4/141 (2%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 70
A +++ G+ +LHRR I++RDLK N+++D + +K+ DFG+ + +++++ GT
Sbjct: 107 AAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGT 164
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
P+++APE++ +P + D +++GV+L+E+ Q P+ + ++ ++ + P+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPK 222
Query: 131 NVNPHVASIIEACWANEPWKR 151
+++ SI + P KR
Sbjct: 223 SLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-16
Identities = 53/172 (30%), Positives = 91/172 (52%), Gaps = 20/172 (11%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 72
++A +++LH I++RDLK N+L+D++ +K+ DFGLS+ + + S GT E
Sbjct: 106 ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 73 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 132
+MAPEV+ + +D +SFGV+++E+ T P+ + + + + K K L +P+ +
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI-LKAK-LGMPQFL 221
Query: 133 NPHVASIIEACWANEPWKR--------------PSFSTI--MELLRPLIKSP 168
+P S++ A + P R P FSTI +L R IK P
Sbjct: 222 SPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPP 273
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-16
Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 11/161 (6%)
Query: 8 LNMAY---DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS 64
+AY + +G+ YLH + +HRD+K N+L+ VK+ DFG+S T
Sbjct: 106 SQIAYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163
Query: 65 KSAAGTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ---VVAA 118
KS GTP WMAPEV R N+ DI++ G+ ELA LQ P +L+P + ++
Sbjct: 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK 223
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
F+ +L+ + ++ P KRP+ +++
Sbjct: 224 SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-16
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 25/161 (15%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 72
++ +G+++LH+ ++HRD+K N+L+ + VK+ DFG+S T + GTP
Sbjct: 119 EILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176
Query: 73 WMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
WMAPEV+ D + KSD++S G+ E+A P +++P + +
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FL 227
Query: 128 IPRNVNPHVA---------SIIEACWANEPWKRPSFSTIME 159
IPRN P + S IE+C +RP+ +M+
Sbjct: 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-16
Identities = 37/141 (26%), Positives = 80/141 (56%), Gaps = 4/141 (2%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 70
A ++A G+ +LH + I++RDLK N+++D + +K+ DFG+ + ++++ GT
Sbjct: 107 AAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT 164
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
P+++APE++ +P + D ++FGV+L+E+ Q P+ + ++ ++ + P+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPK 222
Query: 131 NVNPHVASIIEACWANEPWKR 151
+++ SI + P KR
Sbjct: 223 SLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-16
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSK 65
++ V +G+ YL R I+HRD+K N+LV+ + +K+CDFG+S AN+F+
Sbjct: 104 ISIAVLRGLTYL-REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 159
Query: 66 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR 125
GT +M+PE L+ +SDI+S G+ L E+A + P + ++ A
Sbjct: 160 ---GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM------- 209
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170
R V+ A + P P I ELL ++ P P
Sbjct: 210 --FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPP 252
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-16
Identities = 42/146 (28%), Positives = 83/146 (56%), Gaps = 9/146 (6%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 72
+++ +NYLH R I++RDLK N+L+D + +K+ D+G+ + ++ + GTP
Sbjct: 104 EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 161
Query: 73 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---GKR 125
++APE+LR E D ++ GV+++E+ + P+ + NP Q F+ K+
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221
Query: 126 LEIPRNVNPHVASIIEACWANEPWKR 151
+ IPR+++ AS++++ +P +R
Sbjct: 222 IRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-15
Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 7/171 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
++E + + V + ++YLH N ++HRD+KS ++L+ +K+ DFG +
Sbjct: 115 MNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
KS GTP WMAPEV+ P + DI+S G+++ E+ + P+ N P Q + +
Sbjct: 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD 232
Query: 122 K-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTP 170
R++ V+ + ++ EP +R +T ELL+ P +K P
Sbjct: 233 NLPPRVKDSHKVSSVLRGFLDLMLVREPSQR---ATAQELLQHPFLKLAGP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-15
Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 17/166 (10%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSA 67
MA ++A G+ +LH+ N +H DL N L+ TVK+ D+GLS K + +++
Sbjct: 105 MACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162
Query: 68 AGTPEWMAPEVLRDEPSN-------EKSDIYSFGVILWELATL-QQPWGNLNPAQVVA-A 118
W+APE++ + N ++S+++S GV +WEL L QP+ +L+ QV+
Sbjct: 163 WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222
Query: 119 VGFKGKRLEIPRNVNPHVA---SIIEACWANEPWKRPSFSTIMELL 161
V + +L PR P +++ CW +P +RPS + LL
Sbjct: 223 VREQQLKLPKPRLKLPLSDRWYEVMQFCWL-QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-15
Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 8/166 (4%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
++ E+ + + ++H R ++HRD+K N+ + VK+ D GL R ++
Sbjct: 102 LIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
++ S GTP +M+PE + + N KSDI+S G +L+E+A LQ P+ + ++
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLC 217
Query: 121 FKGKRLEIPRNVNPHVAS----IIEACWANEPWKRPSFSTIMELLR 162
K ++ + P + H + ++ C +P KRP + + ++ +
Sbjct: 218 KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-15
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 17/148 (11%)
Query: 13 DVAK--------GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLS 63
DVAK YLH ++ I++RDLK NLL+D K VKV DFG + ++ TF
Sbjct: 118 DVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-- 173
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 123
+ GTPE++APEV++ + + D ++ GV+L+E P+ + P ++ + G
Sbjct: 174 --TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-LAG 230
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKR 151
RL+ P + +++ + KR
Sbjct: 231 -RLKFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-15
Identities = 42/164 (25%), Positives = 81/164 (49%), Gaps = 8/164 (4%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
++ ER + + ++H R ++HRD+K N+ + VK+ D GL R ++
Sbjct: 102 LIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
++ S GTP +M+PE + + N KSDI+S G +L+E+A LQ P+ + ++
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLC 217
Query: 121 FKGKRLEIPRNVNPHVAS----IIEACWANEPWKRPSFSTIMEL 160
K ++ + P H + ++ C +P +RP + ++
Sbjct: 218 QKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-15
Identities = 37/141 (26%), Positives = 81/141 (57%), Gaps = 4/141 (2%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 70
A ++A G+ +LH + I++RDLK N+++D + +K+ DFG+ + +++K+ GT
Sbjct: 107 AAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGT 164
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
P+++APE++ +P + D ++FGV+L+E+ Q P+ + ++ ++ + P+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPK 222
Query: 131 NVNPHVASIIEACWANEPWKR 151
+++ +I + P KR
Sbjct: 223 SMSKEAVAICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-15
Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
+A V KG+ YL I+HRD+K N+LV+ + VK+CDFG+S N+ +K+ G
Sbjct: 100 IAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVG 155
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-------GNLNPAQVVAAVGFK 122
T +MAPE + E SD++S G+ ELA + P+ G+L P Q++ + +
Sbjct: 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE 215
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
+ + I C +P +RP+ +M+
Sbjct: 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-15
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 26/158 (16%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 76
G+ +LH +HRD+K N+L+ + VK+ DFG+S +T L ++ GTP WMAP
Sbjct: 136 GLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 77 EVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 131
EV+ D + + D++S G+ EL P +L+P + + +IPRN
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIPRN 244
Query: 132 VNPHVAS----------IIEACWANEPWKRPSFSTIME 159
P + I C + KRP+ S +++
Sbjct: 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-15
Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 4/148 (2%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS 63
E R A ++A + YLH N I++RDLK N+L+D + V + DFGL + +
Sbjct: 95 EPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT 152
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 123
+ + GTPE++APEVLR +P + D + G +L+E+ P+ + + A++ +
Sbjct: 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--LN 210
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKR 151
K L + N++ ++E + KR
Sbjct: 211 KPLRLKPNISVSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-15
Identities = 41/125 (32%), Positives = 77/125 (61%), Gaps = 9/125 (7%)
Query: 18 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAP 76
+ YLH + IV+RDLK N+L+DK+ +K+ DFG ++ L+ T+ + GTPE++AP
Sbjct: 114 LEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYLAP 167
Query: 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 136
EV++ + N+ D ++ G++++E+ P+ + NP + + GK LE PR+++ +
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-LAGK-LEFPRHLDLYA 225
Query: 137 ASIIE 141
+I+
Sbjct: 226 KDLIK 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-15
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 22/159 (13%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR------ 55
D R A ++ G+ +LH + IV+RDLK N+L+D +K+ DFG+ +
Sbjct: 93 FDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD 150
Query: 56 LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 115
K TF GTP+++APE+L + N D +SFGV+L+E+ Q P+ + ++
Sbjct: 151 AKTCTF------CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204
Query: 116 VAAVGFKGKRLE---IPRNVNPHVASIIEACWANEPWKR 151
F+ R++ PR + I+ + EP +R
Sbjct: 205 -----FQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-15
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 72
++ +G+ +LH ++HRD+K N+L+ + VK+ DFG+S T + GTP
Sbjct: 129 EILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186
Query: 73 WMAPEVLR-----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
WMAPEV+ D + +SDI+S G+ E+A P +++P + +
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---------FL 237
Query: 128 IPRNVNPHVAS---------IIEACWANEPWKRPSFSTIME 159
IPRN P + S IE C RPS +++
Sbjct: 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-15
Identities = 38/97 (39%), Positives = 57/97 (58%), Gaps = 2/97 (2%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS 63
E R A +VA + YLH N I++RDLK N+L+D + V + DFGL + +
Sbjct: 95 EPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+ + GTPE++APEVLR EP + D + G +L+E+
Sbjct: 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-15
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 20/165 (12%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---------LKA 58
+++ +A GM +L + +VH+DL + N+LV K VK+ D GL R L
Sbjct: 127 VHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVA 117
N+ L + WM+PE + + SDI+S+GV+LWE+ + QP+ + V+
Sbjct: 185 NSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+ + + L P + V +++ CW P +RP F I LR
Sbjct: 238 MIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-15
Identities = 52/184 (28%), Positives = 94/184 (51%), Gaps = 34/184 (18%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-- 68
A ++ G+ +LH + I++RDLK N+++D+ +K+ DFG+ K N F ++++
Sbjct: 102 AAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFC 157
Query: 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 128
GTP+++APE+L+ D +SFGV+L+E+ Q P+ + ++ F+ R++
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDT 212
Query: 129 ---PRNVNPHVASIIEACWANEPWKR----------PSFSTI-------MEL---LRPLI 165
PR + I+E + +P +R P F TI EL +P +
Sbjct: 213 PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKV 272
Query: 166 KSPT 169
KSP+
Sbjct: 273 KSPS 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-15
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E + Y + +G+ + H I+HRDLK NLL++ + +K+ DFGL+R
Sbjct: 95 LPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARS----- 147
Query: 62 LSSKSAAGTPE----WM-APEVL-RDEPSNEKSDIYSFGVILWELATLQ 104
S T W APE+L D+ + DI+S G I EL + +
Sbjct: 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-15
Identities = 31/100 (31%), Positives = 45/100 (45%), Gaps = 29/100 (29%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGLS-----------------------------RLKAN 59
+HRD+K N+L+D +K+ DFGL R
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 99
+ + S GTP+++APEVLR P + D +S GVIL+E
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 5e-15
Identities = 46/177 (25%), Positives = 84/177 (47%), Gaps = 5/177 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+DE + + + + +++LH ++HRD+KS N+L+ +VK+ DFG
Sbjct: 112 MDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ GTP WMAPEV+ + K DI+S G++ E+ + P+ N NP + + +
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229
Query: 122 KGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
G L+ P ++ + C + +R S +++ P +K P S T +
Sbjct: 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-15
Identities = 39/107 (36%), Positives = 59/107 (55%), Gaps = 5/107 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANT 60
E R + A + G+ +LH+R IV+RDLK N+L+D V++ D GL+ LK
Sbjct: 92 FPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
K AGTP +MAPEVL+ E + D ++ G L+E+ + P+
Sbjct: 150 --KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 7e-15
Identities = 49/190 (25%), Positives = 77/190 (40%), Gaps = 50/190 (26%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
E ++ Y + +G+ ++H+ HRDLK NLLV VK+ DFGL+R
Sbjct: 96 FSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR------ 147
Query: 62 LSSKSAA------GTPEWMAPEV-LRDEPSNEKSDIYSFGVILWELATL----------- 103
+S T + APE+ LR + DI++ G I+ EL TL
Sbjct: 148 -EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206
Query: 104 -------------QQPWGNLNPAQVVAAVGFK-----GKRLE--IPRNVNPHVASIIEAC 143
+Q W ++ + +GF+ L IP N +P +I+
Sbjct: 207 QLYKICSVLGTPTKQDW--PEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDM 263
Query: 144 WANEPWKRPS 153
+P KRP+
Sbjct: 264 LRWDPKKRPT 273
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-15
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 5/175 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+DE + + + + + +LH ++HRD+KS N+L+ +VK+ DFG
Sbjct: 112 MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ GTP WMAPEV+ + K DI+S G++ E+ + P+ N NP + + +
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229
Query: 122 KGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPT 175
G L+ P ++ + C + KR S +++ P +K P S T
Sbjct: 230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAKPLSSLT 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-15
Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 6/168 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L+ R R A ++A + YLH N IV+RDLK N+L+D + + + DFGL +
Sbjct: 94 LEPRARF-YAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 150
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
++ + GTPE++APEVL +P + D + G +L+E+ P+ + N A++ +
Sbjct: 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-- 208
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST-IMELLRPLIKSP 168
K L++ N+ ++E + KR ME+ + SP
Sbjct: 209 LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-15
Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 45/177 (25%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSA---- 67
+ + Y+H + ++HRDLK N+L+ V + D+G + K L
Sbjct: 122 ICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 68 ------------AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 115
GTP++MAPE L P++E +DIY+ GVIL+++ TL P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK----- 234
Query: 116 VAAVGFKGK------RLEIPRNVNPH------VASIIEACWANEPWKRPSFSTIMEL 160
KG+ + P V P+ ++ I A +P +R +S++ EL
Sbjct: 235 ------KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER--YSSVQEL 283
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-15
Identities = 44/155 (28%), Positives = 87/155 (56%), Gaps = 7/155 (4%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAG 69
Y + ++ +H R ++HRDLKS N+ + +K+ DFG S+ +++ + S G
Sbjct: 176 YQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP 129
TP ++APE+ + ++K+D++S GVIL+EL TL +P+ + +++ V + GK P
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFP 292
Query: 130 RNVNPHVASIIEACWANEPWKRPSFSTIM--ELLR 162
V+ + ++++ + P RP+ ++ E L+
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-14
Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L+E + + V + + YLH + ++HRD+KS ++L+ VK+ DFG +
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
KS GTP WMAPEV+ P + DI+S G+++ E+ + P+ + +P Q +
Sbjct: 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM----- 226
Query: 122 KGKRLEIP---RN---VNPHVASIIEACWANEPWKRPSFSTIME 159
K R P +N ++P + +E EP +R + +++
Sbjct: 227 KRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-14
Identities = 43/131 (32%), Positives = 75/131 (57%), Gaps = 6/131 (4%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
++R + +A ++ + +LH+ + IV+RDLK N+L+D + +CDFGLS+
Sbjct: 95 EDRAKFYIA-ELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
++ + GT E++APEVL DE K D +S GV+++E+ P+ + Q+ + F
Sbjct: 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
Query: 122 KGKRLEIPRNV 132
GK + P+NV
Sbjct: 212 -GK-VRFPKNV 220
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-14
Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 3/174 (1%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+DE + + + + + +LH ++HRD+KS N+L+ +VK+ DFG
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ GTP WMAPEV+ + K DI+S G++ E+ + P+ N NP + + +
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
Query: 122 KGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 174
G L+ P ++ + C + KR S +++ I P +P
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-14
Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 7/171 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
++E + + V K ++ LH + ++HRD+KS ++L+ VK+ DFG +
Sbjct: 113 MNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
KS GTP WMAPE++ P + DI+S G+++ E+ + P+ N P + + +
Sbjct: 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 230
Query: 122 K-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTP 170
+L+ V+P + ++ +P +R +T ELL+ P + P
Sbjct: 231 NLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR---ATAAELLKHPFLAKAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-13
Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 7/146 (4%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 70
A ++ +N+LH R I++RDLK N+L+D +K+ D+G+ + ++ + GT
Sbjct: 102 AAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL--NPAQVVAAVGFK---GKR 125
P ++APE+LR E D ++ GV+++E+ + P+ + NP F+ K
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP 219
Query: 126 LEIPRNVNPHVASIIEACWANEPWKR 151
+ IPR ++ + +++ +P +R
Sbjct: 220 IRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-13
Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 27/181 (14%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANT 60
+ E + Y V KG+ +L + I+HRD+K N+LV+ VK+CDFG+S L A+
Sbjct: 99 IPEDVLRRITYAVVKGLKFL-KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNE------KSDIYSFGVILWELATLQQPWGNLNP-- 112
+K+ G +MAPE ++ N+ +SD++S G+ + E+A + P+ P
Sbjct: 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPE 210
Query: 113 ------AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
AQ+ A V G +P + + C P +RP+++ ++E P +
Sbjct: 211 TYANIFAQLSAIV--DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLV 266
Query: 167 S 167
Sbjct: 267 K 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-13
Identities = 36/97 (37%), Positives = 57/97 (58%), Gaps = 2/97 (2%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS 63
E R A ++A + YLH N IV+RDLK N+L+D + V + DFGL + +
Sbjct: 95 EPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+ + GTPE++APEV+R +P + D + G +L+E+
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-13
Identities = 50/167 (29%), Positives = 84/167 (50%), Gaps = 31/167 (18%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGTPEW 73
+G+ YLH N ++HRD+K+ N+L+ + VK+ DFG + + AN+F+ GTP W
Sbjct: 136 QGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYW 187
Query: 74 MAPEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
MAPEV+ DE + K D++S G+ ELA + P N+N + I +
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHIAQ 238
Query: 131 NVNPHVAS---------IIEACWANEPWKRPSFSTIMELLRPLIKSP 168
N +P + S +++C P RP+ +++ + L + P
Sbjct: 239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-13
Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 34/161 (21%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTPEW 73
+G+ YLH N ++HRD+K+ N+L+ + VK+ DFG + AN+F+ GTP W
Sbjct: 132 QGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYW 183
Query: 74 MAPEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
MAPEV+ DE + K D++S G+ ELA + P N+N + I +
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHIAQ 234
Query: 131 NVNPHVAS---------IIEACWANEPWKRPSFSTIMELLR 162
N +P + S ++ C P +RP ELLR
Sbjct: 235 NDSPTLQSNEWTDSFRGFVDYCLQKIPQERP---ASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-13
Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 5/93 (5%)
Query: 18 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTPEWMAP 76
+++LH+ I++RD+K N+L+D + V + DFGLS+ A + S GT E+MAP
Sbjct: 118 LDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 77 EVLRDEPS--NEKSDIYSFGVILWELATLQQPW 107
EV+R ++ D +S GV+ +EL T P+
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 5e-13
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 12/93 (12%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
+G+ YLH I+HRD+K N+L++ +K+ DFGL+R + SA T
Sbjct: 111 EGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVIT 164
Query: 73 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 102
W PE+L + D++S G IL EL
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-13
Identities = 32/105 (30%), Positives = 61/105 (58%), Gaps = 2/105 (1%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
DE R A +V + +LHR +++RDLK N+L+D + K+ DFG+ + +
Sbjct: 94 DEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
++ + GTP+++APE+L++ D ++ GV+++E+ Q P+
Sbjct: 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-13
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 75
+G+ YLH N ++HRD+K+ N+L+ + VK+ DFG A+ + GTP WMA
Sbjct: 126 QGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANXFVGTPYWMA 179
Query: 76 PEVL--RDEPSNE-KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 132
PEV+ DE + K D++S G+ ELA + P N+N + + +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239
Query: 133 NPHVASIIEACWANEPWKRPSFSTIME 159
+ + + +++C P RP+ +++
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-12
Identities = 34/86 (39%), Positives = 52/86 (60%), Gaps = 7/86 (8%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEK 87
VHRD+K N+L+D+ +K+ DFG + RL AN ++SK GTP+++APEVL + K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 88 S------DIYSFGVILWELATLQQPW 107
D +S GVI +E+ + P+
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-12
Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT- 60
L + L + + +G+ YLH + I+HRD+K+ N+ ++ V + D G ++
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211
Query: 61 -FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
FL AGT E APEVL + N K+DI+S G++L+E+
Sbjct: 212 AFLG---LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-12
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 21/98 (21%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + K + Y+H N ++HRDLK N+L++ VK+ DFGL+R + + P
Sbjct: 114 YQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENP 167
Query: 72 --------EWM-APEVLRDEPSNEKSDIYSFGVILWEL 100
W APE+L S Y+ GV +W +
Sbjct: 168 VLTDYVATRWYRAPEILL------GSTRYTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-12
Identities = 40/148 (27%), Positives = 83/148 (56%), Gaps = 9/148 (6%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 70
+ +++ +N+LH R I++RDLK N+L+D + +K+ D+G+ + ++ + GT
Sbjct: 102 SAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW----GNLNPAQVVAAVGFK---G 123
P ++APE+LR E D ++ GV+++E+ + P+ + NP Q F+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKR 151
K++ IPR+++ +S+++ +P +R
Sbjct: 220 KQIRIPRSLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-12
Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD R + Y + G+ +LH + I+HRDLK N++V T+K+ DFGL+R +F
Sbjct: 115 LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+ + T + APEV+ E DI+S G I+ E+
Sbjct: 173 MMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-12
Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 25/170 (14%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL--SRLKANTFLSSKSA 67
MA ++A G+ ++H+ N +H DL N + TVKV D+G+ SR K + +
Sbjct: 104 MACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161
Query: 68 AGTPEWMAPEV-------LRDEPSNEKSDIYSFGVILWEL-ATLQQPWGNLNPAQVVAAV 119
W+APE+ L + S++++ GV LWEL QP+ +L+ +V+ V
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221
Query: 120 GFKGKRLEIPRNVNPHVA--------SIIEACWANEPWKRPSFSTIMELL 161
K +++++ + P + +++ CW + P KR + + LL
Sbjct: 222 -IKDQQVKLFK---PQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-12
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 3/103 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++ + +G+++LH IVHRDLK N+LV VK+ DFGL+R+ +
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE- 160
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ 104
++ S T + APEVL D++S G I EL +
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 3e-12
Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 20/102 (19%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + +G+ YLH N ++HRDLK N+LV+ +K+CDFGL+R
Sbjct: 110 YQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE-------DEK 160
Query: 72 EWM----------APEVLRDEPSNEKS-DIYSFGVILWELAT 102
++ APE+L K+ DI+S G I EL T
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-12
Identities = 36/134 (26%), Positives = 70/134 (52%), Gaps = 4/134 (2%)
Query: 18 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77
+ LH+ N +++RDLK N+L+D + + +CDFGL +L + + GTPE++APE
Sbjct: 106 LENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPE 163
Query: 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVA 137
+L + D ++ GV+L+E+ T P+ + N ++ + + L P +
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPLRFPDGFDRDAK 221
Query: 138 SIIEACWANEPWKR 151
++ + +P +R
Sbjct: 222 DLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-12
Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 14/98 (14%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA--- 68
+ + + + Y H N I+HRD+K N+LV + +K+CDFG +R L ++ A+
Sbjct: 107 WQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLT 159
Query: 69 ---GTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELAT 102
T + APE+L + + K D+++ G I+ EL
Sbjct: 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-12
Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 10/95 (10%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-----FLSSKS 66
Y + +G+ Y+H N ++HRDLK NLL++ +K+CDFGL+R+ FL+
Sbjct: 113 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 67 AAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 100
A T + APE++ + K+ DI+S G IL E+
Sbjct: 171 A--TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-12
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 4/158 (2%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 73
V KG+ YL R I+HRD+K N+LV+ + +K+CDFG+S ++ + S GT +
Sbjct: 112 VIKGLTYL-REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSY 168
Query: 74 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 133
M+PE L+ + +SDI+S G+ L E+A + P + ++ G + +
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228
Query: 134 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
P + P RP + I ELL ++ P P+
Sbjct: 229 PRPRPPGRPLSSYGPDSRPPMA-IFELLDYIVNEPPPK 265
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-12
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 3/102 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDE R + + +G+ + H N I+HRD+K N+LV + VK+CDFG +R A
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELAT 102
T + APE+L + ++ DI++ G ++ E+ T
Sbjct: 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-12
Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 19/98 (19%)
Query: 18 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----------------KANTF 61
+ YLH N IVHRDLK NLL+ +K+ DFGLS++ F
Sbjct: 114 LEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 99
L K GTPE++APEV+ + + D ++ G+IL+E
Sbjct: 172 L-DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-12
Identities = 31/106 (29%), Positives = 59/106 (55%), Gaps = 2/106 (1%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
DE R A ++ + +LH + I++RDLK N+L+D + K+ DFG+ +
Sbjct: 93 FDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
++ + GTP+++APE+L++ D ++ GV+L+E+ P+
Sbjct: 151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-12
Identities = 35/99 (35%), Positives = 47/99 (47%), Gaps = 12/99 (12%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRL-------KANTFLS 63
V + H + IVHRDLK N++V + KV DFG+ L T
Sbjct: 88 VLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 102
+ GTP + APE LR EP SD+Y++G+I E T
Sbjct: 146 TTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-11
Identities = 53/180 (29%), Positives = 92/180 (51%), Gaps = 14/180 (7%)
Query: 1 MLDERRRL------NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 54
+L E +R+ ++ V +G+ YL R I+HRD+K N+LV+ + +K+CDFG+S
Sbjct: 93 VLKEAKRIPEEILGKVSIAVLRGLAYL-REKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
Query: 55 RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 114
++ + S GT +M+PE L+ + +SDI+S G+ L ELA + P + +
Sbjct: 152 GQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
Query: 115 VVAAVG---FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+ A G G+ E P +++P + RP+ + I ELL ++ P P+
Sbjct: 210 LEAIFGRPVVDGEEGE-PHSISPRPRPPGRPVSGHGMDSRPAMA-IFELLDYIVNEPPPK 267
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-11
Identities = 40/187 (21%), Positives = 70/187 (37%), Gaps = 43/187 (22%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-------LKANTFLSSK 65
DV ++Y+H + +HR +K+ ++L+ V + S + K
Sbjct: 109 DVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166
Query: 66 SAAGTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPW---------------- 107
S+ W++PEVL+ NEKSDIYS G+ ELA P+
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226
Query: 108 --------------GNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWKR 151
+++ ++ ++ P R + H +E C +P R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 152 PSFSTIM 158
PS S ++
Sbjct: 287 PSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 1e-11
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 13/92 (14%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----LKANTFLSSKSAAGTP 71
G+ +LH I+HRDLK+ NLL++ + +K+CDFGL+R LK T L T
Sbjct: 118 GVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-----TL 170
Query: 72 EWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 102
+ APE+L + D++S G I EL T
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-11
Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+E R L A ++ G+ LHR N V+RDLK N+L+D +++ D GL+ +K
Sbjct: 99 FEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEG 155
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
S + GT +MAPEVL ++ D + G +++E+ Q P+
Sbjct: 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-11
Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD R + Y + G+ +LH + I+HRDLK N++V T+K+ DFGL+R F
Sbjct: 120 LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+ + T + APEV+ E DI+S G I+ EL
Sbjct: 178 MMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-11
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSS---KSA 67
Y + G+ Y+H N ++HRDLK NLLV+ +K+CDFGL+R N ++
Sbjct: 112 YQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 68 AGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 100
T + APE++ S K+ D++S G IL EL
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-11
Identities = 33/106 (31%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+E R + A ++ G+ LH+ IV+RDLK N+L+D +++ D GL+ +
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEG 155
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
+ K GT +MAPEV+++E D ++ G +L+E+ Q P+
Sbjct: 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-11
Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 6/91 (6%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGT 70
Y + +G+ Y+H + +VHRDLK N+L+++ +K+CDFGL+R++ S T
Sbjct: 114 LYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS---T 168
Query: 71 PEWMAPEV-LRDEPSNEKSDIYSFGVILWEL 100
+ APE+ L + + + DI+S G I E+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-11
Identities = 28/77 (36%), Positives = 49/77 (63%), Gaps = 5/77 (6%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSN-- 85
+HRD+K N+L+DK +K+ DFG ++ AN + +A GTP++++PEVL+ + +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 86 --EKSDIYSFGVILWEL 100
+ D +S GV L+E+
Sbjct: 224 YGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-11
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTF 61
DE R + A ++ G+ LHR IV+RDLK N+L+D +++ D GL+ +
Sbjct: 100 DEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
+ + GT +MAPEV+++E D + G +++E+ + P+
Sbjct: 158 I--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 6e-11
Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 3/86 (3%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 75
+G+ YLH I+HRDLK NLL+ K +K+ DFGL+R T + A
Sbjct: 119 RGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176
Query: 76 PEVLRDEPSNEKS-DIYSFGVILWEL 100
PE+L + + D+++ G IL EL
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-11
Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 25/103 (24%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + +G+ + H R ++HRDLK NLL+D K +K+ DFGL+R A G P
Sbjct: 108 YQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLAR-----------AFGIP 154
Query: 72 E-----------WMAPEVLRDEPS-NEKSDIYSFGVILWELAT 102
+ APEVL P + DI+S G I E+AT
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-11
Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG-- 69
Y + +G+ YLH I+HRD+K NLLV+ +K+CDFGL+R++ SK
Sbjct: 110 YQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVE--EPDESKHMTQEV 165
Query: 70 -TPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 100
T + APE+L DI+S G I EL
Sbjct: 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-11
Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD R + Y + G+ +LH + I+HRDLK N++V T+K+ DFGL+R +F
Sbjct: 123 LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+ + T + APEV+ E DI+S G I+ E+
Sbjct: 181 MMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-11
Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGTP 71
++ + +LH+ I++RD+K N+L+D V + DFGLS+ + + S GT
Sbjct: 113 EIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 72 EWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRL 126
E+MAP+++R D ++ D +S GV+++EL T P+ G N ++ K
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEP 229
Query: 127 EIPRNVNPHVASIIEACWANEPWKR 151
P+ ++ II+ +P KR
Sbjct: 230 PYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 9e-11
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + +G+ Y+H N ++HRDLK NLL++ +K+CDFGL+R + T
Sbjct: 115 YQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR 172
Query: 72 EWMAPEVLRDEPSNEKS-DIYSFGVILWEL 100
+ APE+L + + D++S G I EL
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 4/87 (4%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWM 74
KG+ Y+H I+HRDLK NLL+ +K+ DFGL+RL + T +
Sbjct: 110 KGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYR 167
Query: 75 APEVLRDEPS-NEKSDIYSFGVILWEL 100
APE+L + D+++ G I EL
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-10
Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD R + Y + G+ +LH + I+HRDLK N++V T+K+ DFGL+R +F
Sbjct: 116 LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+ + T + APEV+ E DI+S G I+ E+
Sbjct: 174 MMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-10
Identities = 36/101 (35%), Positives = 61/101 (60%), Gaps = 12/101 (11%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK-----SA 67
++ + +LH+ IV+RD+K N+L+D + V + DFGLS+ FLS + S
Sbjct: 113 EIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSF 166
Query: 68 AGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW 107
GT E+MAPE++R + + K+ D +S G++++EL T P+
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-10
Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 32/188 (17%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ E + + + +N+ H+ N +HRD+K N+L+ K+ +K+CDFG +R+
Sbjct: 97 VPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154
Query: 62 LSSKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW------------- 107
T + APE+L D D+++ G + EL T Q W
Sbjct: 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR 214
Query: 108 ---GNLNP--AQVVAAVG-FKGKRLEIP----------RNVNPHVASIIEACWANEPWKR 151
G+L P Q+ + FKG + P N++ S ++ C +P +R
Sbjct: 215 KTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTER 274
Query: 152 PSFSTIME 159
S ++E
Sbjct: 275 LSCEELLE 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-10
Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANT 60
L E + + + +N LH+ N I+H D+K N+L D K + +CD+GL ++
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKII--- 160
Query: 61 FLSSKSAA-GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP 106
+ S GT ++ +PE ++ + D ++ GV+ +EL T + P
Sbjct: 161 --GTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-10
Identities = 35/94 (37%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
+ + +G++Y H+R I+HRDLK NLL+++K +K+ DFGL+R K+ + + T
Sbjct: 110 FQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL 167
Query: 72 EWMAPEVLRDEPSNEKS---DIYSFGVILWELAT 102
+ P+VL S E S D++ G IL+E+AT
Sbjct: 168 WYRPPDVLLG--STEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-10
Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPEW 73
+G+ YLH I+HRDLK NLL+ +K+ DFGL+R N ++ + T +
Sbjct: 113 RGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWY 168
Query: 74 MAPEVLRDEPSNEKS---DIYSFGVILWEL 100
APE+L + D++S G I EL
Sbjct: 169 RAPELLFG--ARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-10
Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
DE+R + A ++ G+ L R IV+RDLK N+L+D + +++ D GL+ ++
Sbjct: 99 FDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEG 155
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
+ + GT +MAPEV+ +E D + G +++E+ Q P+
Sbjct: 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-10
Identities = 36/123 (29%), Positives = 67/123 (54%), Gaps = 4/123 (3%)
Query: 18 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77
+ +LH++ I++RDLK N+L+D + VK+ DFGL + + + + GT E+MAPE
Sbjct: 113 LEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170
Query: 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVA 137
+L + D +S G +++++ T P+ N + + + KGK L +P + P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-LKGK-LNLPPYLTPEAR 228
Query: 138 SII 140
++
Sbjct: 229 DLL 231
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-10
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKSAAGT 70
Y + K +++ H+ + IVHRD+K NLL+ +K+CDFG +R L + + T
Sbjct: 107 YQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVAT 164
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ 104
+ +PE+L P + D++S G IL EL+ Q
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-10
Identities = 29/92 (31%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
+ + +G+NY HRR ++HRDLK NLL++++ +K+ DFGL+R K+ + + T
Sbjct: 111 FQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL 168
Query: 72 EWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 102
+ P++L + + D++ G I +E++T
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-10
Identities = 30/82 (36%), Positives = 51/82 (62%), Gaps = 7/82 (8%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEWMAPEV 78
YL N IV+RDLK NLL+DK +K+ DFG +++ T+ + GTPE++APE+
Sbjct: 146 YLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TLCGTPEYIAPEI 199
Query: 79 LRDEPSNEKSDIYSFGVILWEL 100
L + + +D ++ G+ ++E+
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-10
Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 15/113 (13%)
Query: 2 LDERRR------LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS- 54
L +R L + V + + YLH I+HRD+K+ N+ ++ V + DFG +
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230
Query: 55 ---RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ 104
+ AN + AGT APE+L +P DI+S G++L+E+AT
Sbjct: 231 FPVDINANKYYG---WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-09
Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + +G+ Y HRR ++HRDLK NLL++++ +K+ DFGL+R K+ + + T
Sbjct: 111 YQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168
Query: 72 EWMAPEVLRDEPSNEKS---DIYSFGVILWELAT 102
+ P+VL S+E S D++ G I +E+A+
Sbjct: 169 WYRPPDVLLG--SSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYT----VKVCDFGLSRLKA 58
+L +A +A +++L + + H ++ + N+L+ D+K +K+ D G+S
Sbjct: 102 KLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI--- 156
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT-LQQPWGNLNPAQVV 116
T L + W+ PE + + + + +D +SFG LWE+ + +P L+ +
Sbjct: 157 -TVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-- 213
Query: 117 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158
+ F R ++P +A++I C EP RPSF I+
Sbjct: 214 -KLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-09
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 38/110 (34%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGL---------------------------------SR 55
+HRD+K NLL+D K +K+ DFGL S+
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 56 LKANTFLSSK-----SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
KA T+ ++ S GTP+++APEV N++ D +S GVI++E+
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-09
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 23/113 (20%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E+R + Y + K ++++HR I HRD+K N+L+ K +K+ DFG
Sbjct: 97 LPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILI-KDDILKLADFG--------- 144
Query: 62 LSSKSAAGTP--------EWM-APE-VLRDEPSNEKSDIYSFGVILWELATLQ 104
S + P W APE +L D K DI++ G + +E+ +L
Sbjct: 145 -SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-09
Identities = 32/109 (29%), Positives = 64/109 (58%), Gaps = 5/109 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANT 60
L+ R ++ + + G+ +LH + IV+RD+K N+L+D + ++ D GL+ LK
Sbjct: 92 LEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 109
++ + AGT +MAPE+L++EP + D ++ G ++E+ + P+ +
Sbjct: 150 TITQR--AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-09
Identities = 19/47 (40%), Positives = 32/47 (68%), Gaps = 2/47 (4%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55
+ +G+NYLH + I+HRD+K+ N+L+D + +K+ DFGL+R
Sbjct: 119 CYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-09
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 60/206 (29%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKS 66
N+ + +G+NYLH+ +HR++K+ ++L+ V + GLS L + +K
Sbjct: 105 NILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160
Query: 67 AAGTPE-------WMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQ--- 114
P+ W++PE+LR + N KSDIYS G+ ELAT + P+ ++ Q
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220
Query: 115 -------------------------------------VVAAVG---FKGKRLEIP--RNV 132
VVAA +RL P +
Sbjct: 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280
Query: 133 NPHVASIIEACWANEPWKRPSFSTIM 158
+P +++E C +P KRPS S+++
Sbjct: 281 SPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-09
Identities = 33/103 (32%), Positives = 47/103 (45%), Gaps = 25/103 (24%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + +G+ Y H ++HRDLK NLL+D++ +K+ DFGL+R A G P
Sbjct: 106 YQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLAR-----------AFGVP 152
Query: 72 E----------WM-APEVLRDEPSNEKS-DIYSFGVILWELAT 102
W APE+L DI+S G I E+
Sbjct: 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-09
Identities = 27/84 (32%), Positives = 49/84 (58%), Gaps = 5/84 (5%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSN-- 85
+HRD+K N+L+DK +K+ DFG ++ + +A GTP++++PEVL+ + +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 86 --EKSDIYSFGVILWELATLQQPW 107
+ D +S GV L+E+ P+
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-09
Identities = 29/100 (29%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTP 71
+V ++ +H ++HRD+K N+L+DK +K+ DFG ++ + +A GTP
Sbjct: 150 EVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP 207
Query: 72 EWMAPEVLRDEPSN----EKSDIYSFGVILWELATLQQPW 107
++++PEVL+ + + + D +S GV L+E+ P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-09
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA 68
+M + + +G+++LH +VHRDLK N+LV +K+ DFGL+R+ + + S
Sbjct: 114 DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVV 170
Query: 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
T + APEVL D++S G I E+
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-09
Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---LKANTFLSSK 65
+ Y + KG+ + H ++HRDLK NLL++K+ +K+ DFGL+R + NTF
Sbjct: 104 SFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---S 158
Query: 66 SAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELAT 102
+ T + AP+VL + S DI+S G I+ E+ T
Sbjct: 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-09
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
+ Y + +G+ Y+H I+HRDLK N+ V++ +K+ DFGL+R + ++ A
Sbjct: 123 LVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTGYVA-- 177
Query: 70 TPEWMAPEVLRDEPS-NEKSDIYSFGVILWELAT 102
T + APE++ + N+ DI+S G I+ EL T
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-09
Identities = 36/105 (34%), Positives = 51/105 (48%), Gaps = 4/105 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANT 60
L + + Y + KG+ + H+ ++HRDLK NLLVDK K +K+ D GL R +
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP 164
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQ 104
S T + APEVL DI+S G I E++ Q
Sbjct: 165 VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-09
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
+ Y + +G+ Y+H + I+HRDLK NL V++ +K+ DFGL+R +
Sbjct: 125 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVA 179
Query: 70 TPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 102
T + APE++ + N+ DI+S G I+ EL T
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 8e-09
Identities = 29/85 (34%), Positives = 50/85 (58%), Gaps = 6/85 (7%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEK 87
VHRD+K N+L+DK +++ DFG RL A+ + S A GTP++++PE+L+ +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 88 S-----DIYSFGVILWELATLQQPW 107
D +S GV ++E+ + P+
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-08
Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 9/100 (9%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAA-- 68
A ++ G+ ++H R +V+RDLK N+L+D+ V++ D GL A F K A
Sbjct: 103 AAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASV 156
Query: 69 GTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW 107
GT +MAPEVL+ + + S D +S G +L++L P+
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-08
Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 9/100 (9%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK--SAA 68
A ++ G+ ++H R +V+RDLK N+L+D+ V++ D GL A F K ++
Sbjct: 103 ATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASV 156
Query: 69 GTPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW 107
GT +MAPEVL+ + + S D +S G +L++L P+
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-08
Identities = 37/126 (29%), Positives = 56/126 (44%), Gaps = 35/126 (27%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGL------------------------------SRLKA 58
+HRD+K NLL+D K VK+ DFGL S+ KA
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 59 NTFLSSK-----SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 113
T+ ++ S GTP+++APEV N+ D +S GVI++E+ P+ + P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 114 QVVAAV 119
+ V
Sbjct: 243 ETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-08
Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 17/102 (16%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG------ 69
G+N LH+ +HRDL N+ ++ K K+ DFGL+R S +
Sbjct: 130 NGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 70 ---TPE-----WMAPEVLR-DEPSNEKSDIYSFGVILWELAT 102
T + + APE+L E + D++S G I EL T
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 52/189 (27%), Positives = 81/189 (42%), Gaps = 39/189 (20%)
Query: 4 ERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
ERRR +A +AK + +LH R +P +V +L +++D K + L L
Sbjct: 780 ERRR-KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK 837
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
S+A ++APE + EKSDIY FG+IL EL T + +PA A G
Sbjct: 838 CFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGK------SPAD--AEFGVH 885
Query: 123 GKRLE------------------IPRNVNPHVASIIEA------CWANEPWKRPSFSTIM 158
G +E I +V+ + I+E C A +P RP + ++
Sbjct: 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945
Query: 159 ELLRPLIKS 167
+ L +S
Sbjct: 946 KTLESASRS 954
|
Length = 968 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-08
Identities = 37/126 (29%), Positives = 56/126 (44%), Gaps = 35/126 (27%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGL------------------------------SRLKA 58
+HRD+K NLL+D K VK+ DFGL S+ KA
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 59 NTFLSSK-----SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 113
T+ ++ S GTP+++APEV N+ D +S GVI++E+ P+ + P
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 114 QVVAAV 119
+ V
Sbjct: 243 ETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-08
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 11/96 (11%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN------TFLSSK 65
Y + +G+ Y+H N ++HRDLK NLLV++ +++ DFG++R ++ F++
Sbjct: 114 YQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 66 SAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 100
A T + APE+L P D++S G I E+
Sbjct: 172 VA--TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-08
Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E R + Y + KG+ Y+H I+HRDLK NL V++ +K+ DFGL+R + ++
Sbjct: 115 LSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE 171
Query: 62 LSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 102
++ T + APEV+ + + DI+S G I+ E+ T
Sbjct: 172 MTGYVV--TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-08
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 6/94 (6%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
+ Y + G+ Y+H I+HRDLK NL V++ +K+ DFGL+R A+ ++
Sbjct: 122 LVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV-- 176
Query: 70 TPEWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 102
T + APEV+ + N+ DI+S G I+ E+ T
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-08
Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 12/92 (13%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE---- 72
G+NY H++N +HRD+K N+L++ K +K+ DFGL+RL + S +S T +
Sbjct: 128 GLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL----YNSEESRPYTNKVITL 181
Query: 73 WMAPE--VLRDEPSNEKSDIYSFGVILWELAT 102
W P +L +E D++S G IL EL T
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-08
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 21/162 (12%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV-----DKKYT--VKVCDFGLSRLKANT 60
L++A +A ++YL + +VH ++ N+LV ++ Y +K+ D G+ T
Sbjct: 104 LDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----T 157
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKS--DIYSFGVILWELATLQQPWGN--LNPAQVV 116
LS + W+APE +R+ ++ D +SFG L E+ + G L+
Sbjct: 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS----NGEEPLSTLSSS 213
Query: 117 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158
F + +P +A++I CW +P KRPSF I+
Sbjct: 214 EKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-08
Identities = 34/145 (23%), Positives = 57/145 (39%), Gaps = 45/145 (31%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------------------ 54
++ + +H+ +HRD+K N+L+D+ +K+ DFGL
Sbjct: 109 ELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 55 -------------------------RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 89
R + + + S GTP ++APEVL + D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 90 IYSFGVILWELATLQQPWGNLNPAQ 114
+S GVIL+E+ Q P+ PA+
Sbjct: 227 WWSVGVILYEMLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-08
Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
+ + KG+ + H N ++HRDLK NLL++K +K+ DFGL+R + T
Sbjct: 106 FQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL 163
Query: 72 EWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQP 106
+ P+VL S D++S G I ELA +P
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-08
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 15/95 (15%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG------- 69
G+ Y+HR I+HRD+K+ N+L+ K +K+ DFGL+R F SK++
Sbjct: 131 GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNRYTNRV 184
Query: 70 -TPEWMAPEV-LRDEPSNEKSDIYSFGVILWELAT 102
T + PE+ L + D++ G I+ E+ T
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-08
Identities = 29/110 (26%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEVLRDEPSNE- 86
VHRD+K N+L+D +++ DFG +L + + S A GTP++++PE+L+ +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 87 ----KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 132
+ D +S GV ++E+ + P+ + + + +R + P V
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-07
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
+ + +G+ Y H+R ++HRDLK NLL+ ++ +K+ DFGL+R K+ + + T
Sbjct: 110 FQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 72 EWMAPEVLRDEPSNEKS---DIYSFGVILWELAT 102
+ P+VL S E S D++ G I +E+AT
Sbjct: 168 WYRPPDVLLG--STEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-07
Identities = 31/92 (33%), Positives = 56/92 (60%), Gaps = 6/92 (6%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
+ Y + +G+ Y+H + I+HRDLK N+ V++ +++ DFGL+R +A+ ++ A
Sbjct: 123 LIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEMTGYVA-- 177
Query: 70 TPEWMAPEVLRD-EPSNEKSDIYSFGVILWEL 100
T + APE++ + N+ DI+S G I+ EL
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-07
Identities = 30/84 (35%), Positives = 51/84 (60%), Gaps = 4/84 (4%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSA-AGTPEWMAPE 77
YLH R I+HRD+K+ N+ +D+ + DFG + +L A+ +GT E +PE
Sbjct: 200 YLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE 257
Query: 78 VLRDEPSNEKSDIYSFGVILWELA 101
+L +P K+DI+S G++L+E++
Sbjct: 258 LLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-07
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-------VKVCDFGLSRLKAN 59
++ +A +A ++YL +N +VH ++ + N+L+ + +K+ D G+S
Sbjct: 119 KITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF---- 172
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVA 117
T LS + W+APE + S + +D +SFG L E+ + P P++
Sbjct: 173 TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
F K+ +P +A++I C EP +RPSF TI+ L
Sbjct: 230 KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-07
Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 8/111 (7%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEPS-- 84
VHRD+K N+L+D +++ DFG S LK N + S A GTP++++PE+L+
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 85 ---NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 132
+ D +S GV ++E+ + P+ + + + +R + P ++
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-07
Identities = 27/74 (36%), Positives = 40/74 (54%), Gaps = 2/74 (2%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
DE + +VA ++YLHR I+HRDLK N+L+ + +K+ DFGLS++ N L
Sbjct: 102 DEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL 159
Query: 63 SSKSAAGTPEWMAP 76
+ TP P
Sbjct: 160 NMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-07
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 11/98 (11%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-----TFLSSKS 66
Y + + + Y+H N + HRDLK N+L + +K+CDFGL+R+ N F +
Sbjct: 110 YQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 67 AAGTPEWMAPEVLRDEPSNEKS--DIYSFGVILWELAT 102
A T + APE+ S DI+S G I E+ T
Sbjct: 168 A--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-07
Identities = 31/85 (36%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 75
+G+++LH IVHRDLK N+LV VK+ DFGL+R+ + ++ T + A
Sbjct: 119 RGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRA 175
Query: 76 PEVLRDEPSNEKSDIYSFGVILWEL 100
PEVL D++S G I E+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 5e-07
Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 10/96 (10%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKAN---TFLSSKSAAG 69
G++YLH ++HRDLK N+LV ++ VK+ D GL+RL
Sbjct: 120 GVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 70 TPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQ 104
T + APE+L K+ DI++ G I EL TL+
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-06
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 4/95 (4%)
Query: 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKS 66
RL M + + +G+ Y+H ++ I+HRDLK NLL+ +K+ DFGL+R K+ + S
Sbjct: 106 RLFM-FQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162
Query: 67 AAGTPEWMAPEVLRDEPSNEKS-DIYSFGVILWEL 100
T + P+VL + DI+ G I E+
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-06
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 7/92 (7%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
+ + +G++Y+H+R I+HRDLK NLL+ +K+ DFGL+R K+ + + T
Sbjct: 110 FQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTL 167
Query: 72 EWMAPEVLRDEPSNEKS---DIYSFGVILWEL 100
+ P+VL S E S D++ G I E+
Sbjct: 168 WYRPPDVLLG--STEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-06
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGT 70
Y + +G+ Y H ++HRDLK NLL+D++ +K+ DFGL+R + T
Sbjct: 109 YQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT 166
Query: 71 PEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQP 106
+ APE+L + DI+S G I E+ Q+P
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 4e-06
Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 24/105 (22%)
Query: 28 IVHRDLKSPNLLV-----------------DKKYTVKVCDFGLSRLKANTFLSS--KSAA 68
++HRDLK N+ + + + K+ DFGLS+ N + S S
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---NIGIESMAHSCV 202
Query: 69 GTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLN 111
GTP + +PE+L E ++KSD+++ G I++EL + + P+ N
Sbjct: 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-06
Identities = 28/86 (32%), Positives = 49/86 (56%), Gaps = 4/86 (4%)
Query: 18 MNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMA 75
++Y+H I+HRD+K+ N+LV+ + + DFG + ++ + AGT + A
Sbjct: 273 IDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330
Query: 76 PEVLRDEPSNEKSDIYSFGVILWELA 101
PEVL +P DI+S G++++E A
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-06
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
+ + +G+ + H ++HRDLK NLL++ + +K+ DFGL+R + T
Sbjct: 107 FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 164
Query: 72 EWMAPEVLRD-EPSNEKSDIYSFGVILWELAT 102
+ APE+L + + DI+S G I E+ T
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-06
Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 12/109 (11%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKAN 59
+ +E RL M Y + +G+ Y+H N ++HRDLK N+ ++ + V K+ DFGL+R+ +
Sbjct: 111 LSEEHARLFM-YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARI-VD 166
Query: 60 TFLSSK---SAAGTPEWM-APEVLRDEPSN--EKSDIYSFGVILWELAT 102
S K S +W +P +L P+N + D+++ G I E+ T
Sbjct: 167 PHYSHKGYLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-05
Identities = 53/216 (24%), Positives = 80/216 (37%), Gaps = 64/216 (29%)
Query: 2 LDERRRLNMAY---DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL----- 53
+D L +AY V K ++Y+H VHR +K+ ++L+ KV GL
Sbjct: 95 MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLS 150
Query: 54 -----SRLKANTFLSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQP 106
RL+ S P W++PEVL+ + + KSDIYS G+ ELA P
Sbjct: 151 MINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
Query: 107 WGN------------------------------LNPAQVVAAVGF-KGKRLEIPRNVN-- 133
+ + + P++ A G + + PR N
Sbjct: 210 FKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGE 269
Query: 134 -----------PHVASIIEACWANEPWKRPSFSTIM 158
PH +E C P RPS ST++
Sbjct: 270 SSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-05
Identities = 29/97 (29%), Positives = 54/97 (55%), Gaps = 15/97 (15%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFG-----LSRLKANTFLSS 64
+Y + + + Y+H + I HRDLK NLL+D +T+K+CDFG L+ ++ +++ S
Sbjct: 176 SYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233
Query: 65 KSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWEL 100
+ + APE++ + D++S G I+ E+
Sbjct: 234 RF------YRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 31/118 (26%), Positives = 51/118 (43%), Gaps = 47/118 (39%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGLS-------------RL---KANTF----------- 61
+HRD+K N+L+D+ +K+ DFGLS +L K+N
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 62 -----LSSK---------------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWE 99
+SSK S GTP+++APE+ + ++ D +S G I++E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-05
Identities = 40/161 (24%), Positives = 62/161 (38%), Gaps = 49/161 (30%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGL----------------------------------- 53
+HRD+K N+L+D+ +K+ DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 54 ----SRLKANTFLSSK--------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 101
RLK +++ S GTP ++APEVL + D +S GVIL+E+
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 102 TLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASII 140
Q P+ P + V L IP ++P + +I
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-05
Identities = 51/212 (24%), Positives = 75/212 (35%), Gaps = 59/212 (27%)
Query: 29 VHRDLKSPNLLVDKKYTVKVCDFGL----------------------------------- 53
+HRD+K N+L+D +K+ DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 54 ----SRLKANTFLSSK--------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 101
RLK ++K S GTP ++APEVL + + D +S GVIL+E+
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 102 TLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV--NPHVASIIE--ACWANE--------PW 149
Q P+ P + V L IP V +P +I C A E
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 150 KRPSFSTIMELLRPLIKSPTPQPSPTDMPLLT 181
K F + ++ + P P P+ T
Sbjct: 303 KAHPFFSEVDFSSDIRTQPAPYVPKISHPMDT 334
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 1e-04
Identities = 31/119 (26%), Positives = 50/119 (42%), Gaps = 31/119 (26%)
Query: 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT---------- 60
A +V + YLH IV+RDLK N+L+ + + + DF LS+
Sbjct: 109 AAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 61 -------------FLS------SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
S S S GT E++APEV+ + D ++ G++L+E+
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 3e-04
Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 18/161 (11%)
Query: 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV-----DKKYT--VKVCDFGLSRLKAN 59
+ +A +A ++YL ++ +VH ++ + N+L+ D + +K+ D G+
Sbjct: 107 KFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI---- 160
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVA 117
T LS + W+APE + D + + +D +SFG LWE+ + P L +
Sbjct: 161 TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP---LKDKTLAE 217
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158
F + + +A ++ C +P +RP F IM
Sbjct: 218 KERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 7e-04
Identities = 16/42 (38%), Positives = 26/42 (61%)
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELA 101
F + + + P +MAPEV++ + EK+DIYS G+ L+E
Sbjct: 57 AFKTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 7e-04
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 10/102 (9%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF--L 62
++ Y + G++YLH ++HRDLK N+LV ++ VK+ D G +RL + L
Sbjct: 112 SLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 63 SSKSAAGTPEWM-APEVLRDEPSNEKS-DIYSFGVILWELAT 102
+ W APE+L K+ DI++ G I EL T
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.001
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 10/102 (9%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF--L 62
++ Y + G++YLH ++HRDLK N+LV ++ VK+ D G +RL + L
Sbjct: 112 SLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 63 SSKSAAGTPEWM-APEVLRDEPSNEKS-DIYSFGVILWELAT 102
+ W APE+L K+ DI++ G I EL T
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 181 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.98 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.92 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.91 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.9 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.89 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.89 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.88 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.87 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.85 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.83 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.77 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.77 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.62 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.61 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.38 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.32 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.31 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.24 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.24 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.17 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.15 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.6 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.58 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.56 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.43 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.19 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.13 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.84 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.81 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.79 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.35 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.04 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 96.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.88 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 96.78 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.17 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.4 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.38 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.32 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.06 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.8 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.8 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 94.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 94.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.37 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 94.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 93.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.38 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.18 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.54 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 92.47 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.18 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 92.05 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 91.84 | |
| PLN02236 | 344 | choline kinase | 91.64 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 91.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 91.27 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.2 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 90.31 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 87.87 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 87.55 | |
| PF10140 | 359 | YukC: WXG100 protein secretion system (Wss), prote | 86.73 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 86.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 85.82 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 84.05 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 83.21 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 82.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 82.2 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 81.92 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 81.36 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 81.03 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 80.14 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=241.32 Aligned_cols=159 Identities=27% Similarity=0.518 Sum_probs=147.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|+|.+++++++||+.||.|||+++ |+|||+|..|+|++.+.++|++|||++...........+..|||.|.|||++..
T Consensus 115 ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k 192 (592)
T KOG0575|consen 115 LTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK 192 (592)
T ss_pred CCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhcc
Confidence 689999999999999999999999 999999999999999999999999999988776666778899999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
.+.+..+||||+||++|.+|.|++||......+...++.... ..+|..++.+.++||.++|+.||.+|||++++++
T Consensus 193 ~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~-- 268 (592)
T KOG0575|consen 193 SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD-- 268 (592)
T ss_pred CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc--
Confidence 889999999999999999999999999999999998885444 4556689999999999999999999999999999
Q ss_pred HHhhh
Q 030203 162 RPLIK 166 (181)
Q Consensus 162 ~~~~~ 166 (181)
+++++
T Consensus 269 h~Ff~ 273 (592)
T KOG0575|consen 269 HPFFK 273 (592)
T ss_pred CHhhh
Confidence 99994
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=230.42 Aligned_cols=163 Identities=34% Similarity=0.588 Sum_probs=144.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++|....+++.+|++||.|||+ ++ |+||||||+|++++..|.+||+|||++....+. ...+.+||..|++||++.
T Consensus 175 i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~ 250 (364)
T KOG0581|consen 175 IPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERIS 250 (364)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhc
Confidence 5788899999999999999996 77 999999999999999999999999999866655 456779999999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhccCCccCCCCC-CCHHHHHHHHHHhcCCCCCCCCH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNL-----NPAQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
+..|+.++||||||+.++|++.|+.|+... +..++...+. .+.....|.. +|+++++|+..||+.||.+||++
T Consensus 251 g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~ 329 (364)
T KOG0581|consen 251 GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSA 329 (364)
T ss_pred CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCH
Confidence 999999999999999999999999999774 5566777775 5555666665 99999999999999999999999
Q ss_pred HHHHHHHHHhhhCCCCC
Q 030203 155 STIMELLRPLIKSPTPQ 171 (181)
Q Consensus 155 ~~~l~~L~~~~~~~~~~ 171 (181)
+++++ |+|+++...+
T Consensus 330 ~qLl~--Hpfi~~~~~~ 344 (364)
T KOG0581|consen 330 KQLLQ--HPFIKKFEDP 344 (364)
T ss_pred HHHhc--CHHHhhcccc
Confidence 99999 9998875543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=217.34 Aligned_cols=162 Identities=26% Similarity=0.484 Sum_probs=142.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhC--CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRR--NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~--~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++|+.+|+++.|++.||.++|+. ..-+.||||||.|||++.+|.+||+|||+++...+...-..+.+|||.|++||.
T Consensus 120 ~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~ 199 (375)
T KOG0591|consen 120 LIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPER 199 (375)
T ss_pred cCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHH
Confidence 478999999999999999999992 112899999999999999999999999999877776666677899999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCC-CCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP-RNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+++.+|+.++|+||+||++|+|..-+.||.+.+..++..++. .+...+.| ..+|.++..+|..|+..||..||+...+
T Consensus 200 i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 200 IHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred HhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 999999999999999999999999999999999999999887 44444556 6789999999999999999999985555
Q ss_pred HHHHHH
Q 030203 158 MELLRP 163 (181)
Q Consensus 158 l~~L~~ 163 (181)
+.-+..
T Consensus 279 v~di~~ 284 (375)
T KOG0591|consen 279 VQDIQS 284 (375)
T ss_pred HHHHHH
Confidence 554443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=232.47 Aligned_cols=165 Identities=30% Similarity=0.595 Sum_probs=150.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|.+++.|++++++||+|||.+| |+|+|||.+||+++.+|.+|++|||++.+.........+.+|++.|+|||....
T Consensus 366 ~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr 443 (550)
T KOG0578|consen 366 MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR 443 (550)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh
Confidence 689999999999999999999999 999999999999999999999999999887777767788999999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..|..++||||||++++||+-|++||-..++...+..+..++. ....+..+|+.+++|+++||..|+.+|+++.++|+
T Consensus 444 k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~- 522 (550)
T KOG0578|consen 444 KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE- 522 (550)
T ss_pred cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc-
Confidence 9999999999999999999999999988888777777765544 45678899999999999999999999999999999
Q ss_pred HHHhhhCCCC
Q 030203 161 LRPLIKSPTP 170 (181)
Q Consensus 161 L~~~~~~~~~ 170 (181)
+++++.+.+
T Consensus 523 -HpFl~~a~p 531 (550)
T KOG0578|consen 523 -HPFLKMAKP 531 (550)
T ss_pred -ChhhhhcCC
Confidence 898866544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=216.99 Aligned_cols=155 Identities=26% Similarity=0.435 Sum_probs=139.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|+|..+.-++.+|+.||.|||+.| |+|||+||+||+++.+|+++|+|||+++..........+..||+.|+|||++.+
T Consensus 122 F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 122 FSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred cchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhc
Confidence 678889999999999999999999 999999999999999999999999999977776667777899999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC----CHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP----SFSTI 157 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~~ 157 (181)
.+++..+|.||||+++|+|++|.+||.+.+...+.+++.. ......+..++.+.++++.+++..||.+|. ++.++
T Consensus 200 ~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~-~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~i 278 (357)
T KOG0598|consen 200 KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK-GKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEI 278 (357)
T ss_pred CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc-CcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHh
Confidence 9999999999999999999999999999999999988853 334555667999999999999999999996 56665
Q ss_pred HH
Q 030203 158 ME 159 (181)
Q Consensus 158 l~ 159 (181)
.+
T Consensus 279 k~ 280 (357)
T KOG0598|consen 279 KR 280 (357)
T ss_pred hc
Confidence 54
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=219.05 Aligned_cols=168 Identities=50% Similarity=0.842 Sum_probs=150.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++...++.|+.+|+.|+.|||++++ ++|+|||++|++++.++ ++|++|||+++.............||..|+|||.++
T Consensus 139 l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~ 217 (362)
T KOG0192|consen 139 LPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLR 217 (362)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhc
Confidence 6788899999999999999999986 89999999999999997 999999999976554322333468889999999999
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
...++.++||||+|+++|++++|+.||.+.........+.....+..++..+++.+..++.+||+.||.+||++.+++
T Consensus 218 ~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 218 GEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred CCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 568999999999999999999999999999988888888778888888998999999999999999999999999999
Q ss_pred HHHHHhhhCCCC
Q 030203 159 ELLRPLIKSPTP 170 (181)
Q Consensus 159 ~~L~~~~~~~~~ 170 (181)
..|+.+.+....
T Consensus 298 ~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 298 SRLESIMSHISS 309 (362)
T ss_pred HHHHHHHHhhcc
Confidence 999988775443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=223.26 Aligned_cols=159 Identities=29% Similarity=0.527 Sum_probs=140.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-----------ccC--CCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-----------LSS--KSAA 68 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-----------~~~--~~~~ 68 (181)
|+|..+..++.||+.||.|||++| |+||||||+|||++.+|+++|+|||.++...... ... ...+
T Consensus 171 fde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFV 248 (604)
T KOG0592|consen 171 FDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFV 248 (604)
T ss_pred chHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCccccee
Confidence 678899999999999999999999 9999999999999999999999999987432211 111 4578
Q ss_pred CCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCC
Q 030203 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEP 148 (181)
Q Consensus 69 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 148 (181)
|+-.|.+||++.+...+..+|+|+|||++|+|+.|++||.+.++.-+.+++ .......+..+++.+++|++++|..||
T Consensus 249 GTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--~~l~y~fp~~fp~~a~dLv~KLLv~dp 326 (604)
T KOG0592|consen 249 GTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--QALDYEFPEGFPEDARDLIKKLLVRDP 326 (604)
T ss_pred eeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--HHhcccCCCCCCHHHHHHHHHHHccCc
Confidence 999999999999999999999999999999999999999999998888887 445566788899999999999999999
Q ss_pred CCCCCHHHHHHHHHHhhh
Q 030203 149 WKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 149 ~~Rps~~~~l~~L~~~~~ 166 (181)
.+|++..+|.+ |.+|.
T Consensus 327 ~~Rlt~~qIk~--HpFF~ 342 (604)
T KOG0592|consen 327 SDRLTSQQIKA--HPFFE 342 (604)
T ss_pred cccccHHHHhh--Ccccc
Confidence 99999999988 65544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=219.40 Aligned_cols=160 Identities=31% Similarity=0.516 Sum_probs=143.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC-CcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+.|.++.+++.|+++|+.|||++| ++|||||++|++++.+ +++|++|||++...........+..|++.|.|||++.
T Consensus 117 l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~ 194 (370)
T KOG0583|consen 117 LKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLS 194 (370)
T ss_pred CChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhC
Confidence 578899999999999999999999 9999999999999999 9999999999987643334456778999999999999
Q ss_pred CCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCC-CHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 81 DEP-SN-EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV-NPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 81 ~~~-~~-~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.. |+ .++|+||+|+++|.|++|..||...+...+..++ ......+|..+ ++++++++.+|+..||.+|+++.++
T Consensus 195 ~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i 272 (370)
T KOG0583|consen 195 GKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEI 272 (370)
T ss_pred CCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 877 75 7899999999999999999999998888887776 55556677777 9999999999999999999999999
Q ss_pred HHHHHHhhhC
Q 030203 158 MELLRPLIKS 167 (181)
Q Consensus 158 l~~L~~~~~~ 167 (181)
++ ++|++.
T Consensus 273 ~~--h~w~~~ 280 (370)
T KOG0583|consen 273 LE--HPWFQK 280 (370)
T ss_pred hh--Chhhcc
Confidence 95 999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=215.92 Aligned_cols=165 Identities=32% Similarity=0.590 Sum_probs=138.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCcccccc---ccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKAN---TFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~---~~~~~~~~~~~~~~~~pe 77 (181)
|+|..+..+..|+++||.|||++| ++|+|||++||+++. ++.+||+|||.+..... .........|++.|++||
T Consensus 114 l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPE 191 (313)
T KOG0198|consen 114 LPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPE 191 (313)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCch
Confidence 688999999999999999999999 999999999999999 79999999998875442 112234568899999999
Q ss_pred ccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDE-PSNEKSDIYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+..+ ....++|+||+||++.+|+||+.||.. .........+......+++|..++.+.++++.+||..+|.+|||+.
T Consensus 192 vi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~ 271 (313)
T KOG0198|consen 192 VIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAE 271 (313)
T ss_pred hhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHH
Confidence 99853 233589999999999999999999998 5555555566555555688899999999999999999999999999
Q ss_pred HHHHHHHHhhhCCCC
Q 030203 156 TIMELLRPLIKSPTP 170 (181)
Q Consensus 156 ~~l~~L~~~~~~~~~ 170 (181)
++++ +.+++....
T Consensus 272 eLL~--hpf~~~~~~ 284 (313)
T KOG0198|consen 272 ELLE--HPFLKQNSI 284 (313)
T ss_pred HHhh--Chhhhcccc
Confidence 9999 777765443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=224.44 Aligned_cols=166 Identities=31% Similarity=0.543 Sum_probs=150.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|.++++++.||+.|+.|+|..+ |+|+|++|+|++++..+++|++|||++...... ....+..|++.|.+||+++|
T Consensus 109 l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-klLeTSCGSPHYA~PEIV~G 185 (786)
T KOG0588|consen 109 LPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KLLETSCGSPHYAAPEIVSG 185 (786)
T ss_pred CCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-ccccccCCCcccCCchhhcC
Confidence 578999999999999999999999 999999999999999999999999999765544 34466789999999999999
Q ss_pred CCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..| ..++||||.|+++|.+|+|+.||++.+...++.++ .....++|..+++++++|+.+|+..||.+|.|.++|++
T Consensus 186 ~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k- 262 (786)
T KOG0588|consen 186 RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK- 262 (786)
T ss_pred CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh-
Confidence 987 46899999999999999999999999999999988 55667889999999999999999999999999999999
Q ss_pred HHHhhhCCCCCCCC
Q 030203 161 LRPLIKSPTPQPSP 174 (181)
Q Consensus 161 L~~~~~~~~~~~~~ 174 (181)
|.|+..-...+.+
T Consensus 263 -HP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 263 -HPFLSGYTSLPSS 275 (786)
T ss_pred -CchhhcCCCCChh
Confidence 9998877766654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=221.11 Aligned_cols=163 Identities=25% Similarity=0.395 Sum_probs=138.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC---CcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+.|.....+++|++.|+.|||++| |.||||||+||++..+ ..+|++|||+++..+... --.+..||+.|.|||+
T Consensus 273 l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s-fm~TlCGTpsYvAPEV 349 (475)
T KOG0615|consen 273 LREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS-FMKTLCGTPSYVAPEV 349 (475)
T ss_pred cccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhccccce-ehhhhcCCccccChhh
Confidence 567778899999999999999999 9999999999999765 678999999999876443 3356789999999999
Q ss_pred cCCCCC---CCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 79 LRDEPS---NEKSDIYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 79 ~~~~~~---~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+.+.+. ..++|+||+||++|.+++|.+||.+...+. +.+++.....-. ..+..++.+..++|++||..||++||
T Consensus 350 l~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~ 429 (475)
T KOG0615|consen 350 LASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP 429 (475)
T ss_pred eecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc
Confidence 987653 347899999999999999999998775544 666665444332 35567899999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCC
Q 030203 153 SFSTIMELLRPLIKSPT 169 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~ 169 (181)
|++++|+ ++|++..+
T Consensus 430 s~~eaL~--hpW~~~~~ 444 (475)
T KOG0615|consen 430 SADEALN--HPWFKDAP 444 (475)
T ss_pred CHHHHhc--Chhhhccc
Confidence 9999999 99999665
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=213.75 Aligned_cols=166 Identities=36% Similarity=0.665 Sum_probs=147.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
++-.+.+.++.|||+|.+||++++ ++|||+.+.|||++.+..+|++|||+++...+... ......-...|+|||.+.
T Consensus 300 l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~ 377 (468)
T KOG0197|consen 300 LNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALN 377 (468)
T ss_pred cchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHh
Confidence 455688999999999999999999 99999999999999999999999999995444333 223333445899999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...++.++||||||++++|+.| |+.|+.+....+.++.+. .+.+.+-|..+|+.+.+++..||+.+|++|||++.+..
T Consensus 378 ~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 378 YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 9999999999999999999997 899999999999999997 78888889999999999999999999999999999999
Q ss_pred HHHHhhhCCCC
Q 030203 160 LLRPLIKSPTP 170 (181)
Q Consensus 160 ~L~~~~~~~~~ 170 (181)
.|+++.....+
T Consensus 457 ~l~~~~~~~~~ 467 (468)
T KOG0197|consen 457 VLEDFFTSTEG 467 (468)
T ss_pred HHHHhhhcccC
Confidence 99998876543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=210.73 Aligned_cols=164 Identities=34% Similarity=0.661 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.|||+++ ++|+||||.||+++.++.++++|||+++...... .......++..|+|||.+
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 567888999999999999999999 9999999999999999999999999986533211 111223445689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+...................+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~ 328 (338)
T cd05102 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328 (338)
T ss_pred hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88888999999999999999997 99999876543333222223444455677899999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+++.
T Consensus 329 ~~l~~~~~~ 337 (338)
T cd05102 329 EILGDLLQE 337 (338)
T ss_pred HHHHHHHhc
Confidence 999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=195.39 Aligned_cols=175 Identities=22% Similarity=0.295 Sum_probs=147.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+|+..++..++.++++||+|||++. ++|||+||.|++++.+|.+|+.|||+++....+.......+.+.+|.|||.+.
T Consensus 97 ~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLf 174 (318)
T KOG0659|consen 97 ILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLF 174 (318)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhc
Confidence 4678899999999999999999999 99999999999999999999999999999888877777778899999999998
Q ss_pred CCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--c------------------------CCCCCCC
Q 030203 81 DEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--L------------------------EIPRNVN 133 (181)
Q Consensus 81 ~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~------------------------~~~~~~~ 133 (181)
|.+ |...+|+||.||++.|++-|.+-|.+.+.-+.+.++-..-.. . .+-...+
T Consensus 175 Gsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas 254 (318)
T KOG0659|consen 175 GSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAAS 254 (318)
T ss_pred cchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccccccccc
Confidence 754 889999999999999999999999888776655544111110 0 0112345
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCCCCCCCCC
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 179 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~~~~~~~~ 179 (181)
.+..+|+.+|+.+||.+|+++.++++ +.+++..+.+..|..+|.
T Consensus 255 ~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~~P~pt~~~~lp~ 298 (318)
T KOG0659|consen 255 SDALDLLSKMLTYNPKKRITASQALK--HPYFKSLPLPTPPSKLPI 298 (318)
T ss_pred HHHHHHHHhhhccCchhcccHHHHhc--chhhhcCCCCCChhhCcC
Confidence 67889999999999999999999999 999999888777776653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=212.47 Aligned_cols=174 Identities=22% Similarity=0.330 Sum_probs=147.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 80 (181)
|++.++..+++||+.||.|||++| ++|||||.+|||++.+|.+||+|||+++++... ....++.+.|.+|.+||.+.
T Consensus 215 ft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLL 292 (560)
T KOG0600|consen 215 FTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLL 292 (560)
T ss_pred cChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhc
Confidence 688999999999999999999999 999999999999999999999999999965543 33467778899999999998
Q ss_pred CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--------CCC-------------------CCC
Q 030203 81 DE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--------EIP-------------------RNV 132 (181)
Q Consensus 81 ~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~-------------------~~~ 132 (181)
|. .|+.++|+||.||++.||+.|++.|.+....+.+.+|-...... .+| ..+
T Consensus 293 G~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~ 372 (560)
T KOG0600|consen 293 GATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDF 372 (560)
T ss_pred CCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccC
Confidence 75 48999999999999999999999999998887777652211100 111 235
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCCCCCCCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 179 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~~~~~~~~ 179 (181)
++...+|+..+|..||.+|.|+.++++ .++|+..+.+..|..+|.
T Consensus 373 ~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 373 PASALDLLEKLLSLDPDKRGTASSALQ--SEYFTTEPLPCDPSSLPK 417 (560)
T ss_pred CHHHHHHHHHHhccCccccccHHHHhc--CcccccCCCCCCcccCCC
Confidence 667889999999999999999999999 999988777778877775
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=194.86 Aligned_cols=164 Identities=28% Similarity=0.399 Sum_probs=144.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc---CCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
++|..+.+.+.||+++|.|+|.+| |+|||++|+|+++. ....+||+|||++.... .........|+|.|++||+
T Consensus 107 ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEv 183 (355)
T KOG0033|consen 107 YSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEV 183 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHH
Confidence 577888999999999999999999 99999999999993 34568999999998666 3445567899999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
++..+++..+|+|+.|+++|-++.|..||.+.+...+.+.+...... .+...+++++.++|+.+||..||.+|.|+.|
T Consensus 184 vrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~E 263 (355)
T KOG0033|consen 184 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADE 263 (355)
T ss_pred hhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHH
Confidence 99999999999999999999999999999999999988888655443 3356789999999999999999999999999
Q ss_pred HHHHHHHhhhCCCC
Q 030203 157 IMELLRPLIKSPTP 170 (181)
Q Consensus 157 ~l~~L~~~~~~~~~ 170 (181)
.++ ++|+.+...
T Consensus 264 AL~--HpWi~~r~~ 275 (355)
T KOG0033|consen 264 ALK--HPWICNRER 275 (355)
T ss_pred HhC--CchhcchHH
Confidence 999 888876543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=201.45 Aligned_cols=175 Identities=22% Similarity=0.290 Sum_probs=151.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|.+.++.-++.|++.|+.|||.+. |+|||+|++|++++..|.+|++|||+++.++++....+..+.+.+|.|||.+.+
T Consensus 174 F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG 251 (419)
T KOG0663|consen 174 FLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLG 251 (419)
T ss_pred CchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcC
Confidence 467788999999999999999999 999999999999999999999999999999998777788899999999999987
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCccC----------------------------CCC-
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGKRLE----------------------------IPR- 130 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~----------------------------~~~- 130 (181)
.. |+.+.|+||+||++.+++.+++-|.+....+.+.++-. .+.+.+ .+.
T Consensus 252 ~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~ 331 (419)
T KOG0663|consen 252 AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGAL 331 (419)
T ss_pred CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhcccc
Confidence 65 89999999999999999999999999887766665511 111100 000
Q ss_pred CCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCCCCCCCCCC
Q 030203 131 NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLL 180 (181)
Q Consensus 131 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~~~~~~~~~ 180 (181)
.++..-.+|++.+|.+||.+|.|+.+.++ ++|+...+.+-.|..+|++
T Consensus 332 ~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~P~~~Pt~ 379 (419)
T KOG0663|consen 332 SLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPIDPSMFPTW 379 (419)
T ss_pred ccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCChhhcCCC
Confidence 14577889999999999999999999999 9999999999899998875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=210.96 Aligned_cols=160 Identities=29% Similarity=0.514 Sum_probs=136.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||++..............+++.|+|||.+.+
T Consensus 92 ~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05571 92 FSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC
Confidence 578899999999999999999999 999999999999999999999999988643332222334568889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+||++|+|++|+.||...+.......+.. .....+..+++++.+++.+||+.||.+|| ++.+
T Consensus 170 ~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05571 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE 247 (323)
T ss_pred CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 8889999999999999999999999988887776665532 23455678999999999999999999999 8999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++|++.
T Consensus 248 ll~--h~~f~~ 256 (323)
T cd05571 248 IME--HRFFAS 256 (323)
T ss_pred HHc--CCCcCC
Confidence 988 666643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=211.02 Aligned_cols=164 Identities=34% Similarity=0.574 Sum_probs=143.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|.++..++.+++.|+.|+|.++ .+|+||++.||++..+|.+++.|||++.+.........+.+|++.|+|||++..
T Consensus 108 ~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~ 185 (467)
T KOG0201|consen 108 LDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ 185 (467)
T ss_pred CccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhcc
Confidence 467788889999999999999999 999999999999999999999999999877776666688999999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..|+.++|+||||++.++|++|.+|+....+......+- ...++.+...+++.+++|+..||..||+.||++.++++
T Consensus 186 ~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK-- 262 (467)
T KOG0201|consen 186 SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK-- 262 (467)
T ss_pred ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh--
Confidence 899999999999999999999999999988754333332 33344455689999999999999999999999999999
Q ss_pred HHhhhCCCC
Q 030203 162 RPLIKSPTP 170 (181)
Q Consensus 162 ~~~~~~~~~ 170 (181)
+.+++...+
T Consensus 263 h~FIk~a~k 271 (467)
T KOG0201|consen 263 HKFIKRAKK 271 (467)
T ss_pred hHHHHhcCC
Confidence 888887543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=198.18 Aligned_cols=161 Identities=25% Similarity=0.408 Sum_probs=139.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|++..+|++|++.+++|||.++ |+|+|+||+||+++++.+++++|||++++...+. ......|+++|+|||.++.
T Consensus 120 lSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge-kLrelCGTPgYLAPEtikC 196 (411)
T KOG0599|consen 120 LSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE-KLRELCGTPGYLAPETIKC 196 (411)
T ss_pred ecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceeeccCCch-hHHHhcCCCcccChhheee
Confidence 689999999999999999999999 9999999999999999999999999998766553 3345689999999999853
Q ss_pred ------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--cCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 82 ------EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 82 ------~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
-+|+..+|.|++|+++|.++.|.+||...+..-++..+...... .+.+.+++.+.++||.+||+.||.+|.|
T Consensus 197 ~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit 276 (411)
T KOG0599|consen 197 SMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT 276 (411)
T ss_pred ecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc
Confidence 34677899999999999999999999998887777777654443 3445678999999999999999999999
Q ss_pred HHHHHHHHHHhhhC
Q 030203 154 FSTIMELLRPLIKS 167 (181)
Q Consensus 154 ~~~~l~~L~~~~~~ 167 (181)
+++++. ++++..
T Consensus 277 ake~La--Hpff~q 288 (411)
T KOG0599|consen 277 AKEALA--HPFFIQ 288 (411)
T ss_pred HHHHhc--ChHHHH
Confidence 999998 777643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=199.39 Aligned_cols=160 Identities=34% Similarity=0.572 Sum_probs=135.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....... .......+++.|+|||.+
T Consensus 121 l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05048 121 LDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI 198 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHh
Confidence 567788999999999999999999 9999999999999999999999999876432211 112233456789999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+....+....+. .......+..+++.+.+++.+||+.||.+||++++++
T Consensus 199 ~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~ 277 (283)
T cd05048 199 LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIH 277 (283)
T ss_pred ccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88888999999999999999997 999999888877776664 3334456778999999999999999999999999999
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+.|+++
T Consensus 278 ~~l~~~ 283 (283)
T cd05048 278 TRLRSW 283 (283)
T ss_pred HHHhcC
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=205.08 Aligned_cols=166 Identities=25% Similarity=0.388 Sum_probs=137.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+|+|..+..|++||++||.|+|.+| ++|||+||+||++..+..+|++|||+++...+. ...+.-+.|.+|+|||++.
T Consensus 106 ~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-pPYTeYVSTRWYRAPEvLL 182 (538)
T KOG0661|consen 106 LFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRSK-PPYTEYVSTRWYRAPEVLL 182 (538)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccccC-CCcchhhhcccccchHHhh
Confidence 4889999999999999999999999 999999999999998889999999999854432 2345567888999999774
Q ss_pred -CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc----------------------------CCCCC
Q 030203 81 -DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL----------------------------EIPRN 131 (181)
Q Consensus 81 -~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~ 131 (181)
.+.|+.+.|+|++||+++|+.+-++-|.+.++.+.+.++....... .+-.+
T Consensus 183 rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~ 262 (538)
T KOG0661|consen 183 RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN 262 (538)
T ss_pred hccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc
Confidence 5558999999999999999999999999998877776652211110 01134
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
+++++.+++.+|++.||.+|||+.++++ +.+++.....
T Consensus 263 ~s~~~~~li~~ll~WDP~kRpTA~~al~--~pffq~~~~~ 300 (538)
T KOG0661|consen 263 ASSEAASLIERLLAWDPDKRPTASQALQ--HPFFQVGRAS 300 (538)
T ss_pred cCHHHHHHHHHHhcCCCccCccHHHHhc--Cccccccccc
Confidence 7789999999999999999999999999 8888755444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=213.01 Aligned_cols=149 Identities=30% Similarity=0.484 Sum_probs=138.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|++..+.-++..|+.||.|||++| |+|||+|.+||++|..|++||+|||+++........+.+..||+.|+|||++.+
T Consensus 465 F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e 542 (694)
T KOG0694|consen 465 FSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE 542 (694)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhcc
Confidence 688899999999999999999999 999999999999999999999999999877755556778899999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
..|+.++|.|+||+++|+|+.|+.||.+.+.+++.+.+ ......+|..+|.+..+++.++|..+|++|..+
T Consensus 543 ~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI--~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 543 QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI--VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--hcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 99999999999999999999999999999999999888 444556788899999999999999999999954
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=206.95 Aligned_cols=159 Identities=28% Similarity=0.499 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 92 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 169 (328)
T cd05593 92 FSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED 169 (328)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcC
Confidence 578899999999999999999999 999999999999999999999999987643322222234467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+|+++|+|++|+.||...+.......+. ......+..+++++.+++.+||..||.+|+ ++.+
T Consensus 170 ~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 888999999999999999999999998887776665553 233456778999999999999999999997 8999
Q ss_pred HHHHHHHhhh
Q 030203 157 IMELLRPLIK 166 (181)
Q Consensus 157 ~l~~L~~~~~ 166 (181)
+++ +.|+.
T Consensus 248 il~--h~~~~ 255 (328)
T cd05593 248 IMR--HSFFT 255 (328)
T ss_pred Hhc--CCCcC
Confidence 987 45543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=205.85 Aligned_cols=159 Identities=28% Similarity=0.521 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 92 ~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05595 92 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccC
Confidence 578899999999999999999999 999999999999999999999999987643322222234567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+|+++|+|++|+.||...+.......+.. .....+..+++++.+++.+||..||.+|+ ++.+
T Consensus 170 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 8889999999999999999999999988887766665532 23345678899999999999999999998 8999
Q ss_pred HHHHHHHhhh
Q 030203 157 IMELLRPLIK 166 (181)
Q Consensus 157 ~l~~L~~~~~ 166 (181)
+++ +.++.
T Consensus 248 ~l~--h~~~~ 255 (323)
T cd05595 248 VME--HRFFL 255 (323)
T ss_pred HHc--CCCcC
Confidence 887 55544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=199.37 Aligned_cols=159 Identities=28% Similarity=0.464 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++...+.++.+++.|+.+||+. + ++|+||+|+||+++.++.++++|||++...... .....++..|+|||.+.
T Consensus 119 ~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~ 193 (283)
T PHA02988 119 LSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLN 193 (283)
T ss_pred CChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhh
Confidence 46778899999999999999985 7 889999999999999999999999987643322 12346678899999987
Q ss_pred C--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 81 D--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 81 ~--~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
+ ..++.++|+||||+++|++++|+.||.+.+..++...+.....+...+..+++.+.+++.+||+.||.+|||+++++
T Consensus 194 ~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell 273 (283)
T PHA02988 194 DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273 (283)
T ss_pred hccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 6 56889999999999999999999999998877777666445555566667899999999999999999999999999
Q ss_pred HHHHHhh
Q 030203 159 ELLRPLI 165 (181)
Q Consensus 159 ~~L~~~~ 165 (181)
+.|+.+.
T Consensus 274 ~~l~~~~ 280 (283)
T PHA02988 274 YNLSLYK 280 (283)
T ss_pred HHHHHHH
Confidence 9998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=195.68 Aligned_cols=144 Identities=26% Similarity=0.484 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|+++.+.-++.||+.||+|||+.+ +++||+||+||++|.+|++|++|||.++..... ..+..|++.|+|||.+..
T Consensus 141 F~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 141 FSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred CCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhc
Confidence 678889999999999999999999 999999999999999999999999999765443 456789999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
.++..++|-|+||+++|||+.|.+||...++..+.+++ .......|..+++++++|+.++++.|-.+|.
T Consensus 216 k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 216 KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--LEGKVKFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--HhCcccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 99999999999999999999999999999998888888 4555667889999999999999999999993
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=196.80 Aligned_cols=160 Identities=23% Similarity=0.404 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++.+.++++|++.|+.|+|+++ ++||||||+||+++.+|.+||+|||+++....+....+.-+.|.+|.|||.+.+
T Consensus 98 ~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 98 VPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVG 175 (396)
T ss_pred CCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcc
Confidence 467788999999999999999999 999999999999999999999999999876655555566678889999999987
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------------------ccCCC----------CC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-------------------RLEIP----------RN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~----------~~ 131 (181)
.+|...+|||++||++.||++|.+-|.+.+..+....+...-. +.+.+ ..
T Consensus 176 DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~ 255 (396)
T KOG0593|consen 176 DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPK 255 (396)
T ss_pred cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhccc
Confidence 6799999999999999999999999999877665554422111 11111 23
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhh
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~ 165 (181)
++.-+.+++.+||+.||.+|++.++++. +++|
T Consensus 256 ~s~~~ld~~k~cL~~dP~~R~sc~qll~--H~yF 287 (396)
T KOG0593|consen 256 ISNVLLDLLKKCLKMDPDDRLSCEQLLH--HPYF 287 (396)
T ss_pred chHHHHHHHHHHhcCCccccccHHHHhc--ChHH
Confidence 5567889999999999999999999986 4443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=208.01 Aligned_cols=157 Identities=31% Similarity=0.554 Sum_probs=145.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+|+|+.+.+|+.|++.|+.|||++. |+|||++..|||++.++.++|+|||+++..........+.+|++.|++||.+.
T Consensus 102 ~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~ 179 (426)
T KOG0589|consen 102 LFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILS 179 (426)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhC
Confidence 4789999999999999999999998 99999999999999999999999999998777665666789999999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
+..|..++|+|||||++|+|++-+++|...+...+..++. .....+++..++.+++.++..||..+|..||++.+++..
T Consensus 180 d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 180 DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 9999999999999999999999999999999999998885 344677888999999999999999999999999999985
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=205.31 Aligned_cols=160 Identities=26% Similarity=0.455 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 93 l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (320)
T cd05590 93 FDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170 (320)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC
Confidence 578889999999999999999999 999999999999999999999999987643322222334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH------H
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF------S 155 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~ 155 (181)
..++.++|+||+|+++|+|++|+.||...+.......+. ......+..+++++.+++.+||+.||.+|+++ +
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 248 (320)
T cd05590 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEE 248 (320)
T ss_pred CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHH
Confidence 888899999999999999999999999988877776664 23334566789999999999999999999998 7
Q ss_pred HHHHHHHHhhhC
Q 030203 156 TIMELLRPLIKS 167 (181)
Q Consensus 156 ~~l~~L~~~~~~ 167 (181)
++++ ++|++.
T Consensus 249 ~~~~--h~~f~~ 258 (320)
T cd05590 249 AILR--HPFFKE 258 (320)
T ss_pred HHHc--CCCcCC
Confidence 7777 666643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=194.44 Aligned_cols=161 Identities=37% Similarity=0.650 Sum_probs=134.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC-CCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~pe~~~ 80 (181)
+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+.......... .....+..|++||...
T Consensus 101 l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 178 (263)
T cd05052 101 VNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 178 (263)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhc
Confidence 567888999999999999999999 9999999999999999999999999886544332111 1122345799999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||||+++|+|++ |..||.+.+.......+. .......+..+++.+.+++.+|+..+|.+||++.++++
T Consensus 179 ~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 179 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8888899999999999999998 999998887777666654 33344556778999999999999999999999999999
Q ss_pred HHHHhh
Q 030203 160 LLRPLI 165 (181)
Q Consensus 160 ~L~~~~ 165 (181)
.|+.++
T Consensus 258 ~l~~~~ 263 (263)
T cd05052 258 AFETMF 263 (263)
T ss_pred HHHhhC
Confidence 998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=204.50 Aligned_cols=160 Identities=25% Similarity=0.448 Sum_probs=134.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++..............+++.|+|||.+.+
T Consensus 90 ~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 167 (312)
T cd05585 90 FDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG 167 (312)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcC
Confidence 567889999999999999999999 999999999999999999999999998753332222334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC---HHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS---FSTIM 158 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l 158 (181)
..++.++|+||+|+++|+|++|+.||...........+. ......+..+++.+.+++.+||..||.+||+ +.+++
T Consensus 168 ~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 888999999999999999999999999888777666653 2344566789999999999999999999985 67777
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+ +++++.
T Consensus 246 ~--hp~~~~ 252 (312)
T cd05585 246 N--HPFFSQ 252 (312)
T ss_pred c--CCCcCC
Confidence 6 566554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=203.71 Aligned_cols=159 Identities=29% Similarity=0.470 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 98 l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 175 (324)
T cd05589 98 FSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE 175 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcC
Confidence 578899999999999999999999 999999999999999999999999987643322222334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+|+++|+|++|+.||.+.+.......+... ....+..+++.+.+++.+||..||.+|| ++.+
T Consensus 176 ~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 253 (324)
T cd05589 176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAED 253 (324)
T ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 88899999999999999999999999998877776666432 3345677899999999999999999999 5777
Q ss_pred HHHHHHHhhh
Q 030203 157 IMELLRPLIK 166 (181)
Q Consensus 157 ~l~~L~~~~~ 166 (181)
+++ +.+++
T Consensus 254 l~~--~~~f~ 261 (324)
T cd05589 254 VKK--QPFFR 261 (324)
T ss_pred Hhh--CCCcC
Confidence 777 44443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=204.02 Aligned_cols=159 Identities=26% Similarity=0.481 Sum_probs=132.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||++..............+++.|+|||.+.+
T Consensus 93 ~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05620 93 FDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC
Confidence 567888999999999999999999 999999999999999999999999987643222222234567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH-HHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~~ 160 (181)
..++.++|+||+|+++|+|++|..||...+.......+.. .....+..+++++++++.+||+.||.+|+++. ++++
T Consensus 171 ~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~- 247 (316)
T cd05620 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG- 247 (316)
T ss_pred CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc-
Confidence 8889999999999999999999999998888777766642 23445667899999999999999999999874 6664
Q ss_pred HHHhhh
Q 030203 161 LRPLIK 166 (181)
Q Consensus 161 L~~~~~ 166 (181)
+++++
T Consensus 248 -h~~f~ 252 (316)
T cd05620 248 -HPFFK 252 (316)
T ss_pred -CCCcC
Confidence 44443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=203.80 Aligned_cols=154 Identities=30% Similarity=0.538 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|++||.+.+
T Consensus 93 ~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05592 93 FDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC
Confidence 577889999999999999999999 999999999999999999999999998654332223334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH-HHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~ 159 (181)
..++.++|+||+|+++|+|++|+.||.+.+.......+. ......+..+++++.+++.+||+.||.+||++. ++++
T Consensus 171 ~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 888999999999999999999999999988877766663 234456677899999999999999999999875 5555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=197.01 Aligned_cols=164 Identities=37% Similarity=0.595 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.|+.|||+++ ++|+||+|.||+++.++.++++|||++....... .......++..|++||..
T Consensus 120 ~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 197 (291)
T cd05094 120 LGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 197 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHh
Confidence 577889999999999999999999 9999999999999999999999999986433221 112233456789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |+.||.........+.+. .......+..++..+.+++.+|++.+|.+||++++++
T Consensus 198 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~ 276 (291)
T cd05094 198 MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276 (291)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 88888899999999999999998 999998887776666554 3333344556788999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+++.+..
T Consensus 277 ~~l~~~~~~~ 286 (291)
T cd05094 277 KILHALGKAT 286 (291)
T ss_pred HHHHHHHhhc
Confidence 9999997753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=205.37 Aligned_cols=162 Identities=32% Similarity=0.589 Sum_probs=132.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++........ ......++..|+|||.+
T Consensus 209 l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 286 (374)
T cd05106 209 LDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 286 (374)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHh
Confidence 577889999999999999999999 99999999999999999999999999865433211 11122344579999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |+.||.....................+..+++++.+++.+||+.||.+||++.+++
T Consensus 287 ~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 287 FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88888999999999999999997 99999876554433333334444445566789999999999999999999999999
Q ss_pred HHHHHhh
Q 030203 159 ELLRPLI 165 (181)
Q Consensus 159 ~~L~~~~ 165 (181)
+.|++++
T Consensus 367 ~~l~~~~ 373 (374)
T cd05106 367 QLIQRQL 373 (374)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-31 Score=193.52 Aligned_cols=160 Identities=30% Similarity=0.564 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++..+..++.|++.||.+||+++ ++|+||+|.||+++.++.++++|||.+........ ......++..|++||.
T Consensus 92 ~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 169 (257)
T cd05116 92 VTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhH
Confidence 578889999999999999999999 99999999999999999999999999865433211 1122233468999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+....++.++|+||||+++|++++ |+.||...........+. .......+..+++++.+++.+|+..||.+||++++|
T Consensus 170 ~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i 248 (257)
T cd05116 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248 (257)
T ss_pred hccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence 877778889999999999999997 999999888777777775 333455677899999999999999999999999999
Q ss_pred HHHHHHh
Q 030203 158 MELLRPL 164 (181)
Q Consensus 158 l~~L~~~ 164 (181)
.+.|+++
T Consensus 249 ~~~l~~~ 255 (257)
T cd05116 249 ELRLRNY 255 (257)
T ss_pred HHHHhcc
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-31 Score=196.60 Aligned_cols=164 Identities=35% Similarity=0.590 Sum_probs=137.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||.+
T Consensus 117 l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 194 (288)
T cd05093 117 LTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 194 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHh
Confidence 678899999999999999999999 9999999999999999999999999886433221 111223345689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||||+++++|++ |..||...........+.. ......+..+++.+.+++.+||+.||.+|||+.++.
T Consensus 195 ~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 195 MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 88888899999999999999998 8999988887777666653 333344567889999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+++.+..
T Consensus 274 ~~l~~~~~~~ 283 (288)
T cd05093 274 SLLQNLAKAS 283 (288)
T ss_pred HHHHHHHHhc
Confidence 9999888653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=200.66 Aligned_cols=158 Identities=23% Similarity=0.364 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++...... .......+++.|+|||.+.+
T Consensus 107 ~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 183 (290)
T cd07862 107 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ 183 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhC
Confidence 577899999999999999999999 999999999999999999999999998654332 22234467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-c------------------------cCCCCCCCHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-R------------------------LEIPRNVNPHV 136 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~------------------------~~~~~~~~~~~ 136 (181)
..++.++|+||+|+++|+|++|+.||.+....+....+..... . ......+++.+
T Consensus 184 ~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (290)
T cd07862 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 263 (290)
T ss_pred CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHH
Confidence 8888999999999999999999999988776554444321100 0 00123577889
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHh
Q 030203 137 ASIIEACWANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 137 ~~li~~~l~~~p~~Rps~~~~l~~L~~~ 164 (181)
.+++.+||+.||.+|||+.++++ ++|
T Consensus 264 ~~li~~~l~~~P~~R~s~~~~l~--hp~ 289 (290)
T cd07862 264 KDLLLKCLTFNPAKRISAYSALS--HPY 289 (290)
T ss_pred HHHHHHHhccCchhcCCHHHHhc--CCC
Confidence 99999999999999999999997 544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-31 Score=196.83 Aligned_cols=168 Identities=33% Similarity=0.619 Sum_probs=138.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++++++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....... .......+..|++||...+
T Consensus 116 l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 192 (297)
T cd05089 116 LTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNY 192 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhcc
Confidence 567889999999999999999999 9999999999999999999999999875332211 1111223456999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||||+++|+|++ |..||...........+. .......+..++..+.+++.+|+..+|.+||+++++++.
T Consensus 193 ~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 193 SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 778899999999999999997 999998888777666654 333444566789999999999999999999999999999
Q ss_pred HHHhhhCCCCCCC
Q 030203 161 LRPLIKSPTPQPS 173 (181)
Q Consensus 161 L~~~~~~~~~~~~ 173 (181)
|+.+++.......
T Consensus 272 l~~~~~~~~~~~~ 284 (297)
T cd05089 272 LSRMLEARKAYVN 284 (297)
T ss_pred HHHHHHhhccccc
Confidence 9999887654433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=203.31 Aligned_cols=160 Identities=28% Similarity=0.504 Sum_probs=134.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+
T Consensus 93 l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 170 (318)
T cd05570 93 FDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170 (318)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcC
Confidence 578899999999999999999999 999999999999999999999999987643222222233457889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH-----HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----ST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ 156 (181)
..++.++|+||+|+++|+|++|+.||...+.......+.. .....+..+++.+.+++.+||..||.+||++ .+
T Consensus 171 ~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ 248 (318)
T cd05570 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE--DEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQD 248 (318)
T ss_pred CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 8889999999999999999999999998887776665532 2334566789999999999999999999999 88
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++|++.
T Consensus 249 ll~--~~~~~~ 257 (318)
T cd05570 249 IKG--HPFFRE 257 (318)
T ss_pred Hhc--CCCcCC
Confidence 887 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-31 Score=194.21 Aligned_cols=160 Identities=33% Similarity=0.579 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
++++.+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++........ ......++..|++||..
T Consensus 109 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 186 (272)
T cd05075 109 LPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHc
Confidence 578889999999999999999999 99999999999999999999999999875433211 12223445679999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |+.||.+.....+...+. .......+..++..+.+++.+||+.||.+|||+.+++
T Consensus 187 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~ 265 (272)
T cd05075 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLR 265 (272)
T ss_pred cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 88888999999999999999998 789998877777666664 3333445567889999999999999999999999999
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+.|+.+
T Consensus 266 ~~l~~~ 271 (272)
T cd05075 266 CELEKA 271 (272)
T ss_pred HHHHhh
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=200.17 Aligned_cols=157 Identities=27% Similarity=0.480 Sum_probs=134.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.+|.++++|||++...... .....+++.|+|||.+.+
T Consensus 98 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 98 FSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQS 172 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---cccccCChhhcCHHHHcC
Confidence 567888999999999999999999 999999999999999999999999998654332 223467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----HHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ 156 (181)
..++.++|+||+|+++|+|++|+.||.+.+.......+.. .....+..+++.+++++.+||+.||.+|++ +.+
T Consensus 173 ~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 250 (291)
T cd05612 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--GKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADD 250 (291)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHH
Confidence 8888999999999999999999999999887776666632 234556778999999999999999999995 999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ +.|++.
T Consensus 251 ~l~--h~~~~~ 259 (291)
T cd05612 251 VKN--HRWFKS 259 (291)
T ss_pred Hhc--CccccC
Confidence 998 777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-30 Score=193.59 Aligned_cols=164 Identities=29% Similarity=0.554 Sum_probs=136.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||..
T Consensus 106 ~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~ 183 (279)
T cd05111 106 LDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHh
Confidence 578889999999999999999999 9999999999999999999999999986533221 112233455689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||.+.........+. .......+..++.++.+++.+|+..||.+|||+.+++
T Consensus 184 ~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~ 262 (279)
T cd05111 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELA 262 (279)
T ss_pred ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 88888999999999999999998 999998887766555543 3344445566788999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|..+.+++
T Consensus 263 ~~l~~~~~~~ 272 (279)
T cd05111 263 NEFTRMARDP 272 (279)
T ss_pred HHHHHHHhCC
Confidence 9999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=196.20 Aligned_cols=160 Identities=29% Similarity=0.514 Sum_probs=133.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++..+..++.|++.||.|+|+++ ++|+||+|.||+++.++.++++|||++....... .......+++.|++||.+
T Consensus 121 ~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05091 121 LEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI 198 (283)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHH
Confidence 466778899999999999999999 9999999999999999999999999876433221 111223445689999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+.......+.+. .......+..++..+.+++.+|++.+|.+||++++++
T Consensus 199 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~ 277 (283)
T cd05091 199 MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIH 277 (283)
T ss_pred hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 87778899999999999999998 888998888777776664 3333445677899999999999999999999999999
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
..|++|
T Consensus 278 ~~l~~~ 283 (283)
T cd05091 278 SRLRTW 283 (283)
T ss_pred HHhhCC
Confidence 999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=203.84 Aligned_cols=159 Identities=27% Similarity=0.464 Sum_probs=135.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 93 ~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (321)
T cd05591 93 FDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170 (321)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcC
Confidence 567889999999999999999999 999999999999999999999999988653333223334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-------CH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-------SF 154 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------s~ 154 (181)
..++.++|+||+|+++|+|++|+.||...+.......+... ....+..+++++.+++.+||..||.+|+ ++
T Consensus 171 ~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~ 248 (321)
T cd05591 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGE 248 (321)
T ss_pred CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCH
Confidence 88899999999999999999999999998888777766432 2344566899999999999999999999 88
Q ss_pred HHHHHHHHHhhh
Q 030203 155 STIMELLRPLIK 166 (181)
Q Consensus 155 ~~~l~~L~~~~~ 166 (181)
.++++ ++++.
T Consensus 249 ~~~~~--hp~~~ 258 (321)
T cd05591 249 DAIKQ--HPFFK 258 (321)
T ss_pred HHHhc--CCccC
Confidence 88887 55553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=202.94 Aligned_cols=154 Identities=26% Similarity=0.500 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 98 ~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 175 (324)
T cd05587 98 FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY 175 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcC
Confidence 578889999999999999999999 999999999999999999999999987643222222334467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH-----HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----ST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ 156 (181)
..++.++|+||+|+++|+|++|+.||.+.+.......+. ......+..+++.+.+++.+||..||.+|++. .+
T Consensus 176 ~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 253 (324)
T cd05587 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERD 253 (324)
T ss_pred CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH
Confidence 888899999999999999999999999988877776664 23345567789999999999999999999976 66
Q ss_pred HHH
Q 030203 157 IME 159 (181)
Q Consensus 157 ~l~ 159 (181)
+++
T Consensus 254 ~~~ 256 (324)
T cd05587 254 IRE 256 (324)
T ss_pred Hhc
Confidence 665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=206.22 Aligned_cols=159 Identities=28% Similarity=0.517 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.
T Consensus 92 l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05594 92 FSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHc
Confidence 5788999999999999999997 78 99999999999999999999999998764332222233456888999999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFS 155 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ 155 (181)
+..++.++|+||+|+++|+|++|..||.+.+.......+. ......+..+++++.+++.+||+.||.+|+ ++.
T Consensus 170 ~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (325)
T cd05594 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAK 247 (325)
T ss_pred cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence 8888999999999999999999999999888776666553 233445677899999999999999999997 899
Q ss_pred HHHHHHHHhhh
Q 030203 156 TIMELLRPLIK 166 (181)
Q Consensus 156 ~~l~~L~~~~~ 166 (181)
++++ +.++.
T Consensus 248 ~il~--h~~~~ 256 (325)
T cd05594 248 EIMQ--HKFFA 256 (325)
T ss_pred HHhc--CCCcC
Confidence 9987 55554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=202.38 Aligned_cols=159 Identities=23% Similarity=0.426 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+.+..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (323)
T cd05584 97 FMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR 174 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccC
Confidence 567788899999999999999999 999999999999999999999999987643332223334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+|+++|+|++|+.||...+.......+. ......+..+++.+.+++.+||+.||.+|| ++.+
T Consensus 175 ~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 252 (323)
T cd05584 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAE 252 (323)
T ss_pred CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHH
Confidence 888899999999999999999999999888776666653 234456778899999999999999999999 8898
Q ss_pred HHHHHHHhhh
Q 030203 157 IMELLRPLIK 166 (181)
Q Consensus 157 ~l~~L~~~~~ 166 (181)
+++ +++++
T Consensus 253 l~~--h~~~~ 260 (323)
T cd05584 253 VQS--HPFFR 260 (323)
T ss_pred Hhc--CCCcC
Confidence 887 55543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=200.24 Aligned_cols=163 Identities=34% Similarity=0.675 Sum_probs=133.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.|||+++ ++|+||+|.||+++.++.++|+|||++....... .......++..|++||.+
T Consensus 170 l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 170 LTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 578889999999999999999999 9999999999999999999999999987543221 112223445679999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQ-VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..++.++|+||+||+++++++ |..||.+....+ ....+. .......+..+++.+.+++.+|++.+|.+||++.++
T Consensus 248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK-EGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh-ccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 88889999999999999999997 999997754433 222222 333444556788999999999999999999999999
Q ss_pred HHHHHHhhhC
Q 030203 158 MELLRPLIKS 167 (181)
Q Consensus 158 l~~L~~~~~~ 167 (181)
++.|+.+++.
T Consensus 327 l~~l~~~~~~ 336 (337)
T cd05054 327 VEILGDLLQE 336 (337)
T ss_pred HHHHHHHHhc
Confidence 9999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=210.65 Aligned_cols=155 Identities=32% Similarity=0.560 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++..+..++.|++.||.|+|+++ ++|+||+|+||+++.++.++|+|||+++..... ........+++.|+|||.+
T Consensus 140 l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 217 (496)
T PTZ00283 140 FREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217 (496)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHh
Confidence 577889999999999999999999 999999999999999999999999998754322 1122345688899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
.+..++.++|+||+|+++|+|++|+.||.+.+.......+. .......+..+++++.+++.+||+.||.+||++.++++
T Consensus 218 ~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL-AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 98889999999999999999999999999988877666654 33344567789999999999999999999999999987
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=203.05 Aligned_cols=154 Identities=26% Similarity=0.499 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 98 ~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05616 98 FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC
Confidence 578889999999999999999999 999999999999999999999999988643322223334567889999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH-----HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----ST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ 156 (181)
..++.++|+||+||++|+|++|+.||.+.+.......+.. .....+..+++++.+++.+|++.||.+|++. .+
T Consensus 176 ~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ 253 (323)
T cd05616 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 253 (323)
T ss_pred CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHH
Confidence 8899999999999999999999999999888777776643 3344567789999999999999999999974 66
Q ss_pred HHH
Q 030203 157 IME 159 (181)
Q Consensus 157 ~l~ 159 (181)
+++
T Consensus 254 i~~ 256 (323)
T cd05616 254 IKE 256 (323)
T ss_pred Hhc
Confidence 655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=202.52 Aligned_cols=163 Identities=27% Similarity=0.388 Sum_probs=139.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-----cccCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-----FLSSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~~~p 76 (181)
++++++++++..++.||.|||.+| ++||||||+|++++.+|++|++|||++...... .......+||+.|+||
T Consensus 207 ls~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP 284 (576)
T KOG0585|consen 207 LSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP 284 (576)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccch
Confidence 678999999999999999999999 999999999999999999999999998644211 1112236899999999
Q ss_pred cccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 77 EVLRDEP----SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 77 e~~~~~~----~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
|...+.. .+.+.|+||+|+++|.++.|+.||.+....++..++.......+..+.+.+.+++||.+||..||.+|.
T Consensus 285 E~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri 364 (576)
T KOG0585|consen 285 ELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRI 364 (576)
T ss_pred HhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhee
Confidence 9987733 257899999999999999999999999999988888655555555566899999999999999999999
Q ss_pred CHHHHHHHHHHhhhCC
Q 030203 153 SFSTIMELLRPLIKSP 168 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~ 168 (181)
++.++.. +.|....
T Consensus 365 ~l~~ik~--Hpwvt~~ 378 (576)
T KOG0585|consen 365 TLPDIKL--HPWVTRD 378 (576)
T ss_pred ehhhhee--cceeccC
Confidence 9999988 7777654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=201.46 Aligned_cols=154 Identities=28% Similarity=0.476 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+
T Consensus 93 ~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05619 93 FDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC
Confidence 567888999999999999999999 999999999999999999999999987643222222334467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH-HHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~ 159 (181)
..++.++|+||+|+++|+|++|..||...+.......+.... ...+..++.++.+++.+||..||.+||++. ++++
T Consensus 171 ~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 888999999999999999999999999888777776664332 335567899999999999999999999997 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=203.27 Aligned_cols=154 Identities=29% Similarity=0.469 Sum_probs=130.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||++| ++|+||+|.||+++.++.++++|||++..............+++.|++||.+.+
T Consensus 93 ~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (323)
T cd05575 93 FPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC
Confidence 567889999999999999999999 999999999999999999999999987643332223334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH----HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS----TI 157 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~----~~ 157 (181)
..++.++|+||||+++|+|++|..||...+.......+. ......+..+++.+.+++.+||+.||.+||+++ ++
T Consensus 171 ~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (323)
T cd05575 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEI 248 (323)
T ss_pred CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHH
Confidence 888999999999999999999999999888777666653 223445667899999999999999999999874 55
Q ss_pred HH
Q 030203 158 ME 159 (181)
Q Consensus 158 l~ 159 (181)
++
T Consensus 249 l~ 250 (323)
T cd05575 249 KN 250 (323)
T ss_pred Hc
Confidence 54
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=193.30 Aligned_cols=164 Identities=31% Similarity=0.560 Sum_probs=135.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc--CCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......... ......+..|++||..
T Consensus 106 ~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05109 106 IGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHh
Confidence 578889999999999999999999 999999999999999999999999988754322111 1122334679999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||...........+. .....+.+..++.++.+++.+|+..||.+||++.+++
T Consensus 184 ~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~ 262 (279)
T cd05109 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262 (279)
T ss_pred ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88888999999999999999998 899998877766655554 3333445667889999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+.+.+.+
T Consensus 263 ~~l~~~~~~~ 272 (279)
T cd05109 263 DEFSRMARDP 272 (279)
T ss_pred HHHHHhhcCC
Confidence 9998886664
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=197.29 Aligned_cols=162 Identities=25% Similarity=0.415 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++....... ......++..|+|||.+.+
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 99 FDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINN 175 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-eecCCCCCCCccCHhhhcC
Confidence 578889999999999999999999 9999999999999999999999999986543221 1234467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--ccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----H
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG--FKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----F 154 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~ 154 (181)
..++.++|+||+|+++|+|++|+.||...+.......+. ........+..+++++.+|+.+||..||.+||+ +
T Consensus 176 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~ 255 (285)
T cd05631 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGA 255 (285)
T ss_pred CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCH
Confidence 889999999999999999999999998765432221111 122334456678999999999999999999997 8
Q ss_pred HHHHHHHHHhhhCC
Q 030203 155 STIMELLRPLIKSP 168 (181)
Q Consensus 155 ~~~l~~L~~~~~~~ 168 (181)
+++++ +++++..
T Consensus 256 ~~~~~--h~~~~~~ 267 (285)
T cd05631 256 AGVKQ--HPIFKNI 267 (285)
T ss_pred HHHhc--CHhhcCC
Confidence 89988 6666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=200.95 Aligned_cols=166 Identities=25% Similarity=0.399 Sum_probs=129.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.
T Consensus 100 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 177 (338)
T cd07859 100 LTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHH
Confidence 578899999999999999999999 9999999999999999999999999986432211 11233467889999998
Q ss_pred cCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------------------cCCcc---C
Q 030203 79 LRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF--------------------------KGKRL---E 127 (181)
Q Consensus 79 ~~~--~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~--------------------------~~~~~---~ 127 (181)
+.+ ..++.++|+||+|+++|+|++|+.||.+.+.......+.. ..... .
T Consensus 178 ~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
T cd07859 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQ 257 (338)
T ss_pred HhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHH
Confidence 865 4578899999999999999999999987654332211100 00000 0
Q ss_pred CCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
....+++.+.+++.+||..||.+|||+.++++ ++|++.....
T Consensus 258 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~--hp~f~~~~~~ 299 (338)
T cd07859 258 KFPNADPLALRLLERLLAFDPKDRPTAEEALA--DPYFKGLAKV 299 (338)
T ss_pred hcCCCChHHHHHHHHHcCcCcccCCCHHHHhc--CchhhhcCcc
Confidence 11246788999999999999999999999999 8888765543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=208.47 Aligned_cols=166 Identities=34% Similarity=0.616 Sum_probs=139.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccc--cccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~~~pe~~ 79 (181)
|+....+.|+.|+++|+.|||.++ |+|+|+|..|||+.+++.++++|||++.... ..........+...|+|||++
T Consensus 485 fdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvI 562 (678)
T KOG0193|consen 485 FDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVI 562 (678)
T ss_pred hhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHH
Confidence 355678899999999999999999 9999999999999999999999999986322 222233445667789999999
Q ss_pred CCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 80 RDE---PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 80 ~~~---~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
+.. .|++.+||||+|+++|||++|..||...+.++++..+... .........+++++++|+..||.+++++||.
T Consensus 563 Rmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~ 642 (678)
T KOG0193|consen 563 RMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPL 642 (678)
T ss_pred hhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCcc
Confidence 754 4789999999999999999999999988888888777644 2223355678889999999999999999999
Q ss_pred HHHHHHHHHHhhhCCC
Q 030203 154 FSTIMELLRPLIKSPT 169 (181)
Q Consensus 154 ~~~~l~~L~~~~~~~~ 169 (181)
+.+++..|+.++...+
T Consensus 643 F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 643 FPQLLSKLEELLPSLP 658 (678)
T ss_pred HHHHHHHHHHhhhccc
Confidence 9999999999988543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=197.54 Aligned_cols=159 Identities=22% Similarity=0.320 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||++..............+++.|+|||.+.+
T Consensus 100 ~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 100 MSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcC
Confidence 567889999999999999999999 999999999999999999999999988654333223334566789999998865
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------------------c---------cCCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-------------------R---------LEIPRNV 132 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~ 132 (181)
..++.++|+||+|+++|+|++|+.||.+.+..+....+..... . ......+
T Consensus 178 ~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (288)
T cd07871 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRL 257 (288)
T ss_pred CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCC
Confidence 4478899999999999999999999988766544333211000 0 0011346
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHh
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~ 164 (181)
++++.+++.+||..||.+|||++++++ ++|
T Consensus 258 ~~~~~dll~~mL~~dp~~R~t~~~~l~--hp~ 287 (288)
T cd07871 258 DTDGIDLLSSLLLYETKSRISAEAALR--HSY 287 (288)
T ss_pred CHHHHHHHHHhcCcCcccCCCHHHHhc--CCC
Confidence 788999999999999999999999997 544
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=198.61 Aligned_cols=165 Identities=22% Similarity=0.337 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+
T Consensus 100 ~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 177 (303)
T cd07869 100 LHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177 (303)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcC
Confidence 567889999999999999999999 999999999999999999999999988643333223334567789999998765
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcc-CCc--------------------cCCC---------
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFK-GKR--------------------LEIP--------- 129 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~-~~~--------------------~~~~--------- 129 (181)
. .++.++|+||+||++|+|++|..||.+.... .....+... ... ...+
T Consensus 178 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (303)
T cd07869 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNK 257 (303)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhc
Confidence 4 4678899999999999999999999875432 222221100 000 0000
Q ss_pred CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 130 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
...++.+.+++.+||..||.+|||+.++++ +++++..++
T Consensus 258 ~~~~~~~~dli~~mL~~dp~~R~s~~~~l~--h~~f~~~~~ 296 (303)
T cd07869 258 LSYVNHAEDLASKLLQCFPKNRLSAQAALS--HEYFSDLPP 296 (303)
T ss_pred cCCChHHHHHHHHHhccCchhccCHHHHhc--CcccccCCh
Confidence 124567899999999999999999999999 999987654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=198.95 Aligned_cols=166 Identities=31% Similarity=0.533 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc----cCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~~~pe 77 (181)
|+|..+..|++++++||.|||.+| .+|||||+.||+++.+|.++|+|||++-....... ...+.++++.|++||
T Consensus 123 l~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPE 200 (516)
T KOG0582|consen 123 LEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPE 200 (516)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChH
Confidence 678899999999999999999999 99999999999999999999999998653222211 115668999999999
Q ss_pred ccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhccCCcc-------CCCCCCCHHHHHHHHHHhcCC
Q 030203 78 VLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA-AVGFKGKRL-------EIPRNVNPHVASIIEACWANE 147 (181)
Q Consensus 78 ~~~~--~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~ 147 (181)
.+.. .+|++++|+||||++..|+++|..||....+...+- ++......+ +....++..++.++..||..|
T Consensus 201 vl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kD 280 (516)
T KOG0582|consen 201 VLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKD 280 (516)
T ss_pred HhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcC
Confidence 9543 458999999999999999999999999887765443 332222111 112346678999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 148 PWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 148 p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
|.+|||+.++++ +.+|+.....
T Consensus 281 P~kRptAskLlk--h~FFk~~k~~ 302 (516)
T KOG0582|consen 281 PSKRPTASKLLK--HAFFKKAKSK 302 (516)
T ss_pred cccCCCHHHHhc--cHHHhhccch
Confidence 999999999999 8888865543
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=191.11 Aligned_cols=160 Identities=36% Similarity=0.616 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+..............++..|++||...+
T Consensus 101 ~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 178 (261)
T cd05148 101 LPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc
Confidence 567889999999999999999999 999999999999999999999999988654433222223344567999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+|++|++++++++ |+.||...........+. .......+..+++.+.+++.+|+..||.+|||++++++.
T Consensus 179 ~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~ 257 (261)
T cd05148 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREE 257 (261)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 788899999999999999998 899998887766666654 344455567889999999999999999999999999999
Q ss_pred HHHh
Q 030203 161 LRPL 164 (181)
Q Consensus 161 L~~~ 164 (181)
|+.+
T Consensus 258 L~~~ 261 (261)
T cd05148 258 LDNI 261 (261)
T ss_pred HhcC
Confidence 9853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=201.03 Aligned_cols=161 Identities=32% Similarity=0.611 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||++........ .......+..|++||.+
T Consensus 211 l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 288 (375)
T cd05104 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESI 288 (375)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHh
Confidence 578899999999999999999999 99999999999999999999999999865432211 11122334579999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.....................+...+.++.+++.+|++.||.+||++.+++
T Consensus 289 ~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 368 (375)
T cd05104 289 FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368 (375)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 88889999999999999999997 88899776544333333223334444556788999999999999999999999999
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+.|+..
T Consensus 369 ~~l~~~ 374 (375)
T cd05104 369 QLIEQQ 374 (375)
T ss_pred HHHHhh
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=207.35 Aligned_cols=155 Identities=27% Similarity=0.500 Sum_probs=132.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+
T Consensus 166 l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 243 (478)
T PTZ00267 166 FQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW 243 (478)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHh
Confidence 577889999999999999999999 99999999999999999999999999875443211 22344688899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
.+..++.++|+||+||++|+|++|+.||...+...+...+... .....+..+++.+.+++.+||..||.+||++.+++.
T Consensus 244 ~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 244 ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 8888899999999999999999999999988887777666433 333456678999999999999999999999999865
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=190.97 Aligned_cols=155 Identities=30% Similarity=0.589 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.+++.++.+||+++ ++|+||+|+||+++.++.++++|||++..............+++.|++||...+
T Consensus 99 l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 99 LPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcC
Confidence 578899999999999999999999 999999999999999999999999988654433333334466788999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..++.++|+||+|++++++++|..||...+.......+. .......+..+++.+.+++.+|++.+|.+||++.++++
T Consensus 177 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 888889999999999999999999998877666555443 23333456678899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=202.34 Aligned_cols=157 Identities=25% Similarity=0.467 Sum_probs=134.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...... .....+++.|+|||.+.+
T Consensus 115 ~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 115 FPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQS 189 (329)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcC
Confidence 567888899999999999999999 999999999999999999999999998654332 123467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----HHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ 156 (181)
..++.++|+||+|+++|+|++|..||.+.........+. ......+..+++.+++++.+||..||.+|++ +++
T Consensus 190 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 267 (329)
T PTZ00263 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVAD 267 (329)
T ss_pred CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH
Confidence 888999999999999999999999999888777666664 2344566778999999999999999999996 788
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ +++++.
T Consensus 268 ll~--hp~f~~ 276 (329)
T PTZ00263 268 VKN--HPYFHG 276 (329)
T ss_pred Hhc--CCccCC
Confidence 887 666543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=192.07 Aligned_cols=158 Identities=35% Similarity=0.600 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.|+.+||+++ ++|+||+|+||+++.++.++++|||.+....... ........++.|+|||.+
T Consensus 119 l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (280)
T cd05049 119 LTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI 196 (280)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhh
Confidence 467888999999999999999999 9999999999999999999999999876432211 112223445689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||...+.......+. .......+..++..+.+++.+||..||.+||++.+++
T Consensus 197 ~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 275 (280)
T cd05049 197 MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275 (280)
T ss_pred ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 88888999999999999999998 999998887777666665 3333444567899999999999999999999999999
Q ss_pred HHHH
Q 030203 159 ELLR 162 (181)
Q Consensus 159 ~~L~ 162 (181)
+.|+
T Consensus 276 ~~l~ 279 (280)
T cd05049 276 ERLQ 279 (280)
T ss_pred HHhh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=189.82 Aligned_cols=160 Identities=33% Similarity=0.576 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc---CCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~~~pe~ 78 (181)
+++..++.++.|++.++.|||+++ ++|+||+|+||+++.++.++++|||.+......... .....++..|++||.
T Consensus 92 ~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 169 (257)
T cd05060 92 IPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHH
Confidence 578899999999999999999999 999999999999999999999999988654332211 111223357999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
..+..++.++|+||+|+++|++++ |..||...+..+....+. .......+..+++.+++++.+|+..+|.+||++.++
T Consensus 170 ~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred hcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 988888999999999999999997 999998888777666664 333445667789999999999999999999999999
Q ss_pred HHHHHHh
Q 030203 158 MELLRPL 164 (181)
Q Consensus 158 l~~L~~~ 164 (181)
++.|+..
T Consensus 249 ~~~l~~~ 255 (257)
T cd05060 249 ESTFRRD 255 (257)
T ss_pred HHHHHhc
Confidence 9999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=200.28 Aligned_cols=163 Identities=33% Similarity=0.523 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
.++..+..++.|++.||.|||+++ ++|+||+++||+++.++.++|+|||++..............++..|++||.+..
T Consensus 165 ~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (353)
T PLN00034 165 ADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242 (353)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCcccccc
Confidence 457788899999999999999999 999999999999999999999999998754433222334578889999998743
Q ss_pred C-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 82 E-----PSNEKSDIYSFGVILWELATLQQPWGNLNPAQV---VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 82 ~-----~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
. ..+.++|+|||||++|+|++|+.||......+. ...+. .......+..+++++.+++.+||..||.+||+
T Consensus 243 ~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt 321 (353)
T PLN00034 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASREFRHFISCCLQREPAKRWS 321 (353)
T ss_pred ccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCHHHHHHHHHHccCChhhCcC
Confidence 2 234589999999999999999999975433222 22221 22334456678999999999999999999999
Q ss_pred HHHHHHHHHHhhhCCC
Q 030203 154 FSTIMELLRPLIKSPT 169 (181)
Q Consensus 154 ~~~~l~~L~~~~~~~~ 169 (181)
+.++++ +.|+....
T Consensus 322 ~~ell~--hp~~~~~~ 335 (353)
T PLN00034 322 AMQLLQ--HPFILRAQ 335 (353)
T ss_pred HHHHhc--CcccccCC
Confidence 999999 88888764
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=193.04 Aligned_cols=163 Identities=33% Similarity=0.606 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+........ ......++..|++||..
T Consensus 124 l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 201 (290)
T cd05045 124 LTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201 (290)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence 467888999999999999999999 99999999999999999999999999864322211 11222345679999988
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||||+++++|++ |..||.+.....+.+.+. .......+..++..+.+++.+|++.+|.+||++++++
T Consensus 202 ~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 202 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 77778899999999999999998 999998888777766654 3334445677889999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|++++..
T Consensus 281 ~~l~~~~~~ 289 (290)
T cd05045 281 KELEKMMVK 289 (290)
T ss_pred HHHHHHHhc
Confidence 999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=191.01 Aligned_cols=161 Identities=33% Similarity=0.611 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+........ .......+..|++||.+
T Consensus 110 ~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05035 110 LPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 187 (273)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhc
Confidence 567888999999999999999999 99999999999999999999999999865432211 11112334579999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+....+....+. .......+..+++.+.+++.+|++.||.+||++.+++
T Consensus 188 ~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~ 266 (273)
T cd05035 188 ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLR 266 (273)
T ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88888999999999999999998 899998888777766664 3344556778899999999999999999999999999
Q ss_pred HHHHHhh
Q 030203 159 ELLRPLI 165 (181)
Q Consensus 159 ~~L~~~~ 165 (181)
+.|++++
T Consensus 267 ~~l~~~~ 273 (273)
T cd05035 267 EVLENIL 273 (273)
T ss_pred HHHHhhC
Confidence 9998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=190.27 Aligned_cols=161 Identities=28% Similarity=0.568 Sum_probs=134.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||++........ ......++..|++||.
T Consensus 92 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 169 (257)
T cd05115 92 ITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHH
Confidence 578899999999999999999999 99999999999999999999999998864332211 1111223467999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+....++.++|+||||+++|++++ |..||......+....+. .......+..+++++.+++.+||..+|.+||++.++
T Consensus 170 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i 248 (257)
T cd05115 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248 (257)
T ss_pred HccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 887778889999999999999996 999999888777666664 334455667789999999999999999999999999
Q ss_pred HHHHHHhh
Q 030203 158 MELLRPLI 165 (181)
Q Consensus 158 l~~L~~~~ 165 (181)
.+.|+.++
T Consensus 249 ~~~l~~~~ 256 (257)
T cd05115 249 EERMRTYY 256 (257)
T ss_pred HHHHhhhc
Confidence 99998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=190.10 Aligned_cols=158 Identities=37% Similarity=0.626 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.+||+++ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||..
T Consensus 102 ~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (262)
T cd00192 102 LSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHh
Confidence 578999999999999999999999 9999999999999999999999999887544321 222334566789999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
....++.++|+||+|++++++++ |..||...........+.. ......+..+++++.+++.+|+..+|.+|||+.+++
T Consensus 180 ~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~ 258 (262)
T cd00192 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258 (262)
T ss_pred ccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHH
Confidence 88788899999999999999998 6999999888777777753 445566778899999999999999999999999999
Q ss_pred HHHH
Q 030203 159 ELLR 162 (181)
Q Consensus 159 ~~L~ 162 (181)
+.|+
T Consensus 259 ~~l~ 262 (262)
T cd00192 259 ERLE 262 (262)
T ss_pred HhhC
Confidence 8763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=187.83 Aligned_cols=165 Identities=21% Similarity=0.368 Sum_probs=128.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc---------cccCCCCCCCC
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT---------FLSSKSAAGTP 71 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~---------~~~~~~~~~~~ 71 (181)
.++|.++++|+.++++||.+||+..+++.|+||||.||+++.++.+.++|||.+....-. ........++.
T Consensus 123 ~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~ 202 (302)
T KOG2345|consen 123 FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTI 202 (302)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCC
Confidence 378999999999999999999999888999999999999999999999999988642211 11122346788
Q ss_pred CccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcC
Q 030203 72 EWMAPEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKGKRLEIPRNVNPHVASIIEACWAN 146 (181)
Q Consensus 72 ~~~~pe~~~~---~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 146 (181)
.|+|||.+.- ...++++|+|||||++|.|++|..||+..... .+.-.+.......+..+.+|..+.+++++|++.
T Consensus 203 pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqv 282 (302)
T KOG2345|consen 203 PYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQV 282 (302)
T ss_pred cccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcC
Confidence 9999998853 33578999999999999999999999653221 100011111112222344899999999999999
Q ss_pred CCCCCCCHHHHHHHHHHhh
Q 030203 147 EPWKRPSFSTIMELLRPLI 165 (181)
Q Consensus 147 ~p~~Rps~~~~l~~L~~~~ 165 (181)
||.+||+..+++..++.+.
T Consensus 283 dP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 283 DPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CcccCCCHHHHHHHHHhhc
Confidence 9999999999999988764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=192.74 Aligned_cols=160 Identities=33% Similarity=0.578 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....... .......++..|++||.+
T Consensus 121 ~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05090 121 LDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI 198 (283)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHh
Confidence 467788999999999999999999 9999999999999999999999999986543221 112223345679999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++++|++ |..||.+.....+.+.+. .......+..+++.+.+++.+|++.||.+||++.+++
T Consensus 199 ~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 277 (283)
T cd05090 199 MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277 (283)
T ss_pred ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 87778899999999999999998 999998887776666664 3334456677899999999999999999999999999
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+.|+.|
T Consensus 278 ~~l~~~ 283 (283)
T cd05090 278 TRLRSW 283 (283)
T ss_pred HHhhcC
Confidence 998765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=195.38 Aligned_cols=160 Identities=29% Similarity=0.477 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+..............+++.|++||.+.+
T Consensus 94 l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 171 (280)
T cd05608 94 FPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG 171 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcC
Confidence 578899999999999999999999 999999999999999999999999988654433223334467889999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP----- 152 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 152 (181)
..++.++|+||+|+++|+|++|+.||...... .....+ .......+..+++.+.+++.+||+.||.+||
T Consensus 172 ~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 249 (280)
T cd05608 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDG 249 (280)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 88899999999999999999999999765432 112211 2223345567899999999999999999999
Q ss_pred CHHHHHHHHHHhhhC
Q 030203 153 SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 s~~~~l~~L~~~~~~ 167 (181)
+++++++ ++|++.
T Consensus 250 ~~~~~l~--h~~~~~ 262 (280)
T cd05608 250 NCDGLRT--HPLFRD 262 (280)
T ss_pred CHHHHhc--Chhhhc
Confidence 7888988 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=201.93 Aligned_cols=151 Identities=29% Similarity=0.461 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 93 ~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05602 93 FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK 170 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC
Confidence 467788899999999999999999 999999999999999999999999998643332223344568889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
..++.++|+||+|+++|+|++|..||.+.+.......+. ......+..+++.+.+++.+|++.||.+|+++.+
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 888999999999999999999999999888777666553 2234455678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=205.85 Aligned_cols=165 Identities=32% Similarity=0.619 Sum_probs=147.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCccc--
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL-- 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~-- 79 (181)
|++.++..+++|++.||.|||+++ |+|+|++..||+++-+|.++|.|||++...........+.+|++.|+|||+.
T Consensus 127 LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmC 204 (1187)
T KOG0579|consen 127 LTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMC 204 (1187)
T ss_pred cchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheee
Confidence 689999999999999999999999 9999999999999999999999999987766666667788999999999976
Q ss_pred ---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 80 ---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 80 ---~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+.+|++++||||||+.+.+|..+.+|....++...+-++..... .+-.|..|+..|.+++.+||..||..||++.
T Consensus 205 ET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aa 284 (1187)
T KOG0579|consen 205 ETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAA 284 (1187)
T ss_pred ccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHH
Confidence 356789999999999999999999999999999888887765443 3446788999999999999999999999999
Q ss_pred HHHHHHHHhhhCCCC
Q 030203 156 TIMELLRPLIKSPTP 170 (181)
Q Consensus 156 ~~l~~L~~~~~~~~~ 170 (181)
++++ ++|++..++
T Consensus 285 qll~--Hpfv~~~~S 297 (1187)
T KOG0579|consen 285 QLLK--HPFVQNAPS 297 (1187)
T ss_pred HHhh--CcccccCCc
Confidence 9999 898886544
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=190.19 Aligned_cols=155 Identities=28% Similarity=0.532 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+..............+++.|++||...+
T Consensus 98 ~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08529 98 LPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcC
Confidence 567889999999999999999999 999999999999999999999999987654443333334456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..++.++|+||+|+++++|++|+.||...+.......+. .......+..+++.+.+++.+|++.+|.+||++.++++
T Consensus 176 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 888899999999999999999999998888766665554 33334455578899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=194.96 Aligned_cols=159 Identities=22% Similarity=0.336 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+........ ......+++.|+|||.+.
T Consensus 97 ~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 174 (287)
T cd07848 97 VPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHc
Confidence 567889999999999999999999 99999999999999999999999999875433211 122345778899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------------------cc-----------CCCC
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-------------------RL-----------EIPR 130 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------~~-----------~~~~ 130 (181)
+..++.++|+||+|+++|+|++|+.||...+..+....+..... .. ....
T Consensus 175 ~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T cd07848 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLG 254 (287)
T ss_pred CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhc
Confidence 88888999999999999999999999987665433222211000 00 0112
Q ss_pred CCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHh
Q 030203 131 NVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 131 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~ 164 (181)
.+++.+.+++.+||+.||.+|||++++++ ++|
T Consensus 255 ~~s~~~~dll~~~L~~~P~~R~s~~~~l~--hp~ 286 (287)
T cd07848 255 ILSGVLLDLMKNLLKLNPTDRYLTEQCLN--HPA 286 (287)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhc--CCC
Confidence 36788999999999999999999999997 554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=189.54 Aligned_cols=162 Identities=33% Similarity=0.580 Sum_probs=134.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc-CCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.++|+++ ++|+||+|.||+++.++.++++|||.+......... .....++..|++||...
T Consensus 99 ~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 176 (262)
T cd05071 99 LRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhc
Confidence 567889999999999999999999 999999999999999999999999988654332211 12233456799999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|++++ |..||.+.........+. .......+..++..+.+++.+|++.+|.+||++.++++
T Consensus 177 ~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8788999999999999999999 888998877766666554 23334445678899999999999999999999999999
Q ss_pred HHHHhhh
Q 030203 160 LLRPLIK 166 (181)
Q Consensus 160 ~L~~~~~ 166 (181)
.|++++.
T Consensus 256 ~l~~~~~ 262 (262)
T cd05071 256 FLEDYFT 262 (262)
T ss_pred HHHHhcC
Confidence 9998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=208.26 Aligned_cols=160 Identities=19% Similarity=0.317 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCC----------------cEEEcccCCccccccccccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKY----------------TVKVCDFGLSRLKANTFLSS 64 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~----------------~~~l~d~g~~~~~~~~~~~~ 64 (181)
+++.++..++.|++.||.|||+ .| ++|+||||+||+++.++ .++|+|||.+..... ..
T Consensus 228 l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~---~~ 302 (467)
T PTZ00284 228 FSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH---SR 302 (467)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc---cc
Confidence 5778899999999999999998 48 99999999999998655 489999998653222 22
Q ss_pred CCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc------------------
Q 030203 65 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL------------------ 126 (181)
Q Consensus 65 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 126 (181)
....+++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+.+..+....+.......
T Consensus 303 ~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~ 382 (467)
T PTZ00284 303 TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYN 382 (467)
T ss_pred ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhh
Confidence 34578889999999998889999999999999999999999998876544333221110000
Q ss_pred ---C------------------C-CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 127 ---E------------------I-PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 127 ---~------------------~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
. . ....++.+.+||.+||..||.+|||++++++ |+|+...
T Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~--Hp~~~~~ 444 (467)
T PTZ00284 383 SAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT--HPYVLKY 444 (467)
T ss_pred hcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc--Ccccccc
Confidence 0 0 0012456789999999999999999999999 8888764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=200.18 Aligned_cols=159 Identities=27% Similarity=0.440 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..... ......+++.|+|||.+.+
T Consensus 98 l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 98 LSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRG 172 (333)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcC
Confidence 578899999999999999999999 99999999999999999999999999865433 2234567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCC------CCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP------RNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
..++.++|+||+||++|+|++|..||...+..+....+.........+ ..+++++.+++.+|+..+|.+||++.
T Consensus 173 ~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~ 252 (333)
T cd05600 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLE 252 (333)
T ss_pred CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHH
Confidence 888999999999999999999999999888776665553222211111 24689999999999999999999999
Q ss_pred HHHHHHHHhhhC
Q 030203 156 TIMELLRPLIKS 167 (181)
Q Consensus 156 ~~l~~L~~~~~~ 167 (181)
++++ +.+++.
T Consensus 253 ~ll~--h~~~~~ 262 (333)
T cd05600 253 DIKN--HPFFKE 262 (333)
T ss_pred HHHh--CcccCC
Confidence 9998 666654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=189.72 Aligned_cols=157 Identities=35% Similarity=0.648 Sum_probs=132.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... .....+..|++||...+
T Consensus 99 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~ 173 (256)
T cd05082 99 LGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALRE 173 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHcc
Confidence 567888999999999999999999 9999999999999999999999999876433221 22233457999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|+++|+|++ |+.||...........+. .......+..+++.+.+++.+|+..+|.+|||+.++++.
T Consensus 174 ~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQ 252 (256)
T ss_pred CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 888899999999999999997 999998887777666664 333445566789999999999999999999999999998
Q ss_pred HHHh
Q 030203 161 LRPL 164 (181)
Q Consensus 161 L~~~ 164 (181)
|+.+
T Consensus 253 l~~~ 256 (256)
T cd05082 253 LEHI 256 (256)
T ss_pred HhcC
Confidence 8753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=189.57 Aligned_cols=160 Identities=34% Similarity=0.595 Sum_probs=133.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+........ ......++..|++||...
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 176 (260)
T cd05070 99 LKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHh
Confidence 577889999999999999999999 99999999999999999999999998865332211 112223445799999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||||++++++++ |..||...+..+....+. .....+.+...+..+.+++.+|+..+|.+|||++++.+
T Consensus 177 ~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 7778899999999999999998 899998877776666664 33344556678899999999999999999999999999
Q ss_pred HHHHh
Q 030203 160 LLRPL 164 (181)
Q Consensus 160 ~L~~~ 164 (181)
.|+++
T Consensus 256 ~l~~~ 260 (260)
T cd05070 256 FLEDY 260 (260)
T ss_pred HHhcC
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=199.03 Aligned_cols=160 Identities=28% Similarity=0.369 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+
T Consensus 120 ~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~ 196 (359)
T cd07876 120 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYVVTRYYRAPEVILG 196 (359)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccccccCc-cCCCCcccCCCCCchhccC
Confidence 467888999999999999999999 9999999999999999999999999986533221 2233467788999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------------cCCc--------------
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF----------------------KGKR-------------- 125 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~----------------------~~~~-------------- 125 (181)
..++.++|+||+|+++|+|++|+.||.+.+.......+.. ....
T Consensus 197 ~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (359)
T cd07876 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWI 276 (359)
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccc
Confidence 8889999999999999999999999987754332211100 0000
Q ss_pred ----cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 126 ----LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 126 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
.......++.+++++.+||..||.+|||+.++++ ++|+.
T Consensus 277 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~ 319 (359)
T cd07876 277 FPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR--HPYIT 319 (359)
T ss_pred cccccccccccchhHHHHHHHHhccCcccCCCHHHHhc--Cchhh
Confidence 0011224678999999999999999999999999 66665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=194.23 Aligned_cols=164 Identities=32% Similarity=0.611 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+........ .......+..|++||.+
T Consensus 137 l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (307)
T cd05098 137 LSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214 (307)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh
Confidence 567889999999999999999999 99999999999999999999999998765432211 11122234579999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||...........+. .......+..++.++.+++.+|+..+|.+||++.+++
T Consensus 215 ~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 293 (307)
T cd05098 215 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293 (307)
T ss_pred ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 88888899999999999999998 889998877766666554 3334455667899999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+.++...
T Consensus 294 ~~l~~~~~~~ 303 (307)
T cd05098 294 EDLDRILALT 303 (307)
T ss_pred HHHHHHHHHh
Confidence 9999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=192.32 Aligned_cols=159 Identities=28% Similarity=0.485 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.|+.|||+++ ++|+|++|.||+++.++.++++|||++..............++..|++||.+.+
T Consensus 108 l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 185 (272)
T cd06637 108 LKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhcc
Confidence 578889999999999999999999 999999999999999999999999998654333223344567788999998752
Q ss_pred -----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 82 -----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 82 -----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
..++.++|+||+|+++|+|++|..||........................++..+.+++.+||..+|.+|||+.+
T Consensus 186 ~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 265 (272)
T cd06637 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ 265 (272)
T ss_pred ccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 346789999999999999999999998766555444443333333344567899999999999999999999999
Q ss_pred HHHHHHHh
Q 030203 157 IMELLRPL 164 (181)
Q Consensus 157 ~l~~L~~~ 164 (181)
+++ ++|
T Consensus 266 il~--~~~ 271 (272)
T cd06637 266 LMK--HPF 271 (272)
T ss_pred Hhh--CCC
Confidence 987 544
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=193.34 Aligned_cols=161 Identities=32% Similarity=0.646 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||.+........ ......++..|++||..
T Consensus 129 l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 206 (293)
T cd05053 129 LTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206 (293)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh
Confidence 567888999999999999999999 99999999999999999999999998875433211 11122334579999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||......+....+. .......+..++..+.+++.+|+..||.+|||+.+++
T Consensus 207 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil 285 (293)
T cd05053 207 FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285 (293)
T ss_pred ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 88888899999999999999997 999998887766665554 3334455667889999999999999999999999999
Q ss_pred HHHHHhh
Q 030203 159 ELLRPLI 165 (181)
Q Consensus 159 ~~L~~~~ 165 (181)
+.|+.++
T Consensus 286 ~~l~~~~ 292 (293)
T cd05053 286 EDLDRML 292 (293)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=194.30 Aligned_cols=165 Identities=32% Similarity=0.578 Sum_probs=136.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc--CCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~ 79 (181)
+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++......... ......+..|++||.+
T Consensus 106 ~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~ 183 (316)
T cd05108 106 IGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHh
Confidence 467788999999999999999999 999999999999999999999999998754432211 1122334579999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||.+.....+...+. .......+..++.++.+++.+|+..+|.+||++.+++
T Consensus 184 ~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~ 262 (316)
T cd05108 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262 (316)
T ss_pred ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88888999999999999999997 999998877666554443 3334445667889999999999999999999999999
Q ss_pred HHHHHhhhCCC
Q 030203 159 ELLRPLIKSPT 169 (181)
Q Consensus 159 ~~L~~~~~~~~ 169 (181)
..+..+.+...
T Consensus 263 ~~l~~~~~~~~ 273 (316)
T cd05108 263 IEFSKMARDPQ 273 (316)
T ss_pred HHHHHHHcCCc
Confidence 99998877653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=189.65 Aligned_cols=160 Identities=29% Similarity=0.589 Sum_probs=132.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc-CCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+......... .....++..|++||...
T Consensus 100 ~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05072 100 VLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhc
Confidence 456788899999999999999999 999999999999999999999999998754432211 12233456799999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|++++ |..||...........+. .....+....++.++.+++.+|+..+|.+||+++++.+
T Consensus 178 ~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8778889999999999999998 999998887776666654 23334445568899999999999999999999999999
Q ss_pred HHHHh
Q 030203 160 LLRPL 164 (181)
Q Consensus 160 ~L~~~ 164 (181)
.|+++
T Consensus 257 ~l~~~ 261 (261)
T cd05072 257 VLDDF 261 (261)
T ss_pred HHhcC
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=190.80 Aligned_cols=161 Identities=24% Similarity=0.435 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 103 ~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 180 (267)
T cd08228 103 IPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhcc
Confidence 577889999999999999999999 999999999999999999999999987654433222233457778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNP--AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...+.++|+||+|++++++++|..||..... ......+............++..+.+++.+||..+|.+||++.++++
T Consensus 181 ~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 8888999999999999999999999866533 34444443333222233457788999999999999999999999999
Q ss_pred HHHHh
Q 030203 160 LLRPL 164 (181)
Q Consensus 160 ~L~~~ 164 (181)
.++++
T Consensus 261 ~~~~~ 265 (267)
T cd08228 261 IAKQM 265 (267)
T ss_pred HHHHh
Confidence 98864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=198.42 Aligned_cols=154 Identities=26% Similarity=0.517 Sum_probs=130.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 98 l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05615 98 FKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY 175 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC
Confidence 578899999999999999999999 999999999999999999999999987643332222334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH-----HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----ST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ 156 (181)
..++.++|+||+|+++|+|++|..||.+.........+.. .....+..++.++.+++.+|++.+|.+|++. .+
T Consensus 176 ~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 253 (323)
T cd05615 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERD 253 (323)
T ss_pred CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHH
Confidence 8888999999999999999999999999887777666642 3345567789999999999999999999974 55
Q ss_pred HHH
Q 030203 157 IME 159 (181)
Q Consensus 157 ~l~ 159 (181)
+++
T Consensus 254 i~~ 256 (323)
T cd05615 254 IRE 256 (323)
T ss_pred Hhc
Confidence 555
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=190.26 Aligned_cols=161 Identities=35% Similarity=0.673 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++....... .......+..|++||...+
T Consensus 109 l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~ 185 (270)
T cd05047 109 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNY 185 (270)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHcc
Confidence 567889999999999999999999 9999999999999999999999999875322111 1111223456999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||||+++++|++ |..||.+.+.......+. .......+..++.++.+++.+|+..+|.+|||+.+++..
T Consensus 186 ~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 186 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 778899999999999999997 999998877766665553 223334556688999999999999999999999999999
Q ss_pred HHHhhh
Q 030203 161 LRPLIK 166 (181)
Q Consensus 161 L~~~~~ 166 (181)
|+++++
T Consensus 265 l~~~~~ 270 (270)
T cd05047 265 LNRMLE 270 (270)
T ss_pred HHHhhC
Confidence 998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=189.74 Aligned_cols=160 Identities=28% Similarity=0.535 Sum_probs=133.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||......... .......++..|+|||.+.
T Consensus 104 l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (266)
T cd05064 104 LVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHh
Confidence 578899999999999999999999 9999999999999999999999999765432221 1111223456799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|++++ |..||.+.........+. .....+.+..++..+.+++.+||+.+|.+||+++++.+
T Consensus 182 ~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 8888999999999999999775 999999888777766664 33344567788999999999999999999999999999
Q ss_pred HHHHh
Q 030203 160 LLRPL 164 (181)
Q Consensus 160 ~L~~~ 164 (181)
.|+.+
T Consensus 261 ~l~~~ 265 (266)
T cd05064 261 ILSKM 265 (266)
T ss_pred HHHhh
Confidence 88765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=188.31 Aligned_cols=161 Identities=33% Similarity=0.609 Sum_probs=130.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc----ccCCCCCCCCCccCCcc
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~pe~ 78 (181)
++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||.
T Consensus 96 ~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 173 (262)
T cd05058 96 TVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhH
Confidence 56677889999999999999999 9999999999999999999999999876432211 11112234567999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
..+..++.++|+||+|+++|+|++| ..||...+.......+. .......+..+++.+.+++.+||..+|.+||++.++
T Consensus 174 ~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 252 (262)
T cd05058 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252 (262)
T ss_pred hccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 8888888999999999999999994 66777777666655553 333344456678999999999999999999999999
Q ss_pred HHHHHHhhh
Q 030203 158 MELLRPLIK 166 (181)
Q Consensus 158 l~~L~~~~~ 166 (181)
++.|+.++.
T Consensus 253 l~~l~~~~~ 261 (262)
T cd05058 253 VSRIEQIFS 261 (262)
T ss_pred HHHHHHHhc
Confidence 999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=189.84 Aligned_cols=156 Identities=31% Similarity=0.555 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC---CCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~---~~~~~~~~~~~pe~ 78 (181)
+++..+..++.|++.||.+||+.+ ++|+||+|.||+++.++.++++|||.+.......... ....++..|++||.
T Consensus 101 ~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 178 (263)
T cd06625 101 LTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178 (263)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcce
Confidence 467788999999999999999999 9999999999999999999999999876433221111 22345678999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
+.+..++.++|+||+|+++|++++|+.||.....................+..++..+.+++.+|+..+|.+||++.+++
T Consensus 179 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 179 ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258 (263)
T ss_pred eccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 98888889999999999999999999999887666555555445455567778999999999999999999999999998
Q ss_pred H
Q 030203 159 E 159 (181)
Q Consensus 159 ~ 159 (181)
+
T Consensus 259 ~ 259 (263)
T cd06625 259 R 259 (263)
T ss_pred h
Confidence 7
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=183.73 Aligned_cols=158 Identities=24% Similarity=0.468 Sum_probs=142.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|+..+.+++|++.|+.|+|..+ ++||||+|+|++++..|.+++.|||.+.... .....+..|+..|++||...+
T Consensus 121 f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 121 FDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred ccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCC
Confidence 578889999999999999999999 9999999999999999999999999987654 345667889999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
...+..+|+|++|++.|+++.|.+||.+....+...++ ...+...|..++.+++++|.+|+..+|.+|.+..++++
T Consensus 197 ~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~-- 272 (281)
T KOG0580|consen 197 RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--RKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD-- 272 (281)
T ss_pred CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--HHccccCCcccChhHHHHHHHHhccCccccccHHHHhh--
Confidence 99999999999999999999999999999988888877 44455567899999999999999999999999999999
Q ss_pred HHhhhC
Q 030203 162 RPLIKS 167 (181)
Q Consensus 162 ~~~~~~ 167 (181)
+.|+..
T Consensus 273 hpwI~a 278 (281)
T KOG0580|consen 273 HPWIVA 278 (281)
T ss_pred hHHHHh
Confidence 777654
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=188.71 Aligned_cols=160 Identities=32% Similarity=0.606 Sum_probs=133.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.|+.|||+++ ++|+||+|.||+++.++.++++|||++...... ........++..|++||..
T Consensus 103 ~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~ 180 (266)
T cd05033 103 FTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhh
Confidence 578899999999999999999999 999999999999999999999999998755311 1111122334679999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|++++++++ |..||...........+. .....+.+..+++.+.+++.+|++.+|.+||++.+++
T Consensus 181 ~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~ 259 (266)
T cd05033 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIV 259 (266)
T ss_pred ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 88888999999999999999997 999998877766666554 3334445667899999999999999999999999999
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+.|+.+
T Consensus 260 ~~l~~~ 265 (266)
T cd05033 260 STLDKM 265 (266)
T ss_pred HHHHhh
Confidence 999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=191.98 Aligned_cols=163 Identities=31% Similarity=0.611 Sum_probs=136.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+
T Consensus 134 ~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 211 (304)
T cd05101 134 MTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211 (304)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh
Confidence 456778899999999999999999 99999999999999999999999999875433211 11223345679999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||.+.....+...+. .......+..++..+.+++.+||..+|.+||++.+++
T Consensus 212 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l 290 (304)
T cd05101 212 FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290 (304)
T ss_pred ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 88888899999999999999998 788998888777777664 3333445667889999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.++..
T Consensus 291 ~~l~~~~~~ 299 (304)
T cd05101 291 EDLDRILTL 299 (304)
T ss_pred HHHHHHHHh
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=187.41 Aligned_cols=160 Identities=34% Similarity=0.582 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCC-CCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK-SAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++++|||++........... .......|++||...
T Consensus 100 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05068 100 LKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccc
Confidence 578889999999999999999999 99999999999999999999999998875543221111 112234799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|++++++++ |+.||.+.........+. .......+..++..+.+++.+|++.+|.+||++.++.+
T Consensus 178 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 8888899999999999999999 999999888776666654 33334456678899999999999999999999999999
Q ss_pred HHHHh
Q 030203 160 LLRPL 164 (181)
Q Consensus 160 ~L~~~ 164 (181)
.|+++
T Consensus 257 ~l~~~ 261 (261)
T cd05068 257 KLEDF 261 (261)
T ss_pred HHhcC
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=190.00 Aligned_cols=161 Identities=24% Similarity=0.450 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.|+.|||++| ++|+||+|+||+++.++.++++|||.+..............++..|++||...+
T Consensus 103 ~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~ 180 (267)
T cd08229 103 IPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcC
Confidence 578889999999999999999999 999999999999999999999999987654433222233457778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..++.++|+||+|+++++|++|..||...... .....+.........+..+++.+.+++.+|+..||.+|||+.++++
T Consensus 181 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 88888999999999999999999999765432 3333332222222233457889999999999999999999999999
Q ss_pred HHHHh
Q 030203 160 LLRPL 164 (181)
Q Consensus 160 ~L~~~ 164 (181)
.+..+
T Consensus 261 ~~~~~ 265 (267)
T cd08229 261 VAKRM 265 (267)
T ss_pred HHhhh
Confidence 88764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=189.15 Aligned_cols=160 Identities=31% Similarity=0.618 Sum_probs=133.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||.+.
T Consensus 99 ~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~ 176 (260)
T cd05067 99 LTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhc
Confidence 467888999999999999999999 9999999999999999999999999886544221 1112233456799999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|++++++++ |..||.+.........+. .....+.+...+.++.+++.+|+..+|.+||+++++++
T Consensus 177 ~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8778889999999999999998 999998887777666654 33344566778899999999999999999999999999
Q ss_pred HHHHh
Q 030203 160 LLRPL 164 (181)
Q Consensus 160 ~L~~~ 164 (181)
.|+.+
T Consensus 256 ~l~~~ 260 (260)
T cd05067 256 VLEDF 260 (260)
T ss_pred HhhcC
Confidence 98753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=202.51 Aligned_cols=154 Identities=28% Similarity=0.457 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..............+++.|++||.+.+
T Consensus 95 l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 172 (318)
T cd05582 95 FTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172 (318)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC
Confidence 678899999999999999999999 999999999999999999999999988654433223334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----HHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ 156 (181)
..++.++|+||+|+++|+|++|+.||...........+. ......+..+++.+.+++.+||+.||.+||+ +.+
T Consensus 173 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~ 250 (318)
T cd05582 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEE 250 (318)
T ss_pred CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 888899999999999999999999999888777666553 2334567778999999999999999999999 555
Q ss_pred HHH
Q 030203 157 IME 159 (181)
Q Consensus 157 ~l~ 159 (181)
+++
T Consensus 251 ~~~ 253 (318)
T cd05582 251 IKR 253 (318)
T ss_pred HhC
Confidence 554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=190.43 Aligned_cols=163 Identities=34% Similarity=0.606 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||+++...... .......++..|++||.+
T Consensus 114 l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 114 LSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 568889999999999999999999 9999999999999999999999999986432211 111223445679999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|++++++++ |+.||...+..++...+. .......+..+++.+.+++.+|+..+|.+|||+.+++
T Consensus 192 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 270 (280)
T cd05043 192 VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLV 270 (280)
T ss_pred hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 88888899999999999999998 999998887777666554 3333344556789999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+++.+.
T Consensus 271 ~~l~~~~~~ 279 (280)
T cd05043 271 QCLTDFHAQ 279 (280)
T ss_pred HHHHHHHhc
Confidence 999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=202.07 Aligned_cols=161 Identities=27% Similarity=0.448 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------------------- 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------------------- 61 (181)
+++.++..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (350)
T cd05573 98 FPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175 (350)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccc
Confidence 578889999999999999999999 9999999999999999999999999986543322
Q ss_pred ---------ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--cCCccCCCC
Q 030203 62 ---------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF--KGKRLEIPR 130 (181)
Q Consensus 62 ---------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~ 130 (181)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..........++.. .....+...
T Consensus 176 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 255 (350)
T cd05573 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDP 255 (350)
T ss_pred cccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCC
Confidence 122345678899999999988899999999999999999999999998887766666543 122222333
Q ss_pred CCCHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHhhhC
Q 030203 131 NVNPHVASIIEACWANEPWKRPS-FSTIMELLRPLIKS 167 (181)
Q Consensus 131 ~~~~~~~~li~~~l~~~p~~Rps-~~~~l~~L~~~~~~ 167 (181)
.+++++.+++.+|+. ||.+|++ +.++++ +++++.
T Consensus 256 ~~~~~~~~li~~ll~-dp~~R~~s~~~ll~--hp~~~~ 290 (350)
T cd05573 256 PVSPEAIDLICRLLC-DPEDRLGSFEEIKS--HPFFKG 290 (350)
T ss_pred CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc--CCCcCC
Confidence 469999999999997 9999998 999998 666654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=190.75 Aligned_cols=158 Identities=37% Similarity=0.648 Sum_probs=133.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||.+
T Consensus 116 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05032 116 PTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHH
Confidence 467788999999999999999999 9999999999999999999999999876433221 112233456689999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||...........+. .......+..++..+.+++.+|+..+|.+|||+.+++
T Consensus 194 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 194 KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred hcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 88778899999999999999998 999998888777776665 4444556777899999999999999999999999999
Q ss_pred HHHH
Q 030203 159 ELLR 162 (181)
Q Consensus 159 ~~L~ 162 (181)
+.|+
T Consensus 273 ~~l~ 276 (277)
T cd05032 273 SSLK 276 (277)
T ss_pred HHhc
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=203.01 Aligned_cols=159 Identities=31% Similarity=0.581 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|+++..++.++++||.|||+++ |.|+|++|.||+++.+|.+|++|||+++.............|++.|+|||...+
T Consensus 97 lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e 174 (808)
T KOG0597|consen 97 LPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE 174 (808)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcC
Confidence 689999999999999999999999 999999999999999999999999999876655444556789999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..|+..+|+||+||++||+..|++||.......+...+. ......|...+..+..+++.++..||.+|.+-.+++.
T Consensus 175 ~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~-- 250 (808)
T KOG0597|consen 175 QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG-- 250 (808)
T ss_pred CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc--
Confidence 999999999999999999999999999998888888874 3344456689999999999999999999999999987
Q ss_pred HHhhh
Q 030203 162 RPLIK 166 (181)
Q Consensus 162 ~~~~~ 166 (181)
+++.+
T Consensus 251 HpF~k 255 (808)
T KOG0597|consen 251 HPFWK 255 (808)
T ss_pred ChHHh
Confidence 55543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=191.20 Aligned_cols=166 Identities=23% Similarity=0.318 Sum_probs=137.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
+...+..++.||+.||.|||+++ |+||||||.||+++.+|.+|++|||+++-..-+.....+.+++.+|.|||++.+.
T Consensus 118 ~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs 195 (323)
T KOG0594|consen 118 PPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGS 195 (323)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCC
Confidence 44678899999999999999999 9999999999999999999999999998766666667788899999999999887
Q ss_pred -CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc---CCC-------------------------CCCC
Q 030203 83 -PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL---EIP-------------------------RNVN 133 (181)
Q Consensus 83 -~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~-------------------------~~~~ 133 (181)
.|+...|+||+||+++||++++.-|.+....+.+..+-.....+ ..| ...+
T Consensus 196 ~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~ 275 (323)
T KOG0594|consen 196 TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLD 275 (323)
T ss_pred CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccC
Confidence 58999999999999999999999999988866665542111111 000 1223
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCC
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~ 172 (181)
++..+++.+|+..+|.+|.|++.+++ ++++...+.+.
T Consensus 276 ~~~~dll~~~L~y~p~~R~Sa~~al~--h~yf~~~~~~~ 312 (323)
T KOG0594|consen 276 PDGIELLSKLLQYDPAKRISAKGALT--HPYFSELPEKS 312 (323)
T ss_pred ccHHHHHHHHhccCcccCcCHHHHhc--Chhhcccccch
Confidence 47889999999999999999999999 77777665443
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=193.23 Aligned_cols=155 Identities=25% Similarity=0.333 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||++....... ......++..|+|||.+.+
T Consensus 105 ~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd07863 105 LPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQ 181 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccccccCcc-cCCCccccccccCchHhhC
Confidence 578899999999999999999999 9999999999999999999999999886543321 1223456788999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CC--c----------------------cCCCCCCCHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GK--R----------------------LEIPRNVNPHV 136 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~--~----------------------~~~~~~~~~~~ 136 (181)
..++.++|+||+|+++|+|++|..||..........++... .. . ......++..+
T Consensus 182 ~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (288)
T cd07863 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESG 261 (288)
T ss_pred CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHH
Confidence 88899999999999999999999999877665443332110 00 0 01123567889
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHH
Q 030203 137 ASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 137 ~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
.+++.+||+.||.+|||+.++++
T Consensus 262 ~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 262 AQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHHHhccCcccCCCHHHHhc
Confidence 99999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=194.77 Aligned_cols=164 Identities=22% Similarity=0.330 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+..............++..|.+||.+.+
T Consensus 101 ~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 178 (309)
T cd07872 101 MSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178 (309)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhC
Confidence 567888999999999999999999 999999999999999999999999998654433323334456788999998865
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC---------------------c-------cCCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK---------------------R-------LEIPRNV 132 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~---------------------~-------~~~~~~~ 132 (181)
. .++.++|+||+|+++++|++|+.||.+.+..+....+..... . ......+
T Consensus 179 ~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T cd07872 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRL 258 (309)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCC
Confidence 3 478899999999999999999999987765443332211000 0 0111357
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
++++.+++.+||..||.+|||+.++++ ++|++...
T Consensus 259 ~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~ 293 (309)
T cd07872 259 DTEGIELLTKFLQYESKKRISAEEAMK--HAYFRSLG 293 (309)
T ss_pred CHHHHHHHHHhccCChhhCCCHHHHhc--Chhhhhcc
Confidence 889999999999999999999999999 88888644
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=200.79 Aligned_cols=150 Identities=29% Similarity=0.435 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..............+++.|++||.+.+
T Consensus 93 ~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05604 93 FPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC
Confidence 578899999999999999999999 999999999999999999999999997643332223334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
..++.++|+||+|+++|+|++|..||...+.......+.. .....+...+..+.+++.+|+..+|.+||+++
T Consensus 171 ~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 8889999999999999999999999998887776666532 23344556889999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=193.11 Aligned_cols=164 Identities=31% Similarity=0.627 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.++....... ......++..|++||.+
T Consensus 131 l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (314)
T cd05099 131 LSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL 208 (314)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHH
Confidence 567788999999999999999999 99999999999999999999999999865432111 11122234579999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||...........+. .......+..++.++.+++.+|+..+|.+||++.+++
T Consensus 209 ~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 287 (314)
T cd05099 209 FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV 287 (314)
T ss_pred ccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 88888899999999999999998 889998887777666664 3333445667888999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+.+....
T Consensus 288 ~~l~~~~~~~ 297 (314)
T cd05099 288 EALDKVLAAV 297 (314)
T ss_pred HHHHHHHHHh
Confidence 9999887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=193.16 Aligned_cols=175 Identities=23% Similarity=0.287 Sum_probs=139.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+...............+..|++||.+.+
T Consensus 105 l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 105 FSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182 (309)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcC
Confidence 578899999999999999999999 999999999999999999999999988755433222223344678999998865
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-----------------ccCC-----------CCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-----------------RLEI-----------PRNV 132 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~-----------~~~~ 132 (181)
. .++.++|+||+|+++|+|++|..||...+.......+..... .... ....
T Consensus 183 ~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T cd07845 183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWL 262 (309)
T ss_pred CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhcccc
Confidence 3 467899999999999999999999988776655444321100 0000 1235
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCCCCCCCCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPLL 180 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~~~~~~~~~ 180 (181)
++.+.+++.+||..||.+|||+.++++ ++|++...-+-.|..+|.+
T Consensus 263 ~~~~~~li~~ml~~dp~~R~t~~~il~--h~~f~~~~~~~~~~~~~~~ 308 (309)
T cd07845 263 SEAGLRLLNFLLMYDPKKRATAEEALE--SSYFKEKPLPCEPEMMPTF 308 (309)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhccCCCCCCCCcCCCC
Confidence 788999999999999999999999999 9999977777667777765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=192.39 Aligned_cols=162 Identities=27% Similarity=0.417 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
|+++.+-.+++|++.||+|+|+.+ ++|||+||.|++++.+..+|++|||+++...... ..-+.-+.|.+|.|||.+
T Consensus 122 L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPEll 199 (359)
T KOG0660|consen 122 LTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELL 199 (359)
T ss_pred ccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHH
Confidence 567788899999999999999999 9999999999999999999999999998654321 111334678899999988
Q ss_pred CC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC------------------------ccC-----CC
Q 030203 80 RD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK------------------------RLE-----IP 129 (181)
Q Consensus 80 ~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~------------------------~~~-----~~ 129 (181)
.. ..|+.+.|+||+||++.||++|++-|.+.+....+..+..... ... .-
T Consensus 200 l~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f 279 (359)
T KOG0660|consen 200 LNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF 279 (359)
T ss_pred hccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc
Confidence 54 4589999999999999999999999988765544433211100 001 12
Q ss_pred CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 130 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
.+.++...+|+++||.+||.+|+|++++++ ++++..
T Consensus 280 p~a~p~AidLlekmL~fdP~kRita~eAL~--hPYl~~ 315 (359)
T KOG0660|consen 280 PNANPLAIDLLEKMLVFDPKKRITAEEALA--HPYLAP 315 (359)
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhc--Chhhhh
Confidence 467889999999999999999999999999 777764
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=201.80 Aligned_cols=161 Identities=26% Similarity=0.443 Sum_probs=132.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+
T Consensus 93 ~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (330)
T cd05586 93 FSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcC
Confidence 578899999999999999999999 999999999999999999999999988643332223334567889999998865
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC----CHHH
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP----SFST 156 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~ 156 (181)
. .++.++|+||+|+++|+|++|+.||...+.......+........ ...+++.+.+++.+||..||.+|| ++.+
T Consensus 171 ~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 249 (330)
T cd05586 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE 249 (330)
T ss_pred CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHH
Confidence 4 378899999999999999999999998887777666643332222 235789999999999999999998 6778
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++++..
T Consensus 250 ll~--h~~~~~ 258 (330)
T cd05586 250 LKE--HPFFAD 258 (330)
T ss_pred Hhc--CccccC
Confidence 777 666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=198.64 Aligned_cols=160 Identities=26% Similarity=0.512 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+
T Consensus 93 l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (329)
T cd05588 93 LPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG 170 (329)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcC
Confidence 578899999999999999999999 999999999999999999999999987643222222334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------H-HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLN--------P-AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
..++.++|+||+|+++|++++|+.||.... . ....+.+ .......+..++..+.+++.+||..||.+|+
T Consensus 171 ~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 248 (329)
T cd05588 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASSVLKGFLNKDPKERL 248 (329)
T ss_pred CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 888999999999999999999999996321 1 1122222 2334456778899999999999999999999
Q ss_pred C------HHHHHHHHHHhhhC
Q 030203 153 S------FSTIMELLRPLIKS 167 (181)
Q Consensus 153 s------~~~~l~~L~~~~~~ 167 (181)
+ ++++++ ++|+..
T Consensus 249 ~~~~~~~~~~i~~--hp~~~~ 267 (329)
T cd05588 249 GCHPQTGFRDIKS--HPFFRN 267 (329)
T ss_pred CCCCCCCHHHHhc--CCCCCC
Confidence 7 678877 666653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=191.24 Aligned_cols=165 Identities=28% Similarity=0.530 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (296)
T cd06655 112 MDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcC
Confidence 578899999999999999999999 999999999999999999999999987643322222233456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|+++|++++|+.||...+.......+.... .....+..+++.+.+++.+||..||.+||++.++++
T Consensus 190 ~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~- 268 (296)
T cd06655 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ- 268 (296)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh-
Confidence 888899999999999999999999998877655444443222 223345678899999999999999999999999999
Q ss_pred HHHhhhCCCC
Q 030203 161 LRPLIKSPTP 170 (181)
Q Consensus 161 L~~~~~~~~~ 170 (181)
++|++....
T Consensus 269 -~~~~~~~~~ 277 (296)
T cd06655 269 -HPFLKLAKP 277 (296)
T ss_pred -ChHhhhccc
Confidence 999886544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=197.86 Aligned_cols=160 Identities=27% Similarity=0.354 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+
T Consensus 123 ~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~ 199 (364)
T cd07875 123 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG 199 (364)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-cccCCcccCCcCCHHHHhC
Confidence 467788899999999999999999 9999999999999999999999999987543322 2233467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--------------------c----------------
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--------------------R---------------- 125 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--------------------~---------------- 125 (181)
..++.++|+||+|+++|+|++|+.||.+.+.......+..... .
T Consensus 200 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (364)
T cd07875 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL 279 (364)
T ss_pred CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccc
Confidence 8889999999999999999999999988765443333211000 0
Q ss_pred ----cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 126 ----LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 126 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
.......+..+++++.+||..||.+|||+.++++ ++|+.
T Consensus 280 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~--hp~~~ 322 (364)
T cd07875 280 FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYIN 322 (364)
T ss_pred ccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc--Ccccc
Confidence 0001123467899999999999999999999999 66664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=198.96 Aligned_cols=159 Identities=27% Similarity=0.523 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+
T Consensus 93 l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (329)
T cd05618 93 LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170 (329)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcC
Confidence 578889999999999999999999 999999999999999999999999988643322222334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLN---------PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
..++.++|+||+|+++|+|++|+.||.... .......+ .......+..++..+.+++.+||..||.+||
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~ 248 (329)
T cd05618 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAASVLKSFLNKDPKERL 248 (329)
T ss_pred CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHhcCCHHHcC
Confidence 888899999999999999999999995311 11122222 2334456778999999999999999999999
Q ss_pred C------HHHHHHHHHHhhh
Q 030203 153 S------FSTIMELLRPLIK 166 (181)
Q Consensus 153 s------~~~~l~~L~~~~~ 166 (181)
+ +.++++ +++++
T Consensus 249 ~~~~~~~~~~i~~--hp~f~ 266 (329)
T cd05618 249 GCHPQTGFADIQG--HPFFR 266 (329)
T ss_pred CCCCCCCHHHHhc--CCCCC
Confidence 8 567777 66654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=198.72 Aligned_cols=150 Identities=29% Similarity=0.457 Sum_probs=127.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..............+++.|++||.+.+
T Consensus 93 ~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (321)
T cd05603 93 FLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170 (321)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC
Confidence 567888999999999999999999 999999999999999999999999987643332223334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
..++.++|+||+|+++|+|++|..||...+.......+. ......+...+..+.+++.+||+.||.+|++..
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 888999999999999999999999999988777666653 234456667889999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=198.51 Aligned_cols=166 Identities=23% Similarity=0.329 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...... ........+++.|++||.+.
T Consensus 179 l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 256 (391)
T PHA03212 179 IAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLA 256 (391)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhc
Confidence 467889999999999999999999 999999999999999999999999998643221 11223456889999999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHH-HHhc-------------------------cCCc-c
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLN-------PAQVVA-AVGF-------------------------KGKR-L 126 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-------~~~~~~-~~~~-------------------------~~~~-~ 126 (181)
+..++.++|+||+|+++|+|++|+.||.... ...... .+.. .... .
T Consensus 257 ~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (391)
T PHA03212 257 RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKP 336 (391)
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCC
Confidence 8888999999999999999999988764321 000000 0000 0000 0
Q ss_pred CC------CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 127 EI------PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 127 ~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
.. ...++.++.+++.+||+.||.+|||+.++++ ++|++..+.+
T Consensus 337 ~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~--hp~f~~~~~~ 385 (391)
T PHA03212 337 GSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD--FAAFQDIPDP 385 (391)
T ss_pred CCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc--ChhhccCCCC
Confidence 00 0124668999999999999999999999999 9999875544
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=189.72 Aligned_cols=157 Identities=36% Similarity=0.640 Sum_probs=129.9
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCcccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~ 80 (181)
++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++........ ......++..|++||.+.
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05062 117 SLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhh
Confidence 56678899999999999999999 99999999999999999999999998764332211 112233456799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||||+++|++++ |..||.+.........+. .......+..+++.+.+++.+|++.||.+|||+.++++
T Consensus 195 ~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 195 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8888999999999999999998 788998887776666554 33334456678899999999999999999999999999
Q ss_pred HHH
Q 030203 160 LLR 162 (181)
Q Consensus 160 ~L~ 162 (181)
.|+
T Consensus 274 ~l~ 276 (277)
T cd05062 274 SIK 276 (277)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=199.74 Aligned_cols=157 Identities=24% Similarity=0.394 Sum_probs=134.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++...... .....+++.|+|||.+.+
T Consensus 128 ~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~ 202 (340)
T PTZ00426 128 FPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLN 202 (340)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhC
Confidence 577888999999999999999999 999999999999999999999999998654322 233467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+|+++|+|++|..||...+.......+.. .....+..+++.+.+++.+|++.||.+|+ ++++
T Consensus 203 ~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 280 (340)
T PTZ00426 203 VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE--GIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQN 280 (340)
T ss_pred CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHH
Confidence 8888999999999999999999999998887766666642 23345777899999999999999999995 8999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++|++.
T Consensus 281 ~~~--hp~f~~ 289 (340)
T PTZ00426 281 VKE--HPWFGN 289 (340)
T ss_pred HHc--CCCcCC
Confidence 988 666654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=193.69 Aligned_cols=163 Identities=28% Similarity=0.464 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||++ + ++|+||+|+||+++.++.++++|||++...... ......+++.|+|||.+.
T Consensus 100 ~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~ 175 (331)
T cd06649 100 IPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQ 175 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhc
Confidence 56788899999999999999986 6 999999999999999999999999987644332 123346788999999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc--------------------------------------
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-------------------------------------- 122 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-------------------------------------- 122 (181)
+..++.++|+||+|+++|++++|+.||...+...+...+...
T Consensus 176 ~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T cd06649 176 GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFE 255 (331)
T ss_pred CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHH
Confidence 888899999999999999999999999876655443322110
Q ss_pred -------CCccC-CCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 123 -------GKRLE-IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 123 -------~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
..... ....+++++++|+.+||..||.+|||++++++ +.|++....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~--h~~~~~~~~ 309 (331)
T cd06649 256 LLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN--HTFIKRSEV 309 (331)
T ss_pred HHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc--ChHHhhccc
Confidence 00001 11246789999999999999999999999999 777765443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=186.80 Aligned_cols=159 Identities=33% Similarity=0.599 Sum_probs=132.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||.+........ ......++..|++||...
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~ 176 (260)
T cd05069 99 LKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhc
Confidence 467788999999999999999999 99999999999999999999999998865433211 112223456799999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+...+.++|+||+|+++|++++ |..||.+.........+. .......+...+..+.+++.+|+..||.+||+++++++
T Consensus 177 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 7778899999999999999999 899998887766666554 23334455678899999999999999999999999999
Q ss_pred HHHH
Q 030203 160 LLRP 163 (181)
Q Consensus 160 ~L~~ 163 (181)
.|+.
T Consensus 256 ~l~~ 259 (260)
T cd05069 256 FLED 259 (260)
T ss_pred HHhc
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=192.28 Aligned_cols=168 Identities=26% Similarity=0.513 Sum_probs=136.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.|||+++ ++|+||+|.||+++.++.++++|||++..............++..|+|||...+
T Consensus 115 l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (292)
T cd06658 115 MNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR 192 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHcc
Confidence 467889999999999999999999 999999999999999999999999987644333222233456788999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|++++++++|+.||...........+... .........++..+.+++.+|+..||.+|||+.++++
T Consensus 193 ~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~- 271 (292)
T cd06658 193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ- 271 (292)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhh-
Confidence 77889999999999999999999999877665544433211 1112223357889999999999999999999999999
Q ss_pred HHHhhhCCCCCCC
Q 030203 161 LRPLIKSPTPQPS 173 (181)
Q Consensus 161 L~~~~~~~~~~~~ 173 (181)
+++++...+++.
T Consensus 272 -~~~~~~~~~~~~ 283 (292)
T cd06658 272 -HPFLKLAGPPSC 283 (292)
T ss_pred -ChhhhccCCccc
Confidence 899987666553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=192.80 Aligned_cols=164 Identities=34% Similarity=0.660 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++++++.++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||++....... .......+..|++||...+
T Consensus 121 l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 197 (303)
T cd05088 121 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNY 197 (303)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhc
Confidence 567889999999999999999999 9999999999999999999999999875322111 1111223457999998877
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|++++++++ |..||......+....+. .......+..+++.+.+++.+|++.+|.+||++.+++..
T Consensus 198 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 198 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 778889999999999999998 999998877766555553 333344455688999999999999999999999999999
Q ss_pred HHHhhhCCC
Q 030203 161 LRPLIKSPT 169 (181)
Q Consensus 161 L~~~~~~~~ 169 (181)
|..++....
T Consensus 277 l~~~~~~~~ 285 (303)
T cd05088 277 LNRMLEERK 285 (303)
T ss_pred HHHHHHhhh
Confidence 998877544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=188.84 Aligned_cols=155 Identities=31% Similarity=0.532 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++.++.++.|++.||.+||+++ ++|+||+|.||+++.++.++++|||.+..............++..|++||...+
T Consensus 97 ~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 174 (255)
T cd08219 97 FPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174 (255)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHcc
Confidence 567889999999999999999999 999999999999999999999999988654433322334467778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...+.++|+||+|+++++|++|..||...+.......+. .......+..++..+.+++.+||+.||.+||++.+++.
T Consensus 175 ~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 888899999999999999999999999888776666554 33334456778899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=203.94 Aligned_cols=162 Identities=23% Similarity=0.343 Sum_probs=127.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++||||+|+||+++.++ .++|+|||+++...... ......+++.|+|||.+.
T Consensus 167 l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~ 243 (440)
T PTZ00036 167 LPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYICSRFYRAPELML 243 (440)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchhccCCC-CcccCCCCcCccCHHHhc
Confidence 567788999999999999999999 99999999999998654 69999999987543321 222346788999999876
Q ss_pred CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCC--------------------------ccCCCCCC
Q 030203 81 DE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGK--------------------------RLEIPRNV 132 (181)
Q Consensus 81 ~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~ 132 (181)
+. .++.++|+||+||++|+|++|..||.+....+....+.. .+. ....+...
T Consensus 244 ~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~ 323 (440)
T PTZ00036 244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGT 323 (440)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCC
Confidence 54 588999999999999999999999988765443332211 000 00123346
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
++++.+|+.+||..||.+|||+.++++ ++|++..
T Consensus 324 ~~~~~~li~~~L~~dP~~R~ta~e~l~--hp~f~~~ 357 (440)
T PTZ00036 324 PDDAINFISQFLKYEPLKRLNPIEALA--DPFFDDL 357 (440)
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhC--ChhHHhh
Confidence 789999999999999999999999998 8887654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=208.80 Aligned_cols=165 Identities=28% Similarity=0.498 Sum_probs=135.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc---------CCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS---------SKSAAGTPE 72 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~ 72 (181)
|+|.++++|++++++|+.+||..+++++|||||-+|||++.+|++||+|||.+.-....... .-....|+.
T Consensus 141 lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~ 220 (738)
T KOG1989|consen 141 LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQ 220 (738)
T ss_pred CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCcc
Confidence 68999999999999999999999999999999999999999999999999988632221100 012345789
Q ss_pred ccCCccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCC
Q 030203 73 WMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPW 149 (181)
Q Consensus 73 ~~~pe~~---~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 149 (181)
|++||++ ++...+.++|+|+|||++|-+++...||.......++. .....+....++..+++||..||+.||.
T Consensus 221 YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln----g~Y~~P~~p~ys~~l~~LI~~mL~~nP~ 296 (738)
T KOG1989|consen 221 YRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN----GNYSFPPFPNYSDRLKDLIRTMLQPNPD 296 (738)
T ss_pred ccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe----ccccCCCCccHHHHHHHHHHHHhccCcc
Confidence 9999987 35567899999999999999999999999875444332 3344444467899999999999999999
Q ss_pred CCCCHHHHHHHHHHhhhCCCC
Q 030203 150 KRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 150 ~Rps~~~~l~~L~~~~~~~~~ 170 (181)
+||++.++++.+-.+.....+
T Consensus 297 ~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 297 ERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred cCCCHHHHHHHHHHHhcCCCC
Confidence 999999999988877665443
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=189.82 Aligned_cols=167 Identities=30% Similarity=0.542 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++..............++..|++||.+.
T Consensus 100 l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 177 (282)
T cd06643 100 LTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccc
Confidence 578889999999999999999999 99999999999999999999999998765433322233446778899999874
Q ss_pred ----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 81 ----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 81 ----~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
+..++.++|+||+|+++|++++|..||...+............ .....+..++..+++++.+||+.||.+||++.
T Consensus 178 ~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 257 (282)
T cd06643 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTT 257 (282)
T ss_pred cCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHH
Confidence 3346778999999999999999999998877655444443222 22334556889999999999999999999999
Q ss_pred HHHHHHHHhhhCCCCCC
Q 030203 156 TIMELLRPLIKSPTPQP 172 (181)
Q Consensus 156 ~~l~~L~~~~~~~~~~~ 172 (181)
++++ +++++.....+
T Consensus 258 ~il~--~~~~~~~~~~~ 272 (282)
T cd06643 258 QLLQ--HPFVTVNSNKP 272 (282)
T ss_pred HHhc--CCCEeccCCCC
Confidence 9998 88887655443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=186.42 Aligned_cols=159 Identities=33% Similarity=0.615 Sum_probs=133.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++........ ......++..|++||.
T Consensus 94 ~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~ 171 (257)
T cd05040 94 FLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171 (257)
T ss_pred CcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHH
Confidence 577889999999999999999999 99999999999999999999999998875433211 1122345668999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
..+..++.++|+||+|+++++|++ |..||......+....+.........+..++..+.+++.+|+..+|.+||++.++
T Consensus 172 ~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred hcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 988888999999999999999998 9999988877777666654444444556788999999999999999999999999
Q ss_pred HHHHH
Q 030203 158 MELLR 162 (181)
Q Consensus 158 l~~L~ 162 (181)
++.|.
T Consensus 252 ~~~l~ 256 (257)
T cd05040 252 REFLP 256 (257)
T ss_pred HHHhc
Confidence 98774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=197.08 Aligned_cols=160 Identities=27% Similarity=0.370 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||++....... ......++..|+|||.+.+
T Consensus 116 l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~ 192 (355)
T cd07874 116 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG 192 (355)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccccCCCcc-ccCCccccCCccCHHHHcC
Confidence 467888899999999999999999 9999999999999999999999999987543322 2233467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------------cCC---------------
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF----------------------KGK--------------- 124 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~----------------------~~~--------------- 124 (181)
..++.++|+||+|+++|+|++|+.||.+.+.......+.. ...
T Consensus 193 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (355)
T cd07874 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272 (355)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccc
Confidence 8889999999999999999999999987664332211100 000
Q ss_pred ---ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 125 ---RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 125 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
........+..+++++.+||..||.+|||+.++++ ++|+.
T Consensus 273 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~--hp~~~ 315 (355)
T cd07874 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ--HPYIN 315 (355)
T ss_pred cccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc--Ccchh
Confidence 00011224567899999999999999999999999 66664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=192.63 Aligned_cols=157 Identities=38% Similarity=0.738 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccc--ccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.|+.|++.||.|||+++ ++|++|++.||+++.++.+|++|||+...... .............|++||.+
T Consensus 100 ~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 177 (259)
T PF07714_consen 100 LSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVL 177 (259)
T ss_dssp SBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHH
T ss_pred cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 578899999999999999999999 99999999999999999999999998875421 11122333455689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++||||||+++|++++ |+.||...+...+...+. .......+..++..+.+++..||+.+|.+||++.+++
T Consensus 178 ~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~ 256 (259)
T PF07714_consen 178 KDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK-QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEIL 256 (259)
T ss_dssp HHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccc-ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88878999999999999999999 789999998888887774 5555666778999999999999999999999999999
Q ss_pred HHH
Q 030203 159 ELL 161 (181)
Q Consensus 159 ~~L 161 (181)
+.|
T Consensus 257 ~~L 259 (259)
T PF07714_consen 257 QEL 259 (259)
T ss_dssp HHH
T ss_pred hcC
Confidence 875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=189.39 Aligned_cols=158 Identities=37% Similarity=0.614 Sum_probs=131.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++....... .......+++.|++||..
T Consensus 119 l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (280)
T cd05092 119 LTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 196 (280)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHh
Confidence 567889999999999999999999 9999999999999999999999999875432211 111222345679999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||||+++|+|++ |..||...........+. .......+..+++.+.+++.+||+.||.+||+++++.
T Consensus 197 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~ 275 (280)
T cd05092 197 LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIH 275 (280)
T ss_pred ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 88888999999999999999998 899998877766665554 3334455667899999999999999999999999999
Q ss_pred HHHH
Q 030203 159 ELLR 162 (181)
Q Consensus 159 ~~L~ 162 (181)
+.|+
T Consensus 276 ~~l~ 279 (280)
T cd05092 276 SRLQ 279 (280)
T ss_pred HHHh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=186.38 Aligned_cols=157 Identities=34% Similarity=0.633 Sum_probs=130.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC-CCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~pe~~~ 80 (181)
++++.+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||.+.......... .....+..|++||...
T Consensus 97 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~ 174 (256)
T cd05059 97 LGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD 174 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhc
Confidence 578889999999999999999999 9999999999999999999999999876543322111 1112234799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|++++ |..||...........+. .......+..++..+.+++.+|+..+|.+||++.++++
T Consensus 175 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8888899999999999999998 899998877776666664 33344556678999999999999999999999999998
Q ss_pred HH
Q 030203 160 LL 161 (181)
Q Consensus 160 ~L 161 (181)
.|
T Consensus 254 ~l 255 (256)
T cd05059 254 QL 255 (256)
T ss_pred Hh
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=189.17 Aligned_cols=164 Identities=31% Similarity=0.547 Sum_probs=137.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 95 ~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 172 (274)
T cd06609 95 LDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ 172 (274)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhcc
Confidence 578899999999999999999999 999999999999999999999999998765544333334566778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCC-CCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+|++|+++|++++|+.||...+.......+... .....+.. +++.+.+++.+|+..+|.+||+++++++
T Consensus 173 ~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~- 250 (274)
T cd06609 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK- 250 (274)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh-
Confidence 88899999999999999999999999887766555544322 22333333 7889999999999999999999999999
Q ss_pred HHHhhhCCCC
Q 030203 161 LRPLIKSPTP 170 (181)
Q Consensus 161 L~~~~~~~~~ 170 (181)
+++++....
T Consensus 251 -~~~~~~~~~ 259 (274)
T cd06609 251 -HKFIKKAKK 259 (274)
T ss_pred -ChhhcCCCc
Confidence 888876443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=197.85 Aligned_cols=160 Identities=28% Similarity=0.406 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
++++++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 102 ~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 179 (332)
T cd05614 102 FSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhc
Confidence 578899999999999999999999 9999999999999999999999999986533221 1222346788999999987
Q ss_pred CCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC---
Q 030203 81 DEP-SNEKSDIYSFGVILWELATLQQPWGNLN----PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP--- 152 (181)
Q Consensus 81 ~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 152 (181)
+.. ++.++|+||+|+++|+|++|+.||.... .......+ .......+..+++.+.+++.+||+.||.+||
T Consensus 180 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred CCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 653 6788999999999999999999996432 22222222 2333456677899999999999999999999
Q ss_pred --CHHHHHHHHHHhhhC
Q 030203 153 --SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 --s~~~~l~~L~~~~~~ 167 (181)
++.++++ ++|++.
T Consensus 258 ~~~~~~~l~--h~~~~~ 272 (332)
T cd05614 258 PQGASEIKE--HPFFKG 272 (332)
T ss_pred CCCHHHHHc--CCCcCC
Confidence 7888887 666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=190.24 Aligned_cols=161 Identities=32% Similarity=0.608 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+........ ......++..|++||.+
T Consensus 138 l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 215 (302)
T cd05055 138 LTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215 (302)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhh
Confidence 578899999999999999999999 99999999999999999999999999864432211 11222345679999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||.....................+...++.+.+++.+|+..+|.+||++.+++
T Consensus 216 ~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell 295 (302)
T cd05055 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295 (302)
T ss_pred ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 88888899999999999999998 99999877655443333223333444556789999999999999999999999999
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+.|.+.
T Consensus 296 ~~l~~~ 301 (302)
T cd05055 296 QLIGKQ 301 (302)
T ss_pred HHHHhh
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=194.68 Aligned_cols=161 Identities=25% Similarity=0.365 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++...... .....++..|+|||.+.+
T Consensus 115 l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 115 LSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccceecCCC---cCCccccccccCchHhcC
Confidence 578899999999999999999999 999999999999999999999999998754332 233467889999999876
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC---------------------ccC--------CCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK---------------------RLE--------IPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~---------------------~~~--------~~~~ 131 (181)
..++.++|+||+|+++|+|++|+.||...+..+....+..... ... ....
T Consensus 190 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (343)
T cd07878 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRG 269 (343)
T ss_pred CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccC
Confidence 4578899999999999999999999987665443332211000 000 1123
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.++.+.+++.+|+..||.+|||+.++++ ++|+....
T Consensus 270 ~~~~~~~li~~mL~~dp~~R~s~~ell~--hp~~~~~~ 305 (343)
T cd07878 270 ANPLAIDLLEKMLVLDSDKRISASEALA--HPYFSQYH 305 (343)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc--CcchhccC
Confidence 5677899999999999999999999999 88887543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=184.76 Aligned_cols=156 Identities=37% Similarity=0.682 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||.+........ .......|.+||.+.+
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~ 173 (256)
T cd05039 99 ITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALRE 173 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccccc---cCCCcccccCchhhcC
Confidence 578899999999999999999999 99999999999999999999999998865432211 2233457999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|++++++++ |..||...........+.. ......+..+++.+.+++.+|+..+|.+||++.+++++
T Consensus 174 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 788889999999999999997 9999988887776666543 33344556788999999999999999999999999999
Q ss_pred HHH
Q 030203 161 LRP 163 (181)
Q Consensus 161 L~~ 163 (181)
|+.
T Consensus 253 l~~ 255 (256)
T cd05039 253 LAL 255 (256)
T ss_pred Hhc
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=183.27 Aligned_cols=161 Identities=30% Similarity=0.537 Sum_probs=126.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC-
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD- 81 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~- 81 (181)
+|.-+-++.+.+++||.||.+... ++|||+||+||++|..|++|++|||.+-...+... .....|.+.|++||.+.-
T Consensus 189 PE~ilGk~tva~v~AL~YLKeKH~-viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-htrsAGC~~YMaPERidp~ 266 (391)
T KOG0983|consen 189 PERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-HTRSAGCAAYMAPERIDPP 266 (391)
T ss_pred hHHhhhhhHHHHHHHHHHHHHhcc-eeecccCccceEEccCCCEEeecccccceeecccc-cccccCCccccCccccCCC
Confidence 455555888999999999998832 99999999999999999999999999865444332 234577889999999853
Q ss_pred --CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 82 --EPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 82 --~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
..|+.++||||||+.++++.||+.||.+.+.+ +..-++..... .+.....+|+++++++..||..|+.+||.+.++
T Consensus 267 ~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~L 346 (391)
T KOG0983|consen 267 DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKL 346 (391)
T ss_pred CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHH
Confidence 34788999999999999999999999997654 33333432222 222233489999999999999999999999999
Q ss_pred HHHHHHhhhC
Q 030203 158 MELLRPLIKS 167 (181)
Q Consensus 158 l~~L~~~~~~ 167 (181)
++ +++...
T Consensus 347 l~--h~Fi~~ 354 (391)
T KOG0983|consen 347 LE--HPFIKR 354 (391)
T ss_pred hc--Ccceee
Confidence 98 555443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=196.76 Aligned_cols=159 Identities=26% Similarity=0.493 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 93 l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (327)
T cd05617 93 LPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170 (327)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC
Confidence 578899999999999999999999 999999999999999999999999988643322222334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCC------CH-HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNL------NP-AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS- 153 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps- 153 (181)
..++.++|+||+|+++|+|++|..||... .. ......+ .......+..++..+.+++.+||..||.+|++
T Consensus 171 ~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 88899999999999999999999999532 11 1222222 23344567788999999999999999999997
Q ss_pred -----HHHHHHHHHHhhh
Q 030203 154 -----FSTIMELLRPLIK 166 (181)
Q Consensus 154 -----~~~~l~~L~~~~~ 166 (181)
+.++++ +++++
T Consensus 249 ~~~~~~~~i~~--h~~f~ 264 (327)
T cd05617 249 QPQTGFSDIKS--HTFFR 264 (327)
T ss_pred CCCCCHHHHHc--CCCCC
Confidence 467776 55554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=197.87 Aligned_cols=172 Identities=26% Similarity=0.455 Sum_probs=148.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE-cCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV-DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~-~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+.|..+.+++.||+.|+.|+|+.. +||+|+||+|+.| ..-|-+||.|||++-.+..+ ....+..|+..|.|||++.
T Consensus 115 l~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~TsCGSLAYSAPEILL 191 (864)
T KOG4717|consen 115 LNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKLTTSCGSLAYSAPEILL 191 (864)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc-chhhcccchhhccCchhhh
Confidence 568889999999999999999999 9999999999866 56799999999998665544 3345678889999999999
Q ss_pred CCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSN-EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~-~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..|+ +++|+||||+++|.+++|+.||+..+..+.+-++ .......|..++.++++||..||..||++|.+.++|..
T Consensus 192 GDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 192 GDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 88764 6899999999999999999999998877766666 45566788899999999999999999999999999999
Q ss_pred HHHHhhhCCCCCCCCCCCCCCC
Q 030203 160 LLRPLIKSPTPQPSPTDMPLLT 181 (181)
Q Consensus 160 ~L~~~~~~~~~~~~~~~~~~~~ 181 (181)
..|++......+.. +|+++
T Consensus 270 --~~Wlq~~D~~~sT~-iPLvs 288 (864)
T KOG4717|consen 270 --TSWLQAGDRGLSTA-IPLVS 288 (864)
T ss_pred --cccccCCCCCcccc-Cceee
Confidence 99999777666554 77653
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=191.07 Aligned_cols=156 Identities=28% Similarity=0.475 Sum_probs=125.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++..+..++.|++.|+.|||+++ ++|+|++|.||+++.++.++++|||.+..............+++.|++||.+.
T Consensus 118 ~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~ 195 (282)
T cd06636 118 LKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCc
Confidence 567788999999999999999999 99999999999999999999999998765433222233456778899999875
Q ss_pred ----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 81 ----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 81 ----~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
...++.++|+||+|+++|++++|..||...........+............++..+.+++.+||..||.+||++.+
T Consensus 196 ~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e 275 (282)
T cd06636 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275 (282)
T ss_pred ccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence 2346778999999999999999999997766544444333222222334568899999999999999999999999
Q ss_pred HHH
Q 030203 157 IME 159 (181)
Q Consensus 157 ~l~ 159 (181)
+++
T Consensus 276 ll~ 278 (282)
T cd06636 276 LLK 278 (282)
T ss_pred Hhc
Confidence 987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=191.47 Aligned_cols=157 Identities=17% Similarity=0.289 Sum_probs=123.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-------ccCCCCCCCCCccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWMA 75 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------~~~~~~~~~~~~~~ 75 (181)
++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++++|||+++...... .......+++.|+|
T Consensus 124 ~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~a 201 (294)
T PHA02882 124 NKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAG 201 (294)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccC
Confidence 56778899999999999999999 9999999999999999999999999986532111 11123468889999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH-----hccCCccCCCCCCCHHHHHHHHHHhcCCCC
Q 030203 76 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAV-----GFKGKRLEIPRNVNPHVASIIEACWANEPW 149 (181)
Q Consensus 76 pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 149 (181)
||...+..++.++|+||+|+++++|++|+.||.+... ....... .............++.+.++++.|+..+|.
T Consensus 202 pe~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (294)
T PHA02882 202 LDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYE 281 (294)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCC
Confidence 9999888899999999999999999999999987632 2211111 000111112345688999999999999999
Q ss_pred CCCCHHHHHHHH
Q 030203 150 KRPSFSTIMELL 161 (181)
Q Consensus 150 ~Rps~~~~l~~L 161 (181)
+||++.++.+.+
T Consensus 282 ~rp~~~~l~~~~ 293 (294)
T PHA02882 282 EKPDYDALIKIF 293 (294)
T ss_pred CCCCHHHHHHhh
Confidence 999999999865
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=197.08 Aligned_cols=162 Identities=25% Similarity=0.409 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.
T Consensus 100 l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (372)
T cd07853 100 LSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177 (372)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHc
Confidence 578889999999999999999999 9999999999999999999999999886533221 1122345678899999987
Q ss_pred CCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------------------CCc-------cCCC
Q 030203 81 DEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-----------------------GKR-------LEIP 129 (181)
Q Consensus 81 ~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-----------------------~~~-------~~~~ 129 (181)
+.. ++.++|+||+||++++|++|+.||.+.+.......+... ... ....
T Consensus 178 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (372)
T cd07853 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLS 257 (372)
T ss_pred CCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccC
Confidence 644 688999999999999999999999887765544333110 000 0123
Q ss_pred CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 130 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
...++++.+++.+||+.||.+|||+.++++ ++|++.
T Consensus 258 ~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~~ 293 (372)
T cd07853 258 SQATHEAVHLLCRMLVFDPDKRISAADALA--HPYLDE 293 (372)
T ss_pred CCCCHHHHHHHHHhCCCChhhCcCHHHHhc--CHhhCC
Confidence 446788999999999999999999999998 777765
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=184.17 Aligned_cols=158 Identities=35% Similarity=0.628 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC--CCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||.+.......... .....+..|++||.+
T Consensus 91 ~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 168 (252)
T cd05084 91 LKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL 168 (252)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhh
Confidence 578889999999999999999999 9999999999999999999999999876433221111 111223469999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||...........+. .......+..++..+.+++.+|+..+|.+|||+.+++
T Consensus 169 ~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 247 (252)
T cd05084 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVH 247 (252)
T ss_pred cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88888899999999999999997 888998776655555443 3334455667889999999999999999999999999
Q ss_pred HHHH
Q 030203 159 ELLR 162 (181)
Q Consensus 159 ~~L~ 162 (181)
++|.
T Consensus 248 ~~l~ 251 (252)
T cd05084 248 QELQ 251 (252)
T ss_pred HHHh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=190.65 Aligned_cols=159 Identities=34% Similarity=0.526 Sum_probs=126.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++....... .......++..|++||.+
T Consensus 135 ~~~~~~~~i~~~i~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 135 ISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC--ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence 466788999999999999999999 9999999999999999999999999986432221 112223446689999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhcc------CCccCCCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT--LQQPWGNLNPAQVVAAVGFK------GKRLEIPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~--g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
.+..++.++|+||+|+++|+|++ +..||............... ......+..+++.+.+++.+||..||.+|
T Consensus 213 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred hcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhC
Confidence 88888999999999999999986 56788877665544433211 11122345678899999999999999999
Q ss_pred CCHHHHHHHHH
Q 030203 152 PSFSTIMELLR 162 (181)
Q Consensus 152 ps~~~~l~~L~ 162 (181)
||+.++.+.|+
T Consensus 293 Ps~~~i~~~l~ 303 (304)
T cd05096 293 PSFSDIHAFLT 303 (304)
T ss_pred cCHHHHHHHHh
Confidence 99999988876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=190.59 Aligned_cols=165 Identities=27% Similarity=0.500 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+..............+++.|++||...+
T Consensus 113 ~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (296)
T cd06654 113 MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcC
Confidence 467889999999999999999999 999999999999999999999999987643322222233466778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
...+.++|+||+|+++|++++|+.||................ .....+..+++.+.+++.+||..+|.+||++.++++
T Consensus 191 ~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~- 269 (296)
T cd06654 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ- 269 (296)
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh-
Confidence 778899999999999999999999998776644333332222 122345568889999999999999999999999999
Q ss_pred HHHhhhCCCC
Q 030203 161 LRPLIKSPTP 170 (181)
Q Consensus 161 L~~~~~~~~~ 170 (181)
++++....+
T Consensus 270 -~~~~~~~~~ 278 (296)
T cd06654 270 -HQFLKIAKP 278 (296)
T ss_pred -ChhhhccCC
Confidence 777765433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=187.74 Aligned_cols=158 Identities=34% Similarity=0.582 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC---cEEEcccCCccccccccc--cCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~---~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~p 76 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++++|||.+........ .......+..|++|
T Consensus 113 ~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05036 113 LTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCH
Confidence 577889999999999999999999 99999999999998654 589999998875432211 11122334579999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 77 EVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 77 e~~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
|.+.+..++.++|+||+|+++|+|++ |..||.+.........+. .......+..++..+.+++.+|++.+|.+||++.
T Consensus 191 E~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~ 269 (277)
T cd05036 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFA 269 (277)
T ss_pred HHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence 99988889999999999999999996 999998887776666554 3334455677899999999999999999999999
Q ss_pred HHHHHHH
Q 030203 156 TIMELLR 162 (181)
Q Consensus 156 ~~l~~L~ 162 (181)
++++.|.
T Consensus 270 ~vl~~l~ 276 (277)
T cd05036 270 TILERIQ 276 (277)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=189.45 Aligned_cols=165 Identities=27% Similarity=0.527 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.+||+++ ++|+||+|+||+++.++.++++|||.+..............+++.|++||...+
T Consensus 112 ~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (285)
T cd06648 112 MNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcC
Confidence 467888999999999999999999 999999999999999999999999987643332222233457788999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|++++++++|+.||...+.......+..... ....+..++..+.+++.+||..+|.+||++.++++
T Consensus 190 ~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~- 268 (285)
T cd06648 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN- 268 (285)
T ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc-
Confidence 7788999999999999999999999988776665555543321 11123347889999999999999999999999999
Q ss_pred HHHhhhCCCC
Q 030203 161 LRPLIKSPTP 170 (181)
Q Consensus 161 L~~~~~~~~~ 170 (181)
+++++....
T Consensus 269 -~~~~~~~~~ 277 (285)
T cd06648 269 -HPFLAKAGP 277 (285)
T ss_pred -CcccccCCC
Confidence 888887554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=185.78 Aligned_cols=157 Identities=35% Similarity=0.623 Sum_probs=130.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||.+........ ......++..|++||...
T Consensus 97 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~ 174 (256)
T cd05113 97 FQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLL 174 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHh
Confidence 578899999999999999999999 99999999999999999999999998764433221 111223445799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||||+++|+|++ |..||...........+. .......+...+..+.+++.+||+.+|.+||++.++++
T Consensus 175 ~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7778899999999999999998 999998887766666554 33344445667899999999999999999999999998
Q ss_pred HH
Q 030203 160 LL 161 (181)
Q Consensus 160 ~L 161 (181)
.|
T Consensus 254 ~~ 255 (256)
T cd05113 254 SI 255 (256)
T ss_pred hh
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=184.56 Aligned_cols=157 Identities=34% Similarity=0.608 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC-CCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+.......... ....++..|++||...
T Consensus 97 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd05114 97 LSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN 174 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcc
Confidence 567889999999999999999999 9999999999999999999999999876543322111 1223445799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|++++ |+.||...+.......+.. ......+...+..+.+++.+|+..+|.+||++.++++
T Consensus 175 ~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8788899999999999999999 8999998887777776653 3333445667889999999999999999999999998
Q ss_pred HH
Q 030203 160 LL 161 (181)
Q Consensus 160 ~L 161 (181)
.|
T Consensus 254 ~l 255 (256)
T cd05114 254 AI 255 (256)
T ss_pred hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=185.93 Aligned_cols=160 Identities=27% Similarity=0.503 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++++++.++.+++.|+.+||+.| ++|+||+|+||+++.++.++++|||.+..............++..|.+||.+.+
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 180 (267)
T cd08224 103 IPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhcc
Confidence 578899999999999999999999 999999999999999999999999987644332222233456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCccCCCC-CCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNP--AQVVAAVGFKGKRLEIPR-NVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
..++.++|+||+|++++++++|+.||..... ......+. .......+. .++..+.+++.+|+..+|.+||++.+++
T Consensus 181 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il 259 (267)
T cd08224 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259 (267)
T ss_pred CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 8888999999999999999999999965432 23333332 222222333 6788999999999999999999999999
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+.|+++
T Consensus 260 ~~~~~~ 265 (267)
T cd08224 260 QVAKEM 265 (267)
T ss_pred HHHHHh
Confidence 999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=189.01 Aligned_cols=165 Identities=31% Similarity=0.561 Sum_probs=135.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
++++.++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+........ ......++..|++||.+
T Consensus 106 ~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (303)
T cd05110 106 IGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183 (303)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHh
Confidence 467888999999999999999999 99999999999999999999999999875432211 11223345689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||.+.........+. .......+..++..+.+++.+|+..+|.+||++++++
T Consensus 184 ~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~ 262 (303)
T cd05110 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELA 262 (303)
T ss_pred ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88888899999999999999997 899998876655554443 3333444566788999999999999999999999999
Q ss_pred HHHHHhhhCCC
Q 030203 159 ELLRPLIKSPT 169 (181)
Q Consensus 159 ~~L~~~~~~~~ 169 (181)
+.|+.+.+...
T Consensus 263 ~~l~~~~~~~~ 273 (303)
T cd05110 263 AEFSRMARDPQ 273 (303)
T ss_pred HHHHHHHhchh
Confidence 99998876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=185.12 Aligned_cols=163 Identities=31% Similarity=0.611 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+........ ..........|++||.+.
T Consensus 104 ~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (270)
T cd05056 104 LDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181 (270)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhc
Confidence 577889999999999999999999 99999999999999999999999998764333211 111222345799999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...++.++|+||+|++++++++ |..||...........+. .......+..++..+.+++.+|+..+|.+|||+.++++
T Consensus 182 ~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7788899999999999999986 999998887766665554 33344556778999999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
.|+.+...
T Consensus 261 ~l~~~~~~ 268 (270)
T cd05056 261 QLSDILQE 268 (270)
T ss_pred HHHHHHhc
Confidence 99987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=187.39 Aligned_cols=161 Identities=30% Similarity=0.539 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++........ ......++..|++||.
T Consensus 104 l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~ 181 (283)
T cd05080 104 LNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhH
Confidence 578899999999999999999999 99999999999999999999999999875443211 1122234456899999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhccCCccCCCCCCCHHHHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA---------------QVVAAVGFKGKRLEIPRNVNPHVASIIEAC 143 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 143 (181)
..+...+.++|+||||+++++|++|..|+...... .....+ ........+..++..+.+++.+|
T Consensus 182 ~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c 260 (283)
T cd05080 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL-ERGMRLPCPKNCPQEVYILMKNC 260 (283)
T ss_pred hcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh-hcCCCCCCCCCCCHHHHHHHHHH
Confidence 88877889999999999999999999988653211 011111 11222334566789999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhh
Q 030203 144 WANEPWKRPSFSTIMELLRPLI 165 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~ 165 (181)
++.+|.+|||++++++.|+.+.
T Consensus 261 l~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 261 WETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hccChhhCCCHHHHHHHHHHhh
Confidence 9999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=197.89 Aligned_cols=162 Identities=23% Similarity=0.399 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.
T Consensus 139 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 216 (370)
T cd05596 139 IPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhc
Confidence 467888899999999999999999 9999999999999999999999999986543221 1223456889999999886
Q ss_pred CC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCC--CCCCHHHHHHHHHHhcCCCCC--CC
Q 030203 81 DE----PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWK--RP 152 (181)
Q Consensus 81 ~~----~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~--Rp 152 (181)
+. .++.++|+||+||++|+|++|+.||.+.+.......+.........+ ..++.++.+++.+||..+|.+ |+
T Consensus 217 ~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~ 296 (370)
T cd05596 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRN 296 (370)
T ss_pred cCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCC
Confidence 53 36789999999999999999999999988776666664333333333 357899999999999999988 99
Q ss_pred CHHHHHHHHHHhhhC
Q 030203 153 SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 s~~~~l~~L~~~~~~ 167 (181)
++.++++ +++++.
T Consensus 297 s~~ell~--h~~~~~ 309 (370)
T cd05596 297 GVDEIKS--HPFFKN 309 (370)
T ss_pred CHHHHhc--CcccCC
Confidence 9999998 677654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=185.43 Aligned_cols=164 Identities=30% Similarity=0.565 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC--CCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~ 79 (181)
+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......... .....+..|++||..
T Consensus 106 ~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05057 106 IGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHh
Confidence 568899999999999999999999 9999999999999999999999999887544321111 112234579999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
....++.++|+||+|++++++++ |..||.+....++...+. .......+...+.++.+++.+|+..+|..||++.+++
T Consensus 184 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 87778899999999999999998 999999988777766665 3344455667889999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+.+.+..
T Consensus 263 ~~l~~~~~~~ 272 (279)
T cd05057 263 NEFSKMARDP 272 (279)
T ss_pred HHHHHHHhCC
Confidence 9999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=190.19 Aligned_cols=165 Identities=33% Similarity=0.620 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||+++....... ......++..|++||.+
T Consensus 131 l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (334)
T cd05100 131 LTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL 208 (334)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh
Confidence 456778899999999999999999 99999999999999999999999998864432211 11122334579999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+.........+. .......+..++..+.+++.+|++.+|.+||++.+++
T Consensus 209 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell 287 (334)
T cd05100 209 FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287 (334)
T ss_pred ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 88888899999999999999998 889998888777666654 3334445667888999999999999999999999999
Q ss_pred HHHHHhhhCCC
Q 030203 159 ELLRPLIKSPT 169 (181)
Q Consensus 159 ~~L~~~~~~~~ 169 (181)
+.|+.++....
T Consensus 288 ~~l~~~~~~~~ 298 (334)
T cd05100 288 EDLDRVLTVTS 298 (334)
T ss_pred HHHHHHhhhcC
Confidence 99999986443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=185.47 Aligned_cols=155 Identities=30% Similarity=0.517 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-----hCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLH-----RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh-----~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~p 76 (181)
+++.+++.++.|++.||.+|| +.+ ++|+||+|+||+++.++.++++|||.+..............++..|++|
T Consensus 102 l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~p 179 (265)
T cd08217 102 IEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccCh
Confidence 567889999999999999999 888 9999999999999999999999999887654433223344677889999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 77 e~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
|...+...+.++|+|++|++++++++|+.||...+.......+. .......+..++..+.+++.+|+..+|.+||++.+
T Consensus 180 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred hhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 99988778889999999999999999999999887766666664 33344566788999999999999999999999999
Q ss_pred HHH
Q 030203 157 IME 159 (181)
Q Consensus 157 ~l~ 159 (181)
+++
T Consensus 259 il~ 261 (265)
T cd08217 259 LLQ 261 (265)
T ss_pred Hhh
Confidence 998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=184.74 Aligned_cols=159 Identities=33% Similarity=0.595 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||.+........ .......+..|++||...
T Consensus 100 ~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 177 (261)
T cd05034 100 LRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN 177 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhc
Confidence 567888999999999999999999 99999999999999999999999998765432211 111223345799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+...+.++|+||+|++++++++ |+.||.+.........+. .......+...+..+.+++.+|+..+|.+||+++++.+
T Consensus 178 ~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 8888899999999999999998 999998887776666654 33344455667899999999999999999999999999
Q ss_pred HHHH
Q 030203 160 LLRP 163 (181)
Q Consensus 160 ~L~~ 163 (181)
.|+.
T Consensus 257 ~l~~ 260 (261)
T cd05034 257 FLED 260 (261)
T ss_pred HHhc
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=182.53 Aligned_cols=158 Identities=33% Similarity=0.606 Sum_probs=131.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC-CCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS-KSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.+|.|+|+++ ++|+||+|+||+++.++.++++|||++.......... .....+..|++||...
T Consensus 90 ~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 167 (250)
T cd05085 90 LKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167 (250)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhc
Confidence 467889999999999999999999 9999999999999999999999999876433322111 1123345799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|++++ |..||...........+. .......+..++..+.+++.+|+..+|.+||++.++++
T Consensus 168 ~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 8888899999999999999998 999998887776666554 33344556678999999999999999999999999999
Q ss_pred HHH
Q 030203 160 LLR 162 (181)
Q Consensus 160 ~L~ 162 (181)
.|.
T Consensus 247 ~l~ 249 (250)
T cd05085 247 ELA 249 (250)
T ss_pred Hhc
Confidence 774
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=185.10 Aligned_cols=158 Identities=39% Similarity=0.668 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-----cEEEcccCCcccccccc--ccCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-----TVKVCDFGLSRLKANTF--LSSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-----~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~ 74 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++++|||++....... ........+..|+
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 180 (269)
T cd05044 103 LTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180 (269)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCcccc
Confidence 467888999999999999999999 99999999999998877 89999999876433221 1112234456899
Q ss_pred CCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 75 APEVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 75 ~pe~~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
+||.+.+...+.++|+||||+++|+|++ |..||...........+. .......+..++..+.+++.+||..+|.+||+
T Consensus 181 aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 259 (269)
T cd05044 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259 (269)
T ss_pred CHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCcccchHHHHHHHHHHcCCCcccCCC
Confidence 9999988888999999999999999998 999998877766666554 33344556678899999999999999999999
Q ss_pred HHHHHHHHH
Q 030203 154 FSTIMELLR 162 (181)
Q Consensus 154 ~~~~l~~L~ 162 (181)
++++++.|+
T Consensus 260 ~~~i~~~l~ 268 (269)
T cd05044 260 FDRIQEILQ 268 (269)
T ss_pred HHHHHHHHh
Confidence 999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=195.57 Aligned_cols=163 Identities=34% Similarity=0.605 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....... .......++..|++||.+
T Consensus 234 l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 311 (400)
T cd05105 234 LTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI 311 (400)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence 577889999999999999999999 9999999999999999999999999986543221 112223455689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.....................+..+++.+.+++.+||..+|.+||++.++.
T Consensus 312 ~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 391 (400)
T cd05105 312 FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391 (400)
T ss_pred cCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence 88888999999999999999997 89999876544333222223444455667899999999999999999999999999
Q ss_pred HHHHHhhh
Q 030203 159 ELLRPLIK 166 (181)
Q Consensus 159 ~~L~~~~~ 166 (181)
+.|+.+++
T Consensus 392 ~~l~~l~~ 399 (400)
T cd05105 392 DIVESLLP 399 (400)
T ss_pred HHHHHHcC
Confidence 99998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=187.29 Aligned_cols=164 Identities=32% Similarity=0.551 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.++.|||+++ ++|+|++|+||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 107 l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 184 (292)
T cd06644 107 LTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMC 184 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeecc
Confidence 578899999999999999999999 999999999999999999999999987654333222334456778999998742
Q ss_pred -----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 82 -----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 82 -----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
..++.++|+||+|+++|+|++|..||...+......++.... .....+..++.++.+++.+||..+|.+||++.
T Consensus 185 ~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 264 (292)
T cd06644 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAA 264 (292)
T ss_pred ccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHH
Confidence 335778999999999999999999998876655444442221 12234556888999999999999999999999
Q ss_pred HHHHHHHHhhhCCC
Q 030203 156 TIMELLRPLIKSPT 169 (181)
Q Consensus 156 ~~l~~L~~~~~~~~ 169 (181)
++++ ++++....
T Consensus 265 ~il~--~~~~~~~~ 276 (292)
T cd06644 265 QLLE--HPFVSSVT 276 (292)
T ss_pred HHhc--Cccccccc
Confidence 9998 77776533
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=185.70 Aligned_cols=156 Identities=31% Similarity=0.601 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.|||+.+ ++|+|++|.||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 96 l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 173 (256)
T cd06612 96 LTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhc
Confidence 578899999999999999999999 999999999999999999999999998765443323334456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..++.++|+||+|++++++++|+.||...........+.... .....+..++..+.+++.+|++.||.+|||+.++++
T Consensus 174 ~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 888899999999999999999999998776654443332211 122234567889999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=183.78 Aligned_cols=159 Identities=31% Similarity=0.603 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||.+........ ......++..|++||.+.
T Consensus 99 ~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 176 (260)
T cd05073 99 QPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhc
Confidence 456788899999999999999999 99999999999999999999999998764332211 112223456799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|++++++++ |..||...+.......+. .....+.+...+.++.+++.+|++.+|.+||++.++++
T Consensus 177 ~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 8778889999999999999998 899999887776666554 33344455678899999999999999999999999999
Q ss_pred HHHH
Q 030203 160 LLRP 163 (181)
Q Consensus 160 ~L~~ 163 (181)
.|+.
T Consensus 256 ~L~~ 259 (260)
T cd05073 256 VLDD 259 (260)
T ss_pred HHhc
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-29 Score=184.13 Aligned_cols=160 Identities=32% Similarity=0.606 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC---CCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS---KSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~---~~~~~~~~~~~pe~ 78 (181)
+++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++.......... .....+..|++||.
T Consensus 104 ~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~ 181 (268)
T cd05063 104 FSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHH
Confidence 567889999999999999999999 9999999999999999999999999876443221111 11122346999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||+|+++|++++ |..||...........+. .....+.+..++..+.+++.+|+..+|.+||++.++
T Consensus 182 ~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred hhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 888888899999999999999997 999998877766666664 333444455678999999999999999999999999
Q ss_pred HHHHHHh
Q 030203 158 MELLRPL 164 (181)
Q Consensus 158 l~~L~~~ 164 (181)
++.|+++
T Consensus 261 ~~~l~~~ 267 (268)
T cd05063 261 VNLLDKL 267 (268)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=183.04 Aligned_cols=158 Identities=32% Similarity=0.604 Sum_probs=130.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC--CCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~ 79 (181)
+++..++.++.+++.+|.+||+++ ++|+||+|+||+++.++.++++|||.+.......... .....+..|++||..
T Consensus 90 ~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 167 (251)
T cd05041 90 LTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167 (251)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhh
Confidence 467788999999999999999999 9999999999999999999999999886543221111 112234569999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|++++++++ |..||...........+. .......+..++..+.+++.+|+..+|.+||++.+++
T Consensus 168 ~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell 246 (251)
T cd05041 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIY 246 (251)
T ss_pred ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 88888899999999999999998 888998887766666554 3334445667889999999999999999999999999
Q ss_pred HHHH
Q 030203 159 ELLR 162 (181)
Q Consensus 159 ~~L~ 162 (181)
+.|+
T Consensus 247 ~~l~ 250 (251)
T cd05041 247 NELQ 250 (251)
T ss_pred HHhh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=187.91 Aligned_cols=172 Identities=22% Similarity=0.258 Sum_probs=135.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|+++||.|||+++ ++|+||+|+||+++.++.++++|||++...............+..|++||.+.+
T Consensus 99 ~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (298)
T cd07841 99 LTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176 (298)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhC
Confidence 678899999999999999999999 999999999999999999999999998765543323333455678999998754
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--------------------------cCCCCCCCH
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--------------------------LEIPRNVNP 134 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~ 134 (181)
. .++.++|+||+|++++++++|..+|..........++...... .......+.
T Consensus 177 ~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T cd07841 177 ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256 (298)
T ss_pred CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccH
Confidence 3 4678999999999999999998888776654433332110000 001134567
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCCCCCCC
Q 030203 135 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177 (181)
Q Consensus 135 ~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~~~~~~ 177 (181)
.+.+++.+|+..+|.+|||+.++++ ++|++..+.+.++.+.
T Consensus 257 ~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~~~~~~~~~~ 297 (298)
T cd07841 257 DALDLLQRLLTLNPNKRITARQALE--HPYFSNDPAPTPPSQL 297 (298)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhh--CccccCCCCCCCCCCC
Confidence 8999999999999999999999999 9999987776666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=190.74 Aligned_cols=169 Identities=26% Similarity=0.487 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++++|||.+..............+++.|++||...+
T Consensus 112 ~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (297)
T cd06656 112 MDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC
Confidence 467889999999999999999999 999999999999999999999999987643332222233456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|+++|++++|..||...+........... ......+..+++.+++++.+||..+|.+||++.++++
T Consensus 190 ~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~- 268 (297)
T cd06656 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ- 268 (297)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc-
Confidence 87889999999999999999999999876654333222211 1122345567889999999999999999999999999
Q ss_pred HHHhhhCCCCCCCC
Q 030203 161 LRPLIKSPTPQPSP 174 (181)
Q Consensus 161 L~~~~~~~~~~~~~ 174 (181)
++|++.....+..
T Consensus 269 -~~~~~~~~~~~~~ 281 (297)
T cd06656 269 -HPFLKLAKPLSSL 281 (297)
T ss_pred -Cchhccccccccc
Confidence 8998876665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=185.63 Aligned_cols=155 Identities=33% Similarity=0.601 Sum_probs=128.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc------cCCCCCCCCCccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL------SSKSAAGTPEWMA 75 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~~~ 75 (181)
+++.++..++.|++.||.+||+++ ++|+||+|+||+++.++.++++|||.+........ ......++..|++
T Consensus 103 l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~ 180 (267)
T cd06628 103 FEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180 (267)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccC
Confidence 567888899999999999999999 99999999999999999999999998765432111 1112346678999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 76 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 76 pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
||...+..++.++|+|++|++++++++|+.||...+.......+. .......+..++..+.+++.+||+.||.+||++.
T Consensus 181 pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred hhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHH
Confidence 999988888889999999999999999999998876655444443 2334456677899999999999999999999999
Q ss_pred HHHH
Q 030203 156 TIME 159 (181)
Q Consensus 156 ~~l~ 159 (181)
++++
T Consensus 260 ~il~ 263 (267)
T cd06628 260 ELLK 263 (267)
T ss_pred HHhh
Confidence 9987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-29 Score=190.17 Aligned_cols=164 Identities=33% Similarity=0.616 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||++....... .......++..|++||.+
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 253 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 253 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHh
Confidence 577888999999999999999999 9999999999999999999999999876532211 111122345679999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|++++++++ |..||.....................+...++.+.+++.+|++.||.+||++.+++
T Consensus 254 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil 333 (343)
T cd05103 254 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333 (343)
T ss_pred cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88888899999999999999996 89999775433222222223344455566788999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+++.
T Consensus 334 ~~l~~~~~~ 342 (343)
T cd05103 334 EHLGNLLQA 342 (343)
T ss_pred HHHHHHHhc
Confidence 999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=185.25 Aligned_cols=155 Identities=28% Similarity=0.554 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.|+.+||+++ ++|+||+|+||+++.++.++++|||.+..............++..|.+||...+
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 175 (256)
T cd08218 98 FPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC
Confidence 467888999999999999999999 999999999999999999999999988654443222233456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...+.++|+||+|++++++++|+.||...+.......+. .......+..++.++.+++.+|++.+|.+||+++++++
T Consensus 176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 888889999999999999999999998877776666553 33344456678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=188.33 Aligned_cols=156 Identities=27% Similarity=0.354 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++..............+++.|++||.+.+
T Consensus 98 ~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd07861 98 MDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcC
Confidence 578899999999999999999999 999999999999999999999999987644333222333456778999998765
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---------------------------CCccCCCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---------------------------GKRLEIPRNVN 133 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~ 133 (181)
. .++.++|+||+|++++++++|+.||.+............. .........++
T Consensus 176 ~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T cd07861 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLD 255 (285)
T ss_pred CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCC
Confidence 4 3678899999999999999999999876543322211000 00001123578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+++.+++.+||..||.+|||+.++++
T Consensus 256 ~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 256 EDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 89999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-29 Score=185.39 Aligned_cols=161 Identities=36% Similarity=0.643 Sum_probs=131.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCcccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~ 80 (181)
+...+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....... .......++..|++||.+.
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 194 (288)
T cd05061 117 TLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (288)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhc
Confidence 45678899999999999999999 9999999999999999999999999876433211 1112223456799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|++++++++ |..||.+....+....+. .......+..+++.+.+++.+|++.||.+|||+.++++
T Consensus 195 ~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 195 DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888899999999999999998 788998887777665553 23333445667899999999999999999999999999
Q ss_pred HHHHhhh
Q 030203 160 LLRPLIK 166 (181)
Q Consensus 160 ~L~~~~~ 166 (181)
.|+..+.
T Consensus 274 ~l~~~~~ 280 (288)
T cd05061 274 LLKDDLH 280 (288)
T ss_pred HHHhhcC
Confidence 9887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=189.15 Aligned_cols=165 Identities=22% Similarity=0.334 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 101 ~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 178 (301)
T cd07873 101 INMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178 (301)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhC
Confidence 467888999999999999999999 999999999999999999999999988654333222233456778999998765
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-----------------cc-----------CCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-----------------RL-----------EIPRNV 132 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------------~~-----------~~~~~~ 132 (181)
. .++.++|+||+|+++|+|++|+.||...+.......+..... .. .....+
T Consensus 179 ~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (301)
T cd07873 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRL 258 (301)
T ss_pred CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCC
Confidence 4 367889999999999999999999988765544332211000 00 012357
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
++.+++++.+|+..||.+|||+.++++ ++|++....
T Consensus 259 ~~~~~~li~~ml~~dp~~R~t~~eil~--h~~f~~~~~ 294 (301)
T cd07873 259 DSDGAELLSKLLQFEGRKRISAEEAMK--HPYFHCLGE 294 (301)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhc--Ccccccccc
Confidence 888999999999999999999999999 888876553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=190.28 Aligned_cols=159 Identities=24% Similarity=0.359 Sum_probs=118.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE----cCCCcEEEcccCCccccccccc---cCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~----~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~ 74 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||++ +.++.++++|||++........ ......+++.|+
T Consensus 105 l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~ 182 (317)
T cd07868 105 LPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccccccc
Confidence 567889999999999999999999 9999999999999 4567899999999875443211 223456788999
Q ss_pred CCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH-hccCCcc-----------------
Q 030203 75 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPA---------QVVAAV-GFKGKRL----------------- 126 (181)
Q Consensus 75 ~pe~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---------~~~~~~-~~~~~~~----------------- 126 (181)
|||.+.+. .++.++|+||+||++++|++|+.||...... .....+ ...+...
T Consensus 183 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T cd07868 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLM 262 (317)
T ss_pred CCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhh
Confidence 99988764 4788999999999999999999999654321 111110 0000000
Q ss_pred ------------------CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHh
Q 030203 127 ------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 127 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~ 164 (181)
......+..+.+++.+||..||.+|||++++++ ++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~--hp~ 316 (317)
T cd07868 263 KDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ--DPY 316 (317)
T ss_pred hhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc--CCC
Confidence 001123456889999999999999999999998 554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=195.20 Aligned_cols=166 Identities=25% Similarity=0.349 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||++........ ......+++.|++||.+
T Consensus 182 l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 259 (392)
T PHA03207 182 LPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL 259 (392)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHh
Confidence 578899999999999999999999 99999999999999999999999999865433211 12345688999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HH---HHHHhccC---------------------Ccc--CCC
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA----QV---VAAVGFKG---------------------KRL--EIP 129 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~----~~---~~~~~~~~---------------------~~~--~~~ 129 (181)
.+..++.++|+||+||++|+|++|+.||.+.... .+ ...+.... .+. ..+
T Consensus 260 ~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (392)
T PHA03207 260 ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIP 339 (392)
T ss_pred cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcccc
Confidence 8888899999999999999999999999665321 11 11110000 000 001
Q ss_pred -----CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 130 -----RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 130 -----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
..++.++.++|.+||..||.+||++.+++. ++++...+.+
T Consensus 340 ~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~--~p~f~~~~~~ 384 (392)
T PHA03207 340 PVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS--LPLFTKEPIN 384 (392)
T ss_pred chhhccCcchhHHHHHHHHhccChhhCCCHHHHhh--Cchhhccchh
Confidence 234668899999999999999999999999 8999875544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=194.39 Aligned_cols=161 Identities=27% Similarity=0.392 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------------------- 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------------------- 61 (181)
+++.++..++.|++.||.|||++| ++||||+|+||+++.++.++|+|||++.......
T Consensus 98 l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (363)
T cd05628 98 LTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175 (363)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccc
Confidence 578899999999999999999999 9999999999999999999999999876422110
Q ss_pred ---------------ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc
Q 030203 62 ---------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 126 (181)
Q Consensus 62 ---------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 126 (181)
.......|++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+........++.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~ 255 (363)
T cd05628 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL 255 (363)
T ss_pred cccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcc
Confidence 00123468899999999988888999999999999999999999999888777776664322222
Q ss_pred CCC--CCCCHHHHHHHHHHhcCCCC---CCCCHHHHHHHHHHhhhC
Q 030203 127 EIP--RNVNPHVASIIEACWANEPW---KRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 127 ~~~--~~~~~~~~~li~~~l~~~p~---~Rps~~~~l~~L~~~~~~ 167 (181)
..+ ..+++++++++.+++. +|. .||+++++++ ++|++.
T Consensus 256 ~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~--hp~f~~ 298 (363)
T cd05628 256 IFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT--NPFFEG 298 (363)
T ss_pred cCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC--CCCCCC
Confidence 233 3478999999999764 444 4689999999 666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=185.68 Aligned_cols=160 Identities=30% Similarity=0.561 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||++..............++..|++||.+.+
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06642 98 LEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCc
Confidence 567889999999999999999999 999999999999999999999999988654433222233456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+|++++++++|..|+...........+. ..........++..+.+++.+|+..+|.+||++.++++
T Consensus 176 ~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~-- 252 (277)
T cd06642 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK-- 252 (277)
T ss_pred CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH--
Confidence 888899999999999999999999998766555444432 22233345567889999999999999999999999999
Q ss_pred HHhhh
Q 030203 162 RPLIK 166 (181)
Q Consensus 162 ~~~~~ 166 (181)
++++.
T Consensus 253 ~~~~~ 257 (277)
T cd06642 253 HKFIT 257 (277)
T ss_pred hHHHH
Confidence 56654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-29 Score=182.18 Aligned_cols=155 Identities=37% Similarity=0.682 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... ........|.+||.+.+
T Consensus 97 ~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~y~~pe~~~~ 171 (254)
T cd05083 97 VSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---DNSKLPVKWTAPEALKH 171 (254)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC---CCCCCCceecCHHHhcc
Confidence 467788999999999999999999 9999999999999999999999999876533221 12233457999999887
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|++++++++ |..||...........+. .......+..++..+.+++.+|++.+|.+||+++++++.
T Consensus 172 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788899999999999999997 999998888776666554 333444556788999999999999999999999999998
Q ss_pred HH
Q 030203 161 LR 162 (181)
Q Consensus 161 L~ 162 (181)
|+
T Consensus 251 l~ 252 (254)
T cd05083 251 LE 252 (254)
T ss_pred Hc
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=204.54 Aligned_cols=168 Identities=30% Similarity=0.541 Sum_probs=142.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc-CCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+|..+..+.+||++||.|||++. |||||||.+|++++ -.|.+|++|||-++....-.....+..|+..|+|||++..
T Consensus 673 NEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDq 750 (1226)
T KOG4279|consen 673 NESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQ 750 (1226)
T ss_pred chhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhcc
Confidence 46677888999999999999999 99999999999995 4899999999998876665566777889999999999965
Q ss_pred C--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 82 E--PSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 82 ~--~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
+ +|..++|+|||||.+.+|.||++||...... ....++..-..-+++|..++.+.+.+|.+|+.++|..||++.+++
T Consensus 751 G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 751 GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhc
Confidence 4 4788999999999999999999999877544 344455545556778899999999999999999999999999999
Q ss_pred HHHHHhhhCCCCCCCC
Q 030203 159 ELLRPLIKSPTPQPSP 174 (181)
Q Consensus 159 ~~L~~~~~~~~~~~~~ 174 (181)
. +++++...+.+.|
T Consensus 831 ~--DpFlq~~~kk~r~ 844 (1226)
T KOG4279|consen 831 Q--DPFLQHNNKKPRP 844 (1226)
T ss_pred c--CcccccCCCCCCC
Confidence 9 8888766444433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=189.02 Aligned_cols=163 Identities=25% Similarity=0.497 Sum_probs=140.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC------CcEEEcccCCccccccccccCCCCCCCCCccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK------YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMA 75 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~ 75 (181)
++|..+..++.||+.|+.+||+++ |+||||||.||+++.+ -.+|+.|||+++..... ....+..|++.|+|
T Consensus 106 l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~-~~a~tlcGSplYMA 182 (429)
T KOG0595|consen 106 LPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG-SMAETLCGSPLYMA 182 (429)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch-hHHHHhhCCccccC
Confidence 578899999999999999999999 9999999999999764 35799999999876644 34456789999999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-cCCCCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 76 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-LEIPRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 76 pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
||+++..+|+.++|+||+|+++|++++|+.||......++..++...... ...+..++..+.+++...+..++..|.++
T Consensus 183 PEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~ 262 (429)
T KOG0595|consen 183 PEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISF 262 (429)
T ss_pred HHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCch
Confidence 99999999999999999999999999999999999999888877655443 33556678888999999999999999999
Q ss_pred HHHHHHHHHhhhCCC
Q 030203 155 STIMELLRPLIKSPT 169 (181)
Q Consensus 155 ~~~l~~L~~~~~~~~ 169 (181)
.+... +.++...+
T Consensus 263 ~~~~~--~~~l~~~p 275 (429)
T KOG0595|consen 263 EDFFD--HPFLAANP 275 (429)
T ss_pred HHhhh--hhhcccCc
Confidence 88776 66666544
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=192.03 Aligned_cols=165 Identities=29% Similarity=0.428 Sum_probs=144.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC----CcEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK----YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~----~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
++|.++..++.|++.++.|||+.| ++|+|++|+|+++... +.++++|||++..... ........|++.|+|||
T Consensus 132 ~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APE 208 (382)
T KOG0032|consen 132 YSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPE 208 (382)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCch
Confidence 689999999999999999999999 9999999999999543 4799999999987776 44456679999999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+....++..+|+||+|+++|.|++|..||.+.........+..... ..+....++..+++++.+++..||..|+++.
T Consensus 209 vl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~ 288 (382)
T KOG0032|consen 209 VLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAA 288 (382)
T ss_pred hhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHH
Confidence 99988999999999999999999999999999988777777754444 3445677899999999999999999999999
Q ss_pred HHHHHHHHhhhCCCCC
Q 030203 156 TIMELLRPLIKSPTPQ 171 (181)
Q Consensus 156 ~~l~~L~~~~~~~~~~ 171 (181)
++++ |+|++.....
T Consensus 289 ~~L~--HpWi~~~~~~ 302 (382)
T KOG0032|consen 289 QALQ--HPWIKSIGEA 302 (382)
T ss_pred HHhc--CccccCCccc
Confidence 9999 8998875333
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=184.76 Aligned_cols=166 Identities=26% Similarity=0.374 Sum_probs=137.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
|+|+++..|+.||+.|+.|||+.+ |.||||||+|++++. +..+||+|||+++...... ...+...++.|.|||.
T Consensus 158 fTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~-~L~TPc~TPyYvaPev 234 (400)
T KOG0604|consen 158 FTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG-DLMTPCFTPYYVAPEV 234 (400)
T ss_pred chHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCCc-cccCCcccccccCHHH
Confidence 689999999999999999999999 999999999999954 4568999999998766532 3345577889999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhccCC--ccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP----AQVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~----~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+....|+.+.|+||+|+++|-|++|.+||-+..- ..+-.++..... +.+-+..+|+..+++|.++|..+|.+|.
T Consensus 235 lg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl 314 (400)
T KOG0604|consen 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL 314 (400)
T ss_pred hCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe
Confidence 9888899999999999999999999999976543 233334433333 2334467899999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCCCCC
Q 030203 153 SFSTIMELLRPLIKSPTPQP 172 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~~~~ 172 (181)
|+.++++ +.|+.+.+..+
T Consensus 315 TI~~~m~--hpwi~~~~~vp 332 (400)
T KOG0604|consen 315 TIEEVMD--HPWINQYEAVP 332 (400)
T ss_pred eHHHhhc--CchhcccccCC
Confidence 9999999 99988766554
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=187.23 Aligned_cols=156 Identities=23% Similarity=0.333 Sum_probs=121.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 96 ~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 96 IDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhC
Confidence 578899999999999999999999 999999999999999999999999988654433222334456778999998866
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhccC---------------C---c---------cCCCCCC
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKG---------------K---R---------LEIPRNV 132 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~-~~~~~~~~~~~~~~~~---------------~---~---------~~~~~~~ 132 (181)
.. ++.++|+||+|+++++|++|..|+ .+.+.......+.... . . .+....+
T Consensus 174 ~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07839 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKL 253 (284)
T ss_pred CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccC
Confidence 44 688999999999999999998875 4443333222211000 0 0 0112347
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
++++.+++.+||..||.+|||+.++++
T Consensus 254 ~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 254 NSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-29 Score=185.67 Aligned_cols=158 Identities=35% Similarity=0.609 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||.+....... ........+..|++||..
T Consensus 127 l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (288)
T cd05050 127 LSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI 204 (288)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH
Confidence 467788999999999999999999 9999999999999999999999999876432211 111222345679999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+....+....+. .......+..++..+.+++.+|+..+|.+|||+.+++
T Consensus 205 ~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 205 FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 88888899999999999999997 888998887777666664 2333344567889999999999999999999999999
Q ss_pred HHHH
Q 030203 159 ELLR 162 (181)
Q Consensus 159 ~~L~ 162 (181)
+.|+
T Consensus 284 ~~l~ 287 (288)
T cd05050 284 RILQ 287 (288)
T ss_pred HHhh
Confidence 9876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=195.85 Aligned_cols=161 Identities=24% Similarity=0.374 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.
T Consensus 99 l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 99 FDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhc
Confidence 578889999999999999999999 9999999999999999999999999986543221 1223346788999999886
Q ss_pred ------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 81 ------DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 81 ------~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
...++.++|+||+|+++|+|++|..||..........++........ ....+++.+.+++.+|+. +|.+||
T Consensus 177 ~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred cccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCC
Confidence 34467899999999999999999999988877666655533222222 233578999999999997 999999
Q ss_pred CHHHHHHHHHHhhhC
Q 030203 153 SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 s~~~~l~~L~~~~~~ 167 (181)
++.++++ +++++.
T Consensus 256 t~~~l~~--h~~~~~ 268 (330)
T cd05601 256 GYEGLCC--HPFFSK 268 (330)
T ss_pred CHHHHhC--CCCcCC
Confidence 9999998 666653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-29 Score=186.17 Aligned_cols=159 Identities=36% Similarity=0.561 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||..
T Consensus 127 ~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (296)
T cd05051 127 LSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence 578889999999999999999999 9999999999999999999999999876432221 112233445689999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhcc------CCccCCCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT--LQQPWGNLNPAQVVAAVGFK------GKRLEIPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~--g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
.+..++.++|+||+|+++|++++ |..||............... ......+..++.++.+++.+|++.||.+|
T Consensus 205 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 284 (296)
T cd05051 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284 (296)
T ss_pred hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcC
Confidence 88778899999999999999987 67788877666655544322 11122344577899999999999999999
Q ss_pred CCHHHHHHHHH
Q 030203 152 PSFSTIMELLR 162 (181)
Q Consensus 152 ps~~~~l~~L~ 162 (181)
|++.++++.|+
T Consensus 285 pt~~el~~~L~ 295 (296)
T cd05051 285 PTFREIHLFLQ 295 (296)
T ss_pred CCHHHHHHHhc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=186.06 Aligned_cols=156 Identities=29% Similarity=0.526 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+..............++..|++||.+..
T Consensus 110 ~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (275)
T cd06608 110 LKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIAC 187 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcc
Confidence 567889999999999999999999 999999999999999999999999987654433333344567788999998743
Q ss_pred -----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 82 -----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 82 -----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
..++.++|+|++|++++++++|+.||...........+..... ....+..+++.+.+++.+||..||.+|||+.
T Consensus 188 ~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~ 267 (275)
T cd06608 188 DEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFME 267 (275)
T ss_pred cccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHH
Confidence 2356789999999999999999999987655444444332221 1222334778999999999999999999999
Q ss_pred HHHH
Q 030203 156 TIME 159 (181)
Q Consensus 156 ~~l~ 159 (181)
++++
T Consensus 268 ~ll~ 271 (275)
T cd06608 268 ELLE 271 (275)
T ss_pred HHhc
Confidence 9987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=197.80 Aligned_cols=150 Identities=23% Similarity=0.361 Sum_probs=128.3
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE-cCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCCC
Q 030203 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV-DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP 83 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~-~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 83 (181)
.++..|+.+|+.|+.|||++| ++|||+||.||++ +..|+++++|||.++..... ..+..-+..|.|||......
T Consensus 415 ~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~ 489 (612)
T KOG0603|consen 415 SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQE 489 (612)
T ss_pred HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCC
Confidence 577789999999999999999 9999999999999 68999999999998754443 22334567899999999888
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 030203 84 SNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162 (181)
Q Consensus 84 ~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~ 162 (181)
++.++|+||||+++|+||+|+.||...... ++..++. .......+|...++|+..||+.||.+|+++.++.. +
T Consensus 490 yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~----~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--h 563 (612)
T KOG0603|consen 490 YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ----MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA--H 563 (612)
T ss_pred CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc----CCccccccCHHHHHHHHHhccCChhhCcChhhhcc--C
Confidence 999999999999999999999999876655 4444442 22233789999999999999999999999999999 8
Q ss_pred Hhh
Q 030203 163 PLI 165 (181)
Q Consensus 163 ~~~ 165 (181)
+|+
T Consensus 564 ~w~ 566 (612)
T KOG0603|consen 564 PWF 566 (612)
T ss_pred cch
Confidence 998
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=183.52 Aligned_cols=156 Identities=33% Similarity=0.543 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||.+..............++..|++||...+
T Consensus 98 l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~ 175 (262)
T cd06613 98 LSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcc
Confidence 578899999999999999999999 999999999999999999999999988654433222334456778999999876
Q ss_pred C---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc---cCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 82 E---PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR---LEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 82 ~---~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
. .++.++|+||+|+++++|++|+.||...........+...... ......++.++.+++.+|+..+|.+|||+.
T Consensus 176 ~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 255 (262)
T cd06613 176 ERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTAT 255 (262)
T ss_pred cccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHH
Confidence 6 6788999999999999999999999887765544444323211 122344678899999999999999999999
Q ss_pred HHHH
Q 030203 156 TIME 159 (181)
Q Consensus 156 ~~l~ 159 (181)
++++
T Consensus 256 ~il~ 259 (262)
T cd06613 256 KLLQ 259 (262)
T ss_pred HHhc
Confidence 9986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=183.00 Aligned_cols=160 Identities=32% Similarity=0.571 Sum_probs=131.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||..
T Consensus 110 l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05074 110 LPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESL 187 (273)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHH
Confidence 467788999999999999999999 9999999999999999999999999877543221 112223345679999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
....++.++|+||+|+++|++++ |+.||.+.........+. .......+...+..+.+++.+|++.+|.+||++.+++
T Consensus 188 ~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~ 266 (273)
T cd05074 188 ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLR 266 (273)
T ss_pred hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88778889999999999999998 899998877766555443 2333344456788999999999999999999999999
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+.|+.+
T Consensus 267 ~~l~~~ 272 (273)
T cd05074 267 DQLELI 272 (273)
T ss_pred HHHHhh
Confidence 999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=181.40 Aligned_cols=157 Identities=39% Similarity=0.697 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCC-CCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK-SAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||.+........... ...++..|++||...
T Consensus 100 ~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~ 177 (258)
T smart00219 100 LSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK 177 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhc
Confidence 578899999999999999999999 99999999999999999999999999875443311111 123557899999987
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+|++|++++++++ |..||...+.......+.. ......+..++..+.+++.+|+..||.+|||+.++++
T Consensus 178 ~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 178 DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 7778899999999999999998 8889988877777766653 3344456668999999999999999999999999987
Q ss_pred HH
Q 030203 160 LL 161 (181)
Q Consensus 160 ~L 161 (181)
.|
T Consensus 257 ~l 258 (258)
T smart00219 257 IL 258 (258)
T ss_pred hC
Confidence 54
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=186.75 Aligned_cols=162 Identities=22% Similarity=0.334 Sum_probs=125.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.+
T Consensus 92 ~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 168 (277)
T cd05607 92 LEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKE 168 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCCccCHHHHcc
Confidence 467788899999999999999999 9999999999999999999999999876543321 1223457789999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
..++.++|+||+|+++|+|++|+.||...... ....... ..........+++++++++.+||+.||.+||+++++
T Consensus 169 ~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~ 247 (277)
T cd05607 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREK 247 (277)
T ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-ccccccccccCCHHHHHHHHHHhccCHhhCCCCccc
Confidence 88899999999999999999999999765332 2222221 111111224688999999999999999999999554
Q ss_pred HHHH--HHhhhC
Q 030203 158 MELL--RPLIKS 167 (181)
Q Consensus 158 l~~L--~~~~~~ 167 (181)
++.+ ++|++.
T Consensus 248 ~~~~~~h~~f~~ 259 (277)
T cd05607 248 NDDPRKHEFFKT 259 (277)
T ss_pred hhhhhcChhhcC
Confidence 3211 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=185.41 Aligned_cols=163 Identities=31% Similarity=0.597 Sum_probs=133.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.++..++.|++.++.|||+++ ++|+||+|+||+++.++.++++|||.+..............+++.|++||.+.
T Consensus 100 l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 177 (280)
T cd06611 100 LTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhh
Confidence 578899999999999999999999 99999999999999999999999998765443332333445677899999874
Q ss_pred ----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 81 ----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 81 ----~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
+..++.++|+||+|+++|+|++|+.||...+.......+..... ....+..++..+.+++.+||..+|.+||++.
T Consensus 178 ~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 257 (280)
T cd06611 178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAA 257 (280)
T ss_pred cccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHH
Confidence 23356789999999999999999999988877665555542222 2234556889999999999999999999999
Q ss_pred HHHHHHHHhhhCC
Q 030203 156 TIMELLRPLIKSP 168 (181)
Q Consensus 156 ~~l~~L~~~~~~~ 168 (181)
++++ ++|+...
T Consensus 258 ~il~--~~~~~~~ 268 (280)
T cd06611 258 ELLK--HPFVSDQ 268 (280)
T ss_pred HHhc--Chhhccc
Confidence 9999 8888765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=188.92 Aligned_cols=163 Identities=26% Similarity=0.469 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++++.+..++.|++.|+.|||++ + ++|+||+|+||+++.++.++++|||++...... ......++..|+|||.+.
T Consensus 100 ~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~ 175 (333)
T cd06650 100 IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQ 175 (333)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhc
Confidence 46778889999999999999985 7 999999999999999999999999987644322 122345778999999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----------------------------------------
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG---------------------------------------- 120 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~---------------------------------------- 120 (181)
+..++.++|+||+||++|++++|+.||...........+.
T Consensus 176 ~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (333)
T cd06650 176 GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELL 255 (333)
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHH
Confidence 8888899999999999999999999997655433322110
Q ss_pred ---ccCCccCC-CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 121 ---FKGKRLEI-PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 121 ---~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
........ ...++.++++|+.+||+.||.+|||+.++++ +++++....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~~~~ 307 (333)
T cd06650 256 DYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV--HAFIKRSEA 307 (333)
T ss_pred HHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh--CHHHhcCcc
Confidence 00000111 1235788999999999999999999999998 889886543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=192.17 Aligned_cols=162 Identities=33% Similarity=0.579 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||++....... .......++..|++||.+
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence 577889999999999999999999 9999999999999999999999999987533221 111223456789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++++|++ |..||.................+...+..++..+.+++.+|+..+|.+||++++++
T Consensus 314 ~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell 393 (401)
T cd05107 314 FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393 (401)
T ss_pred cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 88778899999999999999998 88899776554443333224444556667899999999999999999999999999
Q ss_pred HHHHHhh
Q 030203 159 ELLRPLI 165 (181)
Q Consensus 159 ~~L~~~~ 165 (181)
+.|+.++
T Consensus 394 ~~L~~~~ 400 (401)
T cd05107 394 HLVGDLL 400 (401)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=187.09 Aligned_cols=160 Identities=33% Similarity=0.559 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.+++.++.|++.||.+||+++ ++|+||+|+||+++.++.++++|||.+..............++..|.|||...
T Consensus 95 ~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 172 (260)
T PF00069_consen 95 LSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQ 172 (260)
T ss_dssp BBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTT
T ss_pred cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 578899999999999999999999 99999999999999999999999999865322222334456778999999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA---QVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
+...+.++|+||+|+++++|++|..||...... .............. .....++.+.+++.+||+.||.+||++.
T Consensus 173 ~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~ 252 (260)
T PF00069_consen 173 GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAE 252 (260)
T ss_dssp TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHH
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHH
Confidence 677889999999999999999999999987332 22222221111111 1122348999999999999999999999
Q ss_pred HHHHHHHHhh
Q 030203 156 TIMELLRPLI 165 (181)
Q Consensus 156 ~~l~~L~~~~ 165 (181)
++++ ++|+
T Consensus 253 ~l~~--~~~~ 260 (260)
T PF00069_consen 253 ELLK--HPWF 260 (260)
T ss_dssp HHHT--SGGG
T ss_pred HHhc--CCCC
Confidence 9998 5553
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=184.78 Aligned_cols=160 Identities=30% Similarity=0.563 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++....... .......++..|++||.
T Consensus 103 l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 180 (266)
T cd06651 103 LTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHH
Confidence 567888899999999999999999 9999999999999999999999999876432211 11122346778999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
+.+..++.++|+||+|++++++++|+.||.....................+..+++.+++++ +|+..+|.+||++++++
T Consensus 181 ~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred hCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 98888889999999999999999999999887665555444433444555667888999999 67889999999999999
Q ss_pred HHHHHhhh
Q 030203 159 ELLRPLIK 166 (181)
Q Consensus 159 ~~L~~~~~ 166 (181)
+ +++++
T Consensus 260 ~--hp~~~ 265 (266)
T cd06651 260 R--HPFAQ 265 (266)
T ss_pred c--Ccccc
Confidence 8 66654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=186.54 Aligned_cols=164 Identities=27% Similarity=0.512 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||++..............++..|++||.+.+
T Consensus 114 ~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (297)
T cd06659 114 LNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 191 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHcc
Confidence 578889999999999999999999 999999999999999999999999987644333222334457789999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|++++++++|+.||...........+..... .......+++.+.+++.+|+..+|.+||++.++++
T Consensus 192 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~- 270 (297)
T cd06659 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD- 270 (297)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh-
Confidence 7888999999999999999999999987776655554432211 12234467889999999999999999999999999
Q ss_pred HHHhhhCCC
Q 030203 161 LRPLIKSPT 169 (181)
Q Consensus 161 L~~~~~~~~ 169 (181)
+.++.+..
T Consensus 271 -~~~~~~~~ 278 (297)
T cd06659 271 -HPFLLQTG 278 (297)
T ss_pred -ChhhccCC
Confidence 66766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=181.75 Aligned_cols=156 Identities=27% Similarity=0.539 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.++.|||+.+ ++|+||+|+||+++.++.++++|||.+..............+++.|.+||...+
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 98 FEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCC
Confidence 578899999999999999999999 999999999999999999999999988654433323334567789999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
...+.++|+||+|+++++|++|..||......+....+.. +.....+..++..+.+++.+|+..+|.+||++.++++.
T Consensus 176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 7788899999999999999999999988877776666543 33333456688999999999999999999999999883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=187.22 Aligned_cols=161 Identities=25% Similarity=0.402 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++....... ......++..|++||.+.+
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 99 FDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccccccCCCCccCcHHhcC
Confidence 578889999999999999999999 9999999999999999999999999886543221 1233467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--ccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG--FKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SF 154 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~ 154 (181)
..++.++|+||+|+++|++++|..||.+.+.......+. ........+..+++.+.+++.+|+..||.+|| ++
T Consensus 176 ~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 255 (285)
T cd05605 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGA 255 (285)
T ss_pred CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCH
Confidence 888899999999999999999999998866533222221 12223445667899999999999999999999 88
Q ss_pred HHHHHHHHHhhhC
Q 030203 155 STIMELLRPLIKS 167 (181)
Q Consensus 155 ~~~l~~L~~~~~~ 167 (181)
+++++ ++|+..
T Consensus 256 ~~l~~--~~~~~~ 266 (285)
T cd05605 256 EEVKA--HPFFRT 266 (285)
T ss_pred HHHhc--CcCccC
Confidence 89987 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=182.11 Aligned_cols=160 Identities=29% Similarity=0.593 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc---CCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS---SKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.|+.+||+++ ++|+||+|+||+++.++.++++|||.+......... ......+..|++||.
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~ 180 (267)
T cd05066 103 FTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhH
Confidence 567889999999999999999999 999999999999999999999999988654332111 111222457999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
..+..++.++|+|++|++++++++ |..||......+....+. .....+.+..+++.+.+++.+|++.+|.+||++.++
T Consensus 181 ~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (267)
T cd05066 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI 259 (267)
T ss_pred hccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence 988888999999999999999886 999998877666555554 333444556788999999999999999999999999
Q ss_pred HHHHHHh
Q 030203 158 MELLRPL 164 (181)
Q Consensus 158 l~~L~~~ 164 (181)
++.|+.+
T Consensus 260 ~~~l~~~ 266 (267)
T cd05066 260 VSILDKL 266 (267)
T ss_pred HHHHHhh
Confidence 9998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=182.78 Aligned_cols=158 Identities=27% Similarity=0.490 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.++.|||+ .+ ++|+||+|.||+++.++.++++|||.+....... ......++..|++||...
T Consensus 110 ~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~ 186 (269)
T cd08528 110 FTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVK 186 (269)
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhc
Confidence 5678899999999999999996 67 9999999999999999999999999986544332 223445677899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
+..++.++|+||+|+++|++++|+.||...........+............+++.+.+++.+|+..||.+||++.++..+
T Consensus 187 ~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 187 NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 87788999999999999999999999988877666655543332222233678999999999999999999999999987
Q ss_pred HH
Q 030203 161 LR 162 (181)
Q Consensus 161 L~ 162 (181)
+.
T Consensus 267 ~~ 268 (269)
T cd08528 267 IS 268 (269)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=187.60 Aligned_cols=163 Identities=26% Similarity=0.382 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------------------- 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------------------- 61 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+.......
T Consensus 100 l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (316)
T cd05574 100 LSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccc
Confidence 577888999999999999999999 9999999999999999999999999875432110
Q ss_pred ---------ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCC
Q 030203 62 ---------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNV 132 (181)
Q Consensus 62 ---------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (181)
.......++..|++||.+.+..++.++|+||+|+++|++++|..||.+.+.......+.............
T Consensus 178 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
T cd05574 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPV 257 (316)
T ss_pred hhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCcccc
Confidence 01112356778999999988888899999999999999999999998887766555543233333333337
Q ss_pred CHHHHHHHHHHhcCCCCCCCC----HHHHHHHHHHhhhCC
Q 030203 133 NPHVASIIEACWANEPWKRPS----FSTIMELLRPLIKSP 168 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps----~~~~l~~L~~~~~~~ 168 (181)
++.+.+++.+|+..||.+||+ +.++++ ++|++..
T Consensus 258 ~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~--~~~~~~~ 295 (316)
T cd05574 258 SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ--HPFFRGV 295 (316)
T ss_pred CHHHHHHHHHHccCCHhHCCCchhhHHHHHc--CchhhcC
Confidence 899999999999999999999 888888 6776654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=194.42 Aligned_cols=161 Identities=26% Similarity=0.422 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL------------------- 62 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~------------------- 62 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++........
T Consensus 98 l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (364)
T cd05599 98 FTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175 (364)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccc
Confidence 578899999999999999999999 99999999999999999999999998753221100
Q ss_pred -------------------cCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC
Q 030203 63 -------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 123 (181)
Q Consensus 63 -------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~ 123 (181)
......|++.|+|||.+....++.++|+||+||++|+|++|..||.+.+.......+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~ 255 (364)
T cd05599 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWK 255 (364)
T ss_pred cccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 0012357889999999988888999999999999999999999999888776655553222
Q ss_pred CccCC--CCCCCHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHhhhC
Q 030203 124 KRLEI--PRNVNPHVASIIEACWANEPWKRPS---FSTIMELLRPLIKS 167 (181)
Q Consensus 124 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~L~~~~~~ 167 (181)
..... ...+++.+.+++.+|+. +|.+|++ ++++++ ++|++.
T Consensus 256 ~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~--h~~~~~ 301 (364)
T cd05599 256 ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS--HPFFKG 301 (364)
T ss_pred CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc--CCCcCC
Confidence 22222 23578999999999996 9999998 999988 666543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=182.63 Aligned_cols=161 Identities=28% Similarity=0.462 Sum_probs=134.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|+|+++ ++|+||+|.||+++.++.++++|||.+....... ......++..|++||...+
T Consensus 90 l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~ 166 (262)
T cd05572 90 FDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILN 166 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcC
Confidence 567889999999999999999999 9999999999999999999999999887554432 2223456778999999887
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----H
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLN--PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----F 154 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~ 154 (181)
..++.++|+|++|+++|++++|..||.... .......+.........+...++.+.+++.+||..+|.+||+ +
T Consensus 167 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 246 (262)
T cd05572 167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGI 246 (262)
T ss_pred CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCH
Confidence 778899999999999999999999998776 445555443334455566677899999999999999999999 8
Q ss_pred HHHHHHHHHhhhC
Q 030203 155 STIMELLRPLIKS 167 (181)
Q Consensus 155 ~~~l~~L~~~~~~ 167 (181)
+++++ ++|++.
T Consensus 247 ~~l~~--~~~~~~ 257 (262)
T cd05572 247 KDIKK--HKWFNG 257 (262)
T ss_pred HHHhc--ChhhhC
Confidence 99998 777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=184.17 Aligned_cols=162 Identities=30% Similarity=0.559 Sum_probs=132.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.++|+++ ++|+||+|+||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 98 l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 175 (277)
T cd06640 98 FDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhcc
Confidence 467788899999999999999999 999999999999999999999999988654433222233456678999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
...+.++|+||+|+++|+|++|+.||...........+. .......+..++..+.+++.+||..+|.+||++.++++
T Consensus 176 ~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~-- 252 (277)
T cd06640 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK-- 252 (277)
T ss_pred CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh--
Confidence 888899999999999999999999998877665554432 22234455567889999999999999999999999998
Q ss_pred HHhhhCC
Q 030203 162 RPLIKSP 168 (181)
Q Consensus 162 ~~~~~~~ 168 (181)
++++...
T Consensus 253 ~~~~~~~ 259 (277)
T cd06640 253 HKFIVKN 259 (277)
T ss_pred ChHhhhc
Confidence 6666543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=185.04 Aligned_cols=160 Identities=31% Similarity=0.507 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||.+..............++..|++||.+..
T Consensus 125 ~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (291)
T cd06639 125 LDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 202 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcC
Confidence 567889999999999999999999 999999999999999999999999987654432222233456778999998754
Q ss_pred CC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 82 EP-----SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 82 ~~-----~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.. ++.++|+||+|+++|++++|+.||...........+..... ....+..++..+.+++.+|++.+|.+||++.
T Consensus 203 ~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 282 (291)
T cd06639 203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVT 282 (291)
T ss_pred CCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHH
Confidence 32 57899999999999999999999988776554444432211 2223445778899999999999999999999
Q ss_pred HHHHHHHHhh
Q 030203 156 TIMELLRPLI 165 (181)
Q Consensus 156 ~~l~~L~~~~ 165 (181)
++++ ++++
T Consensus 283 ~il~--~~~~ 290 (291)
T cd06639 283 HLLE--HPFI 290 (291)
T ss_pred HHhc--Cccc
Confidence 9998 5554
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=181.41 Aligned_cols=160 Identities=29% Similarity=0.568 Sum_probs=131.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc--CCCCC---CCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--SKSAA---GTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~---~~~~~~~p 76 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+......... ..... .+..|++|
T Consensus 103 ~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 180 (269)
T cd05065 103 FTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180 (269)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCH
Confidence 567889999999999999999999 999999999999999999999999987643322111 01111 13469999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 77 EVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 77 e~~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
|...+..++.++|+||+|++++++++ |..||...+.......+. .....+.+..++..+.+++.+|+..+|.+||+++
T Consensus 181 E~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (269)
T cd05065 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFG 259 (269)
T ss_pred hHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99988888899999999999999886 999998887776666664 3334445567889999999999999999999999
Q ss_pred HHHHHHHHh
Q 030203 156 TIMELLRPL 164 (181)
Q Consensus 156 ~~l~~L~~~ 164 (181)
+++..|+.+
T Consensus 260 ~i~~~l~~~ 268 (269)
T cd05065 260 QIVSTLDKM 268 (269)
T ss_pred HHHHHHHhh
Confidence 999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=186.33 Aligned_cols=161 Identities=24% Similarity=0.365 Sum_probs=128.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC-CcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC-C
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE-P 83 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~ 83 (181)
.+.-+..||++||.|||+.| ++||||||.|+++|.+ |.+|++|||.++...... ...+-.++..|.|||.+.+. .
T Consensus 126 ~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e-pniSYicSRyYRaPELifga~~ 202 (364)
T KOG0658|consen 126 EIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 202 (364)
T ss_pred eeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeeccCC-CceeEEEeccccCHHHHcCccc
Confidence 45667899999999999999 9999999999999985 899999999998654432 22344667789999999875 4
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccCCcc-------------------------C-CCCCCCHHH
Q 030203 84 SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKGKRL-------------------------E-IPRNVNPHV 136 (181)
Q Consensus 84 ~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~-------------------------~-~~~~~~~~~ 136 (181)
|+.+.|+||.||++.||+.|++-|.+.+..+.+..+ +..+.+. . .....+++.
T Consensus 203 Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~ 282 (364)
T KOG0658|consen 203 YTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDA 282 (364)
T ss_pred cCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHH
Confidence 899999999999999999999999998765544433 1111100 0 224578899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 137 ASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 137 ~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
.+|+.++|..+|.+|.++.+++. ++++.....+
T Consensus 283 ~dll~~~L~Y~P~~R~~~~~~l~--h~fFdelr~~ 315 (364)
T KOG0658|consen 283 LDLLSKLLQYSPSKRLSALEALA--HPFFDELRDP 315 (364)
T ss_pred HHHHHHHhccChhhcCCHHHHhc--chhhHHhhCc
Confidence 99999999999999999999998 7777765544
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=194.24 Aligned_cols=162 Identities=25% Similarity=0.429 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.
T Consensus 139 ~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 216 (370)
T cd05621 139 VPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHh
Confidence 467889999999999999999999 99999999999999999999999999875432211 223456889999999986
Q ss_pred CCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCC--CCCCHHHHHHHHHHhcCCCCC--CC
Q 030203 81 DEP----SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWK--RP 152 (181)
Q Consensus 81 ~~~----~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~--Rp 152 (181)
+.. ++.++|+||+|+++|+|++|..||...+.......+.........+ ..+++.+++++.+|+..++.+ |+
T Consensus 217 ~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~ 296 (370)
T cd05621 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRN 296 (370)
T ss_pred ccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCC
Confidence 542 6789999999999999999999999888776666664333333333 357899999999999765544 88
Q ss_pred CHHHHHHHHHHhhhC
Q 030203 153 SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 s~~~~l~~L~~~~~~ 167 (181)
++.++++ ++|++.
T Consensus 297 ~~~e~l~--hp~~~~ 309 (370)
T cd05621 297 GVEEIKQ--HPFFKN 309 (370)
T ss_pred CHHHHhc--CcccCC
Confidence 9999999 888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=182.99 Aligned_cols=164 Identities=27% Similarity=0.527 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++++|||.+..............++..|++||...+
T Consensus 98 l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06917 98 IAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhcc
Confidence 578899999999999999999999 999999999999999999999999988654443323334467778999998765
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCC-CCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR-NVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
. .++.++|+||+|+++|+|++|..||...........+... .....+. .++.++.+++.+|+..||.+||++.++++
T Consensus 176 ~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 3 3678999999999999999999999887665544333222 1222222 37889999999999999999999999999
Q ss_pred HHHHhhhCCCC
Q 030203 160 LLRPLIKSPTP 170 (181)
Q Consensus 160 ~L~~~~~~~~~ 170 (181)
++|++....
T Consensus 255 --~~~~~~~~~ 263 (277)
T cd06917 255 --SKWIKAHSK 263 (277)
T ss_pred --ChHhhcccc
Confidence 788876543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=183.41 Aligned_cols=159 Identities=35% Similarity=0.527 Sum_probs=126.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....... .......++..|++||..
T Consensus 126 ~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 203 (295)
T cd05097 126 VSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI 203 (295)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh
Confidence 466788999999999999999999 9999999999999999999999999876432221 111222345689999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhc------cCCccCCCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT--LQQPWGNLNPAQVVAAVGF------KGKRLEIPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~--g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
.+..++.++|+||||+++++|++ |..||.............. .......+..+++.+.+++.+|++.||.+|
T Consensus 204 ~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 283 (295)
T cd05097 204 LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDR 283 (295)
T ss_pred ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 88888999999999999999987 6678887766555443321 111122345678999999999999999999
Q ss_pred CCHHHHHHHHH
Q 030203 152 PSFSTIMELLR 162 (181)
Q Consensus 152 ps~~~~l~~L~ 162 (181)
|+++++++.|+
T Consensus 284 Ps~~~i~~~l~ 294 (295)
T cd05097 284 PTFNKIHHFLR 294 (295)
T ss_pred cCHHHHHHHHh
Confidence 99999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=183.34 Aligned_cols=162 Identities=30% Similarity=0.492 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++...... ......++..|++||.+.+
T Consensus 92 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 167 (279)
T cd06619 92 IPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISG 167 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecC
Confidence 467788999999999999999999 999999999999999999999999988654332 1233467789999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhccCCccC-CCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNP-------AQVVAAVGFKGKRLE-IPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
..++.++|+||+|+++|+|++|+.||..... ......+. ...... .....++++.+++.+|++.+|.+||+
T Consensus 168 ~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 246 (279)
T cd06619 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246 (279)
T ss_pred CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCC
Confidence 8888999999999999999999999965321 11111111 111111 23457889999999999999999999
Q ss_pred HHHHHHHHHHhhhCCCC
Q 030203 154 FSTIMELLRPLIKSPTP 170 (181)
Q Consensus 154 ~~~~l~~L~~~~~~~~~ 170 (181)
++++++ ++|+.....
T Consensus 247 ~~eil~--~~~~~~~~~ 261 (279)
T cd06619 247 PENLMD--HPFIVQYND 261 (279)
T ss_pred HHHHhc--CcccccccC
Confidence 999998 777765433
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=179.53 Aligned_cols=157 Identities=36% Similarity=0.644 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
++++.++.++.|++.++.+||+++ ++|+||+|+||+++.++.++++|||.+........ .......+..|++||...
T Consensus 97 ~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~ 174 (256)
T cd05112 97 FSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFS 174 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhc
Confidence 467888999999999999999999 99999999999999999999999998764433211 111223346799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|++++ |..||...........+... .....+...+..+.+++.+|++.+|.+||++.++++
T Consensus 175 ~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 8888899999999999999998 99999888777777666422 233345557899999999999999999999999998
Q ss_pred HH
Q 030203 160 LL 161 (181)
Q Consensus 160 ~L 161 (181)
.|
T Consensus 254 ~l 255 (256)
T cd05112 254 QL 255 (256)
T ss_pred hh
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=184.16 Aligned_cols=161 Identities=25% Similarity=0.383 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||++....... ......++..|++||.+.+
T Consensus 99 ~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~~~aPE~~~~ 175 (285)
T cd05632 99 FEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVLNN 175 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-cccCCCCCcCccChHHhcC
Confidence 578899999999999999999999 9999999999999999999999999876433221 1233467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--cCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----H
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF--KGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----F 154 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~ 154 (181)
..++.++|+||+|++++++++|..||...........+.. .......+..+++.+.+++.+|++.||.+||+ +
T Consensus 176 ~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 255 (285)
T cd05632 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGA 255 (285)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccCh
Confidence 8888999999999999999999999988765433333221 22223455678899999999999999999999 7
Q ss_pred HHHHHHHHHhhhC
Q 030203 155 STIMELLRPLIKS 167 (181)
Q Consensus 155 ~~~l~~L~~~~~~ 167 (181)
+++++ +++++.
T Consensus 256 ~~l~~--~~~~~~ 266 (285)
T cd05632 256 GEVKR--HPFFRN 266 (285)
T ss_pred HHHHc--Chhhhc
Confidence 78887 555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=183.80 Aligned_cols=166 Identities=32% Similarity=0.611 Sum_probs=134.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.+||+.| ++|+|++|.||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 113 l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 190 (286)
T cd06614 113 MNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcC
Confidence 578889999999999999999999 999999999999999999999999987543332222233346678999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+|++|+++|++++|+.||...+.......+..... ....+..++..+.+++.+|++.+|.+||++.++++
T Consensus 191 ~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~- 269 (286)
T cd06614 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ- 269 (286)
T ss_pred CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh-
Confidence 7788999999999999999999999988776655444432222 12223347889999999999999999999999998
Q ss_pred HHHhhhCCCCC
Q 030203 161 LRPLIKSPTPQ 171 (181)
Q Consensus 161 L~~~~~~~~~~ 171 (181)
+.+++.....
T Consensus 270 -~~~~~~~~~~ 279 (286)
T cd06614 270 -HPFLKKACPK 279 (286)
T ss_pred -ChHhhccCch
Confidence 8888775444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=183.63 Aligned_cols=159 Identities=34% Similarity=0.531 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+........ .......+..|++||..
T Consensus 127 ~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 204 (296)
T cd05095 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI 204 (296)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH
Confidence 456789999999999999999999 99999999999999999999999999864332211 11122334679999988
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhc------cCCccCCCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT--LQQPWGNLNPAQVVAAVGF------KGKRLEIPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~--g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
.+..++.++|+||+|+++|+|++ |..||......+....... .....+.+..+++.+.+++.+|+..||.+|
T Consensus 205 ~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 284 (296)
T cd05095 205 LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKER 284 (296)
T ss_pred hcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 77778899999999999999998 7788877766554443311 111223345678999999999999999999
Q ss_pred CCHHHHHHHHH
Q 030203 152 PSFSTIMELLR 162 (181)
Q Consensus 152 ps~~~~l~~L~ 162 (181)
|++.++.+.|+
T Consensus 285 p~~~~i~~~l~ 295 (296)
T cd05095 285 PSFQEIHATLL 295 (296)
T ss_pred CCHHHHHHHHh
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=199.06 Aligned_cols=169 Identities=34% Similarity=0.611 Sum_probs=148.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc-cccccccCC-CCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSK-SAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~-~~~~~~~~~-~~~~~~~~~~pe~~ 79 (181)
|+..|.++|+.||+.|..||-++. +||||+...|++++.+-.+|++|||+++. +...+.... ...-...|++||.+
T Consensus 600 L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI 677 (774)
T KOG1026|consen 600 LSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI 677 (774)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh
Confidence 567899999999999999999999 99999999999999999999999999874 222222222 23335689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
..+.|+.++||||+|+++||+.+ |+.|+.+...++.++.+. .+...+-|..++.++.+|+..||+.+|.+||++++|-
T Consensus 678 ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~-~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 678 LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR-AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH-cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 99999999999999999999995 999999999999999997 5555889999999999999999999999999999999
Q ss_pred HHHHHhhhCCCCCCC
Q 030203 159 ELLRPLIKSPTPQPS 173 (181)
Q Consensus 159 ~~L~~~~~~~~~~~~ 173 (181)
..|+.+.+..+.-..
T Consensus 757 ~~L~~~~~~s~~~~~ 771 (774)
T KOG1026|consen 757 SRLQAWAQASPKYSS 771 (774)
T ss_pred HHHHHHHhcCccccc
Confidence 999999988766543
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=182.65 Aligned_cols=161 Identities=32% Similarity=0.558 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++........ ......++..|++||.
T Consensus 106 ~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~ 183 (284)
T cd05079 106 INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHH
Confidence 577889999999999999999999 99999999999999999999999998875432211 1122345567999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHhccCCccCCCCCCCHHHHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNL---------------NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEAC 143 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 143 (181)
..+..++.++|+||+|+++++++++..|.... ........+. .......+..++..+.+++.+|
T Consensus 184 ~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 262 (284)
T cd05079 184 LIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE-EGKRLPRPPNCPEEVYQLMRKC 262 (284)
T ss_pred hccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHH
Confidence 88877888999999999999999976654221 1111111121 2233445667899999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhh
Q 030203 144 WANEPWKRPSFSTIMELLRPLI 165 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~ 165 (181)
++.||.+||++.++++.++.++
T Consensus 263 l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 263 WEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred ccCCcccCcCHHHHHHHHHhhC
Confidence 9999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=183.67 Aligned_cols=159 Identities=28% Similarity=0.477 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||.+...... ....++..|++||.+.
T Consensus 112 l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~ 185 (307)
T cd06607 112 LQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILA 185 (307)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC----CCccCCccccCceeeec
Confidence 578889999999999999999999 999999999999999999999999987543322 2345667899999874
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
...++.++|+||+|+++|++++|+.||...+.......+.........+..++..+.+++.+||..+|.+||++.+++
T Consensus 186 ~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 265 (307)
T cd06607 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265 (307)
T ss_pred cCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 344778999999999999999999999887766655544433322223345788999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
. +.++...
T Consensus 266 ~--~~~~~~~ 273 (307)
T cd06607 266 K--HRFVLRE 273 (307)
T ss_pred c--Chhhccc
Confidence 8 6666654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=194.62 Aligned_cols=162 Identities=25% Similarity=0.375 Sum_probs=123.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||+++....... ......++..|++||.+
T Consensus 257 l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~ 334 (461)
T PHA03211 257 LGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVL 334 (461)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHH
Confidence 678899999999999999999999 99999999999999999999999999865332211 11234678899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhccCCc-cCC----------------------
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNL--------NPAQVVAAVGFKGKR-LEI---------------------- 128 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~--------~~~~~~~~~~~~~~~-~~~---------------------- 128 (181)
.+..++.++|+|||||++|+|++|..++... ....+...+...... ...
T Consensus 335 ~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 414 (461)
T PHA03211 335 AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRP 414 (461)
T ss_pred cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCC
Confidence 8888999999999999999999886544221 112222222111100 000
Q ss_pred --C-------CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 129 --P-------RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 129 --~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
. ..+++++.+||.+||..||.+|||+.|+++ +.|++.
T Consensus 415 ~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~--hp~f~~ 460 (461)
T PHA03211 415 AYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR--LPLFQS 460 (461)
T ss_pred ccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh--CcccCC
Confidence 0 134568999999999999999999999999 888754
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=181.25 Aligned_cols=161 Identities=34% Similarity=0.584 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..++.++.|++.++.+||+ .+ ++|+||+|+||+++.++.++++|||.+..............++..|++||...
T Consensus 96 l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 173 (264)
T cd06623 96 IPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173 (264)
T ss_pred CCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhC
Confidence 5788999999999999999999 99 99999999999999999999999998765443322222345667899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCccCCCCC-CCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+..++.++|+|+||+++|++++|..||.... .......+. .......+.. ++..+.+++.+|+..+|.+||++.+
T Consensus 174 ~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ 252 (264)
T cd06623 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252 (264)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 8888899999999999999999999998874 333444443 3333344555 8899999999999999999999999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ +++++.
T Consensus 253 ll~--~~~~~~ 261 (264)
T cd06623 253 LLQ--HPFIKK 261 (264)
T ss_pred HHh--CHHHHh
Confidence 999 777764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=183.79 Aligned_cols=157 Identities=29% Similarity=0.477 Sum_probs=122.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.++..++.|++.|+.|||+.+ ++|+|++|.||+++.++.++++|||.+..............++..|++||.+.
T Consensus 103 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 180 (267)
T cd06646 103 LSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHccc
Confidence 467889999999999999999999 99999999999999999999999999875443322223345677899999874
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc---cCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR---LEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
...++.++|+||+|+++++|++|+.||.................. ......++..+.+++.+||..+|.+||+++
T Consensus 181 ~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 260 (267)
T cd06646 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAE 260 (267)
T ss_pred ccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHH
Confidence 333677899999999999999999998665443322222111111 112235788999999999999999999999
Q ss_pred HHHHH
Q 030203 156 TIMEL 160 (181)
Q Consensus 156 ~~l~~ 160 (181)
++++.
T Consensus 261 ~il~~ 265 (267)
T cd06646 261 RLLTH 265 (267)
T ss_pred HHhcC
Confidence 99873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=190.95 Aligned_cols=162 Identities=25% Similarity=0.403 Sum_probs=134.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccc------------------c--
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN------------------T-- 60 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~------------------~-- 60 (181)
.|+|+.+..++.+.+.|+..+|..| ++|+||||+|+++|..|++||+|||++.-... .
T Consensus 237 ~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~ 314 (550)
T KOG0605|consen 237 TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAK 314 (550)
T ss_pred cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCC
Confidence 3788999999999999999999999 99999999999999999999999999851100 0
Q ss_pred ---cc------------------------cCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 030203 61 ---FL------------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA 113 (181)
Q Consensus 61 ---~~------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~ 113 (181)
.. .....+|+|.|+|||++.+.+|....|.|||||++||||.|.+||.+..+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~ 394 (550)
T KOG0605|consen 315 PSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ 394 (550)
T ss_pred CccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 00 001246899999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCC--ccCCCCCCCHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHhhhC
Q 030203 114 QVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPS---FSTIMELLRPLIKS 167 (181)
Q Consensus 114 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~L~~~~~~ 167 (181)
+...++..-.. ..+-...++++.++||.+|+. ||.+|.. +.||.+ +++|+.
T Consensus 395 ~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~--HPfF~~ 450 (550)
T KOG0605|consen 395 ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK--HPFFKG 450 (550)
T ss_pred HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc--CCcccc
Confidence 88887754332 223334577999999999998 9999995 777777 677654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=189.73 Aligned_cols=159 Identities=25% Similarity=0.356 Sum_probs=118.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE----cCCCcEEEcccCCccccccccc---cCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~----~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~ 74 (181)
+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++........ ......+++.|+
T Consensus 105 l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~ 182 (317)
T cd07867 105 LPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceeccccc
Confidence 567888999999999999999999 9999999999999 4567899999999875443221 123346678899
Q ss_pred CCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHhccC--------------------
Q 030203 75 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPA----------QVVAAVGFKG-------------------- 123 (181)
Q Consensus 75 ~pe~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~----------~~~~~~~~~~-------------------- 123 (181)
|||.+.+. .++.++|+||+|+++|+|++|+.||...... .........+
T Consensus 183 aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T cd07867 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQ 262 (317)
T ss_pred CcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhh
Confidence 99988764 4688999999999999999999999654321 0100000000
Q ss_pred -----Cc----------cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHh
Q 030203 124 -----KR----------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 124 -----~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~ 164 (181)
.. .......+..+.+++.+||..||.+|||+.++++ ++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~--hp~ 316 (317)
T cd07867 263 KDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ--DPY 316 (317)
T ss_pred hhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc--CCC
Confidence 00 0011123557889999999999999999999997 544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=197.18 Aligned_cols=158 Identities=39% Similarity=0.734 Sum_probs=141.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++....+.|.++|+.|..|||.++ |+|||+|..||+++.+..+|++|||-++....- .......|+..|+|||+++.
T Consensus 209 itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrn 285 (904)
T KOG4721|consen 209 ITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRN 285 (904)
T ss_pred cCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhc
Confidence 345667889999999999999999 999999999999999999999999987644433 23455678899999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
...+.++||||||+++|+||||..|+...+...++.-+..+..-+.+|..+++.|+-|++.||+..|..||++++++..|
T Consensus 286 ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 286 EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 99999999999999999999999999998888887777767777889999999999999999999999999999999988
Q ss_pred H
Q 030203 162 R 162 (181)
Q Consensus 162 ~ 162 (181)
+
T Consensus 366 d 366 (904)
T KOG4721|consen 366 D 366 (904)
T ss_pred h
Confidence 6
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=181.00 Aligned_cols=159 Identities=29% Similarity=0.494 Sum_probs=128.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc------cccCCCCCCCCCccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT------FLSSKSAAGTPEWMA 75 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~~~ 75 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||.+...... ........++..|++
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (265)
T cd06631 99 LPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccC
Confidence 467888999999999999999999 999999999999999999999999987643211 111123456778999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 76 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 76 pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
||...+..++.++|+|++|++++++++|..||...+.......+... ......+..++..+.+++.+|+..+|.+||++
T Consensus 177 pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 256 (265)
T cd06631 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSA 256 (265)
T ss_pred hhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCH
Confidence 99998888889999999999999999999999876654433333222 23344566789999999999999999999999
Q ss_pred HHHHHHHHHh
Q 030203 155 STIMELLRPL 164 (181)
Q Consensus 155 ~~~l~~L~~~ 164 (181)
.++++ ++|
T Consensus 257 ~~~l~--~~~ 264 (265)
T cd06631 257 LQLLR--HDF 264 (265)
T ss_pred HHHhc--CCC
Confidence 99987 544
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=191.63 Aligned_cols=162 Identities=22% Similarity=0.364 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.
T Consensus 139 ~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~ 216 (371)
T cd05622 139 VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216 (371)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHh
Confidence 467788899999999999999999 9999999999999999999999999986543221 1223456889999999986
Q ss_pred CCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCC--CC
Q 030203 81 DEP----SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWK--RP 152 (181)
Q Consensus 81 ~~~----~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~--Rp 152 (181)
+.. ++.++|+||+|+++|+|++|..||...+......++........ ....+++.+++++.+|+..++.+ |+
T Consensus 217 ~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~ 296 (371)
T cd05622 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRN 296 (371)
T ss_pred ccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCC
Confidence 542 67899999999999999999999999887766666643332222 33468999999999999744443 77
Q ss_pred CHHHHHHHHHHhhhC
Q 030203 153 SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 s~~~~l~~L~~~~~~ 167 (181)
++.++++ +.+++.
T Consensus 297 ~~~ei~~--h~~~~~ 309 (371)
T cd05622 297 GVEEIKR--HLFFKN 309 (371)
T ss_pred CHHHHhc--CcccCC
Confidence 9999998 555543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=192.59 Aligned_cols=162 Identities=27% Similarity=0.380 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------------------- 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------------------- 61 (181)
+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (381)
T cd05626 98 FPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175 (381)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccc
Confidence 567888899999999999999999 9999999999999999999999999864211000
Q ss_pred ---------------------------ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 030203 62 ---------------------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 114 (181)
Q Consensus 62 ---------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~ 114 (181)
.......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~ 255 (381)
T cd05626 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE 255 (381)
T ss_pred ccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH
Confidence 00123468889999999988888999999999999999999999998877665
Q ss_pred HHHHHhccCCccCC--CCCCCHHHHHHHHHHh--cCCCCCCCCHHHHHHHHHHhhhC
Q 030203 115 VVAAVGFKGKRLEI--PRNVNPHVASIIEACW--ANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 115 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l--~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
....+......... ...+++++.+++.+|+ ..++..|+++.++++ +++++.
T Consensus 256 ~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~--hp~f~~ 310 (381)
T cd05626 256 TQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA--HPFFSE 310 (381)
T ss_pred HHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc--CcccCC
Confidence 55444322222222 3358899999999965 455556999999999 777754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=183.71 Aligned_cols=163 Identities=27% Similarity=0.380 Sum_probs=138.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccc---------------------
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--------------------- 59 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~--------------------- 59 (181)
.|+++.+.-++.+++-||+|||..| |++||+||+||++..+|++.|+||.++.....
T Consensus 175 ~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~ 252 (459)
T KOG0610|consen 175 RFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRS 252 (459)
T ss_pred ccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccccc
Confidence 3788899999999999999999999 99999999999999999999999988642110
Q ss_pred ------------c-c----------------------ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCC
Q 030203 60 ------------T-F----------------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQ 104 (181)
Q Consensus 60 ------------~-~----------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~ 104 (181)
. . ......+||-.|+|||+++|.+-+.++|.|+||+++|||+.|.
T Consensus 253 ~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~ 332 (459)
T KOG0610|consen 253 RQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGT 332 (459)
T ss_pred ccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCC
Confidence 0 0 0012346778999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC----HHHHHHHHHHhhhC
Q 030203 105 QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS----FSTIMELLRPLIKS 167 (181)
Q Consensus 105 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~L~~~~~~ 167 (181)
-||.+.+..+...++.......+-...++-.+++||.++|..||.+|.. +.||-+ +++++.
T Consensus 333 TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~--HpFF~g 397 (459)
T KOG0610|consen 333 TPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR--HPFFEG 397 (459)
T ss_pred CCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc--CccccC
Confidence 9999999888888876566555555578899999999999999999998 888877 666654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=192.40 Aligned_cols=161 Identities=22% Similarity=0.351 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--------------c-----
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--------------L----- 62 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--------------~----- 62 (181)
+++..+..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||+++...... .
T Consensus 98 ~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (377)
T cd05629 98 FSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175 (377)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccc
Confidence 567888999999999999999999 9999999999999999999999999885221100 0
Q ss_pred ----------------------------cCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 030203 63 ----------------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 114 (181)
Q Consensus 63 ----------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~ 114 (181)
......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 255 (377)
T cd05629 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE 255 (377)
T ss_pred ccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH
Confidence 0012357889999999988888999999999999999999999998887766
Q ss_pred HHHHHhccCCccCCC--CCCCHHHHHHHHHHhcCCCCCC---CCHHHHHHHHHHhhhC
Q 030203 115 VVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWKR---PSFSTIMELLRPLIKS 167 (181)
Q Consensus 115 ~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R---ps~~~~l~~L~~~~~~ 167 (181)
....+.........+ ..+++++.+++.+|+. +|.+| +++.++++ ++|++.
T Consensus 256 ~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~--hp~~~~ 310 (377)
T cd05629 256 TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS--HPFFRG 310 (377)
T ss_pred HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc--CCCcCC
Confidence 555553222223333 3578999999999997 66665 59999998 777664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=181.28 Aligned_cols=162 Identities=28% Similarity=0.443 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--------cCCCCCCCCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--------SSKSAAGTPEW 73 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--------~~~~~~~~~~~ 73 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++........ ......++..|
T Consensus 90 ~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (265)
T cd05579 90 LDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccc
Confidence 578899999999999999999999 99999999999999999999999998764333211 22234566789
Q ss_pred cCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 74 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 74 ~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
++||.......+.++|+|++|++++++++|..||...........+............+++.+.+++.+|++.+|.+||+
T Consensus 168 ~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt 247 (265)
T cd05579 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLG 247 (265)
T ss_pred cCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCC
Confidence 99999888778889999999999999999999999888777766664322222222234899999999999999999999
Q ss_pred H---HHHHHHHHHhhhC
Q 030203 154 F---STIMELLRPLIKS 167 (181)
Q Consensus 154 ~---~~~l~~L~~~~~~ 167 (181)
+ .++++ ++|++.
T Consensus 248 ~~~~~~~l~--~~~~~~ 262 (265)
T cd05579 248 AKSIEEIKN--HPFFKG 262 (265)
T ss_pred CccHHHHhc--CccccC
Confidence 9 66666 566653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=181.52 Aligned_cols=156 Identities=29% Similarity=0.463 Sum_probs=123.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.+++.++.|++.|+.|||+.| ++|+||+|+||+++.++.++++|||++..............++..|+|||.+.
T Consensus 103 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (267)
T cd06645 103 LSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhcc
Confidence 578899999999999999999999 99999999999999999999999998765433322333446778999999874
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC---CCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE---IPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
...++.++|+||+|+++|+|++|..||.................... ....++..+.+++.+|+..+|.+||+++
T Consensus 181 ~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 260 (267)
T cd06645 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAE 260 (267)
T ss_pred ccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 34477899999999999999999999876554333322221211111 1224778899999999999999999999
Q ss_pred HHHH
Q 030203 156 TIME 159 (181)
Q Consensus 156 ~~l~ 159 (181)
++++
T Consensus 261 ~ll~ 264 (267)
T cd06645 261 KLLQ 264 (267)
T ss_pred HHhc
Confidence 9886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=184.31 Aligned_cols=162 Identities=31% Similarity=0.573 Sum_probs=126.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+. + ++|+||+|+||+++.++.++++|||++....... ......++..|++||.+.
T Consensus 104 l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 180 (288)
T cd06616 104 IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERID 180 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhccCC-ccccccCccCccCHHHhc
Confidence 56788999999999999999985 8 9999999999999999999999999886443322 112335677899999987
Q ss_pred CC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCcc----CCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 81 DE---PSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRL----EIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 81 ~~---~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+. .++.++|+||+|++++++++|+.||...... ....... ..... ..+..++.++.+++.+|++.+|.+||
T Consensus 181 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 259 (288)
T cd06616 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP 259 (288)
T ss_pred cccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCc
Confidence 65 5788999999999999999999999766521 1111111 11111 12235788999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCC
Q 030203 153 SFSTIMELLRPLIKSPT 169 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~ 169 (181)
|+.++++ +++++...
T Consensus 260 t~~~i~~--~~~~~~~~ 274 (288)
T cd06616 260 KYKELLE--HPFIKDYE 274 (288)
T ss_pred CHHHHhc--Chhhhchh
Confidence 9999999 88876543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=182.06 Aligned_cols=160 Identities=34% Similarity=0.608 Sum_probs=128.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.++.++|+ .+ ++|+||+|+||+++.++.++++|||.+........ ....++..|++||...
T Consensus 97 ~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~y~~PE~~~ 172 (265)
T cd06605 97 IPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPERIQ 172 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--hcccCChhccCHHHHc
Confidence 5678889999999999999999 89 99999999999999999999999998764433211 1255677899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhccCCccCCCCC-CCHHHHHHHHHHhcCCCCCCCCH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLN-----PAQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
+..++.++|+||+|++++++++|..||.... ......... .......+.. +++++.++|.+|+..||.+|||+
T Consensus 173 ~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 251 (265)
T cd06605 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSY 251 (265)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCH
Confidence 8888999999999999999999999997652 222222222 2222233333 88999999999999999999999
Q ss_pred HHHHHHHHHhhhCC
Q 030203 155 STIMELLRPLIKSP 168 (181)
Q Consensus 155 ~~~l~~L~~~~~~~ 168 (181)
.++++ ++|++.-
T Consensus 252 ~~ll~--~~~~~~~ 263 (265)
T cd06605 252 KELLE--HPFIKKY 263 (265)
T ss_pred HHHhh--Cchhhcc
Confidence 99998 7887653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=183.05 Aligned_cols=156 Identities=23% Similarity=0.391 Sum_probs=123.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.+|.|||+.+ ++|+||+|.||+++.++.++++|||++..............++..|++||.+.+
T Consensus 97 ~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 97 VPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhC
Confidence 578899999999999999999999 999999999999999999999999998754443222233456678999998865
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------------------ccC----------CCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-------------------RLE----------IPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~----------~~~~ 131 (181)
..++.++|+||+|+++++|++|..||.+....+....+..... ... ....
T Consensus 175 ~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07847 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPN 254 (286)
T ss_pred CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhcc
Confidence 3467899999999999999999999987765443332211000 000 0124
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
++..+.+++.+||..+|.+||++.+++.
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 255 ISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 6788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=179.90 Aligned_cols=155 Identities=32% Similarity=0.593 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.+++.|+.+||+++ ++|+||+|+||+++.++.++++|||.+..............+++.|++||...+
T Consensus 100 ~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 177 (258)
T cd08215 100 FPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177 (258)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhcc
Confidence 577889999999999999999999 999999999999999999999999988755443322333456778999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..++.++|+|++|++++++++|..||...+......... .......+..++..+.+++.+||..+|.+||++.++++
T Consensus 178 ~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 888899999999999999999999998887777666654 33345566678999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=179.31 Aligned_cols=154 Identities=33% Similarity=0.582 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC-CcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.+++.++.+||+++ ++|+||+|.||+++.+ +.++++|||.+....... ......++..|++||...
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08220 98 LDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCE 174 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-cccccccCCcccCchhcc
Confidence 578899999999999999999999 9999999999999864 457999999887554332 122345677899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+...+.++|+||+|++++++++|..||...+.......+. .......+..+++++.+++.+|+..+|.+|||++++++
T Consensus 175 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 8878889999999999999999999998887766665553 33334456678999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=189.67 Aligned_cols=161 Identities=24% Similarity=0.382 Sum_probs=121.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.+
T Consensus 154 ~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 230 (357)
T PHA03209 154 LPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-AFLGLAGTVETNAPEVLAR 230 (357)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc-ccccccccccccCCeecCC
Confidence 578899999999999999999999 9999999999999999999999999886432211 1223457889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCC-CCCCCH----------HHHHHHHhccCC-ccCC---------------------
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQP-WGNLNP----------AQVVAAVGFKGK-RLEI--------------------- 128 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p-~~~~~~----------~~~~~~~~~~~~-~~~~--------------------- 128 (181)
..++.++|+||+|+++|+|+++..+ |..... ..+...+..... ....
T Consensus 231 ~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (357)
T PHA03209 231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQ 310 (357)
T ss_pred CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCC
Confidence 8899999999999999999986444 333211 011111110000 0000
Q ss_pred ---------CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 129 ---------PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 129 ---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
...++.++.++|.+||..||.+|||+.++++ ++|+++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~--hp~f~~ 356 (357)
T PHA03209 311 PYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN--YPMFAQ 356 (357)
T ss_pred cccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc--Cchhcc
Confidence 1145667788999999999999999999999 888765
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=192.19 Aligned_cols=161 Identities=27% Similarity=0.372 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc---------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--------------------- 60 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--------------------- 60 (181)
+++..+..++.|++.||.|||+++ ++|+||||+||+++.+|.++|+|||++......
T Consensus 98 ~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (382)
T cd05625 98 FPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175 (382)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccc
Confidence 577888999999999999999999 999999999999999999999999986421100
Q ss_pred --------------------------cccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 030203 61 --------------------------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 114 (181)
Q Consensus 61 --------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~ 114 (181)
........+++.|+|||.+.+..++.++|+||+||++|+|++|+.||...+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 255 (382)
T cd05625 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE 255 (382)
T ss_pred cccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHH
Confidence 000112357889999999988889999999999999999999999999887765
Q ss_pred HHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHhhhC
Q 030203 115 VVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPS---FSTIMELLRPLIKS 167 (181)
Q Consensus 115 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~L~~~~~~ 167 (181)
....+........ ....+++++.+++.+|+ .+|.+|++ +.++++ +++++.
T Consensus 256 ~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~--hp~f~~ 310 (382)
T cd05625 256 TQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA--HPFFKT 310 (382)
T ss_pred HHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc--CCCcCC
Confidence 5554432222222 23467899999999986 59999997 888887 666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=179.86 Aligned_cols=155 Identities=33% Similarity=0.563 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.+||+++ ++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+..
T Consensus 99 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~ 175 (258)
T cd06632 99 FPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQ 175 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcC
Confidence 567888999999999999999999 9999999999999999999999999876543322 2233456778999998876
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
.. ++.++|+||+|++++++++|..||...........+.........+..+++.+.+++.+|+..+|.+||++.++++
T Consensus 176 ~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 66 7889999999999999999999998877555555544333444566778999999999999999999999999987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=182.59 Aligned_cols=167 Identities=25% Similarity=0.497 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.++.|||++| ++|+||+|.||+++.++.++++|||.+..............++..|++||...+
T Consensus 113 ~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 190 (292)
T cd06657 113 MNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR 190 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcC
Confidence 467889999999999999999999 999999999999999999999999987644332222233456778999999877
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|++++++++|..||.+.........+.... ........+++.+.+++.+||..+|.+||++.++++
T Consensus 191 ~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~- 269 (292)
T cd06657 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK- 269 (292)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc-
Confidence 777889999999999999999999998877665544443221 122233467899999999999999999999999999
Q ss_pred HHHhhhCCCCCC
Q 030203 161 LRPLIKSPTPQP 172 (181)
Q Consensus 161 L~~~~~~~~~~~ 172 (181)
++++.....++
T Consensus 270 -~~~~~~~~~~~ 280 (292)
T cd06657 270 -HPFLAKAGPPS 280 (292)
T ss_pred -ChHHhccCCCc
Confidence 89988766533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=194.87 Aligned_cols=160 Identities=33% Similarity=0.586 Sum_probs=133.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++.+.+..|++||++||.|||++.|+|+|||||=+|||++. .|.+|++|+|++........ ...+|||.|+|||...
T Consensus 140 vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a--ksvIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 140 VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA--KSVIGTPEFMAPEMYE 217 (632)
T ss_pred CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc--ceeccCccccChHHHh
Confidence 35677889999999999999999999999999999999965 69999999999986555432 3369999999999885
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCcc-CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRL-EIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
..|...+||||||++|++|+|+..|+..+... ++..++. .+..+ ....--++++++||.+|+.. ...|+|+.++|
T Consensus 218 -E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 218 -ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred -hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHh
Confidence 56899999999999999999999999887655 4555554 44433 33444478999999999988 99999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+ +++|..-
T Consensus 295 ~--d~Ff~~d 302 (632)
T KOG0584|consen 295 K--DPFFDED 302 (632)
T ss_pred h--Chhhccc
Confidence 9 8888753
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=182.48 Aligned_cols=156 Identities=28% Similarity=0.478 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+.+ ++|+|++|+||+++.++.++++|||.+..............++..|++||.+..
T Consensus 121 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (286)
T cd06638 121 MEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198 (286)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhch
Confidence 467788899999999999999999 999999999999999999999999987654433223334567889999998753
Q ss_pred -----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 82 -----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 82 -----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
..++.++|+||+|+++|++++|+.||................ .....+..++..+.+++.+||+.||.+|||+.
T Consensus 199 ~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 278 (286)
T cd06638 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVS 278 (286)
T ss_pred hhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHH
Confidence 336789999999999999999999998776544333322111 12223455678999999999999999999999
Q ss_pred HHHH
Q 030203 156 TIME 159 (181)
Q Consensus 156 ~~l~ 159 (181)
++++
T Consensus 279 ell~ 282 (286)
T cd06638 279 DLLQ 282 (286)
T ss_pred HHhh
Confidence 9998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=182.65 Aligned_cols=156 Identities=21% Similarity=0.299 Sum_probs=122.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||.+..............++..|++||...+
T Consensus 97 l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 97 IPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 174 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEec
Confidence 567889999999999999999999 999999999999999999999999987654333222333455678999998866
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCc--------------------------cCCCCCCC
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGKR--------------------------LEIPRNVN 133 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~~ 133 (181)
.. .+.++|+||+|+++|++++|+.||.+.+......++.. .... ......++
T Consensus 175 ~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
T cd07860 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLD 254 (284)
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCC
Confidence 44 57789999999999999999999987765433322210 0000 01123477
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+.+.++|.+|++.||.+||+++++++
T Consensus 255 ~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 255 EDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 88999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=182.82 Aligned_cols=157 Identities=26% Similarity=0.446 Sum_probs=132.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||++...... .....+++.|++||.+.+
T Consensus 98 l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 98 FPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILS 172 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcC
Confidence 578889999999999999999999 999999999999999999999999988654433 233456788999999887
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
...+.++|+||+|+++++|++|+.||...........+. ......+..+++.+++++.+||..||.+|+ ++++
T Consensus 173 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~ 250 (290)
T cd05580 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVND 250 (290)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHH
Confidence 778889999999999999999999998887665555553 334456677899999999999999999999 8888
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ +++++.
T Consensus 251 l~~--~~~~~~ 259 (290)
T cd05580 251 IKN--HPWFAG 259 (290)
T ss_pred HHc--Cccccc
Confidence 886 565544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=180.33 Aligned_cols=159 Identities=31% Similarity=0.568 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++...... ........++..|++||.+.
T Consensus 114 l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 191 (275)
T cd05046 114 LSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ 191 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhc
Confidence 578899999999999999999999 999999999999999999999999987533221 11222334456799999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+...+.++|+||+|++++++++ |..||...........+.........+..++..+.+++.+|+..+|.+||++.++++
T Consensus 192 ~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 192 EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7778889999999999999998 788998776666666554333334445678899999999999999999999999999
Q ss_pred HHH
Q 030203 160 LLR 162 (181)
Q Consensus 160 ~L~ 162 (181)
.|.
T Consensus 272 ~l~ 274 (275)
T cd05046 272 ALG 274 (275)
T ss_pred Hhc
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=183.54 Aligned_cols=160 Identities=27% Similarity=0.326 Sum_probs=125.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++. ++.++++|||.+..............+++.|.+||.+.
T Consensus 107 ~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 184 (295)
T cd07837 107 LPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184 (295)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhh
Confidence 578899999999999999999999 999999999999998 88999999998765433322333345677899999876
Q ss_pred C-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--c------------------------cCCCCCCC
Q 030203 81 D-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--R------------------------LEIPRNVN 133 (181)
Q Consensus 81 ~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~------------------------~~~~~~~~ 133 (181)
+ ..++.++|+||+|+++|+|++|..||.+.........+..... . ......++
T Consensus 185 ~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (295)
T cd07837 185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLS 264 (295)
T ss_pred CCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccC
Confidence 5 3468899999999999999999999987655443322211000 0 00113478
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhh
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIMELLRPLI 165 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~ 165 (181)
+.+.++|.+||..||.+||++.+++. ++|+
T Consensus 265 ~~~~~~i~~~l~~~P~~R~~~~eil~--~~~~ 294 (295)
T cd07837 265 PEGLDLLQKMLRYDPAKRISAKAALT--HPYF 294 (295)
T ss_pred HHHHHHHHHHccCChhhcCCHHHHhc--CCCc
Confidence 88999999999999999999999998 6654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=184.07 Aligned_cols=160 Identities=28% Similarity=0.450 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++....... ......++..|+|||.+.+
T Consensus 99 l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 99 FEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKN 175 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cccCCCCCccccChHHHcC
Confidence 567889999999999999999999 9999999999999999999999999876433221 1223467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPA---QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS----- 153 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----- 153 (181)
..++.++|+||+|+++|+|++|..||...... ....... .......+..+++++.+++.+||+.||.+|||
T Consensus 176 ~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 254 (285)
T cd05630 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGG 254 (285)
T ss_pred CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCc
Confidence 88899999999999999999999999875432 1111111 11223355678999999999999999999999
Q ss_pred HHHHHHHHHHhhhC
Q 030203 154 FSTIMELLRPLIKS 167 (181)
Q Consensus 154 ~~~~l~~L~~~~~~ 167 (181)
+.++++ ++|++.
T Consensus 255 ~~~~~~--h~~~~~ 266 (285)
T cd05630 255 AREVKE--HPLFKQ 266 (285)
T ss_pred hHHHHc--Chhhhc
Confidence 899998 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=188.24 Aligned_cols=160 Identities=26% Similarity=0.377 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.+
T Consensus 115 l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 191 (353)
T cd07850 115 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG 191 (353)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-CCCCCcccccccCHHHHhC
Confidence 467888999999999999999999 9999999999999999999999999987544322 1223456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----------------------CCcc------C------
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----------------------GKRL------E------ 127 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~----------------------~~~~------~------ 127 (181)
..++.++|+||+|+++++|++|+.||...+.......+... .... .
T Consensus 192 ~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
T cd07850 192 MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVL 271 (353)
T ss_pred CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccc
Confidence 88899999999999999999999999876543322221100 0000 0
Q ss_pred -------CCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 128 -------IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 128 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
.+...++.+++++.+||..||.+|||+.++++ ++|++
T Consensus 272 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~--~~~~~ 315 (353)
T cd07850 272 FPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ--HPYIN 315 (353)
T ss_pred cCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc--ChhHh
Confidence 01134567899999999999999999999998 66554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=193.69 Aligned_cols=161 Identities=26% Similarity=0.344 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc---------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--------------------- 60 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--------------------- 60 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (376)
T cd05598 98 FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175 (376)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccc
Confidence 577888999999999999999999 999999999999999999999999986421100
Q ss_pred ----------------------cccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 030203 61 ----------------------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118 (181)
Q Consensus 61 ----------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~ 118 (181)
........|++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+.........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~ 255 (376)
T cd05598 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLK 255 (376)
T ss_pred cccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHH
Confidence 0001123688899999999888889999999999999999999999998887665555
Q ss_pred HhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHhhhC
Q 030203 119 VGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRP---SFSTIMELLRPLIKS 167 (181)
Q Consensus 119 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~L~~~~~~ 167 (181)
+........ ....+++.+.+++.+|+ .+|.+|+ ++.++++ ++|++.
T Consensus 256 i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~--h~~~~~ 306 (376)
T cd05598 256 VINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA--HPFFKG 306 (376)
T ss_pred HhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC--CCCcCC
Confidence 432222222 23468899999999976 5999999 8999998 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=201.64 Aligned_cols=166 Identities=26% Similarity=0.420 Sum_probs=130.9
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc------------------cccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT------------------FLSS 64 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~------------------~~~~ 64 (181)
+...++.++.|++.||.|||++| ++||||||+||+++.++.++++|||++...... ....
T Consensus 111 sv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~ 188 (932)
T PRK13184 111 SVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIP 188 (932)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccC
Confidence 34567889999999999999999 999999999999999999999999998654110 0011
Q ss_pred CCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-cCCCCCCCHHHHHHHHHH
Q 030203 65 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-LEIPRNVNPHVASIIEAC 143 (181)
Q Consensus 65 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 143 (181)
....|++.|+|||.+.+..++.++|+||+||++++|++|..||.................. ......+++.+.+++.+|
T Consensus 189 g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rc 268 (932)
T PRK13184 189 GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKA 268 (932)
T ss_pred CCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHH
Confidence 1245889999999998888899999999999999999999999876554433322111111 111246789999999999
Q ss_pred hcCCCCCCC-CHHHHHHHHHHhhhCCCC
Q 030203 144 WANEPWKRP-SFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 144 l~~~p~~Rp-s~~~~l~~L~~~~~~~~~ 170 (181)
+..||.+|+ +++++++.|+.+++..+.
T Consensus 269 L~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 269 LAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred ccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 999999997 788889999998886543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=192.55 Aligned_cols=161 Identities=26% Similarity=0.397 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------------------- 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------------------- 61 (181)
+++..+..++.|++.||.|||++| ++|+||+|+||+++.+|.++|+|||++.......
T Consensus 98 l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (360)
T cd05627 98 LSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175 (360)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccc
Confidence 578889999999999999999999 9999999999999999999999999875322110
Q ss_pred ---------------ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc
Q 030203 62 ---------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 126 (181)
Q Consensus 62 ---------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 126 (181)
.......|++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+.........+.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~ 255 (360)
T cd05627 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETL 255 (360)
T ss_pred cccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCce
Confidence 00113467889999999988889999999999999999999999999888877666664322222
Q ss_pred CCC--CCCCHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHhhhC
Q 030203 127 EIP--RNVNPHVASIIEACWANEPWKRPS---FSTIMELLRPLIKS 167 (181)
Q Consensus 127 ~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~L~~~~~~ 167 (181)
..+ ..+++.+++++.+++ .||.+|++ +.++++ ++|+++
T Consensus 256 ~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~--hp~f~~ 298 (360)
T cd05627 256 VFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS--HPFFEG 298 (360)
T ss_pred ecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc--CCCCCC
Confidence 223 347899999999977 59999984 788888 777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=186.28 Aligned_cols=164 Identities=26% Similarity=0.385 Sum_probs=123.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-------cCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~ 74 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.+++.||+.......... ......++..|+
T Consensus 98 l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 175 (327)
T cd08227 98 MSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL 175 (327)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceeccc
Confidence 578889999999999999999999 99999999999999999999999875432211100 011224456799
Q ss_pred CCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc---------------------------
Q 030203 75 APEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--------------------------- 125 (181)
Q Consensus 75 ~pe~~~~--~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------------------------- 125 (181)
+||.+.+ ..++.++|+||+|++++++++|+.||..................
T Consensus 176 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T cd08227 176 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLG 255 (327)
T ss_pred ChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCC
Confidence 9999875 34788999999999999999999999875543322221111000
Q ss_pred -----------------cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 126 -----------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 126 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
......+++.+.+++.+||+.||.+|||++++++ +++++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~--~p~f~~~~ 314 (327)
T cd08227 256 ESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN--HSFFKQIK 314 (327)
T ss_pred cccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc--Chhhhhcc
Confidence 0011235678999999999999999999999999 77777644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=178.22 Aligned_cols=159 Identities=35% Similarity=0.648 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.++.|||+.+ ++|+|++|+||+++.++.++++|||.+........ ......++..|.+||..
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~ 175 (260)
T cd06606 98 LPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhh
Confidence 578899999999999999999999 99999999999999999999999998875544322 12334667789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+...+.++|+|++|++++++++|..||.... .......+........++..+++.+.+++.+|+..||.+||++.+++
T Consensus 176 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence 88778899999999999999999999998876 33333333322344556777899999999999999999999999998
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+ ++|
T Consensus 256 ~--~~~ 259 (260)
T cd06606 256 Q--HPF 259 (260)
T ss_pred h--CCC
Confidence 8 544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=180.02 Aligned_cols=163 Identities=31% Similarity=0.571 Sum_probs=134.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.++.+||+++ ++|+||+|.||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 175 (277)
T cd06641 98 LDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhcc
Confidence 568889999999999999999999 999999999999999999999999987644332222233456778999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
...+.++|+||+|++++++++|..||...........+. .......+..++.++.+++.+|+..+|.+||++.++++
T Consensus 176 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~-- 252 (277)
T cd06641 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK-- 252 (277)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh--
Confidence 778889999999999999999999998877665555443 23334455678899999999999999999999999999
Q ss_pred HHhhhCCC
Q 030203 162 RPLIKSPT 169 (181)
Q Consensus 162 ~~~~~~~~ 169 (181)
++++....
T Consensus 253 ~~~~~~~~ 260 (277)
T cd06641 253 HKFIVRFA 260 (277)
T ss_pred CHHHhhhh
Confidence 77776543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=179.70 Aligned_cols=160 Identities=33% Similarity=0.577 Sum_probs=124.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||++........ ..........|++||.
T Consensus 105 l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 182 (284)
T cd05081 105 LDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHH
Confidence 567889999999999999999999 99999999999999999999999998875432211 1111223345899999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhccCCccCCCCCCCHHHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA----------------QVVAAVGFKGKRLEIPRNVNPHVASIIEA 142 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 142 (181)
..+..++.++|+||+|++++++++|..++...... .+.+.+ ........+..++..+.+++.+
T Consensus 183 ~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 261 (284)
T cd05081 183 LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL-KNNGRLPAPPGCPAEIYAIMKE 261 (284)
T ss_pred hccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH-hcCCcCCCCCCCCHHHHHHHHH
Confidence 98888889999999999999999987765433211 111111 1222333456688999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHh
Q 030203 143 CWANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 143 ~l~~~p~~Rps~~~~l~~L~~~ 164 (181)
|+..+|.+|||+.++++.|+.+
T Consensus 262 cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 262 CWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HccCChhhCCCHHHHHHHHHhc
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=178.27 Aligned_cols=155 Identities=32% Similarity=0.585 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++|+|++|.||+++.++ .++++|||.+..............+++.|.+||...
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~ 175 (257)
T cd08225 98 FSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHc
Confidence 578889999999999999999999 99999999999998875 469999998765443322223345677899999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|++++++++|..||...+......... ..........++.++.+++.+|+..+|.+|||+.++++
T Consensus 176 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 7778899999999999999999999998877666555443 33334455667889999999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=181.61 Aligned_cols=156 Identities=24% Similarity=0.332 Sum_probs=124.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+..............++..|.+||...+
T Consensus 95 ~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 95 LPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhc
Confidence 567889999999999999999999 999999999999999999999999987654443222233456678999998876
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc----------------------------cCCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR----------------------------LEIPRNV 132 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~ 132 (181)
. ..+.++|+||+|++++++++|+.||...+..+....+...... ......+
T Consensus 173 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd05118 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNA 252 (283)
T ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhh
Confidence 6 5788999999999999999999999877655443332111000 0112346
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..+.+++.+|+..||.+||++.+++.
T Consensus 253 ~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 253 SPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 789999999999999999999999987
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=179.62 Aligned_cols=164 Identities=27% Similarity=0.529 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.|+.|||++ + ++|+||+|+||+++.++.++++|||.+...... ......++..|++||.+.
T Consensus 99 ~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~ 174 (286)
T cd06622 99 IPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIK 174 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhc
Confidence 57889999999999999999974 8 999999999999999999999999987654322 223345677899999885
Q ss_pred CCC------CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--ccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 81 DEP------SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG--FKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 81 ~~~------~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+.. ++.++|+||+|++++++++|+.||...........+. ........+..+++++.+++.+||..+|.+||
T Consensus 175 ~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (286)
T cd06622 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRP 254 (286)
T ss_pred CCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCC
Confidence 543 3678999999999999999999997665444333221 12333455667899999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCCCC
Q 030203 153 SFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~~~ 171 (181)
++.++++ ++|+......
T Consensus 255 ~~~~l~~--~~~~~~~~~~ 271 (286)
T cd06622 255 TYAQLLE--HPWLVKYKNA 271 (286)
T ss_pred CHHHHhc--ChhhhhccCC
Confidence 9999999 7777654433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=178.18 Aligned_cols=155 Identities=34% Similarity=0.645 Sum_probs=123.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC----CCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS----KSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~----~~~~~~~~~~~pe 77 (181)
+++..+..++.|++.|+.|||+.+ ++|+||++.||+++.++.++++|||.+.......... ....++..|++||
T Consensus 96 ~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE 173 (264)
T cd06626 96 LDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173 (264)
T ss_pred CChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChh
Confidence 567888999999999999999999 9999999999999999999999999876543322111 1234567899999
Q ss_pred ccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCC--CCCHHHHHHHHHHhcCCCCCC
Q 030203 78 VLRDEP---SNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPR--NVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 78 ~~~~~~---~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R 151 (181)
.+.+.. .+.++|+|++|++++++++|+.||...... .....+. .......+. .+++.+.+++.+|++.+|.+|
T Consensus 174 ~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 252 (264)
T cd06626 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKR 252 (264)
T ss_pred hccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccCHHHHHHHHHHccCCcccC
Confidence 987765 788999999999999999999999766433 2222232 222233333 348999999999999999999
Q ss_pred CCHHHHHH
Q 030203 152 PSFSTIME 159 (181)
Q Consensus 152 ps~~~~l~ 159 (181)
|++.+++.
T Consensus 253 ~~~~~i~~ 260 (264)
T cd06626 253 PTASELLQ 260 (264)
T ss_pred CCHHHHhc
Confidence 99999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=182.11 Aligned_cols=156 Identities=24% Similarity=0.311 Sum_probs=124.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++..............++..|++||.+.+
T Consensus 103 l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 180 (293)
T cd07843 103 FLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG 180 (293)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcC
Confidence 678899999999999999999999 999999999999999999999999988755443222233456778999998876
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-----------------------------CccCCCCC
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-----------------------------KRLEIPRN 131 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 131 (181)
.. .+.++|+||+|+++++|++|..||..........++.... .....+..
T Consensus 181 ~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (293)
T cd07843 181 AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL 260 (293)
T ss_pred CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccccc
Confidence 44 5788999999999999999999998776554433321100 00111222
Q ss_pred -CCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 132 -VNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 132 -~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+++.+.+++.+||+.+|.+|||+.++++
T Consensus 261 ~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 261 SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 5888999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=180.64 Aligned_cols=159 Identities=25% Similarity=0.441 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.|||+.+ ++|+||+|.||+++.++.++++|||.+...... ......++..|++||.+.+
T Consensus 94 l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 169 (278)
T cd05606 94 FSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQK 169 (278)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcC
Confidence 678999999999999999999999 999999999999999999999999987643322 2233467889999999864
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP----- 152 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 152 (181)
. .++.++|+||+|+++++|++|+.||.... ........ .......+..+++.+.+++.+|+..+|.+||
T Consensus 170 ~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~ 247 (278)
T cd05606 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGR 247 (278)
T ss_pred CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCC
Confidence 4 57889999999999999999999997763 22222222 3334556677899999999999999999999
Q ss_pred CHHHHHHHHHHhhhCC
Q 030203 153 SFSTIMELLRPLIKSP 168 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~ 168 (181)
++.++++ +++++..
T Consensus 248 ~~~~ll~--~~~~~~~ 261 (278)
T cd05606 248 GAQEVKE--HPFFRSL 261 (278)
T ss_pred CHHHHHh--CccccCC
Confidence 9999998 7776654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=176.96 Aligned_cols=153 Identities=32% Similarity=0.547 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++++++.++.|++.||.+||+.| ++|+||+|.||+++.++.++++|||.+...... ......++..|.+||...+
T Consensus 100 ~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 100 IPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCC
Confidence 567888999999999999999999 999999999999999999999999988655443 2223456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..++.++|+||+|++++++++|+.||...+.......+. .......+..++.++.+++.+|+..+|.+||++.++++
T Consensus 176 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 888889999999999999999999999888776666554 33333455578899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=178.98 Aligned_cols=155 Identities=31% Similarity=0.526 Sum_probs=126.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++..+..++.|++.||.+||+++ ++|+||+|.||+++.++.++++|||.+....... .......++..|++||.
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 180 (265)
T cd06652 103 LTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhh
Confidence 467788999999999999999999 9999999999999999999999999876432211 11222346778999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
..+...+.++|+||+|+++|++++|+.||.....................+..++..+.+++.+|+ .+|.+||++++++
T Consensus 181 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il 259 (265)
T cd06652 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELL 259 (265)
T ss_pred hcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHh
Confidence 988778899999999999999999999998776555444443333344456677889999999999 5999999999998
Q ss_pred H
Q 030203 159 E 159 (181)
Q Consensus 159 ~ 159 (181)
+
T Consensus 260 ~ 260 (265)
T cd06652 260 R 260 (265)
T ss_pred c
Confidence 7
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=184.02 Aligned_cols=173 Identities=24% Similarity=0.294 Sum_probs=135.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--------------cccCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--------------FLSSKSA 67 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~ 67 (181)
++++.+..++.|++.||.+||+.+ ++|+||+++||+++.++.++++|||.+...... .......
T Consensus 116 ~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (335)
T PTZ00024 116 LTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193 (335)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccccc
Confidence 577889999999999999999999 999999999999999999999999987644311 1111223
Q ss_pred CCCCCccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--c-------------------
Q 030203 68 AGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--R------------------- 125 (181)
Q Consensus 68 ~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~------------------- 125 (181)
.++..|++||.+.+.. ++.++|+||+|++++++++|+.||.+.+.......+..... .
T Consensus 194 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
T PTZ00024 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR 273 (335)
T ss_pred ccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcC
Confidence 4466899999887643 58899999999999999999999988776554433311000 0
Q ss_pred -----cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCCCCCCCC
Q 030203 126 -----LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 178 (181)
Q Consensus 126 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~~~~~~~ 178 (181)
.......+..+.+++.+|++.+|.+||++++++. ++|++..+.+..+.+.|
T Consensus 274 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~--~~~~~~~~~~~~~~~~~ 329 (335)
T PTZ00024 274 KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK--HEYFKSDPLPCDPSQLP 329 (335)
T ss_pred CcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc--CcccCCCCCCCCcccCC
Confidence 0011345788999999999999999999999999 99999877776665555
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=179.73 Aligned_cols=157 Identities=23% Similarity=0.458 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++++++..++.|++.||.+||+.+ ++|+||+|.||+++.++ .++++|||.+...... ....++..|++||.+.
T Consensus 106 l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~ 179 (267)
T PHA03390 106 LSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIK 179 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhc
Confidence 578999999999999999999999 99999999999999888 9999999987644322 2235677899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-HHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-FSTI 157 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~~ 157 (181)
+..++.++|+||+|++++++++|..||........ .............+..+++.+.+++.+||+.+|.+||+ ++++
T Consensus 180 ~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 259 (267)
T PHA03390 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEI 259 (267)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence 88888999999999999999999999976543321 11111112233445578999999999999999999995 6999
Q ss_pred HHHHHHhhh
Q 030203 158 MELLRPLIK 166 (181)
Q Consensus 158 l~~L~~~~~ 166 (181)
++ ++|++
T Consensus 260 l~--h~~~~ 266 (267)
T PHA03390 260 IK--HPFLK 266 (267)
T ss_pred hc--CCccc
Confidence 98 77764
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=180.67 Aligned_cols=156 Identities=22% Similarity=0.358 Sum_probs=124.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.|+.|||+++ ++|+|++|+||+++.++.++++|||.+........ ......++..|++||.+.
T Consensus 97 ~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 174 (288)
T cd07833 97 LPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhc
Confidence 467899999999999999999999 99999999999999999999999998875444322 223345667899999998
Q ss_pred CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC------------------------------ccCCC
Q 030203 81 DE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK------------------------------RLEIP 129 (181)
Q Consensus 81 ~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~ 129 (181)
+. .++.++|+||+|++++++++|+.||.+....+....+..... ....+
T Consensus 175 ~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (288)
T cd07833 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYP 254 (288)
T ss_pred CCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcC
Confidence 87 678899999999999999999999987655433322211000 00123
Q ss_pred CCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 130 RNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 130 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..+++++.+++.+||..+|.+||+++++++
T Consensus 255 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 255 GKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 345888999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=181.79 Aligned_cols=160 Identities=26% Similarity=0.479 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.+++.++.|++.++.|||++| ++|+||+|.||+++.++.++++|||.+..... .....++..|++||.+.
T Consensus 118 l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~ 191 (313)
T cd06633 118 LQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANSFVGTPYWMAPEVILA 191 (313)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----CCCccccccccChhhccc
Confidence 567889999999999999999999 99999999999999999999999998753221 12345677899999874
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
...++.++|+||+|+++++|++|..||...+.......+............++..+++++.+|++.+|.+||++.+++
T Consensus 192 ~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 345678899999999999999999999887766555555433333333445778899999999999999999999999
Q ss_pred HHHHHhhhCCC
Q 030203 159 ELLRPLIKSPT 169 (181)
Q Consensus 159 ~~L~~~~~~~~ 169 (181)
+ +++++..+
T Consensus 272 ~--~~~~~~~~ 280 (313)
T cd06633 272 R--HDFVRRDR 280 (313)
T ss_pred c--CcccCCCc
Confidence 8 77777644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=183.16 Aligned_cols=157 Identities=25% Similarity=0.464 Sum_probs=136.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|+|.++.++++||.+|+.|+|.++ ++|+|++.+||++|.++++|+.|||++-.+..... .++..|++.|.+||+..+
T Consensus 150 LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf-LqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 150 LSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF-LQTFCGSPLYASPEIVNG 226 (668)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccccH-HHHhcCCcccCCccccCC
Confidence 688999999999999999999999 99999999999999999999999999876655432 346788999999999999
Q ss_pred CCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..| .+.+|.||||+++|.++.|..||++.+-..+..++.....+.+ .-+.+...||.+||..||.+|.|+.++..
T Consensus 227 ~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAs- 302 (668)
T KOG0611|consen 227 TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIAS- 302 (668)
T ss_pred CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhh-
Confidence 887 4689999999999999999999999998888888864444322 34567899999999999999999999998
Q ss_pred HHHhhh
Q 030203 161 LRPLIK 166 (181)
Q Consensus 161 L~~~~~ 166 (181)
+.|+.
T Consensus 303 -HWWvN 307 (668)
T KOG0611|consen 303 -HWWVN 307 (668)
T ss_pred -hheee
Confidence 55543
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=182.05 Aligned_cols=164 Identities=27% Similarity=0.506 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.|||+++ ++|+|++|+||+++.++.++++|||++..............+++.|++||.+.+
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 189 (293)
T cd06647 112 MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189 (293)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhcc
Confidence 467888999999999999999999 999999999999999999999999987543332222233456778999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|+++|++++|+.||...+.......+.... .....+..++..+.+++.+||..+|.+||++++++.
T Consensus 190 ~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~- 268 (293)
T cd06647 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ- 268 (293)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc-
Confidence 778889999999999999999999998776544332222111 112233456788999999999999999999999999
Q ss_pred HHHhhhCCC
Q 030203 161 LRPLIKSPT 169 (181)
Q Consensus 161 L~~~~~~~~ 169 (181)
+++++...
T Consensus 269 -h~~~~~~~ 276 (293)
T cd06647 269 -HPFLKIAK 276 (293)
T ss_pred -CHHHhcCc
Confidence 88888655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=178.03 Aligned_cols=158 Identities=30% Similarity=0.476 Sum_probs=129.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||++..... .....++..|++||...+
T Consensus 94 ~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~ 167 (260)
T cd05611 94 LPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILG 167 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcC
Confidence 578899999999999999999999 99999999999999999999999998764332 223356678999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--ccCCCCCCCHHHHHHHHHHhcCCCCCCCCH---HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSF---ST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~ 156 (181)
..++.++|+|++|++++++++|..||...+.......+..... .......+++.+.+++.+||..+|.+||++ .+
T Consensus 168 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 7788999999999999999999999988877766555532222 222334678999999999999999999965 56
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ +++++.
T Consensus 248 ~l~--~~~~~~ 256 (260)
T cd05611 248 IKS--HPFFKS 256 (260)
T ss_pred HHc--ChHhhc
Confidence 665 566654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=191.83 Aligned_cols=159 Identities=24% Similarity=0.342 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC--CCcEEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
|+...+..++.||+.||.+||+.+ |+|+||||+||++.. ...+|++|||.++....... +-+.+..|.|||++
T Consensus 286 lsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVI 360 (586)
T KOG0667|consen 286 LSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVI 360 (586)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccccCCcce---eeeeccccccchhh
Confidence 466788999999999999999999 999999999999954 34799999999976655433 45667799999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCcc--------------------------------
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGKRL-------------------------------- 126 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~-------------------------------- 126 (181)
.|.+|+.+.|+|||||+++||.+|.+-|.+.+..+.+..+.. .+.+.
T Consensus 361 LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~ 440 (586)
T KOG0667|consen 361 LGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRG 440 (586)
T ss_pred ccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeeccccc
Confidence 999999999999999999999999999999988776665410 00000
Q ss_pred -----------------CCC-----------CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 127 -----------------EIP-----------RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 127 -----------------~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
..| ..-...+.+++.+||..||.+|+|..++++ |++++.
T Consensus 441 ~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~--Hpfl~~ 507 (586)
T KOG0667|consen 441 TKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN--HPFLTG 507 (586)
T ss_pred ccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc--Cccccc
Confidence 011 011235789999999999999999999999 999883
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=180.43 Aligned_cols=156 Identities=24% Similarity=0.330 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 96 ~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 173 (283)
T cd07835 96 LDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 173 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeec
Confidence 578899999999999999999999 999999999999999999999999998654332222233355678999998765
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---------------------------CccCCCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG---------------------------KRLEIPRNVN 133 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~ 133 (181)
. .++.++|+||+|+++|++++|+.||...+.......+.... ........++
T Consensus 174 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (283)
T cd07835 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLD 253 (283)
T ss_pred CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCC
Confidence 4 36789999999999999999999998776543322211000 0001224567
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..+.+++.+|++.+|.+||++.++++
T Consensus 254 ~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 254 EDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 88999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=179.31 Aligned_cols=156 Identities=34% Similarity=0.543 Sum_probs=125.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc----CCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS----SKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~~~~~~pe 77 (181)
+++..+..++.|++.|+.+||+++ ++|+|++|+||+++.++.++++|||++......... .....++..|++||
T Consensus 99 ~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe 176 (267)
T cd06610 99 LDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChH
Confidence 578889999999999999999999 999999999999999999999999987644432211 12335677899999
Q ss_pred ccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCC---CCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 78 VLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEI---PRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 78 ~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
.+... .++.++|+||+|+++++|++|+.||................. .... ...+++.+.+++.+|+..||.+||
T Consensus 177 ~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 256 (267)
T cd06610 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRP 256 (267)
T ss_pred HHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCc
Confidence 88766 678899999999999999999999987765544443322211 1111 135778999999999999999999
Q ss_pred CHHHHHH
Q 030203 153 SFSTIME 159 (181)
Q Consensus 153 s~~~~l~ 159 (181)
++.++++
T Consensus 257 ~~~~ll~ 263 (267)
T cd06610 257 TAEELLK 263 (267)
T ss_pred CHHHHhh
Confidence 9999988
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-28 Score=180.94 Aligned_cols=155 Identities=27% Similarity=0.487 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.++..++.|++.|+.|||+++ ++|+||+|.||+++.++.++++|||++..... .....++..|++||.+.
T Consensus 122 l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~ 195 (317)
T cd06635 122 LQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILA 195 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC----cccccCCccccChhhhhc
Confidence 578889999999999999999999 99999999999999999999999998754322 22345677899999873
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
...++.++|+||+|+++++|++|..||...........+............+++.+.+++.+|++.+|.+||++.+++
T Consensus 196 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred CCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHH
Confidence 345788999999999999999999999887665555555433333334456788999999999999999999999999
Q ss_pred HHHH
Q 030203 159 ELLR 162 (181)
Q Consensus 159 ~~L~ 162 (181)
+...
T Consensus 276 ~~~~ 279 (317)
T cd06635 276 KHMF 279 (317)
T ss_pred hChh
Confidence 8433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=180.86 Aligned_cols=164 Identities=26% Similarity=0.524 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..++.++.|++.|+.|||++ + ++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.
T Consensus 100 ~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 176 (283)
T cd06617 100 IPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERIN 176 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhhcC
Confidence 57889999999999999999998 8 9999999999999999999999999986543321 112245677899999875
Q ss_pred C----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccCCccCC-CCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 81 D----EPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKGKRLEI-PRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 81 ~----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
+ ..++.++|+|++|+++++|++|+.||..... ........ ....... ...++.++.+++.+||..+|.+||++
T Consensus 177 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~ 255 (283)
T cd06617 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNY 255 (283)
T ss_pred CcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccCHHHHHHHHHHccCChhhCcCH
Confidence 4 3457889999999999999999999975322 12222221 2222222 23578999999999999999999999
Q ss_pred HHHHHHHHHhhhCCCCC
Q 030203 155 STIMELLRPLIKSPTPQ 171 (181)
Q Consensus 155 ~~~l~~L~~~~~~~~~~ 171 (181)
.++++ ++|++....+
T Consensus 256 ~~il~--~~~~~~~~~~ 270 (283)
T cd06617 256 PELLQ--HPFFELHLSK 270 (283)
T ss_pred HHHhc--Cchhhhcccc
Confidence 99999 7887765433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=183.81 Aligned_cols=164 Identities=25% Similarity=0.363 Sum_probs=130.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.+||++| ++|+||+|.||+++.++.++++|||.+....... .......++..|++||.
T Consensus 100 l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 177 (330)
T cd07834 100 LTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCcee
Confidence 578889999999999999999999 9999999999999999999999999987654432 11233456778999999
Q ss_pred cCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-----------------------------cCC
Q 030203 79 LRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-----------------------------LEI 128 (181)
Q Consensus 79 ~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~ 128 (181)
+.+. ..+.++|+||+|+++++|++|..||.+.........+...... ...
T Consensus 178 ~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
T cd07834 178 LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKL 257 (330)
T ss_pred eecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHh
Confidence 9877 6888999999999999999999999887655433332111000 001
Q ss_pred CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 129 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
...+++.+.+++.+||+.+|.+||++.++++ ++|++...
T Consensus 258 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~~~~~~~~ 296 (330)
T cd07834 258 FPGASPEAIDLLEKMLVFDPKKRITADEALA--HPYLAQLH 296 (330)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh--CccHHhhc
Confidence 2346788999999999999999999999998 77776433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=178.57 Aligned_cols=158 Identities=32% Similarity=0.547 Sum_probs=124.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++.++..++.|++.|+.|||+++ ++|+||+|.||+++. ++.++++|||.+..............++..|++||....
T Consensus 106 ~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 183 (268)
T cd06624 106 NEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183 (268)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhcc
Confidence 56778889999999999999999 999999999999976 678999999987644332222233456788999998765
Q ss_pred CC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 82 EP--SNEKSDIYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 82 ~~--~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.. ++.++|+||+|++++++++|..||....... .............++..+++++.+++.+||+.+|.+|||+.+++
T Consensus 184 ~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263 (268)
T ss_pred ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence 33 6789999999999999999999997654322 22222222333456677889999999999999999999999998
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+ ++|
T Consensus 264 ~--~~~ 267 (268)
T cd06624 264 Q--DPF 267 (268)
T ss_pred h--CCC
Confidence 8 544
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=180.66 Aligned_cols=159 Identities=25% Similarity=0.441 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++...... ......++..|++||....
T Consensus 94 l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 94 FSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQK 169 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcC
Confidence 678899999999999999999999 999999999999999999999999987543322 1223467889999998763
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----C
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----S 153 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 153 (181)
..++.++|+||+|++++++++|..||...... ....... .......+..+++++.+++.+||..||.+|+ +
T Consensus 170 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 248 (279)
T cd05633 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRG 248 (279)
T ss_pred CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence 45788999999999999999999999754321 1121111 2233456677899999999999999999999 5
Q ss_pred HHHHHHHHHHhhhC
Q 030203 154 FSTIMELLRPLIKS 167 (181)
Q Consensus 154 ~~~~l~~L~~~~~~ 167 (181)
++++++ +++++.
T Consensus 249 ~~~~~~--h~~~~~ 260 (279)
T cd05633 249 AQEVKE--HVFFKG 260 (279)
T ss_pred HHHHHh--CccccC
Confidence 999998 666554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=176.50 Aligned_cols=155 Identities=30% Similarity=0.586 Sum_probs=130.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..++.++.|++.++.+||+.| ++|+||+|+||+++.++.++++|||.+..............++..|++||...+
T Consensus 96 l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 173 (254)
T cd06627 96 FPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173 (254)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcC
Confidence 578889999999999999999999 999999999999999999999999988765543332333456778999999887
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...+.++|+|++|++++++++|..||............. .......+..++..+.+++.+||..+|++||++.+++.
T Consensus 174 ~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 778889999999999999999999998776554444433 23344566778999999999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=180.50 Aligned_cols=160 Identities=31% Similarity=0.462 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+...... .......++..|++||...+
T Consensus 92 ~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~~PE~~~~ 168 (277)
T cd05577 92 FPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQG 168 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCCcCCHHHhcC
Confidence 578889999999999999999999 999999999999999999999999987643321 12233456678999999888
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--ccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG--FKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SF 154 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~ 154 (181)
..++.++|+||+|++++++++|+.||...........+. ........+..+++.+.+++.+||+.+|.+|| ++
T Consensus 169 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 248 (277)
T cd05577 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSA 248 (277)
T ss_pred CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccH
Confidence 778889999999999999999999997765421111111 12233445667899999999999999999999 77
Q ss_pred HHHHHHHHHhhh
Q 030203 155 STIMELLRPLIK 166 (181)
Q Consensus 155 ~~~l~~L~~~~~ 166 (181)
.++++ ++|++
T Consensus 249 ~~ll~--h~~~~ 258 (277)
T cd05577 249 DEVRE--HPLFK 258 (277)
T ss_pred HHHHh--Chhhh
Confidence 77877 66654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=179.34 Aligned_cols=154 Identities=23% Similarity=0.322 Sum_probs=121.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+.+ ++|+||+|.||+++. +.++++|||.+........ .....++..|++||....
T Consensus 97 ~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~ 172 (282)
T cd07831 97 LPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLLT 172 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCCCCCCcccCChhHhhc
Confidence 578899999999999999999999 999999999999999 9999999998865433221 122346778999997644
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC----------------CccC-----------CCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG----------------KRLE-----------IPRNVN 133 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~----------------~~~~-----------~~~~~~ 133 (181)
..++.++|+||+|+++++|++|..||.+.+..+....+.... .... ....++
T Consensus 173 ~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd07831 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNAS 252 (282)
T ss_pred CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHccccc
Confidence 446789999999999999999999998876544333221100 0000 112467
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..+.+++.+||..+|.+||++.++++
T Consensus 253 ~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 253 AEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHHhccCcccccCHHHHhh
Confidence 89999999999999999999999988
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=176.38 Aligned_cols=151 Identities=26% Similarity=0.489 Sum_probs=120.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-------cEEEcccCCccccccccccCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-------TVKVCDFGLSRLKANTFLSSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 74 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++++|||++..... .....+...|+
T Consensus 98 ~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~ 171 (259)
T cd05037 98 VSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWI 171 (259)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCcc
Confidence 567889999999999999999999 99999999999998877 799999998765433 22234556799
Q ss_pred CCcccCCC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 75 APEVLRDE--PSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 75 ~pe~~~~~--~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
+||.+.+. .++.++|+||+|++++++++ |..||............. .....+......+.+++.+||..+|.+|
T Consensus 172 aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R 248 (259)
T cd05037 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLPMPDCAELANLINQCWTYDPTKR 248 (259)
T ss_pred ChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCCCCCCchHHHHHHHHHhccChhhC
Confidence 99998776 67889999999999999999 577887765433333222 1122223334789999999999999999
Q ss_pred CCHHHHHHHH
Q 030203 152 PSFSTIMELL 161 (181)
Q Consensus 152 ps~~~~l~~L 161 (181)
|++.++++.|
T Consensus 249 pt~~~il~~l 258 (259)
T cd05037 249 PSFRAILRDL 258 (259)
T ss_pred CCHHHHHHhc
Confidence 9999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=175.97 Aligned_cols=155 Identities=33% Similarity=0.609 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+........ .....++..|++||...+
T Consensus 95 ~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~ 171 (253)
T cd05122 95 LTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVING 171 (253)
T ss_pred CCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcC
Confidence 578889999999999999999999 99999999999999999999999998765444321 233456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...+.++|+|++|++++++++|..||................. .......++..+.+++.+|+..||.+|||+.++++
T Consensus 172 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 7788899999999999999999999988755554444432211 22223334889999999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=180.52 Aligned_cols=164 Identities=28% Similarity=0.523 Sum_probs=126.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......... ....++..|++||.+.
T Consensus 111 l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~ 187 (296)
T cd06618 111 IPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-TRSAGCAAYMAPERID 187 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-cCCCCCccccCHhhcC
Confidence 5778889999999999999997 48 999999999999999999999999987654332211 2234567899999886
Q ss_pred CCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 81 DEP----SNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 81 ~~~----~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
+.. ++.++|+||+|+++|+|++|+.||...... +....+.... ...+....++.++.+++.+|+..||.+||++
T Consensus 188 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~ 267 (296)
T cd06618 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKY 267 (296)
T ss_pred CCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 543 678899999999999999999999764332 2222222111 1222223478899999999999999999999
Q ss_pred HHHHHHHHHhhhCCCC
Q 030203 155 STIMELLRPLIKSPTP 170 (181)
Q Consensus 155 ~~~l~~L~~~~~~~~~ 170 (181)
.++++ ++|++...+
T Consensus 268 ~~il~--~~~~~~~~~ 281 (296)
T cd06618 268 RELLQ--HPFIRRYET 281 (296)
T ss_pred HHHhc--Chhhhccch
Confidence 99998 777765443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=191.46 Aligned_cols=161 Identities=27% Similarity=0.483 Sum_probs=139.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+.|.++..|+.+.+.||.|||+.+ .+|+|||..||+++..|.+||+|||.+..... ..+.+|+|.|+|||++.
T Consensus 123 lqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----AnsFvGTPywMAPEVILA 196 (948)
T KOG0577|consen 123 LQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANSFVGTPYWMAPEVILA 196 (948)
T ss_pred chHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc----hhcccCCccccchhHhee
Confidence 467899999999999999999999 99999999999999999999999998754332 35679999999999885
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.++|+.++||||||+++.++...++|....+-...+.-+..+..+--....|+..|++|++.||..-|.+|||..+++
T Consensus 197 MDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 197 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred ccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 356899999999999999999999999888877777777655554444678999999999999999999999999999
Q ss_pred HHHHHhhhCCCC
Q 030203 159 ELLRPLIKSPTP 170 (181)
Q Consensus 159 ~~L~~~~~~~~~ 170 (181)
+ +.++....+
T Consensus 277 ~--H~fv~R~Rp 286 (948)
T KOG0577|consen 277 K--HRFVLRERP 286 (948)
T ss_pred h--cchhccCCC
Confidence 9 777665443
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=181.33 Aligned_cols=161 Identities=27% Similarity=0.501 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+ .+ ++|+||+|.||+++.++.++++|||++....... .....++..|++||.+.
T Consensus 96 ~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~ 171 (308)
T cd06615 96 IPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ 171 (308)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc--cccCCCCcCccChhHhc
Confidence 4678889999999999999998 58 9999999999999999999999999876433221 23346678999999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-----------------------------------c
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-----------------------------------R 125 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------~ 125 (181)
+..++.++|+||+|++++++++|..||...+............. .
T Consensus 172 ~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (308)
T cd06615 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPP 251 (308)
T ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCC
Confidence 87788899999999999999999999976554433322211100 0
Q ss_pred cCCC-CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 126 LEIP-RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 126 ~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
...+ ..++.++++++.+|+..+|.+||++.++++ ++|+...
T Consensus 252 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~~~~~~~ 293 (308)
T cd06615 252 PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK--HPFIKRA 293 (308)
T ss_pred ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhhc
Confidence 0111 136778999999999999999999999999 8887653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=193.53 Aligned_cols=159 Identities=32% Similarity=0.646 Sum_probs=139.5
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccCCCC
Q 030203 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDEP 83 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~ 83 (181)
.....+++||+.|+.|||+.+ +|||||...||++..+..+||+|||+++..... ........-...|++||.+..++
T Consensus 491 ~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRr 568 (974)
T KOG4257|consen 491 RTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRR 568 (974)
T ss_pred HHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhc
Confidence 345678999999999999999 999999999999999999999999999865543 22233334456899999999999
Q ss_pred CCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 030203 84 SNEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162 (181)
Q Consensus 84 ~~~~~Dv~slG~~~~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~ 162 (181)
++.++|||.||+++|+++ .|..||.+....+.+-.+. ++.+.+.|.++++.+..+..+||+.+|.+||++.++...|+
T Consensus 569 FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 569 FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 999999999999999988 5999999988877776665 77788999999999999999999999999999999999999
Q ss_pred Hhhh
Q 030203 163 PLIK 166 (181)
Q Consensus 163 ~~~~ 166 (181)
++++
T Consensus 648 dv~q 651 (974)
T KOG4257|consen 648 DVLQ 651 (974)
T ss_pred HHHH
Confidence 8877
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=180.40 Aligned_cols=166 Identities=23% Similarity=0.331 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++. ++.++++|||.+..............++..|++||.+.
T Consensus 99 ~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 176 (294)
T PLN00009 99 KNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176 (294)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHh
Confidence 356778899999999999999999 999999999999985 56789999998865443322233345677899999876
Q ss_pred CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCc--------------------------cCCCCCC
Q 030203 81 DE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGKR--------------------------LEIPRNV 132 (181)
Q Consensus 81 ~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~ 132 (181)
+. .++.++|+||+|++++++++|..||..........+... .... ......+
T Consensus 177 ~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (294)
T PLN00009 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTL 256 (294)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCC
Confidence 64 467899999999999999999999987655433332210 0000 0012356
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
++.+.+++.+|++.+|.+||++.++++ ++|++....+
T Consensus 257 ~~~~~~~i~~~l~~~P~~Rps~~~~l~--~~~~~~~~~~ 293 (294)
T PLN00009 257 EPAGVDLLSKMLRLDPSKRITARAALE--HEYFKDLGDA 293 (294)
T ss_pred ChHHHHHHHHHccCChhhCcCHHHHhc--CchHhHHhcC
Confidence 888999999999999999999999999 8888765543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=177.31 Aligned_cols=151 Identities=24% Similarity=0.432 Sum_probs=120.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc--------EEEcccCCccccccccccCCCCCCCCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--------VKVCDFGLSRLKANTFLSSKSAAGTPEW 73 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~--------~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 73 (181)
+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++. ++++|||.+...... ....++..|
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y 170 (258)
T cd05078 97 INISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK----EILLERIPW 170 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccccCCc----hhccccCCc
Confidence 577888999999999999999999 999999999999977654 689999987543321 223456789
Q ss_pred cCCcccCCC-CCCCchhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 74 MAPEVLRDE-PSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 74 ~~pe~~~~~-~~~~~~Dv~slG~~~~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
++||.+.+. .++.++|+||+|+++|++++|. .|+............ ......+...+.++.+++.+||+.||.+|
T Consensus 171 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (258)
T cd05078 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---EDRHQLPAPKWTELANLINQCMDYEPDFR 247 (258)
T ss_pred cCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---HccccCCCCCcHHHHHHHHHHhccChhhC
Confidence 999998764 4688999999999999999984 566665544433222 22344566677899999999999999999
Q ss_pred CCHHHHHHHH
Q 030203 152 PSFSTIMELL 161 (181)
Q Consensus 152 ps~~~~l~~L 161 (181)
||++++++.|
T Consensus 248 ps~~~il~~l 257 (258)
T cd05078 248 PSFRAIIRDL 257 (258)
T ss_pred CCHHHHHHhc
Confidence 9999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=168.24 Aligned_cols=150 Identities=23% Similarity=0.350 Sum_probs=117.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ +|+||+++.++.+++ ||.+...... ...+++.|+|||.+.+
T Consensus 14 l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~~~y~aPE~~~~ 78 (176)
T smart00750 14 LNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVDPYFMAPEVIQG 78 (176)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCCCcccccChHHhcC
Confidence 689999999999999999999995 899999999999998 9987654332 2256789999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCcc-----CCCCCCCH--HHHHHHHHHhcCCCCCCCC
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRL-----EIPRNVNP--HVASIIEACWANEPWKRPS 153 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~--~~~~li~~~l~~~p~~Rps 153 (181)
..++.++||||+|+++|+|++|+.||...... .....+....... ..+..++. .+.+++.+|+..+|.+||+
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~ 158 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA 158 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC
Confidence 88999999999999999999999999765432 2222221111111 11223333 6999999999999999999
Q ss_pred HHHHHHHHHHhhh
Q 030203 154 FSTIMELLRPLIK 166 (181)
Q Consensus 154 ~~~~l~~L~~~~~ 166 (181)
+.++++.+.....
T Consensus 159 ~~~ll~~~~~~~~ 171 (176)
T smart00750 159 ANHYLAHCRALFA 171 (176)
T ss_pred HHHHHHHHHHHHH
Confidence 9999997765543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=175.09 Aligned_cols=154 Identities=29% Similarity=0.460 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.|+.++|+.+ ++|+||+|.||+++.++.++++|||.+..............++..|++||...+
T Consensus 90 l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 167 (250)
T cd05123 90 FSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG 167 (250)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCC
Confidence 578899999999999999999999 999999999999999999999999987654433222334456778999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH---HHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF---STIM 158 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~~l 158 (181)
...+.++|+|++|++++++++|..||...+.......+.. .....+...+..+.+++.+|+..||.+||++ .+++
T Consensus 168 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~ 245 (250)
T cd05123 168 KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIK 245 (250)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence 7788899999999999999999999988876665555532 4455677789999999999999999999999 5655
Q ss_pred H
Q 030203 159 E 159 (181)
Q Consensus 159 ~ 159 (181)
+
T Consensus 246 ~ 246 (250)
T cd05123 246 A 246 (250)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=179.83 Aligned_cols=155 Identities=32% Similarity=0.531 Sum_probs=137.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
.|+|....-+..+|+.||.|||+++ |++||+|.+|.+++.+|++|+.|||+++..........+..|++.|+|||++.
T Consensus 264 ~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVle 341 (516)
T KOG0690|consen 264 VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE 341 (516)
T ss_pred cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhc
Confidence 3678888889999999999999999 99999999999999999999999999987666666677889999999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFS 155 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ 155 (181)
+..|..++|.|.+|+++|+|++|+.||...+...+.+-+. -.....|..++++.+.|+..+|..||++|. .++
T Consensus 342 DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDak 419 (516)
T KOG0690|consen 342 DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--MEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAK 419 (516)
T ss_pred cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHH
Confidence 9999999999999999999999999999888777776653 334556888999999999999999999997 356
Q ss_pred HHHH
Q 030203 156 TIME 159 (181)
Q Consensus 156 ~~l~ 159 (181)
++.+
T Consensus 420 Ei~~ 423 (516)
T KOG0690|consen 420 EIMR 423 (516)
T ss_pred HHHh
Confidence 6655
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=178.81 Aligned_cols=160 Identities=32% Similarity=0.595 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++.++..++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||.+........ ......+...|.+||.
T Consensus 106 ~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~ 183 (284)
T cd05038 106 INLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183 (284)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHH
Confidence 577889999999999999999999 99999999999999999999999998875442211 1112233456999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhccCCccCCCCCCCHHHHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA---------------QVVAAVGFKGKRLEIPRNVNPHVASIIEAC 143 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 143 (181)
..+..++.++|+||+|+++++|++|..|+...... .....+. .......+..++..+.+++.+|
T Consensus 184 ~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c 262 (284)
T cd05038 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK-EGERLPRPPSCPDEVYDLMKLC 262 (284)
T ss_pred HccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH-cCCcCCCCccCCHHHHHHHHHH
Confidence 88888889999999999999999999888654221 1222222 2223334556788999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHh
Q 030203 144 WANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~ 164 (181)
+..+|.+||++.+++++|+.+
T Consensus 263 l~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 263 WEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred hccChhhCCCHHHHHHHHhhc
Confidence 999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=180.91 Aligned_cols=158 Identities=27% Similarity=0.472 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.++..++.|++.|+.|||+++ ++|+||+|.||+++.++.++++|||++...... ....++..|++||.+.
T Consensus 112 l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~ 185 (308)
T cd06634 112 LQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILA 185 (308)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc----ccccCCccccCHHHHhh
Confidence 577889999999999999999999 999999999999999999999999987543321 2335667899999874
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
....+.++|+||+|++++++++|..||...+.......+............++..+.+++.+||..+|.+||++.+++
T Consensus 186 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll 265 (308)
T cd06634 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (308)
T ss_pred cccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHh
Confidence 244678999999999999999999999877655544444323332223446888999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+ +.++..
T Consensus 266 ~--~~~~~~ 272 (308)
T cd06634 266 K--HRFVLR 272 (308)
T ss_pred h--Cccccc
Confidence 8 566555
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-28 Score=176.45 Aligned_cols=151 Identities=22% Similarity=0.416 Sum_probs=118.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc-------EEEcccCCccccccccccCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-------VKVCDFGLSRLKANTFLSSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~-------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 74 (181)
+++..++.++.|++.|+.|||+++ ++|+||+|.||+++.++. ++++|||.+...... ....++..|+
T Consensus 102 ~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~ 175 (262)
T cd05077 102 LTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWI 175 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc----cccccccccc
Confidence 577889999999999999999999 999999999999976653 899999987543221 2235667899
Q ss_pred CCcccC-CCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 75 APEVLR-DEPSNEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 75 ~pe~~~-~~~~~~~~Dv~slG~~~~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
|||.+. +..++.++|+||+|+++|+|+ .|..||............ ..........++++.+++.+||+.||.+||
T Consensus 176 aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 252 (262)
T cd05077 176 APECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCMLVTPSCKELADLMTHCMNYDPNQRP 252 (262)
T ss_pred ChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCccCCCCChHHHHHHHHHHcCCChhhCc
Confidence 999886 455788999999999999998 588888776544332211 111222334567899999999999999999
Q ss_pred CHHHHHHHH
Q 030203 153 SFSTIMELL 161 (181)
Q Consensus 153 s~~~~l~~L 161 (181)
++.++++.|
T Consensus 253 ~~~~il~~~ 261 (262)
T cd05077 253 FFRAIMRDI 261 (262)
T ss_pred CHHHHHHhc
Confidence 999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=184.50 Aligned_cols=162 Identities=25% Similarity=0.395 Sum_probs=126.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++..............++..|++||.+..
T Consensus 105 l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 105 LSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhc
Confidence 578899999999999999999999 999999999999999999999999988754433222233456778999998754
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------------cCCc-----cCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF------------------------KGKR-----LEIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~------------------------~~~~-----~~~~~~ 131 (181)
..++.++|+||+|++++++++|+.||.+.+.......+.. .... ......
T Consensus 183 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (337)
T cd07858 183 CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPH 262 (337)
T ss_pred CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHccc
Confidence 4578899999999999999999999977653321111100 0000 011235
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
+++.+.+++.+||..+|.+|||++++++ ++|++.
T Consensus 263 ~~~~~~~li~~~l~~~P~~Rps~~ell~--h~~~~~ 296 (337)
T cd07858 263 ANPLAIDLLEKMLVFDPSKRITVEEALA--HPYLAS 296 (337)
T ss_pred CCHHHHHHHHHHhcCChhhccCHHHHHc--Ccchhh
Confidence 7889999999999999999999999999 677654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=185.59 Aligned_cols=162 Identities=20% Similarity=0.381 Sum_probs=128.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........+++.|++||.+.
T Consensus 99 l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 99 LPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHh
Confidence 567888999999999999999999 999999999999999999999999987643222 11222346788999999885
Q ss_pred C-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCC---CCCCHHHHHHHHHHhcCCCCC--
Q 030203 81 D-----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWANEPWK-- 150 (181)
Q Consensus 81 ~-----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~-- 150 (181)
+ ..++.++|+||+|+++|+|++|+.||...+......++.........+ ..+++++.+++.+|+..++.+
T Consensus 177 ~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~ 256 (332)
T cd05623 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLG 256 (332)
T ss_pred ccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcC
Confidence 2 346789999999999999999999999888777666664333333333 357899999999999665554
Q ss_pred CCCHHHHHHHHHHhhhC
Q 030203 151 RPSFSTIMELLRPLIKS 167 (181)
Q Consensus 151 Rps~~~~l~~L~~~~~~ 167 (181)
|+++.++++ ++|+..
T Consensus 257 r~~~~~~~~--h~~f~~ 271 (332)
T cd05623 257 QNGIEDFKQ--HPFFTG 271 (332)
T ss_pred CCCHHHHhC--CCCcCC
Confidence 689999998 666543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=185.77 Aligned_cols=159 Identities=30% Similarity=0.446 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|+|+++.-++.+|+.||.+||.++ ||+||+||+||++|+.|++.++|+|++....... .....+||.+|+|||++..
T Consensus 284 F~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~-~~~~rvGT~GYMAPEvl~n 360 (591)
T KOG0986|consen 284 FDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK-PIRGRVGTVGYMAPEVLQN 360 (591)
T ss_pred CchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCCCC-ccccccCcccccCHHHHcC
Confidence 689999999999999999999999 9999999999999999999999999998665543 2234589999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH--
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-- 155 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-- 155 (181)
..|+++.|.|++||++|+|+.|+.||...+.. ++..++ .....+++..+|++++++...+|..||.+|...+
T Consensus 361 e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ 438 (591)
T KOG0986|consen 361 EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGE 438 (591)
T ss_pred CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCc
Confidence 88999999999999999999999999876543 333333 3445567789999999999999999999998654
Q ss_pred ---HHHHHHHHhhhC
Q 030203 156 ---TIMELLRPLIKS 167 (181)
Q Consensus 156 ---~~l~~L~~~~~~ 167 (181)
++.+ +++++.
T Consensus 439 ga~evk~--HpfFk~ 451 (591)
T KOG0986|consen 439 GAQEVKE--HPFFKD 451 (591)
T ss_pred Ccchhhh--Cccccc
Confidence 5555 555443
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=193.39 Aligned_cols=161 Identities=19% Similarity=0.274 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccCCC
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~ 82 (181)
..++..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++........ ......++..|++||.+.+.
T Consensus 266 ~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 343 (501)
T PHA03210 266 LKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD 343 (501)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC
Confidence 4567789999999999999999 99999999999999999999999999875443221 12235688999999999888
Q ss_pred CCCCchhHHHHHHHHHHHHhCCC-CCCCCC--H-HHHHHHHhccCC-cc-----------------------C-----CC
Q 030203 83 PSNEKSDIYSFGVILWELATLQQ-PWGNLN--P-AQVVAAVGFKGK-RL-----------------------E-----IP 129 (181)
Q Consensus 83 ~~~~~~Dv~slG~~~~~ll~g~~-p~~~~~--~-~~~~~~~~~~~~-~~-----------------------~-----~~ 129 (181)
.++.++|+||+||++|+|++|.. |+.... . ..+...+..... .. . ..
T Consensus 344 ~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 423 (501)
T PHA03210 344 GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN 423 (501)
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh
Confidence 89999999999999999999875 443221 1 111111110000 00 0 01
Q ss_pred CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 130 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
..++.++.+++.+||..||.+|||+.+++. ++|+...
T Consensus 424 ~~~~~~~~~li~kmL~~DP~~Rpsa~elL~--hp~f~~~ 460 (501)
T PHA03210 424 LGLPADFEYPLVKMLTFDWHLRPGAAELLA--LPLFSAE 460 (501)
T ss_pred cCCChHHHHHHHHHhccCcccCcCHHHHhh--ChhhhcC
Confidence 135667888999999999999999999998 7777653
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=183.30 Aligned_cols=162 Identities=25% Similarity=0.355 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++.+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++...... .....++..|++||.+.+
T Consensus 114 ~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 114 LSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILN 188 (342)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC---CCCceeeecccChhhhcC
Confidence 567889999999999999999999 999999999999999999999999987643221 122345678999998866
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC----------------------c----c---CCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK----------------------R----L---EIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~----------------------~----~---~~~~~ 131 (181)
..++.++|+||+|++++++++|+.||.+.+.......+..... . . .....
T Consensus 189 ~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (342)
T cd07879 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK 268 (342)
T ss_pred ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcC
Confidence 3478899999999999999999999988765433322211000 0 0 01124
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
.++.+.+++.+||+.||.+||++.+++. +++++....
T Consensus 269 ~~~~~~~li~~~l~~dP~~R~~~~e~l~--h~~f~~~~~ 305 (342)
T cd07879 269 ASPQAVDLLEKMLELDVDKRLTATEALE--HPYFDSFRD 305 (342)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhc--Ccchhhccc
Confidence 6788999999999999999999999998 677665443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=178.37 Aligned_cols=160 Identities=27% Similarity=0.351 Sum_probs=124.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||.+.
T Consensus 96 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07832 96 LPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeee
Confidence 578899999999999999999999 9999999999999999999999999876543322 1223446778899999886
Q ss_pred CCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc----------------------------cCCCCC
Q 030203 81 DEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR----------------------------LEIPRN 131 (181)
Q Consensus 81 ~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~ 131 (181)
+.. ++.++|+||+|++++++++|..+|.+.........+...... ......
T Consensus 174 ~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T cd07832 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPD 253 (286)
T ss_pred ccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCC
Confidence 544 578999999999999999998888776554333322110000 001134
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhh
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~ 165 (181)
.+..+.+++.+|+..+|.+||+++++++ ++|+
T Consensus 254 ~~~~~~~li~~~l~~~p~~R~~~~~~l~--h~~~ 285 (286)
T cd07832 254 ASPEALDLLKGLLVYDPSKRLSAAEALR--HPYF 285 (286)
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHhh--CcCc
Confidence 5788999999999999999999999998 5554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=179.23 Aligned_cols=164 Identities=26% Similarity=0.384 Sum_probs=127.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---------------ccCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---------------LSSKS 66 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---------------~~~~~ 66 (181)
+++..+..++.|++.|+.|||+++ ++|+||+|.||+++.++.++++|||.+....... .....
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (305)
T cd05609 98 LPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175 (305)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccC
Confidence 567888999999999999999999 9999999999999999999999999875321100 01112
Q ss_pred CCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-cCCCCCCCHHHHHHHHHHhc
Q 030203 67 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-LEIPRNVNPHVASIIEACWA 145 (181)
Q Consensus 67 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 145 (181)
..++..|++||.+.+..++.++|+||+|++++++++|..||.+................ ......+++++.+++.+|++
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 255 (305)
T cd05609 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLR 255 (305)
T ss_pred CccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhc
Confidence 34567899999988878889999999999999999999999888777666655433222 22233678999999999999
Q ss_pred CCCCCCCCHHHHHHHHH-HhhhC
Q 030203 146 NEPWKRPSFSTIMELLR-PLIKS 167 (181)
Q Consensus 146 ~~p~~Rps~~~~l~~L~-~~~~~ 167 (181)
.+|.+||+..++.+.|. +++..
T Consensus 256 ~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 256 QNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cChhhccCccCHHHHHhCccccC
Confidence 99999998544444433 55543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=182.91 Aligned_cols=163 Identities=25% Similarity=0.384 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+.| ++|+||+|+||+++.++.++++|||.+...... .....++..|++||...+
T Consensus 115 l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 115 LSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhC
Confidence 578899999999999999999999 999999999999999999999999998654332 223355678999998765
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-----------------------------cCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-----------------------------LEIPRN 131 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~ 131 (181)
. .++.++|+||+|++++++++|+.||...........+...... ......
T Consensus 190 ~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (343)
T cd07851 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSG 269 (343)
T ss_pred CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhcc
Confidence 3 5678999999999999999999999877655433332111000 011124
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
+++.+.+++.+||..||.+|||+.++++ ++|++....+
T Consensus 270 ~s~~l~dli~~~l~~~P~~Rpt~~ell~--h~~~~~~~~~ 307 (343)
T cd07851 270 ANPLAIDLLEKMLVLDPDKRITAAEALA--HPYLAEYHDP 307 (343)
T ss_pred CCHHHHHHHHHhCCCChhhCCCHHHHhc--CCCccccCCC
Confidence 6889999999999999999999999998 7888755444
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=183.89 Aligned_cols=162 Identities=20% Similarity=0.350 Sum_probs=127.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 99 LPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHh
Confidence 578889999999999999999999 99999999999999999999999998764332211 122245788999999886
Q ss_pred C-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCC---CCCCCHHHHHHHHHHhcCCCCC--
Q 030203 81 D-----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI---PRNVNPHVASIIEACWANEPWK-- 150 (181)
Q Consensus 81 ~-----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~-- 150 (181)
. ..++.++|+||+||++|+|++|+.||...+..+....+......... ...+++.+++++.+|+..++.+
T Consensus 177 ~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~ 256 (331)
T cd05597 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLG 256 (331)
T ss_pred hccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccC
Confidence 3 33577899999999999999999999888776665555332222222 2347899999999988654444
Q ss_pred CCCHHHHHHHHHHhhhC
Q 030203 151 RPSFSTIMELLRPLIKS 167 (181)
Q Consensus 151 Rps~~~~l~~L~~~~~~ 167 (181)
|+++.++++ ++|+..
T Consensus 257 r~~~~~~l~--hp~~~~ 271 (331)
T cd05597 257 RNGLQDFKD--HPFFEG 271 (331)
T ss_pred CCCHHHHhc--CCCCCC
Confidence 789999999 777754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=178.68 Aligned_cols=156 Identities=27% Similarity=0.396 Sum_probs=122.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+|++|+||+++.++.++++|||++..............++..|++||...+
T Consensus 97 ~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07846 97 LDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhcc
Confidence 578899999999999999999999 999999999999999999999999987654333222333456778999998865
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-------------------Ccc----------CCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-------------------KRL----------EIPRN 131 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-------------------~~~----------~~~~~ 131 (181)
. .++.++|+||+|++++++++|..||...........+.... ... .....
T Consensus 175 ~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07846 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK 254 (286)
T ss_pred ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCC
Confidence 3 36778999999999999999999997665433222221000 000 01235
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
++..+.+++.+||..+|.+||++.++++
T Consensus 255 ~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 255 LSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 6788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=175.68 Aligned_cols=156 Identities=30% Similarity=0.566 Sum_probs=123.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.+||+++ ++|+||+|+||+++.++.++++|||.+....... .......++..|++||..
T Consensus 105 l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 182 (272)
T cd06629 105 FEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHh
Confidence 567888999999999999999999 9999999999999999999999999876433221 112233466789999988
Q ss_pred CCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC----CCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 80 RDEP--SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE----IPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 80 ~~~~--~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
.... ++.++|+||+|++++++++|..||...........+........ ....++..+.+++.+|+..+|.+||+
T Consensus 183 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred ccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC
Confidence 7644 68899999999999999999999976655443333322222221 22356889999999999999999999
Q ss_pred HHHHHH
Q 030203 154 FSTIME 159 (181)
Q Consensus 154 ~~~~l~ 159 (181)
++++++
T Consensus 263 ~~~il~ 268 (272)
T cd06629 263 ARELLQ 268 (272)
T ss_pred HHHHhh
Confidence 999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=178.56 Aligned_cols=156 Identities=25% Similarity=0.383 Sum_probs=118.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+..............++..|++||...+
T Consensus 100 ~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 100 LSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhc
Confidence 567889999999999999999999 999999999999999999999999987643322222223345678999998865
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc-cCC------------------c---------cCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGF-KGK------------------R---------LEIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-~~~~~~~~~~-~~~------------------~---------~~~~~~ 131 (181)
..++.++|+||+|+++++|++|+.||.... ..+....+.. ... . ......
T Consensus 178 ~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07844 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPR 257 (291)
T ss_pred CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcC
Confidence 347889999999999999999999997655 2222111100 000 0 000112
Q ss_pred CC--HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 132 VN--PHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 132 ~~--~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
++ .++.+++.+|++.+|.+||++.++++
T Consensus 258 ~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 258 LDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 34 78899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=174.59 Aligned_cols=154 Identities=32% Similarity=0.558 Sum_probs=127.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.|+.|||+.+ ++|+|++|+||+++. +.++++|||.+..............++..|++||...+
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 179 (260)
T cd08222 103 LSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179 (260)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc
Confidence 578889999999999999999999 999999999999975 56999999988654433323333456778999999887
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..++.++|+|++|++++++++|..||...........+. .......+..++.++.+++.+|+..+|.+||++.++++
T Consensus 180 ~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 778889999999999999999999998776655555543 33334455678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=177.73 Aligned_cols=153 Identities=25% Similarity=0.398 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||.+....... ......++..|++||....
T Consensus 97 l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~ 173 (258)
T cd05578 97 FSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCR 173 (258)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcc
Confidence 568889999999999999999999 9999999999999999999999999876544332 2233456678999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH--HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF--ST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~~ 156 (181)
...+.++|+||+|+++|++++|..||..... ....... .......+..++..+.+++.+||..||.+||++ ++
T Consensus 174 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 251 (258)
T cd05578 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKD 251 (258)
T ss_pred cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHHHHHccCChhHcCCccHHH
Confidence 7788999999999999999999999988764 3333322 214455667789999999999999999999999 77
Q ss_pred HHH
Q 030203 157 IME 159 (181)
Q Consensus 157 ~l~ 159 (181)
+++
T Consensus 252 l~~ 254 (258)
T cd05578 252 LKN 254 (258)
T ss_pred Hhc
Confidence 665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=181.68 Aligned_cols=164 Identities=23% Similarity=0.407 Sum_probs=125.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++..+..++.|++.||.+||+++ ++|+||+|+||+++.++.++++|||++........ ......++..|+|||.
T Consensus 103 l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 180 (336)
T cd07849 103 LSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180 (336)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHH
Confidence 577889999999999999999999 99999999999999999999999998865432211 1122356778999998
Q ss_pred cCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-c-----------------------CCcc-----CC
Q 030203 79 LRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-K-----------------------GKRL-----EI 128 (181)
Q Consensus 79 ~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~-~-----------------------~~~~-----~~ 128 (181)
+.+ ..++.++|+||+|+++++|++|+.||.+.+.......+.. . .... ..
T Consensus 181 ~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T cd07849 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKL 260 (336)
T ss_pred hhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHH
Confidence 654 4578899999999999999999999977654322111100 0 0000 01
Q ss_pred CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 129 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
....++.+.+++.+||+.+|.+|||+.++++ +++++...
T Consensus 261 ~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~--hp~~~~~~ 299 (336)
T cd07849 261 FPNADPKALDLLDKMLTFNPHKRITVEEALA--HPYLEQYH 299 (336)
T ss_pred hcccCcHHHHHHHHHcCCChhhCcCHHHHhc--CccccccC
Confidence 1246788999999999999999999999999 66665443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=198.59 Aligned_cols=167 Identities=37% Similarity=0.620 Sum_probs=144.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc-cccccccCCCC-CCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSA-AGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~-~~~~~~~~~~~-~~~~~~~~pe~~ 79 (181)
++.++.+.++.+|++|..||++++ ++||||...|++++....+|++|||+++- +...+...... .-...|+|||.+
T Consensus 799 L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl 876 (1025)
T KOG1095|consen 799 LSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESL 876 (1025)
T ss_pred CCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHH
Confidence 567889999999999999999999 99999999999999999999999999982 22222222111 334589999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
..+.++.++||||||+++||+++ |..||.+.+..+....+...+ +++.|..++..+.+++..||+.+|+.||+++.++
T Consensus 877 ~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~ 955 (1025)
T KOG1095|consen 877 KDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIV 955 (1025)
T ss_pred hhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHH
Confidence 99999999999999999999997 899999999988888666444 8889999999999999999999999999999999
Q ss_pred HHHHHhhhCCCCC
Q 030203 159 ELLRPLIKSPTPQ 171 (181)
Q Consensus 159 ~~L~~~~~~~~~~ 171 (181)
+.++.+++.....
T Consensus 956 ~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 956 EQDPAISNAALGT 968 (1025)
T ss_pred hhhhhhhhhhccC
Confidence 9999888765544
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=177.86 Aligned_cols=156 Identities=24% Similarity=0.329 Sum_probs=118.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+..............+++.|++||...+
T Consensus 100 ~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 177 (291)
T cd07870 100 LHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeec
Confidence 456788899999999999999999 999999999999999999999999988654333222333456788999998865
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc-cC---------------CccC-----CC---------
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGF-KG---------------KRLE-----IP--------- 129 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~-~~---------------~~~~-----~~--------- 129 (181)
. .++.++|+||+|++++++++|..||...... ........ .+ .... .+
T Consensus 178 ~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07870 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKR 257 (291)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccc
Confidence 4 4678899999999999999999999765432 11111100 00 0000 00
Q ss_pred CCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 130 RNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 130 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
-..++.+.+++.+|+..||.+|||+.+++.
T Consensus 258 ~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 258 LSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 012568899999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=181.05 Aligned_cols=166 Identities=22% Similarity=0.369 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc----CCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS----SKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~~~~~~pe 77 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+......... .....++..|.+||
T Consensus 104 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (334)
T cd07855 104 LTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181 (334)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChH
Confidence 578899999999999999999999 999999999999999999999999988654332111 12345677899999
Q ss_pred ccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------------cCCccC-----
Q 030203 78 VLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF------------------------KGKRLE----- 127 (181)
Q Consensus 78 ~~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~------------------------~~~~~~----- 127 (181)
.+.+ ..++.++|+||+|+++|+|++|+.||.+.+.......+.. ......
T Consensus 182 ~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (334)
T cd07855 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSK 261 (334)
T ss_pred HhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHH
Confidence 8765 3478899999999999999999999977654332221110 000001
Q ss_pred CCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
.....++.+.+++.+||+.+|.+||++.+++. ++|++....+
T Consensus 262 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~--~~~~~~~~~~ 303 (334)
T cd07855 262 IFPKASPEALDLLSQMLQFDPEERITVEQALQ--HPFLAQYHDP 303 (334)
T ss_pred HcccCCHHHHHHHHHHccCChhhCcCHHHHHh--ChhhhhccCC
Confidence 11346889999999999999999999999999 8888755544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=177.52 Aligned_cols=155 Identities=25% Similarity=0.317 Sum_probs=123.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.+||+.+ ++|+|++|+||+++.++.++++|||.+......... ....++..|++||.+.+
T Consensus 104 l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~PE~~~~ 180 (287)
T cd07838 104 LPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL-TSVVVTLWYRAPEVLLQ 180 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceeccCCccc-ccccccccccChHHhcc
Confidence 578899999999999999999999 999999999999999999999999987654332211 22345678999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC------------------c-------cCCCCCCCHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK------------------R-------LEIPRNVNPHV 136 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~------------------~-------~~~~~~~~~~~ 136 (181)
..++.++|+||+|+++++|++|..||......+...++..... . ......+++.+
T Consensus 181 ~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (287)
T cd07838 181 SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEG 260 (287)
T ss_pred CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHH
Confidence 8888999999999999999999999988776554443311000 0 00012346778
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHH
Q 030203 137 ASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 137 ~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
.+++.+||..||.+||++.+++.
T Consensus 261 ~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 261 LDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHhccCCccCCCHHHHhc
Confidence 99999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=175.41 Aligned_cols=160 Identities=28% Similarity=0.528 Sum_probs=126.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccc----cCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~~~p 76 (181)
+++..++.++.|++.||.+||++| ++|+||+|.||+++.++ .++++|||.+........ ......++..|++|
T Consensus 100 ~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~P 177 (268)
T cd06630 100 FKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCH
Confidence 567889999999999999999999 99999999999998765 589999998765433211 11223567789999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 77 e~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
|.+.+..++.++|+|++|++++++++|..||..... ................+..+++++.+++.+|+..+|.+||+
T Consensus 178 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 257 (268)
T cd06630 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP 257 (268)
T ss_pred hHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC
Confidence 998877788999999999999999999999965432 22222222233344556678899999999999999999999
Q ss_pred HHHHHHHHHHhh
Q 030203 154 FSTIMELLRPLI 165 (181)
Q Consensus 154 ~~~~l~~L~~~~ 165 (181)
+.++++ ++++
T Consensus 258 ~~~ll~--~~~~ 267 (268)
T cd06630 258 SRELLK--HPVF 267 (268)
T ss_pred HHHHhc--Cccc
Confidence 999997 5554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=176.73 Aligned_cols=154 Identities=28% Similarity=0.506 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------------------- 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------------------- 61 (181)
+++.+++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||.+.......
T Consensus 99 l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (280)
T cd05581 99 LDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccc
Confidence 578899999999999999999999 9999999999999999999999999876443322
Q ss_pred ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHH
Q 030203 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIE 141 (181)
Q Consensus 62 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 141 (181)
.......++..|++||.......+.++|+|++|++++++++|..||...........+. ......+..+++.+.+++.
T Consensus 177 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 254 (280)
T cd05581 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL--KLEYSFPPNFPPDAKDLIE 254 (280)
T ss_pred cccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--hcCCCCCCccCHHHHHHHH
Confidence 11122345678999999887778889999999999999999999999887655444442 3344566778999999999
Q ss_pred HHhcCCCCCCCCH----HHHHH
Q 030203 142 ACWANEPWKRPSF----STIME 159 (181)
Q Consensus 142 ~~l~~~p~~Rps~----~~~l~ 159 (181)
+||..+|.+||++ .++++
T Consensus 255 ~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 255 KLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHhcCCHhhCCCcccCHHHHhc
Confidence 9999999999999 88876
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=205.41 Aligned_cols=157 Identities=31% Similarity=0.510 Sum_probs=131.7
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc----ccCCCCCCCCCccCCcccC
Q 030203 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~pe~~~ 80 (181)
.-...+..|++.|+.|||+.| |||+||||.||+++.+|.+|++|||.+....... ...+...||+.|+|||.+.
T Consensus 1334 ~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1334 MVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred hHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhc
Confidence 334466789999999999999 9999999999999999999999999998655442 2234568999999999997
Q ss_pred CCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 81 DEP---SNEKSDIYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 81 ~~~---~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.. -..++|||||||++.||+||+.||...+..- +...++ .+-.+++|..++++-+++|+.||..||++|.++.+
T Consensus 1412 ~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1412 GTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred ccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence 643 3468999999999999999999998887664 444444 67778889899999999999999999999999999
Q ss_pred HHHHHHHhhh
Q 030203 157 IMELLRPLIK 166 (181)
Q Consensus 157 ~l~~L~~~~~ 166 (181)
+++ +.+-+
T Consensus 1491 lle--~~f~~ 1498 (1509)
T KOG4645|consen 1491 LLE--HAFGK 1498 (1509)
T ss_pred HHH--hhccc
Confidence 888 55444
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=172.41 Aligned_cols=157 Identities=25% Similarity=0.462 Sum_probs=120.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCcccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~~ 80 (181)
++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++...... ........++..|++||...
T Consensus 97 ~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 97 QLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174 (268)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcc
Confidence 34567789999999999999999 999999999999999999999999987532211 11122345667899999874
Q ss_pred C-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccC----CccCCCCCCCHHHHHHHHHHhcCCC
Q 030203 81 D-------EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKG----KRLEIPRNVNPHVASIIEACWANEP 148 (181)
Q Consensus 81 ~-------~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p 148 (181)
. ..++.++|+||+|+++|+|++ |..||...........+.... ........+++.+.+++..|+ .+|
T Consensus 175 ~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P 253 (268)
T cd05086 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSP 253 (268)
T ss_pred cccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCc
Confidence 3 234678999999999999996 577887776655554432221 123344567889999999999 789
Q ss_pred CCCCCHHHHHHHHH
Q 030203 149 WKRPSFSTIMELLR 162 (181)
Q Consensus 149 ~~Rps~~~~l~~L~ 162 (181)
.+||+++++++.|.
T Consensus 254 ~~Rp~~~~i~~~l~ 267 (268)
T cd05086 254 EKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCHHHHHHHhc
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=179.34 Aligned_cols=156 Identities=24% Similarity=0.319 Sum_probs=120.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc----cCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+........ ......++..|+|||
T Consensus 116 ~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 193 (310)
T cd07865 116 FTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193 (310)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcH
Confidence 578899999999999999999999 99999999999999999999999998864332211 112234567899999
Q ss_pred ccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--c---------------CC-----------
Q 030203 78 VLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--L---------------EI----------- 128 (181)
Q Consensus 78 ~~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~---------------~~----------- 128 (181)
.+.+.. ++.++|+||+|+++++|++|..||.+.+.......+...... . ..
T Consensus 194 ~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (310)
T cd07865 194 LLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKER 273 (310)
T ss_pred HhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHh
Confidence 876543 678899999999999999999999887655433322211000 0 00
Q ss_pred --CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 129 --PRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 129 --~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+...+..+.+++.+||..||.+|||++++++
T Consensus 274 l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 274 LKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1123567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=175.08 Aligned_cols=159 Identities=23% Similarity=0.336 Sum_probs=124.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.+||+++ ++|+||+|+||+++.++.++++|||.+...............+..|++||.+.+
T Consensus 95 ~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 172 (282)
T cd07829 95 LSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG 172 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcC
Confidence 578899999999999999999999 999999999999999999999999988654433222233445667999998876
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------------CCcc--------CCCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-------------------GKRL--------EIPRNVN 133 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-------------------~~~~--------~~~~~~~ 133 (181)
. .++.++|+|++|++++++++|..||..........++... .... ......+
T Consensus 173 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd07829 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLD 252 (282)
T ss_pred CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccccc
Confidence 6 6788999999999999999999999887654433322110 0000 0112347
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHh
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~ 164 (181)
..+.+++.+|+..||.+||++.++++ ++|
T Consensus 253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~--~p~ 281 (282)
T cd07829 253 PEGIDLLSKMLQYNPAKRISAKEALK--HPY 281 (282)
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhh--CcC
Confidence 78999999999999999999999987 544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=178.63 Aligned_cols=156 Identities=24% Similarity=0.329 Sum_probs=122.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++++++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+..............++..|++||.+.+
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 174 (284)
T cd07836 97 LDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174 (284)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcC
Confidence 578899999999999999999999 999999999999999999999999988644332222233455678999998765
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC----------------Ccc-----------CCCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG----------------KRL-----------EIPRNVN 133 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~----------------~~~-----------~~~~~~~ 133 (181)
. .++.++|+|++|++++++++|+.||.+.+..+....+.... ... .....++
T Consensus 175 ~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
T cd07836 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHAD 254 (284)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcC
Confidence 4 35789999999999999999999998776554333221000 000 0112457
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+.+.+++.+|++.||.+||++.++++
T Consensus 255 ~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 255 PLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 88999999999999999999999987
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=173.46 Aligned_cols=155 Identities=28% Similarity=0.506 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....... .......++..|++||.
T Consensus 103 l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 180 (264)
T cd06653 103 LTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180 (264)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhh
Confidence 467888999999999999999999 9999999999999999999999999886543211 11123356778999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
..+...+.++|+||+|++++++++|..||...........+.........+..+++.+.+++.+|+. +|.+||+..+++
T Consensus 181 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred hcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 9887788999999999999999999999988766655555543444556778899999999999998 579999999888
Q ss_pred H
Q 030203 159 E 159 (181)
Q Consensus 159 ~ 159 (181)
+
T Consensus 260 ~ 260 (264)
T cd06653 260 R 260 (264)
T ss_pred c
Confidence 6
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=180.32 Aligned_cols=162 Identities=28% Similarity=0.398 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc----cCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~~~pe 77 (181)
+++.++..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+........ ......++..|++||
T Consensus 102 ~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE 179 (332)
T cd07857 102 LTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcH
Confidence 578889999999999999999999 99999999999999999999999998864332211 112235678899999
Q ss_pred ccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------------------CC----ccC
Q 030203 78 VLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-------------------------GK----RLE 127 (181)
Q Consensus 78 ~~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-------------------------~~----~~~ 127 (181)
...+ ..++.++|+||+|++++++++|+.||...+.......+... .. ...
T Consensus 180 ~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (332)
T cd07857 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES 259 (332)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh
Confidence 8765 35788999999999999999999999876543322211100 00 001
Q ss_pred CCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
.....+..+.+++.+|++.||.+|||+.++++ ++|++.
T Consensus 260 ~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~--~~~~~~ 297 (332)
T cd07857 260 IFPNANPLALDLLEKLLAFDPTKRISVEEALE--HPYLAI 297 (332)
T ss_pred hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--Chhhhh
Confidence 12345788999999999999999999999998 788763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=173.29 Aligned_cols=156 Identities=29% Similarity=0.516 Sum_probs=120.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCcccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~ 80 (181)
++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....... .......++..|++||...
T Consensus 98 ~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05042 98 QKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175 (269)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHh
Confidence 46677899999999999999999 9999999999999999999999999875432211 1112233456799999864
Q ss_pred C-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCC----ccCCCCCCCHHHHHHHHHHhcCCC
Q 030203 81 D-------EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGK----RLEIPRNVNPHVASIIEACWANEP 148 (181)
Q Consensus 81 ~-------~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p 148 (181)
. ..++.++|+||+|+++|++++ |..||......+.......... ....+..+++.+.+++..|+ .||
T Consensus 176 ~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp 254 (269)
T cd05042 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDP 254 (269)
T ss_pred hccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCc
Confidence 3 235779999999999999998 7888887766554443322211 22344567888999999998 599
Q ss_pred CCCCCHHHHHHHH
Q 030203 149 WKRPSFSTIMELL 161 (181)
Q Consensus 149 ~~Rps~~~~l~~L 161 (181)
.+||+++++++.|
T Consensus 255 ~~Rpt~~~v~~~l 267 (269)
T cd05042 255 ETRPTAEEVHELL 267 (269)
T ss_pred ccccCHHHHHHHh
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=183.69 Aligned_cols=161 Identities=20% Similarity=0.359 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++........ ......+++.|+|||.+.
T Consensus 99 l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05624 99 LPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHh
Confidence 567888999999999999999999 99999999999999999999999999865433221 122346788999999886
Q ss_pred C-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCC---CCCCHHHHHHHHHHhcCCCCC--
Q 030203 81 D-----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWANEPWK-- 150 (181)
Q Consensus 81 ~-----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~-- 150 (181)
+ ..++.++|+||+|+++|+|++|+.||...+.......+.....+...+ ..+++.+++++.+|+..++.+
T Consensus 177 ~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~ 256 (331)
T cd05624 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLG 256 (331)
T ss_pred ccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcC
Confidence 5 346788999999999999999999999887776666654333333333 346899999999999866554
Q ss_pred CCCHHHHHHHHHHhhh
Q 030203 151 RPSFSTIMELLRPLIK 166 (181)
Q Consensus 151 Rps~~~~l~~L~~~~~ 166 (181)
|++++++++ +.+++
T Consensus 257 ~~~~~~~~~--h~~f~ 270 (331)
T cd05624 257 QNGIEDFKK--HAFFE 270 (331)
T ss_pred CCCHHHHhc--CCCcC
Confidence 468888887 45543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=175.59 Aligned_cols=163 Identities=31% Similarity=0.543 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+.+ ++|+|+++.||+++.++.++++|||++........ ....++..|++||...+
T Consensus 102 l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 102 IGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPERIQG 177 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccccccccccc--ccccCCccccCHHHhcC
Confidence 467788899999999999999999 99999999999999999999999998754332211 12345678999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhccCCccCCC------CCCCHHHHHHHHHHhcCCCCC
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLN-----PAQVVAAVGFKGKRLEIP------RNVNPHVASIIEACWANEPWK 150 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~ 150 (181)
..++.++|+|++|+++|+|++|+.||.... ..+....+.. ......+ ..+++.+.+++.+||..+|.+
T Consensus 178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 256 (287)
T cd06621 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTR 256 (287)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCCCCchHHHHHHHHHHHcCCCccc
Confidence 888899999999999999999999997652 2233333321 1111111 235678999999999999999
Q ss_pred CCCHHHHHHHHHHhhhCCCCC
Q 030203 151 RPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 151 Rps~~~~l~~L~~~~~~~~~~ 171 (181)
|||+.++++ ++|++....+
T Consensus 257 Rpt~~eil~--~~~~~~~~~~ 275 (287)
T cd06621 257 RPTPWDMLE--HPWIKAQMKK 275 (287)
T ss_pred CCCHHHHHh--Cccccccccc
Confidence 999999999 8888665444
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=178.29 Aligned_cols=156 Identities=24% Similarity=0.338 Sum_probs=120.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc-----------CCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS-----------SKSAAGT 70 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-----------~~~~~~~ 70 (181)
+++.++..++.|+++||.|||+++ ++|+|++|+||+++.++.++++|||++......... .....++
T Consensus 112 ~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (311)
T cd07866 112 LTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189 (311)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceec
Confidence 578899999999999999999999 999999999999999999999999988643322111 1122446
Q ss_pred CCccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc---------------------cCC
Q 030203 71 PEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR---------------------LEI 128 (181)
Q Consensus 71 ~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~~ 128 (181)
+.|++||...+. .++.++|+||+|+++++|++|+.||.+.+.......+...... ...
T Consensus 190 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (311)
T cd07866 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNY 269 (311)
T ss_pred cCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCC
Confidence 679999987654 4688999999999999999999999877665444332111000 000
Q ss_pred -------CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 129 -------PRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 129 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...+++.+.+++.+|+..||.+|||+.+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 270 PRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=179.80 Aligned_cols=162 Identities=22% Similarity=0.395 Sum_probs=123.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccc---cCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe 77 (181)
+++.++..++.|++.||.|||+.| ++|+||+|+||+++. ++.++++|||.+........ ......++..|.|||
T Consensus 111 l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 188 (342)
T cd07854 111 LSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188 (342)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHH
Confidence 578899999999999999999999 999999999999974 56789999998764322111 112234577899999
Q ss_pred ccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------------------CCcc-----CC
Q 030203 78 VLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-----------------------GKRL-----EI 128 (181)
Q Consensus 78 ~~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-----------------------~~~~-----~~ 128 (181)
.+.. ..++.++|+||+|+++++|++|+.||...+........... .... ..
T Consensus 189 ~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (342)
T cd07854 189 LLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDL 268 (342)
T ss_pred HHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHH
Confidence 7654 44678899999999999999999999776544332222100 0000 01
Q ss_pred CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 129 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
...++.++.+++.+||..||.+|||+.++++ ++|++.
T Consensus 269 ~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--h~~~~~ 305 (342)
T cd07854 269 LPGVNPEALDFLEQILTFNPMDRLTAEEALM--HPYMSC 305 (342)
T ss_pred ccCCCHHHHHHHHHHhCCCchhccCHHHHhC--CCcccc
Confidence 2357788999999999999999999999998 888873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=182.84 Aligned_cols=165 Identities=32% Similarity=0.541 Sum_probs=125.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCC-CceecCCCCCCEEEcCCCcEEEcccCCcccccc-ccccCCCC-CCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSA-AGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~-~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~-~~~~~~~~-~~~~~~~~pe~ 78 (181)
++|.++++|+.++++||.|||.... +++|||||++||++|.+.+.|++|||+++.... .... ... .|+.+|++||+
T Consensus 171 L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy 249 (361)
T KOG1187|consen 171 LDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV-STTVMGTFGYLAPEY 249 (361)
T ss_pred CCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce-eeecCCCCccCChhh
Confidence 5899999999999999999999743 699999999999999999999999999965543 2111 112 78899999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhccC-----CccCCC-CCCC-----HHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLN------PAQVVAAVGFKG-----KRLEIP-RNVN-----PHVASIIE 141 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~------~~~~~~~~~~~~-----~~~~~~-~~~~-----~~~~~li~ 141 (181)
...+..+.++||||+|++++|+++|+.+..... ..++.......+ ....+. ...+ ..+..+..
T Consensus 250 ~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~ 329 (361)
T KOG1187|consen 250 ASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELAL 329 (361)
T ss_pred hccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHH
Confidence 988889999999999999999999998776432 122211111111 111122 2233 23567888
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 142 ACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 142 ~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
+|++.+|..||++.+++++|+.....
T Consensus 330 ~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 330 RCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999999999999999766544
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=173.43 Aligned_cols=151 Identities=25% Similarity=0.438 Sum_probs=119.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-------cEEEcccCCccccccccccCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-------TVKVCDFGLSRLKANTFLSSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 74 (181)
+++..+..++.|++.||.|||+++ ++|+||+|.||+++..+ .+++.|||.+...... ....++..|+
T Consensus 114 ~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~ 187 (274)
T cd05076 114 VPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWI 187 (274)
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCccc
Confidence 567889999999999999999999 99999999999997543 3799999986533221 2234567899
Q ss_pred CCcccCC-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 75 APEVLRD-EPSNEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 75 ~pe~~~~-~~~~~~~Dv~slG~~~~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+||.+.+ ..++.++|+||+|+++|+++ +|+.||.............. ....+...++.+.+++.+||+.+|.+||
T Consensus 188 aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 188 APECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK---KHRLPEPSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred CchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh---ccCCCCCCChHHHHHHHHHcccChhhCc
Confidence 9998865 44788999999999999985 68999987766554333321 2223445667899999999999999999
Q ss_pred CHHHHHHHH
Q 030203 153 SFSTIMELL 161 (181)
Q Consensus 153 s~~~~l~~L 161 (181)
++.++++.|
T Consensus 265 s~~~il~~L 273 (274)
T cd05076 265 SFRTILRDL 273 (274)
T ss_pred CHHHHHHhh
Confidence 999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=178.16 Aligned_cols=163 Identities=27% Similarity=0.425 Sum_probs=124.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-------ccCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------~~~~~~~~~~~~~ 74 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+++.||+.+....... .......++..|+
T Consensus 98 ~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 175 (314)
T cd08216 98 LPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175 (314)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccccccc
Confidence 467888999999999999999999 9999999999999999999999999775332111 1112234556799
Q ss_pred CCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhccCC---------------------------
Q 030203 75 APEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV-AAVGFKGK--------------------------- 124 (181)
Q Consensus 75 ~pe~~~~--~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~-~~~~~~~~--------------------------- 124 (181)
+||.+.. ..++.++|+||+|+++++|++|..||......... +++. ...
T Consensus 176 aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
T cd08216 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR-GTVPCLLDKSTYPLYEDSMSQSRSSNEHPN 254 (314)
T ss_pred CHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCccccccCchhhhcCCcCcccccccccc
Confidence 9998865 34778999999999999999999999876544322 2211 000
Q ss_pred -----ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 125 -----RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 125 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.......++.++.+++.+||..||.+|||++++++ +++++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~p~~~~~~ 302 (314)
T cd08216 255 NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN--HSFFKQCK 302 (314)
T ss_pred hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc--CchHhhhc
Confidence 00111234567889999999999999999999999 88887553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=186.53 Aligned_cols=167 Identities=35% Similarity=0.623 Sum_probs=147.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++..+...++.+.+.|++|||+++ ++||||-+.|++++.++.+|++|||+++.............-...|+|||.+..
T Consensus 259 v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~ 336 (474)
T KOG0194|consen 259 LPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT 336 (474)
T ss_pred CCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhcc
Confidence 567789999999999999999999 999999999999999999999999998765422111112244568999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
.-+++++||||+|+++||+.+ |..||.+....+...++...+.+...+...+..+..++..|+..+|..||++.++.+.
T Consensus 337 ~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 337 GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence 999999999999999999997 8889999999999999977888888888899999999999999999999999999999
Q ss_pred HHHhhhCCCC
Q 030203 161 LRPLIKSPTP 170 (181)
Q Consensus 161 L~~~~~~~~~ 170 (181)
++.+.+....
T Consensus 417 l~~~~~~~~~ 426 (474)
T KOG0194|consen 417 LEALEKKKEA 426 (474)
T ss_pred HHHHHhcccc
Confidence 9998886554
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=196.00 Aligned_cols=162 Identities=25% Similarity=0.454 Sum_probs=124.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCEEEcC-----------------CCcEEEcccCCcccccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRN-----PPIVHRDLKSPNLLVDK-----------------KYTVKVCDFGLSRLKAN 59 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~-----~~~~h~~i~~~nil~~~-----------------~~~~~l~d~g~~~~~~~ 59 (181)
+++..++.|+.||+.||.|||+.+ ..|+|+||+|+||+++. .+.++|+|||++.....
T Consensus 115 L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccc
Confidence 678899999999999999999832 12999999999999954 23489999999865433
Q ss_pred ccccCCCCCCCCCccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCCCCCHHH
Q 030203 60 TFLSSKSAAGTPEWMAPEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNPHV 136 (181)
Q Consensus 60 ~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 136 (181)
.. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...... .+...+. ...... ....++++
T Consensus 195 ~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk-~~p~lp-i~~~S~eL 271 (1021)
T PTZ00266 195 ES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK-RGPDLP-IKGKSKEL 271 (1021)
T ss_pred cc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHh-cCCCCC-cCCCCHHH
Confidence 22 1234467889999998854 34678999999999999999999999765543 3333332 222222 23468899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 137 ASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 137 ~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
.+||..||..+|.+||++.+++. +++++..
T Consensus 272 ~dLI~~~L~~dPeeRPSa~QlL~--h~~ik~i 301 (1021)
T PTZ00266 272 NILIKNLLNLSAKERPSALQCLG--YQIIKNV 301 (1021)
T ss_pred HHHHHHHhcCChhHCcCHHHHhc--cHHHhhc
Confidence 99999999999999999999997 5666543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-27 Score=171.42 Aligned_cols=157 Identities=29% Similarity=0.479 Sum_probs=119.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCcccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~ 80 (181)
++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||.+........ ......++..|++||.+.
T Consensus 98 ~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 98 DPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175 (269)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhc
Confidence 45567789999999999999999 99999999999999999999999998864332211 112234567899999875
Q ss_pred CC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccC-C---ccCCCCCCCHHHHHHHHHHhcCCC
Q 030203 81 DE-------PSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKG-K---RLEIPRNVNPHVASIIEACWANEP 148 (181)
Q Consensus 81 ~~-------~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~li~~~l~~~p 148 (181)
+. .++.++|+||+|++++++++ |..||......+......... . ........++.+.+++++|+ .+|
T Consensus 176 ~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P 254 (269)
T cd05087 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQP 254 (269)
T ss_pred cccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCc
Confidence 32 24678999999999999996 999998776655443321111 1 11222346788999999998 689
Q ss_pred CCCCCHHHHHHHHH
Q 030203 149 WKRPSFSTIMELLR 162 (181)
Q Consensus 149 ~~Rps~~~~l~~L~ 162 (181)
.+|||+++++..|.
T Consensus 255 ~~Rpt~~~l~~~l~ 268 (269)
T cd05087 255 EQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCHHHHHHHhc
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=176.57 Aligned_cols=156 Identities=24% Similarity=0.318 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||.+....... ........+..|++||.+.
T Consensus 113 ~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 190 (302)
T cd07864 113 FSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190 (302)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhc
Confidence 578899999999999999999999 9999999999999999999999999886543322 1112234466899999876
Q ss_pred CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc----------------------------CCCCC
Q 030203 81 DE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL----------------------------EIPRN 131 (181)
Q Consensus 81 ~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~ 131 (181)
+. ..+.++|+|++|++++++++|+.||...+.......+....... .....
T Consensus 191 ~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (302)
T cd07864 191 GEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF 270 (302)
T ss_pred CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCC
Confidence 53 36789999999999999999999998776554443332211000 01224
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
++..+.+++.+||..||.+||++.++++
T Consensus 271 ~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 271 IPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 6889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=182.42 Aligned_cols=160 Identities=25% Similarity=0.479 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|++..+.-++--+++|+.|||..| |++||+||+|.+++.+|.+||.|||+++...... .+.+..|++.|.|||++..
T Consensus 517 Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-KTwTFcGTpEYVAPEIILn 593 (732)
T KOG0614|consen 517 FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-KTWTFCGTPEYVAPEIILN 593 (732)
T ss_pred cccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccCC-ceeeecCCcccccchhhhc
Confidence 455566677788899999999999 9999999999999999999999999999877754 4457799999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----HHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ 156 (181)
.+.+.++|.|+||+++|++++|.+||.+.++......+.........|..++....+++.++-..+|.+|.. +.+
T Consensus 594 KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~D 673 (732)
T KOG0614|consen 594 KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGIND 673 (732)
T ss_pred cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHH
Confidence 888999999999999999999999999999998888887677778889999999999999999999999986 677
Q ss_pred HHHHHHHhhh
Q 030203 157 IMELLRPLIK 166 (181)
Q Consensus 157 ~l~~L~~~~~ 166 (181)
+.+ |.|+.
T Consensus 674 Ikk--H~Wf~ 681 (732)
T KOG0614|consen 674 IKK--HRWFE 681 (732)
T ss_pred HHh--hhhhh
Confidence 777 55543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=183.30 Aligned_cols=157 Identities=26% Similarity=0.452 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCcccCCCC
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVLRDEP 83 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~ 83 (181)
.+..+++|++.|+.++|+.| |+|.|+||.|+++-. |.+||+|||.+...... .......+|++.|++||.+....
T Consensus 461 ~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~ 537 (677)
T KOG0596|consen 461 FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMS 537 (677)
T ss_pred HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcc
Confidence 56678999999999999999 999999999999865 68999999998765543 22345678999999999885422
Q ss_pred -----------CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCCCCCH-HHHHHHHHHhcCCCCC
Q 030203 84 -----------SNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNP-HVASIIEACWANEPWK 150 (181)
Q Consensus 84 -----------~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~li~~~l~~~p~~ 150 (181)
.+.++|||||||++|+|+.|+.||...... .-...+..-.-..+.+..-+. ++.++++.||..||++
T Consensus 538 s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkk 617 (677)
T KOG0596|consen 538 SSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKK 617 (677)
T ss_pred ccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCccc
Confidence 357899999999999999999999875421 111122111112233333333 3999999999999999
Q ss_pred CCCHHHHHHHHHHhhhC
Q 030203 151 RPSFSTIMELLRPLIKS 167 (181)
Q Consensus 151 Rps~~~~l~~L~~~~~~ 167 (181)
||+..++|+ +.+++.
T Consensus 618 R~si~eLLq--hpFl~~ 632 (677)
T KOG0596|consen 618 RWSIPELLQ--HPFLQI 632 (677)
T ss_pred CCCcHHHhc--Cccccc
Confidence 999999999 777765
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=177.94 Aligned_cols=156 Identities=24% Similarity=0.354 Sum_probs=119.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC----CCcEEEcccCCccccccccc---cCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK----KYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~----~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~ 74 (181)
+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.++++|||++........ ......++..|+
T Consensus 105 ~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 182 (316)
T cd07842 105 IPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR 182 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCcccccccc
Confidence 567888999999999999999999 999999999999998 89999999998875433221 122335677899
Q ss_pred CCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHH-hc----------------------
Q 030203 75 APEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQ---------VVAAV-GF---------------------- 121 (181)
Q Consensus 75 ~pe~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~---------~~~~~-~~---------------------- 121 (181)
|||.+.+. .++.++|+||+|+++++|++|..||....... ....+ ..
T Consensus 183 aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (316)
T cd07842 183 APELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLM 262 (316)
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhh
Confidence 99987664 46889999999999999999999997654321 00000 00
Q ss_pred -cCCccCCC-----------CCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 122 -KGKRLEIP-----------RNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 122 -~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
.......+ ...+..+.+++.+|++.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 263 KDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred hhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000011 156678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-27 Score=176.68 Aligned_cols=162 Identities=23% Similarity=0.340 Sum_probs=124.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-----ccCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-----LSSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~~~p 76 (181)
+++.++..++.|++.||.|||+.| ++|+||+|.||+++.++.++++|||.+....... .......++..|++|
T Consensus 104 ~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 181 (337)
T cd07852 104 LEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCc
Confidence 577888899999999999999999 9999999999999999999999999886433221 112233567789999
Q ss_pred cccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC--------------------------C---cc
Q 030203 77 EVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG--------------------------K---RL 126 (181)
Q Consensus 77 e~~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~--------------------------~---~~ 126 (181)
|.+.+ ...+.++|+||+|+++|++++|+.||.+.........+.... . ..
T Consensus 182 E~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (337)
T cd07852 182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD 261 (337)
T ss_pred eeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchh
Confidence 98754 346788999999999999999999997765443222211000 0 00
Q ss_pred CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
.....++.++.+++.+|++.||.+|||+.++++ +++++.
T Consensus 262 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~--~~~~~~ 300 (337)
T cd07852 262 ELLPKASDDALDLLKKLLVFNPNKRLTAEEALE--HPYVAQ 300 (337)
T ss_pred hhccCCCHHHHHHHHHhccCCcccccCHHHHhh--Chhhhh
Confidence 112336889999999999999999999999998 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=177.63 Aligned_cols=162 Identities=24% Similarity=0.375 Sum_probs=126.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+++ ++|+||+|.||+++.++.++++|||++...... .....++..|++||...+
T Consensus 117 l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 117 LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLN 191 (345)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccccccccc---ccccccCCCccCHHHHhC
Confidence 577889999999999999999999 999999999999999999999999987653322 223456778999998765
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-C-----------------------Ccc-----CCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-G-----------------------KRL-----EIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~-----------------------~~~-----~~~~~ 131 (181)
..++.++|+||+|++++++++|+.||...+.......+... . ... .....
T Consensus 192 ~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (345)
T cd07877 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 271 (345)
T ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCC
Confidence 45678899999999999999999999766543322221100 0 000 01123
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
.++.+.+++.+|+..||.+||++.++++ ++++++...
T Consensus 272 ~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~f~~~~~ 308 (345)
T cd07877 272 ANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHD 308 (345)
T ss_pred CCHHHHHHHHHHcCCChhhcCCHHHHhc--ChhhhhcCC
Confidence 5788999999999999999999999999 888875443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=177.51 Aligned_cols=160 Identities=26% Similarity=0.368 Sum_probs=126.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+...... .....+++.|++||.+.+
T Consensus 115 l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 115 LSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILN 189 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhC
Confidence 578889999999999999999999 999999999999999999999999988654322 123355678999998865
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-----------------------------ccCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-----------------------------RLEIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~ 131 (181)
..++.++|+||+|++++++++|..||...+.......+..... .......
T Consensus 190 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (343)
T cd07880 190 WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPN 269 (343)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccC
Confidence 3477899999999999999999999987665433222110000 0012245
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
+++.+.+++.+|+..||.+|||+.++++ +++++..
T Consensus 270 ~~~~~~~li~~~l~~dP~~R~t~~~~l~--~~~~~~~ 304 (343)
T cd07880 270 ANPLAVNVLEKMLVLDAESRITAAEALA--HPYFEEF 304 (343)
T ss_pred CChHHHHHHHHHcCCChhhCCCHHHHhc--CccHhhh
Confidence 7888999999999999999999999997 7777654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=173.33 Aligned_cols=156 Identities=22% Similarity=0.297 Sum_probs=122.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.+||+.+ ++|+||+|.||+++.++.++++|||.+........ ......++..|++||.+.
T Consensus 97 ~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 174 (287)
T cd07840 97 FTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeE
Confidence 578899999999999999999999 99999999999999999999999998875443321 122334567899999776
Q ss_pred CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc-----------------------------CCCC
Q 030203 81 DE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL-----------------------------EIPR 130 (181)
Q Consensus 81 ~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~ 130 (181)
+. .++.++|+|++|++++++++|+.||...+.......+....... ....
T Consensus 175 ~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T cd07840 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKH 254 (287)
T ss_pred ccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcc
Confidence 53 46889999999999999999999998877654443332110000 0011
Q ss_pred CCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 131 NVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 131 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
.+++.+.+++.+|+..+|.+||++.++++
T Consensus 255 ~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 255 LIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 13788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=171.85 Aligned_cols=154 Identities=27% Similarity=0.497 Sum_probs=122.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.+++.++.|||+ .+ ++|+||+|+||+++.++.++++|||++...... ......++..|++||.+.
T Consensus 100 ~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~ 175 (284)
T cd06620 100 IPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQ 175 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccCccccCcccCCHHHHc
Confidence 4678889999999999999997 47 999999999999999999999999987543222 122346778999999988
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhccCCccCCC-CCCCHHHHHHHHHHhcCCC
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-----------QVVAAVGFKGKRLEIP-RNVNPHVASIIEACWANEP 148 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p 148 (181)
+...+.++|+||+|++++++++|..||...... .....+. .......+ ..++..+.+++.+|+..||
T Consensus 176 ~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp 254 (284)
T cd06620 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPSSDFPEDLRDFVDACLLKDP 254 (284)
T ss_pred cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCchhcCHHHHHHHHHHhcCCc
Confidence 777888999999999999999999999865542 1122221 11112222 2377899999999999999
Q ss_pred CCCCCHHHHHHH
Q 030203 149 WKRPSFSTIMEL 160 (181)
Q Consensus 149 ~~Rps~~~~l~~ 160 (181)
.+||++.++++.
T Consensus 255 ~~Rpt~~e~~~~ 266 (284)
T cd06620 255 TERPTPQQLCAM 266 (284)
T ss_pred ccCcCHHHHhcC
Confidence 999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=170.04 Aligned_cols=147 Identities=24% Similarity=0.291 Sum_probs=117.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... ....++..|++||...+
T Consensus 82 l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 82 IPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEVGGI 156 (237)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCcccCC
Confidence 578889999999999999999999 9999999999999999999999999765433321 12234567999999877
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH-----HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----ST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ 156 (181)
..++.++|+||+|++++++++|..++...... .. .......+..+++.+++++.+|++.||.+||++ .+
T Consensus 157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 230 (237)
T cd05576 157 SEETEACDWWSLGAILFELLTGKTLVECHPSG-IN-----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVED 230 (237)
T ss_pred CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc-----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHH
Confidence 77888999999999999999999887543211 00 112234566789999999999999999999986 55
Q ss_pred HHH
Q 030203 157 IME 159 (181)
Q Consensus 157 ~l~ 159 (181)
+++
T Consensus 231 ~~~ 233 (237)
T cd05576 231 IKS 233 (237)
T ss_pred HHc
Confidence 554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=176.84 Aligned_cols=165 Identities=28% Similarity=0.520 Sum_probs=145.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|+|+++..+++..++||.|||... -+||||+..||+++.+|..||.|||++-+.........+..|++.|++||++..
T Consensus 126 L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E 203 (502)
T KOG0574|consen 126 LSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE 203 (502)
T ss_pred ccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHH
Confidence 678999999999999999999998 899999999999999999999999999888877777888899999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
-+|...+|+||||+...+|..|++|+....+...+..+-.+.. ...-|..+|.++-+++.+||..+|++|.|+-++++
T Consensus 204 IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~- 282 (502)
T KOG0574|consen 204 IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE- 282 (502)
T ss_pred hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh-
Confidence 8999999999999999999999999988877665544432222 23456778999999999999999999999999999
Q ss_pred HHHhhhCCCC
Q 030203 161 LRPLIKSPTP 170 (181)
Q Consensus 161 L~~~~~~~~~ 170 (181)
+.+++.++.
T Consensus 283 -H~FiknA~g 291 (502)
T KOG0574|consen 283 -HTFIKNAPG 291 (502)
T ss_pred -hhhhcCCCc
Confidence 888777654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=163.67 Aligned_cols=166 Identities=20% Similarity=0.250 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc----cccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~~~pe 77 (181)
|+..++.+++.+++.||.|+|.+. ++|||+++.|++++.+|.+++.|||+++..... ....++.+.+.+|++||
T Consensus 121 ~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppE 198 (376)
T KOG0669|consen 121 FSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPE 198 (376)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHH
Confidence 466788999999999999999999 999999999999999999999999998532211 22245667789999999
Q ss_pred ccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC--CccCCCC------------------------
Q 030203 78 VLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG--KRLEIPR------------------------ 130 (181)
Q Consensus 78 ~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~------------------------ 130 (181)
.+.|. .+..+.|+|..||++.+|++|.+.+.+......+..+.... ...+.++
T Consensus 199 llLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv 278 (376)
T KOG0669|consen 199 LLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKV 278 (376)
T ss_pred HhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhh
Confidence 88775 48899999999999999999999999987765554432111 1111110
Q ss_pred -------CCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 131 -------NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 131 -------~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
.-+++..+|+++++..||.+|+.+++++. +.+|...+.+
T Consensus 279 ~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln--h~~F~kdp~p 324 (376)
T KOG0669|consen 279 KNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN--HDFFWKDPMP 324 (376)
T ss_pred hhhcccccCChhHHHHHHHHhccCcccCcchHhhhc--hhhhhcCCcc
Confidence 12346789999999999999999999999 8998876655
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=175.01 Aligned_cols=165 Identities=25% Similarity=0.436 Sum_probs=121.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc-------CCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS-------SKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-------~~~~~~~~~~~ 74 (181)
+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+++.||+........... .....+...|+
T Consensus 98 ~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 175 (328)
T cd08226 98 MSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175 (328)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCcc
Confidence 467888899999999999999999 999999999999999999999998643211110000 01112345699
Q ss_pred CCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC----------------------------
Q 030203 75 APEVLRDE--PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK---------------------------- 124 (181)
Q Consensus 75 ~pe~~~~~--~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~---------------------------- 124 (181)
+||.+.+. .++.++|+||+|++++++++|+.||.................
T Consensus 176 aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (328)
T cd08226 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIG 255 (328)
T ss_pred ChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccc
Confidence 99998663 367899999999999999999999987654433222110000
Q ss_pred -----------------ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 125 -----------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 125 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
....+..+++.+.+++.+||..||.+|||+.++++ ++|++....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~--~~~~~~~~~ 316 (328)
T cd08226 256 ESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS--HAFFKQVKE 316 (328)
T ss_pred cchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh--CHHHHHHHH
Confidence 00112235678999999999999999999999998 777765443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=176.10 Aligned_cols=160 Identities=23% Similarity=0.396 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC--------------------CCcEEEcccCCcccccccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK--------------------KYTVKVCDFGLSRLKANTF 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~--------------------~~~~~l~d~g~~~~~~~~~ 61 (181)
++...+..|++|++.++.+||+.+ ++|.|+||+||++.. +..++++|||.++......
T Consensus 189 fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 189 FPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc
Confidence 456789999999999999999999 999999999999831 2357899999987654432
Q ss_pred ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhccCC--------------
Q 030203 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ---VVAAVGFKGK-------------- 124 (181)
Q Consensus 62 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~---~~~~~~~~~~-------------- 124 (181)
...+.|..|.|||++.+.+++...||||+||+++|+.+|..-|...+..+ +.+++ .+.
T Consensus 267 ---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI--lGp~P~~mi~r~~~~Ky 341 (415)
T KOG0671|consen 267 ---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI--LGPIPSRMIKKTRKEKY 341 (415)
T ss_pred ---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh--hCCCcHHHhhhhhhHhh
Confidence 44577889999999999999999999999999999999999887765433 22222 110
Q ss_pred ----ccCCCC-------------------------CCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 125 ----RLEIPR-------------------------NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 125 ----~~~~~~-------------------------~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
+...+. .-..++.+|+++||.+||.+|+|++|++. +++|+...+
T Consensus 342 f~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~--HpFF~~~~~ 414 (415)
T KOG0671|consen 342 FRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS--HPFFARLTP 414 (415)
T ss_pred hhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc--CHHhhcCCC
Confidence 011000 01125889999999999999999999999 999887654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=193.92 Aligned_cols=159 Identities=21% Similarity=0.232 Sum_probs=115.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc-------------------EEEcccCCcccccccc-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-------------------VKVCDFGLSRLKANTF- 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~-------------------~~l~d~g~~~~~~~~~- 61 (181)
+++.+++.++.||+.||.|||++| |+||||||+||+++..|. ++++|||+++......
T Consensus 77 ~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~ 154 (793)
T PLN00181 77 VDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSE 154 (793)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccc
Confidence 578899999999999999999999 999999999999965444 4555555554211000
Q ss_pred ---------------ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc
Q 030203 62 ---------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 126 (181)
Q Consensus 62 ---------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 126 (181)
.......+++.|+|||.+.+..++.++||||+||++|+|++|..|+..... ....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~ 232 (793)
T PLN00181 155 RRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPP 232 (793)
T ss_pred cchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcCh
Confidence 000113467789999999888899999999999999999999888754322 111111111111
Q ss_pred CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
... ...+...+++.+||..+|.+||++.++++ ++++..
T Consensus 233 ~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~--h~~~~~ 270 (793)
T PLN00181 233 QIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQ--SEFINE 270 (793)
T ss_pred hhh-hcCHHHHHHHHHhCCCChhhCcChHHHhh--chhhhh
Confidence 111 12456778999999999999999999998 777754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=168.19 Aligned_cols=155 Identities=27% Similarity=0.406 Sum_probs=120.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.+|.|||+++ ++|+||+|.||+++.++.++++|||.+....... ......++..|++||....
T Consensus 96 ~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~ 172 (283)
T cd07830 96 FSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTDYVSTRWYRAPEILLR 172 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCCCCCcccccCceeeec
Confidence 578899999999999999999999 9999999999999999999999999886543321 1123456678999998754
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CC---------------------------ccCCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GK---------------------------RLEIPRNV 132 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~ 132 (181)
...+.++|+||+|++++++++|+.||......+........ .. ........
T Consensus 173 ~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd07830 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA 252 (283)
T ss_pred CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccC
Confidence 44688999999999999999999999776554433222100 00 00011123
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..+.+++.+|+..+|.+||++++++.
T Consensus 253 ~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 253 SPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=164.49 Aligned_cols=155 Identities=32% Similarity=0.490 Sum_probs=126.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++++|||.+....... ......+...|++||...+
T Consensus 84 ~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~ 160 (244)
T smart00220 84 LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLG 160 (244)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHcc
Confidence 467889999999999999999999 9999999999999999999999999887544432 2234456778999999887
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCccCCCCC-CCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKGKRLEIPRN-VNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...+.++|+|++|++++++++|..||.. .+.......+............ ++..+.+++.+|+..+|.+||++.++++
T Consensus 161 ~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 161 KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 7788899999999999999999999987 5555555544322222111111 8889999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=170.42 Aligned_cols=162 Identities=25% Similarity=0.384 Sum_probs=124.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.+|.|||+.+ ++|+||+|.||+++.++.++++|||++........ ......++..|.+||...
T Consensus 102 ~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (288)
T cd05583 102 FTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179 (288)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhc
Confidence 567888999999999999999999 99999999999999999999999998764332211 112234677899999886
Q ss_pred CCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 81 DEP--SNEKSDIYSFGVILWELATLQQPWGNLNP----AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 81 ~~~--~~~~~Dv~slG~~~~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
+.. .+.++|+|++|+++++|++|..||..... ..+...+ .......+..+++.+.+++.+||+.||.+|||+
T Consensus 180 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~ 257 (288)
T cd05583 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGA 257 (288)
T ss_pred CCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCcccCHHHHHHHHHHhcCCHhhccCc
Confidence 654 67889999999999999999999964322 2222222 222345566788999999999999999999997
Q ss_pred HHHHHHHH-HhhhC
Q 030203 155 STIMELLR-PLIKS 167 (181)
Q Consensus 155 ~~~l~~L~-~~~~~ 167 (181)
.++.+.|+ .+++.
T Consensus 258 ~~~~~~l~~~~~~~ 271 (288)
T cd05583 258 NGADEIKNHPFFQG 271 (288)
T ss_pred chHHHHhcCccccc
Confidence 76655554 44443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=189.58 Aligned_cols=151 Identities=29% Similarity=0.528 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccc------c------------ccccCC
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA------N------------TFLSSK 65 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~------~------------~~~~~~ 65 (181)
-...|+++.+|+.||.|+|++| ++||||||.|||++.++++|++|||+++... . .....+
T Consensus 696 ~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T 773 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT 773 (1351)
T ss_pred hHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence 4578999999999999999999 9999999999999999999999999987411 0 011234
Q ss_pred CCCCCCCccCCcccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCccC--CCCCCCHHHHHH
Q 030203 66 SAAGTPEWMAPEVLRDEP---SNEKSDIYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKGKRLE--IPRNVNPHVASI 139 (181)
Q Consensus 66 ~~~~~~~~~~pe~~~~~~---~~~~~Dv~slG~~~~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 139 (181)
..+||-.|.|||.+.+.. |+.++|+||||++++||+. ||.. +....++..+.....+.+ ....--+.-+.+
T Consensus 774 s~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 774 SQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASL 850 (1351)
T ss_pred cccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHH
Confidence 568889999999997655 8999999999999999976 3544 344455555542222222 011122345789
Q ss_pred HHHHhcCCCCCCCCHHHHHH
Q 030203 140 IEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 140 i~~~l~~~p~~Rps~~~~l~ 159 (181)
|.+|++.||.+|||+.++|+
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999998
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=168.69 Aligned_cols=161 Identities=30% Similarity=0.529 Sum_probs=141.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccc--ccccccCCCCCCCCCccCCcccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~--~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+..|...++.|++.|+.|||..+ ++|.||...|.++++.-.+|++|-.+++-. .+....+.+......|+++|.+.
T Consensus 394 tt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~ 471 (563)
T KOG1024|consen 394 TTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ 471 (563)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHh
Confidence 45678899999999999999999 999999999999999999999998877632 12222333444556899999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...|++.+|+||||+++||+++ |+.|+..-++.++..+++ .+.+...|.++++++..++.-||+..|++||++.++..
T Consensus 472 n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 472 NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999999999999997 899999999999998886 88889999999999999999999999999999999999
Q ss_pred HHHHhhh
Q 030203 160 LLRPLIK 166 (181)
Q Consensus 160 ~L~~~~~ 166 (181)
+|.++-.
T Consensus 551 cLseF~~ 557 (563)
T KOG1024|consen 551 CLSEFHT 557 (563)
T ss_pred HHHHHHH
Confidence 9987643
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=170.84 Aligned_cols=161 Identities=25% Similarity=0.449 Sum_probs=124.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||.+...... .....++..|++||.+.+
T Consensus 105 ~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 105 LEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC---cCCCcccccccCceeeec
Confidence 456778889999999999999999 999999999999999999999999987643221 123355678999998765
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------------cCCcc-----CCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF------------------------KGKRL-----EIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~------------------------~~~~~-----~~~~~ 131 (181)
..++.++|+|++|++++++++|+.||...........+.. ..... .....
T Consensus 180 ~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (328)
T cd07856 180 WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKN 259 (328)
T ss_pred cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCC
Confidence 4578899999999999999999999977654321111100 00000 01134
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
+++.+.+++.+|+..+|.+||++.+++. ++++....
T Consensus 260 ~~~~~~~li~~~l~~~P~~R~t~~ell~--~~~~~~~~ 295 (328)
T cd07856 260 ADPSAIDLLEKMLVFDPQKRISAAEALA--HPYLAPYH 295 (328)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc--CCcccccc
Confidence 6789999999999999999999999998 77776433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=168.29 Aligned_cols=161 Identities=25% Similarity=0.384 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||++....... .......++..|++||...
T Consensus 102 l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (290)
T cd05613 102 FKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhcc
Confidence 567888899999999999999999 9999999999999999999999999876433221 1122345677899999886
Q ss_pred CC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC--
Q 030203 81 DE--PSNEKSDIYSFGVILWELATLQQPWGNLNP----AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-- 152 (181)
Q Consensus 81 ~~--~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-- 152 (181)
+. ..+.++|+|++|+++|++++|..||..... ..+...+. ....+.+..+++.+.+++.+|+..||.+||
T Consensus 180 ~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred CCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh--ccCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 53 356789999999999999999999964322 22333222 223345667889999999999999999997
Q ss_pred ---CHHHHHHHHHHhhhCC
Q 030203 153 ---SFSTIMELLRPLIKSP 168 (181)
Q Consensus 153 ---s~~~~l~~L~~~~~~~ 168 (181)
++.++++ +++++..
T Consensus 258 ~~~~~~~l~~--~~~~~~~ 274 (290)
T cd05613 258 GPSDADEIKK--HPFFQKI 274 (290)
T ss_pred CCCCHHHHHc--CcccccC
Confidence 7888877 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=186.53 Aligned_cols=166 Identities=31% Similarity=0.604 Sum_probs=145.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCC--CCCccCCccc
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAG--TPEWMAPEVL 79 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~--~~~~~~pe~~ 79 (181)
+.-|..-|++.|+.|.+||-+.+ +||||+.+.|||++.+-.+|++|||+++...+.. ....+..| ...|+|||.+
T Consensus 729 tviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAI 806 (996)
T KOG0196|consen 729 TVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAI 806 (996)
T ss_pred EeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHh
Confidence 34577889999999999999999 9999999999999999999999999998654332 22233322 3589999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
..+.+++++||||+|++|||.+ .|..|+......+.+..+. .+.+++.|-.++..+.+|+..||+.|-.+||++.+|+
T Consensus 807 a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV 885 (996)
T KOG0196|consen 807 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIV 885 (996)
T ss_pred hhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHH
Confidence 9999999999999999999977 6999999999999888886 7788888999999999999999999999999999999
Q ss_pred HHHHHhhhCCCCC
Q 030203 159 ELLRPLIKSPTPQ 171 (181)
Q Consensus 159 ~~L~~~~~~~~~~ 171 (181)
..|+.+++++.+-
T Consensus 886 ~~lDklIrnP~SL 898 (996)
T KOG0196|consen 886 STLDKLIRNPNSL 898 (996)
T ss_pred HHHHHHhcCchhh
Confidence 9999998876543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=169.63 Aligned_cols=147 Identities=27% Similarity=0.515 Sum_probs=132.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
.|..+.-++.+|+-||-+||++| |++||++.+||+++..|++|+.|||+++...-......+..|++.|+|||++...
T Consensus 448 KEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Yq 525 (683)
T KOG0696|consen 448 KEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQ 525 (683)
T ss_pred CCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEec
Confidence 45567788999999999999999 9999999999999999999999999998766666677888999999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 83 PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 83 ~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
+|..++|.|++|+++|+|+.|++||.+.+.+++.+.+. .-.-.+|..+|.+..++....+..+|.+|..
T Consensus 526 PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--ehnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 526 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--EHNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 99999999999999999999999999999999888884 3334567889999999999999999999974
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=164.58 Aligned_cols=170 Identities=26% Similarity=0.428 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC----CcEEEcccCCccccccccc---cCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK----YTVKVCDFGLSRLKANTFL---SSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~----~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~ 74 (181)
++...+..|+.||+.|+.|||++= ++|||+||.||++..+ |.+|++|+|+++.+.++-. .....+.+.+|.
T Consensus 129 lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYR 206 (438)
T KOG0666|consen 129 LPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYR 206 (438)
T ss_pred CCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEec
Confidence 566678899999999999999998 9999999999999766 8999999999998776532 234456788999
Q ss_pred CCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH-hccCCcc--------CCC------
Q 030203 75 APEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPA---------QVVAAV-GFKGKRL--------EIP------ 129 (181)
Q Consensus 75 ~pe~~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---------~~~~~~-~~~~~~~--------~~~------ 129 (181)
|||.+.|.. |+.+.|+|++||++.|+++.++.|.+.... +...++ ...+.+. .+|
T Consensus 207 APELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~l 286 (438)
T KOG0666|consen 207 APELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLL 286 (438)
T ss_pred ChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHH
Confidence 999998755 899999999999999999988887654211 111111 1011100 000
Q ss_pred --------------------CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCCCCC
Q 030203 130 --------------------RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPT 175 (181)
Q Consensus 130 --------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~~~~ 175 (181)
..-++...+|+.++|..||.+|.|+.++++ +.+|+..+.+|.|.
T Consensus 287 s~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle--h~yF~~d~lpp~pt 350 (438)
T KOG0666|consen 287 SDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE--HPYFTEDPLPPLPT 350 (438)
T ss_pred HHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc--ccccccCCCCCCcc
Confidence 112345778999999999999999999999 99999877766554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-25 Score=180.31 Aligned_cols=162 Identities=35% Similarity=0.699 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCC--CCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAA--GTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~--~~~~~~~pe~ 78 (181)
++..+.+.++.||+.|.+||++.. ++|||+...||+++.+..+|++|||+++..... ........ -...|+|||.
T Consensus 415 L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEs 492 (609)
T KOG0200|consen 415 LTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPES 492 (609)
T ss_pred cCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHH
Confidence 567889999999999999999999 999999999999999999999999999843332 11111112 2346999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLN-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+..++.++||||+|+++||+.+ |..|+.+.. ..++.+.+. .+.+...|..+++++.+++..||+.+|.+||++.+
T Consensus 493 l~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~-~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~ 571 (609)
T KOG0200|consen 493 LFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK-EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE 571 (609)
T ss_pred hccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 999889999999999999999997 788998865 555555454 77788889999999999999999999999999999
Q ss_pred HHHHHHHhhh
Q 030203 157 IMELLRPLIK 166 (181)
Q Consensus 157 ~l~~L~~~~~ 166 (181)
+.+.+...+.
T Consensus 572 ~~~~~~~~l~ 581 (609)
T KOG0200|consen 572 CVEFFEKHLQ 581 (609)
T ss_pred HHHHHHHHHH
Confidence 9999998654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=180.04 Aligned_cols=162 Identities=18% Similarity=0.158 Sum_probs=113.6
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccCCC
Q 030203 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
..+..++.|++.||.|||+++ ++|+||||+||+++. ++.++++|||++...... ........+++.|++||.+...
T Consensus 255 ~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~ 332 (566)
T PLN03225 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS 332 (566)
T ss_pred HHHHHHHHHHHHHHHHHHHCC--EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhcc
Confidence 346689999999999999999 999999999999985 678999999998643221 1122345678899999965322
Q ss_pred ----------------------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc---------c-----
Q 030203 83 ----------------------PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR---------L----- 126 (181)
Q Consensus 83 ----------------------~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------~----- 126 (181)
.+..+.|+||+||++|+|+++..++.... ......+...... .
T Consensus 333 ~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 411 (566)
T PLN03225 333 TQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPD 411 (566)
T ss_pred CCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchh
Confidence 12345699999999999999776654321 1111111100000 0
Q ss_pred -----CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 127 -----EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 127 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
+.....+....+|+.+||..||.+|||++++++ ++|++.....
T Consensus 412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~--Hpff~~~~~~ 459 (566)
T PLN03225 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA--HPYFDREGLL 459 (566)
T ss_pred hhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC--CcCcCCCCcc
Confidence 001112234568999999999999999999999 8999865543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=184.07 Aligned_cols=161 Identities=25% Similarity=0.405 Sum_probs=136.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccc-cccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-NTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~-~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++|+-+.-++.+|+.||..+|+.| +|||||||+||++|..|+++|.|||.+-... ++.....+.+|||.|.+||+++
T Consensus 172 ~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLq 249 (1317)
T KOG0612|consen 172 LPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQ 249 (1317)
T ss_pred ChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHH
Confidence 678888999999999999999999 9999999999999999999999999765433 5555566789999999999996
Q ss_pred C-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCC--CCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 81 D-----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP--RNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 81 ~-----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
. +.|....|.||+|+++|+|+.|.-||.........-+|.........| ..+|++.++||.+.+ -+|..|..
T Consensus 250 s~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLg 328 (1317)
T KOG0612|consen 250 SQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLG 328 (1317)
T ss_pred hhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcc
Confidence 3 347789999999999999999999999988887777776554444444 569999999999998 67888887
Q ss_pred ---HHHHHHHHHHhhhC
Q 030203 154 ---FSTIMELLRPLIKS 167 (181)
Q Consensus 154 ---~~~~l~~L~~~~~~ 167 (181)
+.++.. |++|.+
T Consensus 329 rngiedik~--HpFF~g 343 (1317)
T KOG0612|consen 329 RNGIEDIKN--HPFFEG 343 (1317)
T ss_pred cccHHHHHh--CccccC
Confidence 999888 777653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=161.90 Aligned_cols=148 Identities=26% Similarity=0.497 Sum_probs=127.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|+-+..+--+|+.||.|||++| |+++|+|.+|++++..|++||+|||+++....+.....+..|++.|.|||++++
T Consensus 348 lpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrg 425 (593)
T KOG0695|consen 348 LPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 425 (593)
T ss_pred CcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcc
Confidence 567788888899999999999999 999999999999999999999999999877777777788899999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCC-------C-HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNL-------N-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~-------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
..|.+++|.|+||+++++|+.|+.||.-. + .+.+.+.+ ......+|..+|-....+++..|..||++|..
T Consensus 426 eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--lekqiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 426 EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--LEKQIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--hhhcccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 99999999999999999999999999432 1 12222222 44556678888888899999999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=159.87 Aligned_cols=159 Identities=27% Similarity=0.355 Sum_probs=125.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
+-+.+.++++|++.|+.|||+.+ |+|||+||+||++..++.+|+.|||+++...... .-...+.+..|.|||.+.+.
T Consensus 116 DH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~-~mtpyVvtRyyrapevil~~ 192 (369)
T KOG0665|consen 116 DHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF-MMTPYVVTRYYRAPEVILGM 192 (369)
T ss_pred chHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccCccc-ccCchhheeeccCchheecc
Confidence 44677899999999999999999 9999999999999999999999999987655442 22345667789999999999
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccCCc-------------------c----------------
Q 030203 83 PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKGKR-------------------L---------------- 126 (181)
Q Consensus 83 ~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~-~~~~~~-------------------~---------------- 126 (181)
++...+|+||+||++.+|++|..-|.+.+.-+...++ ...+.. .
T Consensus 193 ~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f 272 (369)
T KOG0665|consen 193 GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLF 272 (369)
T ss_pred CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccc
Confidence 9999999999999999999999988876543322221 000000 0
Q ss_pred ----CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 127 ----EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 127 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
+.+..-+..+++++.+||..||++|.+++++|+ |+.++
T Consensus 273 ~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~--HPY~~ 314 (369)
T KOG0665|consen 273 PVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR--HPYIK 314 (369)
T ss_pred cccccCCccchHHHHHHHHHhhccChhhcccHHHHhc--CCeee
Confidence 000112235889999999999999999999999 88885
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=173.63 Aligned_cols=151 Identities=36% Similarity=0.710 Sum_probs=133.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc---cccCCCCCCCCCccCCcccCCC
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT---FLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
....++.||+.|+.||.+++ ++|||+...|+++-....+|++|||+.+-.... +...........|.+||.++.+
T Consensus 213 ~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~ 290 (1039)
T KOG0199|consen 213 RLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR 290 (1039)
T ss_pred HHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc
Confidence 34568999999999999999 999999999999988889999999998743322 1222334556689999999999
Q ss_pred CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 83 PSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 83 ~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
.++.++|+|++|+++|||.+ |..||.+....+++++++ .+.+++-+..+++++.+++..||..+|.+|||+..|.+
T Consensus 291 kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 291 KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 99999999999999999996 899999999999999998 77788888999999999999999999999999999975
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-26 Score=175.55 Aligned_cols=157 Identities=27% Similarity=0.461 Sum_probs=136.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
.+..+..++.|+.+|+.|||+++ ++|+|++++|++++.+.+++++|||++...... ....+..+++.|.|||+..+.
T Consensus 153 ~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~~lqt~cgsppyAaPEl~~g~ 229 (596)
T KOG0586|consen 153 KEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDYG-LMLQTFCGSPPYAAPELFNGK 229 (596)
T ss_pred hhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeeccc-ccccccCCCCCccChHhhcCc
Confidence 45788899999999999999999 999999999999999999999999998766633 344677899999999999988
Q ss_pred CC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 83 PS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 83 ~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
.+ .+.+|+|++|+++|.+++|..||.+.+...+..++ ......++..++-++.++|.+++..+|.+|++++++++
T Consensus 230 ~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv--l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~-- 305 (596)
T KOG0586|consen 230 KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV--LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK-- 305 (596)
T ss_pred ccCCcceehhhhhhhheeeeecccccCCcccccccchh--eeeeecccceeechhHHHHHHhhccCccccCCHHHhhh--
Confidence 75 57899999999999999999999998877777666 44445567778899999999999999999999999988
Q ss_pred HHhhh
Q 030203 162 RPLIK 166 (181)
Q Consensus 162 ~~~~~ 166 (181)
+.|..
T Consensus 306 ~~W~n 310 (596)
T KOG0586|consen 306 DRWRN 310 (596)
T ss_pred hcccc
Confidence 55543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=169.73 Aligned_cols=160 Identities=38% Similarity=0.653 Sum_probs=138.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCC-CCCCCCCccCCcccCCCCC
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK-SAAGTPEWMAPEVLRDEPS 84 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~ 84 (181)
-.++|+.||.+|+.||..++ ++|||+...|.+++.+..+|+.|||+++.......... ...-...|++||.+....+
T Consensus 366 vLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtF 443 (1157)
T KOG4278|consen 366 VLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTF 443 (1157)
T ss_pred HHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCccccccccc
Confidence 45789999999999999999 99999999999999999999999999986544322221 1222357999999988889
Q ss_pred CCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 030203 85 NEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 163 (181)
Q Consensus 85 ~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~ 163 (181)
+.++|||+||+++|++.| |..|+.+.+......-+. ++.+..-|..|++.+..|+..||+.+|..||+++++-+.++.
T Consensus 444 SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 444 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 999999999999999996 999999998877666554 778888899999999999999999999999999999999998
Q ss_pred hhhCC
Q 030203 164 LIKSP 168 (181)
Q Consensus 164 ~~~~~ 168 (181)
++...
T Consensus 523 mf~~s 527 (1157)
T KOG4278|consen 523 MFSSS 527 (1157)
T ss_pred Hhccc
Confidence 87653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-26 Score=162.02 Aligned_cols=159 Identities=25% Similarity=0.481 Sum_probs=122.9
Q ss_pred CHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+|+-.-+|..-.+.||.||... + ++|||+||+||+++..|.+||+|||.+-...... ..+...|...|+|||.+..
T Consensus 165 pE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-AkT~daGCrpYmAPERi~p 241 (361)
T KOG1006|consen 165 PENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-AKTVDAGCRPYMAPERIDP 241 (361)
T ss_pred cHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHHH-HhhhccCCccccChhccCC
Confidence 4444456666778899999877 5 9999999999999999999999999976544432 3345677889999999853
Q ss_pred --CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCc-cCCC---CCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 82 --EPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKR-LEIP---RNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 82 --~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~---~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
.+|+.++|+||||++++|+.||..|+...+.. +.+..+.....+ ...+ -+++..+..+|+.|+..|-..||++
T Consensus 242 ~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky 321 (361)
T KOG1006|consen 242 SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKY 321 (361)
T ss_pred ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcch
Confidence 35889999999999999999999999887653 333333323222 1222 2478899999999999999999999
Q ss_pred HHHHHHHHHhhh
Q 030203 155 STIMELLRPLIK 166 (181)
Q Consensus 155 ~~~l~~L~~~~~ 166 (181)
.++.+ .++.+
T Consensus 322 ~~Lk~--~~fyr 331 (361)
T KOG1006|consen 322 DDLKK--FPFYR 331 (361)
T ss_pred hhhhc--Cchhh
Confidence 99987 44443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=150.76 Aligned_cols=161 Identities=19% Similarity=0.317 Sum_probs=125.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
|+..++...+.++++||.|+|++| |.|||++|.|++++. ...++|+|+|++..+... ......+.+..|..||.+.
T Consensus 129 l~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-~eYnVRVASRyfKGPELLV 205 (338)
T KOG0668|consen 129 LTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLV 205 (338)
T ss_pred hchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCC-ceeeeeeehhhcCCchhee
Confidence 456678899999999999999999 999999999999976 567999999999875543 3455566777889999998
Q ss_pred CCC-CCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhccCC----------------------------------
Q 030203 81 DEP-SNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKGK---------------------------------- 124 (181)
Q Consensus 81 ~~~-~~~~~Dv~slG~~~~~ll~g~~p~-~~~~~~~~~~~~~~~~~---------------------------------- 124 (181)
..+ ++.+.|+||+||++..|++.+.|| .+.+..+.+.++.....
T Consensus 206 dy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~F 285 (338)
T KOG0668|consen 206 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRF 285 (338)
T ss_pred echhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHh
Confidence 765 789999999999999999998887 33333333322211000
Q ss_pred -ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 125 -RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 125 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
..+....++++..++++++|..|-.+|+|++|.+. ++++..
T Consensus 286 i~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~--HpyF~~ 327 (338)
T KOG0668|consen 286 INSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA--HPYFAP 327 (338)
T ss_pred CCccccccCChHHHHHHHHHHhhccccccchHHHhc--CchHHH
Confidence 00122346789999999999999999999999998 777654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=145.95 Aligned_cols=164 Identities=22% Similarity=0.308 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++.+-+..++.|++.+|.++|+.+ +.|+|++|.|.+++.+|.+|+.|||+++-.+-+.......+.+.+|.+|..+.+
T Consensus 98 ~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 98 LDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_pred CCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeee
Confidence 456778889999999999999999 999999999999999999999999999887777767777788999999999988
Q ss_pred CC-CCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhccCCcc---CCC------------------------CCC
Q 030203 82 EP-SNEKSDIYSFGVILWELA-TLQQPWGNLNPAQVVAAVGFKGKRL---EIP------------------------RNV 132 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~---~~~------------------------~~~ 132 (181)
.. |+.+.|+||.||++.++. .|.+-|.+.+..+...++-..-... ..| +.+
T Consensus 176 akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~l 255 (292)
T KOG0662|consen 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKL 255 (292)
T ss_pred eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhh
Confidence 66 788999999999999998 5888899998887776652211111 000 122
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
+..-++++++++.-+|.+|.++++.++ ++.+.+..
T Consensus 256 ns~grdllqkll~cnp~qrisaeaalq--hpyf~d~s 290 (292)
T KOG0662|consen 256 NSTGRDLLQKLLKCNPAQRISAEAALQ--HPYFSDFS 290 (292)
T ss_pred cchhHHHHHHHhccCcccccCHHHHhc--CccccccC
Confidence 335679999999999999999999998 77776543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-24 Score=170.56 Aligned_cols=164 Identities=33% Similarity=0.594 Sum_probs=142.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC--CCCCCCCCccCCcccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVLR 80 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~~ 80 (181)
--++.+.|++||++|+.|||.+. ++||||-..||++....++|+.|||+++.......+. ......+.|++-|.++
T Consensus 796 gsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~ 873 (1177)
T KOG1025|consen 796 GSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR 873 (1177)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhh
Confidence 34678899999999999999999 9999999999999999999999999998655433333 2334456799999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...+++.+||||+|+++||++| |..|+.+..-.++-..+. .+.++..|+.++.++..++.+||..|+..||+++++..
T Consensus 874 ~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 874 IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999996 999999998888777776 56668889999999999999999999999999999999
Q ss_pred HHHHhhhCCC
Q 030203 160 LLRPLIKSPT 169 (181)
Q Consensus 160 ~L~~~~~~~~ 169 (181)
.+....+.+.
T Consensus 953 ~fs~~ardpq 962 (1177)
T KOG1025|consen 953 EFSRMARDPQ 962 (1177)
T ss_pred HHHHHhcCcc
Confidence 8887776643
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=172.35 Aligned_cols=159 Identities=28% Similarity=0.460 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC---CcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
|+|.-...++.||+.||+|||.++ |+|+|+||+||++... -++||+|||+++..++.... ...+|++.|+|||.
T Consensus 661 L~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-rsVVGTPAYLaPEV 737 (888)
T KOG4236|consen 661 LPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-RSVVGTPAYLAPEV 737 (888)
T ss_pred chHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhh-hhhcCCccccCHHH
Confidence 355556678899999999999999 9999999999999553 36899999999987775433 45689999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
++..+|..+.|+||+|+++|.-++|..||+... ++.++++.... +...+.+++++..+||+.+|+..=.+|.|.+.
T Consensus 738 LrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 738 LRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred HhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHh
Confidence 999999999999999999999999999997753 33344433332 33345679999999999999999999999998
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
.+. +.|+++
T Consensus 816 ~ls--h~Wlq~ 824 (888)
T KOG4236|consen 816 SLS--HPWLQD 824 (888)
T ss_pred hcc--chhhhc
Confidence 887 666654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=176.55 Aligned_cols=160 Identities=28% Similarity=0.473 Sum_probs=124.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---C--CcEEEcccCCccccccc---cccCCCCCCCCCccCCc
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---K--YTVKVCDFGLSRLKANT---FLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~--~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~~~pe 77 (181)
..+.++.|+++||.|||+.+ |+|||+||.||+++. + ..++++|||+++..... .....+..|+.+|.|||
T Consensus 607 ~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE 684 (903)
T KOG1027|consen 607 DPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPE 684 (903)
T ss_pred cHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHH
Confidence 34678999999999999999 999999999999966 3 45789999999864433 22234567889999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+....-+.++|+||+||++|+.++| .+||......+.. +..... ...+...-..+..+||.+|++++|..||++.
T Consensus 685 ~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~ 762 (903)
T KOG1027|consen 685 QLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSAT 762 (903)
T ss_pred HHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHH
Confidence 99988878899999999999999975 9999887654432 211221 1222222222889999999999999999999
Q ss_pred HHHHHHHHhhhCCCCC
Q 030203 156 TIMELLRPLIKSPTPQ 171 (181)
Q Consensus 156 ~~l~~L~~~~~~~~~~ 171 (181)
+++. |++|...+++
T Consensus 763 ~VL~--HPlFW~~ekr 776 (903)
T KOG1027|consen 763 DVLN--HPLFWDSEKR 776 (903)
T ss_pred HHhC--CCccCChHHH
Confidence 9998 8877765543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=179.73 Aligned_cols=162 Identities=25% Similarity=0.331 Sum_probs=117.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHH---hCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLH---RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh---~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.++.+++.|++.|+.||| +.+ ++|+|++|+||+++.++..++. ++....... .....++..|+|||.
T Consensus 777 l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~ 849 (968)
T PLN00113 777 LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPET 849 (968)
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCccc
Confidence 578899999999999999999 557 9999999999999988777664 443322111 122356789999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcc-----CCccCCC------CCCCHHHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-----PAQVVAAVGFK-----GKRLEIP------RNVNPHVASIIEA 142 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-----~~~~~~~~~~~-----~~~~~~~------~~~~~~~~~li~~ 142 (181)
..+..++.++||||+|+++|||++|+.||.... ........... ....... .....++.+++.+
T Consensus 850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 929 (968)
T PLN00113 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH 929 (968)
T ss_pred ccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHh
Confidence 988889999999999999999999999985421 11111110000 0000111 1112256789999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 143 CWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 143 ~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
|++.||.+||+++++++.|+...+..+.
T Consensus 930 Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 930 CTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred hCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 9999999999999999999998775543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=172.51 Aligned_cols=161 Identities=27% Similarity=0.500 Sum_probs=139.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+.|..+++|+..++.|+.+||.+. ++|+||+..||+++.+|.+||.|||++.+.........+.+|++.|+|||++..
T Consensus 120 l~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac 197 (953)
T KOG0587|consen 120 LKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIAC 197 (953)
T ss_pred hhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeec
Confidence 568889999999999999999999 999999999999999999999999999888877777788899999999998853
Q ss_pred -----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-cCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 82 -----EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-LEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 82 -----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
..|+.++|+||||++..+|.-|.+|+....+...+..+-.+..+ +.-+..+++++-++|..||..|..+||+..
T Consensus 198 ~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~ 277 (953)
T KOG0587|consen 198 DESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTE 277 (953)
T ss_pred ccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchh
Confidence 33678999999999999999999999998887766544322221 223567899999999999999999999999
Q ss_pred HHHHHHHHhhh
Q 030203 156 TIMELLRPLIK 166 (181)
Q Consensus 156 ~~l~~L~~~~~ 166 (181)
++++ +.+++
T Consensus 278 ~ll~--hpFi~ 286 (953)
T KOG0587|consen 278 ELLK--HPFIT 286 (953)
T ss_pred hhcc--CCccc
Confidence 9998 76666
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=159.50 Aligned_cols=163 Identities=23% Similarity=0.418 Sum_probs=129.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCccccccccc-------cCCCCCCC
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTFL-------SSKSAAGT 70 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~ 70 (181)
+++|+++..|++||+.||.||.+.+++|+|.|++|.||++-. -|.+|+.|||+++....... ......|+
T Consensus 564 lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGT 643 (775)
T KOG1151|consen 564 LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGT 643 (775)
T ss_pred hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCce
Confidence 478999999999999999999999999999999999999943 57899999999985443321 22345788
Q ss_pred CCccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcc---CCccCCCCCCCHHHHHHHHH
Q 030203 71 PEWMAPEVLRDE----PSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFK---GKRLEIPRNVNPHVASIIEA 142 (181)
Q Consensus 71 ~~~~~pe~~~~~----~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~ 142 (181)
.+|++||.+.-. ..+.++||||+|+++|+++.|+.||..... .++++...+. ....+..+.++.+.+++|.+
T Consensus 644 YWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRR 723 (775)
T KOG1151|consen 644 YWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRR 723 (775)
T ss_pred eeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHH
Confidence 999999988644 247799999999999999999999987643 3444433222 22344557799999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHhh
Q 030203 143 CWANEPWKRPSFSTIMELLRPLI 165 (181)
Q Consensus 143 ~l~~~p~~Rps~~~~l~~L~~~~ 165 (181)
||++--..|....++.. ++++
T Consensus 724 CLaYRKeDR~DV~qLA~--dpyl 744 (775)
T KOG1151|consen 724 CLAYRKEDRIDVQQLAC--DPYL 744 (775)
T ss_pred HHHhhhhhhhhHHHHcc--Cccc
Confidence 99999999999888876 4444
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=152.38 Aligned_cols=161 Identities=24% Similarity=0.417 Sum_probs=124.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC---cEEEcccCCccccccc-------cccCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANT-------FLSSKSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~---~~~l~d~g~~~~~~~~-------~~~~~~~~~~~ 71 (181)
|+|.++..+.+.|+.||.+||.+| |.|||+||+||+-.... -+|++||.+....... .....+.+|+-
T Consensus 173 F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSA 250 (463)
T KOG0607|consen 173 FNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSA 250 (463)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccch
Confidence 789999999999999999999999 99999999999986543 4799999876421111 11224457778
Q ss_pred CccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHHhccCCcc--CCC
Q 030203 72 EWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNLNP---------------AQVVAAVGFKGKRL--EIP 129 (181)
Q Consensus 72 ~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~---------------~~~~~~~~~~~~~~--~~~ 129 (181)
.|+|||+... .-|+.+.|.||||+++|-|++|.+||.+.-. ..+.+.++...... .-+
T Consensus 251 EfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW 330 (463)
T KOG0607|consen 251 EFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW 330 (463)
T ss_pred hhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh
Confidence 9999997742 3367899999999999999999999977521 23444443333322 244
Q ss_pred CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 130 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
..+|.+.++++..++..|+.+|.++.++++ ++|++
T Consensus 331 ahIS~eakdlisnLlvrda~~rlsa~~vln--hPw~~ 365 (463)
T KOG0607|consen 331 AHISSEAKDLISNLLVRDAKQRLSAAQVLN--HPWVQ 365 (463)
T ss_pred HHhhHHHHHHHHHHHhccHHhhhhhhhccC--Ccccc
Confidence 678999999999999999999999999998 66665
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.7e-23 Score=166.92 Aligned_cols=97 Identities=27% Similarity=0.463 Sum_probs=79.7
Q ss_pred CCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCC
Q 030203 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANE 147 (181)
Q Consensus 69 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~ 147 (181)
|++.|++||.+.+..++.++|+||+||++|+|++|..||.+.........+..... .......++..+.+++.+||..|
T Consensus 542 GT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~d 621 (669)
T cd05610 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMD 621 (669)
T ss_pred eCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccC
Confidence 46789999999888889999999999999999999999998887776665532221 22223467888999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhC
Q 030203 148 PWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 148 p~~Rps~~~~l~~L~~~~~~ 167 (181)
|.+||++.++++ +.|+..
T Consensus 622 P~~R~ta~e~l~--h~~~~~ 639 (669)
T cd05610 622 PTKRAGLKELKQ--HPLFHG 639 (669)
T ss_pred hhHCcCHHHHHh--CHhhcC
Confidence 999999999999 777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=159.38 Aligned_cols=160 Identities=21% Similarity=0.210 Sum_probs=115.9
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~ 81 (181)
++..+..++.|++.+|.|+|+.+ ++|+||+|.||+++.++.++++|||++........ .......++.|.+||.+..
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 45678899999999999999999 99999999999999999999999999864332211 1112234678999998753
Q ss_pred CC----------------------CCCchhHHHHHHHHHHHHhCCC-CCCCCCHHH-----------HHHHHhccCCccC
Q 030203 82 EP----------------------SNEKSDIYSFGVILWELATLQQ-PWGNLNPAQ-----------VVAAVGFKGKRLE 127 (181)
Q Consensus 82 ~~----------------------~~~~~Dv~slG~~~~~ll~g~~-p~~~~~~~~-----------~~~~~~~~~~~~~ 127 (181)
.. ...+.|+||+||++++|++|.. ||....... .............
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~ 464 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS 464 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc
Confidence 21 1124699999999999999875 665421110 0001111112223
Q ss_pred CCCCCCHHHHHHHHHHhcCCC---CCCCCHHHHHHHHHHhhh
Q 030203 128 IPRNVNPHVASIIEACWANEP---WKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 128 ~~~~~~~~~~~li~~~l~~~p---~~Rps~~~~l~~L~~~~~ 166 (181)
....+++..++++.++|..+| .+|+|++++++ |+|+.
T Consensus 465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~--Hp~f~ 504 (507)
T PLN03224 465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS--HRFFL 504 (507)
T ss_pred cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC--CCCcC
Confidence 345678899999999998766 68999999999 88874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=149.44 Aligned_cols=156 Identities=26% Similarity=0.369 Sum_probs=119.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc-CCCCCCCCCccCCcccCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS-SKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~ 81 (181)
+..-+.-+++||+.||.|||+.+ |.||||||.|.+++.+..+|++|||+++........ -+..+.+-.|.+||++.|
T Consensus 154 s~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMG 231 (449)
T KOG0664|consen 154 TPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMG 231 (449)
T ss_pred CcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhc
Confidence 44556778999999999999999 999999999999999999999999999865433222 123355668999999987
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc---------------------C-----------C
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL---------------------E-----------I 128 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------------------~-----------~ 128 (181)
.+ |+...|+||+||++.|++.++.-|...++.+..+.+....... . .
T Consensus 232 aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS 311 (449)
T KOG0664|consen 232 ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIAS 311 (449)
T ss_pred chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecC
Confidence 55 8999999999999999999999898877765554431111000 0 0
Q ss_pred CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 129 PRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
+..-..+...++.+++.+||..|.+..+.+..
T Consensus 312 ~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 312 PDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred CcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 11223356778999999999999999988763
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=157.74 Aligned_cols=157 Identities=33% Similarity=0.539 Sum_probs=129.6
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccc-cc-cccCCCCCCCCCccCCcccCCC
Q 030203 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-NT-FLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~-~~-~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
+....|+.||++|++||.+.+ ++|||+.+.|++++.++++|++|||+++..- .. .......+-...|+|+|.+.-+
T Consensus 637 ~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg 714 (807)
T KOG1094|consen 637 APGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG 714 (807)
T ss_pred chhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc
Confidence 456779999999999999999 9999999999999999999999999987322 21 1122223445689999999889
Q ss_pred CCCCchhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHhccCC------ccCCCCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 83 PSNEKSDIYSFGVILWELA--TLQQPWGNLNPAQVVAAVGFKGK------RLEIPRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 83 ~~~~~~Dv~slG~~~~~ll--~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
.++.++|+|++|+++||++ +...||.....++..++..-... .+..|.-++..+.+++.+||..+-.+||++
T Consensus 715 kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsF 794 (807)
T KOG1094|consen 715 KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSF 794 (807)
T ss_pred cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCH
Confidence 9999999999999999975 67889999988887776532221 123567789999999999999999999999
Q ss_pred HHHHHHHHH
Q 030203 155 STIMELLRP 163 (181)
Q Consensus 155 ~~~l~~L~~ 163 (181)
+++-..|.+
T Consensus 795 e~lh~~lq~ 803 (807)
T KOG1094|consen 795 EQLHLFLQE 803 (807)
T ss_pred HHHHHHHHH
Confidence 999887764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=138.96 Aligned_cols=115 Identities=31% Similarity=0.585 Sum_probs=92.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++|.-+-+|+..++.|+.|||++ + ++|||+||+||+++..|++|++|||.+-...+... .+...|.-.|+|||.+.
T Consensus 145 ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-kt~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 145 IPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-KTMDAGCKPYMAPERIN 221 (282)
T ss_pred CchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhhH-HHHhcCCCccCChhhcC
Confidence 45666679999999999999998 5 99999999999999999999999998754443321 22245667899999885
Q ss_pred C----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 030203 81 D----EPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAV 119 (181)
Q Consensus 81 ~----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-~~~~~~~~ 119 (181)
. .+|+.++|+||||+.+.||.+++.|+.... +-+.+.++
T Consensus 222 ~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 222 PELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred cccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 3 358899999999999999999999997754 33444444
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=158.97 Aligned_cols=149 Identities=25% Similarity=0.360 Sum_probs=118.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc---------cccc-----------
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---------KANT----------- 60 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~---------~~~~----------- 60 (181)
+|+|..+..++.++..|+.+.|..| ++||||||+|||+|.+|++||+|||+++- +++.
T Consensus 725 IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~ 802 (1034)
T KOG0608|consen 725 IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPS 802 (1034)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCc
Confidence 5788899999999999999999999 99999999999999999999999999851 1110
Q ss_pred ----------------------cccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 030203 61 ----------------------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118 (181)
Q Consensus 61 ----------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~ 118 (181)
.......+|++.|++||++...+++...|.|+.|+++|+|+.|+.||-...+.....+
T Consensus 803 ~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~k 882 (1034)
T KOG0608|consen 803 PEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYK 882 (1034)
T ss_pred hhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceee
Confidence 0111235788999999999988899999999999999999999999987766554444
Q ss_pred Hhc--cCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 119 VGF--KGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 119 ~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+.. .......-.++++++.++|.++. -+++.|.
T Consensus 883 v~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 883 VINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred eeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 421 11122344679999999999875 5677776
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-23 Score=157.83 Aligned_cols=159 Identities=19% Similarity=0.309 Sum_probs=120.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
..+.+..++.|++-||..|..-| ++|.||+|+|||+.... .+||+|||.+....... .+....+..|.|||++.|
T Consensus 534 ~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG 609 (752)
T KOG0670|consen 534 HIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILG 609 (752)
T ss_pred eehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCcccccccccc--ccHHHHHHhccCcceeec
Confidence 34567889999999999999999 99999999999998754 56999999876444321 122234557999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc-------------CCC-------------------
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL-------------EIP------------------- 129 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~------------------- 129 (181)
..|++..|+||+||++|++.||+.-|.+.....++.......... +..
T Consensus 610 ~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~ 689 (752)
T KOG0670|consen 610 LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKR 689 (752)
T ss_pred CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeE
Confidence 999999999999999999999999998876555444221100000 000
Q ss_pred -------------------CCCC-------HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 130 -------------------RNVN-------PHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 130 -------------------~~~~-------~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
+.++ .+|++|+.+||..||.+|.|..++|. +++++.
T Consensus 690 ~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~--HpFi~~ 751 (752)
T KOG0670|consen 690 TVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK--HPFITE 751 (752)
T ss_pred EEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc--CCcccC
Confidence 0011 15889999999999999999999998 776653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=155.75 Aligned_cols=164 Identities=25% Similarity=0.382 Sum_probs=124.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC--CC--cEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK--KY--TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~--~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
|+|.+.+.++..++.|++|||++| |+||||||.||++.. +| -.||+|||.++-..... .-...+||..|++||
T Consensus 117 LpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPe 193 (732)
T KOG4250|consen 117 LPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPE 193 (732)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC-eeeeecCchhhcChH
Confidence 678899999999999999999999 999999999998833 23 35999999998655543 445679999999999
Q ss_pred ccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhccCC-------------------ccCCCCCCC
Q 030203 78 VLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFKGK-------------------RLEIPRNVN 133 (181)
Q Consensus 78 ~~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~----~~~~~~~~~~-------------------~~~~~~~~~ 133 (181)
.... ..|+..+|.||+|+++|+.+||..||....... +...+..... ..+.+...+
T Consensus 194 l~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls 273 (732)
T KOG4250|consen 194 LYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLS 273 (732)
T ss_pred HHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCccccc
Confidence 9874 668899999999999999999999985543221 1111110100 112233344
Q ss_pred HH----HHHHHHHHhcCCCCCCC--CHHHHHHHHHHhhhCC
Q 030203 134 PH----VASIIEACWANEPWKRP--SFSTIMELLRPLIKSP 168 (181)
Q Consensus 134 ~~----~~~li~~~l~~~p~~Rp--s~~~~l~~L~~~~~~~ 168 (181)
+. +-.++..+|..+|.+|- .+.+....+.++++..
T Consensus 274 ~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 274 RGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred HHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 33 44578889999999999 8888888888877653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=136.21 Aligned_cols=124 Identities=44% Similarity=0.710 Sum_probs=106.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.+++.++.+||+.+ ++|+||++.||+++. ++.++++|||.+..............+...|.+||...
T Consensus 89 ~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 166 (215)
T cd00180 89 LSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL 166 (215)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhc
Confidence 467889999999999999999999 999999999999999 89999999998765443321223345667899999987
Q ss_pred CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
.. ..+.+.|+|++|++++++ ..+.+++.+|+..+|.+||++.++++
T Consensus 167 ~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 167 GKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred ccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence 76 678899999999999999 67899999999999999999999987
Q ss_pred H
Q 030203 160 L 160 (181)
Q Consensus 160 ~ 160 (181)
.
T Consensus 214 ~ 214 (215)
T cd00180 214 H 214 (215)
T ss_pred C
Confidence 4
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-20 Score=141.60 Aligned_cols=169 Identities=29% Similarity=0.437 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC-------CCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRN-------PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPE 72 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~-------~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~ 72 (181)
++|.+..+|+..+++||+|||+.- ++|+|||||+.||++..++...++|||++...... .......+||..
T Consensus 304 isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~R 383 (534)
T KOG3653|consen 304 ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRR 383 (534)
T ss_pred ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhh
Confidence 689999999999999999999762 25999999999999999999999999999754432 223345789999
Q ss_pred ccCCcccCCCC-CC-----CchhHHHHHHHHHHHHhCCCCC------------C-----CCCHHHHHHHHhccCCccCCC
Q 030203 73 WMAPEVLRDEP-SN-----EKSDIYSFGVILWELATLQQPW------------G-----NLNPAQVVAAVGFKGKRLEIP 129 (181)
Q Consensus 73 ~~~pe~~~~~~-~~-----~~~Dv~slG~~~~~ll~g~~p~------------~-----~~~~~~~~~~~~~~~~~~~~~ 129 (181)
|+|||++.+.- +. .+.||||+|.++||++++...+ . ....+++.+.+.....++.++
T Consensus 384 YMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p 463 (534)
T KOG3653|consen 384 YMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIP 463 (534)
T ss_pred hcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCCh
Confidence 99999997642 21 3699999999999999864433 1 123345555555555566555
Q ss_pred CCC-----CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 130 RNV-----NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 130 ~~~-----~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
..+ -..+++.++.||..|+..|.|+.=+.+.+.++....+.
T Consensus 464 ~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 464 DAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 432 34688999999999999999999888887777666544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=141.81 Aligned_cols=166 Identities=33% Similarity=0.548 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC------CCCceecCCCCCCEEEcCCCcEEEcccCCccccccc----cccCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR------NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~------~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~ 71 (181)
++-+..++++..++.||.|||.. +|+|.|||||+.||++..+|.+.++|+|++...... .......+|+-
T Consensus 305 v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTK 384 (513)
T KOG2052|consen 305 VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTK 384 (513)
T ss_pred CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCcccee
Confidence 45678899999999999999954 446999999999999999999999999999754432 12335678999
Q ss_pred CccCCcccCCCC------CCCchhHHHHHHHHHHHHhC----------CCCCCC-----CCHHHHHHHHhccCCccCCCC
Q 030203 72 EWMAPEVLRDEP------SNEKSDIYSFGVILWELATL----------QQPWGN-----LNPAQVVAAVGFKGKRLEIPR 130 (181)
Q Consensus 72 ~~~~pe~~~~~~------~~~~~Dv~slG~~~~~ll~g----------~~p~~~-----~~~~~~~~~~~~~~~~~~~~~ 130 (181)
.|+|||++...- .-..+|+||+|.++||++.+ +.||.+ .+.+++..-+.....++.+|.
T Consensus 385 RYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn 464 (513)
T KOG2052|consen 385 RYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN 464 (513)
T ss_pred eccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCc
Confidence 999999985432 12469999999999998743 446633 344555555555555666665
Q ss_pred CCCH-----HHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 131 NVNP-----HVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 131 ~~~~-----~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
.+.. .+..++..||..||..|.|+-.+-+.|.++.+.
T Consensus 465 rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 465 RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 5542 466789999999999999999999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-21 Score=156.11 Aligned_cols=162 Identities=24% Similarity=0.329 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc----ccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~pe 77 (181)
++..++-.+++|++.|+.|+|+.| +.|+|+|++|+++..+|.++++|||.+.....+. .......|+..|+|||
T Consensus 417 ~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE 494 (601)
T KOG0590|consen 417 LTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPE 494 (601)
T ss_pred cchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcc
Confidence 456788899999999999999999 9999999999999999999999999987544432 2335567888999999
Q ss_pred ccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhc-----cCCccCCCCCCCHHHHHHHHHHhcCCCC
Q 030203 78 VLRDEPSN-EKSDIYSFGVILWELATLQQPWGNLNPAQVV--AAVGF-----KGKRLEIPRNVNPHVASIIEACWANEPW 149 (181)
Q Consensus 78 ~~~~~~~~-~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~ 149 (181)
.+.+..|. ...|+|+.|+++..|.+|+.||.-....+.. ..... ......+...++...+.++.+||+.+|.
T Consensus 495 ~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~ 574 (601)
T KOG0590|consen 495 VLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPT 574 (601)
T ss_pred cccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChh
Confidence 99888875 4699999999999999999999766544321 11100 1111223356777899999999999999
Q ss_pred CCCCHHHHHHHHHHhhhC
Q 030203 150 KRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 150 ~Rps~~~~l~~L~~~~~~ 167 (181)
+|.|+.++++ .+|++.
T Consensus 575 ~R~ti~~i~~--d~W~~~ 590 (601)
T KOG0590|consen 575 KRITIEQILN--DEWIRS 590 (601)
T ss_pred heecHHHHhh--ChHhhh
Confidence 9999999999 888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=148.17 Aligned_cols=162 Identities=30% Similarity=0.516 Sum_probs=137.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
++|.|+.+++++.++++.|||+.| -+|||||..||+++..|.+++.|||.+-.+.......+..+|++.|++||+..
T Consensus 109 lselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaav 186 (829)
T KOG0576|consen 109 LSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 186 (829)
T ss_pred chhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHH
Confidence 678999999999999999999999 89999999999999999999999999988887777788899999999999873
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG---KRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.++|....|+|++|+...++..-++|-....+......-.... ...+-+..+++.|.+|++.++-.+|++||++.
T Consensus 187 erkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptae 266 (829)
T KOG0576|consen 187 ERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAE 266 (829)
T ss_pred HhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChh
Confidence 4567889999999999999988888876666655444333233 23445678999999999999999999999999
Q ss_pred HHHHHHHHhhhC
Q 030203 156 TIMELLRPLIKS 167 (181)
Q Consensus 156 ~~l~~L~~~~~~ 167 (181)
.++. +++...
T Consensus 267 klL~--h~fvs~ 276 (829)
T KOG0576|consen 267 KLLQ--HPFVSQ 276 (829)
T ss_pred hhee--ceeecc
Confidence 8887 555443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=136.46 Aligned_cols=101 Identities=21% Similarity=0.302 Sum_probs=71.8
Q ss_pred CCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHhccCCcc---------------
Q 030203 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-------NPAQVVAAVGFKGKRL--------------- 126 (181)
Q Consensus 69 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~-------~~~~~~~~~~~~~~~~--------------- 126 (181)
.|..|.+||++.+.+|+..+|+||++|+++|++||..-|... +.+.+...+...+.-+
T Consensus 413 QTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFn 492 (590)
T KOG1290|consen 413 QTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFN 492 (590)
T ss_pred hhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhc
Confidence 345699999999999999999999999999999998866432 2222222111111000
Q ss_pred ------------------------CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 127 ------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 127 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
..+..-..++.+|+.-||+++|.+|||+.+.++ ++|+...+.+
T Consensus 493 r~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~--hPwLn~~~~~ 559 (590)
T KOG1290|consen 493 RRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK--HPWLNPVAGP 559 (590)
T ss_pred cccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc--CccccCCCCC
Confidence 011111236788999999999999999999999 9999865554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=127.53 Aligned_cols=150 Identities=25% Similarity=0.359 Sum_probs=106.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC--CCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
-|....+++.|+++|+.|||+.+ +||||||.+||++-. ...+||+|||..+..+..... ......|.+||...
T Consensus 119 gE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~---~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 119 GEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY---LEYVNNYHAPELCD 193 (378)
T ss_pred cHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCceehh---hhhhcccCCcHHHh
Confidence 45667889999999999999999 999999999999832 347999999998655443211 12234677887664
Q ss_pred CC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc-cCCccC---CCCCCCHHHHHHHHHHhcCCCC
Q 030203 81 DE-----PSNEKSDIYSFGVILWELATLQQPWGNLNPA--QVVAAVGF-KGKRLE---IPRNVNPHVASIIEACWANEPW 149 (181)
Q Consensus 81 ~~-----~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~--~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~~l~~~p~ 149 (181)
.. .....+|+|.||++++.+++|+.||+..... ...+..+. .+.... .-..+++.+..+..+-|..+++
T Consensus 194 ~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~ 273 (378)
T KOG1345|consen 194 TVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFK 273 (378)
T ss_pred hccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccc
Confidence 32 2357899999999999999999999743211 11111111 222222 2345788899999999999999
Q ss_pred CCCCHHHH
Q 030203 150 KRPSFSTI 157 (181)
Q Consensus 150 ~Rps~~~~ 157 (181)
+|-...+.
T Consensus 274 drcki~~~ 281 (378)
T KOG1345|consen 274 DRCKIWTA 281 (378)
T ss_pred ccchhHHH
Confidence 99444333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-20 Score=135.54 Aligned_cols=134 Identities=21% Similarity=0.290 Sum_probs=93.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC----
Q 030203 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE---- 82 (181)
Q Consensus 7 ~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---- 82 (181)
.+.+..|+++.+.+||..| ++|+||+++|++++.+|.+.|+||+.....+..... ...+..|.+||.....
T Consensus 147 rl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 147 RLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCH
T ss_pred HHHHHHHHHHHHHHHhhcc--eEecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccC
Confidence 3566689999999999999 999999999999999999999999876655543332 1223568888866432
Q ss_pred ----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 83 ----PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 83 ----~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
.++++.|.|+||+++|.++||..||........... ...... ++++.+++||..+|+.||.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 357889999999999999999999987654332211 111223 688999999999999999987
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-19 Score=132.48 Aligned_cols=161 Identities=26% Similarity=0.372 Sum_probs=115.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccc-cc------c-------------
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKA-NT------F------------- 61 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~-~~------~------------- 61 (181)
+-.++...+..++.||.++|.+| |+|+||||.|++++. .+.-.|+|||++.... .. .
T Consensus 130 ~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~ 207 (418)
T KOG1167|consen 130 SLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKD 207 (418)
T ss_pred CHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCc
Confidence 45678899999999999999999 999999999999976 4667899999986100 00 0
Q ss_pred ------------------------ccCCCCCCCCCccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH--H
Q 030203 62 ------------------------LSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPA--Q 114 (181)
Q Consensus 62 ------------------------~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~--~ 114 (181)
...-+..|+++|.|||.+...+ .+.++|+||.|+++..++++..||-....+ .
T Consensus 208 ~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~a 287 (418)
T KOG1167|consen 208 VHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADA 287 (418)
T ss_pred ccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccch
Confidence 0011245889999999886654 578899999999999999999988433211 1
Q ss_pred HHHHH-----------hccCCc------------------------------------cCC-CCCCCHHHHHHHHHHhcC
Q 030203 115 VVAAV-----------GFKGKR------------------------------------LEI-PRNVNPHVASIIEACWAN 146 (181)
Q Consensus 115 ~~~~~-----------~~~~~~------------------------------------~~~-~~~~~~~~~~li~~~l~~ 146 (181)
+.+.. ...... ... ....+..+.+++++|++.
T Consensus 288 l~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~ 367 (418)
T KOG1167|consen 288 LAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLEL 367 (418)
T ss_pred HHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccC
Confidence 11100 000000 000 012344788999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhhC
Q 030203 147 EPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 147 ~p~~Rps~~~~l~~L~~~~~~ 167 (181)
||.+|.|++++|+ ++++..
T Consensus 368 np~kRitAEeALk--HpFF~~ 386 (418)
T KOG1167|consen 368 NPQKRITAEDALK--HPFFDE 386 (418)
T ss_pred ChhhcccHHHHhc--CcCCcc
Confidence 9999999999998 777653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.6e-18 Score=121.44 Aligned_cols=116 Identities=35% Similarity=0.513 Sum_probs=94.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCccc-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVL- 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~- 79 (181)
+++.++..++.+++.++.+||+.+ ++|+|+++.||+++.++.++++|||.+....... .......+...|++||..
T Consensus 95 ~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 172 (225)
T smart00221 95 LSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL 172 (225)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhc
Confidence 567889999999999999999999 9999999999999999999999999876544332 112234556689999988
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGN-LNPA-QVVAAV 119 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~-~~~~-~~~~~~ 119 (181)
....++.++|+|++|++++++++|+.||.+ .+.. .+.+.+
T Consensus 173 ~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 173 GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 555677799999999999999999999977 3433 444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-19 Score=140.01 Aligned_cols=103 Identities=32% Similarity=0.538 Sum_probs=91.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|.++..|++|++-|+++||++| |+|||||-+|+.++.+|.++++|||.+....++ .....+|+..|.|||.+.|
T Consensus 667 m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgsaa~~ksg--pfd~f~gtv~~aapevl~g 742 (772)
T KOG1152|consen 667 MDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG--PFDVFVGTVDYAAPEVLGG 742 (772)
T ss_pred cchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccchhhhcCC--CcceeeeeccccchhhhCC
Confidence 578999999999999999999999 999999999999999999999999988655544 2345789999999999998
Q ss_pred CCC-CCchhHHHHHHHHHHHHhCCCCCC
Q 030203 82 EPS-NEKSDIYSFGVILWELATLQQPWG 108 (181)
Q Consensus 82 ~~~-~~~~Dv~slG~~~~~ll~g~~p~~ 108 (181)
..| ....|+|++|+++|.++....||-
T Consensus 743 ~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 743 EKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CccCCCcchhhhhhheeeEEEeccCCCc
Confidence 876 456999999999999999888874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=141.45 Aligned_cols=145 Identities=20% Similarity=0.236 Sum_probs=108.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccc----cccccc---CCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK----ANTFLS---SKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~----~~~~~~---~~~~~~~~~~~ 74 (181)
+..-+...|+.|++.||..+|..| ++|||||.+||+++.-.++.|+||...+-. .++..- ..+...-.-|.
T Consensus 117 L~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYi 194 (1431)
T KOG1240|consen 117 LVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYI 194 (1431)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeec
Confidence 455677889999999999999999 999999999999999999999999765311 111000 01112223699
Q ss_pred CCcccCCCC-----------CCCchhHHHHHHHHHHHHh-CCCCCCCC-----------CHHHHHHHHhccCCccCCCCC
Q 030203 75 APEVLRDEP-----------SNEKSDIYSFGVILWELAT-LQQPWGNL-----------NPAQVVAAVGFKGKRLEIPRN 131 (181)
Q Consensus 75 ~pe~~~~~~-----------~~~~~Dv~slG~~~~~ll~-g~~p~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 131 (181)
|||++.... .+++.|+||+||++.|+++ |+++|.-. +.....++ -
T Consensus 195 APERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~------------I 262 (1431)
T KOG1240|consen 195 APERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEK------------I 262 (1431)
T ss_pred ChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHh------------C
Confidence 999885411 3578999999999999986 78888431 11222221 2
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
-+..++.++..|++.||.+|.++++.|+.
T Consensus 263 ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 263 EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 34578999999999999999999999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-17 Score=120.32 Aligned_cols=164 Identities=15% Similarity=0.336 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-----cEEEcccCCccccccc-------cccCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-----TVKVCDFGLSRLKANT-------FLSSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-----~~~l~d~g~~~~~~~~-------~~~~~~~~~ 69 (181)
|+.+.++-++.|++.-+.++|+.. +++|||||+|++++..+ .+.++|||+++.+.++ ..+.+...|
T Consensus 121 FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsG 198 (449)
T KOG1165|consen 121 FSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSG 198 (449)
T ss_pred ccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccccccc
Confidence 567788999999999999999999 99999999999997643 5789999999876654 334466788
Q ss_pred CCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC------CCCCCCHHHHHHHHHH
Q 030203 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE------IPRNVNPHVASIIEAC 143 (181)
Q Consensus 70 ~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~ 143 (181)
+-.|++-..+.++..+.+.|+-|||.+++++|-|..||.+.+-+..-++....+.... +-..++.++...+...
T Consensus 199 TARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yv 278 (449)
T KOG1165|consen 199 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYV 278 (449)
T ss_pred ceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHH
Confidence 9999999999999899999999999999999999999999876654444433332221 2246888999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
-..+-.+.|.++-+.+.+.+++..
T Consensus 279 R~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 279 RRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HhcCcccCCCHHHHHHHHHHHHHh
Confidence 999999999999998888887764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-17 Score=122.93 Aligned_cols=174 Identities=22% Similarity=0.315 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC-----CcEEEcccCCcc--cccccc----c---c-CCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSR--LKANTF----L---S-SKS 66 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~-----~~~~l~d~g~~~--~~~~~~----~---~-~~~ 66 (181)
|+...++.++.|++.+|.++|+.| ++||||+|.|+.++.. ..+.++|||+++ ...... . . ...
T Consensus 119 fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~ 196 (322)
T KOG1164|consen 119 FSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGL 196 (322)
T ss_pred cCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccC
Confidence 567788999999999999999999 9999999999999764 358999999998 322111 1 1 123
Q ss_pred CCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC---CCCCCCHHHHHHHHHH
Q 030203 67 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE---IPRNVNPHVASIIEAC 143 (181)
Q Consensus 67 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~ 143 (181)
..|+..|.++..+.+...+.+.|+||++.++.++..|..||...........+........ .....+..+..+...+
T Consensus 197 ~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (322)
T KOG1164|consen 197 FRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYI 276 (322)
T ss_pred CCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHh
Confidence 4588999999999998899999999999999999999999977664332322221221111 2234557888888888
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhCCCCC-CCCCCC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKSPTPQ-PSPTDM 177 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~~~~~-~~~~~~ 177 (181)
-..+...+|.+..+...+.+.+...... ..|-++
T Consensus 277 ~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw 311 (322)
T KOG1164|consen 277 DSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDW 311 (322)
T ss_pred hccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcc
Confidence 8899999999999999999888765333 244443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.2e-17 Score=115.54 Aligned_cols=156 Identities=31% Similarity=0.664 Sum_probs=127.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEE--cccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l--~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
++..|+.+++..++.|..|||+..+-+...-++..++.++.+-..++ .|-.++. ........+.|++||.+
T Consensus 286 vd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-------qe~gr~y~pawmspeal 358 (448)
T KOG0195|consen 286 VDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------QEVGRAYSPAWMSPEAL 358 (448)
T ss_pred EecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-------eccccccCcccCCHHHH
Confidence 45678999999999999999999754555678888999988654443 3322211 11223456789999998
Q ss_pred CCCCC---CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 80 RDEPS---NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 80 ~~~~~---~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
...+. -.+.|+|||++++|++.|...||....+.+...++...+.+..+|+.++..+..+++-|+..||.+||.++.
T Consensus 359 qrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdm 438 (448)
T KOG0195|consen 359 QRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDM 438 (448)
T ss_pred hcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcce
Confidence 76543 357999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHh
Q 030203 157 IMELLRPL 164 (181)
Q Consensus 157 ~l~~L~~~ 164 (181)
++--|+..
T Consensus 439 ivpilekm 446 (448)
T KOG0195|consen 439 IVPILEKM 446 (448)
T ss_pred ehhhHHHh
Confidence 98877754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.7e-16 Score=114.34 Aligned_cols=157 Identities=30% Similarity=0.468 Sum_probs=123.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccc------cCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFL------SSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~~ 74 (181)
+++.....++.|++.++.++|..+ ++|+|++|+||+++..+ .+++.|||.+........ ......++..|.
T Consensus 98 ~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~ 175 (384)
T COG0515 98 LSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175 (384)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccC
Confidence 567889999999999999999999 99999999999999988 799999998864333221 235567888999
Q ss_pred CCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhccCCc-cC--CCCCC----CHHHHHHH
Q 030203 75 APEVLRD---EPSNEKSDIYSFGVILWELATLQQPWGNLNP----AQVVAAVGFKGKR-LE--IPRNV----NPHVASII 140 (181)
Q Consensus 75 ~pe~~~~---~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~----~~~~~~~~~~~~~-~~--~~~~~----~~~~~~li 140 (181)
+||...+ .......|+|++|++++++++|..||..... ......+...... .. ..... ...+.+++
T Consensus 176 ~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (384)
T COG0515 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLL 255 (384)
T ss_pred CHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHH
Confidence 9999987 4678899999999999999999999877763 4444444333322 11 11111 25789999
Q ss_pred HHHhcCCCCCCCCHHHHHHH
Q 030203 141 EACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 141 ~~~l~~~p~~Rps~~~~l~~ 160 (181)
.+++..+|..|.+..+....
T Consensus 256 ~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 256 KKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhcCchhcCCHHHHhhc
Confidence 99999999999988887763
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.7e-16 Score=116.78 Aligned_cols=159 Identities=24% Similarity=0.365 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE--cCCC--cEEEcccCCccccccc-----cccCC-CCCCCCCcc
Q 030203 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV--DKKY--TVKVCDFGLSRLKANT-----FLSSK-SAAGTPEWM 74 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~--~~~~--~~~l~d~g~~~~~~~~-----~~~~~-~~~~~~~~~ 74 (181)
....-|+.|+++|+.|||.+| +.|+|+|++||++ ++++ ++.+.|||.+--..+. +.... ...|+-..+
T Consensus 341 r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 341 RTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 455678899999999999999 9999999999998 4444 4578999976422221 11111 223444679
Q ss_pred CCcccCCCCC------CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCC
Q 030203 75 APEVLRDEPS------NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEP 148 (181)
Q Consensus 75 ~pe~~~~~~~------~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 148 (181)
+||+.....- ..++|.|+.|.+.||++....||-+.....+.-+.=...-...++..+++.+++++..+|+.||
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDP 498 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCc
Confidence 9998865431 3689999999999999999999977443322211101222345778899999999999999999
Q ss_pred CCCCCHHHHHHHHHHhh
Q 030203 149 WKRPSFSTIMELLRPLI 165 (181)
Q Consensus 149 ~~Rps~~~~l~~L~~~~ 165 (181)
.+|++.+=..+.|+=.+
T Consensus 499 skRvsp~iAANvl~LsL 515 (598)
T KOG4158|consen 499 SKRVSPNIAANVLNLSL 515 (598)
T ss_pred cccCCccHHHhHHHHHH
Confidence 99999887766665433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8e-17 Score=132.44 Aligned_cols=154 Identities=28% Similarity=0.415 Sum_probs=121.7
Q ss_pred HHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---------------ccCCCCCCCCCccCCc
Q 030203 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---------------LSSKSAAGTPEWMAPE 77 (181)
Q Consensus 13 ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---------------~~~~~~~~~~~~~~pe 77 (181)
+++.++.|+|+-+ ++|+|++|+|.+++.-|++|++|||+.+...... ...+...+++.|.+||
T Consensus 151 dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 3478999999999 9999999999999999999999999987433221 1123347899999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-CHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGKRLEIPRNVNPHVASIIEACWANEPWKRP-SFS 155 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~ 155 (181)
++.-.+|...+|.|++|+++|+++-|+.||.+..++++...+.. .....+-....+++.++++.++|+.+|..|. +..
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 99888899999999999999999999999999988877665522 2223334556789999999999999999998 444
Q ss_pred HHHHHHHHhhhCC
Q 030203 156 TIMELLRPLIKSP 168 (181)
Q Consensus 156 ~~l~~L~~~~~~~ 168 (181)
++.-.=+.+++..
T Consensus 309 a~evk~h~ff~~L 321 (1205)
T KOG0606|consen 309 ALEVKQHGFFQLL 321 (1205)
T ss_pred hhhhhhccceeec
Confidence 4333335555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-17 Score=128.59 Aligned_cols=139 Identities=29% Similarity=0.448 Sum_probs=117.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++........+++-++.++|..+ ++|+|+|++||+++.+|++++.|||.++........ .|+..|++||+..
T Consensus 94 f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cgt~eymApEI~~- 166 (612)
T KOG0603|consen 94 FDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGTYEYRAPEIIN- 166 (612)
T ss_pred hHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhhc----ccchhhhhhHhhh-
Confidence 456677788889999999999999 999999999999999999999999998754443222 6678999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
+...++|.|++|++++++++|..||.+ +...++ ......+|+..+...++++..++..+|..|...
T Consensus 167 -gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 167 -GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 356789999999999999999999999 333333 344567788999999999999999999999955
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7e-17 Score=124.32 Aligned_cols=150 Identities=26% Similarity=0.412 Sum_probs=107.2
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc------cccCCCCCCCCCccCCc
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT------FLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~~~pe 77 (181)
....+.++.|+..++.| ++ .+|+|++|.||++..+..++++|||+....... ........++..|++||
T Consensus 358 ~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPE 432 (516)
T KOG1033|consen 358 LSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPE 432 (516)
T ss_pred hhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHH
Confidence 44677899999999999 77 999999999999999999999999987643322 22335578899999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
.+.+.+|+.++|+|+||+++++++.- .-++....- ...+.....+.....+. +.-..|++.++.+.|..||++
T Consensus 433 Qi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~-- 506 (516)
T KOG1033|consen 433 QIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---LTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSA-- 506 (516)
T ss_pred HHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchH--
Confidence 99999999999999999999999872 222222111 11111111111112222 344689999999999999943
Q ss_pred HHHHHHHh
Q 030203 157 IMELLRPL 164 (181)
Q Consensus 157 ~l~~L~~~ 164 (181)
+...++.+
T Consensus 507 ~~~~~~~~ 514 (516)
T KOG1033|consen 507 IEVALHEF 514 (516)
T ss_pred HHHhhhhh
Confidence 44444443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=117.02 Aligned_cols=165 Identities=33% Similarity=0.537 Sum_probs=123.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccc--ccccCCCCCCCCCccCCcccC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--TFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++.-...+++.++.|+.|+|+... .+|+.++..|.+++..-.+|+.|||+...... .............|.+||.++
T Consensus 46 d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr 124 (484)
T KOG1023|consen 46 DYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLR 124 (484)
T ss_pred cHHHHHHHHHHHHHHHHHHhcCcc-eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhc
Confidence 445567788999999999999961 39999999999999999999999998765432 111111222345789999987
Q ss_pred CCC-------CCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhccCC---ccCCC--CCCCHHHHHHHHHHh
Q 030203 81 DEP-------SNEKSDIYSFGVILWELATLQQPWGNL----NPAQVVAAVGFKGK---RLEIP--RNVNPHVASIIEACW 144 (181)
Q Consensus 81 ~~~-------~~~~~Dv~slG~~~~~ll~g~~p~~~~----~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~li~~~l 144 (181)
+.. .+.+.|+||+|++++++++.+.||... ...+++.++..... ++.+. ...++++..++..||
T Consensus 125 ~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw 204 (484)
T KOG1023|consen 125 GALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCW 204 (484)
T ss_pred ccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhc
Confidence 641 356799999999999999999999663 33456666654122 11111 145667999999999
Q ss_pred cCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 145 ANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 145 ~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
..+|..||+++.+...++...+..
T Consensus 205 ~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 205 EEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccChhhCccHHHHHhhhhhhcccc
Confidence 999999999999999988887754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.5e-15 Score=104.42 Aligned_cols=165 Identities=20% Similarity=0.358 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC---CcEEEcccCCccccccc-------cccCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRLKANT-------FLSSKSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~---~~~~l~d~g~~~~~~~~-------~~~~~~~~~~~ 71 (181)
|+.+.++-++-|++.-++|+|.++ ++|+||||+|++.+-+ ..+.++|||+++.+.+. ..+.....|+.
T Consensus 108 ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTa 185 (341)
T KOG1163|consen 108 FTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTA 185 (341)
T ss_pred hhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceee
Confidence 456778889999999999999999 9999999999998653 35789999999864432 33445667788
Q ss_pred CccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCccC-----CCCCCCHHHHHHHHHHhc
Q 030203 72 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGKRLE-----IPRNVNPHVASIIEACWA 145 (181)
Q Consensus 72 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~li~~~l~ 145 (181)
.|.+-..+.+...+.+.|+-|+|.++.++.-|..||++.....-.++... ...... +=..+|.++...+..|-.
T Consensus 186 RYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~ 265 (341)
T KOG1163|consen 186 RYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRG 265 (341)
T ss_pred eehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhh
Confidence 88888777776678899999999999999999999999866543332211 111122 224578899999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCC
Q 030203 146 NEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 146 ~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
..=.+-|...-+.+..+-+++..
T Consensus 266 L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 266 LGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred cCCCCCCcHHHHHHHHHHHHhhc
Confidence 99999999988888777776554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.8e-12 Score=104.69 Aligned_cols=151 Identities=17% Similarity=0.156 Sum_probs=109.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-------CCcEEEcccCCcccccc--ccccCCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-------KYTVKVCDFGLSRLKAN--TFLSSKSAAGTPE 72 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-------~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~ 72 (181)
++|.-+..+.+|++..+.+||..+ |+||||||+|+++.. ...++|+|||.+.-..- ..........+..
T Consensus 791 m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~ 868 (974)
T KOG1166|consen 791 MDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDL 868 (974)
T ss_pred CCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeecccc
Confidence 567788899999999999999999 999999999999842 34589999998742111 1112233445668
Q ss_pred ccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC----CCCCCCHHHH-HHHHHHhcCC
Q 030203 73 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE----IPRNVNPHVA-SIIEACWANE 147 (181)
Q Consensus 73 ~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-~li~~~l~~~ 147 (181)
+-.+|+..|+..++.+|.|.++.+++.||+|+.-- . .++..-. ++..+..++. .+...+|..|
T Consensus 869 f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~-~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~ 936 (974)
T KOG1166|consen 869 FDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------V-KNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPD 936 (974)
T ss_pred chhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------h-cCCcceeccccchhhhhHHHHHHHHHHHhCcC
Confidence 89999999999999999999999999999996521 1 1111111 2333444433 4777777777
Q ss_pred CCCCCCHHHHHHHHHHhhh
Q 030203 148 PWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 148 p~~Rps~~~~l~~L~~~~~ 166 (181)
-..=|...++...++.++.
T Consensus 937 ~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 937 CDTLPNLQELRTELEEVLA 955 (974)
T ss_pred cccchhHHHHHHHHHHHHH
Confidence 6677788888887777764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.7e-11 Score=90.29 Aligned_cols=164 Identities=18% Similarity=0.266 Sum_probs=118.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
.+|+-.++++++++.+...||+.| .+-||++++|+++++++.+.|.|-.......+. ......++...|++||.-.
T Consensus 114 ~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng-~~~~cpVg~~eftPPElQ~~ 190 (637)
T COG4248 114 CAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG-TLHLCPVGVSEFTPPELQTL 190 (637)
T ss_pred cccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceeeccCC-ceEecccCccccCCHHHhcc
Confidence 467888999999999999999999 999999999999999999999886544333222 2233457888999999754
Q ss_pred ----CCCCCCchhHHHHHHHHHHHHhC-CCCCCCCC-------HH--HHHHH-----HhccCCccCCC-----CCCCHHH
Q 030203 81 ----DEPSNEKSDIYSFGVILWELATL-QQPWGNLN-------PA--QVVAA-----VGFKGKRLEIP-----RNVNPHV 136 (181)
Q Consensus 81 ----~~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~-------~~--~~~~~-----~~~~~~~~~~~-----~~~~~~~ 136 (181)
+...+...|.|.||+++++++.| .+||.+.. +. ++..- -+........| .-+++.+
T Consensus 191 ~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~v 270 (637)
T COG4248 191 PSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDV 270 (637)
T ss_pred ccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHH
Confidence 23346789999999999999976 99997642 11 11110 00011111111 2367889
Q ss_pred HHHHHHHhcC--CCCCCCCHHHHHHHHHHhhhCC
Q 030203 137 ASIIEACWAN--EPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 137 ~~li~~~l~~--~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
..+...||.. ++.-|||++.++..|..+-++.
T Consensus 271 qAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 271 QALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 9999999954 3678999999998888765543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.9e-12 Score=90.25 Aligned_cols=102 Identities=21% Similarity=0.175 Sum_probs=75.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCceecCC-CCCCEEEcCCCcEEEcccCCcccccccccc-------------CCCCCCCCCc
Q 030203 8 LNMAYDVAKGMNYLHRRNPPIVHRDL-KSPNLLVDKKYTVKVCDFGLSRLKANTFLS-------------SKSAAGTPEW 73 (181)
Q Consensus 8 ~~i~~ql~~~l~~lh~~~~~~~h~~i-~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-------------~~~~~~~~~~ 73 (181)
..++.|++.+|.++|++| ++|+|| +|.||+++.+|.++++|||++......... ..-...++.+
T Consensus 94 ~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~ 171 (218)
T PRK12274 94 LAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAA 171 (218)
T ss_pred HHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 467889999999999999 999999 799999999999999999998743332210 0011245677
Q ss_pred cCCcccCCC-CCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 030203 74 MAPEVLRDE-PSN-EKSDIYSFGVILWELATLQQPWGNLN 111 (181)
Q Consensus 74 ~~pe~~~~~-~~~-~~~Dv~slG~~~~~ll~g~~p~~~~~ 111 (181)
+.|+...-. ..+ .+.+.++-|+-+|.++|+..++-+..
T Consensus 172 l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 172 LTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 777655433 222 45667778999999999988775543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1e-12 Score=106.28 Aligned_cols=160 Identities=23% Similarity=0.347 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCCCceecCCCCCCEEEcCCC-cEEEcccCCcccccc-cc--ccCCCCCC-CCCccCCc
Q 030203 4 ERRRLNMAYDVAKGMNYLH-RRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKAN-TF--LSSKSAAG-TPEWMAPE 77 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh-~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~-~~--~~~~~~~~-~~~~~~pe 77 (181)
...+-..+.|+..++.|+| ..+ +.|+|++|+|.+++.++ .++..|||++..... .. .......+ ++.|.+||
T Consensus 122 ~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E 199 (601)
T KOG0590|consen 122 SSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPE 199 (601)
T ss_pred CcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcc
Confidence 3455678899999999999 888 99999999999999999 999999999976555 21 22233456 88999999
Q ss_pred ccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--Hhcc-CCccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 78 VLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA--VGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 78 ~~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
...+.. .....|+|+.|+++..+++|..|+........... .... .........++....+++.+++..+|..|.+
T Consensus 200 ~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s 279 (601)
T KOG0590|consen 200 HLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS 279 (601)
T ss_pred cccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccc
Confidence 987743 45789999999999999999999877654332211 1111 1123345678889999999999999999999
Q ss_pred HHHHHHHHHHhhhC
Q 030203 154 FSTIMELLRPLIKS 167 (181)
Q Consensus 154 ~~~~l~~L~~~~~~ 167 (181)
.+++.. +.|+..
T Consensus 280 ~~~~~~--d~~~~~ 291 (601)
T KOG0590|consen 280 IEELKL--DNWLSS 291 (601)
T ss_pred cccccc--cccccc
Confidence 999877 666555
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-11 Score=94.49 Aligned_cols=72 Identities=24% Similarity=0.247 Sum_probs=57.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCceecCC-CCCCEEEcCCCcEEEcccCCccccccccccC--------CCCCCCCCccCCcc
Q 030203 8 LNMAYDVAKGMNYLHRRNPPIVHRDL-KSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--------KSAAGTPEWMAPEV 78 (181)
Q Consensus 8 ~~i~~ql~~~l~~lh~~~~~~~h~~i-~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--------~~~~~~~~~~~pe~ 78 (181)
..++.+++++|.|||++| ++|+|| ||+||+++.++.++|+|||+++......... .+..+++.|.+||.
T Consensus 114 ~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~ 191 (365)
T PRK09188 114 PAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDA 191 (365)
T ss_pred HHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCccc
Confidence 568899999999999999 999999 9999999988999999999987544332111 23456667888988
Q ss_pred cCC
Q 030203 79 LRD 81 (181)
Q Consensus 79 ~~~ 81 (181)
+..
T Consensus 192 ~~~ 194 (365)
T PRK09188 192 LTP 194 (365)
T ss_pred CCh
Confidence 754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.8e-11 Score=88.74 Aligned_cols=151 Identities=22% Similarity=0.336 Sum_probs=102.8
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc--cccc--cccCCCCCCCCCccCCccc
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~--~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
.+.-.+|+.||+.||.|||+-.+.++|++++-..|+...+|-++++.-.-... .... ........+.++|.+|+.=
T Consensus 175 ~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg 254 (458)
T KOG1266|consen 175 QKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG 254 (458)
T ss_pred HHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC
Confidence 45556899999999999999999999999999999999888777653211100 0000 1112233456788889876
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQP-WGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
...+.+..+|+|++|+...+|.-+... -.+.......+.+.......+ ++--+.++.+|++..|..||+++.++
T Consensus 255 ~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 255 TTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-----NGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred cccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-----CccccCcCcccccCCCCCCcchhhhh
Confidence 666677889999999999999887553 333322222222221111111 12236789999999999999999887
Q ss_pred H
Q 030203 159 E 159 (181)
Q Consensus 159 ~ 159 (181)
.
T Consensus 330 f 330 (458)
T KOG1266|consen 330 F 330 (458)
T ss_pred c
Confidence 5
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-11 Score=98.83 Aligned_cols=148 Identities=16% Similarity=0.286 Sum_probs=108.4
Q ss_pred HHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc----cccCC-----CCCCCCCccCCcccCC
Q 030203 11 AYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSK-----SAAGTPEWMAPEVLRD 81 (181)
Q Consensus 11 ~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~----~~~~~-----~~~~~~~~~~pe~~~~ 81 (181)
+-+++.|+.++|... +++|++|.|++|.++.+|.+|+.+|+.+.....+ ...+. -......|.+||++.+
T Consensus 105 l~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345568899999883 3999999999999999999999999876532221 11111 1123457999999988
Q ss_pred CCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHH--HHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELA-TLQQPWGNLNPAQ--VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll-~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
...+.++|+||+|+++|.+. .|+..+...+... -......+-....+...+++++++-+.+++..++.-||++..+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 77889999999999999988 5666665543222 22222223333446678999999999999999999999877766
Q ss_pred H
Q 030203 159 E 159 (181)
Q Consensus 159 ~ 159 (181)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 5
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.8e-11 Score=83.75 Aligned_cols=52 Identities=27% Similarity=0.287 Sum_probs=47.0
Q ss_pred CCHHHHHHHHHHHHHHHHHH-HhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYL-HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~l-h~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
+++++++.++.|++.+|.++ |+.| ++|+||+|.||+++ ++.++++|||++..
T Consensus 114 ~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 114 LSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence 46778999999999999999 6889 99999999999998 47899999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=8e-11 Score=82.67 Aligned_cols=53 Identities=23% Similarity=0.231 Sum_probs=47.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCcccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 57 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~ 57 (181)
+++.+...++.|++.++.++|+ .| ++|+||+|.||+++ ++.++++|||++...
T Consensus 114 ~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 114 LEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 3567889999999999999999 99 99999999999998 789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.8e-11 Score=86.72 Aligned_cols=77 Identities=18% Similarity=0.250 Sum_probs=57.5
Q ss_pred HHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCCCCCCchh
Q 030203 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 89 (181)
Q Consensus 10 i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D 89 (181)
...++..++..+|..| ++|+|++|.||+++++| ++++|||........... . . ....+.+..++|
T Consensus 140 ~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------d-~-----~vler~y~~~~d 204 (232)
T PRK10359 140 VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------D-R-----IDLERHYGIKNE 204 (232)
T ss_pred HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH------H-H-----HHHHhHhccccc
Confidence 4669999999999999 99999999999999988 999999976433221100 0 0 122233556899
Q ss_pred HHHHHHHHHHHH
Q 030203 90 IYSFGVILWELA 101 (181)
Q Consensus 90 v~slG~~~~~ll 101 (181)
+|+||+.+..+.
T Consensus 205 i~~lg~~~~~~~ 216 (232)
T PRK10359 205 IKDLGYYLLIYK 216 (232)
T ss_pred ccceeEeehHHH
Confidence 999999977654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.3e-10 Score=86.61 Aligned_cols=154 Identities=23% Similarity=0.246 Sum_probs=112.1
Q ss_pred CCHHHHHHHHHHHHH----HHHHHHhCCCCceecCCCCCCEEEcCC-CcEEEcccCCccccccccccC-----CCCCCCC
Q 030203 2 LDERRRLNMAYDVAK----GMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSS-----KSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~----~l~~lh~~~~~~~h~~i~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~-----~~~~~~~ 71 (181)
+++...+..+.+... ||.++|+.+ ++|.++++.||+...+ ...+++|||+........... ....+..
T Consensus 215 ~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~ 292 (524)
T KOG0601|consen 215 LPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDC 292 (524)
T ss_pred CCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCc
Confidence 566778888888888 999999999 9999999999999988 889999999887655443221 2225666
Q ss_pred CccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 72 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 72 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
.|.+||...+. ++...|++++|.++.+..++...+.......+.+ +...-...++-...+-.+...+..|++.+|..|
T Consensus 293 ~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~ 370 (524)
T KOG0601|consen 293 IYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLR 370 (524)
T ss_pred eEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cccccCchhhhcCcchhhhhHHHHhcCcchhhh
Confidence 89999988665 5778999999999999988866554432211111 100111222223345567779999999999999
Q ss_pred CCHHHHHH
Q 030203 152 PSFSTIME 159 (181)
Q Consensus 152 ps~~~~l~ 159 (181)
++.+.++.
T Consensus 371 ~~~q~~~~ 378 (524)
T KOG0601|consen 371 LTAQILTA 378 (524)
T ss_pred hHHHHHhc
Confidence 99987755
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.5e-08 Score=79.12 Aligned_cols=97 Identities=14% Similarity=0.166 Sum_probs=68.5
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCCC
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEP 83 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 83 (181)
...+...+.||+.||.|||+.+. ++|+||+...|+++..|.++|++|.+.................-.|..|+.+....
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~-lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCN-LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCC-eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence 34566778999999999986532 99999999999999999999999977543222111111111122455666542221
Q ss_pred CCCchhHHHHHHHHHHHHhC
Q 030203 84 SNEKSDIYSFGVILWELATL 103 (181)
Q Consensus 84 ~~~~~Dv~slG~~~~~ll~g 103 (181)
-..|.|.|||+++++..|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 357999999999999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.7e-09 Score=75.36 Aligned_cols=52 Identities=27% Similarity=0.325 Sum_probs=45.6
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccc
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 57 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~ 57 (181)
..++..++.|++.++.+||+.|. ++|+|++|.||+++ ++.++++|||.+...
T Consensus 147 ~~~~~~i~~qi~~~l~~LH~~g~-iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 147 EEEEFELYDDILEEMRKLYKEGE-LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCC-EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 44567899999999999999964 99999999999999 789999999986543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.2e-09 Score=85.99 Aligned_cols=147 Identities=24% Similarity=0.309 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc-cccc-------------------------
Q 030203 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANT------------------------- 60 (181)
Q Consensus 7 ~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~-~~~~------------------------- 60 (181)
+...+..+..++.+||... +.|++++|.+.+...+|+.++.+++.... ....
T Consensus 906 aRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~ 983 (1205)
T KOG0606|consen 906 ARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQ 983 (1205)
T ss_pred ccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccc
Confidence 3445677888999999998 89999999999999999999999873221 0000
Q ss_pred -c----ccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCH
Q 030203 61 -F----LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNP 134 (181)
Q Consensus 61 -~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 134 (181)
. .......+++.|.+||...+......+|.|+.|.++++.++|..||+.....++.+++..... ...-+...++
T Consensus 984 l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~ 1063 (1205)
T KOG0606|consen 984 LSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSY 1063 (1205)
T ss_pred cccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccCh
Confidence 0 011234578899999999998888899999999999999999999999998888876643222 2334567889
Q ss_pred HHHHHHHHHhcCCCCCCCCHH
Q 030203 135 HVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 135 ~~~~li~~~l~~~p~~Rps~~ 155 (181)
..++++.+.+..+|.+|..+.
T Consensus 1064 ~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1064 EAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhccCchhccCcc
Confidence 999999999999999999776
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.5e-08 Score=71.61 Aligned_cols=48 Identities=19% Similarity=0.259 Sum_probs=44.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
....++.+++.++.++|+.+ ++|+||+|.||+++.++.++++|||.+.
T Consensus 126 ~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~~~liDfg~~~ 173 (198)
T cd05144 126 DPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEKIYIIDWPQMV 173 (198)
T ss_pred cHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCcEEEEECCccc
Confidence 45678899999999999999 9999999999999999999999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.2e-08 Score=74.10 Aligned_cols=45 Identities=22% Similarity=0.325 Sum_probs=41.3
Q ss_pred HHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 10 i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
.+.+++.++.+||+.| ++|+|++|.||+++.++.++++|||.+..
T Consensus 147 ~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 147 QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 4678999999999999 99999999999999888999999998654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.7e-08 Score=69.45 Aligned_cols=49 Identities=27% Similarity=0.254 Sum_probs=44.9
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 5 RRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
.++..++.+++.++.++|. .+ ++|+|++|+||+++ ++.++++|||.+..
T Consensus 114 ~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 114 EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CCcEEEEECccccc
Confidence 4678899999999999999 88 99999999999999 88999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.7e-08 Score=67.87 Aligned_cols=48 Identities=25% Similarity=0.549 Sum_probs=43.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
+...++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 96 ~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 96 EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 45689999999999999999 99999999999999 78899999998654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.8e-08 Score=78.44 Aligned_cols=152 Identities=22% Similarity=0.266 Sum_probs=105.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC-CcEEEcccCCccccccccccCCCCCCCCCcc--CCc
Q 030203 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWM--APE 77 (181)
Q Consensus 1 ~l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~--~pe 77 (181)
++++...+++..|++.++.++|+.. ++|+|++|.||+...+ +..+++|++........ .........+. ++.
T Consensus 362 ~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~ 436 (524)
T KOG0601|consen 362 MLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEI 436 (524)
T ss_pred hcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccccccee---cccccccccccccchh
Confidence 4678889999999999999999999 9999999999999886 67788888876531111 11111122233 444
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
......+..+.|++++|.-+.+.+++..--.....- ..+ .............++..+.+.+...++..||.+.++
T Consensus 437 ~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i--~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 437 LLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI--RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVEL 511 (524)
T ss_pred hccccccccccccccccccccccccCcccCcccccc---eee--ecccccCCCchHHhhhhhhhhhcCCccccchhhhhh
Confidence 555566778999999999999999886533222211 111 111122223334788899999999999999999887
Q ss_pred HHHHH
Q 030203 158 MELLR 162 (181)
Q Consensus 158 l~~L~ 162 (181)
....+
T Consensus 512 ~~~~~ 516 (524)
T KOG0601|consen 512 SLHSE 516 (524)
T ss_pred cccch
Confidence 66433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.1e-08 Score=68.11 Aligned_cols=44 Identities=30% Similarity=0.489 Sum_probs=36.3
Q ss_pred HHHHHHHHHHH-HHHHhCCCCceecCCCCCCEEEcC----CCcEEEcc-cCC
Q 030203 8 LNMAYDVAKGM-NYLHRRNPPIVHRDLKSPNLLVDK----KYTVKVCD-FGL 53 (181)
Q Consensus 8 ~~i~~ql~~~l-~~lh~~~~~~~h~~i~~~nil~~~----~~~~~l~d-~g~ 53 (181)
..++.+++.++ .|||+++ |+|+||||+||+++. ++.++|+| ||.
T Consensus 107 ~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 107 VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 35577888777 9999999 999999999999974 23799999 454
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.3e-07 Score=66.71 Aligned_cols=45 Identities=29% Similarity=0.570 Sum_probs=41.8
Q ss_pred HHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 9 ~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
.++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 94 ~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 68999999999999999 99999999999999 78999999998654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.5e-07 Score=76.21 Aligned_cols=47 Identities=30% Similarity=0.525 Sum_probs=42.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 7 ~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
...++.+++.+|.+||+.+ ++|+|++|.||++ .++.++++|||+++.
T Consensus 430 ~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 430 NPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 5678999999999999999 9999999999999 567899999998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.8e-07 Score=63.57 Aligned_cols=53 Identities=28% Similarity=0.270 Sum_probs=44.6
Q ss_pred CHHHHHHHHHHHHHHHHHH-HhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccc
Q 030203 3 DERRRLNMAYDVAKGMNYL-HRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA 58 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~l-h~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~ 58 (181)
++++...+..+++.++..+ |..| ++|+|+++.||+++. +.+.++|||.+....
T Consensus 122 ~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 122 NDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 3456677889999999998 8999 999999999999974 679999999775443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.3e-06 Score=56.92 Aligned_cols=49 Identities=24% Similarity=0.383 Sum_probs=43.6
Q ss_pred HHHHHHHHHHHHHHHHHHhC---CCCceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 5 RRRLNMAYDVAKGMNYLHRR---NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~~---~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
.....++.+++.++..+|.. + ++|+|+++.||+++..+.++++||+.+.
T Consensus 86 ~~~~~~~~~~~~~l~~lh~~~~~~--i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 86 EEKEDIAEQLAELLAKLHQLPLLV--LCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred HHHHHHHHHHHHHHHHHhCCCceE--EEecCCCcceEEEECCcEEEEEeccccc
Confidence 45677899999999999985 6 9999999999999998899999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.7e-05 Score=60.31 Aligned_cols=132 Identities=13% Similarity=0.229 Sum_probs=95.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
.+|...|.++.|+..||.++|+.| +.-+-+.+.+|+++.+..+++..-|......... . +.+.+
T Consensus 390 ~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------------~--~~le~ 453 (655)
T KOG3741|consen 390 APEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------------T--EPLES 453 (655)
T ss_pred chHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCCC------------C--cchhH
Confidence 468899999999999999999999 9889999999999887777777655543322211 0 11112
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHH-HHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQV-VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..+.|.-.||.+++.+.+|..--... ...+. ...+ ...++.++++++......++++ -++.+++.
T Consensus 454 ---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I---------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 454 ---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI---------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred ---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 23579999999999999996542222 22111 2222 3457889999999999998887 78888876
Q ss_pred HHH
Q 030203 160 LLR 162 (181)
Q Consensus 160 ~L~ 162 (181)
++-
T Consensus 521 ~~~ 523 (655)
T KOG3741|consen 521 MIG 523 (655)
T ss_pred HHH
Confidence 654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.3e-06 Score=59.46 Aligned_cols=52 Identities=29% Similarity=0.404 Sum_probs=45.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC---cEEEcccCCccc
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRL 56 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~---~~~l~d~g~~~~ 56 (181)
+......++.+++..+.-||..| ++|+|+++.||+++.++ .+.++||+.+..
T Consensus 116 ~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 116 DPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred chhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 35567789999999999999999 99999999999998876 788999986543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.2e-06 Score=60.94 Aligned_cols=50 Identities=22% Similarity=0.241 Sum_probs=43.2
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-------CCcEEEcccCCcc
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-------KYTVKVCDFGLSR 55 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-------~~~~~l~d~g~~~ 55 (181)
+.....++.+++..+.-||..| ++|+|+++.||+++. +..+.++||+.+.
T Consensus 137 ~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 137 PRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 3456689999999999999999 999999999999975 4578999998653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.7e-06 Score=56.62 Aligned_cols=47 Identities=23% Similarity=0.227 Sum_probs=39.1
Q ss_pred HHHHHHHHHHHHHHHhCCC---CceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 8 LNMAYDVAKGMNYLHRRNP---PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 8 ~~i~~ql~~~l~~lh~~~~---~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
...+.+++.++..||..+. .++|+|+++.||+++ ++.++++||+.+.
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 3467899999999999971 139999999999999 5689999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.9e-06 Score=56.76 Aligned_cols=45 Identities=29% Similarity=0.558 Sum_probs=39.6
Q ss_pred HHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 9 ~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
.++..+-.-+.-||..| ++|+|++++||+++..+ +.++|||++..
T Consensus 96 ~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 96 DLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred HHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 56778888899999999 99999999999998764 99999999753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.6e-05 Score=56.31 Aligned_cols=51 Identities=22% Similarity=0.172 Sum_probs=44.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc--EEEcccCCcc
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSR 55 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~--~~l~d~g~~~ 55 (181)
++.+...++.+++.++.-||+.| +.|+|+.+.||+++.+|. +.++||..++
T Consensus 126 ~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 126 SDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred chHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 34556789999999999999999 999999999999986667 8999997654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.84 E-value=2.7e-05 Score=54.52 Aligned_cols=49 Identities=31% Similarity=0.438 Sum_probs=37.0
Q ss_pred HHHHHHHHHHHHHHHH-HHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 5 RRRLNMAYDVAKGMNY-LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~-lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
++...++.+++..+.. +|..| ++|||+++.||+++.+ .+.++|||.+..
T Consensus 106 ~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 106 EEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp STHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred hhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEecCccee
Confidence 3456778888885554 57999 9999999999999887 899999997643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=5.1e-05 Score=52.60 Aligned_cols=47 Identities=32% Similarity=0.519 Sum_probs=40.3
Q ss_pred HHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC---cEEEcccCCccc
Q 030203 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRL 56 (181)
Q Consensus 8 ~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~---~~~l~d~g~~~~ 56 (181)
..++..+-+.+.-||.++ ++|||++.+||++.+++ .+.++|||++..
T Consensus 116 ~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 116 AELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 678899999999999999 99999999999996544 347999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.79 E-value=5.5e-05 Score=59.86 Aligned_cols=49 Identities=27% Similarity=0.352 Sum_probs=40.8
Q ss_pred HHHHHHHHH-HHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccc
Q 030203 8 LNMAYDVAK-GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA 58 (181)
Q Consensus 8 ~~i~~ql~~-~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~ 58 (181)
..++..++. .+..+|..| ++|+|++|.||+++.+|.++++|||++....
T Consensus 259 ~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 259 KALAENLARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 346666665 478899999 9999999999999999999999999875433
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0053 Score=43.05 Aligned_cols=52 Identities=15% Similarity=0.106 Sum_probs=46.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhC--CCCceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 3 DERRRLNMAYDVAKGMNYLHRR--NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~--~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+|+++++|+.++++.+.+++.. +. +.-.|++++|+.++.+|.++++|.....
T Consensus 57 ~w~~R~~iA~~lL~~l~~l~~~~~~~-~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 57 PWEQRAKIALQLLELLEELDHGPLGF-FYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCc-EEEeecchHHeEEeCCCcEEEEechhcc
Confidence 6889999999999999999984 22 8899999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0004 Score=49.67 Aligned_cols=42 Identities=21% Similarity=0.368 Sum_probs=36.3
Q ss_pred HHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 10 i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
+...+.+++.-+|..| ++|+|.+|.|++++.++ +.++|++..
T Consensus 140 ~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~iID~~~k 181 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRIIDTQGK 181 (229)
T ss_pred HHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEEEECccc
Confidence 4466788899999999 99999999999998664 899999754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0015 Score=48.06 Aligned_cols=49 Identities=24% Similarity=0.283 Sum_probs=39.2
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+..-.++..|+.-+..+=..| ++|+|++.-||+++.+|.+.++||-.+.
T Consensus 202 en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 202 ENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCCEEEEeCcccc
Confidence 344556666666666666788 9999999999999999999999996543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.00074 Score=54.69 Aligned_cols=35 Identities=23% Similarity=0.365 Sum_probs=30.1
Q ss_pred HHHhCCCCceecCCCCCCEEEcCCC----cEEEcccCCccc
Q 030203 20 YLHRRNPPIVHRDLKSPNLLVDKKY----TVKVCDFGLSRL 56 (181)
Q Consensus 20 ~lh~~~~~~~h~~i~~~nil~~~~~----~~~l~d~g~~~~ 56 (181)
.+...| ++|+|++|.||+++.+| .++++|||+...
T Consensus 275 Qif~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 275 QVFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HHHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 344678 99999999999999887 899999998753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.01 Score=51.72 Aligned_cols=149 Identities=17% Similarity=0.203 Sum_probs=92.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCC---CEEEcCCCcEEEc--ccCCccccccccccCCCCCCCCCccCCc
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSP---NLLVDKKYTVKVC--DFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~---nil~~~~~~~~l~--d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+....+.+..++..|+.++|+.. ..|.-+..+ +...+..+....+ +|+........... ........+.++|
T Consensus 284 ~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e 360 (1351)
T KOG1035|consen 284 PLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADE 360 (1351)
T ss_pred CHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCcccccccc
Confidence 44566778889999999999997 766666555 2333444455544 66655433332211 1223334556666
Q ss_pred ccCCCCCC--CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDEPSN--EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~~~~--~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
......+. ...|+|.+|.....+..|..+-.-..... .-++........+...+|+..++++|++..
T Consensus 361 ~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~-----------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 361 DLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV-----------SLLDVLSTSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred ccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh-----------hhhccccchhhhhhhhhhcchhhhhccchh
Confidence 65544433 34799999999999988765432211100 011222222678899999999999999999
Q ss_pred HHHHHHHHhhhC
Q 030203 156 TIMELLRPLIKS 167 (181)
Q Consensus 156 ~~l~~L~~~~~~ 167 (181)
+++. +.+++.
T Consensus 430 ~ll~--~~f~~~ 439 (1351)
T KOG1035|consen 430 ELLT--HPFLRF 439 (1351)
T ss_pred hhhh--chhccc
Confidence 9998 555443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0051 Score=43.65 Aligned_cols=28 Identities=32% Similarity=0.469 Sum_probs=24.3
Q ss_pred ceecCCCCCCEEEcC--CCcEEEcccCCcc
Q 030203 28 IVHRDLKSPNLLVDK--KYTVKVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~~~--~~~~~l~d~g~~~ 55 (181)
++|+|+++.||+++. ++.+.++||+.+.
T Consensus 176 l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 176 LVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred EEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 799999999999988 5668899998653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.015 Score=42.42 Aligned_cols=51 Identities=24% Similarity=0.224 Sum_probs=41.3
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCcccccc
Q 030203 6 RRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN 59 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~ 59 (181)
++..+..++++.+.-|=. .+ +||+|+..-||++. .+.+.++|++.+....+
T Consensus 167 e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 167 EAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred hHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 566777788888777766 67 99999999999999 67899999997754443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.049 Score=40.93 Aligned_cols=28 Identities=25% Similarity=0.402 Sum_probs=24.7
Q ss_pred CceecCCCCCCEEEcCC----CcEEEcccCCc
Q 030203 27 PIVHRDLKSPNLLVDKK----YTVKVCDFGLS 54 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~----~~~~l~d~g~~ 54 (181)
+++|+|+.+.||+++.+ +.+.++||+.+
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 48999999999999874 78999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.019 Score=41.42 Aligned_cols=39 Identities=26% Similarity=0.270 Sum_probs=32.8
Q ss_pred HHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCC
Q 030203 15 AKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 53 (181)
Q Consensus 15 ~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~ 53 (181)
+.+|...|+.+.-.+|||.+|+||+-+..|.+|+.|-+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 566888896544499999999999999999999999653
|
The function of this family is unknown. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.027 Score=40.75 Aligned_cols=27 Identities=41% Similarity=0.475 Sum_probs=23.5
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+.+.||+++.++...++||+.+
T Consensus 166 l~HGD~~~~Nvlv~~~~i~giIDw~~a 192 (235)
T cd05155 166 WFHGDLAPGNLLVQDGRLSAVIDFGCL 192 (235)
T ss_pred EEeCCCCCCcEEEECCCEEEEEeCccc
Confidence 899999999999987665679999865
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.061 Score=41.72 Aligned_cols=52 Identities=31% Similarity=0.529 Sum_probs=44.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
.++|++.++.+-+..+.-+...= ++-|+|+.-.||+++ .|++.|+||-+++.
T Consensus 319 ~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 319 RSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee-cCceEEEEeeeeec
Confidence 46788899998888887777662 389999999999999 89999999998874
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.065 Score=39.83 Aligned_cols=47 Identities=17% Similarity=0.260 Sum_probs=34.9
Q ss_pred HHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 9 ~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+.+..+-.++.-.+..-.+++|+|+++.|++.++.|.+.|+||..+.
T Consensus 136 ~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 136 KKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 34455555555555551138999999999999998999999997653
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.045 Score=39.46 Aligned_cols=28 Identities=32% Similarity=0.517 Sum_probs=24.6
Q ss_pred CceecCCCCCCEEEcC-CCcEEEcccCCc
Q 030203 27 PIVHRDLKSPNLLVDK-KYTVKVCDFGLS 54 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~-~~~~~l~d~g~~ 54 (181)
+++|+|+++.||+++. ++.+.++||..+
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a 199 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYA 199 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence 3899999999999997 578999999765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.067 Score=40.38 Aligned_cols=27 Identities=33% Similarity=0.481 Sum_probs=24.3
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+++.|++++.++...++||+.+
T Consensus 189 l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 189 VIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred cCCCCCCcCcEEEECCceEEEeecccc
Confidence 999999999999998876789999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.03 Score=39.19 Aligned_cols=28 Identities=18% Similarity=0.323 Sum_probs=24.5
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+.+|+|+.|.|++++.+| ++++||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 369999999999998877 8899998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.1 Score=39.24 Aligned_cols=26 Identities=31% Similarity=0.478 Sum_probs=23.0
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+++.||+++. +.+.++||+.+
T Consensus 189 liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 189 FCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred eEcCCCCcccEEEeC-CcEEEEECccc
Confidence 899999999999987 57889999754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.077 Score=38.33 Aligned_cols=28 Identities=25% Similarity=0.234 Sum_probs=24.7
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
.++|+|+.+.||+++.++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 479999999999999888 9999998653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.079 Score=39.63 Aligned_cols=27 Identities=33% Similarity=0.457 Sum_probs=24.3
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+++.|++++.++.+.++||+.+
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhh
Confidence 999999999999998877789999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.032 Score=40.50 Aligned_cols=28 Identities=29% Similarity=0.357 Sum_probs=24.7
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
+++|+|+.+.||+++.++...++||+.+
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 4899999999999998777789999754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.12 Score=39.16 Aligned_cols=27 Identities=26% Similarity=0.402 Sum_probs=23.6
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+.+.||+++.+....++||+.+
T Consensus 189 liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 189 VIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred cCCCCCCCCcEEEECCceEEEEecccc
Confidence 999999999999987655689999865
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.024 Score=40.29 Aligned_cols=29 Identities=34% Similarity=0.548 Sum_probs=20.4
Q ss_pred CceecCCCCCCEEE-cCCCcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLV-DKKYTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~-~~~~~~~l~d~g~~~ 55 (181)
++.|+|+.+.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 778899999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.032 Score=40.89 Aligned_cols=28 Identities=25% Similarity=0.393 Sum_probs=24.2
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+++|+|+++.||+++.++ +.++||+.+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 389999999999999876 7899998653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.033 Score=39.70 Aligned_cols=27 Identities=33% Similarity=0.570 Sum_probs=19.0
Q ss_pred ceecCCCCCCEEEc-CCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVD-KKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~-~~~~~~l~d~g~~ 54 (181)
++|+|+++.||+++ .++.+.++||+.+
T Consensus 168 ~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 168 LIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp EE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred EEEeccccccceeeeccceeEEEecccc
Confidence 99999999999999 5566689999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.88 E-value=0.018 Score=47.46 Aligned_cols=96 Identities=28% Similarity=0.349 Sum_probs=70.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCCCCC
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSN 85 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 85 (181)
+..+++..-..+++++|+.. -+|+| ||+.+. +..+.++++......... ...+..+++.+++||......+.
T Consensus 337 ~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~ 408 (829)
T KOG0576|consen 337 QFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTID 408 (829)
T ss_pred hhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccc
Confidence 44556666677899999885 47887 555544 578889998876544443 44566788899999998888888
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCC
Q 030203 86 EKSDIYSFGVILWELATLQQPWGN 109 (181)
Q Consensus 86 ~~~Dv~slG~~~~~ll~g~~p~~~ 109 (181)
...|+|++|.--.++.-|.+|-..
T Consensus 409 ~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 409 GCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cCCCccCCCcchhhcCCCCCCCCC
Confidence 899999999766667666665443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.38 E-value=0.19 Score=38.61 Aligned_cols=47 Identities=19% Similarity=0.240 Sum_probs=39.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 7 ~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+-.+...++.-+-.|-.+| ++|||++--||+++.++.++++||-...
T Consensus 204 ~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 204 PPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred hHHHHHHHHHHHHHHHHcC--ceecccchheeEEecCCCEEEeechHhh
Confidence 3456677777788889999 9999999999999999999999996543
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.18 E-value=0.087 Score=37.13 Aligned_cols=28 Identities=32% Similarity=0.423 Sum_probs=22.9
Q ss_pred CceecCCCCCCEEEcCCC-----cEEEcccCCc
Q 030203 27 PIVHRDLKSPNLLVDKKY-----TVKVCDFGLS 54 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~-----~~~l~d~g~~ 54 (181)
+++|||+++.|+++..++ .+.++||..+
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~ 153 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLS 153 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccC
Confidence 389999999999997543 5789999764
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.54 E-value=0.27 Score=37.14 Aligned_cols=28 Identities=21% Similarity=0.288 Sum_probs=25.3
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
++|+|+.++|++++.++.+.++||..+.
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 9999999999999998889999997653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=92.47 E-value=0.011 Score=53.51 Aligned_cols=83 Identities=17% Similarity=0.149 Sum_probs=63.0
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~ 107 (181)
-+|.++++.|.++..+.+++++++|+.+.............+++.|+.++....-.++.++|+|..|+-+|..-.|..+|
T Consensus 1361 ~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred chhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 57899999999999888999999999873333222334456666778888777767777899999999999887777666
Q ss_pred CCC
Q 030203 108 GNL 110 (181)
Q Consensus 108 ~~~ 110 (181)
...
T Consensus 1441 i~f 1443 (2724)
T KOG1826|consen 1441 IFF 1443 (2724)
T ss_pred HHH
Confidence 443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.18 E-value=0.14 Score=38.26 Aligned_cols=29 Identities=24% Similarity=0.465 Sum_probs=23.8
Q ss_pred CceecCCCCCCEEEcCCCc-EEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKKYT-VKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~-~~l~d~g~~~ 55 (181)
.++|+|+++.||+++.++. ..++||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 3899999999999987454 4699998654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.05 E-value=0.17 Score=38.58 Aligned_cols=32 Identities=31% Similarity=0.484 Sum_probs=27.9
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCccccc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA 58 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~ 58 (181)
.++|||+.+.|+++++.+-+-++||+.+....
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 38999999999999998889999999876433
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=91.84 E-value=0.14 Score=39.27 Aligned_cols=28 Identities=29% Similarity=0.428 Sum_probs=24.3
Q ss_pred CceecCCCCCCEEEcC-CCcEEEcccCCc
Q 030203 27 PIVHRDLKSPNLLVDK-KYTVKVCDFGLS 54 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~-~~~~~l~d~g~~ 54 (181)
+++|+|+.+.||+++. ++.+.++||+.+
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 4799999999999975 578999999875
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.64 E-value=0.32 Score=37.51 Aligned_cols=28 Identities=21% Similarity=0.536 Sum_probs=24.3
Q ss_pred CceecCCCCCCEEEcC-CCcEEEcccCCc
Q 030203 27 PIVHRDLKSPNLLVDK-KYTVKVCDFGLS 54 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~-~~~~~l~d~g~~ 54 (181)
+++|+|+++.||+++. ++.+.++||..+
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya 229 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYA 229 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence 3899999999999976 467999999765
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.58 E-value=0.14 Score=41.54 Aligned_cols=74 Identities=22% Similarity=0.212 Sum_probs=49.5
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-cC---------CCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 86 EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-LE---------IPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 86 ~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
+++|||++|.++.++.-|..-+...........+..-... .. .--.++..+.++..+|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 5899999999999998887766655444333332211111 10 1123566788899999999999999776
Q ss_pred HHHH
Q 030203 156 TIME 159 (181)
Q Consensus 156 ~~l~ 159 (181)
++.+
T Consensus 190 ~~~k 193 (725)
T KOG1093|consen 190 ELSK 193 (725)
T ss_pred HHhc
Confidence 6654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.27 E-value=0.55 Score=38.31 Aligned_cols=34 Identities=29% Similarity=0.431 Sum_probs=29.6
Q ss_pred HHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 21 LHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 21 lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
+=..| ++|.|..|-||++..+|.+.+.|||....
T Consensus 281 ~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 281 LLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred HHhcC--ccccCCCccceEEecCCcEEEEcCcceec
Confidence 33457 99999999999999999999999998653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.20 E-value=0.2 Score=38.44 Aligned_cols=27 Identities=33% Similarity=0.500 Sum_probs=23.9
Q ss_pred ceecCCCCCCEEEcCCCc-EEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYT-VKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~-~~l~d~g~~ 54 (181)
++|+|+.+.||+++.+.. ..++||+-+
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccc
Confidence 799999999999998875 789999864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.31 E-value=0.45 Score=42.10 Aligned_cols=28 Identities=32% Similarity=0.549 Sum_probs=23.8
Q ss_pred ceecCCCCCCEEEcCCC--cE-EEcccCCcc
Q 030203 28 IVHRDLKSPNLLVDKKY--TV-KVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~--~~-~l~d~g~~~ 55 (181)
++|+|+++.||+++.++ .+ -++|||-+.
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 99999999999998764 44 499999764
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=87.87 E-value=0.31 Score=36.47 Aligned_cols=28 Identities=29% Similarity=0.401 Sum_probs=22.4
Q ss_pred CceecCCCCCCEEEcCC--C---cEEEcccCCc
Q 030203 27 PIVHRDLKSPNLLVDKK--Y---TVKVCDFGLS 54 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~--~---~~~l~d~g~~ 54 (181)
+++|||++..||++..+ | .+.++||..+
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~ 248 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLA 248 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccc
Confidence 48999999999999654 3 5788888653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.55 E-value=0.85 Score=40.26 Aligned_cols=28 Identities=29% Similarity=0.310 Sum_probs=22.9
Q ss_pred ceecCCCCCCEEEcCC--Cc---EEEcccCCcc
Q 030203 28 IVHRDLKSPNLLVDKK--YT---VKVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~--~~---~~l~d~g~~~ 55 (181)
++|+|++..||+++.+ +. ..++|||-+.
T Consensus 210 ~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 210 AVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred ccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 9999999999999864 23 3799998764
|
|
| >PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria | Back alignment and domain information |
|---|
Probab=86.73 E-value=1.1 Score=34.75 Aligned_cols=80 Identities=18% Similarity=0.312 Sum_probs=42.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
+..+.++++.+ +.+|.. |... -+|--++|+|++++.++.+++...|+.. -++|...
T Consensus 57 ~~~eklr~~~n-i~~l~~-~~~~--~~~f~l~P~Nl~fd~~~~p~i~hrGi~~-----------------~l~P~~~--- 112 (359)
T PF10140_consen 57 DKSEKLRLLIN-IAALKE-HLNS--RYTFILHPENLVFDKNLMPKILHRGIKE-----------------ILPPYEL--- 112 (359)
T ss_dssp -HHHHHHHHHH-GGGGGG-GGGS--SEE---SGGGEEE-TTS-EEES--EETT-----------------TBS-------
T ss_pred CHHHHHHHHHH-HHHHHH-HhcC--ceeEEEechheEEcCCCCEEEEEcCCcC-----------------CCCCCCC---
Confidence 45677888888 445543 3333 5899999999999999999999887631 1222211
Q ss_pred CCCCchh-HHHHHHHHHHHHhCCCCCCC
Q 030203 83 PSNEKSD-IYSFGVILWELATLQQPWGN 109 (181)
Q Consensus 83 ~~~~~~D-v~slG~~~~~ll~g~~p~~~ 109 (181)
...| .-.+-|++..++.++..|..
T Consensus 113 ---~ee~fl~qyKali~~ll~~k~~Fe~ 137 (359)
T PF10140_consen 113 ---DEEDFLKQYKALIIALLDPKYSFED 137 (359)
T ss_dssp ----HHHHHHHHHHHHHHHH-TT--HHH
T ss_pred ---CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 2234 33467778888887776643
|
This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.02 E-value=1.8 Score=33.07 Aligned_cols=26 Identities=23% Similarity=0.279 Sum_probs=22.0
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
++|+|+.+.||+++ + .+.++||+-+.
T Consensus 198 liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 198 RLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 89999999999995 3 57899998654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=85.82 E-value=2.3 Score=30.13 Aligned_cols=42 Identities=26% Similarity=0.413 Sum_probs=29.4
Q ss_pred HHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC--C--cEEEcc-cCC
Q 030203 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK--Y--TVKVCD-FGL 53 (181)
Q Consensus 10 i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~--~--~~~l~d-~g~ 53 (181)
+...+-.-..+|-+.+ |+.+|++|.||++..+ + .+.++| ||.
T Consensus 123 ~~~~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 123 LRQALDEFKRYLLDHH--IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred HHHHHHHHHHHHHHcC--CeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 3344445566777888 9999999999999543 2 466666 554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=84.05 E-value=1 Score=35.60 Aligned_cols=29 Identities=24% Similarity=0.415 Sum_probs=24.4
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
+++|||+.+.||++..+ .++++|+..+..
T Consensus 224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred ceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 49999999999999776 589999986543
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=83.21 E-value=2.7 Score=32.58 Aligned_cols=35 Identities=23% Similarity=0.179 Sum_probs=23.6
Q ss_pred HHHHHHHHHHHHHHH---H-hCCCCceecCCCCCCEEEcCC
Q 030203 7 RLNMAYDVAKGMNYL---H-RRNPPIVHRDLKSPNLLVDKK 43 (181)
Q Consensus 7 ~~~i~~ql~~~l~~l---h-~~~~~~~h~~i~~~nil~~~~ 43 (181)
+..++.|++--.-.+ - ..+ ++|.||||+||++-++
T Consensus 281 ikfifLQiaLLyikIYelp~c~n--F~H~DLKPdNILiFds 319 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDN--FLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcce--eeeccCCCCcEEEecC
Confidence 345667776554233 2 345 8999999999998443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=82.69 E-value=2.2 Score=33.78 Aligned_cols=29 Identities=24% Similarity=0.430 Sum_probs=24.3
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
+++|||+.+.||+++.+ ..+++|...+..
T Consensus 228 aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy 256 (409)
T PRK12396 228 ALIHGDLHTGSVFVKND-STKVIDPEFAFY 256 (409)
T ss_pred hhccCcCCCCCEEecCC-ceEEEccccccc
Confidence 39999999999999986 588999776643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=82.20 E-value=2.3 Score=32.08 Aligned_cols=27 Identities=19% Similarity=0.299 Sum_probs=20.5
Q ss_pred CCceecCCCCCCEEEcCC-Cc-EEEcccC
Q 030203 26 PPIVHRDLKSPNLLVDKK-YT-VKVCDFG 52 (181)
Q Consensus 26 ~~~~h~~i~~~nil~~~~-~~-~~l~d~g 52 (181)
+.++|||+++.||+++.+ +. +.++|..
T Consensus 193 psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 193 CVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CeeEeCCCCcccEEECCCCCceEEEECch
Confidence 459999999999999864 33 5566654
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=81.92 E-value=3.1 Score=32.44 Aligned_cols=48 Identities=23% Similarity=0.218 Sum_probs=38.7
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
....++++.|.+..|.-+... -.|.-+.|+||+++.++.+.+..+|+-
T Consensus 84 k~~Klr~a~~~I~~l~e~~~t---r~~~~laPeNilf~~~l~p~~vH~Glk 131 (434)
T COG4499 84 KTRKLRLALQNIATLSELNNT---RYTFFLAPENILFDGGLTPFFVHRGLK 131 (434)
T ss_pred HHHHHHHHHHHHHHHHHhhcc---ceeEEecchheEEcCCCceEEEecchh
Confidence 345667788888888775444 578899999999999999999999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=81.36 E-value=1.2 Score=34.65 Aligned_cols=28 Identities=29% Similarity=0.402 Sum_probs=23.3
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
++|||+.+.||+++.++ ++++|+..+..
T Consensus 194 llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 194 LLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred eeeccCCcccEEEcCCC-CEEEcCccccc
Confidence 89999999999997764 77999876543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=81.03 E-value=3.3 Score=36.00 Aligned_cols=29 Identities=34% Similarity=0.543 Sum_probs=23.5
Q ss_pred ceecCCCCCCEEEcCC-C-cEEEcccCCccc
Q 030203 28 IVHRDLKSPNLLVDKK-Y-TVKVCDFGLSRL 56 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~-~-~~~l~d~g~~~~ 56 (181)
++|+|+++.|++++.+ + ..-++||+.+..
T Consensus 227 LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 227 IVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred eEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 9999999999999753 3 357999988764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=80.14 E-value=0.81 Score=34.42 Aligned_cols=28 Identities=29% Similarity=0.300 Sum_probs=18.6
Q ss_pred CCCceecCCCCCCEEEcCCCcEEEcccC
Q 030203 25 NPPIVHRDLKSPNLLVDKKYTVKVCDFG 52 (181)
Q Consensus 25 ~~~~~h~~i~~~nil~~~~~~~~l~d~g 52 (181)
.+.++|||+.+-|+..+.+|.+.+.|=.
T Consensus 187 ~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 187 KPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp --EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred CceeeEcCccccceeecCCCCceeeccc
Confidence 3459999999999999999888888854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 181 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-91 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-89 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-25 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-25 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-24 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-24 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-24 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-24 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-24 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-24 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-23 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-23 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-23 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-23 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-23 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-23 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-23 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-23 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-23 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-23 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-23 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-23 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-23 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-23 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-23 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-23 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-23 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-23 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-23 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-23 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-23 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-23 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-23 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-23 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-23 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-23 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-23 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-23 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-23 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-23 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-22 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-22 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-22 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-22 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-22 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-22 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-22 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-21 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-21 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-21 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-21 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-21 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-21 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-21 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-21 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-21 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-21 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-21 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-21 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-20 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-20 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-20 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-20 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-20 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-20 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-20 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-20 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-20 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-20 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-20 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-18 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-18 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-18 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-18 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-18 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-18 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-05 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-105
Identities = 156/176 (88%), Positives = 167/176 (94%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LDERRRL+MAYDVAKGMNYLH RNPPIVHR+LKSPNLLVDKKYTVKVCDFGLSRLKA+TF
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
LSSKSAAGTPEWMAPEVLRDEPSNEKSD+YSFGVILWELATLQQPWGNLNPAQVVAAVGF
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
K KRLEIPRN+NP VA+IIE CW NEPWKRPSF+TIM+LLRPLIKS P P+ +D+
Sbjct: 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 5e-91
Identities = 49/166 (29%), Positives = 89/166 (53%), Gaps = 8/166 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+D+ + + A D+A+GM +LH P I L S ++++D+ T ++ +
Sbjct: 108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----S 162
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSN---EKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
S P W+APE L+ +P + +D++SF V+LWEL T + P+ +L+ ++
Sbjct: 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK 222
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164
V +G R IP ++PHV+ +++ C +P KRP F I+ +L +
Sbjct: 223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 8e-91
Identities = 65/172 (37%), Positives = 95/172 (55%), Gaps = 11/172 (6%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNP-PIVHRDLKSPNLLVDKKY--------TVKVCDFG 52
+ +N A +A+GMNYLH PI+HRDLKS N+L+ +K +K+ DFG
Sbjct: 102 IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161
Query: 53 LSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP 112
L+R T + SAAG WMAPEV+R ++ SD++S+GV+LWEL T + P+ ++
Sbjct: 162 LAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219
Query: 113 AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164
V V L IP A ++E CW +P RPSF+ I++ L +
Sbjct: 220 LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 3e-89
Identities = 59/172 (34%), Positives = 95/172 (55%), Gaps = 12/172 (6%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSRL 56
+ +L + D+A G+ Y+ +NPPIVHRDL+SPN+ + KV DFGLS+
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 57 KANTFLSSKSAAGTPEWMAPEVL--RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ 114
++ G +WMAPE + +E EK+D YSF +IL+ + T + P+ + +
Sbjct: 179 SVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 115 V--VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164
+ + + +G R IP + P + ++IE CW+ +P KRP FS I++ L L
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 6e-89
Identities = 56/180 (31%), Positives = 95/180 (52%), Gaps = 6/180 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNP-PIVHRDLKSPNLLVDKKYTV-KVCDFGLSRLKAN 59
++ ++G+ YLH P ++HRDLK PNLL+ TV K+CDFG +
Sbjct: 99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAA 118
++K G+ WMAPEV +EK D++S+G+ILWE+ T ++P+ + PA +
Sbjct: 159 HMTNNK---GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW 215
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 178
G R + +N+ + S++ CW+ +P +RPS I++++ L++ P P
Sbjct: 216 AVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 3e-84
Identities = 58/174 (33%), Positives = 100/174 (57%), Gaps = 11/174 (6%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ ++ +++A A+GM+YLH ++ I+HRDLKS N+ + + TVK+ DFGL+ K+
Sbjct: 117 FEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 62 LSSK--SAAGTPEWMAPEVLRDEPSN---EKSDIYSFGVILWELATLQQPWGNLNPA-QV 115
S + +G+ WMAPEV+R + SN +SD+Y+FG++L+EL T Q P+ N+N Q+
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234
Query: 116 VAAVGFKGKR---LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
+ VG ++ N + ++ C + +RPSF I+ + L +
Sbjct: 235 IEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 4e-84
Identities = 59/195 (30%), Positives = 82/195 (42%), Gaps = 18/195 (9%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----- 56
+R++ A D+A GM YLH N I+HRDL S N LV + V V DFGL+RL
Sbjct: 105 YPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162
Query: 57 ---------KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
K + G P WMAPE++ +EK D++SFG++L E+
Sbjct: 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
Query: 108 GNLNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
+ P + + + P N P I C +P KRPSF + L L
Sbjct: 223 PDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
Query: 167 SPTPQ-PSPTDMPLL 180
P + L
Sbjct: 283 HLAGHLPLGPQLEQL 297
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 3e-82
Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 17/190 (8%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD + +A ++ KGM YLH + I+H+DLKS N+ D V + DFGL +
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQ 183
Query: 62 LSSKS-----AAGTPEWMAPEVLR---------DEPSNEKSDIYSFGVILWELATLQQPW 107
+ G +APE++R P ++ SD+++ G I +EL + P+
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
Query: 108 GNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
++ +G K + ++ I+ CWA E +RP+F+ +M++L L K
Sbjct: 244 KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303
Query: 168 PTPQPSPTDM 177
P
Sbjct: 304 NRRLSHPGHF 313
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-75
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 2 LDERRRLNMAYDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55
LD + L +AY G+ +LH + P I HRDLKS N+LV K T + D GL+
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 56 LKANT----FLSSKSAAGTPEWMAPEVL------RDEPSNEKSDIYSFGVILWELAT--- 102
+ + + GT +M PEVL S +D+YSFG+ILWE+A
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250
Query: 103 -------LQQPWGNLNPAQ-----VVAAVGFKGKRLEIPRNVNPH-----VASIIEACWA 145
Q P+ +L P+ + V K R P + + ++ CWA
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310
Query: 146 NEPWKRPSFSTIMELLRPLIKSPTPQ 171
+ P R + + + L + +S +
Sbjct: 311 HNPASRLTALRVKKTLAKMSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 7e-75
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 36/199 (18%)
Query: 2 LDERRRLNMAYDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55
LD L + +A G+ +LH + P I HRDLKS N+LV K + D GL+
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
Query: 56 LKANTF----LSSKSAAGTPEWMAPEVLRDEP------SNEKSDIYSFGVILWELAT--- 102
+ + + + + GT +MAPEVL + S ++ DI++FG++LWE+A
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221
Query: 103 -------LQQPWGNLNP-----AQVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWA 145
+ P+ ++ P + V +R IP +A +++ CW
Sbjct: 222 SNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY 281
Query: 146 NEPWKRPSFSTIMELLRPL 164
P R + I + L +
Sbjct: 282 QNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-70
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 36/202 (17%)
Query: 2 LDERRRLNMAYDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55
+ + +A A G+ +LH + P I HRDLKS N+LV K T + D GL+
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195
Query: 56 LKANT----FLSSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELATL-- 103
+ ++ GT +MAPEVL D S +++DIY+ G++ WE+A
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255
Query: 104 --------QQPWGNLNPA-----QVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWA 145
Q P+ +L P+ ++ V + R IP +A I+ CW
Sbjct: 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 315
Query: 146 NEPWKRPSFSTIMELLRPLIKS 167
R + I + L L +
Sbjct: 316 ANGAARLTALRIKKTLSQLSQQ 337
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 1e-69
Identities = 48/202 (23%), Positives = 78/202 (38%), Gaps = 36/202 (17%)
Query: 2 LDERRRLNMAYDVAKGMNYLH--------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 53
+ ++A +A+G+ YLH P I HRD+KS N+L+ T + DFGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 54 SRLK--ANTFLSSKSAAGTPEWMAPEVLRDEP-----SNEKSDIYSFGVILWELATLQQP 106
+ + + GT +MAPEVL + + D+Y+ G++LWELA+
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 107 WGNLNPA----------------QVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWA 145
+ V K KR + H + IE CW
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297
Query: 146 NEPWKRPSFSTIMELLRPLIKS 167
++ R S + E + + +
Sbjct: 298 HDAEARLSAGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 7e-63
Identities = 54/223 (24%), Positives = 83/223 (37%), Gaps = 46/223 (20%)
Query: 2 LDERRRLNMAYDVAKGMNYLH-------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 54
D +A+ V +G+ YLH P I HRDL S N+LV T + DFGLS
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
Query: 55 RLKANTFL--------SSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWE 99
L ++ S GT +MAPEVL E + ++ D+Y+ G+I WE
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 100 LA---TLQQPWGNLNPAQV---------------VAAVGFKGKRLEIPRNVNPH------ 135
+ T P ++ Q+ V + +R + P +
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 136 VASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 178
+ IE CW + R + E + L+ S +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-50
Identities = 57/171 (33%), Positives = 88/171 (51%), Gaps = 9/171 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANT 60
+ + + + KG+ +LH R PPI+HRDLK N+ + +VK+ D GL+ LK +
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAV 119
F +K+ GTPE+MAPE+ +E +E D+Y+FG+ + E+AT + P+ N AQ+ V
Sbjct: 186 F--AKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPT 169
K + P V IIE C +R S +LL + T
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIK---DLLNHAFFQEET 290
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-49
Identities = 65/170 (38%), Positives = 91/170 (53%), Gaps = 6/170 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L + L M D A GM YL + +HRDL + N LV +K +K+ DFG+SR
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ +S P +W APE L + +SD++SFG++LWE +L P+ NL+ Q
Sbjct: 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
V KG RL P V ++E CWA EP +RPSFSTI + L+ + K
Sbjct: 328 VE-KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-47
Identities = 55/178 (30%), Positives = 91/178 (51%), Gaps = 6/178 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L + + D+A GM YL RN +HRDL + N ++ + TV V DFGLSR + +
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ A+ P +W+A E L D SD+++FGV +WE+ T Q P+ + A++
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176
+ G RL+ P V ++ CW+ +P +RPSF+ + L ++ + + D
Sbjct: 252 LI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-47
Identities = 58/171 (33%), Positives = 90/171 (52%), Gaps = 5/171 (2%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++MA +A GM Y+ R N VHRDL++ N+LV + KV DFGL+RL + +++
Sbjct: 283 VDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A P +W APE KSD++SFG++L EL T + P+ + +V+ V +G R
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 399
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176
+ P + ++ CW EP +RP+F + L S PQ P +
Sbjct: 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-47
Identities = 51/166 (30%), Positives = 89/166 (53%), Gaps = 5/166 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L+MA +A+GM ++ RN +HRDL++ N+LV + K+ DFGL+RL + +++
Sbjct: 112 LDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A P +W APE + KSD++SFG++L E+ T + P+ + +V+ + +G R
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYR 228
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+ P N + ++ CW P RP+F + +L + Q
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-47
Identities = 54/164 (32%), Positives = 83/164 (50%), Gaps = 6/164 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
LN +AKGMNYL R +VHRDL + N+LV VK+ DFGL++ L A
Sbjct: 120 LNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
P +WMA E + +SD++S+GV +WEL T +P+ + +++ + + KG+
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGE 236
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
RL P V I+ CW + RP F ++ + + P
Sbjct: 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-47
Identities = 57/163 (34%), Positives = 90/163 (55%), Gaps = 5/163 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L M DV +GM YL ++HRDL + N LV + +KV DFG++R + +S +
Sbjct: 107 LGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
P +W +PEV + KSD++SFGV++WE+ + + P+ N + ++VV + G R
Sbjct: 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFR 223
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
L PR + HV I+ CW P RP+FS ++ L + +S
Sbjct: 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-46
Identities = 52/163 (31%), Positives = 86/163 (52%), Gaps = 5/163 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L M DV + M YL + +HRDL + N LV+ + VKV DFGLSR + +S
Sbjct: 123 LEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
+ P W PEVL + KSDI++FGV++WE+ +L + P+ ++ + +G R
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLR 239
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
L P + V +I+ +CW + +RP+F ++ + ++
Sbjct: 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-46
Identities = 60/172 (34%), Positives = 90/172 (52%), Gaps = 6/172 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L + L +A VA GM YL + VHRDL + N LV + VK+ DFG+SR + +
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ P WM PE + +SD++SFGV+LWE+ T +QPW L+ + +
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170
+ +G+ LE PR P V +I+ CW EP +R S + L+ L ++P
Sbjct: 273 IT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 3e-46
Identities = 56/161 (34%), Positives = 88/161 (54%), Gaps = 5/161 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L M YDV +GM +L +HRDL + N LVD+ VKV DFG++R + S
Sbjct: 107 LEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
P +W APEV + KSD+++FG+++WE+ +L + P+ ++VV V +G R
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHR 223
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
L P + + I+ +CW P KRP+F ++ + PL +
Sbjct: 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-46
Identities = 59/166 (35%), Positives = 90/166 (54%), Gaps = 5/166 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L MA ++ M YL ++N +HRDL + N LV + + VKV DFGLSRL ++ +
Sbjct: 114 LYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A P +W APE L + KSD+++FGV+LWE+AT P+ ++ +QV + K R
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYR 230
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+E P V ++ ACW P RPSF+ I + + + +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-46
Identities = 57/166 (34%), Positives = 90/166 (54%), Gaps = 5/166 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
L MA ++ M YL ++N +HR+L + N LV + + VKV DFGLSR + +T+ +
Sbjct: 321 LYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 67 AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A +W APE L + KSD+++FGV+LWE+AT P+ ++ +QV + K R
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYR 437
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+E P V ++ ACW P RPSF+ I + + + +
Sbjct: 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-46
Identities = 58/164 (35%), Positives = 88/164 (53%), Gaps = 6/164 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
L++A +A GM YL ++ VHRDL + N LV VK+ DFG+SR + + +
Sbjct: 136 LHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
P WM PE + +SD++SFGVILWE+ T +QPW L+ +V+ + +G+
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-QGR 252
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
LE PR V ++ CW EP +R + I ++L L K+
Sbjct: 253 VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-46
Identities = 51/166 (30%), Positives = 93/166 (56%), Gaps = 5/166 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++ + +A+GM ++ +RN +HRDL++ N+LV K+ DFGL+R+ + +++
Sbjct: 287 IDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A P +W APE + KSD++SFG++L E+ T + P+ ++ +V+ A+ +G R
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYR 403
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+ P N + +I+ CW N P +RP+F I +L + Q
Sbjct: 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-46
Identities = 57/174 (32%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L + ++ AY VA+GM YL + +HRDL + N+LV + +K+ DFGL+R +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 62 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
K+ G P +WMAPE L D +SD++SFGV+LWE+ TL P+ + ++
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172
+ +G R++ P N + ++ CW P +RP+F ++E L ++ + Q
Sbjct: 306 LK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-46
Identities = 59/174 (33%), Positives = 93/174 (53%), Gaps = 6/174 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
+ MA ++A GM YL+ VHRDL + N +V + +TVK+ DFG++R + +
Sbjct: 141 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
P WM+PE L+D SD++SFGV+LWE+ATL +QP+ L+ QV+ V +G
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGG 257
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 178
L+ P N + ++ CW P RPSF I+ ++ ++ + S
Sbjct: 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 311
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-46
Identities = 55/169 (32%), Positives = 88/169 (52%), Gaps = 6/169 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
+ + L D+A GM YL RN +HRDL + N ++ TV V DFGLS+ + +
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ A P +W+A E L D KSD+++FGV +WE+AT P+ + ++
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+ G RL+ P + + I+ +CW +P RP+FS + L L++S
Sbjct: 262 LL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-45
Identities = 58/171 (33%), Positives = 90/171 (52%), Gaps = 5/171 (2%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
++MA +A GM Y+ R N VHRDL++ N+LV + KV DFGL+RL + +++
Sbjct: 366 VDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
A P +W APE KSD++SFG++L EL T + P+ + +V+ V +G R
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 482
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176
+ P + ++ CW EP +RP+F + L S PQ P +
Sbjct: 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-45
Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 5/166 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
+ AY ++ + YL + VHRD+ + N+LV VK+ DFGLSR ++ S
Sbjct: 119 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
P +WMAPE + SD++ FGV +WE+ +P+ + V+ + G+R
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGER 235
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
L +P N P + S++ CWA +P +RP F+ + L +++ Q
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-45
Identities = 55/179 (30%), Positives = 85/179 (47%), Gaps = 20/179 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR------ 55
L +L +A VA GM YL R VHRDL + N LV + VK+ DFGLSR
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 56 ---LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 111
N + + WM PE + +SD++++GV+LWE+ + QP+ +
Sbjct: 229 YYKADGNDAIPIR-------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 112 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170
+V+ V G L P N + +++ CW+ P RPSF +I +L+ + +
Sbjct: 282 HEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-45
Identities = 52/184 (28%), Positives = 91/184 (49%), Gaps = 9/184 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LK 57
L L++A D+A G YL + +HRD+ + N L+ K+ DFG++R +
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 58 ANTFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQV 115
++ A P +WM PE + K+D +SFGV+LWE+ +L P+ + + +V
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 116 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPT 175
+ V G R++ P+N V I+ CW ++P RP+F+ I+E + + P +
Sbjct: 255 LEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 176 DMPL 179
+
Sbjct: 314 PIEY 317
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-45
Identities = 53/176 (30%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSK 65
++ VA+GM YL + VHRDL + N ++D+ +TVKV DFGL+R + +
Sbjct: 127 ISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184
Query: 66 SAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 122
P +W A E L+ KSD++SFGV+LWEL T P+ +++P + + +
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-Q 243
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 178
G+RL P + +++ CW +P RP+F ++ + ++ S +P
Sbjct: 244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV-SALLGDHYVQLP 298
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-45
Identities = 54/174 (31%), Positives = 94/174 (54%), Gaps = 6/174 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ + ++ Y +A+GM YL + +HRDL + N+LV + +K+ DFGL+R N
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 62 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
K+ G P +WMAPE L D +SD++SFGV++WE+ TL P+ + ++
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172
+ +G R++ P N + ++ CW P +RP+F ++E L ++ T +
Sbjct: 272 LK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-45
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 5/166 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
+ + + K M YL N VHRD+ N+LV VK+ DFGLSR + S
Sbjct: 116 VLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
P +WM+PE + SD++ F V +WE+ + +QP+ L V+ + KG R
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDR 232
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
L P P + +++ CW +P RP F+ ++ L + +
Sbjct: 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-45
Identities = 55/169 (32%), Positives = 87/169 (51%), Gaps = 8/169 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKANTFLSSK 65
+ VAKGM YL + VHRDL + N ++D+K+TVKV DFGL+R +
Sbjct: 131 IGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 188
Query: 66 SAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 122
P +WMA E L+ + KSD++SFGV+LWEL T P+ ++N + + +
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-Q 247
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
G+RL P + ++ CW + RPSFS ++ + + + +
Sbjct: 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-45
Identities = 58/167 (34%), Positives = 91/167 (54%), Gaps = 6/167 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++ A+ +++GM YL +VHRDL + N+LV + +K+ DFGLSR
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 62 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
K + G P +WMA E L D +SD++SFGV+LWE+ TL P+ + P ++
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL 264
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
+ G R+E P N + + ++ CW EP KRP F+ I + L ++
Sbjct: 265 LK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-45
Identities = 53/175 (30%), Positives = 93/175 (53%), Gaps = 7/175 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
R L+ + VA+GM +L +N +HRD+ + N+L+ + K+ DFGL+R +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQVVA 117
++ +A +WMAPE + D +SD++S+G++LWE+ +L P+ G L ++
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172
V G ++ P ++ SI++ACWA EP RP+F I L+ + +
Sbjct: 279 LVK-DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-44
Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 6/165 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
LN +AKGM YL +VHR+L + N+L+ V+V DFG++ L + S
Sbjct: 118 LNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
A TP +WMA E + +SD++S+GV +WEL T +P+ L A+V + KG+
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGE 234
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169
RL P+ V ++ CW + RP+F + + + P
Sbjct: 235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-44
Identities = 53/180 (29%), Positives = 91/180 (50%), Gaps = 20/180 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----- 56
+ + ++ Y +A+GM YL + +HRDL + N+LV + +K+ DFGL+R
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 57 ----KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLN 111
N L K WMAPE L D +SD++SFGV++WE+ TL P+ +
Sbjct: 258 YYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310
Query: 112 PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
++ + +G R++ P N + ++ CW P +RP+F ++E L ++ T +
Sbjct: 311 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-44
Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 9/184 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LK 57
L L++A D+A G YL + +HRD+ + N L+ K+ DFG++R +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235
Query: 58 ANTFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQV 115
+ A P +WM PE + K+D +SFGV+LWE+ +L P+ + + +V
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
Query: 116 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPT 175
+ V G R++ P+N V I+ CW ++P RP+F+ I+E + + P +
Sbjct: 296 LEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 354
Query: 176 DMPL 179
+
Sbjct: 355 PIEY 358
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-44
Identities = 51/166 (30%), Positives = 85/166 (51%), Gaps = 5/166 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
+ AY ++ + YL + VHRD+ + N+LV VK+ DFGLSR ++ S
Sbjct: 494 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
P +WMAPE + SD++ FGV +WE+ +P+ + V+ + G+R
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGER 610
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
L +P N P + S++ CWA +P +RP F+ + L +++ Q
Sbjct: 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-44
Identities = 54/164 (32%), Positives = 83/164 (50%), Gaps = 6/164 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
LN +AKGMNYL R +VHRDL + N+LV VK+ DFGL++ L A
Sbjct: 120 LNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
P +WMA E + +SD++S+GV +WEL T +P+ + +++ + + KG+
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGE 236
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
RL P V I+ CW + RP F ++ + + P
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-44
Identities = 57/174 (32%), Positives = 90/174 (51%), Gaps = 7/174 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
+ M V GM YL VHRDL + N+LVD KV DFGLSR+ + ++ +
Sbjct: 154 VGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211
Query: 68 AGT--P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
G P W APE + + SD++SFGV++WE+ ++P+ N+ V+++V +G
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EG 270
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
RL P + ++ CW + +RP FS I+ +L LI+SP + +
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATV 324
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-44
Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 7/174 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L + ++ VAKGM +L R +HRDL + N+L+ +K VK+CDFGL+R + +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 61 FLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQVVA 117
K A P +WMAPE + D +SD++SFGV+LWE+ +L P+ G +
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+ +G R+ P P + + CW EP +RP+FS ++E L L+++ Q
Sbjct: 263 RLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-44
Identities = 57/169 (33%), Positives = 91/169 (53%), Gaps = 8/169 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
+ VAKGM +L + VHRDL + N ++D+K+TVKV DFGL+R + F S +
Sbjct: 195 IGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 252
Query: 67 AAGT--P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFK 122
G P +WMA E L+ + KSD++SFGV+LWEL T P+ ++N + + +
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-Q 311
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
G+RL P + ++ CW + RPSFS ++ + + + +
Sbjct: 312 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-44
Identities = 56/167 (33%), Positives = 91/167 (54%), Gaps = 7/167 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
+ M +A GM YL N VHRDL + N+LV+ KV DFGLSR+ + ++ +
Sbjct: 150 VGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 68 AGT--P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
+G P W APE + SD++SFG+++WE+ T ++P+ L+ +V+ A+ G
Sbjct: 208 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DG 266
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170
RL P + + ++ CW E +RP F+ I+ +L LI++P
Sbjct: 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-44
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSK 65
A VA+GM YL + +HRDL + NLL+ + VK+ DFGL R + + +
Sbjct: 124 SRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181
Query: 66 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
P W APE L+ + SD + FGV LWE+ T Q+PW LN +Q++ + +G
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+RL P + + +++ CWA++P RP+F + + L
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-43
Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 7/174 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
LD L+ +Y VAKGM +L +N +HRDL + N+L+ K+CDFGL+R N
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 62 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQVVA 117
P +WMAPE + + +SD++S+G+ LWEL +L P+ G ++
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+ +G R+ P + + I++ CW +P KRP+F I++L+ I T
Sbjct: 260 MIK-EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNH 312
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-43
Identities = 56/164 (34%), Positives = 91/164 (55%), Gaps = 5/164 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L+ A DVA+GM+YL ++ +HRDL + N+LV + Y K+ DFGLSR ++
Sbjct: 145 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMG 201
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRL 126
WMA E L SD++S+GV+LWE+ +L P+ + A++ + +G RL
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRL 260
Query: 127 EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170
E P N + V ++ CW +P++RPSF+ I+ L +++
Sbjct: 261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-43
Identities = 46/166 (27%), Positives = 91/166 (54%), Gaps = 5/166 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
E + L+ + + ++H R I+HRD+KS N+ + K TV++ DFG++R+ +T
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+++ GTP +++PE+ ++P N KSDI++ G +L+EL TL+ + + +V +
Sbjct: 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII- 238
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
G + + + + S++ + P RPS ++I+E + I
Sbjct: 239 SGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE--KGFIAK 282
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-43
Identities = 56/163 (34%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L + DV + M YL N VHRDL + N+LV + KV DFGL++ ++T + K
Sbjct: 120 LKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-- 175
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
P +W APE LR++ + KSD++SFG++LWE+ + + P+ + VV V KG +
Sbjct: 176 --LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYK 232
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
++ P P V +++ CW + RPSF + E L +
Sbjct: 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-43
Identities = 51/168 (30%), Positives = 94/168 (55%), Gaps = 7/168 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSK 65
+ + V+ GM YL +N VHRDL + N+L+ ++ K+ DFGLS+ +++ +++
Sbjct: 113 AELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170
Query: 66 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
SA P +W APE + + +SD++S+GV +WE + Q+P+ + +V+A + +G
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QG 229
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
KR+E P P + +++ CW + RP F T+ + +R S +
Sbjct: 230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-43
Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 6/168 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPP---IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA 58
LDE L + + + HRR+ ++HRDLK N+ +D K VK+ DFGL+R+
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
+ +K+ GTP +M+PE + NEKSDI+S G +L+EL L P+ + ++
Sbjct: 168 HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
+ +GK IP + + II + + RPS I+E PLI
Sbjct: 228 IR-EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE--NPLIL 272
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-43
Identities = 57/172 (33%), Positives = 86/172 (50%), Gaps = 7/172 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L L AY VAKGM +L ++ VHRDL + N+LV VK+CDFGL+R +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 62 LSSKSAAGT-P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQVVA 117
P +WMAPE L + KSD++S+G++LWE+ +L P+ G A
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169
+ G +++ P + I+++CWA + KRPSF + L +
Sbjct: 287 LIQ-NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-43
Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
+++ +A GM YL + +VH+DL + N+LV K VK+ D GL R + A +
Sbjct: 131 VHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGK 124
+ P WMAPE + + SDI+S+GV+LWE+ + QP+ + VV + +
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQ 247
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
L P + V +++ CW P +RP F I LR
Sbjct: 248 VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-43
Identities = 55/163 (33%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
L + DV + M YL N VHRDL + N+LV + KV DFGL++ ++T + K
Sbjct: 292 LKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-- 347
Query: 68 AGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKR 125
P +W APE LR++ + KSD++SFG++LWE+ + + P+ + VV V KG +
Sbjct: 348 --LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYK 404
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
++ P P V +++ CW + RP+F + E L +
Sbjct: 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-43
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 22/186 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
+D + L + KGM YL + +HRDL + N+LV+ + VK+ DFGL+++ +
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 60 TFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--------------- 103
F K +P W APE L + + SD++SFGV+L+EL T
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
Query: 104 -QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
G + ++ + RL P + I+ CW N +RPSF + +
Sbjct: 229 GNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 163 PLIKSP 168
+ +
Sbjct: 288 QIRDNM 293
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-42
Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 7/169 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSK 65
+ + + V+ GM YL N VHRDL + N+L+ ++ K+ DFGLS+ + ++
Sbjct: 120 IELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177
Query: 66 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
+ P +W APE + + KSD++SFGV++WE + Q+P+ + ++V A + KG
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KG 236
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172
+R+ P + ++ CW + RP F+ + LR +
Sbjct: 237 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 50/173 (28%), Positives = 94/173 (54%), Gaps = 7/173 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSK 65
+ + V+ GM YL +N VHR+L + N+L+ ++ K+ DFGLS+ +++ +++
Sbjct: 439 AELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496
Query: 66 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
SA P +W APE + + +SD++S+GV +WE + Q+P+ + +V+A + +G
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QG 555
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176
KR+E P P + +++ CW + RP F T+ + +R S +
Sbjct: 556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-42
Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 7/173 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSA 67
+ M +A GM YL VHRDL + N+L++ KV DFGL R+ + ++ +
Sbjct: 150 VGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207
Query: 68 AGT--P-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKG 123
G P W +PE + SD++S+G++LWE+ + ++P+ ++ V+ AV +G
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG 266
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176
RL P + + ++ CW + RP F I+ +L LI++P T
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITS 319
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-42
Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 22/185 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
+D + L + KGM YL + +HRDL + N+LV+ + VK+ DFGL++ L +
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
Query: 61 FLSSKSAAG-TP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--------------- 103
G +P W APE L + + SD++SFGV+L+EL T
Sbjct: 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
Query: 104 -QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
G + ++ + RL P + I+ CW N +RPSF + +
Sbjct: 260 GNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
Query: 163 PLIKS 167
+
Sbjct: 319 QIRDQ 323
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-41
Identities = 58/164 (35%), Positives = 93/164 (56%), Gaps = 7/164 (4%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFLSSKS 66
+ ++ VAKGM +L R +HRDL + N+L+ +K VK+CDFGL+R + + K
Sbjct: 196 ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 67 AAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPW-GNLNPAQVVAAVGFKG 123
A P +WMAPE + D +SD++SFGV+LWE+ +L P+ G + + +G
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEG 312
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
R+ P P + + CW EP +RP+FS ++E L L+++
Sbjct: 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-41
Identities = 40/171 (23%), Positives = 79/171 (46%), Gaps = 13/171 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
LD+ L + + KG++Y+H + +++RDLK N+ + VK+ DFGL LK +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
+ GT +M+PE + + ++ D+Y+ G+IL EL + A +
Sbjct: 177 KR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD------TAFETSKFF 228
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+ I + ++++ + +P RP+ S I+ + +P+
Sbjct: 229 TDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR--TLTVWKKSPE 277
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-41
Identities = 58/191 (30%), Positives = 85/191 (44%), Gaps = 19/191 (9%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
LD R L + + KGM YL R VHRDL + N+LV+ + VK+ DFGL++L
Sbjct: 124 LDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
Query: 60 TFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVA 117
+ + +P W APE L D + +SD++SFGV+L+EL T + +
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241
Query: 118 AVGF-------------KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164
+G+RL P V +++ CWA P RPSFS + L L
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
Query: 165 IKSPTPQPSPT 175
+
Sbjct: 302 WSGSRGCETHA 312
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-40
Identities = 57/183 (31%), Positives = 88/183 (48%), Gaps = 21/183 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
++ +++L A + KGM+YL R VHRDL + N+LV+ ++ VK+ DFGL++
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 60 TFLSSKSAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL--------------- 103
+ + K +P W APE L SD++SFGV L EL T
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240
Query: 104 QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRP 163
G + ++V + +GKRL P N V ++ CW +P R SF ++E
Sbjct: 241 GPTHGQMTVTRLVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
Query: 164 LIK 166
L+K
Sbjct: 300 LLK 302
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-40
Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 22/185 (11%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSK 65
L A + +GM YLH ++ +HRDL + N+L+D VK+ DFGL++ + + + +
Sbjct: 137 LLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 194
Query: 66 SAAGTP-EWMAPEVLRDEPSNEKSDIYSFGVILWELATL---------------QQPWGN 109
+P W APE L++ SD++SFGV L+EL T G
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254
Query: 110 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169
+ ++ + +G+RL P V +++ CW E RP+F ++ +L+ + +
Sbjct: 255 MTVLRLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
Query: 170 PQ-PS 173
Q PS
Sbjct: 314 GQAPS 318
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-40
Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
++ ER + + ++H R ++HRD+K N+ + VK+ D GL R ++
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG--NLNPAQVVAA 118
++ S GTP +M+PE + + N KSDI+S G +L+E+A LQ P+ +N +
Sbjct: 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249
Query: 119 VGFKGKRLEIPRNV-NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 173
+ + +P + + + ++ C +P KRP + + ++ S
Sbjct: 250 I-EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV--AKRMHACTASS 302
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-39
Identities = 40/171 (23%), Positives = 75/171 (43%), Gaps = 21/171 (12%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--------VKVCDFGLSRLKAN 59
L +A +A M++L ++H ++ + N+L+ ++ +K+ D G+S
Sbjct: 116 LEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--- 170
Query: 60 TFLSSKSAAGTP-EWMAPEVLRDEPS-NEKSDIYSFGVILWELATL-QQPWGNLNPAQVV 116
+ K W+ PE + + + N +D +SFG LWE+ + +P L+ + +
Sbjct: 171 --VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 117 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+L P+ +A++I C EP RPSF I+ L L
Sbjct: 229 QFYE-DRHQLPAPKA--AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-37
Identities = 38/169 (22%), Positives = 73/169 (43%), Gaps = 13/169 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E + D + +LH + +VH D+K N+ + + K+ DFGL + T
Sbjct: 154 LPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTA 210
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ + G P +MAPE+L+ +D++S G+ + E+A + Q +
Sbjct: 211 GAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----R 265
Query: 122 KGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSP 168
+G E ++ + S++ +P R + LL P+++ P
Sbjct: 266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRAT---AEALLALPVLRQP 311
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-36
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 23/196 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L L + Y + + ++HR+ PPI+HRDLK NLL+ + T+K+CDFG + ++
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 62 LSSKSAA------------GTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQP 106
S SA TP + PE++ + P EK DI++ G IL+ L Q P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 107 WGNLNPAQVVAAVGFKGKRLEIPRNVN--PHVASIIEACWANEPWKRPSFSTIMELLRPL 164
+ + ++V + IP + S+I A P +R S + ++ L+ +
Sbjct: 253 FEDGAKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306
Query: 165 IKSPTPQPSPTDMPLL 180
+ P LL
Sbjct: 307 AAARNVNPKSPITELL 322
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-36
Identities = 40/178 (22%), Positives = 70/178 (39%), Gaps = 19/178 (10%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ L++ +A+ + +LH + ++HRDLK N+ VKV DFGL
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 62 LSSK------------SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGN 109
GT +M+PE + + K DI+S G+IL+EL L
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQ 230
Query: 110 LNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+ + + V K + P +++ + P +RP I+E + +
Sbjct: 231 MERVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFED 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-35
Identities = 47/168 (27%), Positives = 70/168 (41%), Gaps = 12/168 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSR----- 55
L E R L +G+ YLH R I+H D+K+ N+L+ +CDFG +
Sbjct: 147 LPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 56 LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQV 115
+ L+ GT MAPEV+ +P + K DI+S ++ + PW +
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264
Query: 116 VAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+ + EIP + P A I+ EP R S EL R
Sbjct: 265 CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAM---ELRR 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-34
Identities = 34/187 (18%), Positives = 75/187 (40%), Gaps = 34/187 (18%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK------------------- 42
E ++ V +G+ Y+H + +VH D+K N+ + +
Sbjct: 112 FKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169
Query: 43 KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELA 101
K K+ D G ++ + G ++A EVL+ + K+DI++ + + A
Sbjct: 170 KVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225
Query: 102 TLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ N + + +G+ IP+ ++ +++ +P +RPS M L+
Sbjct: 226 GAEPLPRNGDQWHEIR----QGRLPRIPQVLSQEFTELLKVMIHPDPERRPS---AMALV 278
Query: 162 R-PLIKS 167
+ ++ S
Sbjct: 279 KHSVLLS 285
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-34
Identities = 49/168 (29%), Positives = 83/168 (49%), Gaps = 12/168 (7%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWM 74
+G+ YLH IVHRD+K N+L++ +K+ DFG S+ A +++ GT ++M
Sbjct: 133 EGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190
Query: 75 APEVLRDEPS--NEKSDIYSFG-VILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIPR 130
APE++ P + +DI+S G I+ E+AT + P+ L P + VG EIP
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249
Query: 131 NVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 177
+++ + I C+ +P KR +LL +K + +
Sbjct: 250 SMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLKVSSKKKKTQPK 294
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-34
Identities = 39/190 (20%), Positives = 75/190 (39%), Gaps = 22/190 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E + L + + +G+ +H HRDLK N+L+ + + D G
Sbjct: 131 LTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188
Query: 62 LSSKSAA---------GTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQP--W 107
S+ A T + APE+ +E++D++S G +L+ + + P
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 108 GNLNPAQVVAAVGFKGKRLEIPRN--VNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
V AV +L IP++ + + ++ + +P +RP ++ L +
Sbjct: 249 VFQKGDSVALAV---QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE-AL 304
Query: 166 KSPTPQPSPT 175
+ P P T
Sbjct: 305 QPPAPGQHTT 314
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-34
Identities = 46/192 (23%), Positives = 84/192 (43%), Gaps = 24/192 (12%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-- 59
+D R + ++ + ++ +H+ IVH DLK N L+ +K+ DFG++
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPS-----------NEKSDIYSFGVILWELATLQQPWG 108
T + S GT +M PE ++D S + KSD++S G IL+ + + P+
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 109 NL-NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIK 166
+ N + A+ +E P + +++ C +P +R S ELL P ++
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP---ELLAHPYVQ 297
Query: 167 ---SPTPQPSPT 175
P Q +
Sbjct: 298 IQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-34
Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 21/189 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-- 59
+D R + ++ + ++ +H+ IVH DLK N L+ +K+ DFG++
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 161
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPS-----------NEKSDIYSFGVILWELATLQQPWG 108
T + S GT +M PE ++D S + KSD++S G IL+ + + P+
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221
Query: 109 NL-NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIK 166
+ N + A+ +E P + +++ C +P +R +I ELL P ++
Sbjct: 222 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 278
Query: 167 SPTPQPSPT 175
T +
Sbjct: 279 IQTHPVNQM 287
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-33
Identities = 44/189 (23%), Positives = 83/189 (43%), Gaps = 21/189 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-- 59
+D R + ++ + ++ +H+ IVH DLK N L+ +K+ DFG++
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 208
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSN-----------EKSDIYSFGVILWELATLQQPWG 108
T + S G +M PE ++D S+ KSD++S G IL+ + + P+
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
Query: 109 NL-NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIK 166
+ N + A+ +E P + +++ C +P +R +I ELL P ++
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 325
Query: 167 SPTPQPSPT 175
T +
Sbjct: 326 IQTHPVNQM 334
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-33
Identities = 37/178 (20%), Positives = 71/178 (39%), Gaps = 21/178 (11%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
+ L++ +A+ + +LH + ++HRDLK N+ VKV DFGL
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219
Query: 63 SSKSAA------------GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 110
GT +M+PE + + K DI+S G+IL+EL +
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QM 277
Query: 111 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKS 167
+++ V K + P +++ + P +RP +++ + ++
Sbjct: 278 ERVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE---ATDIIENAIFEN 331
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-32
Identities = 44/185 (23%), Positives = 74/185 (40%), Gaps = 29/185 (15%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ + + ++Y+H + I+HRDLK N+ +D+ VK+ DFGL++ +
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 62 LSS--------------KSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQP 106
SA GT ++A EVL NEK D+YS G+I +E+
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--F 228
Query: 107 WGNLNPAQVVAAVGFKGKRLEIP----RNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+ ++ + + +E P N II ++P KRP LL
Sbjct: 229 STGMERVNILKKL--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLN 283
Query: 163 -PLIK 166
+
Sbjct: 284 SGWLP 288
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-31
Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KA 58
+ +RL + A+G++YLH I+HRD+KS N+L+D+ + K+ DFG+S+
Sbjct: 136 MSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT------LQQPWGNLNP 112
T LS+ GT ++ PE EKSD+YSFGV+L+E+ P +N
Sbjct: 194 QTHLSTV-VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 113 AQVVAAVGFKGKRLEI--PR---NVNPH----VASIIEACWANEPWKRPSFSTIMELL 161
A+ G+ +I P + P C A RPS ++ L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-31
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSK 65
+ + + +LH ++HRD+KS N+L+ +VK+ DFG + K +T
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---- 176
Query: 66 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK- 124
GTP WMAPEV+ + K DI+S G++ E+ + P+ N NP + + + G
Sbjct: 177 --VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 177
L+ P ++ + C + KR S ELL+ +K P S T +
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHQFLKIAKPLSSLTPL 285
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-31
Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 19/174 (10%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSK 65
KG+ YLH +HRD+K+ N+L++ + K+ DFG++ K NT +
Sbjct: 132 QSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--- 186
Query: 66 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK- 124
GTP WMAPEV+++ N +DI+S G+ E+A + P+ +++P + + +
Sbjct: 187 ---GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP 243
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 177
P + + ++ C P +R + + +LL+ P ++S D+
Sbjct: 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATAT---QLLQHPFVRSAKGVSILRDL 294
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-30
Identities = 57/177 (32%), Positives = 88/177 (49%), Gaps = 35/177 (19%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSK 65
++ KG++YLH +HRD+K+ N+L+ + VK+ DFG++ ++K NTF
Sbjct: 126 REILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF---- 179
Query: 66 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR 125
GTP WMAPEV++ + K+DI+S G+ ELA + P L+P +V+
Sbjct: 180 --VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL--------- 228
Query: 126 LEIPRNVNPHVAS--------IIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPS 173
IP+N P + +EAC EP RP+ ELL+ I + S
Sbjct: 229 FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK---ELLKHKFILRNAKKTS 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-30
Identities = 45/184 (24%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-----YTVKVCDFGLSRL-- 56
+ + G+ +LH N IVHRDLK N+L+ + DFGL +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 57 -KANTFLSSKSAAGTPEWMAPEVLRDEPS---NEKSDIYSFGVILWELATL-QQPWGNLN 111
++F GT W+APE+L ++ DI+S G + + + + P+G
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 112 PAQVVAAVG-FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPT 169
Q +G L ++ + +IE A +P KRP + +L+ P S
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAKHVLKHPFFWSLE 291
Query: 170 PQPS 173
Q
Sbjct: 292 KQLQ 295
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-30
Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 19/176 (10%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLS 63
+ V + + YLH + ++HRD+KS ++L+ VK+ DFG K +
Sbjct: 146 VCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-- 201
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 123
GTP WMAPEV+ + DI+S G+++ E+ + P+ + +P Q + +
Sbjct: 202 ----VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP 257
Query: 124 K-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 177
+L+ V+P + +E +P +R + ELL P + +
Sbjct: 258 PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQ---ELLDHPFLLQTGLPECLVPL 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-30
Identities = 30/188 (15%), Positives = 60/188 (31%), Gaps = 19/188 (10%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L RL + V + + LH +VH L+ ++++D++ V + F A+
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEK-----SDIYSFGVILWELATLQQPWGNLNPAQV 115
PE A +L + D ++ G+ ++ + P +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325
Query: 116 VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME-----LLRPLIKSPTP 170
+ +N+ V +++E R ME LR + + P
Sbjct: 326 SEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 379
Query: 171 QPSPTDMP 178
P
Sbjct: 380 LYQTDGEP 387
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-29
Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 14/169 (8%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFG----LSRLKANTFLSSK 65
++ V KG+ YL ++ I+HRD+K N+LV+ + +K+CDFG L AN+F
Sbjct: 136 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---- 190
Query: 66 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR 125
GT +M+PE L+ + +SDI+S G+ L E+A + P + ++ G +
Sbjct: 191 --VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF---GCQ 245
Query: 126 LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 174
+E P I ELL ++ P P+
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-29
Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 24/185 (12%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---K 57
L R +A A G+N+LH +HRD+KS N+L+D+ +T K+ DFGL+R
Sbjct: 129 PLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 58 ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA 117
A T ++S+ GT +MAPE LR E KSDIYSFGV+L E+ T Q++
Sbjct: 187 AQTVMTSR-IVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL- 243
Query: 118 AVGFKGKRLEIPRN----VNP-----------HVASIIEACWANEPWKRPSFSTIMELLR 162
+ K + + + ++ + S+ C + KRP + +LL+
Sbjct: 244 -LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 163 PLIKS 167
+ S
Sbjct: 303 EMTAS 307
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-29
Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 24/179 (13%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANTFLSSK 65
+ + +N+LH + I+HRDLK+ N+L+ + +++ DFG+S K ++F+
Sbjct: 124 RQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--- 178
Query: 66 SAAGTPEWMAPEV-----LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
GTP WMAPEV ++D P + K+DI+S G+ L E+A ++ P LNP +V+ +
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 235
Query: 121 FKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDM 177
L P + ++ P RPS + +LL P + S T + ++
Sbjct: 236 KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAA---QLLEHPFVSSITSNKALREL 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-29
Identities = 41/176 (23%), Positives = 78/176 (44%), Gaps = 10/176 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L +N + G+ + H IVHRD+K N+L+D T+K+ DFG+++ L +
Sbjct: 108 LSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
+ GT ++ +PE + E ++E +DIYS G++L+E+ + P+ +A
Sbjct: 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-IAIKH 224
Query: 121 FKGKRLEIPRNVNPHVA----SIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172
+ + +V + ++I + R + TI E+ L
Sbjct: 225 IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR--YKTIQEMKDDLSSVLHENR 278
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-29
Identities = 27/186 (14%), Positives = 59/186 (31%), Gaps = 28/186 (15%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L RL + V + + LH +VH L+ ++++D++ V + F +
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV-RDGAR 259
Query: 62 LSSKSAAGTPEWMAPEVLRDE-----------PSNEKSDIYSFGVILWELATLQQPWGNL 110
+ S + + + PE+ D ++ G++++ + P
Sbjct: 260 VVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316
Query: 111 NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME-----LLRPLI 165
+N+ V +++E R ME LR +
Sbjct: 317 AALGGSE------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370
Query: 166 KSPTPQ 171
+ P
Sbjct: 371 SAALPL 376
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-28
Identities = 49/181 (27%), Positives = 86/181 (47%), Gaps = 29/181 (16%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
++ +G+++LH+ ++HRD+K N+L+ + VK+ DFG+S T + GTP
Sbjct: 136 REILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 72 EWMAPEVLRDEPS-----NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 126
WMAPEV+ + + + KSD++S G+ E+A P +++P + + F
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FL---- 245
Query: 127 EIPRNVNPHVASI---------IEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTD 176
IPRN P + S IE+C +RP +L++ P I+ +
Sbjct: 246 -IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKHPFIRDQPNERQVRI 301
Query: 177 M 177
Sbjct: 302 Q 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-28
Identities = 41/104 (39%), Positives = 67/104 (64%), Gaps = 4/104 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KA 58
LD +R +A A+G+ YLH +P I+HRD+K+ N+L+D+++ V DFGL++L
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 102
+T +++ GT +APE L S+EK+D++ +GV+L EL T
Sbjct: 188 DTHVTTA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-28
Identities = 37/158 (23%), Positives = 72/158 (45%), Gaps = 6/158 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
DE+R ++A ++Y H + ++HRD+K NLL+ +K+ DFG S ++
Sbjct: 106 FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
GT +++ PE++ +EK D++S GV+ +E + P+ + +
Sbjct: 164 R--TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-S 220
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
+ + P V +I + P +RP ++E
Sbjct: 221 RVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-28
Identities = 45/181 (24%), Positives = 81/181 (44%), Gaps = 25/181 (13%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-----RLKANTFLSS 64
M + K + YL ++ ++HRD+K N+L+D++ +K+CDFG+S +
Sbjct: 129 MTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--- 184
Query: 65 KSAAGTPEWMAPEVLRDEPSNE-----KSDIYSFGVILWELATLQQPWGNLNP--AQVVA 117
AG +MAPE + + ++D++S G+ L ELAT Q P+ N +
Sbjct: 185 ---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK 241
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTD 176
+ + L + S ++ C + KRP ++ +LL IK + D
Sbjct: 242 VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN---KLLEHSFIKR--YETLEVD 296
Query: 177 M 177
+
Sbjct: 297 V 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 44/181 (24%), Positives = 69/181 (38%), Gaps = 21/181 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-L 56
L E L + DV GMN+L IVHR++K N++ D + K+ DFG +R L
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 57 KANTFLSSKSAAGTPEWMAPEVLRDEPS--------NEKSDIYSFGVILWELATLQQPWG 108
+ + S GT E++ P++ D++S GV + AT P+
Sbjct: 167 EDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
Query: 109 NLNPAQVVAAVGFK---GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
+ V +K GK V I+ S + LL P++
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-RGLQVLLTPVL 283
Query: 166 K 166
Sbjct: 284 A 284
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-27
Identities = 40/177 (22%), Positives = 78/177 (44%), Gaps = 11/177 (6%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
DE+R ++A ++Y H R ++HRD+K NLL+ K +K+ DFG S +
Sbjct: 111 FDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
++ GT +++ PE++ + +EK D++ GV+ +E P+ + + + +
Sbjct: 169 R--RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI-V 225
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME-----LLRPLIKSPTPQPS 173
L+ P ++ +I P +R +ME + P Q +
Sbjct: 226 NVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-27
Identities = 43/188 (22%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KA 58
+ +R + + D + +N+ H+ I+HRD+K N+++ VKV DFG++R
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
N+ + + GT ++++PE R + + +SD+YS G +L+E+ T + P+ +P V
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-- 228
Query: 119 VGFKGKRLEIPR------NVNPHVASIIEACWANEPWKRPSFSTIMELLRPL--IKSPTP 170
++ R + ++ + +++ A P R + T E+ L + + P
Sbjct: 229 --YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR--YQTAAEMRADLVRVHNGEP 284
Query: 171 QPSPTDMP 178
+P +
Sbjct: 285 PEAPKVLT 292
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-27
Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 32/176 (18%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-----------RLKANT 60
+V +G+ YLH+ +HRD+K+ N+L+ + +V++ DFG+S T
Sbjct: 128 REVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 61 FLSSKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
F GTP WMAPEV+ + + K+DI+SFG+ ELAT P+ P +V+
Sbjct: 186 F------VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239
Query: 120 GFKGK-RLEIPRNVNPHVA-------SIIEACWANEPWKRPSFSTIMELLR-PLIK 166
LE + +I C +P KRP+ + ELLR +
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA---ELLRHKFFQ 292
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-27
Identities = 40/185 (21%), Positives = 71/185 (38%), Gaps = 18/185 (9%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L R + + + ++ H HRD+K N+LV + DFG++ +
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188
Query: 62 LSSKSAA-GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
L+ GT +MAPE + + ++DIY+ +L+E T P+ + + A +
Sbjct: 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI- 247
Query: 121 FKGKRLEIPR------NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK--SPTPQP 172
IPR + ++I A P R + T +L + Q
Sbjct: 248 ----NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR--YVTCGDLSAAAHAALATADQD 301
Query: 173 SPTDM 177
TD+
Sbjct: 302 RATDI 306
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-27
Identities = 38/170 (22%), Positives = 66/170 (38%), Gaps = 13/170 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LK 57
L E + D++ + YLH I+HRDLK N+++ K+ D G ++ L
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 58 ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVV 116
GT +++APE+L + D +SFG + +E T +P+ N P Q
Sbjct: 176 QGELC--TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233
Query: 117 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
V + K E + ++ + P L ++
Sbjct: 234 GKV--REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQ 279
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-27
Identities = 44/181 (24%), Positives = 69/181 (38%), Gaps = 21/181 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-L 56
L E L + DV GMN+L IVHR++K N++ D + K+ DFG +R L
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 57 KANTFLSSKSAAGTPEWMAPEVLRDEPS--------NEKSDIYSFGVILWELATLQQPWG 108
+ + S GT E++ P++ D++S GV + AT P+
Sbjct: 167 EDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
Query: 109 NLNPAQVVAAVGFK---GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
+ V +K GK V I+ S + LL P++
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-RGLQVLLTPVL 283
Query: 166 K 166
Sbjct: 284 A 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-26
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 35/181 (19%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS--RLKANTFLSSKSAAG 69
+ +G+ YLH N ++HRD+K+ N+L+ + VK+ DFG + AN+F G
Sbjct: 161 HGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF------VG 212
Query: 70 TPEWMAPEV---LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL 126
TP WMAPEV + + + K D++S G+ ELA + P N+N +
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------Y 263
Query: 127 EIPRNVNPHVA---------SIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTD 176
I +N +P + + +++C P RP+ LL+ + P D
Sbjct: 264 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE---VLLKHRFVLRERPPTVIMD 320
Query: 177 M 177
+
Sbjct: 321 L 321
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-26
Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----LKANTFLSS 64
+A + K + +LH + ++HRD+K N+L++ VK+CDFG+S + +
Sbjct: 114 IAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--- 169
Query: 65 KSAAGTPEWMAPEVLRDEPS----NEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAV 119
AG +MAPE + E + + KSDI+S G+ + ELA L+ P+ P Q + V
Sbjct: 170 ---AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 120 GFKGKRLEIPR----NVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIK 166
P+ + C +RP++ EL++ P
Sbjct: 227 ----VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYP---ELMQHPFFT 271
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-26
Identities = 31/132 (23%), Positives = 53/132 (40%), Gaps = 20/132 (15%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS------RLKANT-FLSS 64
V K ++Y+H VHR +K+ ++L+ V + + +
Sbjct: 135 QGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 65 KSAAGTPEWMAPEVLRDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
K + W++PEVL+ + KSDIYS G+ ELA P+ ++ Q++
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML------ 246
Query: 123 GKRLEIPRNVNP 134
LE P
Sbjct: 247 ---LEKLNGTVP 255
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-26
Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 69
+ K +N+L N I+HRD+K N+L+D+ +K+CDFG+S ++ ++ AG
Sbjct: 130 ITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAG 187
Query: 70 TPEWMAPEVLRDEPSNE----KSDIYSFGVILWELATLQQPWGNLNP--AQVVAAVGFKG 123
+MAPE + S + +SD++S G+ L+ELAT + P+ N Q+ V
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP 247
Query: 124 KRLEIPRNVN--PHVASIIEACWANEPWKRPSFSTIMELLR-PLIK 166
+L P + + C + KRP + ELL+ P I
Sbjct: 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYK---ELLKHPFIL 290
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-26
Identities = 21/168 (12%), Positives = 44/168 (26%), Gaps = 16/168 (9%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ + + L + +VH NL + + + D
Sbjct: 191 EGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG 248
Query: 62 LSSKSAAGTPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ---- 114
A+ P AP + + G+ ++ + L P+G + P
Sbjct: 249 ----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 115 ---VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
+ G + V ++I + +R ME
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-25
Identities = 41/201 (20%), Positives = 78/201 (38%), Gaps = 34/201 (16%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-------------YTVKV 48
E +++ +A G+ +LH I+HRDLK N+LV + +
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169
Query: 49 CDFGLSRL----KANTFLSSKSAAGTPEWMAPEVLRD-------EPSNEKSDIYSFGVIL 97
DFGL + +++ + + +GT W APE+L + DI+S G +
Sbjct: 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
Query: 98 WELATLQQP--WGNLNPAQVV--AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153
+ + + + + + + R++ +I ++P KRP
Sbjct: 230 YYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP- 288
Query: 154 FSTIMELLR-PLIKSPTPQPS 173
T M++LR PL + +
Sbjct: 289 --TAMKVLRHPLFWPKSKKLE 307
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-24
Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEWMA 75
+ Y H++ IVHRDLK+ NLL+D +K+ DFG S L + G P + A
Sbjct: 126 AVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAA 181
Query: 76 PEVLRDEPSN-EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 134
PE+ + + + + D++S GVIL+ L + P+ N ++ V + IP ++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMST 239
Query: 135 HVASIIEACWANEPWKRPSFSTIME 159
++++ P KR + IM+
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-24
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ + + V +Y+H I HRD+K N+L+DK VK+ DFG S +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 62 LSSKSAAGTPEWMAPEVLRDEP--SNEKSDIYSFGVILWEL 100
+ K + GT E+M PE +E + K DI+S G+ L+ +
Sbjct: 207 I--KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-24
Identities = 41/176 (23%), Positives = 72/176 (40%), Gaps = 21/176 (11%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPE 72
V + + H R +VHRD+K N+L+D + K+ DFG L + GT
Sbjct: 148 VVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRV 203
Query: 73 WMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 131
+ PE + + ++S G++L+++ P+ +++ A L P +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EILEA------ELHFPAH 255
Query: 132 VNPHVASIIEACWANEPWKRPSFSTIME-------LLRPLIKSPTPQPSPTDMPLL 180
V+P ++I C A +P RPS I+ + P+P LL
Sbjct: 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLL 311
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-24
Identities = 35/143 (24%), Positives = 72/143 (50%), Gaps = 24/143 (16%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KANTFLSSKSAAGTP 71
YLH + I+HRDLK N+L+++ +++ DFG +++ +AN+F+ GT
Sbjct: 145 YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTA 196
Query: 72 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRLEI 128
++++PE+L ++ + + SD+++ G I+++L P+ N + F+ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDF 251
Query: 129 PRNVNPHVASIIEACWANEPWKR 151
P P ++E + KR
Sbjct: 252 PEKFFPKARDLVEKLLVLDATKR 274
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-23
Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANT 60
E+ + V + YLH IVHRDLK NLL ++ + + DFGLS+++ N
Sbjct: 105 EKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
+ +A GTP ++APEVL +P ++ D +S GVI
Sbjct: 163 IM--STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-23
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 49/207 (23%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSA 67
+ G+ +LH + IV+RDLK N+L+DK +K+ DFG+ + K NTF
Sbjct: 127 IILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF------ 178
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
GTP+++APE+L + N D +SFGV+L+E+ Q P+ + ++ ++ +
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPF 236
Query: 128 IPRNVNPHVASIIEACWANEPWKR----------PSFSTI--MELLR--------PLIKS 167
PR + ++ + EP KR P F I EL R P +KS
Sbjct: 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKS 296
Query: 168 P-------------TPQPSPTDMPLLT 181
P P+ S D L+
Sbjct: 297 PFDCSNFDKEFLNEKPRLSFADRALIN 323
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-23
Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 13 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANTFLSSKSAAGT 70
D+ KG+ YLH + I+HRD+K NLLV + +K+ DFG+S ++ L + GT
Sbjct: 145 DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGT 200
Query: 71 PEWMAPEVLRDEPSN---EKSDIYSFGVIL 97
P +MAPE L + + D+++ GV L
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-23
Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L E+ + + + + LH+ N IVHRDLK N+L+D +K+ DFG S L
Sbjct: 121 LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPS------NEKSDIYSFGVIL 97
L + GTP ++APE++ + ++ D++S GVI+
Sbjct: 179 KL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-23
Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 16/144 (11%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSA 67
+ + YLH R+ +V+RD+K NL++DK +K+ DFGL + TF
Sbjct: 114 IVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------ 165
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
GTPE++APEVL D D + GV+++E+ + P+ N + ++ + + +
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIR 223
Query: 128 IPRNVNPHVASIIEACWANEPWKR 151
PR ++P S++ +P +R
Sbjct: 224 FPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-23
Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 16/144 (11%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSA 67
+A + YLH N IV+RDLK N+L+D + + + DFGL + +TF
Sbjct: 148 IASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF------ 199
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
GTPE++APEVL +P + D + G +L+E+ P+ + N A++ + K L+
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQ 257
Query: 128 IPRNVNPHVASIIEACWANEPWKR 151
+ N+ ++E + KR
Sbjct: 258 LKPNITNSARHLLEGLLQKDRTKR 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-23
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSR-LKAN 59
E + + + + Y H IVHR+LK NLL+ K VK+ DFGL+ + +
Sbjct: 104 EADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
AGTP +++PEVL+ +P ++ DI++ GVIL
Sbjct: 162 EAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-23
Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 30/175 (17%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 73
+ GM YLH I+HRDL NLL+ + +K+ DFGL+ + GTP +
Sbjct: 121 IITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY 178
Query: 74 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--------- 124
++PE+ +SD++S G + + L G P F
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLI-----GRP-P--------FDTDTVKNTLNKV 224
Query: 125 ---RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176
E+P ++ +I P R S S++++ P + + S +
Sbjct: 225 VLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD--HPFMSRNSSTKSKDE 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-23
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 28/158 (17%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 73
+ G YLHR ++HRDLK NL +++ VK+ DFGL+ K GTP +
Sbjct: 124 IVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 74 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL------- 126
+APEVL + + + D++S G I++ L G P F+ L
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLV-----GKP-P--------FETSCLKETYLRI 227
Query: 127 -----EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
IP+++NP AS+I+ +P RP+ + ++
Sbjct: 228 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-23
Identities = 32/88 (36%), Positives = 52/88 (59%), Gaps = 8/88 (9%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKANTFLSSKSAAG 69
+ +G+ YLH+ N IVH DLK N+L+ +K+ DFG+SR + L + G
Sbjct: 140 ILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMG 195
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
TPE++APE+L +P +D+++ G+I
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-23
Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANT 60
ER + D+ + +LH N I HRD+K NLL +K +K+ DFG ++
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
L ++ TP ++APEVL E ++ D++S GVI+
Sbjct: 185 AL--QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-22
Identities = 42/144 (29%), Positives = 78/144 (54%), Gaps = 16/144 (11%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSA 67
+A +++LH I++RDLK N+L+D++ +K+ DFGLS+ KA +F
Sbjct: 135 LALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----- 187
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
GT E+MAPEV+ + +D +SFGV+++E+ T P+ + + + + +L
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLG 244
Query: 128 IPRNVNPHVASIIEACWANEPWKR 151
+P+ ++P S++ + P R
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-22
Identities = 35/185 (18%), Positives = 69/185 (37%), Gaps = 21/185 (11%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L + ++ ++YLH +V+ DLK N+++ ++ +K+ D G
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RI 231
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
S GTP + APE++R P+ +DIY+ G L L +
Sbjct: 232 NSFGYLYGTPGFQAPEIVRTGPT-VATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDP- 289
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FSTIMELLRPLIKSPTPQPSPTD 176
L+ ++ +P +R + + + +LR ++ T P P
Sbjct: 290 ---VLKTY----DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGL 342
Query: 177 MPLLT 181
+ +
Sbjct: 343 STIFS 347
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-22
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANT 60
E + + ++++H +VHRDLK NLL + +K+ DFG +RLK
Sbjct: 105 ETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
K+ T + APE+L +E D++S GVIL
Sbjct: 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-22
Identities = 35/107 (32%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSRL--- 56
E+ N+ + ++YLH + I HRD+K N L + +K+ DFGLS+
Sbjct: 165 QREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222
Query: 57 -KANTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWEL 100
+ + AGTP ++APEVL +E K D +S GV+L L
Sbjct: 223 LNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-22
Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGTPE 72
G+ YLH + IVH+D+K NLL+ T+K+ G++ A+ +++ G+P
Sbjct: 121 GLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQGSPA 176
Query: 73 WMAPEVLRDEP--SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
+ PE+ S K DI+S GV L+ + T P+ N ++ +G KG IP
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG-KGS-YAIPG 234
Query: 131 NVNPHVASIIEACWANEPWKRPSFSTIME-----LLRPLIKSPTPQPSPTD 176
+ P ++ +++ EP KR S I + P ++P P P D
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPD 285
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-22
Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 11/101 (10%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANTFL 62
E+ ++ + + +++LH N IVHRDLK N+L+D +++ DFG S L+ L
Sbjct: 199 EKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256
Query: 63 SSKSAAGTPEWMAPEVLRDEPS------NEKSDIYSFGVIL 97
+ GTP ++APE+L+ ++ D+++ GVIL
Sbjct: 257 --RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 3e-22
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKA 58
E + G++YLH + I H DLK N+++ +K+ DFG++ ++A
Sbjct: 107 EDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
K+ GTPE++APE++ EP ++D++S GVI
Sbjct: 165 GNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-22
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKA 58
E + + G+NYLH + I H DLK N+++ +K+ DFGL+ ++
Sbjct: 114 EEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
K+ GTPE++APE++ EP ++D++S GVI
Sbjct: 172 GVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-22
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-LKA 58
E + G+ YLH I H DLK N+++ K +K+ DFGL+ +
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
K+ GTPE++APE++ EP ++D++S GVI
Sbjct: 171 GNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 3e-22
Identities = 44/186 (23%), Positives = 87/186 (46%), Gaps = 33/186 (17%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSA 67
+A G+ +L + I++RDLK N+++D + +K+ DFG+ + TF
Sbjct: 451 IAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------ 502
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
GTP+++APE++ +P + D ++FGV+L+E+ Q P+ + ++ ++ +
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVA 560
Query: 128 IPRNVNPHVASIIEACWANEPWKR--------------PSFSTI--MELLRPLIKSP-TP 170
P++++ +I + P KR F I +L R I+ P P
Sbjct: 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP 620
Query: 171 QPSPTD 176
+ S +
Sbjct: 621 KASGRN 626
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-22
Identities = 46/145 (31%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEWMA 75
++Y HR +VHRDLK N+L+D K+ DFGLS + FL +++ G+P + A
Sbjct: 123 AVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAA 178
Query: 76 PEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 134
PEV+ + + DI+S GVIL+ L P+ + + + + G IP +N
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGGV-FYIPEYLNR 236
Query: 135 HVASIIEACWANEPWKRPSFSTIME 159
VA+++ +P KR + I E
Sbjct: 237 SVATLLMHMLQVDPLKRATIKDIRE 261
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-22
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKA 58
L E + + +G+ ++H+ I+H DLK N+L + +K+ DFGL+R K
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
L K GTPE++APEV+ + + +D++S GVI
Sbjct: 242 REKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 4e-22
Identities = 34/141 (24%), Positives = 66/141 (46%), Gaps = 16/141 (11%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGT 70
+ +LH++ I++RDLK N++++ + VK+ DFGL + +TF GT
Sbjct: 133 ALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------GT 184
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
E+MAPE+L N D +S G +++++ T P+ N + + + +L +P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--LKCKLNLPP 242
Query: 131 NVNPHVASIIEACWANEPWKR 151
+ +++ R
Sbjct: 243 YLTQEARDLLKKLLKRNAASR 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-22
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKAN 59
ER + + + + YLH IVHRDLK NLL +K+ DFGLS+ ++
Sbjct: 147 ERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
+ K+ GTP + APE+LR + D++S G+I
Sbjct: 205 VLM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-22
Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEWMA 75
+ Y HR IVHRDLK NLL+D VK+ DFGLS + FL K++ G+P + A
Sbjct: 120 AIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAA 175
Query: 76 PEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 134
PEV+ + + + D++S G++L+ + + P+ + + V +P ++P
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCV-YVMPDFLSP 233
Query: 135 HVASIIEACWANEPWKRPSFSTIME 159
S+I +P +R + I
Sbjct: 234 GAQSLIRRMIVADPMQRITIQEIRR 258
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-22
Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-L 56
L E + + G+NYLH + I H DLK N+++ +K+ DFGL+ +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 57 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
+ K+ GTPE++APE++ EP ++D++S GVI
Sbjct: 170 EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-22
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 28/158 (17%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEW 73
+ G YLHR ++HRDLK NL +++ VK+ DFGL+ K GTP +
Sbjct: 150 IVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207
Query: 74 MAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL------- 126
+APEVL + + + D++S G I++ L G P F+ L
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLV-----GKP-P--------FETSCLKETYLRI 253
Query: 127 -----EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
IP+++NP AS+I+ +P RP+ + ++
Sbjct: 254 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-22
Identities = 36/148 (24%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPE 72
+ + YL ++ I+HRD+K N+++ + +T+K+ DFG + + + GT E
Sbjct: 139 LVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIE 194
Query: 73 WMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRN 131
+ APEVL P + +++S GV L+ L + P+ L + V A + P
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEA------AIHPPYL 246
Query: 132 VNPHVASIIEACWANEPWKRPSFSTIME 159
V+ + S++ P +R + ++
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-22
Identities = 33/151 (21%), Positives = 67/151 (44%), Gaps = 20/151 (13%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 72
V + + + H ++HRD+K N+L+D + +K+ DFG L +T GT
Sbjct: 158 VLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRV 213
Query: 73 WMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNL---NPAQVVAAVGFKGKRLEI 128
+ PE +R + ++S G++L+++ G++ + +++ ++
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIRG------QVFF 262
Query: 129 PRNVNPHVASIIEACWANEPWKRPSFSTIME 159
+ V+ +I C A P RP+F I
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-22
Identities = 35/144 (24%), Positives = 67/144 (46%), Gaps = 16/144 (11%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSA 67
+ + +LH + I++RDLK N+L+D + K+ DFG+ + TF
Sbjct: 133 IISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF------ 184
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
GTP+++APE+L++ D ++ GV+L+E+ P+ N + A+ +
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVV 242
Query: 128 IPRNVNPHVASIIEACWANEPWKR 151
P ++ I+++ P R
Sbjct: 243 YPTWLHEDATGILKSFMTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-22
Identities = 36/144 (25%), Positives = 75/144 (52%), Gaps = 16/144 (11%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSA 67
+A G+ +L + I++RDLK N+++D + +K+ DFG+ + TF
Sbjct: 130 IAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------ 181
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE 127
GTP+++APE++ +P + D ++FGV+L+E+ Q P+ + ++ ++ +
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVA 239
Query: 128 IPRNVNPHVASIIEACWANEPWKR 151
P++++ +I + P KR
Sbjct: 240 YPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-21
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKAN 59
E + + + + Y H IVHR+LK NLL+ K VK+ DFGL+ + +
Sbjct: 127 EADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
AGTP +++PEVL+ +P ++ DI++ GVIL
Sbjct: 185 EAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-21
Identities = 29/99 (29%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKA 58
+ E +N +G+ ++H + IVH D+K N++ + K +VK+ DFGL+ L
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
+ + K T E+ APE++ EP +D+++ GV+
Sbjct: 204 DEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-21
Identities = 41/148 (27%), Positives = 78/148 (52%), Gaps = 21/148 (14%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSAAGT 70
+NYLH R I++RDLK N+L+D + +K+ D+G+ + +TF GT
Sbjct: 122 ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGT 173
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG----FKG--- 123
P ++APE+LR E D ++ GV+++E+ + P+ + + F+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKR 151
K++ IPR+++ AS++++ +P +R
Sbjct: 234 KQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-21
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 11/103 (10%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LK 57
L E Y + + YLH I+HRDLK N+L+ ++ +K+ DFG S+ L
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 58 ANTFLSSKSAAGTPEWMAPEVLRDEPS---NEKSDIYSFGVIL 97
+ + ++ GTP ++APEVL + N D +S GVIL
Sbjct: 294 ETSLM--RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-21
Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPE 72
+ ++YL + I+HRD+K N+L+D+ V + DF ++ L T +++ + GT
Sbjct: 124 LVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKP 179
Query: 73 WMAPEVLRDEPSNEKS---DIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRL 126
+MAPE+ S D +S GV +EL ++P+ + + ++V F+ +
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVV 237
Query: 127 EIPRNVNPHVASIIEACWANEPWKR 151
P + + S+++ P +R
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-21
Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 6/98 (6%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKAN 59
ER + + + K + YLH + +VHRDLK N+L ++++CDFG ++
Sbjct: 115 EREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
+ T ++APEVL + + DI+S GV+L
Sbjct: 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-21
Identities = 41/138 (29%), Positives = 67/138 (48%), Gaps = 6/138 (4%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 76
G+ +LH+RN I++RDLK N+L+D V++ D GL+ +K AGTP +MAP
Sbjct: 301 GLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRLEIPRNVN 133
E+L E + D ++ GV L+E+ + P+ + + + + P +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKFS 417
Query: 134 PHVASIIEACWANEPWKR 151
P EA +P KR
Sbjct: 418 PASKDFCEALLQKDPEKR 435
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-21
Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 4/148 (2%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS 63
+R R A ++ ++YLH +V+RDLK NL++DK +K+ DFGL + +
Sbjct: 248 DRARFYGA-EIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 123
K+ GTPE++APEVL D D + GV+++E+ + P+ N + ++ +
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LM 363
Query: 124 KRLEIPRNVNPHVASIIEACWANEPWKR 151
+ + PR + P S++ +P +R
Sbjct: 364 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-21
Identities = 41/98 (41%), Positives = 57/98 (58%), Gaps = 9/98 (9%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKAN 59
E + V G+ Y+H+ N IVHRDLK N+L+ +K +K+ DFGLS + N
Sbjct: 120 EHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
T + K GT ++APEVLR +EK D++S GVIL
Sbjct: 178 TKM--KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-21
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKAN 59
ER + + + + YLH N I HRD+K NLL +K+ DFG ++ ++
Sbjct: 160 EREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
L + TP ++APEVL E ++ D++S GVI+
Sbjct: 218 NSL--TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-21
Identities = 41/151 (27%), Positives = 80/151 (52%), Gaps = 21/151 (13%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL------KANTFLSSKSA 67
++ +NYLH R I++RDLK N+L+D + +K+ D+G+ + +TF
Sbjct: 162 ISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------ 213
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG----FKG 123
GTP ++APE+LR E D ++ GV+++E+ + P+ + + F+
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273
Query: 124 ---KRLEIPRNVNPHVASIIEACWANEPWKR 151
K++ IPR+++ AS++++ +P +R
Sbjct: 274 ILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-21
Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGT 70
+ + + + H+ +VHR+LK NLL+ K VK+ DFGL+ + AGT
Sbjct: 119 ILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVIL 97
P +++PEVLR +P + D+++ GVIL
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-21
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 9/89 (10%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGTPE 72
G+ YLH I HRD+K NLL+D++ +K+ DFGL+ + L GT
Sbjct: 117 GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLP 172
Query: 73 WMAPEVLRDEP-SNEKSDIYSFGVILWEL 100
++APE+L+ E D++S G++L +
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAM 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-21
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 11/103 (10%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LK 57
L E Y + + YLH I+HRDLK N+L+ + +K+ DFG S+ L
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 58 ANTFLSSKSAAGTPEWMAPEVLRDEPS---NEKSDIYSFGVIL 97
+ + ++ GTP ++APEVL + N D +S GVIL
Sbjct: 169 ETSLM--RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-21
Identities = 37/135 (27%), Positives = 70/135 (51%), Gaps = 13/135 (9%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPEWMAP 76
YLH + +++RDLK NLL+D++ ++V DFG ++ + T GTPE +AP
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL------CGTPEALAP 207
Query: 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHV 136
E++ + N+ D ++ GV+++E+A P+ P Q+ + GK + P + + +
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGK-VRFPSHFSSDL 265
Query: 137 ASIIEACWANEPWKR 151
++ + KR
Sbjct: 266 KDLLRNLLQVDLTKR 280
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 7e-21
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKAN 59
E + DV + Y H+ N + HRDLK N L +K+ DFGL+ K
Sbjct: 105 ESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
+ ++ GTP +++P+VL + D +S GV++
Sbjct: 163 KMM--RTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMM 197
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 9e-21
Identities = 24/87 (27%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKANTFLSSKSAAGT 70
V + + +LH N I H D++ N++ + T+K+ +FG +R LK +
Sbjct: 111 VCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTA 166
Query: 71 PEWMAPEVLRDEPSNEKSDIYSFGVIL 97
PE+ APEV + + + +D++S G ++
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 9e-21
Identities = 18/115 (15%), Positives = 42/115 (36%), Gaps = 19/115 (16%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV-----------DKKYTVKVC 49
++ + ++ A + + +H I+H D+K N ++ D + +
Sbjct: 168 VMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225
Query: 50 DFGLSR----LKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
D G S T + T + E+L ++P N + D + ++ +
Sbjct: 226 DLGQSIDMKLFPKGTIF--TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-20
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 9/89 (10%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGTPE 72
G+ YLH I HRD+K NLL+D++ +K+ DFGL+ + L GT
Sbjct: 117 GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLP 172
Query: 73 WMAPEVLRDEP-SNEKSDIYSFGVILWEL 100
++APE+L+ E D++S G++L +
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAM 201
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-20
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANT 60
E + + + + Y H N I+HRD+K +L+ + VK+ FG++ +
Sbjct: 129 EAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
L + GTP +MAPEV++ EP + D++ GVIL
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-20
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 7/99 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSR-LKA 58
+ E + V KG+ ++H N VH DLK N++ K +K+ DFGL+ L
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
+ K GT E+ APEV +P +D++S GV+
Sbjct: 310 KQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-20
Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 9/100 (9%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LK 57
L E + + + Y H ++ +VH+DLK N+L +K+ DFGL+ K
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 58 ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
++ +AAGT +MAPEV + K DI+S GV++
Sbjct: 179 SDEHS--TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-20
Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 17/109 (15%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR-LKAN 59
E + DVA +++LH + I HRDLK N+L ++ VK+CDF L +K N
Sbjct: 110 ELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 60 TFLSS------KSAAGTPEWMAPEVLRDEPSNEKS-----DIYSFGVIL 97
S + G+ E+MAPEV+ D++S GVIL
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 2e-20
Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFLSSKSAAGTPEWMA 75
G++Y HR +VHRDLK N+L+D K+ DFGLS + FL +++ G+P + A
Sbjct: 128 GVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAA 183
Query: 76 PEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNP 134
PEV+ + + DI+S GVIL+ L P+ + + + + P+ +NP
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNP 241
Query: 135 HVASIIEACWANEPWKRPSFSTIME 159
V S+++ +P KR + I E
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIRE 266
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-20
Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 19/138 (13%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KANTFLSSKSAAGTPEWMAP 76
YLH ++ I++RDLK N+L+DK +K+ DFG ++ T GTP+++AP
Sbjct: 121 YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL------CGTPDYIAP 172
Query: 77 EVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GKRLEIPRNVN 133
EV+ +P N+ D +SFG++++E+ P+ + N + ++ L P N
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELRFPPFFN 227
Query: 134 PHVASIIEACWANEPWKR 151
V ++ + +R
Sbjct: 228 EDVKDLLSRLITRDLSQR 245
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-20
Identities = 34/137 (24%), Positives = 65/137 (47%), Gaps = 13/137 (9%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMA 75
++ +HR VHRD+K N+L+D+ +++ DFG +L+A+ + S A GTP++++
Sbjct: 174 AIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 76 PEVLRDEPSNEKSDIY-------SFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI 128
PE+L+ + Y + GV +E+ Q P+ + A+ + + L +
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 129 P---RNVNPHVASIIEA 142
P V I+
Sbjct: 292 PLVDEGVPEEARDFIQR 308
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-20
Identities = 57/176 (32%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KANTFLSSKSAAG 69
V G+ Y+H+ IVHRDLK NLL++ K +++ DFGLS +A+ + K G
Sbjct: 135 VLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIG 190
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP-WGNLNPAQVVAAVGFKGK-RLE 127
T ++APEVL +EK D++S GVIL+ L + P G N ++ V KGK E
Sbjct: 191 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKV-EKGKYTFE 247
Query: 128 IPR--NVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDMPLL 180
+P+ V+ +I P R + + L I++ T + D+P L
Sbjct: 248 LPQWKKVSESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYTKEQISVDVPSL 300
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-20
Identities = 31/135 (22%), Positives = 67/135 (49%), Gaps = 11/135 (8%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMA 75
++ +H+ + VHRD+K N+L+D +++ DFG +L + + S A GTP++++
Sbjct: 187 AIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 76 PEVLRDEPSNEKS-----DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPR 130
PE+L+ + D +S GV ++E+ + P+ + + + +R + P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
Query: 131 ---NVNPHVASIIEA 142
+V+ + +I
Sbjct: 305 QVTDVSENAKDLIRR 319
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-20
Identities = 36/145 (24%), Positives = 59/145 (40%), Gaps = 15/145 (10%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----LKANTFLSSKSAA 68
+ G+ LHR IV+RDLK N+L+D +++ D GL+
Sbjct: 295 ICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR------V 346
Query: 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--GKRL 126
GT +MAPEV+++E D ++ G +L+E+ Q P+ V
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406
Query: 127 EIPRNVNPHVASIIEACWANEPWKR 151
E +P S+ +P +R
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPAER 431
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 3e-20
Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 18/143 (12%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----KANTFLSSKSAAGTPE 72
G+ ++H R +V+RDLK N+L+D+ V++ D GL+ K + GT
Sbjct: 304 GLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTHG 355
Query: 73 WMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKGKRLEI 128
+MAPEVL+ + + S D +S G +L++L P+ + ++ +E+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVEL 413
Query: 129 PRNVNPHVASIIEACWANEPWKR 151
P + +P + S++E + +R
Sbjct: 414 PDSFSPELRSLLEGLLQRDVNRR 436
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-20
Identities = 41/91 (45%), Positives = 57/91 (62%), Gaps = 9/91 (9%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KANTFLSSKSAAG 69
V G+ Y+H+ N IVHRDLK N+L++ K +K+ DFGLS + NT + K G
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIG 185
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
T ++APEVLR +EK D++S GVIL+ L
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYIL 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-20
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 21/147 (14%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-------KANTFLSSKSAAG 69
+ +LH+ I++RD+K N+L+D V + DFGLS+ +A F G
Sbjct: 171 ALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------G 222
Query: 70 TPEWMAPEVLRDEPSN-EKS-DIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---GK 124
T E+MAP+++R S +K+ D +S GV+++EL T P+ A + +
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKS 281
Query: 125 RLEIPRNVNPHVASIIEACWANEPWKR 151
P+ ++ +I+ +P KR
Sbjct: 282 EPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-20
Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 14 VAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSR-LKANTFLSSKSAAG 69
+ G+ YLH+ N IVHRD+K N+L++ K +K+ DFGLS + L + G
Sbjct: 155 ILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLG 210
Query: 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQP-WGNLNPAQVVAAVGFKGK-RLE 127
T ++APEVL+ + NEK D++S GVI++ L P G N ++ V KGK +
Sbjct: 211 TAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ-NDQDIIKKV-EKGKYYFD 267
Query: 128 IPR--NVNPHVASIIEACWANEPWKRPSFSTIMELLR-PLIKSPTPQPSPTDMPLLT 181
N++ +I+ + KR T E L IK + +D L
Sbjct: 268 FNDWKNISDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKKYANNINKSDQKTLC 321
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-20
Identities = 42/101 (41%), Positives = 59/101 (58%), Gaps = 9/101 (8%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRL-KAN 59
E + V G+ YLH+ N IVHRDLK NLL++ K +K+ DFGLS + +
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+ K GT ++APEVLR + +EK D++S GVIL+ L
Sbjct: 193 KKM--KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFIL 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-19
Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 8/88 (9%)
Query: 17 GMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRL-KANTFLSSKSAAGTPEW 73
G++Y H I HRDLK N L+D +K+CDFG S+ ++ KS GTP +
Sbjct: 128 GVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAY 183
Query: 74 MAPEVLRDEPSN-EKSDIYSFGVILWEL 100
+APEVL + + + +D++S GV L+ +
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVM 211
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-19
Identities = 30/119 (25%), Positives = 57/119 (47%), Gaps = 7/119 (5%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANTFLSSKSAAGTPEWMAPEV 78
+H +HRD+K N+L+DK +K+ DFG ++ + +A GTP++++PEV
Sbjct: 183 AIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 79 LRDEPSNEK----SDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVN 133
L+ + + D +S GV L+E+ P+ + + + L P + +
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-15
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 13/97 (13%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
KG+ + H RN ++HRDLK NLL+++ +K+ +FGL+R + E
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVT 164
Query: 73 -WM-APEVLRDEPS-NEKSDIYSFGVILWELATLQQP 106
W P+VL + D++S G I ELA +P
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-15
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
+ +N+ H+ N +HRD+K N+L+ K +K+CDFG +RL L+ S E
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVAT 165
Query: 73 -WM-APEVL-RDEPSNEKSDIYSFGVILWELATLQ 104
W +PE+L D D+++ G + EL +
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-15
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 13/100 (13%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + + LH N ++HRDLK NLL++ +KVCDFGL+R+ + + G
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 72 EWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 100
M APEV+ + D++S G IL EL
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-15
Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + G+ +LH I+HRDLK N++V T+K+ DFGL+R +F+ + T
Sbjct: 134 YQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TR 190
Query: 72 EWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+ APEV+ E DI+S G I+ E+
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEM 219
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-14
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
G+ + H N I+HRD+K N+LV + VK+CDFG +R L++ E
Sbjct: 135 NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVAT 187
Query: 73 -WM-APEVL-RDEPSNEKSDIYSFGVILWELATLQ 104
W APE+L D + D+++ G ++ E+ +
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-14
Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + G+ +LH I+HRDLK N++V T+K+ DFGL+R +F+ + T
Sbjct: 171 YQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TR 227
Query: 72 EWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+ APEV+ E DI+S G I+ E+
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEM 256
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-14
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 13/93 (13%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
+G+ + H+ I+HRDLK NLL++ +K+ DFGL+R + T E
Sbjct: 130 RGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVT 182
Query: 73 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 102
W AP+VL + DI+S G I E+ T
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-14
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 13/92 (14%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
+G+++LH +VHRDLK N+LV +K+ DFGL+R+ S A T
Sbjct: 131 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY------SFQMALTSVVVT 182
Query: 73 -WM-APEVLRDEPSNEKSDIYSFGVILWELAT 102
W APEVL D++S G I E+
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-14
Identities = 34/94 (36%), Positives = 46/94 (48%), Gaps = 17/94 (18%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--NTFLSSKSAAGTPE- 72
+G+++LH IVHRDLK N+LV TVK+ DFGL+R+ + TP
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVV 180
Query: 73 ---WM-APEVLRDEPSNEKSDIYSFGVILWELAT 102
W APEVL D++S G I E+
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 4e-14
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
G+ Y H R ++HRDLK NLL++++ +K+ DFGL+R T E
Sbjct: 111 NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVT 163
Query: 73 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 102
W AP+VL + DI+S G I E+
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 8e-14
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 13/93 (13%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
+G+ + H I+HRDLK NLL++K+ +K+ DFGL+R + E
Sbjct: 119 QGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSEVVT 171
Query: 73 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 102
W AP+VL + + DI+S G IL E+ T
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-13
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 13/93 (13%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
+G+ Y HR+ ++HRDLK NLL++++ +K+ DFGL+R K S + E
Sbjct: 111 RGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVT 163
Query: 73 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 102
W P++L + + D++ G I +E+AT
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-13
Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 4/90 (4%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + G++ LH +VHRDL N+L+ + +CDF L+R +
Sbjct: 141 YHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HR 197
Query: 72 EWMAPEVLRDEPSNEKS-DIYSFGVILWEL 100
+ APE++ K D++S G ++ E+
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-13
Identities = 26/97 (26%), Positives = 38/97 (39%), Gaps = 27/97 (27%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANT 60
ER + + + + YLH N I HRD+K NLL +K+ DFG
Sbjct: 116 EREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------- 166
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVIL 97
A E E ++ D++S GVI+
Sbjct: 167 --------------AKETTG-EKYDKSCDMWSLGVIM 188
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-13
Identities = 32/90 (35%), Positives = 52/90 (57%), Gaps = 6/90 (6%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + +G+ Y+H + I+HRDLK NL V++ +K+ DFGL+R ++ A T
Sbjct: 139 YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVA--TR 193
Query: 72 EWMAPEVLRDEPS-NEKSDIYSFGVILWEL 100
+ APE++ + N+ DI+S G I+ EL
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-13
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
G+ Y+HR I+HRD+K+ N+L+ + +K+ DFGL+R + +S+ T
Sbjct: 135 NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPNRYTNRVVT 191
Query: 73 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 102
W PE+L E D++ G I+ E+ T
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-13
Identities = 32/90 (35%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + KG+ Y+H I+HRDLK NL V++ +K+ DFGL+R +A++ ++ T
Sbjct: 135 YQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVV--TR 189
Query: 72 EWMAPEVLRDEPSNEKS-DIYSFGVILWEL 100
+ APEV+ + ++ DI+S G I+ E+
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-13
Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 6/90 (6%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + KG+ Y+H +VHRDLK NL V++ +K+ DFGL+R A+ ++ T
Sbjct: 133 YQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV--TR 187
Query: 72 EWMAPEVLRDEPSNEKS-DIYSFGVILWEL 100
+ APEV+ ++ DI+S G I+ E+
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-13
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 20/100 (20%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y + +G+ Y+H N ++HRDLK NLL++ +K+CDFGL+R +
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHT 185
Query: 72 EWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 100
++ APE++ + + DI+S G IL E+
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-12
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 25/112 (22%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y++ G N++H I+HRDLK N L+++ +VKVCDFGL+R + ++
Sbjct: 136 YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 72 EWM----------------------APEVLRDEPS-NEKSDIYSFGVILWEL 100
APE++ + + + DI+S G I EL
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-12
Identities = 30/111 (27%), Positives = 51/111 (45%), Gaps = 24/111 (21%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-----------LKANT 60
Y + K + YLH ++HRD+K N+L++ + VKV DFGLSR + +
Sbjct: 116 YQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 61 FLSSKSAAGTPEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 100
++++ + APE+L + D++S G IL E+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-12
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE--- 72
+G+ YLH+ I+HRDLK NLL+D+ +K+ DFGL++ S + A T +
Sbjct: 123 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GSPNRAYTHQVVT 175
Query: 73 -WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 102
W APE+L D+++ G IL EL
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-12
Identities = 29/98 (29%), Positives = 40/98 (40%), Gaps = 18/98 (18%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSRLKANTFLSSKSAAGT 70
G+N+ H R +HRDLK NLL+ +K+ DFGL+R T
Sbjct: 143 NGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-----GIPIRQFT 195
Query: 71 PE----WM-APEVLRDEPS-NEKSDIYSFGVILWELAT 102
E W PE+L + DI+S I E+
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-12
Identities = 35/138 (25%), Positives = 62/138 (44%), Gaps = 24/138 (17%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD------KKYTVKVCDFGLSRLKANTFLS 63
++ + G++Y+HRR I+H D+K N+L++ +K+ D G + + +
Sbjct: 136 ISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194
Query: 64 SKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG 123
S T E+ +PEVL P +DI+S +++EL T G+ F+
Sbjct: 195 SIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELIT-----GD---------FLFEP 237
Query: 124 KRLEIPRNVNPHVASIIE 141
+ H+A IIE
Sbjct: 238 DEGHSYTKDDDHIAQIIE 255
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 6e-12
Identities = 24/101 (23%), Positives = 45/101 (44%), Gaps = 21/101 (20%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGT 70
Y + +G+ Y+H N ++HRDLK NL ++ + +K+ DFGL+R
Sbjct: 127 YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR-------IMDPHYSH 177
Query: 71 PEWM----------APEVLRDEPS-NEKSDIYSFGVILWEL 100
+ +P +L + + D+++ G I E+
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-11
Identities = 25/98 (25%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRL-KANTFLSSKSAAG 69
Y++ K ++Y H I+HRD+K N+++D ++ +++ D+GL+ + + A
Sbjct: 137 YEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-- 192
Query: 70 TPEWMAPEVLRDEPSNEKS-DIYSFGVILWELATLQQP 106
+ + PE+L D + S D++S G +L + ++P
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-11
Identities = 23/80 (28%), Positives = 37/80 (46%), Gaps = 2/80 (2%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTP 71
Y++ G+ Y+H I+HRDLK N LV++ +VKVCDFGL+R + +P
Sbjct: 163 YNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 72 EWMAPEVLRDEPSNEKSDIY 91
++ +
Sbjct: 221 REDDMNLVTFPHTKNLKRQL 240
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-11
Identities = 15/178 (8%), Positives = 42/178 (23%), Gaps = 34/178 (19%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ +A + HR + + V V +
Sbjct: 126 PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPATMP------ 177
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+N + DI G L+ L + P +A
Sbjct: 178 ---------------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 122 -KGKRLEIPRNVNPHV----ASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSP 174
+ P +++ + +++ + R + + + + + + +
Sbjct: 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLG 274
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-11
Identities = 26/100 (26%), Positives = 46/100 (46%), Gaps = 13/100 (13%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGT 70
+ + + + LH + + HRD+K N+LV++ T+K+CDFG ++ S S
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK------KLSPSEPNV 189
Query: 71 PEWM-----APEVLRDEPSNEKS-DIYSFGVILWELATLQ 104
APE++ + DI+S G I E+ +
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-11
Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 11/98 (11%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV--DKKYTVKVCDFGLSRLKAN---TFLSS 64
A + + +L I+H DLK N+L+ K+ +K+ DFG S ++ S
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS 221
Query: 65 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 102
+ + +PEVL P + D++S G IL E+ T
Sbjct: 222 RF------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 26/100 (26%), Positives = 44/100 (44%), Gaps = 15/100 (15%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGT 70
Y + + + Y+H I HRD+K NLL+D +K+ DFG ++ +
Sbjct: 148 YQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGEPNV 199
Query: 71 PE----WM-APEVLRDEPS-NEKSDIYSFGVILWELATLQ 104
+ APE++ + DI+S G ++ EL Q
Sbjct: 200 SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-10
Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 9/97 (9%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSR-LKANTFLSSKSAAG 69
Y + + + Y+H I HRD+K NLL+D +K+CDFG ++ L S +
Sbjct: 163 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 70 TPEWM-APEV-LRDEPSNEKSDIYSFGVILWELATLQ 104
+ APE+ D++S G +L EL Q
Sbjct: 221 ---YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-10
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 13/98 (13%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV--DKKYTVKVCDFGLSRLKAN---TFLSS 64
A+ + + ++ LH+ I+H DLK N+L+ + +KV DFG S + T++ S
Sbjct: 205 FAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS 262
Query: 65 KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 102
+ + APEV+ D++S G IL EL T
Sbjct: 263 RF------YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 2e-10
Identities = 33/104 (31%), Positives = 47/104 (45%), Gaps = 24/104 (23%)
Query: 16 KGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSR-----LKANTFLSSKS 66
G++YLH ++HRDLK N+LV ++ VK+ D G +R LK
Sbjct: 139 DGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA------ 190
Query: 67 AAGTPE----WM-APEVLRDEPSNEKS-DIYSFGVILWELATLQ 104
P W APE+L K+ DI++ G I EL T +
Sbjct: 191 -DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-10
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 12 YDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSR-LKANTFLSSKSAAG 69
Y + + + ++H I HRD+K NLLV+ K T+K+CDFG ++ L + +
Sbjct: 148 YQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC-- 203
Query: 70 TPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQ 104
+ + APE++ D++S G + EL +
Sbjct: 204 SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-07
Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 30/116 (25%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPN-LLVDKKYT------------------VKVC 49
MAY + K +N+LH + H DLK N L V YT +KV
Sbjct: 122 KMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 50 DFG---LSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 102
DFG +T +S++ + APEV+ ++ D++S G IL E
Sbjct: 180 DFGSATYDDEHHSTLVSTRH------YRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 7e-07
Identities = 29/142 (20%), Positives = 48/142 (33%), Gaps = 53/142 (37%)
Query: 10 MAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----------------------------- 40
+ V +G++YLH + I+H D+K N+L+
Sbjct: 151 IIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 41 --------------------DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80
+K VK+ D G + F T ++ + EVL
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYRSLEVLI 266
Query: 81 DEPSNEKSDIYSFGVILWELAT 102
N +DI+S + +ELAT
Sbjct: 267 GSGYNTPADIWSTACMAFELAT 288
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-06
Identities = 26/116 (22%), Positives = 47/116 (40%), Gaps = 30/116 (25%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPN-LLVDKKYT------------------VKVC 49
+MAY + + +LH + H DLK N L V+ ++ ++V
Sbjct: 127 HMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 50 DFG---LSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELAT 102
DFG T ++++ + PEV+ + + D++S G IL+E
Sbjct: 185 DFGSATFDHEHHTTIVATRH------YRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-06
Identities = 29/122 (23%), Positives = 50/122 (40%), Gaps = 36/122 (29%)
Query: 9 NMAYDVAKGMNYLHRRNPPIVHRDLKSPN-LLVDKKYT---------------------- 45
++ K +NYL + + + H DLK N LL D +
Sbjct: 141 LYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 46 --VKVCDFG---LSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWEL 100
+K+ DFG + ++++ + APEV+ + + SD++SFG +L EL
Sbjct: 199 TGIKLIDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 101 AT 102
T
Sbjct: 253 YT 254
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-05
Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 13/101 (12%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRL-------KANTFLSSKSAAGT 70
Y+H VH D+K+ NLL++ K +V D+GL+ KA + GT
Sbjct: 167 YIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT 224
Query: 71 PEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNL 110
E+ + + PS + D+ G + + T PW +
Sbjct: 225 IEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-05
Identities = 28/108 (25%), Positives = 43/108 (39%), Gaps = 15/108 (13%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRL-------KANTFLSSKSAAGT 70
Y+H VH D+K+ NLL+ K +V D+GLS K K GT
Sbjct: 166 YIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223
Query: 71 PEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNL--NPAQV 115
E+ + + + S +SD+ G + + PW +P V
Sbjct: 224 IEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-05
Identities = 21/104 (20%), Positives = 43/104 (41%), Gaps = 14/104 (13%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSR--LKANT-----FLSSKSA 67
+H ++ +V+RD+K N L+ + + + V DFG+ + T + K+
Sbjct: 121 SIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178
Query: 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 111
+GT +M+ + + D+ + G + PW L
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 1e-04
Identities = 25/105 (23%), Positives = 45/105 (42%), Gaps = 16/105 (15%)
Query: 20 YLHRRNPPIVHRDLKSPNLLV-----DKKYTVKVCDFGLSR--LKANT-----FLSSKSA 67
Y+H +N +++RD+K N L+ + + + DF L++ + T + KS
Sbjct: 120 YVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177
Query: 68 AGTPEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 111
GT +M+ L E S + D+ + G + PW L
Sbjct: 178 TGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 1e-04
Identities = 8/55 (14%), Positives = 18/55 (32%), Gaps = 1/55 (1%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55
+ ++ + + + HRDL N+L+ K K+ +
Sbjct: 157 LSSLATAKSILHQLTASLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 2e-04
Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 21/105 (20%)
Query: 20 YLHRRNPPIVHRDLKSPNLLVDKKYTVKV--CDFGLSRLKANT-------FLSSKSAAGT 70
+LH VH ++ + N+ VD + +V +G + + S G
Sbjct: 174 FLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD 231
Query: 71 PEWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNL 110
E+++ D PS +SD+ S G + + PW N
Sbjct: 232 LEFIS----MDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 38.5 bits (90), Expect = 5e-04
Identities = 29/113 (25%), Positives = 49/113 (43%), Gaps = 12/113 (10%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSR--LKANT-- 60
L +A + + Y+H +N +HRD+K N L+ K V + DFGL++ A T
Sbjct: 108 LLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 61 ---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL 110
+ +K+ GT + + + + D+ S G +L PW L
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 38.1 bits (88), Expect = 8e-04
Identities = 25/114 (21%), Positives = 49/114 (42%), Gaps = 12/114 (10%)
Query: 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRL--KANT-- 60
L +A + + ++H ++ +HRD+K N L+ + V + DFGL++ +T
Sbjct: 106 LMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 61 ---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 111
+ +K+ GT + + + + D+ S G +L PW L
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 181 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.98 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.98 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.98 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.98 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.98 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.98 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.98 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.98 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.98 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.98 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.98 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.98 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.98 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.98 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.98 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.79 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.46 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.12 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.04 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.44 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.61 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.46 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 96.43 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.21 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 95.32 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.18 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 94.68 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.69 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 93.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.59 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 92.03 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.9 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.67 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 91.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 91.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 90.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 90.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.1 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.81 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 86.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 83.12 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 82.49 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=259.88 Aligned_cols=166 Identities=25% Similarity=0.499 Sum_probs=147.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||++| |+||||||+||+++.+|.+||+|||+++..........+..||+.|+|||.+.+
T Consensus 167 l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~ 244 (346)
T 4fih_A 167 MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR 244 (346)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC
Confidence 688999999999999999999999 999999999999999999999999999876555444566789999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+||++|+|++|+.||.+.+..+....+..... ....+..+++++++||.+||..||.+|||+.++++
T Consensus 245 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~- 323 (346)
T 4fih_A 245 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK- 323 (346)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT-
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc-
Confidence 8999999999999999999999999999988887777753322 33445678999999999999999999999999999
Q ss_pred HHHhhhCCCCC
Q 030203 161 LRPLIKSPTPQ 171 (181)
Q Consensus 161 L~~~~~~~~~~ 171 (181)
++|++...++
T Consensus 324 -Hp~~~~~~~p 333 (346)
T 4fih_A 324 -HPFLAKAGPP 333 (346)
T ss_dssp -CGGGGGCCCG
T ss_pred -CHhhcCCCCC
Confidence 9999876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=259.27 Aligned_cols=161 Identities=28% Similarity=0.514 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|.+++.++.||+.||.|||++| |+||||||+||+++.+|.+||+|||+++.............||+.|+|||.+.+
T Consensus 122 ~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 122 FQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCC
Confidence 578999999999999999999999 999999999999999999999999999865543333344578999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+||++|+|++|+.||.+.+..++..++... .....+..+|+++++||.+||+.||.+|||++++++
T Consensus 200 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~-- 276 (350)
T 4b9d_A 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE-- 276 (350)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--
Confidence 99999999999999999999999999999988888777533 334567789999999999999999999999999998
Q ss_pred HHhhhC
Q 030203 162 RPLIKS 167 (181)
Q Consensus 162 ~~~~~~ 167 (181)
++|++.
T Consensus 277 hp~~~~ 282 (350)
T 4b9d_A 277 KGFIAK 282 (350)
T ss_dssp SHHHHT
T ss_pred CHHhhc
Confidence 666653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=260.24 Aligned_cols=166 Identities=25% Similarity=0.499 Sum_probs=147.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||++| |+||||||+||+++.+|.+||+|||+++..........+..|++.|+|||.+.+
T Consensus 244 l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~ 321 (423)
T 4fie_A 244 MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR 321 (423)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC
Confidence 688999999999999999999999 999999999999999999999999999876554444556789999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..|+.++|+|||||++|+|++|+.||.+.+.......+..... ....+..+++++++||.+||..||.+|||+.++++
T Consensus 322 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~- 400 (423)
T 4fie_A 322 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK- 400 (423)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT-
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc-
Confidence 8999999999999999999999999999988887777754332 34456679999999999999999999999999999
Q ss_pred HHHhhhCCCCC
Q 030203 161 LRPLIKSPTPQ 171 (181)
Q Consensus 161 L~~~~~~~~~~ 171 (181)
++|++...++
T Consensus 401 -Hp~~~~~~~p 410 (423)
T 4fie_A 401 -HPFLAKAGPP 410 (423)
T ss_dssp -CGGGGGCCCG
T ss_pred -CHHhcCCCCC
Confidence 9999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=247.41 Aligned_cols=160 Identities=29% Similarity=0.500 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++.++.+||+|||+++...... ...+..||+.|+|||.+.+
T Consensus 109 l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~~GT~~Y~APE~~~~ 185 (275)
T 3hyh_A 109 MSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVISG 185 (275)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC----------------CTTSCHHHHSS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC-ccCCeeECcccCChhhhcC
Confidence 688999999999999999999999 9999999999999999999999999997654432 2345689999999999988
Q ss_pred CCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..+ +.++|+||+||++|+|++|+.||.+.+...+...+... ....+..+|+++++|+.+||+.||.+|||++++++
T Consensus 186 ~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~- 262 (275)
T 3hyh_A 186 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ- 262 (275)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH-
T ss_pred CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc-
Confidence 776 57899999999999999999999999888877777533 34567789999999999999999999999999999
Q ss_pred HHHhhhCC
Q 030203 161 LRPLIKSP 168 (181)
Q Consensus 161 L~~~~~~~ 168 (181)
++|++..
T Consensus 263 -hpw~k~~ 269 (275)
T 3hyh_A 263 -DDWFKVD 269 (275)
T ss_dssp -CHHHHTT
T ss_pred -CcccccC
Confidence 9999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=251.18 Aligned_cols=164 Identities=37% Similarity=0.635 Sum_probs=139.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..... ........+++.|+|||.+
T Consensus 155 l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~ 232 (329)
T 4aoj_A 155 LGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 232 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhh
Confidence 678999999999999999999999 999999999999999999999999999754322 1222345788999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|||||||++|||+| |+.||.+.+..+....+. .+.+.+.|..+++++.+|+.+||+.||.+|||+++++
T Consensus 233 ~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 311 (329)
T 4aoj_A 233 LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVH 311 (329)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred cCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 99999999999999999999998 899999999888887775 4456677888999999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+.+.+.+
T Consensus 312 ~~L~~l~~~p 321 (329)
T 4aoj_A 312 ARLQALAQAP 321 (329)
T ss_dssp HHHHHHHHSC
T ss_pred HHHHHHhhCC
Confidence 9999998764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=250.93 Aligned_cols=160 Identities=26% Similarity=0.440 Sum_probs=140.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.+|.+||+|||+++..........+..||+.|+|||.+.+
T Consensus 123 l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~ 200 (304)
T 3ubd_A 123 FTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200 (304)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhcc
Confidence 689999999999999999999999 999999999999999999999999999865544444556789999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----HHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ 156 (181)
..++.++|+||+||++|+|++|+.||.+.+..++..++... ....+..+|+++++|+.+||+.||.+||| +++
T Consensus 201 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~e 278 (304)
T 3ubd_A 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE 278 (304)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHH
T ss_pred CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHH
Confidence 99999999999999999999999999999988888777533 34567789999999999999999999998 578
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++|++.
T Consensus 279 il~--Hp~f~~ 287 (304)
T 3ubd_A 279 IKR--HSFFST 287 (304)
T ss_dssp HHT--SGGGTT
T ss_pred HHc--CccccC
Confidence 888 788765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=251.97 Aligned_cols=166 Identities=27% Similarity=0.404 Sum_probs=140.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCcccccccc-----ccCCCCCCCCCccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTF-----LSSKSAAGTPEWMA 75 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~~~ 75 (181)
+++.++..++.|++.||.|||+++ |+||||||+||+++.+| .+||+|||+++...... .......||+.|+|
T Consensus 147 l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmA 224 (336)
T 4g3f_A 147 LPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccC
Confidence 689999999999999999999999 99999999999999887 59999999997543321 12233579999999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-cCCCCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 76 PEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-LEIPRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 76 pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
||.+.+..++.++|+||+||++|+|++|+.||.+.+...+..++...... ...+..+++.+.++|.+||+.||.+|||+
T Consensus 225 PE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa 304 (336)
T 4g3f_A 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASA 304 (336)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCH
Confidence 99999999999999999999999999999999887766666665444332 35678899999999999999999999999
Q ss_pred HHHHHHHHHhhhCCC
Q 030203 155 STIMELLRPLIKSPT 169 (181)
Q Consensus 155 ~~~l~~L~~~~~~~~ 169 (181)
.|+++.|..+++...
T Consensus 305 ~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 305 MELRRKVGKALQEVG 319 (336)
T ss_dssp HHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhhhh
Confidence 999999988876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=250.15 Aligned_cols=164 Identities=35% Similarity=0.599 Sum_probs=145.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
|++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+|++|||+++...... .......+++.|+|||.+
T Consensus 125 l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~ 202 (299)
T 4asz_A 125 LTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 202 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHH
Confidence 688999999999999999999999 9999999999999999999999999997543321 222334578899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++||||+||++|||+| |+.||.+.+..++...+. .+...+.|..+++++.+|+.+||+.||.+|||++++.
T Consensus 203 ~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 203 MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999999998 899999999888888776 4445667888999999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+.+.+..
T Consensus 282 ~~L~~~~~~~ 291 (299)
T 4asz_A 282 TLLQNLAKAS 291 (299)
T ss_dssp HHHHHHHHHS
T ss_pred HHHHHHHhcC
Confidence 9999987754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=249.81 Aligned_cols=160 Identities=23% Similarity=0.467 Sum_probs=140.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
++|.++..++.||+.||.|||++| |+||||||+||+++.+|.+||+|||+++..... .....+..||+.|+|||.+
T Consensus 129 l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl 206 (311)
T 4aw0_A 129 FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHH
Confidence 689999999999999999999999 999999999999999999999999999865422 2233456899999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH--
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI-- 157 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~-- 157 (181)
.+..++.++|+||+||++|+|++|+.||.+.+...+..++.... ...+..+++++++||.+||..||.+|||++++
T Consensus 207 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 207 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 99889999999999999999999999999999888888775433 45677899999999999999999999999885
Q ss_pred ----HHHHHHhhhC
Q 030203 158 ----MELLRPLIKS 167 (181)
Q Consensus 158 ----l~~L~~~~~~ 167 (181)
++ |+||++
T Consensus 285 ~~~i~~--Hp~F~~ 296 (311)
T 4aw0_A 285 YGPLKA--HPFFES 296 (311)
T ss_dssp HHHHHT--SGGGTT
T ss_pred CHHHHC--CCCcCC
Confidence 44 577765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=248.53 Aligned_cols=162 Identities=31% Similarity=0.530 Sum_probs=144.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.|+.|||+++ ++||||||+||+++.++.+||+|||+++..... ........+++.|+|||.+
T Consensus 142 l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 219 (308)
T 4gt4_A 142 LEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI 219 (308)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHH
Confidence 678999999999999999999999 999999999999999999999999998754332 2223445788999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++||||||+++|||+| |..||.+.+..++...+. .+...+.+..+++.+.+|+.+||+.||.+|||+.+++
T Consensus 220 ~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~ 298 (308)
T 4gt4_A 220 MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 298 (308)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999999998 899999999988888876 4556677889999999999999999999999999999
Q ss_pred HHHHHhhh
Q 030203 159 ELLRPLIK 166 (181)
Q Consensus 159 ~~L~~~~~ 166 (181)
+.|+.+..
T Consensus 299 ~~L~a~~n 306 (308)
T 4gt4_A 299 SRLRAWGN 306 (308)
T ss_dssp HHHHTSCC
T ss_pred HHHHhccC
Confidence 99997743
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=245.28 Aligned_cols=165 Identities=32% Similarity=0.560 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.|+.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..... ........|++.|+|||.+
T Consensus 129 l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l 206 (307)
T 3omv_A 129 FQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHh
Confidence 678999999999999999999999 999999999999999999999999999754432 2223456799999999998
Q ss_pred CC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-c---cCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 80 RD---EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-R---LEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 80 ~~---~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
.+ ..++.++|||||||++|+|++|+.||.+.+............. . ...+..+++.+.+|+.+||+.||.+||
T Consensus 207 ~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RP 286 (307)
T 3omv_A 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP 286 (307)
T ss_dssp HCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred hccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCc
Confidence 64 3478899999999999999999999988765543333322222 2 235567899999999999999999999
Q ss_pred CHHHHHHHHHHhhhCC
Q 030203 153 SFSTIMELLRPLIKSP 168 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~ 168 (181)
|+.++++.|+.+....
T Consensus 287 s~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 287 LFPQILSSIELLQHSL 302 (307)
T ss_dssp CHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhccC
Confidence 9999999998765544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=245.12 Aligned_cols=161 Identities=32% Similarity=0.560 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.||+.||.|||+++++|+||||||+||+++. +|.+||+|||+++..... ...+..||+.|+|||.+.
T Consensus 126 l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~--~~~~~~GTp~YmAPE~~~ 203 (290)
T 3fpq_A 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--ccCCcccCccccCHHHcC
Confidence 67899999999999999999998766999999999999974 789999999999754332 234568999999999886
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+ .++.++|+||+||++|+|++|+.||.+.. ...+...+.........+..+++++++||.+||+.||.+|||++++++
T Consensus 204 ~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 204 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 5 58999999999999999999999997654 445555554333344556778899999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
++|+++
T Consensus 283 --Hp~~~~ 288 (290)
T 3fpq_A 283 --HAFFQE 288 (290)
T ss_dssp --SGGGC-
T ss_pred --CccccC
Confidence 899875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=252.47 Aligned_cols=165 Identities=33% Similarity=0.617 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.||+.|+.|||+++ ++||||||+||+++.++.+||+|||+++...... .......+++.|+|||.+
T Consensus 182 l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 259 (353)
T 4ase_A 182 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 259 (353)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH
Confidence 688999999999999999999999 9999999999999999999999999997543221 122344678899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|||||||++|||+| |+.||.+.+...........+.+...|..+++++.+++.+||+.||.+|||+.+++
T Consensus 260 ~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil 339 (353)
T 4ase_A 260 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 339 (353)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 99999999999999999999998 89999887654433333335666778888999999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+.+++..
T Consensus 340 ~~L~~llq~~ 349 (353)
T 4ase_A 340 EHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHh
Confidence 9999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=231.26 Aligned_cols=175 Identities=89% Similarity=1.436 Sum_probs=139.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++|++++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (309)
T 3p86_A 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213 (309)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcC
Confidence 67889999999999999999999766999999999999999999999999998765544334455678899999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+|+++|+|++|..||...+.......+.........+..+++.+.+++.+||+.||.+|||+.++++.|
T Consensus 214 ~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 88999999999999999999999999999988888777667777788889999999999999999999999999999999
Q ss_pred HHhhhCCCCCCCCCC
Q 030203 162 RPLIKSPTPQPSPTD 176 (181)
Q Consensus 162 ~~~~~~~~~~~~~~~ 176 (181)
+.+++...+++.+.+
T Consensus 294 ~~~~~~~~p~~~~~~ 308 (309)
T 3p86_A 294 RPLIKSAVPPPNRSD 308 (309)
T ss_dssp HHHHC----------
T ss_pred HHHHHhCCCCCCccc
Confidence 999998877766544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=237.07 Aligned_cols=164 Identities=22% Similarity=0.329 Sum_probs=136.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc----cccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~~~pe 77 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++.+|.+|++|||+++..... .....+..||+.|+|||
T Consensus 155 l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APE 232 (398)
T 4b99_A 155 LTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232 (398)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHH
Confidence 688999999999999999999999 999999999999999999999999999754332 12234568999999999
Q ss_pred ccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc-----------------------------C
Q 030203 78 VLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL-----------------------------E 127 (181)
Q Consensus 78 ~~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~ 127 (181)
.+.+.. ++.++|+||+||++|+|++|+.||.+.+..+....+....... .
T Consensus 233 v~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
T 4b99_A 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWET 312 (398)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHH
T ss_pred HhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHH
Confidence 987754 6889999999999999999999999988877666553211100 0
Q ss_pred CCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
....+++++.+||.+||..||.+|||+.++++ |+|++...
T Consensus 313 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~ 352 (398)
T 4b99_A 313 VYPGADRQALSLLGRMLRFEPSARISAAAALR--HPFLAKYH 352 (398)
T ss_dssp HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGTTTC
T ss_pred hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc--CHhhCcCC
Confidence 11357889999999999999999999999999 99998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=231.92 Aligned_cols=163 Identities=25% Similarity=0.361 Sum_probs=126.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC-CcEEEcccCCcccccccc-------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTF------------------- 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~-~~~~l~d~g~~~~~~~~~------------------- 61 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.+ +.+||+|||+++......
T Consensus 114 l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (361)
T 4f9c_A 114 LSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQN 191 (361)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccc
Confidence 578999999999999999999999 9999999999999876 899999999986432211
Q ss_pred ---------ccCCCCCCCCCccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc---------
Q 030203 62 ---------LSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGF--------- 121 (181)
Q Consensus 62 ---------~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~-~~~~~~~~~~~--------- 121 (181)
....+..||+.|+|||.+.+.. ++.++|+||+||++|+|++|+.||... +..+....+..
T Consensus 192 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~ 271 (361)
T 4f9c_A 192 KCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQ 271 (361)
T ss_dssp --------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred cccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchh
Confidence 1113357899999999987754 788999999999999999999999543 33332222110
Q ss_pred -------------------------------------------cCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 122 -------------------------------------------KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 122 -------------------------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.....+....+|+++.+|+.+||..||.+|+|++|++
T Consensus 272 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 272 AAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp HHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred hhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0000112346789999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+ |+|+++.
T Consensus 352 ~--Hp~f~~i 359 (361)
T 4f9c_A 352 L--HPFFKDM 359 (361)
T ss_dssp T--SGGGTTC
T ss_pred c--CcccCCC
Confidence 9 9999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=230.68 Aligned_cols=159 Identities=25% Similarity=0.419 Sum_probs=119.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc------------cCCCCCCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL------------SSKSAAGT 70 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~------------~~~~~~~~ 70 (181)
++..++.++.||+.||.|||++| ++||||||+||+++.+|.+||+|||+++....... ......||
T Consensus 116 ~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT 193 (299)
T 4g31_A 116 ERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193 (299)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CC
T ss_pred HHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccC
Confidence 34568899999999999999999 99999999999999999999999999875433211 11335799
Q ss_pred CCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCC
Q 030203 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPW 149 (181)
Q Consensus 71 ~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 149 (181)
+.|+|||.+.+..++.++|+||+||++|+|++ ||.+.... .....+. .....+.....++.+.+|+.+||+.||.
T Consensus 194 ~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~ 269 (299)
T 4g31_A 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPM 269 (299)
T ss_dssp CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGG
T ss_pred ccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999996 77653322 2222232 1111122234566788999999999999
Q ss_pred CCCCHHHHHHHHHHhhhCCC
Q 030203 150 KRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 150 ~Rps~~~~l~~L~~~~~~~~ 169 (181)
+|||+.++++ ++|+++..
T Consensus 270 ~Rps~~eil~--h~~~~~~~ 287 (299)
T 4g31_A 270 ERPEAINIIE--NAVFEDLD 287 (299)
T ss_dssp GSCCHHHHHT--SGGGCCC-
T ss_pred HCcCHHHHhc--CHhhCCCC
Confidence 9999999999 89998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=226.50 Aligned_cols=165 Identities=30% Similarity=0.443 Sum_probs=125.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC--------CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc----cCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR--------NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~--------~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~ 69 (181)
++++++++++.|++.||.|||++ + ++||||||+||+++.++.+||+|||+++....... ......|
T Consensus 97 l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~G 174 (303)
T 3hmm_A 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174 (303)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC--EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----C
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--EeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccc
Confidence 57889999999999999999987 7 99999999999999999999999999875443221 2234578
Q ss_pred CCCccCCcccCCC------CCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHhccCCccCC
Q 030203 70 TPEWMAPEVLRDE------PSNEKSDIYSFGVILWELATLQQPWGNL---------------NPAQVVAAVGFKGKRLEI 128 (181)
Q Consensus 70 ~~~~~~pe~~~~~------~~~~~~Dv~slG~~~~~ll~g~~p~~~~---------------~~~~~~~~~~~~~~~~~~ 128 (181)
++.|+|||.+.+. .++.++|||||||++|||++|..||... ....+...+.....+...
T Consensus 175 T~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~ 254 (303)
T 3hmm_A 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 254 (303)
T ss_dssp CGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred cccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCC
Confidence 9999999998754 2456899999999999999997655321 223333333323333344
Q ss_pred CCC-----CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 129 PRN-----VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 129 ~~~-----~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
+.. .++.+.+|+.+||+.||.+|||+.++++.|+.+.++.
T Consensus 255 p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 255 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 332 2346889999999999999999999999999987754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=239.74 Aligned_cols=158 Identities=25% Similarity=0.442 Sum_probs=134.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
|+|.++..++.||+.||.|||++| |+||||||+||+++.+|++||+|||+++..... ...+..||+.|+|||++.
T Consensus 289 l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~ 364 (689)
T 3v5w_A 289 FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQK 364 (689)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHST
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeecCCC--CCCCccCCcCccCHHHHhC
Confidence 689999999999999999999999 999999999999999999999999999765433 234568999999999986
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC----
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS---- 153 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---- 153 (181)
+..++.++|+||+||++|+|++|..||.+.+ ...+...+ .......+..+|+++++||.+||..||.+|++
T Consensus 365 ~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ 442 (689)
T 3v5w_A 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGR 442 (689)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSS
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCC
Confidence 4568999999999999999999999997642 33333333 23345567889999999999999999999997
Q ss_pred -HHHHHHHHHHhhhC
Q 030203 154 -FSTIMELLRPLIKS 167 (181)
Q Consensus 154 -~~~~l~~L~~~~~~ 167 (181)
+.++++ |+|++.
T Consensus 443 ga~ei~~--HpfF~~ 455 (689)
T 3v5w_A 443 GAQEVKE--SPFFRS 455 (689)
T ss_dssp THHHHTT--SGGGTT
T ss_pred CHHHHhc--CccccC
Confidence 799998 888764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=240.04 Aligned_cols=167 Identities=25% Similarity=0.360 Sum_probs=143.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC--CCcEEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
|++.++..++.||+.||.|||+++ ++||||||+||+++. .+.+||+|||+++...... ......|++.|+|||.+
T Consensus 252 l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-~~~~~~GT~~y~APEv~ 328 (573)
T 3uto_A 252 MSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVA 328 (573)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-EEEEECSSGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC-ceeeeEECccccCHHHh
Confidence 578899999999999999999999 999999999999975 4899999999997654322 22345789999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..++.++|+||+||++|+|++|..||.+.+.......+...... ......+++++++||.+||..||.+|||+.++
T Consensus 329 ~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~ 408 (573)
T 3uto_A 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408 (573)
T ss_dssp TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 9999999999999999999999999999999988888877544332 23346789999999999999999999999999
Q ss_pred HHHHHHhhhCCCCCCC
Q 030203 158 MELLRPLIKSPTPQPS 173 (181)
Q Consensus 158 l~~L~~~~~~~~~~~~ 173 (181)
++ |+|++....+..
T Consensus 409 l~--Hpw~~~~~~~~~ 422 (573)
T 3uto_A 409 LE--HPWLTPGNAPGR 422 (573)
T ss_dssp HH--STTTSCCCCTTT
T ss_pred hc--CcCcCCCCCCCc
Confidence 99 899986554433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=218.59 Aligned_cols=166 Identities=26% Similarity=0.479 Sum_probs=143.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 190 (297)
T 3fxz_A 113 MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190 (297)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcC
Confidence 578899999999999999999999 999999999999999999999999998765544444455678999999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|+++|+|++|..||...+.......+... ......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 191 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~- 269 (297)
T 3fxz_A 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ- 269 (297)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT-
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh-
Confidence 88999999999999999999999999988877655554333 2334456678999999999999999999999999999
Q ss_pred HHHhhhCCCCC
Q 030203 161 LRPLIKSPTPQ 171 (181)
Q Consensus 161 L~~~~~~~~~~ 171 (181)
++|++...+.
T Consensus 270 -h~~~~~~~~~ 279 (297)
T 3fxz_A 270 -HQFLKIAKPL 279 (297)
T ss_dssp -CGGGGGCCCG
T ss_pred -ChhhcccCcc
Confidence 8999876544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=218.57 Aligned_cols=159 Identities=28% Similarity=0.521 Sum_probs=139.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.+|.++|+|||+++.............+++.|+|||.+.+
T Consensus 102 ~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 102 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcC
Confidence 678899999999999999999999 999999999999999999999999998754433333445678899999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+|+++|+|++|..||.+.+.......+... ....+..+++++.++|.+||..||.+|| ++.+
T Consensus 180 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~e 257 (337)
T 1o6l_A 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHH
Confidence 88999999999999999999999999998888777766433 3446678999999999999999999999 8999
Q ss_pred HHHHHHHhhh
Q 030203 157 IMELLRPLIK 166 (181)
Q Consensus 157 ~l~~L~~~~~ 166 (181)
+++ +++++
T Consensus 258 i~~--h~~f~ 265 (337)
T 1o6l_A 258 VME--HRFFL 265 (337)
T ss_dssp HHT--SGGGT
T ss_pred HHc--CCCcC
Confidence 998 77764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=213.94 Aligned_cols=161 Identities=26% Similarity=0.402 Sum_probs=137.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 134 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 211 (298)
T 2zv2_A 134 LSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSE 211 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhcc
Confidence 578999999999999999999999 999999999999999999999999998765443333344578899999999876
Q ss_pred CC---CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 82 EP---SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 82 ~~---~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.. .+.++|+||+|+++|+|++|..||...........+.......+....+++.+.+++.+||+.||.+|||+.+++
T Consensus 212 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 212 TRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp TCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 55 267899999999999999999999998877776666544444444567899999999999999999999999999
Q ss_pred HHHHHhhh
Q 030203 159 ELLRPLIK 166 (181)
Q Consensus 159 ~~L~~~~~ 166 (181)
+ ++|++
T Consensus 292 ~--hp~~~ 297 (298)
T 2zv2_A 292 L--HPWVT 297 (298)
T ss_dssp T--CHHHH
T ss_pred c--Ccccc
Confidence 8 77764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=222.26 Aligned_cols=160 Identities=25% Similarity=0.451 Sum_probs=136.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++||||+|+||+++.+|.++|+|||+++.............+++.|+|||.+.+
T Consensus 121 ~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 198 (353)
T 3txo_A 121 FDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCC
Confidence 678899999999999999999999 999999999999999999999999998754444334455678999999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH------H
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF------S 155 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~ 155 (181)
..++.++|+||+|+++|+|++|..||.+.+...+...+... ....+..+++.+.+++.+||..||.+||++ .
T Consensus 199 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~ 276 (353)
T 3txo_A 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEH 276 (353)
T ss_dssp HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTH
T ss_pred CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHH
Confidence 88899999999999999999999999999988888777533 344567799999999999999999999998 8
Q ss_pred HHHHHHHHhhhC
Q 030203 156 TIMELLRPLIKS 167 (181)
Q Consensus 156 ~~l~~L~~~~~~ 167 (181)
++++ ++|++.
T Consensus 277 ~il~--hp~f~~ 286 (353)
T 3txo_A 277 AILR--HPFFKE 286 (353)
T ss_dssp HHHT--SGGGTT
T ss_pred HHhh--CCcccC
Confidence 8888 777764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=218.80 Aligned_cols=163 Identities=30% Similarity=0.606 Sum_probs=140.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 200 ~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 277 (370)
T 2psq_A 200 MTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 277 (370)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh
Confidence 577889999999999999999999 9999999999999999999999999987543321 122334556789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||||+++|+|++ |..||.+.........+. .......+..+++.+.+++.+||+.||.+||++.+++
T Consensus 278 ~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 356 (370)
T 2psq_A 278 FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356 (370)
T ss_dssp HTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88889999999999999999998 999999988777766664 4445566778999999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+++.
T Consensus 357 ~~L~~il~~ 365 (370)
T 2psq_A 357 EDLDRILTL 365 (370)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=213.87 Aligned_cols=166 Identities=26% Similarity=0.343 Sum_probs=134.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 116 ~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 116 LQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcC
Confidence 678899999999999999999999 999999999999999999999999998765544444455677899999999876
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCc---------------------------cCCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF-KGKR---------------------------LEIPRNV 132 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~ 132 (181)
..++.++|+||+|+++|+|++|+.||.+.........+.. .... ......+
T Consensus 194 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (311)
T 3niz_A 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGF 273 (311)
T ss_dssp CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTC
T ss_pred CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCccc
Confidence 4578999999999999999999999987765544433311 0000 0012346
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
++++.+|+.+||..||.+|||++++++ ++|+++..++
T Consensus 274 ~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~~ 310 (311)
T 3niz_A 274 CQEGIDLLSNMLCFDPNKRISARDAMN--HPYFKDLDPQ 310 (311)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTSCTT
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhc--CcccccCCcc
Confidence 789999999999999999999999999 9999986553
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=215.21 Aligned_cols=160 Identities=26% Similarity=0.456 Sum_probs=139.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++++|||++....... ......+++.|+|||.+.+
T Consensus 111 l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 111 MKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-GGGTTSSSGGGCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-ccccccCCcceeCcccccC
Confidence 578899999999999999999999 9999999999999999999999999987544332 2234578899999999988
Q ss_pred CCCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSN-EKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~-~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..+. .++|+||+|+++|+|++|+.||.+.+.......+... ....+..+++++.+++.+||..||.+|||+.++++
T Consensus 188 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~- 264 (328)
T 3fe3_A 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK- 264 (328)
T ss_dssp CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT-
T ss_pred CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc-
Confidence 7764 6899999999999999999999999988887777433 34456778999999999999999999999999999
Q ss_pred HHHhhhCC
Q 030203 161 LRPLIKSP 168 (181)
Q Consensus 161 L~~~~~~~ 168 (181)
++|++..
T Consensus 265 -h~~~~~~ 271 (328)
T 3fe3_A 265 -DRWINAG 271 (328)
T ss_dssp -CTTTTTT
T ss_pred -CHhhcCC
Confidence 8888754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=217.38 Aligned_cols=159 Identities=25% Similarity=0.480 Sum_probs=139.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+|.++|+|||++..............|++.|+|||.+.+
T Consensus 118 ~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (353)
T 2i0e_A 118 FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 195 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcC
Confidence 578899999999999999999999 999999999999999999999999998754433334455678999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----HHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ 156 (181)
..++.++|+||||+++|+|++|+.||.+.+...+...+... ....+..+++++.+++.+||..||.+||+ +++
T Consensus 196 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 273 (353)
T 2i0e_A 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273 (353)
T ss_dssp CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHH
T ss_pred CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH
Confidence 88999999999999999999999999999888887777533 34456789999999999999999999994 688
Q ss_pred HHHHHHHhhh
Q 030203 157 IMELLRPLIK 166 (181)
Q Consensus 157 ~l~~L~~~~~ 166 (181)
+++ +++++
T Consensus 274 i~~--h~~f~ 281 (353)
T 2i0e_A 274 IKE--HAFFR 281 (353)
T ss_dssp HHT--SGGGT
T ss_pred Hhc--Ccccc
Confidence 887 67765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=220.95 Aligned_cols=162 Identities=26% Similarity=0.383 Sum_probs=140.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc---CCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++ .++.++|+|||++..............+++.|+|||.
T Consensus 107 ~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~ 184 (444)
T 3soa_A 107 YSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184 (444)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHH
Confidence 678999999999999999999999 99999999999998 4678999999999765554444455678999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+..++.++|+||+|+++|+|++|..||.+.+.......+........ ....+++++.+++.+||+.||.+|||+.+
T Consensus 185 l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 264 (444)
T 3soa_A 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAE 264 (444)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9888899999999999999999999999999988888877765444332 33578999999999999999999999999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++|++.
T Consensus 265 ~L~--hp~~~~ 273 (444)
T 3soa_A 265 ALK--HPWISH 273 (444)
T ss_dssp HHH--SCTTHH
T ss_pred Hhc--CccccC
Confidence 999 777753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=215.46 Aligned_cols=169 Identities=33% Similarity=0.584 Sum_probs=141.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.
T Consensus 148 ~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~ 225 (325)
T 3kul_A 148 FTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhH
Confidence 578899999999999999999999 99999999999999999999999999875443211 1222344667999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||+|+++|+|++ |..||...........+. .......+..+++.+.+++.+||..||.+|||+.++
T Consensus 226 ~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ei 304 (325)
T 3kul_A 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQI 304 (325)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence 988888999999999999999998 999999998888877775 445556677899999999999999999999999999
Q ss_pred HHHHHHhhhCCCCCCC
Q 030203 158 MELLRPLIKSPTPQPS 173 (181)
Q Consensus 158 l~~L~~~~~~~~~~~~ 173 (181)
++.|+.+++.......
T Consensus 305 l~~L~~l~~~~~~~~~ 320 (325)
T 3kul_A 305 VSVLDALIRSPESLRA 320 (325)
T ss_dssp HHHHHHHHHSCC----
T ss_pred HHHHHHHHhCcccccc
Confidence 9999999998766543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=217.81 Aligned_cols=168 Identities=32% Similarity=0.607 Sum_probs=145.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 188 l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 265 (382)
T 3tt0_A 188 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 265 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh
Confidence 688999999999999999999999 9999999999999999999999999987544322 122334556789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++++|++ |..||.+.........+. .......+..+++++.+++.+||+.||.+|||+++++
T Consensus 266 ~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 266 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp HSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88889999999999999999999 999999998888777765 4445566778999999999999999999999999999
Q ss_pred HHHHHhhhCCCCCC
Q 030203 159 ELLRPLIKSPTPQP 172 (181)
Q Consensus 159 ~~L~~~~~~~~~~~ 172 (181)
+.|+.++.....+.
T Consensus 345 ~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 345 EDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHHHHHHSCSCC
T ss_pred HHHHHHHHHHhcCC
Confidence 99999987665544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=210.10 Aligned_cols=165 Identities=23% Similarity=0.350 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+
T Consensus 98 l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 98 LDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcC
Confidence 578899999999999999999999 999999999999999999999999998765544444455677889999999877
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhccCC---------------------------ccCCCCCC
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQP-WGNLNPAQVVAAVGFKGK---------------------------RLEIPRNV 132 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p-~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 132 (181)
.. ++.++|+||+|+++++|++|..| |.+.+.......+..... .......+
T Consensus 176 ~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (292)
T 3o0g_A 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255 (292)
T ss_dssp CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTC
T ss_pred CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhccccc
Confidence 65 78999999999999999988776 566555554444321100 01122357
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
++.+++++.+||+.||.+|||++++++ ++|+++-.+
T Consensus 256 ~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~p 291 (292)
T 3o0g_A 256 NATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCP 291 (292)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTC--
T ss_pred ChHHHHHHHHHhccChhhCCCHHHHhc--CcccccCCC
Confidence 889999999999999999999999999 999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=214.95 Aligned_cols=169 Identities=31% Similarity=0.528 Sum_probs=135.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+....... .......+++.|++||.+
T Consensus 134 ~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 211 (323)
T 3qup_A 134 LPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL 211 (323)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhh
Confidence 678899999999999999999999 9999999999999999999999999987543322 122233456789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+.........+. .......+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 212 ~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 290 (323)
T 3qup_A 212 ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR 290 (323)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88888999999999999999999 999999988777766664 4445566778999999999999999999999999999
Q ss_pred HHHHHhhhCCCCCCC
Q 030203 159 ELLRPLIKSPTPQPS 173 (181)
Q Consensus 159 ~~L~~~~~~~~~~~~ 173 (181)
+.|+++++.....++
T Consensus 291 ~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 291 MELENILGHLSVLST 305 (323)
T ss_dssp HHHHHHHHC------
T ss_pred HHHHHHHHHhhhcCC
Confidence 999999887665543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=219.11 Aligned_cols=160 Identities=29% Similarity=0.506 Sum_probs=139.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.+|.++|+|||+++.............+++.|+|||.+.+
T Consensus 115 ~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (345)
T 1xjd_A 115 FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 192 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC
Confidence 578899999999999999999999 999999999999999999999999998754433333455678999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH-HHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~~ 160 (181)
..++.++|+||+|+++|+|++|..||.+.+...+...+... ....+..+++++.+++.+||..||.+||++. ++++
T Consensus 193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~- 269 (345)
T 1xjd_A 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ- 269 (345)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG-
T ss_pred CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc-
Confidence 88999999999999999999999999999888877777533 3445677999999999999999999999997 7877
Q ss_pred HHHhhhC
Q 030203 161 LRPLIKS 167 (181)
Q Consensus 161 L~~~~~~ 167 (181)
+++++.
T Consensus 270 -hp~f~~ 275 (345)
T 1xjd_A 270 -HPLFRE 275 (345)
T ss_dssp -SGGGTT
T ss_pred -CccccC
Confidence 666654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=209.22 Aligned_cols=170 Identities=31% Similarity=0.592 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.
T Consensus 106 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 183 (279)
T 1qpc_A 106 LTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhc
Confidence 578899999999999999999999 9999999999999999999999999987544322 2223345567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++++|++ |..||.+.........+. .......+..+++.+.+++.+|++.||.+|||+.++++
T Consensus 184 ~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 7778899999999999999999 999999988887777665 33445556788999999999999999999999999999
Q ss_pred HHHHhhhCCCCCCCC
Q 030203 160 LLRPLIKSPTPQPSP 174 (181)
Q Consensus 160 ~L~~~~~~~~~~~~~ 174 (181)
.|++++.....+..|
T Consensus 263 ~l~~~~~~~~~~~~~ 277 (279)
T 1qpc_A 263 VLEDFFTATEGQYQP 277 (279)
T ss_dssp HHHHHHHHC------
T ss_pred HHHHHHHhccCCCCC
Confidence 999999877666544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=222.41 Aligned_cols=171 Identities=34% Similarity=0.578 Sum_probs=144.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 277 ~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 354 (452)
T 1fmk_A 277 LRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354 (452)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHh
Confidence 578899999999999999999999 9999999999999999999999999987544321 1222334567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||||+++|+|++ |..||.+....+....+. ...+.+.+..+++.+.+++.+||+.||.+|||++++++
T Consensus 355 ~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8889999999999999999999 999999998888777765 44556667889999999999999999999999999999
Q ss_pred HHHHhhhCCCCCCCCC
Q 030203 160 LLRPLIKSPTPQPSPT 175 (181)
Q Consensus 160 ~L~~~~~~~~~~~~~~ 175 (181)
.|++++....++..|.
T Consensus 434 ~L~~~~~~~~~~~~~~ 449 (452)
T 1fmk_A 434 FLEDYFTSTEPQYQPG 449 (452)
T ss_dssp HHHTTTSCSCCCCCCS
T ss_pred HHHHHhccCCcccccc
Confidence 9999999888877654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=212.18 Aligned_cols=164 Identities=26% Similarity=0.489 Sum_probs=140.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+.| ++|+||+|+||+++.++.++++|||++..............+++.|+|||.+.+
T Consensus 138 l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2c30_A 138 LNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 215 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC
Confidence 578899999999999999999999 999999999999999999999999998765443333445678899999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|+++|+|++|..||...........+..... .......+++.+.+++.+||+.||.+|||+.++++
T Consensus 216 ~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~- 294 (321)
T 2c30_A 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD- 294 (321)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT-
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc-
Confidence 8889999999999999999999999998888776666543322 22234468899999999999999999999999999
Q ss_pred HHHhhhCCC
Q 030203 161 LRPLIKSPT 169 (181)
Q Consensus 161 L~~~~~~~~ 169 (181)
++|+....
T Consensus 295 -hp~~~~~~ 302 (321)
T 2c30_A 295 -HPFLLQTG 302 (321)
T ss_dssp -SGGGGGCC
T ss_pred -ChhhccCC
Confidence 88887644
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=210.71 Aligned_cols=168 Identities=16% Similarity=0.276 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc-----EEEcccCCccccccccc-------cCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSRLKANTFL-------SSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~-----~~l~d~g~~~~~~~~~~-------~~~~~~~ 69 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++. ++|+|||.+........ ......+
T Consensus 103 ~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~g 180 (298)
T 1csn_A 103 FSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCC
Confidence 678899999999999999999999 999999999999987765 99999999875443221 2234568
Q ss_pred CCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcc---CCccCCCCCCCHHHHHHHHHH
Q 030203 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN---PAQVVAAVGFK---GKRLEIPRNVNPHVASIIEAC 143 (181)
Q Consensus 70 ~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~ 143 (181)
++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.. .......+... .........+++.+.+++.+|
T Consensus 181 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (298)
T 1csn_A 181 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYA 260 (298)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred CcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHH
Confidence 899999999988889999999999999999999999998743 33333332211 112223457899999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
|+.||.+||+++++++.|+++++.....
T Consensus 261 l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 261 RNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999998865443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=221.64 Aligned_cols=160 Identities=28% Similarity=0.523 Sum_probs=139.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.|++.||.|||+ .| ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.
T Consensus 245 ~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 322 (446)
T 4ejn_A 245 FSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322 (446)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcC
Confidence 6788999999999999999998 89 99999999999999999999999999876444433445567899999999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFS 155 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ 155 (181)
+..++.++|+||+|+++|+|++|+.||.+.+.......+... ....+..+++++.++|.+||+.||.+|| +++
T Consensus 323 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ 400 (446)
T 4ejn_A 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 400 (446)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHH
T ss_pred CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHH
Confidence 888999999999999999999999999999888877776433 3445677999999999999999999999 999
Q ss_pred HHHHHHHHhhhC
Q 030203 156 TIMELLRPLIKS 167 (181)
Q Consensus 156 ~~l~~L~~~~~~ 167 (181)
++++ +++++.
T Consensus 401 ell~--hp~f~~ 410 (446)
T 4ejn_A 401 EIMQ--HRFFAG 410 (446)
T ss_dssp HHHT--SGGGTT
T ss_pred HHHh--CccccC
Confidence 9998 777765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=213.80 Aligned_cols=163 Identities=31% Similarity=0.523 Sum_probs=138.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||+++....... ......++..|+|||.+
T Consensus 112 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 189 (325)
T 3kex_A 112 LGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189 (325)
T ss_dssp SCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHh
Confidence 567789999999999999999999 99999999999999999999999999876443221 22334566789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||.+.........+. .......+..+++.+.+++.+||..||.+||++.+++
T Consensus 190 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~ 268 (325)
T 3kex_A 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELA 268 (325)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHH
T ss_pred ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88889999999999999999999 999999888777666664 4445556777899999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+.+.
T Consensus 269 ~~l~~~~~~ 277 (325)
T 3kex_A 269 NEFTRMARD 277 (325)
T ss_dssp HHHHHHTTS
T ss_pred HHHHHHHhc
Confidence 999988754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=213.61 Aligned_cols=167 Identities=21% Similarity=0.229 Sum_probs=137.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 109 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 186 (346)
T 1ua2_A 109 LTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 186 (346)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhC
Confidence 567789999999999999999999 999999999999999999999999998765544444455678899999999876
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--c------------------------CCCCCCCH
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--L------------------------EIPRNVNP 134 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~------------------------~~~~~~~~ 134 (181)
. .++.++|+||+|+++|+|++|..||.+....+....+...... . .....+++
T Consensus 187 ~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (346)
T 1ua2_A 187 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 266 (346)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCH
T ss_pred CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCH
Confidence 4 4788999999999999999999999998876655544221100 0 01145678
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCC
Q 030203 135 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172 (181)
Q Consensus 135 ~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~ 172 (181)
.+.+++.+||..||.+|||+.++++ ++|++..+.+.
T Consensus 267 ~~~~li~~~L~~dP~~Rpt~~ell~--h~~f~~~~~~~ 302 (346)
T 1ua2_A 267 DLLDLIQGLFLFNPCARITATQALK--MKYFSNRPGPT 302 (346)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTSSSCCC
T ss_pred HHHHHHHHHhccChhhCCCHHHHhc--ChhhhcCCCCC
Confidence 9999999999999999999999999 99998765544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=216.98 Aligned_cols=160 Identities=26% Similarity=0.505 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++.+|.++|+|||+++.............+++.|+|||.+.+
T Consensus 150 l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~ 227 (396)
T 4dc2_A 150 LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227 (396)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcC
Confidence 678899999999999999999999 999999999999999999999999998764444444556688999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLN---------PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
..++.++|+||+|+++|+|++|+.||.... ...+...+ .......+..+++++.++|.+||+.||.+||
T Consensus 228 ~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~ 305 (396)
T 4dc2_A 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAASVLKSFLNKDPKERL 305 (396)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSCTTTST
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCCCcCCHHHHHHHHHHhcCCHhHcC
Confidence 889999999999999999999999996432 22233333 2334556778999999999999999999999
Q ss_pred CH------HHHHHHHHHhhhC
Q 030203 153 SF------STIMELLRPLIKS 167 (181)
Q Consensus 153 s~------~~~l~~L~~~~~~ 167 (181)
++ .++++ ++|++.
T Consensus 306 ~~~~~~~~~ei~~--Hpff~~ 324 (396)
T 4dc2_A 306 GCHPQTGFADIQG--HPFFRN 324 (396)
T ss_dssp TCSTTTHHHHHHH--STTTTT
T ss_pred CCCCCCCHHHHhc--CccccC
Confidence 84 78887 788764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=211.00 Aligned_cols=163 Identities=24% Similarity=0.300 Sum_probs=134.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.+
T Consensus 117 ~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 117 LPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc-ccCCccccccccCchHHcC
Confidence 688999999999999999999999 9999999999999999999999999987544322 2234567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc-------------------------CCCCCCCHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL-------------------------EIPRNVNPHV 136 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~ 136 (181)
..++.++|+||+|+++|+|++|..||.+.........+....... .....+++.+
T Consensus 194 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (308)
T 3g33_A 194 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESG 273 (308)
T ss_dssp SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHH
T ss_pred CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHH
Confidence 889999999999999999999999999988776665542211000 0123578899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 137 ASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 137 ~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.+++.+||+.||.+|||+.++++ ++|++...
T Consensus 274 ~~li~~~L~~dP~~R~t~~e~l~--h~~~~~~~ 304 (308)
T 3g33_A 274 AQLLLEMLTFNPHKRISAFRALQ--HSYLHKDE 304 (308)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHT--STTC----
T ss_pred HHHHHHHhcCCCccCCCHHHHhc--CccccCCC
Confidence 99999999999999999999999 89988644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=218.08 Aligned_cols=164 Identities=34% Similarity=0.641 Sum_probs=138.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...... ........+++.|+|||.+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 267 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhh
Confidence 788999999999999999999999 999999999999999999999999998754322 1122334567789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+...................+..+++++.+++.+||+.||.+|||+.+++
T Consensus 268 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 347 (359)
T 3vhe_A 268 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 347 (359)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 88888999999999999999998 99999887654444333335556667788999999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+++.
T Consensus 348 ~~L~~~~~~ 356 (359)
T 3vhe_A 348 EHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=212.17 Aligned_cols=160 Identities=26% Similarity=0.501 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+|.++|+|||+++.............+++.|+|||.+.+
T Consensus 107 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 184 (345)
T 3a8x_A 107 LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCC
Confidence 578899999999999999999999 999999999999999999999999998754433334455678999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNL---------NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
..++.++|+||+|+++|+|++|..||... ....+...+. ......+..+++.+.+++.+||..||.+||
T Consensus 185 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~ 262 (345)
T 3a8x_A 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPRSLSVKAASVLKSFLNKDPKERL 262 (345)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhcCCHhHCC
Confidence 88999999999999999999999999752 2233333332 223456778999999999999999999999
Q ss_pred CH------HHHHHHHHHhhhC
Q 030203 153 SF------STIMELLRPLIKS 167 (181)
Q Consensus 153 s~------~~~l~~L~~~~~~ 167 (181)
++ .++++ +++++.
T Consensus 263 ~~~~~~~~~~i~~--hp~f~~ 281 (345)
T 3a8x_A 263 GCHPQTGFADIQG--HPFFRN 281 (345)
T ss_dssp TCCTTTHHHHHHT--SGGGTT
T ss_pred CCCCcCCHHHHhc--CCccCC
Confidence 85 78887 788764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=221.60 Aligned_cols=168 Identities=30% Similarity=0.573 Sum_probs=145.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++...... .......++..|+|||.+.
T Consensus 281 ~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 358 (454)
T 1qcf_A 281 QPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358 (454)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhc
Confidence 467788999999999999999999 9999999999999999999999999987644322 1223334567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||||+++|+|++ |+.||.+....+....+. ...+.+.+..+++.+.+++.+||+.||.+|||++++++
T Consensus 359 ~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 8889999999999999999999 999999998888777765 44455667789999999999999999999999999999
Q ss_pred HHHHhhhCCCCCC
Q 030203 160 LLRPLIKSPTPQP 172 (181)
Q Consensus 160 ~L~~~~~~~~~~~ 172 (181)
.|++++.....+.
T Consensus 438 ~L~~~~~~~~~~~ 450 (454)
T 1qcf_A 438 VLDDFYTATESQY 450 (454)
T ss_dssp HHHTSSSSSCCSS
T ss_pred HHHHHHhcccccc
Confidence 9999998766654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=211.49 Aligned_cols=160 Identities=21% Similarity=0.384 Sum_probs=134.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 118 ~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (327)
T 3a62_A 118 FMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR 195 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC
Confidence 578899999999999999999999 999999999999999999999999998754433333345578899999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+|+++|+|++|..||.+.+.......+... ....+..+++.+.+++.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e 273 (327)
T 3a62_A 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGE 273 (327)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHH
T ss_pred CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHH
Confidence 88899999999999999999999999998887777666432 3455678999999999999999999999 8889
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ +++++.
T Consensus 274 ~l~--hp~f~~ 282 (327)
T 3a62_A 274 VQA--HPFFRH 282 (327)
T ss_dssp HHH--SGGGSS
T ss_pred HHc--CCcccC
Confidence 998 788764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=213.77 Aligned_cols=163 Identities=31% Similarity=0.572 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ......+++.|++||.+
T Consensus 114 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3lzb_A 114 IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHH
Confidence 578899999999999999999999 99999999999999999999999999875433221 12233456689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+.........+. .......+..+++++.+++.+||+.||.+||++.+++
T Consensus 192 ~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 270 (327)
T 3lzb_A 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 270 (327)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 88889999999999999999999 999999988877776665 4445566778999999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+.+.
T Consensus 271 ~~L~~~~~~ 279 (327)
T 3lzb_A 271 IEFSKMARD 279 (327)
T ss_dssp HHHHHHHTS
T ss_pred HHHHHHHhC
Confidence 999988754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=216.60 Aligned_cols=168 Identities=17% Similarity=0.285 Sum_probs=134.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc--CCCcEEEcccCCccccccccc-------cCCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD--KKYTVKVCDFGLSRLKANTFL-------SSKSAAGTPE 72 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~--~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~ 72 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||+++....... ......+++.
T Consensus 149 l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~ 226 (364)
T 3op5_A 149 FSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIE 226 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCC
Confidence 678999999999999999999999 99999999999998 889999999999875433211 1123458899
Q ss_pred ccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcc--CCcc------CCCCCCCHHHHHHHHHH
Q 030203 73 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFK--GKRL------EIPRNVNPHVASIIEAC 143 (181)
Q Consensus 73 ~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~-~~~~~~~~~~--~~~~------~~~~~~~~~~~~li~~~ 143 (181)
|+|||.+.+..++.++|+||||+++|+|++|+.||.+... .......... .... -....+++++.+++..|
T Consensus 227 y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 306 (364)
T 3op5_A 227 FTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETV 306 (364)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHH
T ss_pred ccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHH
Confidence 9999999988899999999999999999999999985322 1111111000 0000 01256789999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
+..||.+||++.++++.|+++++....+
T Consensus 307 l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 307 KLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999998865444
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=214.48 Aligned_cols=163 Identities=31% Similarity=0.567 Sum_probs=138.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++....... ......++..|+|||.+
T Consensus 114 ~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3poz_A 114 IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHh
Confidence 578899999999999999999999 99999999999999999999999999875433221 12233456789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||.+.........+. .......+..++..+.+++.+||+.||.+||++.+++
T Consensus 192 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 270 (327)
T 3poz_A 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270 (327)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred ccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 98889999999999999999999 999999988777666664 4445556778899999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+.+.
T Consensus 271 ~~l~~~~~~ 279 (327)
T 3poz_A 271 IEFSKMARD 279 (327)
T ss_dssp HHHHHHHTS
T ss_pred HHHHHHHhh
Confidence 999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=206.47 Aligned_cols=163 Identities=35% Similarity=0.639 Sum_probs=141.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (269)
T 4hcu_A 103 FAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 180 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhc
Confidence 678899999999999999999999 9999999999999999999999999987544332 2223345567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++++|++ |..||...........+. .......+..+++.+.+++.+||+.||.+||++.++++
T Consensus 181 ~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 259 (269)
T 4hcu_A 181 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 259 (269)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8888999999999999999999 999999998888777775 44455567778999999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
.|+.+.+.
T Consensus 260 ~l~~l~~~ 267 (269)
T 4hcu_A 260 QLAEIAES 267 (269)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHHc
Confidence 99998765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=208.80 Aligned_cols=162 Identities=22% Similarity=0.332 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 97 LESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeC
Confidence 578899999999999999999999 999999999999999999999999998754433333344567889999999876
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCc--------------------------cCCCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKR--------------------------LEIPRNVN 133 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~ 133 (181)
. .++.++|+||+|+++|+|++|..||.+.........+... ... ......++
T Consensus 175 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (288)
T 1ob3_A 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254 (288)
T ss_dssp CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcC
Confidence 4 4789999999999999999999999988776555443211 000 01123578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
+.+.+++.+||+.||.+|||+.++++ ++|+++
T Consensus 255 ~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~ 286 (288)
T 1ob3_A 255 ESGIDLLSKMLKLDPNQRITAKQALE--HAYFKE 286 (288)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGGC
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhc--Ccchhh
Confidence 89999999999999999999999999 888875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=207.35 Aligned_cols=163 Identities=25% Similarity=0.497 Sum_probs=138.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++...... ......+++.|+|||.+.+
T Consensus 106 ~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 106 FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCcc--cccccCCCCCccCHhHhcc
Confidence 578899999999999999999999 999999999999999999999999987543332 2234567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+|+++++|++|..||...........+.. .....+..+++.+.+++.+||+.||.+|||++++++
T Consensus 182 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~-- 257 (279)
T 3fdn_A 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE-- 257 (279)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH--
T ss_pred CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh--
Confidence 8889999999999999999999999999888777766643 334456778999999999999999999999999999
Q ss_pred HHhhhCCCCCC
Q 030203 162 RPLIKSPTPQP 172 (181)
Q Consensus 162 ~~~~~~~~~~~ 172 (181)
++|++.....+
T Consensus 258 h~~~~~~~~~~ 268 (279)
T 3fdn_A 258 HPWITANSSKP 268 (279)
T ss_dssp CHHHHHHCSSC
T ss_pred CccccCCccCc
Confidence 89988655544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=209.13 Aligned_cols=163 Identities=31% Similarity=0.622 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (281)
T 1mp8_A 113 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190 (281)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcc
Confidence 578899999999999999999999 99999999999999999999999999875443221 122334567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|++++ |..||.+....+....+. .......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 191 ~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8888999999999999999996 999999888777666664 33445567789999999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
.|+.+++.
T Consensus 270 ~l~~~~~~ 277 (281)
T 1mp8_A 270 QLSTILEE 277 (281)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=229.17 Aligned_cols=160 Identities=24% Similarity=0.480 Sum_probs=141.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.||+.||.|||+++ ++||||||+||+++.+|.++|+|||+++.............|++.|+|||.+.+
T Consensus 439 ~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~ 516 (674)
T 3pfq_A 439 FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516 (674)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC
Confidence 678899999999999999999999 999999999999999999999999998754443344556688999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH-----HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF-----ST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~ 156 (181)
..++.++|+||||+++|+|++|+.||.+.+...+...+.. .....+..+++++.+||.+||..||.+||++ ++
T Consensus 517 ~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~e 594 (674)
T 3pfq_A 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 594 (674)
T ss_dssp CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHH
T ss_pred CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHH
Confidence 8899999999999999999999999999998888887743 3455677899999999999999999999987 88
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ +++++.
T Consensus 595 i~~--h~ff~~ 603 (674)
T 3pfq_A 595 IKE--HAFFRY 603 (674)
T ss_dssp HHS--SGGGSS
T ss_pred Hhc--CccccC
Confidence 887 677653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=213.59 Aligned_cols=165 Identities=33% Similarity=0.577 Sum_probs=139.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 171 l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 171 LSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 248 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh
Confidence 577899999999999999999999 9999999999999999999999999986543221 122334567789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+.........+. .......+..+++.+.+++.+||+.||.+||++.+++
T Consensus 249 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~ 327 (343)
T 1luf_A 249 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 327 (343)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 88888999999999999999998 999999988888777665 3444556778999999999999999999999999999
Q ss_pred HHHHHhhhCCC
Q 030203 159 ELLRPLIKSPT 169 (181)
Q Consensus 159 ~~L~~~~~~~~ 169 (181)
+.|+.+.+...
T Consensus 328 ~~L~~~~~~~~ 338 (343)
T 1luf_A 328 RILQRMCERAE 338 (343)
T ss_dssp HHHHHTTC---
T ss_pred HHHHHHHhhhh
Confidence 99999877543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=205.95 Aligned_cols=163 Identities=34% Similarity=0.653 Sum_probs=139.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.
T Consensus 101 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 178 (268)
T 3sxs_A 101 LEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178 (268)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHh
Confidence 578899999999999999999999 9999999999999999999999999987543322 2223344566799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|++++++++ |..||...........+. .......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 179 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8788899999999999999998 999999988887777665 44445556778999999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
.|+.+.+.
T Consensus 258 ~L~~l~~~ 265 (268)
T 3sxs_A 258 SIEPLREK 265 (268)
T ss_dssp HHGGGCC-
T ss_pred HHHHhhhc
Confidence 99988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=210.61 Aligned_cols=163 Identities=33% Similarity=0.605 Sum_probs=140.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 147 ~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 224 (314)
T 2ivs_A 147 LTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL 224 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh
Confidence 578899999999999999999999 9999999999999999999999999987543321 122334556789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+.........+. .......+..+++.+.+++.+||+.||.+||++.+++
T Consensus 225 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~ 303 (314)
T 2ivs_A 225 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303 (314)
T ss_dssp HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88778899999999999999999 999999888777666664 4445566778999999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.++..
T Consensus 304 ~~l~~~~~~ 312 (314)
T 2ivs_A 304 KDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHhh
Confidence 999998875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=215.01 Aligned_cols=159 Identities=28% Similarity=0.445 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++||||+|+||+++.+|+++|+|||+++.............+++.|+|||.+.+
T Consensus 136 ~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 136 FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCC
Confidence 578899999999999999999999 999999999999999999999999998764443334455678999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH----HH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS----TI 157 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~----~~ 157 (181)
..++.++|+||||+++|+|++|..||.+.+...+...+... ....+..+++.+++++.+||..||.+||++. ++
T Consensus 214 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 88999999999999999999999999999888877776433 3445677999999999999999999999874 55
Q ss_pred HHHHHHhhh
Q 030203 158 MELLRPLIK 166 (181)
Q Consensus 158 l~~L~~~~~ 166 (181)
++ +.+++
T Consensus 292 ~~--h~~f~ 298 (373)
T 2r5t_A 292 KS--HVFFS 298 (373)
T ss_dssp HT--SGGGT
T ss_pred hC--Ccccc
Confidence 55 45543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=210.61 Aligned_cols=164 Identities=24% Similarity=0.309 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 105 ~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 105 LELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhC
Confidence 578889999999999999999999 999999999999999999999999998765443333345577889999999876
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CC-------------------------------ccCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GK-------------------------------RLEI 128 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~-------------------------------~~~~ 128 (181)
. .++.++|+||+|+++|+|++|+.||.+.+.......+... +. ....
T Consensus 183 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T 2pmi_A 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262 (317)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc
Confidence 4 5789999999999999999999999988876655544211 00 0011
Q ss_pred CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 129 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
+..+++++.+++.+||..||.+|||+.++++ ++|++...
T Consensus 263 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~ 301 (317)
T 2pmi_A 263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH--HPWFAEYY 301 (317)
T ss_dssp SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGGGGC
T ss_pred cccCCHHHHHHHHHHCCCCcccCCCHHHHhC--Chhhhccc
Confidence 2357889999999999999999999999999 88887543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=208.78 Aligned_cols=170 Identities=28% Similarity=0.524 Sum_probs=145.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.
T Consensus 107 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 184 (287)
T 1u59_A 107 IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184 (287)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHH
Confidence 578899999999999999999999 9999999999999999999999999987543221 11223345678999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||+|+++++|++ |..||...........+. .......+..+++.+.+++.+||..||.+||++.++
T Consensus 185 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 263 (287)
T 1u59_A 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 263 (287)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred hccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 987778899999999999999998 999999988877776665 344556677899999999999999999999999999
Q ss_pred HHHHHHhhhCCCCCCCC
Q 030203 158 MELLRPLIKSPTPQPSP 174 (181)
Q Consensus 158 l~~L~~~~~~~~~~~~~ 174 (181)
++.|+.++.....+..+
T Consensus 264 ~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 264 EQRMRACYYSLASKVEG 280 (287)
T ss_dssp HHHHHHHHHHHHTTCSS
T ss_pred HHHHHHHHHhcCCcccC
Confidence 99999998876665543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=214.34 Aligned_cols=168 Identities=32% Similarity=0.538 Sum_probs=137.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+
T Consensus 169 l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 246 (344)
T 1rjb_A 169 LTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 246 (344)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence 578899999999999999999999 99999999999999999999999999875433211 12233456789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||||+++|+|++ |..||.+...................+..+++.+.+++.+||..||.+|||+.+++
T Consensus 247 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 326 (344)
T 1rjb_A 247 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 326 (344)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 88888999999999999999998 99999887655444444335555666778899999999999999999999999999
Q ss_pred HHHHHhhhCCCCC
Q 030203 159 ELLRPLIKSPTPQ 171 (181)
Q Consensus 159 ~~L~~~~~~~~~~ 171 (181)
+.|+.++...+..
T Consensus 327 ~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 327 SFLGCQLADAEEA 339 (344)
T ss_dssp HHHHHHC------
T ss_pred HHHHHHHHHHHHH
Confidence 9999998875543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=206.70 Aligned_cols=163 Identities=31% Similarity=0.575 Sum_probs=141.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.
T Consensus 117 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (283)
T 3gen_A 117 FQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 194 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhc
Confidence 578899999999999999999999 9999999999999999999999999987544322 2223344567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|+|++ |+.||...........+. .......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 195 ~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 273 (283)
T 3gen_A 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 273 (283)
T ss_dssp HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 8888999999999999999998 999999998888777775 44455566778999999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
.|.+++..
T Consensus 274 ~L~~~~~~ 281 (283)
T 3gen_A 274 NILDVMDE 281 (283)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhhc
Confidence 99998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=209.11 Aligned_cols=157 Identities=26% Similarity=0.481 Sum_probs=138.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||++| ++|+||+|+||+++.+|.++|+|||++...... .....+++.|+|||.+.+
T Consensus 103 ~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 103 FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc---cccccCCccccCHhHhcC
Confidence 578899999999999999999999 999999999999999999999999998754332 234578899999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+|+++|+|++|..||.+.+......++... ....+..+++++.+++.+||..||.+|| ++++
T Consensus 178 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~ 255 (318)
T 1fot_A 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 255 (318)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHH
T ss_pred CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHH
Confidence 88999999999999999999999999998887777766433 3445678999999999999999999999 8999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++|++.
T Consensus 256 i~~--hp~f~~ 264 (318)
T 1fot_A 256 VKN--HPWFKE 264 (318)
T ss_dssp HHT--SGGGSS
T ss_pred Hhc--CccccC
Confidence 998 788754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=210.32 Aligned_cols=165 Identities=33% Similarity=0.563 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|.+||.+
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 221 (313)
T 3brb_A 144 IPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 221 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhh
Confidence 678899999999999999999999 9999999999999999999999999987543321 122334556789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||...........+. .......+..+++.+.+++.+||..||.+|||+.+++
T Consensus 222 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 300 (313)
T 3brb_A 222 ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLR 300 (313)
T ss_dssp HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88888999999999999999999 899999888777666654 3445556778999999999999999999999999999
Q ss_pred HHHHHhhhCCC
Q 030203 159 ELLRPLIKSPT 169 (181)
Q Consensus 159 ~~L~~~~~~~~ 169 (181)
+.|+.+++..+
T Consensus 301 ~~L~~l~~~lp 311 (313)
T 3brb_A 301 LQLEKLLESLP 311 (313)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHhcC
Confidence 99999987644
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=213.01 Aligned_cols=161 Identities=27% Similarity=0.437 Sum_probs=138.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC----cEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++ .++|+|||++....... ......+++.|+|||
T Consensus 112 l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE 188 (361)
T 2yab_A 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPE 188 (361)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC-CCCCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC-ccccCCCCccEECch
Confidence 578999999999999999999999 99999999999998776 79999999987654432 234457899999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+.+..++.++|+||+|+++|+|++|..||.+.+.......+....... ..+..+++.+++||.+||..||.+|||+.
T Consensus 189 ~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 268 (361)
T 2yab_A 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQ 268 (361)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 9988889999999999999999999999999998888777775333222 22357899999999999999999999999
Q ss_pred HHHHHHHHhhhC
Q 030203 156 TIMELLRPLIKS 167 (181)
Q Consensus 156 ~~l~~L~~~~~~ 167 (181)
++++ ++|++.
T Consensus 269 e~l~--hp~~~~ 278 (361)
T 2yab_A 269 EALR--HPWITP 278 (361)
T ss_dssp HHHT--STTTSC
T ss_pred HHhc--CcCcCC
Confidence 9999 888864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=206.06 Aligned_cols=174 Identities=21% Similarity=0.333 Sum_probs=138.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc---CCCcEEEcccCCccccccccc-------cCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSRLKANTFL-------SSKSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~---~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~ 71 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||.+........ ......+++
T Consensus 102 ~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (296)
T 3uzp_A 102 FSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179 (296)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccccc
Confidence 578899999999999999999999 99999999999994 788999999999875443221 124457888
Q ss_pred CccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh---ccCCccCCCCCCCHHHHHHHHHHhc
Q 030203 72 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA---QVVAAVG---FKGKRLEIPRNVNPHVASIIEACWA 145 (181)
Q Consensus 72 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~ 145 (181)
.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.... .....+. ...........+++.+.+++.+||+
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 259 (296)
T 3uzp_A 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRS 259 (296)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHT
T ss_pred ccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHh
Confidence 999999999888999999999999999999999999764321 1111111 1111122336689999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCC-CCCCCC
Q 030203 146 NEPWKRPSFSTIMELLRPLIKSPTPQ-PSPTDM 177 (181)
Q Consensus 146 ~~p~~Rps~~~~l~~L~~~~~~~~~~-~~~~~~ 177 (181)
.||.+|||+.++++.|+.+++....+ ..+.++
T Consensus 260 ~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 260 LRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp SCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred cCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 99999999999999999998865544 344443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=206.02 Aligned_cols=167 Identities=31% Similarity=0.589 Sum_probs=140.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc----ccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+....... .......++..|.+||
T Consensus 121 ~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 198 (298)
T 3pls_A 121 PTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198 (298)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChh
Confidence 467889999999999999999999 9999999999999999999999999987543321 1223345677899999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
.+.+..++.++|+||+|+++|+|++ |.+||...+.......+. .......+..+++.+.+++.+||+.||.+|||+++
T Consensus 199 ~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 277 (298)
T 3pls_A 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRV 277 (298)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHH
Confidence 9998889999999999999999999 555667766666666554 44455567788999999999999999999999999
Q ss_pred HHHHHHHhhhCCCCC
Q 030203 157 IMELLRPLIKSPTPQ 171 (181)
Q Consensus 157 ~l~~L~~~~~~~~~~ 171 (181)
+++.|+.+++.....
T Consensus 278 ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 278 LVGEVEQIVSALLGD 292 (298)
T ss_dssp HHHHHHHHHHHCCSC
T ss_pred HHHHHHHHHHHHhcc
Confidence 999999998876544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=206.11 Aligned_cols=168 Identities=21% Similarity=0.351 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE---cCCCcEEEcccCCccccccccc-------cCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~ 71 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||++ +.++.++|+|||.+........ ......+++
T Consensus 102 ~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~ 179 (296)
T 4hgt_A 102 FSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179 (296)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCc
Confidence 578899999999999999999999 9999999999999 7889999999999875443211 223457788
Q ss_pred CccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh---ccCCccCCCCCCCHHHHHHHHHHhc
Q 030203 72 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA---QVVAAVG---FKGKRLEIPRNVNPHVASIIEACWA 145 (181)
Q Consensus 72 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~ 145 (181)
.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.... .....+. ...........+++.+.+++.+||+
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 259 (296)
T 4hgt_A 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRS 259 (296)
T ss_dssp GGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHT
T ss_pred cccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHh
Confidence 999999999888999999999999999999999999764321 1111111 1111112335688999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 146 NEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 146 ~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
.||.+|||+.++++.|+++++.....
T Consensus 260 ~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 260 LRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp SCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred cCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999998865443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=208.41 Aligned_cols=163 Identities=24% Similarity=0.461 Sum_probs=113.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+..............+++.|+|||.+.+
T Consensus 109 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 109 FSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186 (278)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC
Confidence 578899999999999999999999 999999999999999999999999998765433333334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+|+++++|++|+.||...........+ .......+..+++++.+++.+||+.||.+|||++++++
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~-- 262 (278)
T 3cok_A 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD-- 262 (278)
T ss_dssp -----CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--CSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--hhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc--
Confidence 88889999999999999999999999876654444333 22234456778999999999999999999999999999
Q ss_pred HHhhhCCCC
Q 030203 162 RPLIKSPTP 170 (181)
Q Consensus 162 ~~~~~~~~~ 170 (181)
++++.....
T Consensus 263 h~~~~~~~~ 271 (278)
T 3cok_A 263 HPFMSRNSS 271 (278)
T ss_dssp STTTC----
T ss_pred CccccCCCC
Confidence 888876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=207.03 Aligned_cols=166 Identities=28% Similarity=0.532 Sum_probs=141.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.
T Consensus 114 ~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 191 (291)
T 1xbb_A 114 VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191 (291)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHH
Confidence 578899999999999999999999 9999999999999999999999999987543321 11222345678999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||+|+++|+|++ |..||...........+. .......+..+++.+.+++.+||+.||.+||++.++
T Consensus 192 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 270 (291)
T 1xbb_A 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 270 (291)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 987778889999999999999999 999999998887777765 344556677899999999999999999999999999
Q ss_pred HHHHHHhhhCCCC
Q 030203 158 MELLRPLIKSPTP 170 (181)
Q Consensus 158 l~~L~~~~~~~~~ 170 (181)
++.|++++.....
T Consensus 271 ~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 271 ELRLRNYYYDVVN 283 (291)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhh
Confidence 9999999875443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=204.39 Aligned_cols=160 Identities=39% Similarity=0.680 Sum_probs=133.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCC-ceecCCCCCCEEEcC--------CCcEEEcccCCccccccccccCCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPP-IVHRDLKSPNLLVDK--------KYTVKVCDFGLSRLKANTFLSSKSAAGTPE 72 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~-~~h~~i~~~nil~~~--------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 72 (181)
+++.+++.++.|++.||.|||+++.+ ++|+||+|+||+++. ++.++++|||.+....... .....+++.
T Consensus 102 ~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~ 179 (271)
T 3dtc_A 102 IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYA 179 (271)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------CCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc--ccCCCCccc
Confidence 57889999999999999999999732 679999999999985 6789999999987544332 223467889
Q ss_pred ccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 73 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 73 ~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
|.|||.+.+..++.++|+||+|++++++++|+.||.+.........+.........+..+++.+.+++.+||+.||.+||
T Consensus 180 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 259 (271)
T 3dtc_A 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRP 259 (271)
T ss_dssp GSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred eeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCc
Confidence 99999998888899999999999999999999999998888777777666666777888999999999999999999999
Q ss_pred CHHHHHHHHHH
Q 030203 153 SFSTIMELLRP 163 (181)
Q Consensus 153 s~~~~l~~L~~ 163 (181)
|+.++++.|+.
T Consensus 260 s~~e~l~~L~~ 270 (271)
T 3dtc_A 260 SFTNILDQLTT 270 (271)
T ss_dssp CHHHHHHHHHC
T ss_pred CHHHHHHHHhc
Confidence 99999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=210.98 Aligned_cols=161 Identities=27% Similarity=0.480 Sum_probs=137.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...... ....+++.|+|||.+.
T Consensus 151 l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~~~~gt~~y~aPE~~~~ 224 (348)
T 1u5q_A 151 LQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILA 224 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC----CcccCCcceeCHhhhcc
Confidence 578899999999999999999999 999999999999999999999999998654332 3456889999999884
Q ss_pred --CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 81 --DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 81 --~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
...++.++|+||+|+++++|++|..||...+.......+.........+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 225 ~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 304 (348)
T 1u5q_A 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304 (348)
T ss_dssp TSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 456788999999999999999999999988877766666544444445667899999999999999999999999999
Q ss_pred HHHHHhhhCCCC
Q 030203 159 ELLRPLIKSPTP 170 (181)
Q Consensus 159 ~~L~~~~~~~~~ 170 (181)
+ +.|+....+
T Consensus 305 ~--h~~~~~~~~ 314 (348)
T 1u5q_A 305 K--HRFVLRERP 314 (348)
T ss_dssp T--CHHHHSCCC
T ss_pred h--ChhhhccCC
Confidence 9 777766443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=210.17 Aligned_cols=165 Identities=33% Similarity=0.598 Sum_probs=138.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+
T Consensus 142 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 219 (313)
T 1t46_A 142 LDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh
Confidence 678899999999999999999999 99999999999999999999999999875443321 12233456689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++++|++ |..||.+...................+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 220 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 299 (313)
T 1t46_A 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (313)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 88888999999999999999998 99999887654433333334444555677899999999999999999999999999
Q ss_pred HHHHHhhhCC
Q 030203 159 ELLRPLIKSP 168 (181)
Q Consensus 159 ~~L~~~~~~~ 168 (181)
+.|+.++...
T Consensus 300 ~~L~~~~~~~ 309 (313)
T 1t46_A 300 QLIEKQISES 309 (313)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHh
Confidence 9999988754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=215.65 Aligned_cols=161 Identities=27% Similarity=0.471 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+
T Consensus 105 l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-~~~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 105 MTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVING 181 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-TTCCCTTSTTTSCGGGSCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc-ccccccCCcCcCCHHHHcC
Confidence 578899999999999999999999 9999999999999999999999999987544332 2344578899999999987
Q ss_pred CCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..+ +.++|+||+|+++|+|++|..||.+.........+ .......+..+++.+.+++.+||..||.+|||+.++++
T Consensus 182 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~- 258 (336)
T 3h4j_B 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR- 258 (336)
T ss_dssp SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT-
T ss_pred CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh-
Confidence 765 67899999999999999999999876544332222 22234466778999999999999999999999999999
Q ss_pred HHHhhhCCC
Q 030203 161 LRPLIKSPT 169 (181)
Q Consensus 161 L~~~~~~~~ 169 (181)
++|++...
T Consensus 259 -hp~~~~~~ 266 (336)
T 3h4j_B 259 -DPWFNVNL 266 (336)
T ss_dssp -CHHHHTTC
T ss_pred -ChhhccCC
Confidence 88988643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=213.18 Aligned_cols=168 Identities=20% Similarity=0.350 Sum_probs=140.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC--CCcEEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++. ++.++++|||++....... ......+++.|+|||.+
T Consensus 99 ~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~ 175 (321)
T 1tki_A 99 LNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVH 175 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-EEEEEESCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-ccccccCChhhcCcHHh
Confidence 678999999999999999999999 999999999999987 7899999999987544322 12234678899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..++.++|+||+|+++|+|++|..||.+.........+........ ....+++++.+++.+||..||.+|||+.++
T Consensus 176 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~ 255 (321)
T 1tki_A 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255 (321)
T ss_dssp TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 887788999999999999999999999999988887777654433222 224689999999999999999999999999
Q ss_pred HHHHHHhhhCCCCCCCC
Q 030203 158 MELLRPLIKSPTPQPSP 174 (181)
Q Consensus 158 l~~L~~~~~~~~~~~~~ 174 (181)
++ ++|++.......+
T Consensus 256 l~--hp~~~~~~~~~~~ 270 (321)
T 1tki_A 256 LQ--HPWLKQKIERVST 270 (321)
T ss_dssp HH--SHHHHSCGGGSCC
T ss_pred hc--ChhhccCcccccH
Confidence 99 8998875444333
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=204.72 Aligned_cols=163 Identities=25% Similarity=0.466 Sum_probs=139.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+...... ......+++.|++||.+.+
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 111 FDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhcc
Confidence 578899999999999999999999 999999999999999999999999987644332 2234567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+|++++++++|..||...........+. ......+..+++.+.+++.+||+.||.+||++.++++
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~-- 262 (284)
T 2vgo_A 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME-- 262 (284)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--
T ss_pred CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh--
Confidence 888999999999999999999999999888777666653 2334566778999999999999999999999999999
Q ss_pred HHhhhCCCCCC
Q 030203 162 RPLIKSPTPQP 172 (181)
Q Consensus 162 ~~~~~~~~~~~ 172 (181)
++|++....+.
T Consensus 263 h~~~~~~~~~~ 273 (284)
T 2vgo_A 263 HPWVKANSRRV 273 (284)
T ss_dssp CHHHHHHCCCC
T ss_pred CHHHHhhcccc
Confidence 78877544443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=217.67 Aligned_cols=168 Identities=22% Similarity=0.302 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc--EEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++. ++|+|||++...... .....+++.|+|||.+
T Consensus 197 ~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~ 271 (429)
T 3kvw_A 197 FSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRFYRAPEVI 271 (429)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccceecCCc---ccccCCCCCccChHHH
Confidence 578899999999999999999999 999999999999999887 999999998654332 2345778899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCc---------------------------------
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKR--------------------------------- 125 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~~--------------------------------- 125 (181)
.+..++.++|+||+||++|+|++|..||.+.+..+....+... +..
T Consensus 272 ~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (429)
T 3kvw_A 272 LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGS 351 (429)
T ss_dssp HTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--
T ss_pred hCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccccccc
Confidence 9888999999999999999999999999998876554433210 000
Q ss_pred -----------------------cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCCCCCC
Q 030203 126 -----------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176 (181)
Q Consensus 126 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~~~~~ 176 (181)
...+...++.+.+|+.+||+.||.+|||+.++++ ++|++...++++...
T Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~--Hpw~~~~~~~~~~~~ 423 (429)
T 3kvw_A 352 VVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR--HPWLRRRLPKPPTGE 423 (429)
T ss_dssp CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT--STTTC----------
T ss_pred ccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC--ChhhccCCCCCCccc
Confidence 0011234788999999999999999999999999 999998776655443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=204.65 Aligned_cols=169 Identities=21% Similarity=0.418 Sum_probs=137.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.
T Consensus 108 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (294)
T 4eqm_A 108 LSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185 (294)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhc
Confidence 578899999999999999999999 9999999999999999999999999987544332 2223446889999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc---cCCCCCCCHHHHHHHHHHhcCCCCCCC-CHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR---LEIPRNVNPHVASIIEACWANEPWKRP-SFST 156 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~ 156 (181)
+..++.++|+||+|+++|+|++|+.||.+................ ...+..+++.+.+++.+|++.||.+|| ++.+
T Consensus 186 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~ 265 (294)
T 4eqm_A 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQE 265 (294)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHH
T ss_pred CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHH
Confidence 888899999999999999999999999998876655444322221 224567899999999999999999999 9999
Q ss_pred HHHHHHHhhhCCCCCC
Q 030203 157 IMELLRPLIKSPTPQP 172 (181)
Q Consensus 157 ~l~~L~~~~~~~~~~~ 172 (181)
+.+.|..++.......
T Consensus 266 l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 266 MKDDLSSVLHENRANE 281 (294)
T ss_dssp HHHHHHTSSSSSSTTC
T ss_pred HHHHHHHHHhhccCCc
Confidence 9999998887655443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=208.94 Aligned_cols=166 Identities=33% Similarity=0.620 Sum_probs=136.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 221 (333)
T 1mqb_A 144 FSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221 (333)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchh
Confidence 578899999999999999999999 99999999999999999999999999875443211 1122344668999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||+|+++|++++ |..||...........+. .......+..+++.+.+++.+||+.||.+||++.++
T Consensus 222 ~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 300 (333)
T 1mqb_A 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 300 (333)
T ss_dssp HHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 988888999999999999999998 999999988877777665 344455667899999999999999999999999999
Q ss_pred HHHHHHhhhCCCC
Q 030203 158 MELLRPLIKSPTP 170 (181)
Q Consensus 158 l~~L~~~~~~~~~ 170 (181)
++.|+.+++....
T Consensus 301 ~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 301 VSILDKLIRAPDS 313 (333)
T ss_dssp HHHHHHHHHSGGG
T ss_pred HHHHHHHHhcchh
Confidence 9999998876443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=212.15 Aligned_cols=157 Identities=24% Similarity=0.408 Sum_probs=138.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+|.++|+|||++...... .....+++.|+|||.+.+
T Consensus 138 ~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC---cccccCCccccCHHHhcC
Confidence 578899999999999999999999 999999999999999999999999998754432 234567899999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----HHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ 156 (181)
..++.++|+||+|+++|+|++|..||.+.+.......+... ....+..+++++.++|.+||..||.+||+ +++
T Consensus 213 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~e 290 (350)
T 1rdq_E 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHH
T ss_pred CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHH
Confidence 88999999999999999999999999999888877777533 34566789999999999999999999998 899
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ +++++.
T Consensus 291 i~~--h~~f~~ 299 (350)
T 1rdq_E 291 IKN--HKWFAT 299 (350)
T ss_dssp HHT--SGGGTT
T ss_pred HHh--CcCcCC
Confidence 998 777754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=205.56 Aligned_cols=163 Identities=34% Similarity=0.636 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...... ........+++.|+|||.+
T Consensus 117 ~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 194 (289)
T 3og7_A 117 FEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhh
Confidence 578899999999999999999999 999999999999999999999999998643321 1122345678899999988
Q ss_pred C---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCc---cCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 80 R---DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKR---LEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 80 ~---~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
. +..++.++|+||+|+++++|++|+.||...... .....+...... ......+++.+.+++.+||+.||.+||
T Consensus 195 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 274 (289)
T 3og7_A 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274 (289)
T ss_dssp C----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC
Confidence 6 455678999999999999999999999876544 333333322222 224457889999999999999999999
Q ss_pred CHHHHHHHHHHhhh
Q 030203 153 SFSTIMELLRPLIK 166 (181)
Q Consensus 153 s~~~~l~~L~~~~~ 166 (181)
|+.++++.|+.+.+
T Consensus 275 s~~ell~~L~~l~~ 288 (289)
T 3og7_A 275 SFPRILAEIEELAR 288 (289)
T ss_dssp CHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhh
Confidence 99999999998765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=211.05 Aligned_cols=165 Identities=21% Similarity=0.314 Sum_probs=130.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus 97 ~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 97 INMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG 174 (324)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcC
Confidence 678899999999999999999999 999999999999999999999999998755444333445577889999999876
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc----------------------------CCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL----------------------------EIPRNV 132 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~ 132 (181)
..++.++|+||+|+++|+|++|+.||.+.........+....... .....+
T Consensus 175 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (324)
T 3mtl_A 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRL 254 (324)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTS
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCC
Confidence 457899999999999999999999999988776555442211000 012357
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
++++.+|+.+||+.||.+|||++++++ ++|+.....
T Consensus 255 ~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~ 290 (324)
T 3mtl_A 255 DSDGADLLTKLLQFEGRNRISAEDAMK--HPFFLSLGE 290 (324)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGGGGCS
T ss_pred CHHHHHHHHHHcCcCcccCCCHHHHhc--Chhhhhccc
Confidence 889999999999999999999999999 888875543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=215.50 Aligned_cols=164 Identities=30% Similarity=0.555 Sum_probs=139.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC---cEEEcccCCccccccc--cccCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~---~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~p 76 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+| .++|+|||+++..... ........+++.|+||
T Consensus 178 ~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 255 (367)
T 3l9p_A 178 LAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECH
Confidence 578899999999999999999999 99999999999998555 4999999998643222 1122334567789999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 77 EVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 77 e~~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
|.+.+..++.++|+||||+++|+|++ |..||...........+. .......+..+++.+.+++.+||+.||.+|||+.
T Consensus 256 E~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 334 (367)
T 3l9p_A 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 334 (367)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHH
Confidence 99988889999999999999999998 999999999888887775 4445556778999999999999999999999999
Q ss_pred HHHHHHHHhhhCC
Q 030203 156 TIMELLRPLIKSP 168 (181)
Q Consensus 156 ~~l~~L~~~~~~~ 168 (181)
++++.|+.+.+..
T Consensus 335 eil~~l~~~~~~~ 347 (367)
T 3l9p_A 335 IILERIEYCTQDP 347 (367)
T ss_dssp HHHHHHHHHHHCH
T ss_pred HHHHHHHHHhhCh
Confidence 9999999887754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=205.85 Aligned_cols=162 Identities=30% Similarity=0.518 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+........ ......+++.|+|||.+.
T Consensus 110 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 187 (281)
T 3cc6_A 110 LKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187 (281)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhc
Confidence 578889999999999999999999 99999999999999999999999999875443221 223344567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|+|++ |+.||...........+. .......+..+++.+.+++.+||..||.+||++.++++
T Consensus 188 ~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8888999999999999999998 999998877666665554 33345566778999999999999999999999999999
Q ss_pred HHHHhhh
Q 030203 160 LLRPLIK 166 (181)
Q Consensus 160 ~L~~~~~ 166 (181)
.|+.+++
T Consensus 267 ~L~~~~~ 273 (281)
T 3cc6_A 267 SLSDVYQ 273 (281)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=222.55 Aligned_cols=171 Identities=34% Similarity=0.578 Sum_probs=148.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++...... .......++..|+|||.+.
T Consensus 360 l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 437 (535)
T 2h8h_A 360 LRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437 (535)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhc
Confidence 578899999999999999999999 9999999999999999999999999987544322 1223334567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++||||||+++|+|++ |..||.+....+....+. ...+...+..+++.+.+++.+||+.||.+|||++++++
T Consensus 438 ~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8889999999999999999999 999999998888777775 44455667789999999999999999999999999999
Q ss_pred HHHHhhhCCCCCCCCC
Q 030203 160 LLRPLIKSPTPQPSPT 175 (181)
Q Consensus 160 ~L~~~~~~~~~~~~~~ 175 (181)
.|+.++....++..+.
T Consensus 517 ~L~~~~~~~~~~~~~~ 532 (535)
T 2h8h_A 517 FLEDYFTSTEPQYQPG 532 (535)
T ss_dssp HHHTSSCCCSCSSCC-
T ss_pred HHHHHhhccCcccCcc
Confidence 9999999888776554
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=208.91 Aligned_cols=166 Identities=34% Similarity=0.652 Sum_probs=140.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++...... .......+++.|+|||.+.+
T Consensus 139 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 215 (327)
T 1fvr_A 139 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY 215 (327)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhcc
Confidence 578899999999999999999999 999999999999999999999999998643322 12233455678999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|+++|+|++ |..||.+.........+. .......+..+++.+.+++.+||..||.+|||+.++++.
T Consensus 216 ~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 778899999999999999998 999999998888777664 334455667889999999999999999999999999999
Q ss_pred HHHhhhCCCCC
Q 030203 161 LRPLIKSPTPQ 171 (181)
Q Consensus 161 L~~~~~~~~~~ 171 (181)
|+.+++.....
T Consensus 295 L~~~~~~~~~~ 305 (327)
T 1fvr_A 295 LNRMLEERKTY 305 (327)
T ss_dssp HHHHHHSSSCS
T ss_pred HHHHHHhhcCc
Confidence 99998875443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=214.51 Aligned_cols=163 Identities=39% Similarity=0.622 Sum_probs=139.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccC--CCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSS--KSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......... ....++..|+|||.+
T Consensus 210 ~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~ 287 (377)
T 3cbl_A 210 LRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287 (377)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHh
Confidence 578899999999999999999999 9999999999999999999999999987543322111 112235579999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|++++ |..||...........+. .....+.+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 288 ~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 366 (377)
T 3cbl_A 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366 (377)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 88788899999999999999998 999999988877776665 4455667788999999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+.+.
T Consensus 367 ~~L~~i~~~ 375 (377)
T 3cbl_A 367 QELQSIRKR 375 (377)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhh
Confidence 999988653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=208.21 Aligned_cols=164 Identities=28% Similarity=0.500 Sum_probs=131.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.
T Consensus 126 ~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 203 (326)
T 2x7f_A 126 LKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhcc
Confidence 578889999999999999999999 99999999999999999999999999875544333334456788999999986
Q ss_pred ----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 81 ----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 81 ----~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+..++.++|+||||+++|+|++|..||...........+.........+..+++.+.+++.+||..||.+||++.+
T Consensus 204 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 283 (326)
T 2x7f_A 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283 (326)
T ss_dssp -------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHH
Confidence 4557889999999999999999999999888776665554444444445678999999999999999999999999
Q ss_pred HHHHHHHhhhCCC
Q 030203 157 IMELLRPLIKSPT 169 (181)
Q Consensus 157 ~l~~L~~~~~~~~ 169 (181)
+++ +++++..+
T Consensus 284 ll~--hp~~~~~~ 294 (326)
T 2x7f_A 284 LMK--HPFIRDQP 294 (326)
T ss_dssp HHT--SHHHHCCT
T ss_pred Hhh--ChHHhhCc
Confidence 999 78887644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=206.52 Aligned_cols=164 Identities=32% Similarity=0.576 Sum_probs=139.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.
T Consensus 118 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 195 (291)
T 1u46_A 118 FLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195 (291)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchh
Confidence 578899999999999999999999 9999999999999999999999999986543321 12223455668999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||+|+++++|++ |..||.+.+.......+.........+..+++.+.+++.+||+.||.+|||+.++
T Consensus 196 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 275 (291)
T 1u46_A 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275 (291)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHH
Confidence 988778889999999999999999 9999999998888887766666666777899999999999999999999999999
Q ss_pred HHHHHHhhhC
Q 030203 158 MELLRPLIKS 167 (181)
Q Consensus 158 l~~L~~~~~~ 167 (181)
++.|+.....
T Consensus 276 ~~~l~~~~~~ 285 (291)
T 1u46_A 276 RDFLLEAQPT 285 (291)
T ss_dssp HHHHHHHC--
T ss_pred HHHHHHhCcc
Confidence 9999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=217.18 Aligned_cols=160 Identities=34% Similarity=0.637 Sum_probs=138.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++..... .....++..|+|||.+.+
T Consensus 286 ~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~ 360 (450)
T 1k9a_A 286 LGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALRE 360 (450)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcC
Confidence 578899999999999999999999 999999999999999999999999998743322 122355678999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||||+++|+|++ |..||......+....+. .+.+...+..+++.+.+++.+||+.||.+|||+.++++.
T Consensus 361 ~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~ 439 (450)
T 1k9a_A 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQ 439 (450)
T ss_dssp SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 889999999999999999998 999999887776666664 445566778899999999999999999999999999999
Q ss_pred HHHhhhC
Q 030203 161 LRPLIKS 167 (181)
Q Consensus 161 L~~~~~~ 167 (181)
|+.+.+.
T Consensus 440 L~~i~~~ 446 (450)
T 1k9a_A 440 LEHIRTH 446 (450)
T ss_dssp HHHHHHT
T ss_pred HHHHHHh
Confidence 9998765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=205.38 Aligned_cols=163 Identities=28% Similarity=0.485 Sum_probs=141.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+..............+++.|++||.+.+
T Consensus 112 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 112 LTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhcc
Confidence 578899999999999999999999 999999999999999999999999998765433333444567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+|+++++|++|..||...........+. ......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 190 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~-- 265 (294)
T 2rku_A 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN-- 265 (294)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh--
Confidence 888999999999999999999999999988777666553 2334566788999999999999999999999999999
Q ss_pred HHhhhCCCC
Q 030203 162 RPLIKSPTP 170 (181)
Q Consensus 162 ~~~~~~~~~ 170 (181)
+++++....
T Consensus 266 ~~~~~~~~~ 274 (294)
T 2rku_A 266 DEFFTSGYI 274 (294)
T ss_dssp SHHHHTSCC
T ss_pred ChheecCCc
Confidence 888876443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-33 Score=203.80 Aligned_cols=160 Identities=37% Similarity=0.715 Sum_probs=133.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc-----EEEcccCCccccccccccCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~-----~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~p 76 (181)
+++..++.++.|++.||.|||+++.+++|+||+|+||+++.++. ++++|||++...... .....+++.|+||
T Consensus 119 ~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~g~~~y~aP 195 (287)
T 4f0f_A 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGNFQWMAP 195 (287)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC---EECCCCCCTTSCG
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc---ccccCCCccccCc
Confidence 57889999999999999999999766999999999999988776 999999998754332 2335678899999
Q ss_pred cccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 77 EVLR--DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 77 e~~~--~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
|.+. ...++.++|+||+|+++|+|++|+.||....... ....+.........+..+++.+.+++.+||+.||.+||
T Consensus 196 E~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 275 (287)
T 4f0f_A 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275 (287)
T ss_dssp GGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCc
Confidence 9984 3446789999999999999999999998765433 34444445556677888999999999999999999999
Q ss_pred CHHHHHHHHHHh
Q 030203 153 SFSTIMELLRPL 164 (181)
Q Consensus 153 s~~~~l~~L~~~ 164 (181)
|+.++++.|+.+
T Consensus 276 s~~~ll~~L~~l 287 (287)
T 4f0f_A 276 HFSYIVKELSEL 287 (287)
T ss_dssp CHHHHHHHHHTC
T ss_pred CHHHHHHHHHhC
Confidence 999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=210.47 Aligned_cols=161 Identities=23% Similarity=0.385 Sum_probs=132.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc---EEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~---~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++. ++++|||++..............+++.|+|||.
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~ 204 (351)
T 3c0i_A 127 YSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHH
Confidence 678899999999999999999999 999999999999976554 999999998765544333445678999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+..++.++|+||+|+++|+|++|..||.+... .....+....... .....+++.+.+++.+||..||.+|||+.+
T Consensus 205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 283 (351)
T 3c0i_A 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYE 283 (351)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 9888889999999999999999999999988643 3333332222211 122568999999999999999999999999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++|++.
T Consensus 284 ~l~--hp~~~~ 292 (351)
T 3c0i_A 284 ALN--HPWLKE 292 (351)
T ss_dssp HHT--SHHHHT
T ss_pred Hhc--ChhhcC
Confidence 998 777764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=211.42 Aligned_cols=161 Identities=29% Similarity=0.435 Sum_probs=136.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC---CcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||++....... ......+++.|+|||.
T Consensus 125 ~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~ 201 (362)
T 2bdw_A 125 YSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEV 201 (362)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-SCCCSCSCTTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-ccccCCCCccccCHHH
Confidence 678999999999999999999999 9999999999999764 459999999987554322 2234578899999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+..++.++|+||+|+++|+|++|..||.+.+.......+........ ....+++++.+++.+||..||.+||++.+
T Consensus 202 ~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 281 (362)
T 2bdw_A 202 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 281 (362)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9888899999999999999999999999999888877777654443322 22467899999999999999999999999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++|+..
T Consensus 282 ~l~--hp~~~~ 290 (362)
T 2bdw_A 282 ALK--VPWICN 290 (362)
T ss_dssp HTT--SHHHHT
T ss_pred Hhc--CcccCC
Confidence 998 777754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=202.29 Aligned_cols=163 Identities=35% Similarity=0.639 Sum_probs=140.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... .......++..|.|||.+.
T Consensus 101 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 178 (267)
T 3t9t_A 101 FAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178 (267)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhc
Confidence 578899999999999999999999 9999999999999999999999999987543322 1223345567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|+|++ |..||...........+. .......+..+++.+.+++.+||+.||.+||++.++++
T Consensus 179 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8888999999999999999999 899999988887777765 33344556778999999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
.|+.+.+.
T Consensus 258 ~L~~l~~~ 265 (267)
T 3t9t_A 258 QLAEIAES 265 (267)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHhc
Confidence 99998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=207.85 Aligned_cols=176 Identities=18% Similarity=0.282 Sum_probs=140.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC--cEEEcccCCccccccccc-------cCCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTFL-------SSKSAAGTPE 72 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~--~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~ 72 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++........ ......+++.
T Consensus 156 l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~ 233 (352)
T 2jii_A 156 LSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLE 233 (352)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCcc
Confidence 678999999999999999999999 99999999999999988 899999999875443211 1133478889
Q ss_pred ccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhc-cCCccCC------CCCCCHHHHHHHHHH
Q 030203 73 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN--PAQVVAAVGF-KGKRLEI------PRNVNPHVASIIEAC 143 (181)
Q Consensus 73 ~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~--~~~~~~~~~~-~~~~~~~------~~~~~~~~~~li~~~ 143 (181)
|+|||.+.+..++.++|+||||+++|+|++|+.||.... ...+...... ....... ...+++.+.+++.+|
T Consensus 234 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 313 (352)
T 2jii_A 234 FISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVV 313 (352)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHH
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHH
Confidence 999999998889999999999999999999999998763 3322222210 1111111 125689999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhCCCCC-CCCCCCCC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKSPTPQ-PSPTDMPL 179 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~~~~~-~~~~~~~~ 179 (181)
|+.||.+||++.++++.|+.+++..... ..|.+++.
T Consensus 314 l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~ 350 (352)
T 2jii_A 314 MALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPM 350 (352)
T ss_dssp HTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC
T ss_pred HhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcC
Confidence 9999999999999999999999866544 46666654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=206.61 Aligned_cols=170 Identities=24% Similarity=0.424 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++..............+++.|++||.+.+
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (310)
T 2wqm_A 133 IPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210 (310)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC
Confidence 678899999999999999999999 999999999999999999999999998755443333344567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNL--NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
..++.++|+||||+++++|++|..||.+. ........+............+++.+.+++.+||+.||.+|||+.++++
T Consensus 211 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 88899999999999999999999999664 3334444444333333334678999999999999999999999999999
Q ss_pred HHHHhhhCCCCCCC
Q 030203 160 LLRPLIKSPTPQPS 173 (181)
Q Consensus 160 ~L~~~~~~~~~~~~ 173 (181)
.|+.+.....++++
T Consensus 291 ~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 291 VAKRMHACTASSLE 304 (310)
T ss_dssp HHHHHHHHHC----
T ss_pred HHHHHHHhhhhhhh
Confidence 99999876665554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=207.54 Aligned_cols=157 Identities=20% Similarity=0.313 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+
T Consensus 154 l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 154 LPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccCC-CCcccCCCccccCHhHhcC
Confidence 678999999999999999999999 9999999999999999999999999986544332 2334568899999999876
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
.++.++|+||+|+++++|++|..++..... ...+.........+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 231 -~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~-- 304 (311)
T 3p1a_A 231 -SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA-- 304 (311)
T ss_dssp -CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--
T ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh--
Confidence 688999999999999999999776655322 22232222333345678999999999999999999999999999
Q ss_pred HHhhhC
Q 030203 162 RPLIKS 167 (181)
Q Consensus 162 ~~~~~~ 167 (181)
++|+++
T Consensus 305 hp~~~~ 310 (311)
T 3p1a_A 305 LPVLRQ 310 (311)
T ss_dssp SGGGSC
T ss_pred CccccC
Confidence 888876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=208.81 Aligned_cols=165 Identities=30% Similarity=0.604 Sum_probs=141.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 154 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 231 (334)
T 2pvf_A 154 MTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231 (334)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHh
Confidence 578899999999999999999999 9999999999999999999999999987544321 122334556789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+.........+. .......+..+++.+.+++.+||+.||.+||++.+++
T Consensus 232 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 310 (334)
T 2pvf_A 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310 (334)
T ss_dssp HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88778899999999999999999 999999988877776664 3344556778999999999999999999999999999
Q ss_pred HHHHHhhhCCC
Q 030203 159 ELLRPLIKSPT 169 (181)
Q Consensus 159 ~~L~~~~~~~~ 169 (181)
+.|+.+++...
T Consensus 311 ~~L~~l~~~~~ 321 (334)
T 2pvf_A 311 EDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHhccc
Confidence 99999987433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=215.40 Aligned_cols=161 Identities=30% Similarity=0.503 Sum_probs=139.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+
T Consensus 113 l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 113 LDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISG 189 (476)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-CBCCCCSCSTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhccccc-cccccCCCcCeEChhhccC
Confidence 578999999999999999999999 9999999999999999999999999987644322 2234578899999999987
Q ss_pred CCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..+ +.++|+||+|+++|+|++|..||.+.+......++... ....+..+++.+.+++.+||..||.+|||+.++++
T Consensus 190 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~- 266 (476)
T 2y94_A 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE- 266 (476)
T ss_dssp CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT-
T ss_pred CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh-
Confidence 765 67899999999999999999999998887777776432 34456778999999999999999999999999999
Q ss_pred HHHhhhCCC
Q 030203 161 LRPLIKSPT 169 (181)
Q Consensus 161 L~~~~~~~~ 169 (181)
++|++...
T Consensus 267 -hp~~~~~~ 274 (476)
T 2y94_A 267 -HEWFKQDL 274 (476)
T ss_dssp -CHHHHTTC
T ss_pred -CHHhhhcC
Confidence 88887643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=210.65 Aligned_cols=166 Identities=25% Similarity=0.395 Sum_probs=116.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC---cEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++..............+++.|+|||.
T Consensus 103 ~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~ 180 (325)
T 3kn6_A 103 FSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180 (325)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHH
Confidence 678999999999999999999999 99999999999997765 7999999998765544334445567889999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCC
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP-------AQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPW 149 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~ 149 (181)
+.+..++.++|+||+|+++|+|++|..||.+.+. ......+........ ....+++++.+++.+||..||.
T Consensus 181 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 260 (325)
T 3kn6_A 181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPN 260 (325)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTT
T ss_pred hcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChh
Confidence 9888899999999999999999999999977543 344444432222111 1135899999999999999999
Q ss_pred CCCCHHHHHHHHHHhhhCCCCC
Q 030203 150 KRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 150 ~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
+|||+.++++ ++|++.....
T Consensus 261 ~Rpt~~ell~--h~w~~~~~~~ 280 (325)
T 3kn6_A 261 KRLKMSGLRY--NEWLQDGSQL 280 (325)
T ss_dssp TCCCTTTSTT--CGGGCTTCCC
T ss_pred HCCCHHHHhc--ChhhccCccC
Confidence 9999999999 9999875444
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=201.69 Aligned_cols=160 Identities=31% Similarity=0.640 Sum_probs=139.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++..++|+||+|+||+++.++.+++.|+++..... .....+++.|+|||.+.+
T Consensus 108 ~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQK 182 (271)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhcc
Confidence 688999999999999999999987669999999999999999999999887754322 223466789999999877
Q ss_pred CCCCC---chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 82 EPSNE---KSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 82 ~~~~~---~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
...+. ++|+||+|+++|+|++|+.||...........+.........+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 183 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 262 (271)
T 3kmu_A 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIV 262 (271)
T ss_dssp CGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 65443 799999999999999999999999888877777667777778888999999999999999999999999999
Q ss_pred HHHHHhhh
Q 030203 159 ELLRPLIK 166 (181)
Q Consensus 159 ~~L~~~~~ 166 (181)
+.|+.+.+
T Consensus 263 ~~L~~l~~ 270 (271)
T 3kmu_A 263 PILEKMQD 270 (271)
T ss_dssp HHHHHHCC
T ss_pred HHHHHhhc
Confidence 99998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=205.16 Aligned_cols=167 Identities=33% Similarity=0.567 Sum_probs=138.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc----ccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... .......+++.|++||
T Consensus 125 ~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (298)
T 3f66_A 125 PTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChH
Confidence 578899999999999999999999 9999999999999999999999999987543322 1123345567899999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
.+.+..++.++|+||+|++++++++ |.+||...........+. .......+..+++.+.+++.+||+.||.+|||+.+
T Consensus 203 ~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e 281 (298)
T 3f66_A 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 281 (298)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9988888999999999999999999 677787776666555554 34445556778999999999999999999999999
Q ss_pred HHHHHHHhhhCCCCC
Q 030203 157 IMELLRPLIKSPTPQ 171 (181)
Q Consensus 157 ~l~~L~~~~~~~~~~ 171 (181)
+++.|+.++......
T Consensus 282 ll~~L~~~~~~~~~~ 296 (298)
T 3f66_A 282 LVSRISAIFSTFIGE 296 (298)
T ss_dssp HHHHHHHHHHTSCCS
T ss_pred HHHHHHHHHHhhccC
Confidence 999999998875543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=209.85 Aligned_cols=162 Identities=28% Similarity=0.489 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+..............+++.|++||.+.+
T Consensus 138 l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 138 LTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhcc
Confidence 578899999999999999999999 999999999999999999999999998765433333445578889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||||+++|+|++|+.||...........+... ....+..+++.+.+++.+||+.||.+||++.++++
T Consensus 216 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~-- 291 (335)
T 2owb_A 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN-- 291 (335)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--
T ss_pred CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--
Confidence 88899999999999999999999999998877766655433 34456778999999999999999999999999999
Q ss_pred HHhhhCCC
Q 030203 162 RPLIKSPT 169 (181)
Q Consensus 162 ~~~~~~~~ 169 (181)
+.|++...
T Consensus 292 ~~~~~~~~ 299 (335)
T 2owb_A 292 DEFFTSGY 299 (335)
T ss_dssp SHHHHTSC
T ss_pred CccccCCC
Confidence 78887643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=212.24 Aligned_cols=164 Identities=29% Similarity=0.601 Sum_probs=131.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~ 221 (373)
T 2qol_A 144 FTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221 (373)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhh
Confidence 578899999999999999999999 99999999999999999999999999875443211 1112234567999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||||+++|++++ |+.||...........+. .......+..+++.+.+++.+||+.||.+||++.++
T Consensus 222 ~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i 300 (373)
T 2qol_A 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300 (373)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHH
Confidence 988889999999999999999997 999999988887777665 344455567789999999999999999999999999
Q ss_pred HHHHHHhhhCC
Q 030203 158 MELLRPLIKSP 168 (181)
Q Consensus 158 l~~L~~~~~~~ 168 (181)
++.|+.+++..
T Consensus 301 ~~~L~~~~~~~ 311 (373)
T 2qol_A 301 VSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHHCG
T ss_pred HHHHHHHHhCc
Confidence 99999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=207.55 Aligned_cols=162 Identities=28% Similarity=0.422 Sum_probs=137.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC----cEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++....... ......+++.|+|||
T Consensus 111 ~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE 187 (326)
T 2y0a_A 111 LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE 187 (326)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS-CCCCCCSCTTTCCHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC-ccccccCCcCcCCce
Confidence 578899999999999999999999 99999999999998877 79999999987544322 223456889999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+.+..++.++|+||+|+++|+|++|..||.+.........+....... .....+++.+.+++.+||..||.+|||+.
T Consensus 188 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 267 (326)
T 2y0a_A 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 267 (326)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred eecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHH
Confidence 9988889999999999999999999999999988877766664333222 12356889999999999999999999999
Q ss_pred HHHHHHHHhhhCC
Q 030203 156 TIMELLRPLIKSP 168 (181)
Q Consensus 156 ~~l~~L~~~~~~~ 168 (181)
++++ ++|++..
T Consensus 268 e~l~--hp~~~~~ 278 (326)
T 2y0a_A 268 DSLQ--HPWIKPK 278 (326)
T ss_dssp HHHH--STTTSCC
T ss_pred HHhc--CCCccCC
Confidence 9999 8888654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=203.62 Aligned_cols=163 Identities=25% Similarity=0.415 Sum_probs=137.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+...... ........+++.|++||.+
T Consensus 106 ~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 183 (305)
T 2wtk_C 106 FPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183 (305)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhc
Confidence 578899999999999999999999 999999999999999999999999998754321 1122345678899999998
Q ss_pred CCCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPS--NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~--~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+... +.++|+||+|+++|+|++|..||.+.+.......+... ....+..+++.+.+++.+||..||.+|||+.++
T Consensus 184 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 261 (305)
T 2wtk_C 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261 (305)
T ss_dssp TCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 76543 67899999999999999999999998887777766433 344567889999999999999999999999999
Q ss_pred HHHHHHhhhCCCC
Q 030203 158 MELLRPLIKSPTP 170 (181)
Q Consensus 158 l~~L~~~~~~~~~ 170 (181)
++ ++|++...+
T Consensus 262 l~--~~~~~~~~~ 272 (305)
T 2wtk_C 262 RQ--HSWFRKKHP 272 (305)
T ss_dssp HH--SHHHHSCCC
T ss_pred hc--CcccccCCC
Confidence 99 788875544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=206.15 Aligned_cols=164 Identities=28% Similarity=0.501 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 188 (295)
T 3ugc_A 111 IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188 (295)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHH
Confidence 578899999999999999999999 9999999999999999999999999987543321 11223345567999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhccCCccCCCCCCCHHHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA----------------QVVAAVGFKGKRLEIPRNVNPHVASIIEA 142 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 142 (181)
+.+..++.++|+||+|++++++++|..|+...... .....+ ......+.+..+++.+.+++.+
T Consensus 189 ~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~ 267 (295)
T 3ugc_A 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTE 267 (295)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred hcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH-hccCcCCCCcCcCHHHHHHHHH
Confidence 98888999999999999999999999988654321 122222 2344556677899999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 143 CWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 143 ~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
||+.||.+|||+.++++.|+.+.+..
T Consensus 268 ~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 268 CWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 99999999999999999999988764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=210.95 Aligned_cols=161 Identities=20% Similarity=0.310 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC--cEEEcccCCccccccccc-------cCCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTFL-------SSKSAAGTPE 72 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~--~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~ 72 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||+++....... ......+++.
T Consensus 148 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~ 225 (345)
T 2v62_A 148 FKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIE 225 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCcc
Confidence 678999999999999999999999 99999999999998777 999999999875432211 1134578899
Q ss_pred ccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhccCCccCC---------CCCCCHHHHHHHH
Q 030203 73 WMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNL--NPAQVVAAVGFKGKRLEI---------PRNVNPHVASIIE 141 (181)
Q Consensus 73 ~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~--~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~ 141 (181)
|+|||.+.+..++.++|+||||+++|+|++|+.||... ......... ....... ...+++++.+++.
T Consensus 226 y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 303 (345)
T 2v62_A 226 FTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLV 303 (345)
T ss_dssp TCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHH
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH--HhhcccccHHHHhhccccccHHHHHHHHH
Confidence 99999999888899999999999999999999999652 222222111 1111111 1268899999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 142 ACWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 142 ~~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
+||..||.+||++.++++.|+...-
T Consensus 304 ~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 304 CAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHhhcCcccCCCHHHHHHHHhccCC
Confidence 9999999999999999999986543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=201.54 Aligned_cols=165 Identities=28% Similarity=0.417 Sum_probs=139.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc---EEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~---~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++. ++|+|||.+....... ......+++.|+|||.
T Consensus 102 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~ 178 (284)
T 3kk8_A 102 YSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEV 178 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-BCCCSCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-cccCCCCCcCCcCchh
Confidence 678899999999999999999999 999999999999976655 9999999986544332 2234567889999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+..++.++|+||+|+++++|++|..||.+.........+........ ....+++.+.+++.+||+.||.+|||+.+
T Consensus 179 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (284)
T 3kk8_A 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 258 (284)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHH
Confidence 9888889999999999999999999999999988887777654443332 33578999999999999999999999999
Q ss_pred HHHHHHHhhhCCCCC
Q 030203 157 IMELLRPLIKSPTPQ 171 (181)
Q Consensus 157 ~l~~L~~~~~~~~~~ 171 (181)
+++ ++|++.....
T Consensus 259 ~l~--h~~~~~~~~~ 271 (284)
T 3kk8_A 259 ALK--VPWICNRERV 271 (284)
T ss_dssp HTT--SHHHHSCCCG
T ss_pred Hhc--CccccCChhH
Confidence 999 8888765444
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=211.32 Aligned_cols=165 Identities=27% Similarity=0.409 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++. ++.++|+|||++....... ......+++.|+|||.
T Consensus 158 l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~ 234 (400)
T 1nxk_A 158 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEV 234 (400)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccCCCC-ccccCCCCCCccCHhh
Confidence 678999999999999999999999 999999999999987 7889999999987544322 2234567889999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+.+..++.++|+||+|+++|+|++|..||.+..... ....+....... .....+++++.+||.+||..||.+||
T Consensus 235 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 314 (400)
T 1nxk_A 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 314 (400)
T ss_dssp SCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc
Confidence 988889999999999999999999999997654321 222332222222 22356899999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCCCC
Q 030203 153 SFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~~~ 171 (181)
|+.++++ +.|+......
T Consensus 315 t~~eil~--hp~~~~~~~~ 331 (400)
T 1nxk_A 315 TITEFMN--HPWIMQSTKV 331 (400)
T ss_dssp CHHHHHH--SHHHHTTTTS
T ss_pred CHHHHhc--CccccCCCCC
Confidence 9999999 8888765443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=213.40 Aligned_cols=162 Identities=24% Similarity=0.338 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc---------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--------------------- 60 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--------------------- 60 (181)
+++..+..++.|++.||.|||++| ++||||+|+||+++.++.++|+|||+++.....
T Consensus 106 ~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (388)
T 3oz6_A 106 LEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183 (388)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccc
Confidence 578889999999999999999999 999999999999999999999999998753221
Q ss_pred cccCCCCCCCCCccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--------------
Q 030203 61 FLSSKSAAGTPEWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-------------- 125 (181)
Q Consensus 61 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------------- 125 (181)
........+++.|+|||.+.+ ..++.++|+||+||++++|++|+.||.+.+.......+......
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 263 (388)
T 3oz6_A 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFA 263 (388)
T ss_dssp ------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHH
Confidence 111233468889999999876 56889999999999999999999999988876655544211000
Q ss_pred -------------------------------cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 126 -------------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 126 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
...+..+++++.+|+.+||..||.+|||+.++++ ++|++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~--Hp~~~~ 334 (388)
T 3oz6_A 264 KTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK--HPFVSI 334 (388)
T ss_dssp HHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT--STTTTT
T ss_pred HHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC--CHHHHH
Confidence 0012267889999999999999999999999999 888764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=206.71 Aligned_cols=162 Identities=35% Similarity=0.608 Sum_probs=138.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 135 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (322)
T 1p4o_A 135 PSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 212 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhh
Confidence 367889999999999999999999 9999999999999999999999999987543321 122233456789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+.........+. .......+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 213 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l 291 (322)
T 1p4o_A 213 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291 (322)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 88888999999999999999999 899999988887777664 3334456678999999999999999999999999999
Q ss_pred HHHHHhhh
Q 030203 159 ELLRPLIK 166 (181)
Q Consensus 159 ~~L~~~~~ 166 (181)
+.|+..+.
T Consensus 292 ~~L~~~~~ 299 (322)
T 1p4o_A 292 SSIKEEME 299 (322)
T ss_dssp HHHGGGSC
T ss_pred HHHHHhhc
Confidence 99987644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=208.64 Aligned_cols=167 Identities=21% Similarity=0.258 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc----cccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT----FLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++...... ........+++.|+|||
T Consensus 121 ~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (351)
T 3mi9_A 121 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCch
Confidence 578899999999999999999999 999999999999999999999999998754321 12223456788999999
Q ss_pred ccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--ccCCCCC-----------------------
Q 030203 78 VLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--RLEIPRN----------------------- 131 (181)
Q Consensus 78 ~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~----------------------- 131 (181)
.+.+. .++.++|+||+|+++++|++|..||.+.........+..... .......
T Consensus 199 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
T 3mi9_A 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 278 (351)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHH
T ss_pred hhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHH
Confidence 88764 478999999999999999999999999887765555432111 1111111
Q ss_pred -----CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCC
Q 030203 132 -----VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172 (181)
Q Consensus 132 -----~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~ 172 (181)
.++.+.+|+.+||+.||.+|||++++++ ++|++..+.+.
T Consensus 279 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~~~ 322 (351)
T 3mi9_A 279 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWSDPMPS 322 (351)
T ss_dssp HHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGSSSCCC
T ss_pred hhhccCChHHHHHHHHHhcCChhhCCCHHHHhC--CCCcCCCCCcc
Confidence 2677999999999999999999999999 99998755544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=203.09 Aligned_cols=160 Identities=34% Similarity=0.629 Sum_probs=133.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... ....++..|.|||.+.+
T Consensus 114 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~ 188 (278)
T 1byg_A 114 LGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALRE 188 (278)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccccccc---cCCCccccccCHHHhCC
Confidence 577889999999999999999999 9999999999999999999999999886543321 22355678999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|+++++|++ |..||...........+. .......+..+++.+.+++.+||+.||.+||++.++++.
T Consensus 189 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267 (278)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHH
Confidence 888999999999999999998 999999888777666664 334455677899999999999999999999999999999
Q ss_pred HHHhhhC
Q 030203 161 LRPLIKS 167 (181)
Q Consensus 161 L~~~~~~ 167 (181)
|+.+...
T Consensus 268 L~~i~~~ 274 (278)
T 1byg_A 268 LEHIKTH 274 (278)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 9988653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-32 Score=202.74 Aligned_cols=164 Identities=31% Similarity=0.667 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCCCceecCCCCCCEEEcCCCc-EEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR---RNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~---~~~~~~h~~i~~~nil~~~~~~-~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||+ ++ ++|+||+|+||+++.++. ++|+|||.+...... .....+++.|+|||
T Consensus 99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE 173 (307)
T 2eva_A 99 YTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPE 173 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChh
Confidence 5678899999999999999999 78 999999999999988876 799999998644332 22346788999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+.+..++.++|+||+|+++++|++|+.||...... ....... .......+..+++.+.+++.+||+.||.+|||++
T Consensus 174 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 252 (307)
T 2eva_A 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSME 252 (307)
T ss_dssp HHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHH
Confidence 998888999999999999999999999999765332 2222222 3444556678999999999999999999999999
Q ss_pred HHHHHHHHhhhCCCCC
Q 030203 156 TIMELLRPLIKSPTPQ 171 (181)
Q Consensus 156 ~~l~~L~~~~~~~~~~ 171 (181)
++++.|+.+.+..+..
T Consensus 253 ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 253 EIVKIMTHLMRYFPGA 268 (307)
T ss_dssp HHHHHHHHHGGGCCCT
T ss_pred HHHHHHHHHHHhccCC
Confidence 9999999987655443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-32 Score=206.58 Aligned_cols=161 Identities=27% Similarity=0.393 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||+++..... .....+++.|+|||.+.+
T Consensus 125 l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 125 LGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeecccccccc---cCcCcCCCCcCCHHHHhC
Confidence 578899999999999999999999 999999999999999999999999998764432 234577889999998876
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-C----------------------------CccCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-G----------------------------KRLEIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~ 131 (181)
..++.++|+||+||++++|++|+.||.+.+.......+... + ........
T Consensus 200 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (367)
T 1cm8_A 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 279 (367)
T ss_dssp TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 56889999999999999999999999988766544433210 0 01123356
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.++.+.+|+.+||..||.+|||+.++++ +++++...
T Consensus 280 ~~~~~~~ll~~mL~~dP~~R~t~~e~l~--hp~f~~~~ 315 (367)
T 1cm8_A 280 ASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFESLH 315 (367)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTC
T ss_pred CCHHHHHHHHHHccCChhHCCCHHHHhc--ChHHHhhc
Confidence 7899999999999999999999999999 89988654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=205.61 Aligned_cols=161 Identities=32% Similarity=0.583 Sum_probs=139.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+
T Consensus 116 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 193 (303)
T 3a7i_A 116 LDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193 (303)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc
Confidence 578899999999999999999999 999999999999999999999999998765544333445578889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+|+++++|++|..||...........+. .......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 194 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~-- 270 (303)
T 3a7i_A 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK-- 270 (303)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT--
T ss_pred CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh--
Confidence 888999999999999999999999999888777666554 33344566788999999999999999999999999998
Q ss_pred HHhhhC
Q 030203 162 RPLIKS 167 (181)
Q Consensus 162 ~~~~~~ 167 (181)
+.++..
T Consensus 271 ~~~~~~ 276 (303)
T 3a7i_A 271 HKFILR 276 (303)
T ss_dssp CHHHHH
T ss_pred Chhhhc
Confidence 666654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=208.06 Aligned_cols=165 Identities=23% Similarity=0.363 Sum_probs=133.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++...... ........+++.|+|||.+
T Consensus 102 ~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 179 (323)
T 3tki_A 102 MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179 (323)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHh
Confidence 578899999999999999999999 999999999999999999999999998754322 2223345788999999999
Q ss_pred CCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..+ +.++|+||+|+++|+|++|..||....... .................+++.+.+++.+||..||.+|||+.++
T Consensus 180 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 259 (323)
T 3tki_A 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259 (323)
T ss_dssp HCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 77664 678999999999999999999998765432 2222222222233345689999999999999999999999999
Q ss_pred HHHHHHhhhCCCC
Q 030203 158 MELLRPLIKSPTP 170 (181)
Q Consensus 158 l~~L~~~~~~~~~ 170 (181)
++ +.|++....
T Consensus 260 l~--h~~~~~~~~ 270 (323)
T 3tki_A 260 KK--DRWYNKPLK 270 (323)
T ss_dssp TT--CTTTTCCCC
T ss_pred hh--Chhhccccc
Confidence 99 888876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=207.75 Aligned_cols=163 Identities=24% Similarity=0.445 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.|||+++ ++|+||+|+||+++ ++.++|+|||++........ ......+++.|+|||.+
T Consensus 105 ~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 181 (343)
T 3dbq_A 105 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHH
Confidence 578899999999999999999999 99999999999997 57899999999875443221 22345789999999998
Q ss_pred CC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCC
Q 030203 80 RD-----------EPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANE 147 (181)
Q Consensus 80 ~~-----------~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 147 (181)
.+ ..++.++|+||+|+++|+|++|+.||...... .....+.........+...++.+.+++.+||+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 261 (343)
T 3dbq_A 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRD 261 (343)
T ss_dssp HHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSS
T ss_pred hhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCC
Confidence 54 45788999999999999999999999875432 3333333344455667778899999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhCCC
Q 030203 148 PWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 148 p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
|.+|||+.++++ ++|++...
T Consensus 262 p~~Rpt~~e~l~--hp~~~~~~ 281 (343)
T 3dbq_A 262 PKQRISIPELLA--HPYVQIQT 281 (343)
T ss_dssp TTTSCCHHHHHT--SHHHHSCC
T ss_pred hhHCCCHHHHHh--CccccccC
Confidence 999999999999 88887543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=211.85 Aligned_cols=167 Identities=32% Similarity=0.569 Sum_probs=132.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc----cCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++....... ......+++.|+|||
T Consensus 189 ~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE 266 (373)
T 3c1x_A 189 PTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266 (373)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChH
Confidence 467889999999999999999999 99999999999999999999999999875432211 112334567899999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
.+.+..++.++|+||+|+++|+|++ |..||...+..+....+. .......+..+++.+.+++.+||+.||.+|||+.+
T Consensus 267 ~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~e 345 (373)
T 3c1x_A 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 345 (373)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9988889999999999999999999 688887776655555553 34445556789999999999999999999999999
Q ss_pred HHHHHHHhhhCCCCC
Q 030203 157 IMELLRPLIKSPTPQ 171 (181)
Q Consensus 157 ~l~~L~~~~~~~~~~ 171 (181)
+++.|+.++......
T Consensus 346 ll~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 346 LVSRISAIFSTFIGE 360 (373)
T ss_dssp HHHHHHHHHHTCCSC
T ss_pred HHHHHHHHHHhcccc
Confidence 999999998876544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=205.15 Aligned_cols=171 Identities=29% Similarity=0.493 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-----cccCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-----FLSSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~~~p 76 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++ ++.++++|||++...... ........+++.|+||
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aP 203 (319)
T 2y4i_B 127 LDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203 (319)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccCh
Confidence 577899999999999999999999 99999999999998 679999999987643211 1112234567889999
Q ss_pred cccCC---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCC
Q 030203 77 EVLRD---------EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANE 147 (181)
Q Consensus 77 e~~~~---------~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 147 (181)
|.+.+ ..++.++|+||+|+++|+|++|..||...........+............+++.+.+++.+||..|
T Consensus 204 E~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 283 (319)
T 2y4i_B 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFE 283 (319)
T ss_dssp HHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSS
T ss_pred HHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCC
Confidence 98864 336789999999999999999999999998887777765444433344568899999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCCC
Q 030203 148 PWKRPSFSTIMELLRPLIKSPTPQPSPT 175 (181)
Q Consensus 148 p~~Rps~~~~l~~L~~~~~~~~~~~~~~ 175 (181)
|.+|||+.++++.|+.+.+.....+.|.
T Consensus 284 p~~Rpt~~~l~~~l~~l~~~~~~~~~~~ 311 (319)
T 2y4i_B 284 QEERPTFTKLMDMLEKLPKRNRRLSHPG 311 (319)
T ss_dssp TTTSCCHHHHHHHHTTC-----------
T ss_pred hhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence 9999999999999999988766655443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=208.95 Aligned_cols=164 Identities=34% Similarity=0.623 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+
T Consensus 145 ~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (316)
T 2xir_A 145 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 222 (316)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh
Confidence 578899999999999999999999 9999999999999999999999999987543221 112233456789999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++ |..||.+...................+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 223 ~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 302 (316)
T 2xir_A 223 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302 (316)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88888999999999999999998 99999877644333322224445556777899999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+++.
T Consensus 303 ~~L~~~~~~ 311 (316)
T 2xir_A 303 EHLGNLLQA 311 (316)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhh
Confidence 999998874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=205.26 Aligned_cols=163 Identities=36% Similarity=0.606 Sum_probs=140.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......+++.|.|||.+.
T Consensus 108 ~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (288)
T 3kfa_A 108 VSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185 (288)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHH
T ss_pred ccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhc
Confidence 578899999999999999999999 9999999999999999999999999987544322 1222334466899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++++|++ |..||...+.......+. .......+..+++.+.+++.+||..||.+|||+.++++
T Consensus 186 ~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 8888999999999999999999 999999888777666664 44455667789999999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
.|+.+++.
T Consensus 265 ~l~~~~~~ 272 (288)
T 3kfa_A 265 AFETMFQE 272 (288)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99988764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=206.57 Aligned_cols=163 Identities=18% Similarity=0.359 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc-----EEEcccCCccccccccc-------cCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSRLKANTFL-------SSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~-----~~l~d~g~~~~~~~~~~-------~~~~~~~ 69 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++. ++|+|||++........ ......+
T Consensus 102 ~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~g 179 (330)
T 2izr_A 102 FSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179 (330)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCC
Confidence 678999999999999999999999 999999999999998887 99999999875433221 1245678
Q ss_pred CCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCcc---CCCCCCCHHHHHHHHHH
Q 030203 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKGKRL---EIPRNVNPHVASIIEAC 143 (181)
Q Consensus 70 ~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~ 143 (181)
++.|+|||.+.+..++.++|+||||+++|+|++|..||.+... ......+....... .....++ ++.+++.+|
T Consensus 180 t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~ 258 (330)
T 2izr_A 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYV 258 (330)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHH
T ss_pred CccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHH
Confidence 8999999999998899999999999999999999999987543 23333321111111 1122344 999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
++.||.+||+++++.+.|+++++.
T Consensus 259 l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 259 RRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCHHHHHHHHHHHHHH
Confidence 999999999999999999988764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-32 Score=203.41 Aligned_cols=169 Identities=18% Similarity=0.283 Sum_probs=128.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|++||.+.
T Consensus 131 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 208 (309)
T 2h34_A 131 LAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208 (309)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHc
Confidence 578899999999999999999999 9999999999999999999999999886544322 1223446788999999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCC-CHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRP-SFSTIM 158 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~~l 158 (181)
+..++.++|+||||+++|+|++|+.||.+.........+..... ....+..+++.+.+++.+||+.||.+|| ++.+++
T Consensus 209 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 209 ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS 288 (309)
T ss_dssp C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence 88888999999999999999999999998877655554433222 2245677899999999999999999999 999999
Q ss_pred HHHHHhhhCCCCCC
Q 030203 159 ELLRPLIKSPTPQP 172 (181)
Q Consensus 159 ~~L~~~~~~~~~~~ 172 (181)
+.|+.++.......
T Consensus 289 ~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 289 AAAHAALATADQDR 302 (309)
T ss_dssp HHHHHTCC------
T ss_pred HHHHHHHHhhcccc
Confidence 99999888765443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=205.54 Aligned_cols=166 Identities=19% Similarity=0.370 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+
T Consensus 99 ~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 99 VPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhc
Confidence 578899999999999999999999 999999999999999999999999998765544333445577889999999876
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-------------------CccC----------CCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-------------------KRLE----------IPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~----------~~~~ 131 (181)
..++.++|+||+|+++++|++|..||.+....+....+.... .... ....
T Consensus 177 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 4agu_A 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN 256 (311)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTT
T ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhccc
Confidence 457899999999999999999999999887765544332110 0000 0135
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
+++.+.+++.+||+.||.+|||++++++ ++|+++....
T Consensus 257 ~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~~ 294 (311)
T 4agu_A 257 ISYPALGLLKGCLHMDPTERLTCEQLLH--HPYFENIREI 294 (311)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCCHHHHHT--SGGGTTCC--
T ss_pred ccHHHHHHHHHHccCChhhcCCHHHHhc--ChHHHhccCH
Confidence 7889999999999999999999999999 8998875443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=218.39 Aligned_cols=161 Identities=27% Similarity=0.380 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.++.++|+|||+++...... ......+++.|+|||.+.+
T Consensus 161 l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 161 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-----CC-CC----CCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc-ccCCCcccccccCHHHHcC
Confidence 578899999999999999999999 9999999999999999999999999987554322 2344578899999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--------------------cC---------CCCC-
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--------------------LE---------IPRN- 131 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------------------~~---------~~~~- 131 (181)
..++.++|+||+||++++|++|+.||.+.+..+....+...... .. .+..
T Consensus 238 ~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (464)
T 3ttj_A 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 317 (464)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGG
T ss_pred CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccc
Confidence 88999999999999999999999999998876555443211000 00 0000
Q ss_pred ----------CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 132 ----------VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 132 ----------~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
.++++.+|+.+||..||.+|||++++++ ++|++.
T Consensus 318 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~~~~ 361 (464)
T 3ttj_A 318 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYINV 361 (464)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTGG
T ss_pred cccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc--Chhhhh
Confidence 1567899999999999999999999999 888874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=222.09 Aligned_cols=166 Identities=28% Similarity=0.534 Sum_probs=140.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++....... ......+++.|+|||.
T Consensus 433 l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~ 510 (613)
T 2ozo_A 433 IPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510 (613)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhh
Confidence 678899999999999999999999 99999999999999999999999999875432211 1122334578999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||||+++|+|++ |+.||.+.+..+....+. .+.+...+..+++.+.+++.+||+.||.+||++.++
T Consensus 511 ~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 988889999999999999999998 999999988888777775 445566778899999999999999999999999999
Q ss_pred HHHHHHhhhCCCC
Q 030203 158 MELLRPLIKSPTP 170 (181)
Q Consensus 158 l~~L~~~~~~~~~ 170 (181)
++.|+.++.....
T Consensus 590 ~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 590 EQRMRACYYSLAS 602 (613)
T ss_dssp HHHHHHHHHHHSC
T ss_pred HHHHHHHHHHhcc
Confidence 9999998765433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=209.50 Aligned_cols=164 Identities=30% Similarity=0.524 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+
T Consensus 161 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 238 (333)
T 2i1m_A 161 ASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238 (333)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHh
Confidence 578899999999999999999999 99999999999999999999999999875433211 12233456689999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||||+++|+|++ |..||.+...................+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 239 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 318 (333)
T 2i1m_A 239 FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318 (333)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 88888999999999999999998 99999887654444444334455556677899999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+.+.+.
T Consensus 319 ~~L~~~~~~ 327 (333)
T 2i1m_A 319 SFLQEQAQE 327 (333)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-32 Score=202.86 Aligned_cols=164 Identities=26% Similarity=0.518 Sum_probs=138.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+
T Consensus 122 ~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 199 (314)
T 3com_A 122 LTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 199 (314)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCC
Confidence 578899999999999999999999 999999999999999999999999998765544333445577889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+|+++|+|++|..||...........+..... ....+..+++.+.+++.+||..||.+|||+.++++
T Consensus 200 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~- 278 (314)
T 3com_A 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ- 278 (314)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT-
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh-
Confidence 8889999999999999999999999998877665554432222 22345567899999999999999999999999999
Q ss_pred HHHhhhCCC
Q 030203 161 LRPLIKSPT 169 (181)
Q Consensus 161 L~~~~~~~~ 169 (181)
++|++...
T Consensus 279 -~~~~~~~~ 286 (314)
T 3com_A 279 -HPFVRSAK 286 (314)
T ss_dssp -SHHHHTCC
T ss_pred -CHHHhcCC
Confidence 78877654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=213.78 Aligned_cols=162 Identities=22% Similarity=0.359 Sum_probs=138.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||++| ++||||+|+||+++.+|.++|+|||++....... .......|++.|+|||.+.
T Consensus 165 ~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~ 242 (410)
T 3v8s_A 165 VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242 (410)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhh
Confidence 578899999999999999999999 9999999999999999999999999987544322 2334567899999999987
Q ss_pred CCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--ccCCCCCCCHHHHHHHHHHhcCCCCC--CC
Q 030203 81 DEP----SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWK--RP 152 (181)
Q Consensus 81 ~~~----~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~--Rp 152 (181)
+.. ++.++|+||+|+++|+|++|+.||.+.+......++..... ..+....+++++++||.+||..+|.+ ||
T Consensus 243 ~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~ 322 (410)
T 3v8s_A 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRN 322 (410)
T ss_dssp TTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSS
T ss_pred ccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCC
Confidence 655 67899999999999999999999999988887777653322 22333578999999999999999988 99
Q ss_pred CHHHHHHHHHHhhhC
Q 030203 153 SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 s~~~~l~~L~~~~~~ 167 (181)
++.++++ ++|++.
T Consensus 323 ~~~ei~~--Hp~f~~ 335 (410)
T 3v8s_A 323 GVEEIKR--HLFFKN 335 (410)
T ss_dssp CHHHHHT--SGGGCC
T ss_pred CHHHHhc--CccccC
Confidence 9999999 899875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=207.33 Aligned_cols=164 Identities=22% Similarity=0.264 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc-----CCCcEEEcccCCccccccccccCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-----KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~-----~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~p 76 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++ ..+.++|+|||.+..............+++.|+||
T Consensus 129 ~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aP 206 (329)
T 3gbz_A 129 VSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCH
Confidence 578899999999999999999999 99999999999994 44569999999987654443334445678899999
Q ss_pred cccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC----------------------------
Q 030203 77 EVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE---------------------------- 127 (181)
Q Consensus 77 e~~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------- 127 (181)
|.+.+.. ++.++|+||+|+++|+|++|..||.+....+....+........
T Consensus 207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
T 3gbz_A 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV 286 (329)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHH
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhh
Confidence 9987754 78999999999999999999999998887665554421110000
Q ss_pred CCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.+..+++++.+|+.+||+.||.+|||+.++++ ++|++...
T Consensus 287 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~ 326 (329)
T 3gbz_A 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALE--HPYFSHND 326 (329)
T ss_dssp HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSSSC
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhC--CcccCCCC
Confidence 01126789999999999999999999999999 99988643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=223.00 Aligned_cols=163 Identities=29% Similarity=0.547 Sum_probs=139.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+++...... .......+++.|+|||.
T Consensus 466 l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~ 543 (635)
T 4fl3_A 466 VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 543 (635)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhh
Confidence 578899999999999999999999 9999999999999999999999999987543321 11223345678999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||+|+++|+|++ |+.||.+.........+. .......+..+++++.+++.+||+.||.+||++.++
T Consensus 544 ~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 622 (635)
T 4fl3_A 544 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 622 (635)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 988889999999999999999998 999999999888877775 445566778899999999999999999999999999
Q ss_pred HHHHHHhhhC
Q 030203 158 MELLRPLIKS 167 (181)
Q Consensus 158 l~~L~~~~~~ 167 (181)
++.|++++.+
T Consensus 623 ~~~L~~~~~~ 632 (635)
T 4fl3_A 623 ELRLRNYYYD 632 (635)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999988753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=209.26 Aligned_cols=163 Identities=23% Similarity=0.446 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++ ++.++|+|||++....... .......+++.|+|||.+
T Consensus 152 ~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 228 (390)
T 2zmd_A 152 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228 (390)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHh
Confidence 567889999999999999999999 99999999999996 5789999999987544322 122345789999999998
Q ss_pred CC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCC
Q 030203 80 RD-----------EPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANE 147 (181)
Q Consensus 80 ~~-----------~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 147 (181)
.+ ..++.++|+||||+++|+|++|+.||..... ......+.........+...++.+.+++.+||..|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 308 (390)
T 2zmd_A 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRD 308 (390)
T ss_dssp HCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSS
T ss_pred hhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccC
Confidence 65 3477899999999999999999999987543 33333443334445566677899999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhCCC
Q 030203 148 PWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 148 p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
|.+|||+.++++ ++|++...
T Consensus 309 P~~Rps~~ell~--hp~~~~~~ 328 (390)
T 2zmd_A 309 PKQRISIPELLA--HPYVQIQT 328 (390)
T ss_dssp TTTSCCHHHHHT--SHHHHSCC
T ss_pred hhhCCCHHHHhh--CcCccccC
Confidence 999999999999 78887543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=205.99 Aligned_cols=164 Identities=27% Similarity=0.374 Sum_probs=133.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC--cEEEcccCCcccccccc----ccCCCCCCCCCccCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAP 76 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~--~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~p 76 (181)
++..++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++....... .......+++.|+||
T Consensus 166 ~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 166 REKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred cHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 46778899999999999999999 99999999999998766 89999999987533211 122345688899999
Q ss_pred cccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCC--CCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 77 EVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 77 e~~~~--~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
|.+.+ ..++.++|+||||+++|+|++|+.||.+.........+......... ...+++.+.+++.+||+.||.+||
T Consensus 244 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred hhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 99865 55788999999999999999999999998887777666544433322 234789999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCCC
Q 030203 153 SFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~~ 170 (181)
++.++++ ++|++....
T Consensus 324 s~~~~l~--hp~~~~~~~ 339 (345)
T 3hko_A 324 DAMRALQ--HPWISQFSD 339 (345)
T ss_dssp CHHHHHH--SHHHHTTSS
T ss_pred CHHHHhc--ChhhccChH
Confidence 9999999 888887543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=218.16 Aligned_cols=164 Identities=35% Similarity=0.598 Sum_probs=140.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++...... .......++..|+|||.+.
T Consensus 315 ~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 392 (495)
T 1opk_A 315 VSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392 (495)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHh
Confidence 577889999999999999999999 9999999999999999999999999987543322 2222334567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||||+++|+|++ |..||.+.+.......+. ...+...+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 393 ~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8888999999999999999998 999999988777666664 44556677889999999999999999999999999999
Q ss_pred HHHHhhhCC
Q 030203 160 LLRPLIKSP 168 (181)
Q Consensus 160 ~L~~~~~~~ 168 (181)
.|+.+++..
T Consensus 472 ~L~~~~~~~ 480 (495)
T 1opk_A 472 AFETMFQES 480 (495)
T ss_dssp HHHTSCSSS
T ss_pred HHHHHHhcc
Confidence 999887653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=210.92 Aligned_cols=164 Identities=24% Similarity=0.401 Sum_probs=138.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC--CCcEEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++. .+.++|+|||++....... ......+++.|+|||.+
T Consensus 146 l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~ 222 (387)
T 1kob_A 146 MSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIV 222 (387)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-CEEEECSSGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCc-ceeeeccCCCccCchhc
Confidence 578999999999999999999999 999999999999974 5779999999987544321 11234678899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..++.++|+||+|+++|+|++|..||.+.+.......+...... ......+++++.+++.+||..||.+|||+.++
T Consensus 223 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 302 (387)
T 1kob_A 223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302 (387)
T ss_dssp TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8888899999999999999999999999998887777666543322 23345789999999999999999999999999
Q ss_pred HHHHHHhhhCCCC
Q 030203 158 MELLRPLIKSPTP 170 (181)
Q Consensus 158 l~~L~~~~~~~~~ 170 (181)
++ ++|++....
T Consensus 303 l~--hp~~~~~~~ 313 (387)
T 1kob_A 303 LE--HPWLKGDHS 313 (387)
T ss_dssp HT--STTTSSCCT
T ss_pred hh--CccccCCcc
Confidence 99 888876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=204.57 Aligned_cols=163 Identities=33% Similarity=0.519 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.
T Consensus 123 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 200 (302)
T 4e5w_A 123 INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200 (302)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCee
Confidence 578899999999999999999999 9999999999999999999999999987544322 22334456778999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------------CHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHh
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNL--------------NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACW 144 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 144 (181)
+.+..++.++|+||+|+++++|++|..|+... ..................+..+++.+.+++.+||
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 280 (302)
T 4e5w_A 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCW 280 (302)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred ecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence 98888888999999999999999998875332 1111122222244455667789999999999999
Q ss_pred cCCCCCCCCHHHHHHHHHHhhh
Q 030203 145 ANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 145 ~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
+.||.+|||+.++++.|+.+++
T Consensus 281 ~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 281 EFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999999999999998864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=208.56 Aligned_cols=164 Identities=34% Similarity=0.506 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc--------------CCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS--------------SKSA 67 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--------------~~~~ 67 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+......... ....
T Consensus 105 ~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (310)
T 3s95_A 105 YPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182 (310)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccccccccccc
Confidence 578899999999999999999999 999999999999999999999999998754332111 1145
Q ss_pred CCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccCCccCCCCCCCHHHHHHHHHHhcC
Q 030203 68 AGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKGKRLEIPRNVNPHVASIIEACWAN 146 (181)
Q Consensus 68 ~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~ 146 (181)
.+++.|+|||.+.+..++.++|+||+|+++|++++|..|+............ .........+..+++.+.+++.+||+.
T Consensus 183 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (310)
T 3s95_A 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDL 262 (310)
T ss_dssp CSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCS
T ss_pred CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccC
Confidence 6888999999999988999999999999999999999988654321100000 000011224567889999999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhhC
Q 030203 147 EPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 147 ~p~~Rps~~~~l~~L~~~~~~ 167 (181)
||.+|||+.++++.|+.+...
T Consensus 263 dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 263 DPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred ChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999987653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-32 Score=209.25 Aligned_cols=163 Identities=20% Similarity=0.261 Sum_probs=133.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc-CCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||++| ++|+||+|+||+++ .++.++|+|||+++...... ......+++.|+|||.+.
T Consensus 138 ~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~ 214 (394)
T 4e7w_A 138 MPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIF 214 (394)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-CCcccccCcCccCHHHHc
Confidence 577889999999999999999999 99999999999998 78999999999987543322 223456788999999987
Q ss_pred CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CC--------------c------------cCCCCCC
Q 030203 81 DE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GK--------------R------------LEIPRNV 132 (181)
Q Consensus 81 ~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~--------------~------------~~~~~~~ 132 (181)
+. .++.++|+||+||++|+|++|+.||.+.+..+....+... +. . ...+..+
T Consensus 215 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (394)
T 4e7w_A 215 GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRT 294 (394)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTC
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccC
Confidence 65 4889999999999999999999999998766544433211 00 0 0123458
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
++++.+|+.+||..||.+|||+.++++ ++|++...
T Consensus 295 ~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~ 329 (394)
T 4e7w_A 295 PPDAIDLISRLLEYTPSARLTAIEALC--HPFFDELR 329 (394)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGSTTT
T ss_pred CHHHHHHHHHHhCCChhhCCCHHHHhc--Chhhhhhc
Confidence 899999999999999999999999999 99988643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-31 Score=201.28 Aligned_cols=164 Identities=23% Similarity=0.345 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+
T Consensus 117 ~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 193 (326)
T 1blx_A 117 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQ 193 (326)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcccccccCCC-CccccccccceeCHHHHhc
Confidence 678899999999999999999999 9999999999999999999999999987544322 2334567889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------------------------ccCCCCCCCHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-------------------------RLEIPRNVNPHV 136 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~ 136 (181)
..++.++|+||+|+++|+|++|+.||.+.........+..... .......+++.+
T Consensus 194 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 1blx_A 194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 273 (326)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHH
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHH
Confidence 8899999999999999999999999998887665554421100 011235688999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 137 ASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 137 ~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
.+++.+||+.||.+|||+.++++ ++|++....
T Consensus 274 ~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~~~~ 305 (326)
T 1blx_A 274 KDLLLKCLTFNPAKRISAYSALS--HPYFQDLER 305 (326)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT--SGGGTTCCC
T ss_pred HHHHHHHcCCCcccCCCHHHHhc--Cccccccch
Confidence 99999999999999999999998 888876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=208.56 Aligned_cols=161 Identities=27% Similarity=0.352 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE--cCCCcEEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV--DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~--~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||++ +.++.++|+|||++....... ......+++.|+|||.+
T Consensus 184 l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~ 260 (373)
T 2x4f_A 184 LTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNFGTPEFLAPEVV 260 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCCCCSSCTTCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccccccCCCcEeChhhc
Confidence 578899999999999999999999 9999999999999 567889999999987654332 22345688999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..++.++|+||||+++|+|++|..||.+.+.......+....... .....+++++.+|+.+||..||.+|||+.++
T Consensus 261 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~ 340 (373)
T 2x4f_A 261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340 (373)
T ss_dssp TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 88888899999999999999999999999988877766664333222 2235689999999999999999999999999
Q ss_pred HHHHHHhhhC
Q 030203 158 MELLRPLIKS 167 (181)
Q Consensus 158 l~~L~~~~~~ 167 (181)
++ ++|++.
T Consensus 341 l~--hp~~~~ 348 (373)
T 2x4f_A 341 LK--HPWLSD 348 (373)
T ss_dssp HH--SHHHHC
T ss_pred hc--CcCcCC
Confidence 99 677654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=208.30 Aligned_cols=162 Identities=26% Similarity=0.474 Sum_probs=133.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC----CcEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK----YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~----~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||++... +.++|+|||++..............+++.|+|||
T Consensus 113 ~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE 190 (342)
T 2qr7_A 113 FSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190 (342)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHH
Confidence 678999999999999999999999 9999999999998442 3599999999876544433344567789999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~---~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
.+.+..++.++|+||+|+++|+|++|..||.+ .....+...+....... ..+..+++.+.+++.+||..||.+||
T Consensus 191 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 270 (342)
T 2qr7_A 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL 270 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred HhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc
Confidence 99877778899999999999999999999976 34555666654333322 23467899999999999999999999
Q ss_pred CHHHHHHHHHHhhhC
Q 030203 153 SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 s~~~~l~~L~~~~~~ 167 (181)
++.++++ ++|+..
T Consensus 271 t~~~il~--hp~~~~ 283 (342)
T 2qr7_A 271 TAALVLR--HPWIVH 283 (342)
T ss_dssp CHHHHTT--SHHHHT
T ss_pred CHHHHhc--CCeecC
Confidence 9999998 777754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=208.77 Aligned_cols=168 Identities=29% Similarity=0.506 Sum_probs=136.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+....... .......++..|++||.
T Consensus 131 ~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~ 208 (318)
T 3lxp_A 131 IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHH
Confidence 578899999999999999999999 9999999999999999999999999987544321 12233456778999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhccCCccCCCCCCCHHHHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA---------------QVVAAVGFKGKRLEIPRNVNPHVASIIEAC 143 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 143 (181)
+.+..++.++|+||+|+++++|++|..||...... .....+ ........+..+++.+.+++.+|
T Consensus 209 ~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~ 287 (318)
T 3lxp_A 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL-ERGERLPRPDKCPAEVYHLMKNC 287 (318)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHH
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH-hcccCCCCCccccHHHHHHHHHH
Confidence 98888888999999999999999999998764322 112222 23445556778999999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhCCCCCC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKSPTPQP 172 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~~~~~~ 172 (181)
|+.||.+|||+.++++.|+.+.+....+.
T Consensus 288 l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 288 WETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred cCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 99999999999999999999887655443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=202.77 Aligned_cols=161 Identities=27% Similarity=0.483 Sum_probs=122.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCccc-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL- 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~- 79 (181)
+++.+++.++.|++.||.|||++ | ++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+
T Consensus 106 ~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 106 IPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPERIN 182 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcccccccc-cccccCCCccccChhhcC
Confidence 67889999999999999999998 9 9999999999999999999999999987544332 22334678899999996
Q ss_pred ---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 80 ---RDEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 80 ---~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+..++.++|+||+|+++++|++|..||.... ....................+++++.+++.+||+.||.+|||+.
T Consensus 183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 262 (290)
T 3fme_A 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYP 262 (290)
T ss_dssp CCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHH
Confidence 45567889999999999999999999998643 33333333223333334457899999999999999999999999
Q ss_pred HHHHHHHHhhhC
Q 030203 156 TIMELLRPLIKS 167 (181)
Q Consensus 156 ~~l~~L~~~~~~ 167 (181)
++++ ++|++.
T Consensus 263 e~l~--hp~f~~ 272 (290)
T 3fme_A 263 ELMQ--HPFFTL 272 (290)
T ss_dssp HHTT--SHHHHH
T ss_pred HHHh--Cccccc
Confidence 9999 777764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-32 Score=199.83 Aligned_cols=160 Identities=28% Similarity=0.473 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE---cCCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||++ +.++.++|+|||++....... ......+++.|+|||.
T Consensus 121 ~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~ 197 (285)
T 3is5_A 121 LSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAAGTALYMAPEV 197 (285)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc-cCcCcccccCcCChHH
Confidence 678899999999999999999999 9999999999999 446789999999987544322 2234567889999998
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC-CCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE-IPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+. ..++.++|+||+|+++++|++|+.||.+.................. ....+++.+.+++.+||+.||.+|||+.++
T Consensus 198 ~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 276 (285)
T 3is5_A 198 FK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276 (285)
T ss_dssp HT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred hc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 75 4578899999999999999999999999988877766654443332 224478999999999999999999999999
Q ss_pred HHHHHHhhhC
Q 030203 158 MELLRPLIKS 167 (181)
Q Consensus 158 l~~L~~~~~~ 167 (181)
++ ++|+++
T Consensus 277 l~--hp~f~~ 284 (285)
T 3is5_A 277 LH--HEWFKQ 284 (285)
T ss_dssp HT--SGGGGC
T ss_pred hc--CHHhhc
Confidence 99 888875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=207.75 Aligned_cols=164 Identities=28% Similarity=0.422 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC----------CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR----------NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~----------~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~ 69 (181)
+++.+++.++.|++.||.|||+. + ++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 118 ~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~g 195 (322)
T 3soc_A 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195 (322)
T ss_dssp BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCcc
Confidence 57889999999999999999999 9 99999999999999999999999999875443221 2233578
Q ss_pred CCCccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCC----------------HHHHHHHHhccCCccCC
Q 030203 70 TPEWMAPEVLRDE-----PSNEKSDIYSFGVILWELATLQQPWGNLN----------------PAQVVAAVGFKGKRLEI 128 (181)
Q Consensus 70 ~~~~~~pe~~~~~-----~~~~~~Dv~slG~~~~~ll~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~ 128 (181)
++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.. ...+...+.........
T Consensus 196 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (322)
T 3soc_A 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVL 275 (322)
T ss_dssp CGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC
T ss_pred CccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCc
Confidence 8999999998763 24457899999999999999999996542 22333333222222222
Q ss_pred CCC-----CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 129 PRN-----VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 129 ~~~-----~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
+.. .++.+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 276 RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 221 234599999999999999999999999999988764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=217.24 Aligned_cols=160 Identities=29% Similarity=0.487 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.||+.||.|||++| ++|+||+|+||+++.+|.++|+|||++..............|++.|+|||.+.+
T Consensus 286 l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 286 FQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT
T ss_pred ccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcC
Confidence 678899999999999999999999 999999999999999999999999998765444333344578999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH---
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLN----PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF--- 154 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 154 (181)
..++.++|+||+||++|+|++|+.||.+.. ...+...+. ......+..+++.+.+++.+||..||.+||++
T Consensus 364 ~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 441 (543)
T 3c4z_A 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441 (543)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTT
T ss_pred CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCcccCHHHHHHHHHhccCCHhHCCCCccc
Confidence 889999999999999999999999998753 344444442 22345567899999999999999999999964
Q ss_pred --HHHHHHHHHhhhC
Q 030203 155 --STIMELLRPLIKS 167 (181)
Q Consensus 155 --~~~l~~L~~~~~~ 167 (181)
.++++ +++++.
T Consensus 442 ~a~ei~~--Hpff~~ 454 (543)
T 3c4z_A 442 SCDGLRT--HPLFRD 454 (543)
T ss_dssp BSHHHHT--SGGGTT
T ss_pred CHHHHHc--CccccC
Confidence 78887 777764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-32 Score=206.62 Aligned_cols=162 Identities=26% Similarity=0.413 Sum_probs=122.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc--EEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++. ++|+|||+++...... ......+++.|+|||.+
T Consensus 113 ~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~ 189 (361)
T 3uc3_A 113 FSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVL 189 (361)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccC-CCCCCcCCCCcCChhhh
Confidence 578899999999999999999999 999999999999987665 9999999986433221 22345688999999999
Q ss_pred CCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCH
Q 030203 80 RDEPSNEK-SDIYSFGVILWELATLQQPWGNLNP----AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSF 154 (181)
Q Consensus 80 ~~~~~~~~-~Dv~slG~~~~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 154 (181)
.+..+..+ +|+||+|+++|+|++|+.||.+... ......+.......+....+++.+.+|+.+||..||.+|||+
T Consensus 190 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 269 (361)
T 3uc3_A 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISI 269 (361)
T ss_dssp HCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCH
T ss_pred cCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCH
Confidence 87776655 8999999999999999999977543 344444433333334445689999999999999999999999
Q ss_pred HHHHHHHHHhhhCC
Q 030203 155 STIMELLRPLIKSP 168 (181)
Q Consensus 155 ~~~l~~L~~~~~~~ 168 (181)
.++++ ++|+...
T Consensus 270 ~ell~--hp~f~~~ 281 (361)
T 3uc3_A 270 PEIKT--HSWFLKN 281 (361)
T ss_dssp HHHHT--SHHHHTT
T ss_pred HHHHh--CcchhcC
Confidence 99999 8888654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-32 Score=204.39 Aligned_cols=162 Identities=26% Similarity=0.460 Sum_probs=135.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++. ++.++|+|||++....... ......+++.|+|||.
T Consensus 128 ~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~ 204 (327)
T 3lm5_A 128 VSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEI 204 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc-ccccccCCcCccCCee
Confidence 678899999999999999999999 999999999999987 7899999999987544332 2234568899999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+..++.++|+||+|+++|+|++|+.||.+.........+..... .......+++.+.+++.+||+.||.+|||+++
T Consensus 205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ 284 (327)
T 3lm5_A 205 LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284 (327)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9888899999999999999999999999999888776665543332 23344678999999999999999999999999
Q ss_pred HHHHHHHhhhCC
Q 030203 157 IMELLRPLIKSP 168 (181)
Q Consensus 157 ~l~~L~~~~~~~ 168 (181)
+++ ++|++..
T Consensus 285 ll~--h~~~~~~ 294 (327)
T 3lm5_A 285 CLS--HSWLQQW 294 (327)
T ss_dssp HTT--CGGGCCC
T ss_pred HhC--CHhhccc
Confidence 999 8888754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-32 Score=207.12 Aligned_cols=159 Identities=23% Similarity=0.407 Sum_probs=131.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.+|.++|+|||++...... .......+++.|+|||.+.+
T Consensus 112 l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 112 FKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeecc
Confidence 678899999999999999999999 999999999999999999999999998754432 22345678999999999864
Q ss_pred ---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-H
Q 030203 82 ---EPSNEKSDIYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-F 154 (181)
Q Consensus 82 ---~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~ 154 (181)
..++.++|+||+|+++|+|++|+.||.... .......+ .......+..+++.+.+++.+||..||.+||+ +
T Consensus 189 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~ 266 (384)
T 4fr4_A 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQL 266 (384)
T ss_dssp CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSH
T ss_pred CCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccH
Confidence 347889999999999999999999997543 33333333 23344567789999999999999999999997 8
Q ss_pred HHHHHHHHHhhhC
Q 030203 155 STIMELLRPLIKS 167 (181)
Q Consensus 155 ~~~l~~L~~~~~~ 167 (181)
.++++ +++++.
T Consensus 267 ~~l~~--hp~f~~ 277 (384)
T 4fr4_A 267 SDVQN--FPYMND 277 (384)
T ss_dssp HHHHT--SGGGTT
T ss_pred HHHHc--Chhhhc
Confidence 88877 566543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.7e-33 Score=207.73 Aligned_cols=165 Identities=35% Similarity=0.568 Sum_probs=133.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.
T Consensus 124 ~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 201 (327)
T 3lxl_A 124 LDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHH
Confidence 578899999999999999999999 9999999999999999999999999987543321 12234456778999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHhccCCccCCCCCCCHHHHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA---------------QVVAAVGFKGKRLEIPRNVNPHVASIIEAC 143 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 143 (181)
+.+..++.++|+||+|+++++|++|..||...... .....+ ........+..+++.+.+++.+|
T Consensus 202 ~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~ 280 (327)
T 3lxl_A 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL-EEGQRLPAPPACPAEVHELMKLC 280 (327)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHH
T ss_pred hccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh-hcccCCCCCCcccHHHHHHHHHH
Confidence 98887889999999999999999999998654332 122222 24445566778999999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
|+.||.+|||+.++++.|+.+.....
T Consensus 281 l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 281 WAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp TCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 99999999999999999998876443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=208.11 Aligned_cols=158 Identities=23% Similarity=0.343 Sum_probs=128.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-------------------------CCcEEEcccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-------------------------KYTVKVCDFGLSRL 56 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-------------------------~~~~~l~d~g~~~~ 56 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++. ++.++|+|||++..
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~ 211 (360)
T 3llt_A 134 FHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCcee
Confidence 578899999999999999999999 999999999999975 78899999999875
Q ss_pred cccccccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc----------
Q 030203 57 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL---------- 126 (181)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 126 (181)
.... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||......+....+.......
T Consensus 212 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 288 (360)
T 3llt_A 212 KSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATK 288 (360)
T ss_dssp TTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTT
T ss_pred cCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhh
Confidence 4332 234567889999999999889999999999999999999999999887766554442211100
Q ss_pred --------------CCC--------------------CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 127 --------------EIP--------------------RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 127 --------------~~~--------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
..+ ...++.+.+|+.+||+.||.+|||++++++ ++|++
T Consensus 289 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~--hp~f~ 360 (360)
T 3llt_A 289 TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK--HKFLE 360 (360)
T ss_dssp SGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGC
T ss_pred ccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc--CcccC
Confidence 001 112367889999999999999999999998 77764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=204.31 Aligned_cols=166 Identities=27% Similarity=0.446 Sum_probs=117.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc------------cCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL------------SSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~------------~~~~~~~ 69 (181)
+++.+++.++.|++.||.|||++++.++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (337)
T 3ll6_A 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccC
Confidence 6788999999999999999999865599999999999999999999999999875433211 1113457
Q ss_pred CCCccCCccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcC
Q 030203 70 TPEWMAPEVL---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAN 146 (181)
Q Consensus 70 ~~~~~~pe~~---~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 146 (181)
++.|+|||.+ .+..++.++|+||||+++|+|++|+.||.......... ...........++.+.+++.+||+.
T Consensus 213 t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~ 288 (337)
T 3ll6_A 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN----GKYSIPPHDTQYTVFHSLIRAMLQV 288 (337)
T ss_dssp -----------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCS
T ss_pred CCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc----CcccCCcccccchHHHHHHHHHccC
Confidence 8899999998 45557889999999999999999999998765443332 2223344566788899999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 147 EPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 147 ~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
||.+|||+.++++.|+.+.......
T Consensus 289 ~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 289 NPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred ChhhCcCHHHHHHHHHHHHhccCCC
Confidence 9999999999999999988754433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=214.01 Aligned_cols=164 Identities=22% Similarity=0.350 Sum_probs=134.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE---cCCCcEEEcccCCccccccccc-------cCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFL-------SSKSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~---~~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~ 71 (181)
+++.+++.++.||+.||.|||+++ ++|+||+|+||++ +.++.++|+|||+++....... ......++.
T Consensus 100 l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~ 177 (483)
T 3sv0_A 100 LSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177 (483)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCc
Confidence 678999999999999999999999 9999999999999 5788999999999875443321 223567889
Q ss_pred CccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhc---cCCccCCCCCCCHHHHHHHHHHhc
Q 030203 72 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP---AQVVAAVGF---KGKRLEIPRNVNPHVASIIEACWA 145 (181)
Q Consensus 72 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~---~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~ 145 (181)
.|++||.+.+..++.++||||||+++|+|++|+.||.+... ......+.. ..........+++++.+++.+||+
T Consensus 178 ~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~ 257 (483)
T 3sv0_A 178 RYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRS 257 (483)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHT
T ss_pred cccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhc
Confidence 99999999998899999999999999999999999987543 222222211 111112335688999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhhhC
Q 030203 146 NEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 146 ~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
.+|.+||++.++++.|++++..
T Consensus 258 ~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 258 LRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999998663
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=198.79 Aligned_cols=167 Identities=23% Similarity=0.369 Sum_probs=133.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+...... ........+++.|.|||.+
T Consensus 102 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (276)
T 2yex_A 102 MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHH
Confidence 578899999999999999999999 999999999999999999999999998654322 1122345678899999999
Q ss_pred CCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..+ +.++|+||+|+++++|++|..||...... ..................+++.+.+++.+||+.||.+|||+.++
T Consensus 180 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 259 (276)
T 2yex_A 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259 (276)
T ss_dssp TCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred hcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHH
Confidence 77664 67899999999999999999999876543 22222222222223345688999999999999999999999999
Q ss_pred HHHHHHhhhCCCCCC
Q 030203 158 MELLRPLIKSPTPQP 172 (181)
Q Consensus 158 l~~L~~~~~~~~~~~ 172 (181)
++ +.|++......
T Consensus 260 l~--~~~~~~~~~~~ 272 (276)
T 2yex_A 260 KK--DRWYNKPLKKG 272 (276)
T ss_dssp TT--CTTTTCCCC--
T ss_pred hc--CccccChhhcc
Confidence 99 89988766554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=214.47 Aligned_cols=162 Identities=20% Similarity=0.385 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++||||||+||+++.+|.++|+|||+++..... ........|++.|+|||.+.
T Consensus 172 l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 172 LPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHh
Confidence 678899999999999999999999 999999999999999999999999998654332 22233457899999999986
Q ss_pred -----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCC---CCCCHHHHHHHHHHhcCCCCC--
Q 030203 81 -----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIP---RNVNPHVASIIEACWANEPWK-- 150 (181)
Q Consensus 81 -----~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~-- 150 (181)
...++.++|+||+|+++|+|++|+.||.+.+..+...++.........+ ..+++++++||.+||..+|.+
T Consensus 250 ~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~ 329 (437)
T 4aw2_A 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLG 329 (437)
T ss_dssp HHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTT
T ss_pred hcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccC
Confidence 4457889999999999999999999999998887777664322222333 458999999999999888888
Q ss_pred CCCHHHHHHHHHHhhhC
Q 030203 151 RPSFSTIMELLRPLIKS 167 (181)
Q Consensus 151 Rps~~~~l~~L~~~~~~ 167 (181)
|++++++++ ++|++.
T Consensus 330 r~~~~eil~--Hpff~~ 344 (437)
T 4aw2_A 330 QNGIEDFKK--HPFFSG 344 (437)
T ss_dssp TTTTHHHHT--SGGGTT
T ss_pred CCCHHHHhC--CCccCC
Confidence 999999999 999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-32 Score=201.11 Aligned_cols=164 Identities=24% Similarity=0.433 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~ 190 (311)
T 3ork_A 113 MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHH
Confidence 578899999999999999999999 9999999999999999999999999987543321 12233467899999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+..++.++|+||+|+++|+|++|+.||.+................. .....+++++.+++.+||+.||.+||+..+
T Consensus 191 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp HHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred hcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 988888999999999999999999999999988776655443332221 123568999999999999999999996655
Q ss_pred HH-HHHHHhhhC
Q 030203 157 IM-ELLRPLIKS 167 (181)
Q Consensus 157 ~l-~~L~~~~~~ 167 (181)
++ ..|......
T Consensus 271 ~l~~~l~~~~~~ 282 (311)
T 3ork_A 271 EMRADLVRVHNG 282 (311)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHhcC
Confidence 54 444444443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-32 Score=199.38 Aligned_cols=161 Identities=32% Similarity=0.579 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc-CCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++.+++|+||+|+||+++ .++.++|+|||++....... .....+++.|+|||.+.
T Consensus 126 ~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~t~~y~aPE~~~ 203 (290)
T 1t4h_A 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS--BEESCSSCCCCCGGGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc--cccccCCcCcCCHHHHh
Confidence 5788999999999999999999865599999999999997 78899999999986433321 22346788999999886
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+ .++.++|+||+|+++++|++|..||..... ......+.........+...++.+.+++.+||+.||.+|||+.++++
T Consensus 204 ~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 204 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 4 488999999999999999999999988544 44444444333344456677899999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
++|+++
T Consensus 283 --h~~f~~ 288 (290)
T 1t4h_A 283 --HAFFQE 288 (290)
T ss_dssp --SGGGC-
T ss_pred --Cccccc
Confidence 888875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=205.36 Aligned_cols=165 Identities=25% Similarity=0.384 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++. ++.++|+|||++....... ......+++.|+|||.
T Consensus 145 ~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~ 221 (349)
T 2w4o_A 145 YSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-LMKTVCGTPGYCAPEI 221 (349)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----------------CGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCccc-ccccccCCCCccCHHH
Confidence 578999999999999999999999 999999999999975 7899999999987544321 2234567889999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCc--cCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
+.+..++.++|+||+|+++|+|++|..||....... ....+...... .+....+++++.+++.+||..||.+|||+.
T Consensus 222 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (349)
T 2w4o_A 222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTF 301 (349)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred hcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHH
Confidence 998889999999999999999999999997765543 44444322222 223357899999999999999999999999
Q ss_pred HHHHHHHHhhhCCCCC
Q 030203 156 TIMELLRPLIKSPTPQ 171 (181)
Q Consensus 156 ~~l~~L~~~~~~~~~~ 171 (181)
++++ ++|++.....
T Consensus 302 e~l~--hp~~~~~~~~ 315 (349)
T 2w4o_A 302 QALQ--HPWVTGKAAN 315 (349)
T ss_dssp HHHH--STTTTSTTCC
T ss_pred HHhc--CcccCCCccc
Confidence 9999 9999876544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=200.61 Aligned_cols=161 Identities=24% Similarity=0.352 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE---cCCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||++ +.++.++++|||.+....... ......+++.|+|||.
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~ 179 (277)
T 3f3z_A 103 FRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQV 179 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-CBCCCCSCTTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-chhccCCCCCccChHH
Confidence 578899999999999999999999 9999999999999 778899999999986544322 2334568889999998
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+. ++.++|+||+|+++++|++|..||...........+........ ....+++.+.+++.+||+.||.+|||+.+
T Consensus 180 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~ 258 (277)
T 3f3z_A 180 LEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQ 258 (277)
T ss_dssp HTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHH
Confidence 8654 78899999999999999999999999888877776654333222 11368999999999999999999999999
Q ss_pred HHHHHHHhhhCC
Q 030203 157 IMELLRPLIKSP 168 (181)
Q Consensus 157 ~l~~L~~~~~~~ 168 (181)
+++ ++|++..
T Consensus 259 ~l~--h~~~~~~ 268 (277)
T 3f3z_A 259 ALE--HEWFEKQ 268 (277)
T ss_dssp HTT--SHHHHHH
T ss_pred Hhc--CHHHhcc
Confidence 998 7777653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-32 Score=209.85 Aligned_cols=162 Identities=20% Similarity=0.267 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC-CcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||++| ++|+||||+||+++.+ +.+||+|||+++...... ......+++.|+|||.+.
T Consensus 153 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~ 229 (420)
T 1j1b_A 153 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIF 229 (420)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCTTSCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC-CceeeeeCCCcCCHHHHc
Confidence 577889999999999999999999 9999999999999864 678999999987543322 223457788999999987
Q ss_pred CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-C--------------CccC------------CCCCC
Q 030203 81 DE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-G--------------KRLE------------IPRNV 132 (181)
Q Consensus 81 ~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~--------------~~~~------------~~~~~ 132 (181)
+. .++.++|+||+||++|+|++|+.||.+.+..+....+... + .... .+..+
T Consensus 230 ~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 309 (420)
T 1j1b_A 230 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 309 (420)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTS
T ss_pred CCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCC
Confidence 65 5889999999999999999999999988765544333210 0 0000 22456
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
++++.+|+.+||..||.+||++.++++ +.|++..
T Consensus 310 ~~~~~~Li~~~L~~dP~~R~t~~e~l~--hp~f~~~ 343 (420)
T 1j1b_A 310 PPEAIALCSRLLEYTPTARLTPLEACA--HSFFDEL 343 (420)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGGG
T ss_pred CHHHHHHHHHhccCChhHCCCHHHHhC--CHhhccc
Confidence 889999999999999999999999999 8888654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.9e-32 Score=200.29 Aligned_cols=162 Identities=27% Similarity=0.428 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE---cCCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||++ +.++.++++|||.+....... .....+++.|+|||.
T Consensus 103 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~ 178 (304)
T 2jam_A 103 YTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEV 178 (304)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--THHHHSCCCBCCTTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--cccccCCCCccChHH
Confidence 578899999999999999999999 9999999999999 678899999999886433321 122346789999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+..++.++|+||+|+++++|++|..||...........+...... ......+++.+.+++.+||..||.+|||+.+
T Consensus 179 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (304)
T 2jam_A 179 LAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEK 258 (304)
T ss_dssp BSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred hccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 98888899999999999999999999999998888777766544332 2344678999999999999999999999999
Q ss_pred HHHHHHHhhhCCC
Q 030203 157 IMELLRPLIKSPT 169 (181)
Q Consensus 157 ~l~~L~~~~~~~~ 169 (181)
+++ +++++...
T Consensus 259 ~l~--h~~~~~~~ 269 (304)
T 2jam_A 259 ALS--HPWIDGNT 269 (304)
T ss_dssp HHT--SHHHHSSC
T ss_pred Hhc--CccccCCC
Confidence 999 88887644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.4e-33 Score=207.07 Aligned_cols=166 Identities=28% Similarity=0.434 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 136 ~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (321)
T 2qkw_B 136 MSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHh
Confidence 578899999999999999999999 9999999999999999999999999987533221 112233467899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhccC-C----c----cCCCCCCCHHHHHHHHHHh
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKG-K----R----LEIPRNVNPHVASIIEACW 144 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~------~~~~~~~~~-~----~----~~~~~~~~~~~~~li~~~l 144 (181)
.+..++.++|+||+|+++|+|++|+.||....... ......... . . ...+...+..+.+++.+||
T Consensus 214 ~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 293 (321)
T 2qkw_B 214 IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293 (321)
T ss_dssp HHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHT
T ss_pred cCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHc
Confidence 88888999999999999999999999997643321 111110010 0 0 1122234567899999999
Q ss_pred cCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 145 ANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 145 ~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
+.||.+|||+.++++.|+.+++...
T Consensus 294 ~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 294 ALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred CCCcccCcCHHHHHHHHHHHhhccc
Confidence 9999999999999999999987644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=8.9e-32 Score=202.56 Aligned_cols=167 Identities=32% Similarity=0.542 Sum_probs=130.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC--------CCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc----CCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR--------NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS----SKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~--------~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~ 69 (181)
+++.+++.++.|++.||.|||++ + ++|+||+|+||+++.++.++|+|||++......... .....+
T Consensus 131 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 208 (337)
T 3mdy_A 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208 (337)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCcc
Confidence 57889999999999999999999 8 999999999999999999999999998654332211 224578
Q ss_pred CCCccCCcccCCCCCCCc------hhHHHHHHHHHHHHhC----------CCCCCCC-----CHHHHHHHHhccCCccCC
Q 030203 70 TPEWMAPEVLRDEPSNEK------SDIYSFGVILWELATL----------QQPWGNL-----NPAQVVAAVGFKGKRLEI 128 (181)
Q Consensus 70 ~~~~~~pe~~~~~~~~~~------~Dv~slG~~~~~ll~g----------~~p~~~~-----~~~~~~~~~~~~~~~~~~ 128 (181)
++.|+|||.+.+...... +|+||+|+++|+|++| +.||... ........+.........
T Consensus 209 t~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (337)
T 3mdy_A 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288 (337)
T ss_dssp CGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred CcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccc
Confidence 899999999987665554 9999999999999999 6777543 223333333333333333
Q ss_pred CC-----CCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 129 PR-----NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 129 ~~-----~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
+. .+++.+.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 32 4556799999999999999999999999999999887543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=203.15 Aligned_cols=161 Identities=31% Similarity=0.548 Sum_probs=125.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--------hCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc----cCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLH--------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh--------~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~ 69 (181)
+++.+++.++.|++.||.||| +.+ ++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 102 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 179 (301)
T 3q4u_A 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179 (301)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccc
Confidence 578899999999999999999 888 99999999999999999999999999865333211 1233478
Q ss_pred CCCccCCcccCCCC------CCCchhHHHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHhccCCccCC
Q 030203 70 TPEWMAPEVLRDEP------SNEKSDIYSFGVILWELATL----------QQPWGNLN-----PAQVVAAVGFKGKRLEI 128 (181)
Q Consensus 70 ~~~~~~pe~~~~~~------~~~~~Dv~slG~~~~~ll~g----------~~p~~~~~-----~~~~~~~~~~~~~~~~~ 128 (181)
++.|+|||.+.+.. ++.++|+||+|+++|+|++| ..||.... .................
T Consensus 180 t~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (301)
T 3q4u_A 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI 259 (301)
T ss_dssp CGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred ccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCC
Confidence 89999999987762 34689999999999999999 88885532 22333323222222222
Q ss_pred C-----CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHh
Q 030203 129 P-----RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 129 ~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~ 164 (181)
+ ..+++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 260 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 260 PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2 22456799999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-32 Score=202.84 Aligned_cols=162 Identities=27% Similarity=0.431 Sum_probs=137.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC----cEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++ .++++|||.+....... ......+++.|+|||
T Consensus 112 ~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE 188 (321)
T 2a2a_A 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPE 188 (321)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC-CCCCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc-cccccCCCCCccCcc
Confidence 467899999999999999999999 99999999999998887 79999999987544332 223456788999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+.+..++.++|+||+|+++|+|++|..||.+.........+....... .....+++.+.+++.+||..||.+|||+.
T Consensus 189 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 268 (321)
T 2a2a_A 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQ 268 (321)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHH
T ss_pred cccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHH
Confidence 9988888999999999999999999999999988877777664332221 12356889999999999999999999999
Q ss_pred HHHHHHHHhhhCC
Q 030203 156 TIMELLRPLIKSP 168 (181)
Q Consensus 156 ~~l~~L~~~~~~~ 168 (181)
++++ ++|++..
T Consensus 269 e~l~--hp~~~~~ 279 (321)
T 2a2a_A 269 EALR--HPWITPV 279 (321)
T ss_dssp HHHH--STTTSCS
T ss_pred HHhc--CccccCC
Confidence 9999 8887654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=207.30 Aligned_cols=163 Identities=23% Similarity=0.409 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc---cCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL---SSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.
T Consensus 125 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~ 202 (364)
T 3qyz_A 125 LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHH
Confidence 578899999999999999999999 99999999999999999999999999875443221 1234578899999998
Q ss_pred cCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CC-----------------------c-----cCC
Q 030203 79 LRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GK-----------------------R-----LEI 128 (181)
Q Consensus 79 ~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~-----------------------~-----~~~ 128 (181)
+.+ ..++.++|+||+|+++|+|++|+.||.+....+....+... +. . ...
T Consensus 203 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (364)
T 3qyz_A 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 282 (364)
T ss_dssp HHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred hcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHh
Confidence 654 44789999999999999999999999887665444433110 00 0 011
Q ss_pred CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 129 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
...+++++.+|+.+||..||.+|||+.++++ ++|++..
T Consensus 283 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~~~ 320 (364)
T 3qyz_A 283 FPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLEQY 320 (364)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTT
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--Ccchhhc
Confidence 2457899999999999999999999999999 9998864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-32 Score=198.49 Aligned_cols=161 Identities=28% Similarity=0.469 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+....... ......+++.|++||.+.+
T Consensus 108 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 108 VEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCCCc-ceecccCCccccCHHHHcC
Confidence 578899999999999999999999 9999999999999999999999999886544322 1233467789999999987
Q ss_pred CCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..+ +.++|+||+|+++++|++|..||...........+... ....+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 185 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~- 261 (276)
T 2h6d_A 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE- 261 (276)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH-
T ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh-
Confidence 665 57899999999999999999999998887777666432 33456778999999999999999999999999999
Q ss_pred HHHhhhCCC
Q 030203 161 LRPLIKSPT 169 (181)
Q Consensus 161 L~~~~~~~~ 169 (181)
++|+++..
T Consensus 262 -h~~~~~~~ 269 (276)
T 2h6d_A 262 -HEWFKQDL 269 (276)
T ss_dssp -SHHHHTTC
T ss_pred -ChhhccCc
Confidence 88887643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=209.37 Aligned_cols=164 Identities=25% Similarity=0.381 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-------ccCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------LSSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------~~~~~~~~~~~~~ 74 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....... .......+++.|+
T Consensus 125 ~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 202 (389)
T 3gni_B 125 MNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202 (389)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccccccccccccccc
Confidence 578899999999999999999999 9999999999999999999999999875332211 1122346778899
Q ss_pred CCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-----------------------------
Q 030203 75 APEVLRD--EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG----------------------------- 123 (181)
Q Consensus 75 ~pe~~~~--~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~----------------------------- 123 (181)
|||.+.+ ..++.++|+||+||++|+|++|+.||.+.........+....
T Consensus 203 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (389)
T 3gni_B 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLS 282 (389)
T ss_dssp CHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------------------------
T ss_pred CHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccc
Confidence 9999987 568899999999999999999999998765443332221000
Q ss_pred ---------------CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 124 ---------------KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 124 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.....+..+++.+.+|+.+||+.||.+|||+.++++ ++|++...
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~--hp~f~~~~ 341 (389)
T 3gni_B 283 DSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN--HSFFKQIK 341 (389)
T ss_dssp -----------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT--SGGGGGC-
T ss_pred cccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc--CHHHHHHh
Confidence 011234567889999999999999999999999998 88877543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=211.46 Aligned_cols=164 Identities=30% Similarity=0.476 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc---CCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.
T Consensus 118 ~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~ 194 (486)
T 3mwu_A 118 FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEV 194 (486)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-ccCCCcCCCCCCCHHH
Confidence 578899999999999999999999 99999999999995 45679999999987544332 2334578899999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+ .++.++|+||+|+++|+|++|..||.+.........+........ ....+++++.+++.+||..||.+|||+.+
T Consensus 195 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~ 273 (486)
T 3mwu_A 195 LRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQ 273 (486)
T ss_dssp GGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 876 488899999999999999999999999998888877765444333 23568999999999999999999999999
Q ss_pred HHHHHHHhhhCCCCC
Q 030203 157 IMELLRPLIKSPTPQ 171 (181)
Q Consensus 157 ~l~~L~~~~~~~~~~ 171 (181)
+++ ++|++.....
T Consensus 274 ~l~--hp~~~~~~~~ 286 (486)
T 3mwu_A 274 CLE--HPWIQKYSSE 286 (486)
T ss_dssp HHH--CHHHHHTCCC
T ss_pred Hhc--CHhhccCccc
Confidence 999 8888765433
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-31 Score=202.49 Aligned_cols=161 Identities=25% Similarity=0.364 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+...... .....+++.|+|||.+.+
T Consensus 123 ~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 123 FSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhC
Confidence 578899999999999999999999 999999999999999999999999998754332 233467889999998876
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-----------------------------CccCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-----------------------------KRLEIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 131 (181)
..++.++|+||+|+++++|++|..||.+.+..+....+.... ........
T Consensus 198 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
T 3coi_A 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 277 (353)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTT
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCC
Confidence 567889999999999999999999999887655444332100 01123346
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
+++.+.+++.+||..||.+|||+.++++ ++|++...
T Consensus 278 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~f~~~~ 313 (353)
T 3coi_A 278 ASPQAADLLEKMLELDVDKRLTAAQALT--HPFFEPFR 313 (353)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTTC
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHhc--Ccchhhcc
Confidence 7899999999999999999999999999 88887543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=206.64 Aligned_cols=161 Identities=24% Similarity=0.364 Sum_probs=124.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||+++..... .....++..|+|||.+.+
T Consensus 129 l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 129 LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccccccc---CCCcCcCcCccChHHHcC
Confidence 578899999999999999999999 999999999999999999999999998754432 234577889999999876
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc---------------------c--------CCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR---------------------L--------EIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------------------~--------~~~~~ 131 (181)
..++.++|+||+||++++|++|+.||.+.+.......+...... . .....
T Consensus 204 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (367)
T 2fst_X 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 283 (367)
T ss_dssp CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTT
T ss_pred CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCC
Confidence 56889999999999999999999999988776554443211000 0 01134
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.++.+.+|+.+||..||.+|||+.++++ ++|++...
T Consensus 284 ~~~~~~dLl~~mL~~dP~~R~t~~e~L~--hp~~~~~~ 319 (367)
T 2fst_X 284 ANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYH 319 (367)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTC
T ss_pred CCHHHHHHHHHhCCCCcccCcCHHHHhc--Chhhhhcc
Confidence 6788999999999999999999999999 89988643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9.8e-32 Score=205.43 Aligned_cols=160 Identities=25% Similarity=0.366 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+...... .....+++.|+|||.+.+
T Consensus 141 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 141 FSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcC
Confidence 578899999999999999999999 999999999999999999999999998754432 234467889999999877
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-----------------------------cCCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR-----------------------------LEIPRN 131 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~ 131 (181)
..++.++|+||+|+++++|++|+.||.+.+..+....+...... ......
T Consensus 216 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (371)
T 4exu_A 216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 295 (371)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTT
T ss_pred CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccc
Confidence 56889999999999999999999999988766555443210000 012245
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
+++.+.+|+.+||+.||.+|||+.++++ ++|++..
T Consensus 296 ~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~ 330 (371)
T 4exu_A 296 ASPQAADLLEKMLELDVDKRLTAAQALT--HPFFEPF 330 (371)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTT
T ss_pred cChHHHHHHHHHCCCChhhcCCHHHHhc--CcccccC
Confidence 7899999999999999999999999999 9998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=201.12 Aligned_cols=166 Identities=28% Similarity=0.491 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..++.++.|++.||.|||++| ++|+||+|+||+++. ++.++|+|||.+..............+++.|+|||.+.
T Consensus 119 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (295)
T 2clq_A 119 DNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196 (295)
T ss_dssp TCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhc
Confidence 357888999999999999999999 999999999999987 89999999999876544333334557788999999986
Q ss_pred CCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 81 DEP--SNEKSDIYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 81 ~~~--~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.. ++.++|+||+|+++|+|++|..||....... ..............+..+++.+.+++.+||+.||.+||++.++
T Consensus 197 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 276 (295)
T 2clq_A 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276 (295)
T ss_dssp HGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred CCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 543 6789999999999999999999997654332 2222222344455677899999999999999999999999999
Q ss_pred HHHHHHhhhCCCCC
Q 030203 158 MELLRPLIKSPTPQ 171 (181)
Q Consensus 158 l~~L~~~~~~~~~~ 171 (181)
++ +++++.....
T Consensus 277 l~--~~~~~~~~~~ 288 (295)
T 2clq_A 277 LV--DEFLKVSSKK 288 (295)
T ss_dssp HT--SGGGCC----
T ss_pred hc--Chhhhhcccc
Confidence 99 8998865544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=217.42 Aligned_cols=164 Identities=30% Similarity=0.447 Sum_probs=138.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE---cCCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||++ +.++.++|+|||++....... ......+++.|+|||.
T Consensus 123 ~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~ 199 (484)
T 3nyv_A 123 FSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEV 199 (484)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-SHHHHTTGGGTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-ccccCCCCccccCcee
Confidence 578899999999999999999999 9999999999999 467899999999886544322 1223467889999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCC--CCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+ .++.++|+||+|+++|+|++|..||.+.+.......+......... ...+++.+++++.+||..||.+|||+.+
T Consensus 200 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 278 (484)
T 3nyv_A 200 LHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARD 278 (484)
T ss_dssp HHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 876 5889999999999999999999999999988888877655444332 3468999999999999999999999999
Q ss_pred HHHHHHHhhhCCCCC
Q 030203 157 IMELLRPLIKSPTPQ 171 (181)
Q Consensus 157 ~l~~L~~~~~~~~~~ 171 (181)
+++ ++|++.....
T Consensus 279 ~l~--h~~~~~~~~~ 291 (484)
T 3nyv_A 279 ALD--HEWIQTYTKE 291 (484)
T ss_dssp HHT--SHHHHHHTC-
T ss_pred Hhh--Chhhcccccc
Confidence 999 8888755443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=205.98 Aligned_cols=162 Identities=23% Similarity=0.370 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+..............+++.|++||.+.+
T Consensus 121 ~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 198 (331)
T 4aaa_A 121 LDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG 198 (331)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccC
Confidence 578899999999999999999999 999999999999999999999999998765444333445578889999999877
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-------------------Ccc----------CCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-------------------KRL----------EIPRN 131 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-------------------~~~----------~~~~~ 131 (181)
. .++.++|+||+|+++|+|++|..||.+.........+.... ... .....
T Consensus 199 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (331)
T 4aaa_A 199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK 278 (331)
T ss_dssp CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTT
T ss_pred CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccc
Confidence 5 57889999999999999999999999887665444332100 000 01135
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
+++.+.+++.+||+.||.+|||+.++++ ++|++.
T Consensus 279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~~ 312 (331)
T 4aaa_A 279 LSEVVIDLAKKCLHIDPDKRPFCAELLH--HDFFQM 312 (331)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHG
T ss_pred hhHHHHHHHHHHhccCcccCCCHHHHhc--Cchhcc
Confidence 7889999999999999999999999999 787764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-33 Score=214.70 Aligned_cols=149 Identities=16% Similarity=0.195 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC-
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE- 82 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~- 82 (181)
+..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||+++..... .....+ +.|+|||.+.+.
T Consensus 205 ~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~ 278 (377)
T 3byv_A 205 HHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRA 278 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccc
Confidence 5778889999999999999999 999999999999999999999999998754332 223455 899999999877
Q ss_pred ----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 83 ----------PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 83 ----------~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
.++.++|+||||+++|+|++|+.||.+.........+ ......+++.+.+++.+||..||.+||
T Consensus 279 ~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp STHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred cccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCC
Confidence 7889999999999999999999999775543322211 122357899999999999999999999
Q ss_pred CHHHHHHHHHHhhh
Q 030203 153 SFSTIMELLRPLIK 166 (181)
Q Consensus 153 s~~~~l~~L~~~~~ 166 (181)
|+.++++ ++|++
T Consensus 353 t~~e~l~--hp~f~ 364 (377)
T 3byv_A 353 LPLQAME--TPEYE 364 (377)
T ss_dssp CHHHHHT--SHHHH
T ss_pred CHHHHhh--ChHHH
Confidence 9999998 55554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=204.66 Aligned_cols=154 Identities=25% Similarity=0.459 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+
T Consensus 127 l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 203 (335)
T 3dls_A 127 LDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFCGTIEYCAPEVLMG 203 (335)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC-CBCEECSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceECCCCC-ceeccCCCccccChhhhcC
Confidence 578899999999999999999999 9999999999999999999999999987544332 2233467899999999988
Q ss_pred CCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..+ +.++|+||+|+++|+|++|..||..... ........+..+++++.+++.+||+.||.+|||+.++++
T Consensus 204 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~- 274 (335)
T 3dls_A 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT- 274 (335)
T ss_dssp CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH-
T ss_pred CCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc-
Confidence 776 7789999999999999999999976331 122233445678999999999999999999999999999
Q ss_pred HHHhhhCC
Q 030203 161 LRPLIKSP 168 (181)
Q Consensus 161 L~~~~~~~ 168 (181)
++|++..
T Consensus 275 -hp~~~~~ 281 (335)
T 3dls_A 275 -DPWVTQP 281 (335)
T ss_dssp -CTTTTCC
T ss_pred -CccccCC
Confidence 8888753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=202.20 Aligned_cols=164 Identities=32% Similarity=0.577 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCccc--
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL-- 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~-- 79 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||++..............+++.|+|||.+
T Consensus 114 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (302)
T 2j7t_A 114 LTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191 (302)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeecc
Confidence 578899999999999999999999 9999999999999999999999999875433322233445678899999987
Q ss_pred ---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 80 ---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 80 ---~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+..++.++|+||+|+++++|++|..||...+.......+..... ....+..++..+.+++.+||+.||.+|||+.
T Consensus 192 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 271 (302)
T 2j7t_A 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAA 271 (302)
T ss_dssp HHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred ccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHH
Confidence 356678899999999999999999999999887766655543332 2234567889999999999999999999999
Q ss_pred HHHHHHHHhhhCCC
Q 030203 156 TIMELLRPLIKSPT 169 (181)
Q Consensus 156 ~~l~~L~~~~~~~~ 169 (181)
++++ +++++...
T Consensus 272 ~ll~--h~~~~~~~ 283 (302)
T 2j7t_A 272 QLLE--HPFVSSIT 283 (302)
T ss_dssp HHTT--STTTTTCC
T ss_pred HHhc--ChHHhhhc
Confidence 9999 88887654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=211.02 Aligned_cols=161 Identities=21% Similarity=0.334 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||+++ ++||||||+||+++.+|+++|+|||+++...... .......+++.|+|||.+.
T Consensus 159 l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 159 IPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHh
Confidence 678899999999999999999999 9999999999999999999999999987544322 1233457899999999986
Q ss_pred -------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc---CCCCCCCHHHHHHHHHHhcCCCCC
Q 030203 81 -------DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL---EIPRNVNPHVASIIEACWANEPWK 150 (181)
Q Consensus 81 -------~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~ 150 (181)
+..++.++|+||+|+++|+|++|+.||.+.+......++....... ..+..++++++++|.+||. +|.+
T Consensus 237 ~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~ 315 (412)
T 2vd5_A 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPET 315 (412)
T ss_dssp HHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGG
T ss_pred hcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-Chhh
Confidence 3457889999999999999999999999988877766664322222 2335799999999999998 9999
Q ss_pred C---CCHHHHHHHHHHhhhC
Q 030203 151 R---PSFSTIMELLRPLIKS 167 (181)
Q Consensus 151 R---ps~~~~l~~L~~~~~~ 167 (181)
| |+++++++ ++|++.
T Consensus 316 Rlgr~~~~ei~~--Hpff~~ 333 (412)
T 2vd5_A 316 RLGRGGAGDFRT--HPFFFG 333 (412)
T ss_dssp CTTTTTHHHHHT--SGGGTT
T ss_pred cCCCCCHHHHhc--CCCcCC
Confidence 8 59999998 888864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=204.66 Aligned_cols=168 Identities=28% Similarity=0.385 Sum_probs=126.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhC---------CCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--------cccCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRR---------NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--------FLSSK 65 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~---------~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--------~~~~~ 65 (181)
++.+++.++.|++.||.|||+. + ++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 109 ~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~ 186 (336)
T 3g2f_A 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------C
T ss_pred chhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccc
Confidence 5778899999999999999999 9 999999999999999999999999998754321 11123
Q ss_pred CCCCCCCccCCcccCCC-------CCCCchhHHHHHHHHHHHHhCCCCCCCC-C-----------------HHHHHHHHh
Q 030203 66 SAAGTPEWMAPEVLRDE-------PSNEKSDIYSFGVILWELATLQQPWGNL-N-----------------PAQVVAAVG 120 (181)
Q Consensus 66 ~~~~~~~~~~pe~~~~~-------~~~~~~Dv~slG~~~~~ll~g~~p~~~~-~-----------------~~~~~~~~~ 120 (181)
...+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||... . .......+.
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (336)
T 3g2f_A 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVS 266 (336)
T ss_dssp CTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHT
T ss_pred cCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhc
Confidence 44688999999998763 3456899999999999999996655321 1 112222222
Q ss_pred ccCCccCCCCC------CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCC
Q 030203 121 FKGKRLEIPRN------VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172 (181)
Q Consensus 121 ~~~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~ 172 (181)
........+.. +++.+.+++.+||+.||.+|||+.++++.|+.++..-....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 267 REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 22333333333 33479999999999999999999999999999887655543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-31 Score=204.28 Aligned_cols=160 Identities=24% Similarity=0.410 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||+.| ++|+||+|.||+++.+|.++++|||++....... ......+++.|+|||.+.+
T Consensus 197 l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 273 (365)
T 2y7j_A 197 LSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKC 273 (365)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcccccCCCc-ccccCCCCCCccChhhccc
Confidence 578899999999999999999999 9999999999999999999999999886544322 2234578899999998853
Q ss_pred ------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 82 ------EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 82 ------~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
..++.++|+||||+++|+|++|..||...........+........ ....+++.+.+++.+||..||.+|||
T Consensus 274 ~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 353 (365)
T 2y7j_A 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT 353 (365)
T ss_dssp TTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC
T ss_pred cccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC
Confidence 2467899999999999999999999998887776666543333222 22467889999999999999999999
Q ss_pred HHHHHHHHHHhhh
Q 030203 154 FSTIMELLRPLIK 166 (181)
Q Consensus 154 ~~~~l~~L~~~~~ 166 (181)
+.++++ ++|++
T Consensus 354 ~~ell~--hp~f~ 364 (365)
T 2y7j_A 354 AEQALQ--HPFFE 364 (365)
T ss_dssp HHHHHH--SGGGC
T ss_pred HHHHhc--CcccC
Confidence 999999 88875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=203.52 Aligned_cols=164 Identities=24% Similarity=0.438 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc--------EEEcccCCccccccccccCCCCCCCCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT--------VKVCDFGLSRLKANTFLSSKSAAGTPEW 73 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~--------~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 73 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++. ++++|||.+....... ...++..|
T Consensus 110 ~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~y 183 (289)
T 4fvq_A 110 INILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----ILQERIPW 183 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH----HHHHTTTT
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceeeeccCcccccccCcc----ccCCcCcc
Confidence 578899999999999999999999 999999999999988876 9999999886443321 12346679
Q ss_pred cCCcccCC-CCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 74 MAPEVLRD-EPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 74 ~~pe~~~~-~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
+|||.+.+ ..++.++|+||+|+++|+|++| ..|+............. .....+...++.+.+++.+||+.||.+|
T Consensus 184 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~R 260 (289)
T 4fvq_A 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---DRHQLPAPKAAELANLINNCMDYEPDHR 260 (289)
T ss_dssp SCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TTCCCCCCSSCTTHHHHHHHSCSSGGGS
T ss_pred cCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh---ccCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 99999877 5588999999999999999995 55666666555444332 2334556678899999999999999999
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCC
Q 030203 152 PSFSTIMELLRPLIKSPTPQPSP 174 (181)
Q Consensus 152 ps~~~~l~~L~~~~~~~~~~~~~ 174 (181)
||+.++++.|+.++......+..
T Consensus 261 ps~~~ll~~l~~l~~p~~~~~~~ 283 (289)
T 4fvq_A 261 PSFRAIIRDLNSLFTPDLVPRGS 283 (289)
T ss_dssp CCHHHHHHHHHTCC---------
T ss_pred cCHHHHHHHHHHhcCCCCCCCCc
Confidence 99999999999998866555433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=204.45 Aligned_cols=165 Identities=30% Similarity=0.539 Sum_probs=137.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCcccccccc--ccCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~p 76 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++. +..++|+|||.+....... .......+++.|+||
T Consensus 137 ~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (327)
T 2yfx_A 137 LAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred ccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCH
Confidence 577889999999999999999999 999999999999984 4469999999876432221 112234557789999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 77 EVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 77 e~~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
|.+.+..++.++|+||||+++|+|++ |..||...........+. .......+..+++.+.+++.+||+.||.+||++.
T Consensus 215 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 293 (327)
T 2yfx_A 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 293 (327)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 99988888999999999999999998 999999988877777665 3344556678999999999999999999999999
Q ss_pred HHHHHHHHhhhCCC
Q 030203 156 TIMELLRPLIKSPT 169 (181)
Q Consensus 156 ~~l~~L~~~~~~~~ 169 (181)
++++.|+.+.+...
T Consensus 294 ~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 294 IILERIEYCTQDPD 307 (327)
T ss_dssp HHHHHHHHHHHCHH
T ss_pred HHHHHHHHHhcCHH
Confidence 99999998877544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=206.41 Aligned_cols=161 Identities=22% Similarity=0.327 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc-CCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||++| ++|+||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.
T Consensus 138 l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~ 214 (383)
T 3eb0_A 138 IPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELML 214 (383)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhc
Confidence 578899999999999999999999 99999999999997 68899999999987543322 223456788999999887
Q ss_pred CCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CC--------------------------ccCCCCCC
Q 030203 81 DEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GK--------------------------RLEIPRNV 132 (181)
Q Consensus 81 ~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~ 132 (181)
+.. ++.++|+||+||++|+|++|+.||.+....+....+... +. ....+..+
T Consensus 215 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (383)
T 3eb0_A 215 GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294 (383)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTC
T ss_pred CCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCC
Confidence 654 889999999999999999999999998776655443211 00 00134568
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
++.+.+|+.+||..||.+|||+.++++ ++|++.
T Consensus 295 ~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~ 327 (383)
T 3eb0_A 295 PSLAIDLLEQILRYEPDLRINPYEAMA--HPFFDH 327 (383)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc--CHHHHH
Confidence 889999999999999999999999998 777653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=208.40 Aligned_cols=166 Identities=23% Similarity=0.339 Sum_probs=124.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE----cCCCcEEEcccCCcccccccc---ccCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~----~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~ 74 (181)
+++.+++.++.||+.||.|||+++ ++|+||+|+||++ +.++.++|+|||++....... .......+++.|+
T Consensus 125 l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~ 202 (405)
T 3rgf_A 125 LPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202 (405)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCccc
Confidence 678899999999999999999999 9999999999999 677899999999987644321 2223457789999
Q ss_pred CCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH-hccCCcc-----------------
Q 030203 75 APEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPA---------QVVAAV-GFKGKRL----------------- 126 (181)
Q Consensus 75 ~pe~~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~---------~~~~~~-~~~~~~~----------------- 126 (181)
|||.+.+.. ++.++|+||+||++|+|++|..||.+.... .....+ ...+...
T Consensus 203 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 282 (405)
T 3rgf_A 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLM 282 (405)
T ss_dssp CHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHH
T ss_pred CchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhh
Confidence 999987744 788999999999999999999999765432 111111 1111000
Q ss_pred ------------------CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 127 ------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 127 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
......++.+.+||.+||..||.+|||++++++ ++|++..+.+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~--hp~f~~~~~~ 343 (405)
T 3rgf_A 283 KDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ--DPYFLEDPLP 343 (405)
T ss_dssp HHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTSSSCC
T ss_pred hhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--ChhhccCCCC
Confidence 011123678999999999999999999999999 9999876544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=208.64 Aligned_cols=161 Identities=26% Similarity=0.349 Sum_probs=123.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+
T Consensus 124 ~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 200 (371)
T 2xrw_A 124 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG 200 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC-----------------CTTCCHHHHTT
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccccccccc-ccCCceecCCccCHHHhcC
Confidence 578889999999999999999999 9999999999999999999999999987544321 2234567889999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--------------------CC-------------
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--------------------EI------------- 128 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------------------~~------------- 128 (181)
..++.++|+||+|+++|+|++|..||.+.+.......+....... ..
T Consensus 201 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (371)
T 2xrw_A 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL 280 (371)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGG
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccccc
Confidence 889999999999999999999999999988766555442211100 00
Q ss_pred -CC------CCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 129 -PR------NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 129 -~~------~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
+. ..++.+.+|+.+||..||.+|||++++++ ++|++.
T Consensus 281 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~~ 324 (371)
T 2xrw_A 281 FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYINV 324 (371)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred CcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC--Ccchhh
Confidence 00 11567899999999999999999999999 888764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=203.20 Aligned_cols=160 Identities=22% Similarity=0.316 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-------------------CCcEEEcccCCccccccccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-------------------KYTVKVCDFGLSRLKANTFL 62 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-------------------~~~~~l~d~g~~~~~~~~~~ 62 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++. ++.++++|||.+......
T Consensus 115 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 190 (339)
T 1z57_A 115 FRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-- 190 (339)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--
T ss_pred CcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--
Confidence 568899999999999999999999 999999999999987 567999999998754332
Q ss_pred cCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc-----------------
Q 030203 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR----------------- 125 (181)
Q Consensus 63 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------------- 125 (181)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+......
T Consensus 191 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 269 (339)
T 1z57_A 191 -HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH 269 (339)
T ss_dssp -CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEET
T ss_pred -cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhh
Confidence 23457788999999999888999999999999999999999999988776544433211000
Q ss_pred -------------------------cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 126 -------------------------LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 126 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
.......++.+.+++.+||+.||.+|||+.++++ ++|++..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~ 335 (339)
T 1z57_A 270 DRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK--HPFFDLL 335 (339)
T ss_dssp TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT--SGGGGGG
T ss_pred ccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc--CHHHHHH
Confidence 0011223567899999999999999999999999 8888754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=208.38 Aligned_cols=163 Identities=26% Similarity=0.387 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-------------------- 61 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-------------------- 61 (181)
+++..+..++.||+.||.|||+.| ++||||||+||+++.++.++|+|||+++......
T Consensus 153 l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (458)
T 3rp9_A 153 LTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230 (458)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccc
Confidence 678999999999999999999999 9999999999999999999999999987543211
Q ss_pred -------ccCCCCCCCCCccCCccc-CCCCCCCchhHHHHHHHHHHHHh-----------CCCCCCCCCH----------
Q 030203 62 -------LSSKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELAT-----------LQQPWGNLNP---------- 112 (181)
Q Consensus 62 -------~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~ll~-----------g~~p~~~~~~---------- 112 (181)
.......+++.|+|||.+ .+..++.++|+||+||++|+|++ |+++|.+...
T Consensus 231 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~ 310 (458)
T 3rp9_A 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAG 310 (458)
T ss_dssp --------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------
T ss_pred cccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccc
Confidence 012334678899999976 45568999999999999999998 6667755431
Q ss_pred ----------HHHHHHH-hccCC----------------------------ccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 113 ----------AQVVAAV-GFKGK----------------------------RLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 113 ----------~~~~~~~-~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
......+ ...+. .......+++++.+|+.+||..||.+|||
T Consensus 311 ~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 390 (458)
T 3rp9_A 311 NDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390 (458)
T ss_dssp ------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred ccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC
Confidence 0111100 00000 01112456899999999999999999999
Q ss_pred HHHHHHHHHHhhhCC
Q 030203 154 FSTIMELLRPLIKSP 168 (181)
Q Consensus 154 ~~~~l~~L~~~~~~~ 168 (181)
++++++ ++|++..
T Consensus 391 ~~e~L~--Hp~f~~~ 403 (458)
T 3rp9_A 391 INECLA--HPFFKEV 403 (458)
T ss_dssp HHHHHH--SGGGTTT
T ss_pred HHHHhc--CHhhhhc
Confidence 999999 9999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=202.20 Aligned_cols=157 Identities=34% Similarity=0.558 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCC---CceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNP---PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~---~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++. .++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.
T Consensus 108 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 187 (279)
T 2w5a_A 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHH
Confidence 6889999999999999999999761 2899999999999999999999999988654332211222356788999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
+.+..++.++|+||+|+++|+|++|..||...........+. .......+..+++.+.+++.+||+.||.+||++.+++
T Consensus 188 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll 266 (279)
T 2w5a_A 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 266 (279)
T ss_dssp HHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-hcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 988888999999999999999999999999988877776665 3334456778999999999999999999999999999
Q ss_pred H
Q 030203 159 E 159 (181)
Q Consensus 159 ~ 159 (181)
+
T Consensus 267 ~ 267 (279)
T 2w5a_A 267 E 267 (279)
T ss_dssp T
T ss_pred h
Confidence 8
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=201.45 Aligned_cols=162 Identities=23% Similarity=0.374 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+ .| ++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.
T Consensus 148 ~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~ 223 (348)
T 2pml_X 148 IPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFS 223 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGS
T ss_pred CCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhc
Confidence 5788999999999999999999 99 999999999999999999999999998754433 233456788999999998
Q ss_pred CC-CCCC-chhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccCCccCC-----------------CCCCCHHHHHHH
Q 030203 81 DE-PSNE-KSDIYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKGKRLEI-----------------PRNVNPHVASII 140 (181)
Q Consensus 81 ~~-~~~~-~~Dv~slG~~~~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~li 140 (181)
+. .++. ++|+||+|+++++|++|..||..... ......+......... ...+++.+.+++
T Consensus 224 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 303 (348)
T 2pml_X 224 NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303 (348)
T ss_dssp SCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHH
T ss_pred CCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHH
Confidence 76 4555 89999999999999999999988766 6666665433222211 156899999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 141 EACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 141 ~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.+||+.||.+|||+.++++ ++|++...
T Consensus 304 ~~~L~~dP~~Rps~~e~l~--hp~f~~~~ 330 (348)
T 2pml_X 304 KLFLRKNPAERITSEDALK--HEWLADTN 330 (348)
T ss_dssp HHHCCSSGGGSCCHHHHHT--SGGGTTCC
T ss_pred HHHccCChhhCCCHHHHhc--CccccCCC
Confidence 9999999999999999999 88887643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-33 Score=211.36 Aligned_cols=153 Identities=12% Similarity=0.110 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC--CCCC
Q 030203 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD--EPSN 85 (181)
Q Consensus 8 ~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~ 85 (181)
+.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++........ ...+++.|+|||.+.+ ..++
T Consensus 197 ~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~ 271 (371)
T 3q60_A 197 HILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPREFLNASTATFT 271 (371)
T ss_dssp HHHHHHHHHHHHHHHHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEECC
T ss_pred HHHHHHHHHHHHHHHHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcChhhccCCCCCcC
Confidence 577799999999999999 99999999999999999999999999875543321 2345589999999977 5688
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----Hh--ccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 86 EKSDIYSFGVILWELATLQQPWGNLNPAQVVAA-----VG--FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 86 ~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~-----~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.++|+||+|+++|+|++|+.||........... .. ...........+++.+.+++.+||+.||.+|||+.+++
T Consensus 272 ~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 999999999999999999999987643211000 00 01111223357899999999999999999999999998
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+ ++|++.
T Consensus 352 ~--hp~f~~ 358 (371)
T 3q60_A 352 E--TPEFLQ 358 (371)
T ss_dssp T--SHHHHH
T ss_pred c--CHHHHH
Confidence 8 666653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=215.23 Aligned_cols=159 Identities=29% Similarity=0.450 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.||+.||.|||++| ++|+||+|+||+++.+|.++|+|||++....... ......+++.|+|||.+.+
T Consensus 283 l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 283 FPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CEECCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecccCc-cccccCCCccccCHHHHcC
Confidence 678999999999999999999999 9999999999999999999999999987544322 2233578999999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLN----PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP----- 152 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 152 (181)
..++.++|+||+|+++|+|++|..||.+.. ...+...+. ......+..+++++.++|.+||..||.+||
T Consensus 360 ~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~ 437 (576)
T 2acx_A 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGG 437 (576)
T ss_dssp CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSS
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCC
Confidence 888999999999999999999999998753 334444442 233445678999999999999999999999
Q ss_pred CHHHHHHHHHHhhhC
Q 030203 153 SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 s~~~~l~~L~~~~~~ 167 (181)
+++++++ ++|++.
T Consensus 438 sa~eil~--HpfF~~ 450 (576)
T 2acx_A 438 SAREVKE--HPLFKK 450 (576)
T ss_dssp HHHHHHT--SGGGTT
T ss_pred CHHHHHh--Chhhcc
Confidence 7899998 888775
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=202.63 Aligned_cols=162 Identities=19% Similarity=0.313 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE-------------------cCCCcEEEcccCCccccccccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV-------------------DKKYTVKVCDFGLSRLKANTFL 62 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~-------------------~~~~~~~l~d~g~~~~~~~~~~ 62 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||++ +.++.++|+|||.+......
T Consensus 120 ~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 195 (355)
T 2eu9_A 120 YPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-- 195 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--
Confidence 578899999999999999999999 9999999999999 56788999999998754332
Q ss_pred cCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc----------------
Q 030203 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL---------------- 126 (181)
Q Consensus 63 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 126 (181)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.......
T Consensus 196 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 274 (355)
T 2eu9_A 196 -HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK 274 (355)
T ss_dssp -CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEET
T ss_pred -ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcc
Confidence 234578899999999988889999999999999999999999999887665444332111000
Q ss_pred --------------------------CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 127 --------------------------EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 127 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
......++.+.+|+.+||+.||.+|||+.++++ ++|++....
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~~ 342 (355)
T 2eu9_A 275 GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL--HPFFAGLTP 342 (355)
T ss_dssp TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT--SGGGGGCCH
T ss_pred cccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhcCCCh
Confidence 001122457889999999999999999999999 899886543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=202.25 Aligned_cols=166 Identities=24% Similarity=0.394 Sum_probs=124.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc---EEEcccCCcccccccc-------ccCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTF-------LSSKSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~---~~l~d~g~~~~~~~~~-------~~~~~~~~~~ 71 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++. ++|+|||++....... .......+++
T Consensus 108 ~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~ 185 (316)
T 2ac3_A 108 FNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCc
Confidence 578899999999999999999999 999999999999988765 9999999876432111 1112345888
Q ss_pred CccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHHhccCCccC--CC
Q 030203 72 EWMAPEVLRD-----EPSNEKSDIYSFGVILWELATLQQPWGNLNP---------------AQVVAAVGFKGKRLE--IP 129 (181)
Q Consensus 72 ~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~---------------~~~~~~~~~~~~~~~--~~ 129 (181)
.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+... ......+.......+ ..
T Consensus 186 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 265 (316)
T 2ac3_A 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDW 265 (316)
T ss_dssp GGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHH
T ss_pred CccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhc
Confidence 9999999865 3467899999999999999999999977542 223333332222111 11
Q ss_pred CCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 130 RNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 130 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
..+++.+.+++.+||..||.+|||+.++++ ++|++...+.
T Consensus 266 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~~~~~~ 305 (316)
T 2ac3_A 266 AHISCAAKDLISKLLVRDAKQRLSAAQVLQ--HPWVQGCAPE 305 (316)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--STTCC-----
T ss_pred ccCCHHHHHHHHHHhhCChhhCCCHHHHhc--ChhhcCCCCc
Confidence 458899999999999999999999999999 8999875444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=209.48 Aligned_cols=160 Identities=34% Similarity=0.513 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC---CcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.. +.++|+|||++....... ......+++.|+|||.
T Consensus 133 ~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~ 209 (494)
T 3lij_A 133 FNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEV 209 (494)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-CBCCCCSCTTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-cccccCCCcCeeCHHH
Confidence 578899999999999999999999 9999999999999764 459999999987654432 2334578899999998
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+. ..++.++|+||+|+++|+|++|..||.+.....+...+........ ....+++.+.+++.+||..||.+|||+.+
T Consensus 210 l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 288 (494)
T 3lij_A 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQ 288 (494)
T ss_dssp HT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred Hc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHH
Confidence 86 4588999999999999999999999999998888877765444332 23568999999999999999999999999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++|++.
T Consensus 289 ~l~--hp~~~~ 297 (494)
T 3lij_A 289 ALE--HPWIKE 297 (494)
T ss_dssp HHT--CHHHHH
T ss_pred Hhc--Cccccc
Confidence 998 666654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=203.35 Aligned_cols=164 Identities=19% Similarity=0.213 Sum_probs=133.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--hCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLH--RRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh--~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++..+..++.|++.||.||| +.| ++|+||+|+||+++. ++.++|+|||++....... ......+++.|+|||.
T Consensus 126 ~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~ 202 (360)
T 3e3p_A 126 PPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPEL 202 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHH
Confidence 467888999999999999999 999 999999999999986 8999999999987544332 2234567889999999
Q ss_pred cCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC------------------------------ccC
Q 030203 79 LRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK------------------------------RLE 127 (181)
Q Consensus 79 ~~~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~ 127 (181)
+.+.. ++.++|+||+|+++|+|++|+.||.+.+.......+..... ...
T Consensus 203 ~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
T 3e3p_A 203 IFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282 (360)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTT
T ss_pred HcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccch
Confidence 86654 78999999999999999999999999887665554421100 011
Q ss_pred CCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 128 IPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
.....++++.+|+.+||+.||.+|||+.++++ ++|++....
T Consensus 283 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~~ 323 (360)
T 3e3p_A 283 HSLKDAKEAYDLLSALLQYLPEERMKPYEALC--HPYFDELHD 323 (360)
T ss_dssp CCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT--SGGGGGGGC
T ss_pred hhccccHHHHHHHHHHhccCccccCCHHHHhc--CccccccCC
Confidence 22235788999999999999999999999999 999886543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=197.87 Aligned_cols=166 Identities=23% Similarity=0.431 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++. +.++|+|||.+........ ......+++.|+|||.+
T Consensus 124 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (313)
T 3cek_A 124 IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHH
Confidence 577899999999999999999999 999999999999965 7999999999875433211 12344678899999998
Q ss_pred CC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCC
Q 030203 80 RD-----------EPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANE 147 (181)
Q Consensus 80 ~~-----------~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 147 (181)
.+ ..++.++|+||||+++++|++|..||...... .....+.........+...++.+.+++.+||+.|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 280 (313)
T 3cek_A 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRD 280 (313)
T ss_dssp TTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSS
T ss_pred hhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCC
Confidence 65 35678999999999999999999999876432 3333333333444566777899999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCC
Q 030203 148 PWKRPSFSTIMELLRPLIKSPTPQP 172 (181)
Q Consensus 148 p~~Rps~~~~l~~L~~~~~~~~~~~ 172 (181)
|.+||++.++++ ++|++....+.
T Consensus 281 p~~Rps~~ell~--h~~~~~~~~~~ 303 (313)
T 3cek_A 281 PKQRISIPELLA--HPYVQIQTHPV 303 (313)
T ss_dssp TTTSCCHHHHHT--SHHHHCC----
T ss_pred cccCcCHHHHhc--CccccCCCCch
Confidence 999999999999 88888755443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=200.87 Aligned_cols=166 Identities=25% Similarity=0.379 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc----------cCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----------SSKSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~ 71 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+........ ......+++
T Consensus 109 ~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~ 186 (353)
T 2b9h_A 109 LSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccc
Confidence 678899999999999999999999 99999999999999999999999999875432211 112346788
Q ss_pred CccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCc------------------------
Q 030203 72 EWMAPEVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKR------------------------ 125 (181)
Q Consensus 72 ~~~~pe~~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~~------------------------ 125 (181)
.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+.......+... +..
T Consensus 187 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (353)
T 2b9h_A 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY 266 (353)
T ss_dssp GGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCC
T ss_pred cccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCC
Confidence 9999998754 56788999999999999999999999988765544332110 000
Q ss_pred -----cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 126 -----LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 126 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
......+++.+.+++.+||..||.+|||+.++++ ++|++....+
T Consensus 267 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~~~ 315 (353)
T 2b9h_A 267 PAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE--HPYLQTYHDP 315 (353)
T ss_dssp CCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTCCT
T ss_pred CCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc--CccccccCCc
Confidence 0012468899999999999999999999999999 9999865443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=217.48 Aligned_cols=163 Identities=31% Similarity=0.622 Sum_probs=138.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-cCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-SSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~ 80 (181)
+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.
T Consensus 488 l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~ 565 (656)
T 2j0j_A 488 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565 (656)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhc
Confidence 578889999999999999999999 99999999999999999999999999875443221 122334567899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|+|++ |..||.+....+....+. .......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 566 ~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888999999999999999997 999999998888777765 34445667889999999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
.|+.+++.
T Consensus 645 ~L~~il~~ 652 (656)
T 2j0j_A 645 QLSTILEE 652 (656)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99988754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=204.34 Aligned_cols=164 Identities=27% Similarity=0.400 Sum_probs=123.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL------------------- 62 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~------------------- 62 (181)
+++..+..++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||+++.......
T Consensus 126 l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (432)
T 3n9x_A 126 LTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203 (432)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC------------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccc
Confidence 688999999999999999999999 99999999999999999999999999875433211
Q ss_pred ---cCCCCCCCCCccCCccc-CCCCCCCchhHHHHHHHHHHHHhC-----------CCCCCCCCH---------------
Q 030203 63 ---SSKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATL-----------QQPWGNLNP--------------- 112 (181)
Q Consensus 63 ---~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~ll~g-----------~~p~~~~~~--------------- 112 (181)
......+++.|+|||.+ ....++.++|+||+||++|+|++| .++|.+.+.
T Consensus 204 ~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~ 283 (432)
T 3n9x_A 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEK 283 (432)
T ss_dssp -------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHH
T ss_pred hhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCccccccccccc
Confidence 12456788999999985 455689999999999999999984 444444320
Q ss_pred ---HHH-----------------------HHHHhccCCccC-----CCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 113 ---AQV-----------------------VAAVGFKGKRLE-----IPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 113 ---~~~-----------------------~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..+ ...+........ ....+++++.+|+.+||..||.+|||+.++++
T Consensus 284 ~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~-- 361 (432)
T 3n9x_A 284 SNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD-- 361 (432)
T ss_dssp HHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--
T ss_pred chHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc--
Confidence 010 111110001111 11458999999999999999999999999999
Q ss_pred HHhhhCCC
Q 030203 162 RPLIKSPT 169 (181)
Q Consensus 162 ~~~~~~~~ 169 (181)
++|++...
T Consensus 362 Hp~f~~~~ 369 (432)
T 3n9x_A 362 HPYLKDVR 369 (432)
T ss_dssp CGGGTTTC
T ss_pred Chhhhhcc
Confidence 99988653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=201.27 Aligned_cols=167 Identities=20% Similarity=0.338 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc---------CCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS---------SKSAAGTPE 72 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~ 72 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+......... .....+++.
T Consensus 131 ~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 208 (317)
T 2buj_A 131 LTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcc
Confidence 678999999999999999999999 999999999999999999999999987643321100 012245788
Q ss_pred ccCCcccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCC
Q 030203 73 WMAPEVLRDEP---SNEKSDIYSFGVILWELATLQQPWGNLNP--AQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANE 147 (181)
Q Consensus 73 ~~~pe~~~~~~---~~~~~Dv~slG~~~~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 147 (181)
|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... ......+. .....+.+..+++.+.+++.+||+.|
T Consensus 209 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~d 287 (317)
T 2buj_A 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-NQLSIPQSPRHSSALWQLLNSMMTVD 287 (317)
T ss_dssp GCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-CC--CCCCTTSCHHHHHHHHHHTCSS
T ss_pred cCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-ccCCCCccccCCHHHHHHHHHHhhcC
Confidence 99999987554 57899999999999999999999954211 11111221 23334445678999999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 148 PWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 148 p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
|.+||++.++++.|+.+....+.+
T Consensus 288 p~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 288 PHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp GGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred hhhCCCHHHHHHHhhhcCCCCCCC
Confidence 999999999999999876554444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=202.06 Aligned_cols=160 Identities=26% Similarity=0.426 Sum_probs=129.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||++ + ++|+||+|+||+++.++.++|+|||++...... ......+++.|+|||.+.
T Consensus 128 ~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~ 203 (360)
T 3eqc_A 128 IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQ 203 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHc
Confidence 57888999999999999999996 8 999999999999999999999999998644322 223457788999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------------------------------------
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV----------------------------------------- 119 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~----------------------------------------- 119 (181)
+..++.++|+||+|+++|+|++|..||...+........
T Consensus 204 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
T 3eqc_A 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283 (360)
T ss_dssp TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhH
Confidence 888999999999999999999999999887665433221
Q ss_pred -hccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 120 -GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 120 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
............+++++.+|+.+||+.||.+|||++++++ ++|++.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 330 (360)
T 3eqc_A 284 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR 330 (360)
T ss_dssp HHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHH
T ss_pred HhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhc
Confidence 1111111223457889999999999999999999999998 777654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=209.79 Aligned_cols=163 Identities=30% Similarity=0.488 Sum_probs=138.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC---cEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++ .++|+|||++....... ......+++.|+|||.
T Consensus 143 ~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~ 219 (504)
T 3q5i_A 143 FDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEV 219 (504)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS-CBCCCCSCTTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC-ccccccCCcCCCCHHH
Confidence 578999999999999999999999 99999999999998765 69999999987554432 2334578899999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+ .++.++|+||+|+++|+|++|..||.+.+...+...+........ ....+++++.+++.+||..||.+|||+.+
T Consensus 220 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 298 (504)
T 3q5i_A 220 LKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298 (504)
T ss_dssp HTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 864 588999999999999999999999999998888887764443322 22578999999999999999999999999
Q ss_pred HHHHHHHhhhCCCC
Q 030203 157 IMELLRPLIKSPTP 170 (181)
Q Consensus 157 ~l~~L~~~~~~~~~ 170 (181)
+++ ++|++....
T Consensus 299 ~l~--h~~~~~~~~ 310 (504)
T 3q5i_A 299 ALN--SRWIKKYAN 310 (504)
T ss_dssp HHT--SHHHHHTCC
T ss_pred Hhc--CHhhhhchh
Confidence 999 888875443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=195.83 Aligned_cols=161 Identities=26% Similarity=0.427 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC----cEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++++|||.+....... ......+++.|+|||
T Consensus 105 ~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE 181 (283)
T 3bhy_A 105 LTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPE 181 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC-cccccCCCcCccCcc
Confidence 578899999999999999999999 99999999999998776 79999999987544322 223346788999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+.+..++.++|+||+|+++++|++|..||.+.........+....... .....+++.+.+++.+||..||.+||++.
T Consensus 182 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 261 (283)
T 3bhy_A 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIA 261 (283)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred eecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 9988888999999999999999999999999988877766654332221 12356889999999999999999999999
Q ss_pred HHHHHHHHhhhC
Q 030203 156 TIMELLRPLIKS 167 (181)
Q Consensus 156 ~~l~~L~~~~~~ 167 (181)
++++ +++++.
T Consensus 262 ~~l~--h~~~~~ 271 (283)
T 3bhy_A 262 QSLE--HSWIKA 271 (283)
T ss_dssp HHHH--CHHHHH
T ss_pred HHHh--CHHHHH
Confidence 9998 566554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=195.55 Aligned_cols=160 Identities=26% Similarity=0.417 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.+
T Consensus 119 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 195 (284)
T 2a19_B 119 LDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISS 195 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhcc
Confidence 578899999999999999999999 9999999999999999999999999987544332 2234467889999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+|+++++|++|..|+.... .....+. ....+..+++.+.+++.+||+.||.+|||+.++++.|
T Consensus 196 ~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 196 QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR----DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH----TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh----cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 888999999999999999999988875321 2222222 1234567899999999999999999999999999999
Q ss_pred HHhhhCCCC
Q 030203 162 RPLIKSPTP 170 (181)
Q Consensus 162 ~~~~~~~~~ 170 (181)
+.+.+....
T Consensus 270 ~~~~~~~~~ 278 (284)
T 2a19_B 270 TVWKKSPEK 278 (284)
T ss_dssp HHHTC----
T ss_pred HHHhhCCCc
Confidence 988776554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=207.37 Aligned_cols=159 Identities=23% Similarity=0.314 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCC------------------------------------
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKY------------------------------------ 44 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~------------------------------------ 44 (181)
+++.+++.++.|++.||.|||++ | ++|+||||+||+++.++
T Consensus 143 ~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (397)
T 1wak_A 143 LPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220 (397)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccc
Confidence 57889999999999999999998 9 99999999999998765
Q ss_pred -------------cEEEcccCCccccccccccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 030203 45 -------------TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 111 (181)
Q Consensus 45 -------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~ 111 (181)
.++|+|||.+...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 221 ~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 221 LVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp SCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 7999999998754432 234577899999999998889999999999999999999999997654
Q ss_pred H------HHHHHHH-hccCCc---------------------------------------cCCCCCCCHHHHHHHHHHhc
Q 030203 112 P------AQVVAAV-GFKGKR---------------------------------------LEIPRNVNPHVASIIEACWA 145 (181)
Q Consensus 112 ~------~~~~~~~-~~~~~~---------------------------------------~~~~~~~~~~~~~li~~~l~ 145 (181)
. ......+ ...+.. ...+...++.+.+|+.+||+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 377 (397)
T 1wak_A 298 GEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE 377 (397)
T ss_dssp CSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGC
T ss_pred ccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhc
Confidence 2 1111111 000000 01122334678899999999
Q ss_pred CCCCCCCCHHHHHHHHHHhhhC
Q 030203 146 NEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 146 ~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
.||.+|||+.++++ ++|+++
T Consensus 378 ~dP~~Rpt~~e~l~--hp~~~~ 397 (397)
T 1wak_A 378 LIPEKRATAAECLR--HPWLNS 397 (397)
T ss_dssp SSGGGSCCHHHHHT--SGGGGC
T ss_pred cChhhcCCHHHHhh--CccccC
Confidence 99999999999999 888763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=203.02 Aligned_cols=163 Identities=18% Similarity=0.296 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.+
T Consensus 131 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 131 ISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcC
Confidence 678899999999999999999999 9999999999999999999999999986433322 2234467788999998876
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc------------------------------cCCCC
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR------------------------------LEIPR 130 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~ 130 (181)
..++.++|+||+|+++|++++|+.||.+.........+...... .....
T Consensus 208 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (362)
T 3pg1_A 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP 287 (362)
T ss_dssp CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHST
T ss_pred CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCC
Confidence 56889999999999999999999999988766555443211000 01224
Q ss_pred CCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 131 NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 131 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.+++.+.+++.+||+.||.+|||+.++++ ++|++...
T Consensus 288 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~ 324 (362)
T 3pg1_A 288 TADPVALDLIAKMLEFNPQRRISTEQALR--HPYFESLF 324 (362)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGTTTC
T ss_pred CCCHHHHHHHHHHhcCChhhCCCHHHHHc--Cchhhhcc
Confidence 56888999999999999999999999999 99988653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=210.48 Aligned_cols=144 Identities=16% Similarity=0.187 Sum_probs=118.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCccc---
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL--- 79 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~--- 79 (181)
++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++..... .....+ +.|+|||.+
T Consensus 209 ~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~ 282 (413)
T 3dzo_A 209 VHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAER 282 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhcc
Confidence 46678899999999999999999 999999999999999999999999998754443 233456 899999998
Q ss_pred -------CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 80 -------RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 80 -------~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
.+..++.++|+||||+++|+|++|+.||...........+ ......+++.+.+++.+||+.||.+||
T Consensus 283 ~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp TSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCc
Confidence 4445778999999999999999999999876543322211 122346889999999999999999999
Q ss_pred CHHHHH
Q 030203 153 SFSTIM 158 (181)
Q Consensus 153 s~~~~l 158 (181)
++.+++
T Consensus 357 t~~~~l 362 (413)
T 3dzo_A 357 LPLQAM 362 (413)
T ss_dssp CHHHHT
T ss_pred CHHHHH
Confidence 966654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=196.08 Aligned_cols=156 Identities=20% Similarity=0.389 Sum_probs=125.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC-------------------CcEEEcccCCccccccccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-------------------YTVKVCDFGLSRLKANTFL 62 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~-------------------~~~~l~d~g~~~~~~~~~~ 62 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.+ ..++++|||.+......
T Consensus 112 ~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 187 (289)
T 1x8b_A 112 FKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-- 187 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS--
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc--
Confidence 678999999999999999999999 9999999999999844 47899999988654432
Q ss_pred cCCCCCCCCCccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHH
Q 030203 63 SSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIE 141 (181)
Q Consensus 63 ~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 141 (181)
....+++.|+|||.+.+. .++.++|+||+|++++++++|..++...... ..+. .......+..+++.+.+++.
T Consensus 188 --~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~li~ 261 (289)
T 1x8b_A 188 --QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIR-QGRLPRIPQVLSQEFTELLK 261 (289)
T ss_dssp --CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHHH-TTCCCCCSSCCCHHHHHHHH
T ss_pred --cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHHH-cCCCCCCCcccCHHHHHHHH
Confidence 234578899999998765 4557999999999999999998877554322 2222 33445567789999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 142 ACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 142 ~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
+||+.||.+|||+.++++ ++|++...
T Consensus 262 ~~l~~dp~~Rps~~~ll~--h~~~~~~~ 287 (289)
T 1x8b_A 262 VMIHPDPERRPSAMALVK--HSVLLSAS 287 (289)
T ss_dssp HHTCSSGGGSCCHHHHHT--CTTC----
T ss_pred HHhCCCcccCCCHHHHhh--ChHhhhhc
Confidence 999999999999999999 88887643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=195.54 Aligned_cols=163 Identities=23% Similarity=0.383 Sum_probs=136.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+....... ......+++.|++||.+.
T Consensus 121 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 197 (298)
T 1phk_A 121 LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIEC 197 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccchhhcCCCc-ccccccCCccccCHHHhcc
Confidence 578899999999999999999999 9999999999999999999999999986544322 223456788999999874
Q ss_pred -----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCC--CCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 81 -----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 81 -----~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
...++.++|+||+|+++++|++|..||...........+......... ...+++.+.+++.+||+.||.+|||
T Consensus 198 ~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 277 (298)
T 1phk_A 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT 277 (298)
T ss_dssp HHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred ccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC
Confidence 345688999999999999999999999988877766666544333222 2468899999999999999999999
Q ss_pred HHHHHHHHHHhhhCCC
Q 030203 154 FSTIMELLRPLIKSPT 169 (181)
Q Consensus 154 ~~~~l~~L~~~~~~~~ 169 (181)
+.++++ ++++++..
T Consensus 278 ~~~ll~--h~~~~~~~ 291 (298)
T 1phk_A 278 AEEALA--HPFFQQYV 291 (298)
T ss_dssp HHHHTT--SGGGCTTC
T ss_pred HHHHHh--ChHhhhcc
Confidence 999999 88887644
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=201.26 Aligned_cols=160 Identities=24% Similarity=0.370 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...... ........+++.|+|||.+.
T Consensus 156 ~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 233 (355)
T 1vzo_A 156 FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhc
Confidence 578899999999999999999999 999999999999999999999999998754322 22223446889999999997
Q ss_pred CC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC--
Q 030203 81 DE--PSNEKSDIYSFGVILWELATLQQPWGNLN----PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-- 152 (181)
Q Consensus 81 ~~--~~~~~~Dv~slG~~~~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-- 152 (181)
+. .++.++|+||||+++|+|++|..||.... ...+...+. ......+..+++.+.+++.+||..||.+||
T Consensus 234 ~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 311 (355)
T 1vzo_A 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 311 (355)
T ss_dssp TCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCC
Confidence 53 36789999999999999999999996542 233333332 233456678999999999999999999999
Q ss_pred ---CHHHHHHHHHHhhhC
Q 030203 153 ---SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 ---s~~~~l~~L~~~~~~ 167 (181)
+++++++ +.+++.
T Consensus 312 ~~~s~~ell~--h~~f~~ 327 (355)
T 1vzo_A 312 GPRDADEIKE--HLFFQK 327 (355)
T ss_dssp STTTHHHHHT--SGGGTT
T ss_pred CCCCHHHHHc--Ccchhc
Confidence 9999998 777654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=201.93 Aligned_cols=163 Identities=25% Similarity=0.429 Sum_probs=110.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++. ++.++|+|||.+...... ......+++.|++||.
T Consensus 125 l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~ 200 (336)
T 3fhr_A 125 FTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEV 200 (336)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceecccc--ccccCCCCcCccChhh
Confidence 678999999999999999999999 999999999999976 455999999998754432 2234466889999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----Hhcc--CCccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA----VGFK--GKRLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+.+..++.++|+||+|+++|+|++|..||........... +... .........+++.+.+++.+||+.||.+||
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 280 (336)
T 3fhr_A 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280 (336)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc
Confidence 9877788899999999999999999999977655433211 1111 112223356899999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCCC
Q 030203 153 SFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~~ 170 (181)
|+.++++ ++|++....
T Consensus 281 t~~ell~--hp~~~~~~~ 296 (336)
T 3fhr_A 281 TITQFMN--HPWINQSMV 296 (336)
T ss_dssp CHHHHHH--SHHHHTGGG
T ss_pred CHHHHhc--Ccccccccc
Confidence 9999999 888876443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=204.11 Aligned_cols=160 Identities=21% Similarity=0.246 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh--CCCCceecCCCCCCEEEc--CCCcEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR--RNPPIVHRDLKSPNLLVD--KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~--~~~~~~h~~i~~~nil~~--~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++ .++.++|+|||++...... .....+++.|+|||
T Consensus 154 ~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE 228 (382)
T 2vx3_A 154 VSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPE 228 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEEEEeccCceecccc---cccccCCccccChH
Confidence 5788999999999999999994 67 99999999999995 4778999999998765432 23457788999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc----------------CCC------------
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL----------------EIP------------ 129 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------~~~------------ 129 (181)
.+.+..++.++|+||+|+++|+|++|+.||.+.+.......+....... .++
T Consensus 229 ~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (382)
T 2vx3_A 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDG 308 (382)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTT
T ss_pred HHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccccccccccccc
Confidence 9999889999999999999999999999999988766555442110000 000
Q ss_pred ------CC----------------------------CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 130 ------RN----------------------------VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 130 ------~~----------------------------~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
.. .++.+.+|+.+||+.||.+|||+.++++ ++|++..
T Consensus 309 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~--hp~f~~~ 379 (382)
T 2vx3_A 309 KREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ--HSFFKKT 379 (382)
T ss_dssp CCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT--SGGGCC-
T ss_pred ccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhc--CcccccC
Confidence 00 0137899999999999999999999999 8998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=197.56 Aligned_cols=163 Identities=19% Similarity=0.312 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++ .++|+|||++....... ......++..|++||.+.
T Consensus 127 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~ 203 (330)
T 3nsz_A 127 LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLV 203 (330)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-ccccccccccccChhhhc
Confidence 578899999999999999999999 99999999999999766 89999999987544322 233456788999999987
Q ss_pred C-CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH-------------hccCC---------------------
Q 030203 81 D-EPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAV-------------GFKGK--------------------- 124 (181)
Q Consensus 81 ~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~-~~~~~~~~~-------------~~~~~--------------------- 124 (181)
+ ..++.++|+||+|+++++|++|..||... ........+ .....
T Consensus 204 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (330)
T 3nsz_A 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 283 (330)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGG
T ss_pred CCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhh
Confidence 7 55889999999999999999999999543 222211111 00000
Q ss_pred -ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 125 -RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 125 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
....+..+++++.+|+.+||+.||.+|||++++++ ++|++...
T Consensus 284 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~--hp~f~~~~ 327 (330)
T 3nsz_A 284 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYFYTVV 327 (330)
T ss_dssp CCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SGGGTTCC
T ss_pred ccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CccHhhhc
Confidence 00112237899999999999999999999999999 89988654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=199.29 Aligned_cols=160 Identities=30% Similarity=0.477 Sum_probs=124.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR---NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~---~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe 77 (181)
+++..++.++.|++.||.|||++ + ++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||
T Consensus 128 ~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (326)
T 3uim_A 128 LDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 205 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHH
Confidence 67889999999999999999999 9 9999999999999999999999999987544322 2223345889999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhccCCc------------cCCCCCCCHHHHHHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-----NPAQVVAAVGFKGKR------------LEIPRNVNPHVASII 140 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~-----~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~li 140 (181)
.+.+..++.++|+||+|+++|+|++|..||... ........+...... ...+...++.+.+++
T Consensus 206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 285 (326)
T 3uim_A 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVA 285 (326)
T ss_dssp HHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHH
T ss_pred HhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHH
Confidence 998878899999999999999999999999521 111111111100000 011122336799999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHH
Q 030203 141 EACWANEPWKRPSFSTIMELLRP 163 (181)
Q Consensus 141 ~~~l~~~p~~Rps~~~~l~~L~~ 163 (181)
.+||+.||.+|||+.++++.|+.
T Consensus 286 ~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 286 LLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhCcCCccCCCHHHHHHHhcC
Confidence 99999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=197.62 Aligned_cols=167 Identities=19% Similarity=0.318 Sum_probs=131.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc-CCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~-~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++ .++.++|+|||.+....... .......++..|++||
T Consensus 117 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (320)
T 2i6l_A 117 LLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcH
Confidence 578899999999999999999999 99999999999997 56799999999987543221 1122335577899999
Q ss_pred ccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc----------------------------cCC
Q 030203 78 VLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR----------------------------LEI 128 (181)
Q Consensus 78 ~~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~ 128 (181)
.+.+ ..++.++|+||+|+++|+|++|+.||.+.........+...... ...
T Consensus 195 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (320)
T 2i6l_A 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL 274 (320)
T ss_dssp HHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHH
T ss_pred HhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHh
Confidence 8765 56788999999999999999999999988776554443211100 012
Q ss_pred CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCC
Q 030203 129 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172 (181)
Q Consensus 129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~ 172 (181)
...+++.+.+++.+||+.||.+|||+.++++ ++|++....+.
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~~p~ 316 (320)
T 2i6l_A 275 LPGISREAVDFLEQILTFSPMDRLTAEEALS--HPYMSIYSFPM 316 (320)
T ss_dssp STTCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SHHHHTTCC--
T ss_pred cchhhHHHHHHHHHHcCCCccccCCHHHHhC--CcccccccCcc
Confidence 2468999999999999999999999999999 99998755443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=204.67 Aligned_cols=161 Identities=25% Similarity=0.407 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC---cEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||+++...... ......+++.|+|||.
T Consensus 236 ~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~ 312 (419)
T 3i6u_A 236 LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEV 312 (419)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceecCCCc-cccccCCCCCccCcee
Confidence 578899999999999999999999 99999999999997544 59999999987654332 2234568899999999
Q ss_pred cCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCc--cCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 79 LRD---EPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 79 ~~~---~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+.+ ..++.++|+||+|+++|+|++|..||...... .....+...... ......+++.+.+++.+||+.||.+||
T Consensus 313 ~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 392 (419)
T 3i6u_A 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 392 (419)
T ss_dssp TC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred eecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCc
Confidence 864 45677999999999999999999999765432 222223211111 122356899999999999999999999
Q ss_pred CHHHHHHHHHHhhhC
Q 030203 153 SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 s~~~~l~~L~~~~~~ 167 (181)
|+.++++ ++|++.
T Consensus 393 s~~e~l~--hp~~~~ 405 (419)
T 3i6u_A 393 TTEEALR--HPWLQD 405 (419)
T ss_dssp CHHHHHH--SGGGCC
T ss_pred CHHHHhC--CcccCC
Confidence 9999999 888865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=199.58 Aligned_cols=166 Identities=31% Similarity=0.483 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--------hCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc----cCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLH--------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL----SSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh--------~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~ 69 (181)
+++.+++.++.|++.||.||| +.+ ++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 136 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~g 213 (342)
T 1b6c_B 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213 (342)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCC
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCc
Confidence 578899999999999999999 888 99999999999999999999999999865443221 2344578
Q ss_pred CCCccCCcccCCCCC------CCchhHHHHHHHHHHHHhC----------CCCCCCC-----CHHHHHHHHhccCCccCC
Q 030203 70 TPEWMAPEVLRDEPS------NEKSDIYSFGVILWELATL----------QQPWGNL-----NPAQVVAAVGFKGKRLEI 128 (181)
Q Consensus 70 ~~~~~~pe~~~~~~~------~~~~Dv~slG~~~~~ll~g----------~~p~~~~-----~~~~~~~~~~~~~~~~~~ 128 (181)
++.|+|||.+.+... +.++|+||+|+++|+|++| ..||... ....+...+.........
T Consensus 214 t~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (342)
T 1b6c_B 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 293 (342)
T ss_dssp CGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred CcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCC
Confidence 889999999876532 2579999999999999999 7788664 233444444323333333
Q ss_pred CC-----CCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 129 PR-----NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 129 ~~-----~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
+. .+++.+.+++.+||+.||.+|||+.++++.|+.+.++..
T Consensus 294 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 294 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 32 234578999999999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=198.47 Aligned_cols=162 Identities=32% Similarity=0.507 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++++|||.+....... .......+++.|+|||.+
T Consensus 130 ~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 207 (307)
T 2nru_A 130 LSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL 207 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHh
Confidence 578899999999999999999999 9999999999999999999999999986543321 122345678899999988
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcc---------CCccCCCCCCCHHHHHHHHHHhcC
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFK---------GKRLEIPRNVNPHVASIIEACWAN 146 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~ 146 (181)
.+ .++.++|+||+|+++|+|++|..||....... +...+... ......+...++.+.+++.+||+.
T Consensus 208 ~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 286 (307)
T 2nru_A 208 RG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHE 286 (307)
T ss_dssp TT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCS
T ss_pred cC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCC
Confidence 65 47889999999999999999999997754321 11211111 111122333456799999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhh
Q 030203 147 EPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 147 ~p~~Rps~~~~l~~L~~~~~ 166 (181)
||.+|||++++++.|+++..
T Consensus 287 ~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 287 KKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp STTTSCCHHHHHHHHHHHC-
T ss_pred CcccCcCHHHHHHHHHHHhc
Confidence 99999999999999998743
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=197.64 Aligned_cols=166 Identities=30% Similarity=0.525 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-----ccCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-----LSSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~~~p 76 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||.+....... .......+++.|+||
T Consensus 118 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (303)
T 2vwi_A 118 LDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195 (303)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCH
Confidence 678899999999999999999999 9999999999999999999999999876433221 112334678899999
Q ss_pred cccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--------cCCCCCCCHHHHHHHHHHhcCC
Q 030203 77 EVLRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--------LEIPRNVNPHVASIIEACWANE 147 (181)
Q Consensus 77 e~~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~ 147 (181)
|.+.+ ..++.++|+||+|+++++|++|..||.................. ......+++.+.+++.+||+.|
T Consensus 196 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 275 (303)
T 2vwi_A 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKD 275 (303)
T ss_dssp HHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSS
T ss_pred HHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCC
Confidence 98865 45788999999999999999999999887665444333212111 1233567899999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 148 PWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 148 p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
|.+||++.++++ ++|++.....
T Consensus 276 p~~Rps~~~ll~--h~~~~~~~~~ 297 (303)
T 2vwi_A 276 PEKRPTAAELLR--HKFFQKAKNK 297 (303)
T ss_dssp GGGSCCHHHHHT--STTC------
T ss_pred hhhCcCHHHHhh--ChhhhcCCCC
Confidence 999999999999 7888765443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=202.26 Aligned_cols=162 Identities=21% Similarity=0.383 Sum_probs=125.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEc------CCCcEEEcccCCccccccccccCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVD------KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 74 (181)
+++.+++.++.|++.||.|||++ | ++|+||+|+||+++ ..+.++|+|||++...... .....+++.|+
T Consensus 128 ~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~ 202 (373)
T 1q8y_A 128 IPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYR 202 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGC
T ss_pred CcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCcccc
Confidence 57889999999999999999998 9 99999999999994 3447999999998754432 23447788999
Q ss_pred CCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-hccCC-----------------------
Q 030203 75 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP------AQVVAAV-GFKGK----------------------- 124 (181)
Q Consensus 75 ~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~------~~~~~~~-~~~~~----------------------- 124 (181)
|||.+.+..++.++|+||+|+++|+|++|..||..... ......+ ...+.
T Consensus 203 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 282 (373)
T 1q8y_A 203 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 282 (373)
T ss_dssp CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS
T ss_pred CcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhc
Confidence 99999988899999999999999999999999986542 1111111 10000
Q ss_pred ----------------ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 125 ----------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 125 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
....+..+++.+.+||.+||+.||.+|||+.++++ ++|++....
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~ 342 (373)
T 1q8y_A 283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN--HPWLKDTLG 342 (373)
T ss_dssp SCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT--CGGGTTCTT
T ss_pred ccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh--ChhhhcccC
Confidence 01122345678899999999999999999999999 899886543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=195.82 Aligned_cols=155 Identities=29% Similarity=0.512 Sum_probs=117.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..++.++.|++.||.|||++ | ++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.
T Consensus 121 ~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 121 IPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERID 197 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-cccccCCCccccChhhcc
Confidence 57889999999999999999996 9 9999999999999999999999999986543322 223346788999999985
Q ss_pred -----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhccC-CccCCCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 81 -----DEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKG-KRLEIPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 81 -----~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
...++.++|+||+|+++++|++|+.||.... .......+.... ........+++.+.+++.+||+.||.+||+
T Consensus 198 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 277 (318)
T 2dyl_A 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK 277 (318)
T ss_dssp --------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC
T ss_pred cccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcC
Confidence 3457889999999999999999999998743 333333332222 122233468999999999999999999999
Q ss_pred HHHHHH
Q 030203 154 FSTIME 159 (181)
Q Consensus 154 ~~~~l~ 159 (181)
++++++
T Consensus 278 ~~~ll~ 283 (318)
T 2dyl_A 278 YNKLLE 283 (318)
T ss_dssp HHHHTT
T ss_pred HHHHhh
Confidence 999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=200.43 Aligned_cols=158 Identities=25% Similarity=0.403 Sum_probs=123.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc------------ccCCCCCCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF------------LSSKSAAGT 70 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~------------~~~~~~~~~ 70 (181)
++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 35568899999999999999999 9999999999999999999999999987544321 122345688
Q ss_pred CCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCC
Q 030203 71 PEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWK 150 (181)
Q Consensus 71 ~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 150 (181)
+.|+|||.+.+..++.++|+||+|+++++|++|..|+... ........ ...........++.+.+++.+||+.||.+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 9999999998888999999999999999999987664321 12222222 11111122345678899999999999999
Q ss_pred CCCHHHHHHHHHHhhhC
Q 030203 151 RPSFSTIMELLRPLIKS 167 (181)
Q Consensus 151 Rps~~~~l~~L~~~~~~ 167 (181)
|||+.++++ ++|+++
T Consensus 317 Rps~~~~l~--~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIE--NAIFEN 331 (332)
T ss_dssp SCCHHHHHH--STTCCC
T ss_pred CCCHHHHhh--chhhhc
Confidence 999999999 777764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=198.66 Aligned_cols=162 Identities=28% Similarity=0.515 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.
T Consensus 142 ~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 219 (326)
T 2w1i_A 142 IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219 (326)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchh
Confidence 578899999999999999999999 9999999999999999999999999987544321 11223455667999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhccCCccCCCCCCCHHHHHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA----------------QVVAAVGFKGKRLEIPRNVNPHVASIIEA 142 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 142 (181)
+.+..++.++|+||||+++++|++|..|+...... .+...+. .......+..+++.+.+++.+
T Consensus 220 ~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 298 (326)
T 2w1i_A 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTE 298 (326)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh-cCCCCCCCCcccHHHHHHHHH
Confidence 98877888999999999999999999888643111 1122222 333445677899999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 143 CWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 143 ~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
||+.||.+|||+.++++.|+.+.+
T Consensus 299 cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 299 CWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999998765
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=197.93 Aligned_cols=158 Identities=29% Similarity=0.571 Sum_probs=107.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCccc-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL- 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~- 79 (181)
+++..+..++.|++.||.|||++ | ++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+
T Consensus 122 ~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 122 IPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERID 198 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------
T ss_pred CcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCceeec
Confidence 57888999999999999999999 9 9999999999999999999999999987544332 12233678899999998
Q ss_pred ---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccC----CCCCCCHHHHHHHHHHhcCCCCCC
Q 030203 80 ---RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLE----IPRNVNPHVASIIEACWANEPWKR 151 (181)
Q Consensus 80 ---~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R 151 (181)
.+..++.++|+||+|+++++|++|..||...... .....+. ...... ....+++.+.+++.+||..||.+|
T Consensus 199 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 277 (327)
T 3aln_A 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR 277 (327)
T ss_dssp -------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGS
T ss_pred cccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhC
Confidence 4555789999999999999999999999875432 1111111 111111 224688999999999999999999
Q ss_pred CCHHHHHHHHHHhh
Q 030203 152 PSFSTIMELLRPLI 165 (181)
Q Consensus 152 ps~~~~l~~L~~~~ 165 (181)
|++.++++ ++++
T Consensus 278 ps~~ell~--hp~~ 289 (327)
T 3aln_A 278 PKYKELLK--HPFI 289 (327)
T ss_dssp CCHHHHTT--SHHH
T ss_pred cCHHHHHh--ChHH
Confidence 99999987 4444
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=196.89 Aligned_cols=160 Identities=23% Similarity=0.334 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE----cCCCcEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~----~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||++ +.++.++|+|||++....... ......+++.|+|||
T Consensus 109 ~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE 185 (319)
T 4euu_A 109 LPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPD 185 (319)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC-CBCCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC-ceeecccCCCccCHH
Confidence 688999999999999999999999 9999999999998 777889999999987554432 223456889999999
Q ss_pred ccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhccCCc--------------------
Q 030203 78 VLR--------DEPSNEKSDIYSFGVILWELATLQQPWGNLNP----AQVVAAVGFKGKR-------------------- 125 (181)
Q Consensus 78 ~~~--------~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~----~~~~~~~~~~~~~-------------------- 125 (181)
.+. +..++.++|+||+|+++|+|++|+.||..... ......+......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 4euu_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265 (319)
T ss_dssp HHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSC
T ss_pred HhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccC
Confidence 875 45678899999999999999999999964332 2233333211110
Q ss_pred ---cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHh
Q 030203 126 ---LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPL 164 (181)
Q Consensus 126 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~ 164 (181)
...+..+++.+.+++.+||+.||.+|||++++++...+-
T Consensus 266 ~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 012223456788999999999999999999999977643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=192.73 Aligned_cols=160 Identities=31% Similarity=0.495 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC---CcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK---YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.+ +.++|+|||.+....... ......+++.|+|||.
T Consensus 118 ~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~ 194 (287)
T 2wei_A 118 FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEV 194 (287)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-SCSCHHHHHTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-ccccccCcccccChHH
Confidence 578899999999999999999999 9999999999999654 469999999886543321 1122345678999998
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCC--CCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEI--PRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+. ++.++|+||+|+++++|++|..||.+.+.......+......... ...+++++.+++.+||..||.+|||+.+
T Consensus 195 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 273 (287)
T 2wei_A 195 LRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQ 273 (287)
T ss_dssp HTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHH
Confidence 8664 788999999999999999999999998888777766544433322 2568999999999999999999999999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ ++++++
T Consensus 274 ll~--hp~~~~ 282 (287)
T 2wei_A 274 CLE--HPWIQK 282 (287)
T ss_dssp HHH--SHHHHH
T ss_pred Hhc--CHHHhc
Confidence 999 677664
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=199.06 Aligned_cols=154 Identities=23% Similarity=0.452 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc-CCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||.+....... .....+++.|+|||.+.
T Consensus 146 l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~ 221 (320)
T 3a99_A 146 LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIR 221 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC--BCCCCSCGGGSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc--ccCCCCCccCCChHHhc
Confidence 578899999999999999999999 99999999999998 68899999999987554332 23356788999999887
Q ss_pred CCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..+ +.++|+||||+++|+|++|+.||..... .. ......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 222 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--II------RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH------HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hh------cccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6654 5788999999999999999999976421 11 1123345678999999999999999999999999999
Q ss_pred HHHHhhhCCC
Q 030203 160 LLRPLIKSPT 169 (181)
Q Consensus 160 ~L~~~~~~~~ 169 (181)
+++++...
T Consensus 294 --hp~~~~~~ 301 (320)
T 3a99_A 294 --HPWMQDVL 301 (320)
T ss_dssp --SGGGSSCC
T ss_pred --CHhhcCcc
Confidence 78877654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=193.08 Aligned_cols=154 Identities=26% Similarity=0.495 Sum_probs=127.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc-CCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++ .++.++|+|||.+....... .....++..|++||.+.
T Consensus 136 ~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~ 211 (312)
T 2iwi_A 136 LGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDGTRVYSPPEWIS 211 (312)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC--BCCCCSCTTTSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc--ccccCCcccccCceeee
Confidence 578899999999999999999999 99999999999998 78999999999987554332 23456788999999887
Q ss_pred CCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..+ +.++|+||+|+++|++++|+.||.... ... ......+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 212 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 212 RHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EIL------EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HHh------hhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6655 348999999999999999999997632 111 1233456778999999999999999999999999999
Q ss_pred HHHHhhhCCC
Q 030203 160 LLRPLIKSPT 169 (181)
Q Consensus 160 ~L~~~~~~~~ 169 (181)
+.|++...
T Consensus 284 --~~~~~~~~ 291 (312)
T 2iwi_A 284 --DPWMQTPA 291 (312)
T ss_dssp --STTTCC--
T ss_pred --ChhhcCch
Confidence 88877543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=195.62 Aligned_cols=159 Identities=12% Similarity=0.090 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-----------CCcEEEcccCCccccc--cccccCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-----------KYTVKVCDFGLSRLKA--NTFLSSKSAA 68 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-----------~~~~~l~d~g~~~~~~--~~~~~~~~~~ 68 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++. ++.++|+|||++.... ..........
T Consensus 169 l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 246 (365)
T 3e7e_A 169 MPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246 (365)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSS
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeec
Confidence 678899999999999999999999 999999999999988 8999999999986432 1122234567
Q ss_pred CCCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCC
Q 030203 69 GTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEP 148 (181)
Q Consensus 69 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 148 (181)
+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||........ ....... ....++.+.+++.+|++.+|
T Consensus 247 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~--~~~~~~~~~~~~~~~l~~~p 320 (365)
T 3e7e_A 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----KPEGLFR--RLPHLDMWNEFFHVMLNIPD 320 (365)
T ss_dssp CTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----EECSCCT--TCSSHHHHHHHHHHHHCCCC
T ss_pred CCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----eechhcc--ccCcHHHHHHHHHHHcCCCC
Confidence 89999999999998899999999999999999999999865432110 0001111 11246788999999999999
Q ss_pred CCCC-CHHHHHHHHHHhhhCC
Q 030203 149 WKRP-SFSTIMELLRPLIKSP 168 (181)
Q Consensus 149 ~~Rp-s~~~~l~~L~~~~~~~ 168 (181)
.+|+ +++++.+.|+.++...
T Consensus 321 ~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 321 CHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp TTCCCCHHHHHHHHHHHHHHH
T ss_pred CCcchHHHHHHHHHHHHHHHh
Confidence 9995 8999999999988753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=194.93 Aligned_cols=155 Identities=26% Similarity=0.405 Sum_probs=121.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc---EEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~---~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++. ++|+|||.+........ .....+++.|+|||.
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~ 187 (322)
T 2ycf_A 111 LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEV 187 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH-HHHHHSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccceecccccc-cccccCCcCccCchh
Confidence 578899999999999999999999 999999999999987654 99999999875443211 112356789999998
Q ss_pred cC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCC--ccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 79 LR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGK--RLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 79 ~~---~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+. ...++.++|+||+|+++|+|++|..||...... .....+..... .......+++.+.+++.+||..||.+||
T Consensus 188 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 267 (322)
T 2ycf_A 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 267 (322)
T ss_dssp HHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred hccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCC
Confidence 63 455788999999999999999999999765432 22222221111 1122356889999999999999999999
Q ss_pred CHHHHHH
Q 030203 153 SFSTIME 159 (181)
Q Consensus 153 s~~~~l~ 159 (181)
++.++++
T Consensus 268 s~~~~l~ 274 (322)
T 2ycf_A 268 TTEEALR 274 (322)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=199.49 Aligned_cols=164 Identities=23% Similarity=0.320 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEE----cCCCcEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~----~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||++ +.++.++|+|||++....... ......+++.|+|||
T Consensus 109 l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE 185 (396)
T 4eut_A 109 LPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPD 185 (396)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG-GSSCSSSCCTTCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC-ccccccCCccccCHH
Confidence 688999999999999999999999 9999999999998 777789999999987544432 223456889999999
Q ss_pred ccCC--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhccCCcc-------------------
Q 030203 78 VLRD--------EPSNEKSDIYSFGVILWELATLQQPWGNLN----PAQVVAAVGFKGKRL------------------- 126 (181)
Q Consensus 78 ~~~~--------~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~------------------- 126 (181)
.+.+ ..++.++|+||+|+++|+|++|+.||.... .......+.......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 265 (396)
T 4eut_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265 (396)
T ss_dssp HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSC
T ss_pred HhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccC
Confidence 8754 345678999999999999999999996432 223333332221110
Q ss_pred ----CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 127 ----EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 127 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
..+..+++.+.+++.+||+.||.+||+++++++.++.++...
T Consensus 266 ~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 111234567889999999999999999999999999988753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-30 Score=188.69 Aligned_cols=159 Identities=26% Similarity=0.421 Sum_probs=120.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--------------cccCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--------------FLSSKSA 67 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~ 67 (181)
+++.+++.++.|++.||.|||++| ++|+||+|+||+++.++.++++|||.+...... .......
T Consensus 113 ~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (303)
T 1zy4_A 113 QQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190 (303)
T ss_dssp GCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC----------------------
T ss_pred cchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccC
Confidence 467888999999999999999999 999999999999999999999999998754321 1112334
Q ss_pred CCCCCccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccC--CccCCCCCCCHHHHHHHHHH
Q 030203 68 AGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKG--KRLEIPRNVNPHVASIIEAC 143 (181)
Q Consensus 68 ~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 143 (181)
.+++.|+|||.+.+. .++.++|+||+|+++|+|++ ||... ........+.... .....+...++.+.+++.+|
T Consensus 191 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 267 (303)
T 1zy4_A 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLL 267 (303)
T ss_dssp ---CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHH
T ss_pred CCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHH
Confidence 678899999998765 57899999999999999998 44432 2233333333221 12234556778899999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
|+.||.+|||+.++++ ++|++.
T Consensus 268 l~~dp~~Rps~~~ll~--h~~~~~ 289 (303)
T 1zy4_A 268 IDHDPNKRPGARTLLN--SGWLPV 289 (303)
T ss_dssp TCSSGGGSCCHHHHHH--SSCSCC
T ss_pred HhcCcccCcCHHHHhC--CCCcCC
Confidence 9999999999999999 888764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=199.22 Aligned_cols=159 Identities=27% Similarity=0.430 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---C--CcEEEcccCCcccccccc---ccCCCCCCCCCccC
Q 030203 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---K--YTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMA 75 (181)
Q Consensus 4 ~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~--~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~ 75 (181)
+.+++.++.|++.||.|||+++ ++|+||+|+||+++. + ..++|+|||++....... .......+++.|+|
T Consensus 117 ~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~A 194 (432)
T 3p23_A 117 GLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194 (432)
T ss_dssp SSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCC
T ss_pred chhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccC
Confidence 3456789999999999999999 999999999999953 2 357899999987544321 22234568999999
Q ss_pred CcccCC---CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCcc-CCCCCCCHHHHHHHHHHhcCCCCC
Q 030203 76 PEVLRD---EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRL-EIPRNVNPHVASIIEACWANEPWK 150 (181)
Q Consensus 76 pe~~~~---~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~ 150 (181)
||.+.+ ..++.++|+||+||++++|++ |..||................... ......+..+.+++.+||+.||.+
T Consensus 195 PE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 274 (432)
T 3p23_A 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQK 274 (432)
T ss_dssp GGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGG
T ss_pred hhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhh
Confidence 999873 456779999999999999999 899997766555443332111111 112234566899999999999999
Q ss_pred CCCHHHHHHHHHHhhh
Q 030203 151 RPSFSTIMELLRPLIK 166 (181)
Q Consensus 151 Rps~~~~l~~L~~~~~ 166 (181)
|||+.++++ ++|++
T Consensus 275 Rps~~evl~--hp~f~ 288 (432)
T 3p23_A 275 RPSAKHVLK--HPFFW 288 (432)
T ss_dssp SCCHHHHHT--STTTC
T ss_pred CCCHHHHHh--Ccccc
Confidence 999999997 55553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=197.79 Aligned_cols=155 Identities=25% Similarity=0.491 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC-------------CcEEEcccCCccccccccc----cCCCCC
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-------------YTVKVCDFGLSRLKANTFL----SSKSAA 68 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~-------------~~~~l~d~g~~~~~~~~~~----~~~~~~ 68 (181)
+++.++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++........ ......
T Consensus 116 ~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~ 193 (434)
T 2rio_A 116 NPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193 (434)
T ss_dssp CHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-------------
T ss_pred hHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCC
Confidence 45789999999999999999 9999999999999654 4899999999876443221 123456
Q ss_pred CCCCccCCcccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccC-C----CCCCCHH
Q 030203 69 GTPEWMAPEVLRD-------EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLE-I----PRNVNPH 135 (181)
Q Consensus 69 ~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~ 135 (181)
+++.|+|||.+.+ ..++.++|+||+||++|+|++ |..||.......... +. ...... . ...++++
T Consensus 194 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i-~~-~~~~~~~~~~~~~~~~~~~ 271 (434)
T 2rio_A 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI-IR-GIFSLDEMKCLHDRSLIAE 271 (434)
T ss_dssp -CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHH-HH-TCCCCCCCTTCCCHHHHHH
T ss_pred CCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHH-hc-CCCCcccccccccccchHH
Confidence 8899999999865 457889999999999999998 999997765443221 11 111111 1 1234578
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHhhh
Q 030203 136 VASIIEACWANEPWKRPSFSTIMELLRPLIK 166 (181)
Q Consensus 136 ~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~ 166 (181)
+.+++.+||+.||.+|||+.++++ +++++
T Consensus 272 ~~~li~~~L~~dP~~Rps~~eil~--hp~f~ 300 (434)
T 2rio_A 272 ATDLISQMIDHDPLKRPTAMKVLR--HPLFW 300 (434)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHT--SGGGS
T ss_pred HHHHHHHHhhCChhhCCCHHHHHh--CCccC
Confidence 999999999999999999999998 66654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-29 Score=184.15 Aligned_cols=145 Identities=27% Similarity=0.468 Sum_probs=113.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++|+||+|+||+++. ++.++++|||++....
T Consensus 114 ~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-------------------- 171 (299)
T 3m2w_A 114 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------------- 171 (299)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccccccc--------------------
Confidence 678899999999999999999999 999999999999988 7889999999874322
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--ccCCC----CCCCHHHHHHHHHHhcCCCCCCC
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--RLEIP----RNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+..++.++|+||+|+++|+|++|..||.+............... ....+ ..+++++.+++.+||+.||.+||
T Consensus 172 --~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 249 (299)
T 3m2w_A 172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 249 (299)
T ss_dssp --TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred --cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC
Confidence 12356789999999999999999999987655433221111111 11112 46889999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCCCCC
Q 030203 153 SFSTIMELLRPLIKSPTPQP 172 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~~~~ 172 (181)
|+.++++ ++|++.....+
T Consensus 250 s~~e~l~--hp~~~~~~~~~ 267 (299)
T 3m2w_A 250 TITEFMN--HPWIMQSTKVP 267 (299)
T ss_dssp CHHHHHT--SHHHHTGGGSC
T ss_pred CHHHHhc--ChhhcccccCC
Confidence 9999999 88888765444
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=191.78 Aligned_cols=164 Identities=19% Similarity=0.271 Sum_probs=123.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCc---EEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~---~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++. ++++|||.+....... ......+++.|+|||.
T Consensus 118 lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~ 194 (676)
T 3qa8_A 118 LKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPEL 194 (676)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC-CCCCCCSCCTTCSSCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccccccccccc-ccccccCCcccCChHH
Confidence 567789999999999999999999 999999999999987664 8999999987654432 2234577889999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------HHHhc-cC--C----------ccCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV---------AAVGF-KG--K----------RLEIPRNVNPHV 136 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~---------~~~~~-~~--~----------~~~~~~~~~~~~ 136 (181)
+.+..++.++|+||+|+++|++++|..||.+....... ..... .. . .......+++.+
T Consensus 195 l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L 274 (676)
T 3qa8_A 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKL 274 (676)
T ss_dssp SCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHH
T ss_pred hccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHH
Confidence 98888999999999999999999999999765432211 00000 00 0 001222356789
Q ss_pred HHHHHHHhcCCCCCCCCHHH-----HHHHHHHhhhCC
Q 030203 137 ASIIEACWANEPWKRPSFST-----IMELLRPLIKSP 168 (181)
Q Consensus 137 ~~li~~~l~~~p~~Rps~~~-----~l~~L~~~~~~~ 168 (181)
.+++.+||..||.+|||+.+ +.+.++.++...
T Consensus 275 ~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 275 ERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp HHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred HHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 99999999999999999988 566677666543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-27 Score=190.67 Aligned_cols=148 Identities=19% Similarity=0.267 Sum_probs=118.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||||+||+++.+ .++|+|||++...... ....+++.|++||.+.+
T Consensus 179 l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~ 251 (681)
T 2pzi_A 179 LPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRT 251 (681)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcC
Confidence 678999999999999999999999 9999999999999885 8999999998754432 34568899999998866
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-CHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-SFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~~l~~ 160 (181)
. .+.++|+||||+++++|++|..||.+..... ..........++.+.+++.+||+.||.+|| +++++...
T Consensus 252 ~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 322 (681)
T 2pzi_A 252 G-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322 (681)
T ss_dssp C-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred C-CCCceehhhhHHHHHHHHhCCCCCccccccc--------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence 5 4789999999999999999988886532100 000000012357899999999999999999 57777777
Q ss_pred HHHhh
Q 030203 161 LRPLI 165 (181)
Q Consensus 161 L~~~~ 165 (181)
|..++
T Consensus 323 l~~~~ 327 (681)
T 2pzi_A 323 LTGVL 327 (681)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=167.83 Aligned_cols=136 Identities=16% Similarity=0.167 Sum_probs=106.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
.+.++..++.|++.||.|||++| ++|+||||+||+++.+|.+++++++. .+
T Consensus 127 ~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~~--------------------~~------- 177 (286)
T 3uqc_A 127 SPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPAT--------------------MP------- 177 (286)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCCC--------------------CT-------
T ss_pred ChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEeccc--------------------cC-------
Confidence 34578899999999999999999 99999999999999999999874432 22
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hc-cCC---ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 83 PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-GF-KGK---RLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 83 ~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~-~~-~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.++.++|+||||+++|+|++|+.||.+.+........ .. ... .......+++.+.+++.+||+.||.+| |+.++
T Consensus 178 ~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el 256 (286)
T 3uqc_A 178 DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTL 256 (286)
T ss_dssp TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHH
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHH
Confidence 2578999999999999999999999876542211000 00 000 012335789999999999999999999 99999
Q ss_pred HHHHHHhhhCC
Q 030203 158 MELLRPLIKSP 168 (181)
Q Consensus 158 l~~L~~~~~~~ 168 (181)
++.|+......
T Consensus 257 ~~~L~~~~~~~ 267 (286)
T 3uqc_A 257 LNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHC--
T ss_pred HHHHHHHhccC
Confidence 99999886644
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=169.45 Aligned_cols=150 Identities=15% Similarity=0.146 Sum_probs=115.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-hCCCCceecCCCCCCEEEcCCC--------------------cEEEcccCCccccccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLH-RRNPPIVHRDLKSPNLLVDKKY--------------------TVKVCDFGLSRLKANT 60 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh-~~~~~~~h~~i~~~nil~~~~~--------------------~~~l~d~g~~~~~~~~ 60 (181)
+++.++..++.||+.||.||| +++ ++||||||+||+++.++ .++|+|||+++.....
T Consensus 158 ~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~ 235 (336)
T 2vuw_A 158 SSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC
Confidence 578999999999999999999 899 99999999999999887 8999999998765432
Q ss_pred cccCCCCCCCCCccCCcccCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHhcc-CCccC----CCCCCC
Q 030203 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVI-LWELATLQQPWGNLNP-AQVVAAVGFK-GKRLE----IPRNVN 133 (181)
Q Consensus 61 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~-~~~ll~g~~p~~~~~~-~~~~~~~~~~-~~~~~----~~~~~~ 133 (181)
...+++.|+|||.+.+.. +.++|+||+|++ .+++++|..||..... ......+... ..... .+..++
T Consensus 236 -----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 236 -----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309 (336)
T ss_dssp -----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHH
T ss_pred -----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcC
Confidence 236788999999998766 889999998777 6678889999854221 1122222111 11111 123478
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHH-HHHHHhhh
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIM-ELLRPLIK 166 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l-~~L~~~~~ 166 (181)
+++.+||.+||+.| |+++++ + ++|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l~~--Hp~f~ 336 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLLCQ--HSLFK 336 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHHHH--CGGGC
T ss_pred HHHHHHHHHHhccC-----CHHHHHhc--CCCcC
Confidence 89999999999976 999999 7 67663
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-20 Score=150.95 Aligned_cols=93 Identities=14% Similarity=0.142 Sum_probs=62.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCCCCCCc
Q 030203 8 LNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEK 87 (181)
Q Consensus 8 ~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 87 (181)
.+|+.||+.||.|+|++| |+||||||+||+++.+|.+||+|||+++..........+..|++.|++||.+.+. +...
T Consensus 342 ~~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~ 418 (569)
T 4azs_A 342 EKILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWN 418 (569)
T ss_dssp HHHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--------
T ss_pred HHHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCc
Confidence 358899999999999999 9999999999999999999999999987655443344456788999999998764 5667
Q ss_pred hhHHHHHHHHHHHHhC
Q 030203 88 SDIYSFGVILWELATL 103 (181)
Q Consensus 88 ~Dv~slG~~~~~ll~g 103 (181)
+|+|++|++.+.+.++
T Consensus 419 ~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 419 GFWRSAPVHPFNLPQP 434 (569)
T ss_dssp ----------CCCCTT
T ss_pred ccccccccchhhhccc
Confidence 9999999987665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=4.2e-15 Score=118.49 Aligned_cols=97 Identities=22% Similarity=0.341 Sum_probs=77.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccccc-------CCCCCCCCCccCCccc
Q 030203 7 RLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS-------SKSAAGTPEWMAPEVL 79 (181)
Q Consensus 7 ~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-------~~~~~~~~~~~~pe~~ 79 (181)
+..++.|++.+|.|||+++ ++|+||||+||+++. .++|+|||+++........ .....+++.|++||.+
T Consensus 433 ~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~ 508 (540)
T 3en9_A 433 NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIW 508 (540)
T ss_dssp CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHH
Confidence 4578999999999999999 999999999999998 9999999999865543211 1244678899999999
Q ss_pred CC--CCCCCchhHHHHHHHHHHHHhCCCCC
Q 030203 80 RD--EPSNEKSDIYSFGVILWELATLQQPW 107 (181)
Q Consensus 80 ~~--~~~~~~~Dv~slG~~~~~ll~g~~p~ 107 (181)
.. ..|+...|.|+..+-..+-+.++.++
T Consensus 509 ~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 509 ERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 76 44666788999888777776655544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=7.8e-11 Score=86.60 Aligned_cols=47 Identities=26% Similarity=0.267 Sum_probs=44.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 6 RRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 6 ~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+...++.|++.||.+||+.| ++|+||+|+||+++ ++.++|+|||++.
T Consensus 194 ~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 194 NPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 45679999999999999999 99999999999999 9999999999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=1.6e-10 Score=83.78 Aligned_cols=48 Identities=23% Similarity=0.257 Sum_probs=44.1
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCCCceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 5 RRRLNMAYDVAKGMNYLH-RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh-~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
.++..++.|++.++.+|| +.| ++|+||+|.||+++. .++++|||++..
T Consensus 170 ~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 170 LDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 467889999999999999 999 999999999999988 899999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.61 E-value=2.1e-08 Score=76.57 Aligned_cols=50 Identities=16% Similarity=0.198 Sum_probs=43.4
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC----------cEEEcccCCccc
Q 030203 5 RRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY----------TVKVCDFGLSRL 56 (181)
Q Consensus 5 ~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~----------~~~l~d~g~~~~ 56 (181)
.++..++.|++.++.+||..| ++|+||+|.||+++.+| .+.++||+.+..
T Consensus 205 ~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 205 PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 345678999999999999999 99999999999998776 378999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.44 E-value=6.7e-06 Score=57.56 Aligned_cols=131 Identities=18% Similarity=0.237 Sum_probs=85.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
|+|+|+|.++.|.+.+|..+-.+.. -...-+.+..|++..+|++.+.+ ..+. .....+.+||...
T Consensus 46 lsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~~~~~~pe~~~- 110 (229)
T 2yle_A 46 INEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGEPPPVAGKLGY- 110 (229)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C------------------------CCSS-
T ss_pred cCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc------------ccccCCCChhhcc-
Confidence 6899999999999999887732210 12334457889999999887764 1110 1112456777653
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcC--------------
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWAN-------------- 146 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-------------- 146 (181)
...+.+.-||+||+++|.-+- |- ....+..+|+++.+||..|...
T Consensus 111 ~~~te~~~IysLG~tLY~ALDygL--------------------~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~ 170 (229)
T 2yle_A 111 SQCMETEVIESLGIIIYKALDYGL--------------------KENEERELSPPLEQLIDHMANTVEADGSNDEGYEAA 170 (229)
T ss_dssp SSSCHHHHHHHHHHHHHHHHTTTC--------------------CTTEEECCCHHHHHHHHHHTTCCC------------
T ss_pred ccchHHHHHHHHHHHHHHHhhcCC--------------------CcccchhhCHHHHHHHHHHHhccccccccccccccc
Confidence 334677889999999998874 32 2223456899999999999865
Q ss_pred -----------CCCCCCCHHHHHHHHHHhhhC
Q 030203 147 -----------EPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 147 -----------~p~~Rps~~~~l~~L~~~~~~ 167 (181)
.+..|.+++++++.=..-++.
T Consensus 171 ~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~ 202 (229)
T 2yle_A 171 EEGLGDEDEKRKISAIRSYRDVMKLCAAHLPT 202 (229)
T ss_dssp --------CCSCCCCCCSHHHHHHHHHTTSSS
T ss_pred ccccccccccccccCcCCHHHHHHHHHhhccC
Confidence 246788999998866654443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.61 E-value=3.1e-05 Score=57.06 Aligned_cols=79 Identities=19% Similarity=0.269 Sum_probs=46.5
Q ss_pred ceecCCCCCCEEEcC--CCcEEEcccCCccccccccccCCCCCCCCCccCCccc----CCCCC----------CCchhHH
Q 030203 28 IVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL----RDEPS----------NEKSDIY 91 (181)
Q Consensus 28 ~~h~~i~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~----------~~~~Dv~ 91 (181)
++|+|+++.||+++. .+.+.++||+.+.................. ..++.. .+.+. ....+.|
T Consensus 193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~-~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~ 271 (304)
T 3sg8_A 193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEE-YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYW 271 (304)
T ss_dssp EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTS-CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHH
T ss_pred eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccc-cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHH
Confidence 799999999999988 556789999987543221111100000000 111111 01110 1125789
Q ss_pred HHHHHHHHHHhCCCCC
Q 030203 92 SFGVILWELATLQQPW 107 (181)
Q Consensus 92 slG~~~~~ll~g~~p~ 107 (181)
++|.+++.+.+|..+|
T Consensus 272 ~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 272 SFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCHHH
Confidence 9999999999997765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00019 Score=54.01 Aligned_cols=54 Identities=24% Similarity=0.333 Sum_probs=44.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------------CC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRR--------------------------------------------------------NP 26 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~--------------------------------------------------------~~ 26 (181)
++.+...++.++...|..||+. ..
T Consensus 137 ~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 216 (359)
T 3dxp_A 137 SPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLT 216 (359)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCC
T ss_pred CHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCc
Confidence 5677888999999999999972 12
Q ss_pred CceecCCCCCCEEEcCCCc--EEEcccCCccc
Q 030203 27 PIVHRDLKSPNLLVDKKYT--VKVCDFGLSRL 56 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~--~~l~d~g~~~~ 56 (181)
.++|+|+++.||+++.++. +.++||+.+..
T Consensus 217 ~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 217 SIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp EEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred eEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 3899999999999987653 68999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00012 Score=52.65 Aligned_cols=27 Identities=30% Similarity=0.415 Sum_probs=23.1
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+++.||+++.++.+.++||+.+
T Consensus 185 l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 185 FSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp EECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred EECCCCCcCcEEEECCcEEEEEEchhc
Confidence 899999999999987655679999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00047 Score=49.06 Aligned_cols=27 Identities=26% Similarity=0.354 Sum_probs=23.7
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+++.||+++.++.+.++||+.+
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhc
Confidence 899999999999987766679999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0091 Score=44.14 Aligned_cols=28 Identities=21% Similarity=0.323 Sum_probs=25.1
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
+++|+|+++.||+++.++.+.++||+.+
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 3999999999999987788999999865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=95.32 E-value=0.042 Score=40.31 Aligned_cols=29 Identities=24% Similarity=0.517 Sum_probs=23.9
Q ss_pred ceecCCCCCCEEEcC---CCc-EEEcccCCccc
Q 030203 28 IVHRDLKSPNLLVDK---KYT-VKVCDFGLSRL 56 (181)
Q Consensus 28 ~~h~~i~~~nil~~~---~~~-~~l~d~g~~~~ 56 (181)
++|+|+++.||+++. ++. ..++||+.+..
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 799999999999987 355 47999987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.18 E-value=0.023 Score=43.64 Aligned_cols=29 Identities=24% Similarity=0.379 Sum_probs=25.6
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCcccc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 57 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~~~ 57 (181)
++|+|+++.||+++.++ +.++||+.+...
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 99999999999998876 999999887543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=94.68 E-value=0.015 Score=41.60 Aligned_cols=28 Identities=25% Similarity=0.386 Sum_probs=24.4
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
++|+|+++.||+++.++.+-++||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 7999999999999987777799998653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.69 E-value=0.12 Score=36.01 Aligned_cols=81 Identities=10% Similarity=0.047 Sum_probs=56.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCCC
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDE 82 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 82 (181)
+..+.++++.+|+....+++. -+|--++|+|++++.++.+++.-.|+.. -++|..
T Consensus 79 ~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f~~~~~p~i~~RGik~-----------------~l~P~~---- 133 (215)
T 4ann_A 79 TKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFFTRDGLPIAKTRGLQN-----------------VVDPLP---- 133 (215)
T ss_dssp CHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEECTTSCEEESCCEETT-----------------TBSCCC----
T ss_pred CHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEEcCCCCEEEEEccCcc-----------------CCCCCC----
Confidence 566788899999888844433 3789999999999999999998887621 122221
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 030203 83 PSNEKSDIYSFGVILWELATLQQPWGN 109 (181)
Q Consensus 83 ~~~~~~Dv~slG~~~~~ll~g~~p~~~ 109 (181)
.+...=.-.+-|++..+++++..|..
T Consensus 134 -~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 134 -VSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp -CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred -CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 12222234578888899998877643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.85 E-value=0.17 Score=37.40 Aligned_cols=30 Identities=40% Similarity=0.490 Sum_probs=25.7
Q ss_pred CceecCCCCCCEEEcCC----CcEEEcccCCccc
Q 030203 27 PIVHRDLKSPNLLVDKK----YTVKVCDFGLSRL 56 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~----~~~~l~d~g~~~~ 56 (181)
+++|+|+++.||+++.+ +.+.++||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 39999999999999874 6789999987754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.59 E-value=0.048 Score=40.01 Aligned_cols=28 Identities=21% Similarity=0.273 Sum_probs=24.1
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
++|+|+++.||+++.++.+.++||+.+.
T Consensus 189 liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 189 VIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCCCCCccCEEEeCCceEEEecchhcc
Confidence 8999999999999887656899998653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.31 E-value=0.1 Score=36.54 Aligned_cols=80 Identities=10% Similarity=0.113 Sum_probs=55.5
Q ss_pred CCHHHHHHHHHHHHHHHH-HHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMN-YLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~-~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++..+.++++.+|+.... +++. -+|--+.|+|++++.++.+++.-.|+.. .++|...
T Consensus 82 ~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f~~~~~p~i~hRGi~~-----------------~lpP~e~- 139 (219)
T 4ano_A 82 TTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMFNRALEPFFLHVGVKE-----------------SLPPDEW- 139 (219)
T ss_dssp SCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEECTTCCEEESCCEETT-----------------TBSSCSC-
T ss_pred cCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEEeCCCcEEEEEcCCcc-----------------cCCCCCC-
Confidence 356678888888887766 4433 4789999999999999999999887621 1233221
Q ss_pred CCCCCCchhH-HHHHHHHHHHHhCCCCCC
Q 030203 81 DEPSNEKSDI-YSFGVILWELATLQQPWG 108 (181)
Q Consensus 81 ~~~~~~~~Dv-~slG~~~~~ll~g~~p~~ 108 (181)
+ ..|. -.+-|++..++.++..|.
T Consensus 140 ----~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 140 ----D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred ----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 1 2333 347788888888777654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=92.03 E-value=0.052 Score=40.48 Aligned_cols=29 Identities=21% Similarity=0.255 Sum_probs=24.2
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+++|+|+++.||+++.++.+.++||+.+.
T Consensus 223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 223 VLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp EEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred eEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 39999999999999864457899998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.90 E-value=0.2 Score=36.73 Aligned_cols=26 Identities=23% Similarity=0.262 Sum_probs=23.0
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
++|+|+++.||+++ + .+.++||+.+.
T Consensus 197 l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 197 RLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp ECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 89999999999998 4 78999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.67 E-value=0.15 Score=37.96 Aligned_cols=29 Identities=24% Similarity=0.477 Sum_probs=25.9
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
++|+|+.+.||+++.++.+.++||+.+..
T Consensus 208 ~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 208 LCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 89999999999999877899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=91.37 E-value=0.2 Score=39.10 Aligned_cols=15 Identities=33% Similarity=0.472 Sum_probs=14.0
Q ss_pred CceecCCCCCCEEEc
Q 030203 27 PIVHRDLKSPNLLVD 41 (181)
Q Consensus 27 ~~~h~~i~~~nil~~ 41 (181)
+++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 489999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.29 E-value=0.09 Score=39.50 Aligned_cols=28 Identities=29% Similarity=0.513 Sum_probs=23.4
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+++|+|+.+.||+++.++ +.++||+.+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 389999999999998654 8999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=90.82 E-value=0.11 Score=39.44 Aligned_cols=28 Identities=21% Similarity=0.402 Sum_probs=24.0
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+++|||+.+.||+++.+ .+.++||..+.
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 39999999999999876 48899997765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=90.46 E-value=0.11 Score=37.89 Aligned_cols=28 Identities=25% Similarity=0.284 Sum_probs=23.6
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+++|+|+.+.||+ ..++.+.++||+.+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 4899999999999 555678999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.10 E-value=0.099 Score=40.38 Aligned_cols=17 Identities=35% Similarity=0.602 Sum_probs=14.7
Q ss_pred CceecCCCCCCEEEcCC
Q 030203 27 PIVHRDLKSPNLLVDKK 43 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~ 43 (181)
+++|+|+.+.||+++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 48999999999999874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.65 E-value=0.16 Score=38.67 Aligned_cols=29 Identities=24% Similarity=0.422 Sum_probs=25.2
Q ss_pred CceecCCCCCCEEEcCC----CcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKK----YTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~----~~~~l~d~g~~~ 55 (181)
+++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 48999999999999876 688999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.81 E-value=0.2 Score=38.19 Aligned_cols=28 Identities=29% Similarity=0.481 Sum_probs=23.9
Q ss_pred ceecCCCCCCEEE------cCCCcEEEcccCCcc
Q 030203 28 IVHRDLKSPNLLV------DKKYTVKVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~------~~~~~~~l~d~g~~~ 55 (181)
++|+|+.+.||++ +.++.+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 345679999998875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=86.74 E-value=0.58 Score=33.69 Aligned_cols=24 Identities=33% Similarity=0.403 Sum_probs=19.4
Q ss_pred CCceecCCCCCCEEEcCCCcEEEcc
Q 030203 26 PPIVHRDLKSPNLLVDKKYTVKVCD 50 (181)
Q Consensus 26 ~~~~h~~i~~~nil~~~~~~~~l~d 50 (181)
+.++|+|+++.|++++.+|. .+.|
T Consensus 188 p~LvHGDlw~gNvl~~~~g~-~~iD 211 (288)
T 3f7w_A 188 PARIHGDLWNGNVLWQDDGA-VVID 211 (288)
T ss_dssp CEEECSCCSGGGEEEETTEE-EECS
T ss_pred CeeeecCCCCCcEEEcCCCe-EEEe
Confidence 34999999999999998874 4555
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=83.12 E-value=0.49 Score=36.52 Aligned_cols=28 Identities=29% Similarity=0.541 Sum_probs=24.7
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
+++|+|+.+.||+ +.++.+.++||..+.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 3899999999999 777889999998765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=82.49 E-value=0.49 Score=34.86 Aligned_cols=26 Identities=27% Similarity=0.417 Sum_probs=22.5
Q ss_pred CCceecCCCCCCEEEcCCCcEEEcccC
Q 030203 26 PPIVHRDLKSPNLLVDKKYTVKVCDFG 52 (181)
Q Consensus 26 ~~~~h~~i~~~nil~~~~~~~~l~d~g 52 (181)
+.++|+|+.+.|++++.++ +.++|+.
T Consensus 207 ~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 207 PSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred ceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3499999999999999887 8888874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 181 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-39 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-51
Identities = 53/175 (30%), Positives = 98/175 (56%), Gaps = 11/175 (6%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
+ + +++A A+GM+YLH ++ I+HRDLKS N+ + + TVK+ DFGL+ + + +
Sbjct: 101 FEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158
Query: 60 TFLSSKSAAGTPEWMAPEVLRDE---PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 116
+ +G+ WMAPEV+R + P + +SD+Y+FG++L+EL T Q P+ N+N +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 117 AAVGFKGKRL----EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+ +G ++ N + ++ C + +RP F I+ + L +S
Sbjct: 219 IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-49
Identities = 54/160 (33%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPN-LLVDKKYTVKVCDFGLSRLKANT 60
+ + + + KG+ +LH R PPI+HRDLK N + +VK+ D GL+ LK +
Sbjct: 109 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAV 119
F +K+ GTPE+MAPE+ E +E D+Y+FG+ + E+AT + P+ N AQ+ V
Sbjct: 169 F--AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
K + P V IIE C +R S ++
Sbjct: 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-49
Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 4/161 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRN---PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA 58
LDE L + + + HRR+ ++HRDLK N+ +D K VK+ DFGL+R+
Sbjct: 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
+ +K+ GTP +M+PE + NEKSDI+S G +L+EL L P+ + ++
Sbjct: 166 HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 225
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
+ +GK IP + + II + + RPS I+E
Sbjct: 226 I-REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-48
Identities = 58/175 (33%), Positives = 91/175 (52%), Gaps = 5/175 (2%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KANTFL 62
+ ++MA +A GM Y+ R N VHRDL++ N+LV + KV DFGL+RL + N +
Sbjct: 112 LPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGF 121
+ + A +W APE KSD++SFG++L EL T + P+ + +V+ V
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE- 228
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176
+G R+ P + ++ CW EP +RP+F + L S PQ P +
Sbjct: 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-47
Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 7/174 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KA 58
+ ++ + + + V+ GM YL N VHRDL + N+L+ ++ K+ DFGLS+
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVA 117
N + + +W APE + + KSD++SFGV++WE + Q+P+ + ++V A
Sbjct: 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 221
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
+ KG+R+ P + ++ CW + RP F+ + LR +
Sbjct: 222 MLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-47
Identities = 48/170 (28%), Positives = 89/170 (52%), Gaps = 7/170 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KA 58
+ + + V+ GM YL +N VHRDL + N+L+ ++ K+ DFGLS+
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVA 117
+ + + + +W APE + + +SD++S+GV +WE + Q+P+ + +V+A
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 223
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+ +GKR+E P P + +++ CW + RP F T+ + +R S
Sbjct: 224 FIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 7e-47
Identities = 55/164 (33%), Positives = 88/164 (53%), Gaps = 5/164 (3%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KA 58
+L L AY VAKGM +L ++ VHRDL + N+LV VK+CDFGL+R
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVA 117
+ ++ +A +WMAPE L + KSD++S+G++LWE+ +L P+ +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161
+ G +++ P + I+++CWA + KRPSF + L
Sbjct: 278 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-46
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E + + +NYLH I+HRDLK+ N+L +K+ DFG+S T
Sbjct: 107 LTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164
Query: 62 LSSKSAAGTPEWMAPEVL-----RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV 116
S GTP WMAPEV+ +D P + K+D++S G+ L E+A ++ P LNP +V+
Sbjct: 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224
Query: 117 AAVG-FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172
+ + L P + + ++ C R + S +++ P + + +P
Sbjct: 225 LKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFVTVDSNKP 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-46
Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 7/162 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L L + DV + M YL N VHRDL + N+LV + KV DFGL++ ++T
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVG 120
+ +W APE LR++ + KSD++SFG++LWE+ + + P+ + VV V
Sbjct: 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
KG +++ P P V +++ CW + RPSF + E L
Sbjct: 215 -KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (384), Expect = 2e-46
Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 9/172 (5%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN--- 59
+ + M +A GM YL N VHRDL + N+LV+ KV DFGLSR +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 60 --TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVV 116
T+ S+ W APE ++ SD++S+G+++WE+ + ++P+ ++ V+
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 117 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
A+ + RL P + + ++ CW + RP F I+ L +I++P
Sbjct: 244 NAIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-46
Identities = 58/178 (32%), Positives = 95/178 (53%), Gaps = 5/178 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L ++ L+ A DVA+GM+YL +HRDL + N+LV + Y K+ DFGLSR + +
Sbjct: 124 LSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVY 180
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVG 120
+ WMA E L SD++S+GV+LWE+ +L P+ + A++ +
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 178
+G RLE P N + V ++ CW +P++RPSF+ I+ L +++ + T
Sbjct: 241 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-46
Identities = 37/158 (23%), Positives = 71/158 (44%), Gaps = 6/158 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
DE+R ++A ++Y H + ++HRD+K NLL+ +K+ DFG S ++
Sbjct: 103 FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ GT +++ PE++ +EK D++S GV+ +E + P+ + +
Sbjct: 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-- 216
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
P V +I + P +RP ++E
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-46
Identities = 53/172 (30%), Positives = 86/172 (50%), Gaps = 7/172 (4%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+ + M +A GM YL N VHRDL + N+LV+ KV DFGLSR+ +
Sbjct: 106 EFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163
Query: 61 FLSSKS---AAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVV 116
++ + W APE + SD++SFG+++WE+ T + L+ +V+
Sbjct: 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223
Query: 117 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168
A+ G RL P + + ++ CW E +RP F+ I+ +L LI++P
Sbjct: 224 KAIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-45
Identities = 58/190 (30%), Positives = 87/190 (45%), Gaps = 15/190 (7%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KANT 60
+ LN +AKGMNYL R +VHRDL + N+LV VK+ DFGL++L
Sbjct: 109 GSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
++ +WMA E + +SD++S+GV +WEL T + PA ++++
Sbjct: 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP-----------T 169
KG+RL P V I+ CW + RP F ++ + + P
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286
Query: 170 PQPSPTDMPL 179
PSPTD
Sbjct: 287 HLPSPTDSNF 296
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 3e-45
Identities = 55/168 (32%), Positives = 87/168 (51%), Gaps = 6/168 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
L +L +A VA GM YL R VHRDL + N LV + VK+ DFGLSR A+
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAA 118
+ + + A WM PE + +SD++++GV+LWE+ + P+ + +V+
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
V G L P N + +++ CW+ P RPSF +I +L+ + +
Sbjct: 255 VR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-45
Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 3/167 (1%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
L + L+MA +A+GM ++ RN +HRDL++ N+LV + K+ DFGL+R ++ N
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
+ + + A +W APE + KSD++SFG++L E+ T + V
Sbjct: 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+G R+ P N + ++ CW P RP+F + +L +
Sbjct: 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 8e-45
Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 5/176 (2%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
DE + + + + + +LH ++HRD+KS N+L+ +VK+ DFG
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
+ GTP WMAPEV+ + K DI+S G++ E+ + P+ N NP + + +
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 123 GK-RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
G L+ P ++ + C + KR S +++ +K P S T +
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTPL 285
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-44
Identities = 57/169 (33%), Positives = 91/169 (53%), Gaps = 5/169 (2%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKAN 59
+ L M DV +GM YL ++HRDL + N LV + +KV DFG++R + +
Sbjct: 97 LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ SS +W +PEV + KSD++SFGV++WE+ + + P+ N + ++VV
Sbjct: 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+ G RL PR + HV I+ CW P RP+FS ++ L + +S
Sbjct: 215 IS-TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-44
Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 6/165 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KA 58
A VA+GM YL + +HRDL + NLL+ + VK+ DFGL R
Sbjct: 108 FLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVA 117
+ ++ + W APE L+ + SD + FGV LWE+ T Q+PW LN +Q++
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 225
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+ +G+RL P + + +++ CWA++P RP+F + + L
Sbjct: 226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 8e-44
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 11/180 (6%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E + + +G+ YLH N ++HRD+K+ N+L+ + VK+ DFG + + A
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168
Query: 62 LSSKSAAGTPEWMAPEVLR---DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
S GTP WMAPEV+ + + K D++S G+ ELA + P N+N +
Sbjct: 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 178
+ + + + + +++C P RP+ +++ + P D+
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERPPTVIMDLI 283
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-43
Identities = 51/167 (30%), Positives = 88/167 (52%), Gaps = 5/167 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
LD + AY ++ + YL + VHRD+ + N+LV VK+ DFGLSR ++ +T
Sbjct: 105 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 119
+ + +WMAPE + SD++ FGV +WE+ +P+ + V+ +
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
G+RL +P N P + S++ CWA +P +RP F+ + L +++
Sbjct: 223 -ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-43
Identities = 57/169 (33%), Positives = 92/169 (54%), Gaps = 5/169 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
L + ++ VAKGM +L R +HRDL + N+L+ +K VK+CDFGL+R K
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAA 118
++ A +WMAPE + D +SD++SFGV+LWE+ +L P+ + +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+G R+ P P + + CW EP +RP+FS ++E L L+++
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-43
Identities = 54/171 (31%), Positives = 90/171 (52%), Gaps = 8/171 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----K 57
+ + VAKGM +L + VHRDL + N ++D+K+TVKV DFGL+R +
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 58 ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVV 116
++ + A +WMA E L+ + KSD++SFGV+LWEL T P+ ++N +
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244
Query: 117 AAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167
+ +G+RL P + ++ CW + RPSFS ++ + + +
Sbjct: 245 VYL-LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 6e-43
Identities = 52/163 (31%), Positives = 87/163 (53%), Gaps = 5/163 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
++ L M DV + M YL + +HRDL + N LV+ + VKV DFGLSR + +
Sbjct: 97 FQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAV 119
+ SS + W PEVL + KSDI++FGV++WE+ +L + P+ ++ +
Sbjct: 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
+G RL P + V +I+ +CW + +RP+F ++ +
Sbjct: 215 A-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-42
Identities = 54/171 (31%), Positives = 90/171 (52%), Gaps = 5/171 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
LD L+ +Y VAKGM +L +N +HRDL + N+L+ K+CDFGL+R +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAA 118
++ +A +WMAPE + + +SD++S+G+ LWEL +L +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169
+ +G R+ P + + I++ CW +P KRP+F I++L+ I T
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 5e-42
Identities = 56/169 (33%), Positives = 85/169 (50%), Gaps = 3/169 (1%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKANT 60
+ L MA ++ M YL ++N +HRDL + N LV + + VKV DFGLSR + +T
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
+ + A +W APE L + KSD+++FGV+LWE+AT V +
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169
K R+E P V ++ ACW P RPSF+ I + + + +
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-40
Identities = 53/166 (31%), Positives = 90/166 (54%), Gaps = 4/166 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
L + ++ AY VA+GM YL + +HRDL + N+LV + +K+ DFGL+R +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
+ + + +WMAPE L D +SD++SFGV+LWE+ TL P + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLI 165
+G R++ P N + ++ CW P +RP+F ++E L ++
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-39
Identities = 40/174 (22%), Positives = 73/174 (41%), Gaps = 8/174 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
+ E + + G+ YLH I HRD+K NLL+D++ +K+ DFGL+ + N
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVA 117
GT ++APE+L+ E D++S G++L + + PW + Q +
Sbjct: 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
Query: 118 AVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171
K L + ++ +++ P R + I + P +
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNKPLKK 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-39
Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 6/177 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ E+ ++ V KG+ YL ++ I+HRD+K N+LV+ + +K+CDFG+S ++
Sbjct: 101 IPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ S GT +M+PE L+ + +SDI+S G+ L E+A + P + ++ F
Sbjct: 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--F 215
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMP 178
+ P + + RP + I ELL ++ P P+
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFS 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-38
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 36/202 (17%)
Query: 2 LDERRRLNMAYDVAKGMNYLH------RRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 55
+ + +A A G+ +LH + P I HRDLKS N+LV K T + D GL+
Sbjct: 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156
Query: 56 LKAN----TFLSSKSAAGTPEWMAPEVLRDE------PSNEKSDIYSFGVILWELAT--- 102
+ ++ GT +MAPEVL D S +++DIY+ G++ WE+A
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 103 -------LQQPWGNLNPA-----QVVAAVGFKGKRLEIPRNVNPH-----VASIIEACWA 145
Q P+ +L P+ ++ V + R IP +A I+ CW
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276
Query: 146 NEPWKRPSFSTIMELLRPLIKS 167
R + I + L L +
Sbjct: 277 ANGAARLTALRIKKTLSQLSQQ 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-38
Identities = 58/175 (33%), Positives = 94/175 (53%), Gaps = 6/175 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KAN 59
+ + MA ++A GM YL+ VHRDL + N +V + +TVK+ DFG++R + +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAA 118
+ WM+PE L+D SD++SFGV+LWE+ATL +QP+ L+ QV+
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247
Query: 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPS 173
V +G L+ P N + ++ CW P RPSF I+ ++ ++ + S
Sbjct: 248 V-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 123 bits (310), Expect = 1e-35
Identities = 38/166 (22%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E+ + + + + LH+ N IVHRDLK N+L+D +K+ DFG S + +
Sbjct: 107 LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPG 163
Query: 62 LSSKSAAGTPEWMAPEVLRDEPS------NEKSDIYSFGVILWELATLQQPWGNLNPAQV 115
+ GTP ++APE++ + ++ D++S GVI++ L P+ + +
Sbjct: 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 223
Query: 116 VAAVGFKGKRLEIPR--NVNPHVASIIEACWANEPWKRPSFSTIME 159
+ + + P + + V ++ +P KR + +
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 123 bits (310), Expect = 1e-35
Identities = 25/185 (13%), Positives = 58/185 (31%), Gaps = 20/185 (10%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT-----VKVCDFGLSR 55
+ A + + +H ++ +V+RD+K N L+ + + + V DFG+ +
Sbjct: 97 KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154
Query: 56 LKANTFLSS-------KSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWG 108
+ K+ +GT +M+ + + D+ + G + PW
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214
Query: 109 NLNPAQV------VAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR 162
L A + E+ + P + + L
Sbjct: 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
Query: 163 PLIKS 167
+++
Sbjct: 275 KVLER 279
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 2e-35
Identities = 36/184 (19%), Positives = 81/184 (44%), Gaps = 11/184 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSRLKAN 59
L+ER ++ + V + + +LH N I H D++ N++ + T+K+ +FG +R
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
+ + PE+ APEV + + + +D++S G +++ L + P+ Q++ +
Sbjct: 157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
Query: 120 GFKGK---RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176
+ E + ++ ++ E R + S ++ P +K + S
Sbjct: 216 -MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQKIERVSTKV 272
Query: 177 MPLL 180
+ L
Sbjct: 273 IRTL 276
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 124 bits (311), Expect = 3e-35
Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 9/181 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKAN 59
+ E + V KG+ ++H N VH DLK N++ K +K+ DFGL+ +
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLD 177
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
S K GT E+ APEV +P +D++S GV+ + L + P+G N + + V
Sbjct: 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 237
Query: 120 GFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
+ ++ I +P R + +E P + + +
Sbjct: 238 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPGNAPGRDSQI 295
Query: 178 P 178
P
Sbjct: 296 P 296
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-35
Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 4/152 (2%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
D R A ++ G+ +LH + IV+RDLK N+L+DK +K+ DFG+ +
Sbjct: 100 FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ + GTP+++APE+L + N D +SFGV+L+E+ Q P+ + ++ ++
Sbjct: 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-- 215
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153
+ PR + ++ + EP KR
Sbjct: 216 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLG 247
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-35
Identities = 34/159 (21%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--N 59
DE ++ + YLH I+HRDLK N+L+++ +++ DFG +++ + +
Sbjct: 105 FDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
+ S GT ++++PE+L ++ + + SD+++ G I+++L P+ N + +
Sbjct: 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 222
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158
+ P P ++E + KR +
Sbjct: 223 --IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-34
Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 7/170 (4%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+ E R ++ + YLH R+ +V+RD+K NL++DK +K+ DFGL + +
Sbjct: 101 VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
+ K+ GTPE++APEVL D D + GV+++E+ + P+ N + ++ +
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI- 217
Query: 121 FKGKRLEIPRNVNPHVASIIEACWANEPWKRPS--FSTIMELLR-PLIKS 167
+ + PR ++P S++ +P +R S E++ S
Sbjct: 218 -LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 120 bits (302), Expect = 8e-34
Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 7/162 (4%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY--TVKVCDFGLSRLKAN 59
+ E +N +G+ ++H + IVH D+K N++ + K +VK+ DFGL+
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181
Query: 60 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
+ + T E+ APE++ EP +D+++ GV+ + L + P+ + + + V
Sbjct: 182 DEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
Query: 120 GFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
+ +V+P I+ EP KR + +E
Sbjct: 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (296), Expect = 2e-33
Identities = 36/196 (18%), Positives = 69/196 (35%), Gaps = 19/196 (9%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRL-- 56
+ L +A + + Y+H +N +HRD+K N L+ K V + DFGL++
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157
Query: 57 -----KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLN 111
+ + +K+ GT + + + + D+ S G +L PW L
Sbjct: 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
Query: 112 PAQVVAAV------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLR-PL 164
A + + A+ + C + +P +S + +L R
Sbjct: 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
Query: 165 IKSPTPQPSPTDMPLL 180
+ D +L
Sbjct: 278 HRQGFSYDYVFDWNML 293
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (295), Expect = 4e-33
Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 9/162 (5%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
A +V + YLH ++ I++RDLK N+L+DK +K+ DFG ++ +
Sbjct: 102 PNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
+ GTP+++APEV+ +P N+ D +SFG++++E+ P+ + N + +
Sbjct: 159 --YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--L 214
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKRPSF--STIMELLR 162
L P N V ++ + +R + ++
Sbjct: 215 NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 116 bits (292), Expect = 5e-33
Identities = 40/170 (23%), Positives = 82/170 (48%), Gaps = 9/170 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KA 58
+ +R + + D + +N+ H+ I+HRD+K N+++ VKV DFG++R
Sbjct: 108 MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
N+ + + GT ++++PE R + + +SD+YS G +L+E+ T + P+ +P V
Sbjct: 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 225
Query: 119 VGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIK 166
+ ++ + +++ A P R T E+ L++
Sbjct: 226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY--QTAAEMRADLVR 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-32
Identities = 37/180 (20%), Positives = 74/180 (41%), Gaps = 16/180 (8%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANT 60
L E + + V + + + H ++HRD+K N+L+D + +K+ DFG L +T
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164
Query: 61 FLSSKSAAGTPEWMAPEVLRDEP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
+ GT + PE +R + ++S G++L+++ P+ +
Sbjct: 165 VYTDF--DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR---- 218
Query: 120 GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 179
++ + V+ +I C A P RP+F I P ++ ++ L
Sbjct: 219 ----GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQETAEIHL 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-32
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY---TVKVCDFGLSRLKA 58
ER + + + + YLH N I HRD+K NLL K +K+ DFG ++ +
Sbjct: 108 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ET 164
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
+ S + TP ++APEVL E ++ D++S GVI++ L P+ + + +
Sbjct: 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224
Query: 119 V--GFKGKRLEIPR----NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQP 172
+ + + E P V+ V +I EP +R + + M P I T P
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQSTKVP 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 2e-31
Identities = 50/184 (27%), Positives = 82/184 (44%), Gaps = 10/184 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKA 58
ER + + V + YLH IVHRDLK NLL D+ + + DFGLS+++
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
+ S +A GTP ++APEVL +P ++ D +S GVI + L P+ + N A++
Sbjct: 162 PGSVLS-TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
Query: 119 VGFKGKRLEIPR--NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTD 176
+ + P +++ I +P KR + ++ P I T
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIAGDTALDKNIH 278
Query: 177 MPLL 180
+
Sbjct: 279 QSVS 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 112 bits (281), Expect = 1e-30
Identities = 40/169 (23%), Positives = 78/169 (46%), Gaps = 9/169 (5%)
Query: 4 ERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLS 63
E A ++ G+ ++H R +V+RDLK N+L+D+ V++ D GL+ +
Sbjct: 106 EADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--K 161
Query: 64 SKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGF 121
++ GT +MAPEVL + + +D +S G +L++L P+ + +
Sbjct: 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPS--FSTIMELLR-PLIKS 167
+E+P + +P + S++E + +R E+ P +S
Sbjct: 222 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 8e-30
Identities = 36/183 (19%), Positives = 70/183 (38%), Gaps = 28/183 (15%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ +M + + +G+++LH +VHRDLK N+LV +K+ DFGL+R+ +
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQ 169
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-- 119
++ S T + APEVL D++S G I E+ + + + + +
Sbjct: 170 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229
Query: 120 -----------------------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156
+ +++ ++ C P KR S +
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 157 IME 159
+
Sbjct: 290 ALS 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (269), Expect = 4e-29
Identities = 36/163 (22%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
E A + YLH + +++RDLK NLL+D++ ++V DFG ++
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 62 LSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF 121
+ GTPE +APE++ + N+ D ++ GV+++E+A P+ P Q+ +
Sbjct: 196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
Query: 122 KGKRLEIPRNVNPHVASIIEACWANEPWKRPS--FSTIMELLR 162
++ P + + + ++ + KR + + ++
Sbjct: 253 --GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 5e-28
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 9/164 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK----KYTVKVCDFGLSRLK 57
L E + G+ YLH I H DLK N+++ K +K+ DFGL+ K
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-K 166
Query: 58 ANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA 117
+ K+ GTPE++APE++ EP ++D++S GVI + L + P+ + +A
Sbjct: 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 118 AVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159
V E N + I +P KR + ++
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 4e-25
Identities = 40/168 (23%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKANT 60
E ++ + +LH+ I++RD+K N+L+D V + DFGLS A+
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183
Query: 61 FLSSKSAAGTPEWMAPEVLR--DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAA 118
+ GT E+MAP+++R D ++ D +S GV+++EL T P+ A
Sbjct: 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243
Query: 119 V--GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS--TIMELLR 162
+ P+ ++ +I+ +P KR E+
Sbjct: 244 ISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.7 bits (237), Expect = 6e-25
Identities = 34/186 (18%), Positives = 67/186 (36%), Gaps = 30/186 (16%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L+ + + G+ Y H R ++HRDLK NLL++++ +K+ DFGL+R
Sbjct: 97 LESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154
Query: 62 LSSKSAAGTPEWMAPEVLR-DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV- 119
T + AP+VL + + DI+S G I E+ + ++ A + +
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214
Query: 120 --------------------------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153
+ ++ ++ +P +R +
Sbjct: 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274
Query: 154 FSTIME 159
+E
Sbjct: 275 AKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 8e-25
Identities = 41/206 (19%), Positives = 71/206 (34%), Gaps = 35/206 (16%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+L +G+ YLH+ I+HRDLK NLL+D+ +K+ DFGL++ +
Sbjct: 96 VLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
+ T + APE+L D+++ G IL EL + + +
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 120 -------------------------GFKGKRL-EIPRNVNPHVASIIEACWANEPWKRPS 153
F G L I + +I+ + P R +
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273
Query: 154 FSTIM------ELLRPLIKSPTPQPS 173
+ + P P+P+
Sbjct: 274 ATQALKMKYFSNRPGPTPGCQLPRPN 299
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 1e-23
Identities = 36/201 (17%), Positives = 73/201 (36%), Gaps = 35/201 (17%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
+ + + + +G+ + H ++HRDLK NLL++ + +K+ DFGL+R
Sbjct: 99 IPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 62 LSSKSAAGTPEWMAPEVL-RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV- 119
+ T + APE+L + + DI+S G I E+ T + + + + +
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 120 --------------------------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153
+ ++ ++ S++ +P KR S
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS 276
Query: 154 FSTIMELLRPLIKS---PTPQ 171
+ P + P P
Sbjct: 277 AKAALA--HPFFQDVTKPVPH 295
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 1e-23
Identities = 42/217 (19%), Positives = 76/217 (35%), Gaps = 41/217 (18%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KA 58
L Y + +G+ Y+H N ++HRDLK NLL++ +K+CDFGL+R+
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163
Query: 59 NTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA 117
+ T + APE++ + + DI+S G IL E+ + + + + +
Sbjct: 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 223
Query: 118 AV-----------------------------GFKGKRLEIPRNVNPHVASIIEACWANEP 148
+ K + N + +++ P
Sbjct: 224 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 283
Query: 149 WKRPSFSTIM------ELLRPLIKSPTPQPSPTDMPL 179
KR + + P + P DM L
Sbjct: 284 HKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMEL 320
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 7e-23
Identities = 39/211 (18%), Positives = 75/211 (35%), Gaps = 42/211 (19%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----K 57
+ + G+ Y+HR I+HRD+K+ N+L+ + +K+ DFGL+R K
Sbjct: 114 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 171
Query: 58 ANTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVV 116
+ + T + PE+L E D++ G I+ E+ T +
Sbjct: 172 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231
Query: 117 AAV-------------------------GFKGKRLEIPRNVNPHVAS-----IIEACWAN 146
A + KG++ ++ + +V +I+
Sbjct: 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291
Query: 147 EPWKRPSFSTIMELLRPLIKSPTPQPSPTDM 177
+P +R + S P P+D+
Sbjct: 292 DPAQRIDSDDALN--HDFFWS---DPMPSDL 317
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 1e-22
Identities = 32/208 (15%), Positives = 56/208 (26%), Gaps = 36/208 (17%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLK-SPNLLVDKKYTVKVCDFGLSRLKANT 60
L Y + + + Y+H I HRD+K LL +K+CDFG ++
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV- 119
+ + D++S G +L EL Q + + + +
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 120 --------------------------GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS 153
P ++ P R +
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 154 FSTIM------ELLRPLIKSPTPQPSPT 175
EL P +K P + +P
Sbjct: 297 PLEACAHSFFDELRDPNVKLPNGRDTPA 324
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (218), Expect = 4e-22
Identities = 38/188 (20%), Positives = 69/188 (36%), Gaps = 31/188 (16%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
LD + + + KG+ + H RN ++HRDLK NLL+++ +K+ +FGL+R
Sbjct: 97 DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV 119
+ T + P+VL + D++S G I ELA +P N
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
Query: 120 GFKG----------------------------KRLEIPRNVNPHVASIIEACWANEPWKR 151
F+ + + +N +++ P +R
Sbjct: 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274
Query: 152 PSFSTIME 159
S ++
Sbjct: 275 ISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 2e-20
Identities = 41/188 (21%), Positives = 70/188 (37%), Gaps = 35/188 (18%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L E R + Y + KG+ Y+H HRDLK NL V++ +K+ DFGL+R +
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM 175
Query: 62 LSSKSAAGTPEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG 120
T + APEV L + DI+S G I+ E+ T + + + + +
Sbjct: 176 ---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 121 ----------------------------FKGKRL-EIPRNVNPHVASIIEACWANEPWKR 151
+ K I N +P +++E + +R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292
Query: 152 PSFSTIME 159
+ +
Sbjct: 293 VTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 3e-19
Identities = 40/180 (22%), Positives = 71/180 (39%), Gaps = 5/180 (2%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL 62
D R + Y + G+ +LH +HRDLK N++V T+K+ DFGL+R +F+
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
Query: 63 SSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 122
+ T + APEV+ E DI+S G I+ E+ + + + V +
Sbjct: 175 MTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV-IE 232
Query: 123 GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM-ELLRPLIKSPTPQPSPTDMPLLT 181
P + ++ + +F + + L P + LL+
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 73.3 bits (179), Expect = 2e-16
Identities = 35/196 (17%), Positives = 69/196 (35%), Gaps = 41/196 (20%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKANT 60
L + Y++ K ++Y H I+HRD+K N+++D + +++ D+GL+
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDIYSFGVILWELATLQQPW--GNLNPAQVVA 117
+ + PE+L D + D++S G +L + ++P+ G+ N Q+V
Sbjct: 184 Q-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
Query: 118 AVGFKGK----------------------------------RLEIPRNVNPHVASIIEAC 143
G E V+P ++
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302
Query: 144 WANEPWKRPSFSTIME 159
+ R + ME
Sbjct: 303 LRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.2 bits (163), Expect = 3e-14
Identities = 40/188 (21%), Positives = 74/188 (39%), Gaps = 35/188 (18%)
Query: 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 61
L + + Y + +G+ Y+H + I+HRDLK NL V++ +K+ DFGL+R +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 62 LSSKSAAGTPEWMAPEV-LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV- 119
T + APE+ L N+ DI+S G I+ EL T + + + + +
Sbjct: 176 ---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 120 --------------------GFKGKRLEIPR--------NVNPHVASIIEACWANEPWKR 151
+ ++P+ NP ++E + KR
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292
Query: 152 PSFSTIME 159
+ + +
Sbjct: 293 ITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.2 bits (160), Expect = 6e-14
Identities = 28/111 (25%), Positives = 52/111 (46%), Gaps = 10/111 (9%)
Query: 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD------KKYTVKVCDFGLSRL 56
++ + G++Y+HRR I+H D+K N+L++ +K+ D G +
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181
Query: 57 KANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPW 107
+ +S T E+ +PEVL P +DI+S +++EL T +
Sbjct: 182 YDEHYTNSI---QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 49.4 bits (117), Expect = 2e-08
Identities = 17/103 (16%), Positives = 31/103 (30%), Gaps = 19/103 (18%)
Query: 1 MLDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT 60
+ + + + + + R IVH DL N+LV + + + DF S
Sbjct: 99 RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQSV----- 150
Query: 61 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDI---YSFGVILWEL 100
E E+L + N + Y +
Sbjct: 151 --------EVGEEGWREILERDVRNIITYFSRTYRTEKDINSA 185
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 181 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.98 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 93.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 93.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 92.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 84.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 84.27 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-41 Score=247.30 Aligned_cols=166 Identities=26% Similarity=0.478 Sum_probs=144.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.+|.++|+|||+++.............|++.|+|||.+.+
T Consensus 113 l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 190 (293)
T d1yhwa1 113 MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcC
Confidence 678999999999999999999999 999999999999999999999999999865544444456689999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++|+||+||++|+|++|..||.+.+.......+... ......+..+++++++|+.+||+.||.+|||+.++++
T Consensus 191 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~- 269 (293)
T d1yhwa1 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ- 269 (293)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT-
T ss_pred CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc-
Confidence 88999999999999999999999999988877665554333 3344566779999999999999999999999999999
Q ss_pred HHHhhhCCCCC
Q 030203 161 LRPLIKSPTPQ 171 (181)
Q Consensus 161 L~~~~~~~~~~ 171 (181)
++|++...+.
T Consensus 270 -Hp~~~~~~~~ 279 (293)
T d1yhwa1 270 -HQFLKIAKPL 279 (293)
T ss_dssp -CGGGGGCCCG
T ss_pred -CHhhCCCCCC
Confidence 8999865433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=241.88 Aligned_cols=158 Identities=25% Similarity=0.493 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.++.+||+|||++...... ......|++.|+|||.+.+
T Consensus 103 l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 103 FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEG 178 (263)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC--cccccCCCCcccCHHHHcC
Confidence 688999999999999999999999 999999999999999999999999998754432 2234578899999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELL 161 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L 161 (181)
..++.++|+||+||++|+|++|+.||.+.+......++.. .....+..+++++++|+.+||+.||.+|||++++++
T Consensus 179 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~-- 254 (263)
T d2j4za1 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE-- 254 (263)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--
T ss_pred CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc--
Confidence 8899999999999999999999999999988888777743 344567789999999999999999999999999999
Q ss_pred HHhhhC
Q 030203 162 RPLIKS 167 (181)
Q Consensus 162 ~~~~~~ 167 (181)
++|++.
T Consensus 255 hp~~~~ 260 (263)
T d2j4za1 255 HPWITA 260 (263)
T ss_dssp CHHHHH
T ss_pred CcCcCC
Confidence 788764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=238.00 Aligned_cols=166 Identities=33% Similarity=0.575 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..... ........+++.|+|||.+
T Consensus 101 ~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 178 (276)
T d1uwha_ 101 FEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHH
Confidence 678999999999999999999999 999999999999999999999999998754432 2223445788999999998
Q ss_pred CCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhccCC---ccCCCCCCCHHHHHHHHHHhcCCCCCCC
Q 030203 80 RDE---PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVV-AAVGFKGK---RLEIPRNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 80 ~~~---~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
.+. .++.++||||+|+++|+|++|+.||.+....... ..+..... ....+..+++.+.+++.+||+.||.+||
T Consensus 179 ~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP 258 (276)
T d1uwha_ 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP 258 (276)
T ss_dssp TTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCc
Confidence 653 3688999999999999999999999887655433 33332222 2235677899999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCC
Q 030203 153 SFSTIMELLRPLIKSPT 169 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~ 169 (181)
|++++++.|+.+.+..|
T Consensus 259 t~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 259 LFPQILASIELLARSLP 275 (276)
T ss_dssp CHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHHHHHcCC
Confidence 99999999998887644
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-39 Score=239.59 Aligned_cols=164 Identities=30% Similarity=0.591 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc-----cCCCCCCCCCccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL-----SSKSAAGTPEWMAP 76 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~~~p 76 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....... ......+++.|+||
T Consensus 125 l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aP 202 (299)
T d1jpaa_ 125 FTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202 (299)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCH
Confidence 688999999999999999999999 99999999999999999999999999875443211 11223467889999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 77 EVLRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 77 e~~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
|.+.+..++.++|||||||++|+|++ |+.||.+....++...+. ...+.+.+..+++.+.+++.+||+.||.+|||++
T Consensus 203 E~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 281 (299)
T d1jpaa_ 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281 (299)
T ss_dssp HHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHH
Confidence 99998889999999999999999997 899999999888887775 4555667788999999999999999999999999
Q ss_pred HHHHHHHHhhhCC
Q 030203 156 TIMELLRPLIKSP 168 (181)
Q Consensus 156 ~~l~~L~~~~~~~ 168 (181)
++++.|+.+++.+
T Consensus 282 ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 282 QIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHHHHHHHSG
T ss_pred HHHHHHHHHhcCh
Confidence 9999999998863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-40 Score=241.30 Aligned_cols=163 Identities=31% Similarity=0.539 Sum_probs=140.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC-
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR- 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~- 80 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.++.+||+|||++..............|++.|+|||.+.
T Consensus 107 l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~ 184 (288)
T d2jfla1 107 LTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhh
Confidence 689999999999999999999999 99999999999999999999999999876544433345568899999999884
Q ss_pred ----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 81 ----DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK-RLEIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 81 ----~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
+..++.++|+||+||++|+|++|+.||.+.+..+...++..... ....+..+++++++|+.+||+.||.+|||+.
T Consensus 185 ~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ 264 (288)
T d2jfla1 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTS 264 (288)
T ss_dssp CSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred cccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 34478899999999999999999999999887777666654332 3345567899999999999999999999999
Q ss_pred HHHHHHHHhhhCC
Q 030203 156 TIMELLRPLIKSP 168 (181)
Q Consensus 156 ~~l~~L~~~~~~~ 168 (181)
++++ ++|++..
T Consensus 265 ell~--hp~~~~~ 275 (288)
T d2jfla1 265 QLLQ--HPFVTVD 275 (288)
T ss_dssp HHTT--SGGGCCC
T ss_pred HHhc--CcccCCC
Confidence 9999 8888753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=236.71 Aligned_cols=164 Identities=30% Similarity=0.626 Sum_probs=142.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..... ........+++.|+|||.+.
T Consensus 106 l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~ 183 (272)
T d1qpca_ 106 LTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183 (272)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHh
Confidence 678999999999999999999999 999999999999999999999999999765432 22334456788999999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++||||+|+++|+|+|| .+|+......+....+. ...+...+..+++++.+|+.+||+.||.+|||++++++
T Consensus 184 ~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 88889999999999999999995 55667777777777765 45566677889999999999999999999999999999
Q ss_pred HHHHhhhCC
Q 030203 160 LLRPLIKSP 168 (181)
Q Consensus 160 ~L~~~~~~~ 168 (181)
.|++++.+.
T Consensus 263 ~L~~~ftst 271 (272)
T d1qpca_ 263 VLEDFFTAT 271 (272)
T ss_dssp HHHHHHHHC
T ss_pred HhhhhhhcC
Confidence 999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-40 Score=239.57 Aligned_cols=160 Identities=34% Similarity=0.561 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCC---CceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNP---PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~---~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++. .++||||||+||+++.++.+||+|||+++.............+++.|+|||.
T Consensus 106 l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~ 185 (269)
T d2java1 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHH
Confidence 6889999999999999999998531 2999999999999999999999999998765544434455678999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
+.+..++.++|+||+||++|+|++|+.||.+.+..++..++.. ......+..+|+++.+|+.+||+.||.+|||+.+++
T Consensus 186 l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9988899999999999999999999999999998888877753 334456778999999999999999999999999998
Q ss_pred HHHHHh
Q 030203 159 ELLRPL 164 (181)
Q Consensus 159 ~~L~~~ 164 (181)
+ ++|
T Consensus 265 ~--hp~ 268 (269)
T d2java1 265 E--NPL 268 (269)
T ss_dssp T--STT
T ss_pred h--CCc
Confidence 8 554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=237.21 Aligned_cols=166 Identities=23% Similarity=0.374 Sum_probs=136.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.++.+||+|||+++..... ........||+.|+|||.+
T Consensus 100 l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~ 177 (271)
T d1nvra_ 100 MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177 (271)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHh
Confidence 688999999999999999999999 999999999999999999999999999754322 2223456799999999999
Q ss_pred CCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPS-NEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..+ +.++|+||+||++|+|++|+.||...... ..................+++++.+|+.+||+.||.+|||++++
T Consensus 178 ~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp HCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 88775 56799999999999999999999765443 22222322333333445789999999999999999999999999
Q ss_pred HHHHHHhhhCCCCC
Q 030203 158 MELLRPLIKSPTPQ 171 (181)
Q Consensus 158 l~~L~~~~~~~~~~ 171 (181)
++ ++|++...++
T Consensus 258 l~--hpwf~~~l~k 269 (271)
T d1nvra_ 258 KK--DRWYNKPLKK 269 (271)
T ss_dssp TT--CTTTTCCCCC
T ss_pred hc--CHhhCcCCCC
Confidence 99 8999876554
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-39 Score=239.23 Aligned_cols=160 Identities=27% Similarity=0.462 Sum_probs=139.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||++..... .....|++.|+|||.+.+
T Consensus 112 l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 112 LQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILA 185 (309)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC----CCccccCccccCHHHHhc
Confidence 689999999999999999999999 99999999999999999999999999875443 234578999999999864
Q ss_pred ---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 82 ---EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 82 ---~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
..++.++|+||+||++|+|++|..||.+........++.........+..+|+++.+|+.+||+.||.+|||+++++
T Consensus 186 ~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 265 (309)
T d1u5ra_ 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (309)
T ss_dssp TTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred cCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 34788999999999999999999999998888777776555554455667899999999999999999999999999
Q ss_pred HHHHHhhhCCC
Q 030203 159 ELLRPLIKSPT 169 (181)
Q Consensus 159 ~~L~~~~~~~~ 169 (181)
+ ++|+....
T Consensus 266 ~--Hp~~~~~~ 274 (309)
T d1u5ra_ 266 K--HRFVLRER 274 (309)
T ss_dssp T--CHHHHSCC
T ss_pred h--CHHhcCCC
Confidence 8 77777543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=236.61 Aligned_cols=171 Identities=34% Similarity=0.582 Sum_probs=143.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++...... .......+++.|+|||.+.
T Consensus 110 l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 187 (285)
T d1fmka3 110 LRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187 (285)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHh
Confidence 689999999999999999999999 9999999999999999999999999987543322 2223356788999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
...++.++||||+|+++|+|++| .+++......++...+. ...+.+.+..+++++.+++.+||+.||.+||+++++++
T Consensus 188 ~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 88899999999999999999995 55567677777777665 44566678899999999999999999999999999999
Q ss_pred HHHHhhhCCCCCCCCC
Q 030203 160 LLRPLIKSPTPQPSPT 175 (181)
Q Consensus 160 ~L~~~~~~~~~~~~~~ 175 (181)
+|++++....++..|.
T Consensus 267 ~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 267 FLEDYFTSTEPQYQPG 282 (285)
T ss_dssp HHHTTTSCSCCCCCCS
T ss_pred HHhhhhcCCCCCCCCC
Confidence 9999999888776664
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-39 Score=236.08 Aligned_cols=162 Identities=29% Similarity=0.568 Sum_probs=141.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc---cccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT---FLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.||+.||.|||+++ ++||||||+||+++.++.++++|||+++..... ........+++.|+|||.
T Consensus 104 l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~ 181 (277)
T d1xbba_ 104 VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchh
Confidence 688999999999999999999999 999999999999999999999999998754322 222334567889999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++||||+|+++|+|++ |+.||.+.+..++...+. .+.+.+.+..+++++.+|+.+||+.||.+|||++++
T Consensus 182 l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i 260 (277)
T d1xbba_ 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260 (277)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 988888999999999999999997 899999998888777775 455667788899999999999999999999999999
Q ss_pred HHHHHHhhh
Q 030203 158 MELLRPLIK 166 (181)
Q Consensus 158 l~~L~~~~~ 166 (181)
++.|++++.
T Consensus 261 ~~~L~~~~~ 269 (277)
T d1xbba_ 261 ELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHH
T ss_pred HHHhhCHHh
Confidence 999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-39 Score=239.24 Aligned_cols=160 Identities=28% Similarity=0.522 Sum_probs=142.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
++|+++..++.|++.||.|||++| ++||||||+||+++.+|.+||+|||+++.............|++.|+|||.+.+
T Consensus 102 ~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 102 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS
T ss_pred CcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccC
Confidence 688999999999999999999999 999999999999999999999999999865554444455678999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----HHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----FST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~ 156 (181)
..++.++|+||+||++|+|++|+.||.+.+...+...+... ....|..+|+++++||.+||+.||.+|++ +.+
T Consensus 180 ~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~e 257 (337)
T d1o6la_ 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHH
Confidence 99999999999999999999999999999988887777433 35567889999999999999999999995 889
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ |+|++.
T Consensus 258 il~--Hp~f~~ 266 (337)
T d1o6la_ 258 VME--HRFFLS 266 (337)
T ss_dssp HHT--SGGGTT
T ss_pred HHc--Cccccc
Confidence 988 777643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=239.13 Aligned_cols=163 Identities=34% Similarity=0.641 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...... .......+++.|+|||.+
T Consensus 131 l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 208 (299)
T d1ywna1 131 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 208 (299)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh
Confidence 678999999999999999999999 9999999999999999999999999987544322 223345688899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++||||+||++|+|++| ..||.+.............+.....+..+++++.+++.+||+.||.+|||+++++
T Consensus 209 ~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil 288 (299)
T d1ywna1 209 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288 (299)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 998899999999999999999986 5678776554444333335566777888999999999999999999999999999
Q ss_pred HHHHHhhh
Q 030203 159 ELLRPLIK 166 (181)
Q Consensus 159 ~~L~~~~~ 166 (181)
+.|+.+++
T Consensus 289 ~~L~~ilq 296 (299)
T d1ywna1 289 EHLGNLLQ 296 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=242.20 Aligned_cols=160 Identities=34% Similarity=0.564 Sum_probs=138.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....... ......+++.|+|||.+
T Consensus 161 l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 161 LTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238 (325)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence 678899999999999999999999 99999999999999999999999999875443321 12334568899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++||||+||++|+|++ |..||.+.+.......+.....+.+.+..+++++++|+.+||+.||.+|||+++++
T Consensus 239 ~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 239 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 98889999999999999999997 89999887665555555446667778889999999999999999999999999999
Q ss_pred HHHHH
Q 030203 159 ELLRP 163 (181)
Q Consensus 159 ~~L~~ 163 (181)
+.|..
T Consensus 319 ~~L~~ 323 (325)
T d1rjba_ 319 SFLGC 323 (325)
T ss_dssp HHHHH
T ss_pred HHHhC
Confidence 98863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-39 Score=232.69 Aligned_cols=160 Identities=32% Similarity=0.564 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc-CCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
++++++..++.|++.||.|||+++++++||||||+||+++ .++.+||+|||+++..... ......|++.|+|||.+.
T Consensus 109 ~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--~~~~~~GT~~Y~aPE~~~ 186 (270)
T d1t4ha_ 109 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYE 186 (270)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGG
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--ccCCcccCccccCHHHhC
Confidence 6789999999999999999999876699999999999996 4789999999998753332 223457899999999986
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+ .++.++|+||+||++|+|++|+.||.+.. ...+...+.........+..+++++++++.+||+.||.+|||++++++
T Consensus 187 ~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 187 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 5 58999999999999999999999997654 445555554343444556678999999999999999999999999999
Q ss_pred HHHHhhh
Q 030203 160 LLRPLIK 166 (181)
Q Consensus 160 ~L~~~~~ 166 (181)
++|++
T Consensus 266 --Hp~fk 270 (270)
T d1t4ha_ 266 --HAFFQ 270 (270)
T ss_dssp --SGGGC
T ss_pred --CcccC
Confidence 77764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=235.64 Aligned_cols=174 Identities=21% Similarity=0.234 Sum_probs=144.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++.++.+||+|||.++.............+++.|+|||.+..
T Consensus 97 l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (299)
T d1ua2a_ 97 LTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174 (299)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHcc
Confidence 577889999999999999999999 999999999999999999999999999766555444556678999999998865
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--------------------------CCCCCCCH
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--------------------------EIPRNVNP 134 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~ 134 (181)
. .++.++|+||+||++|+|++|..||.+....+...++....... .....+++
T Consensus 175 ~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 254 (299)
T d1ua2a_ 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254 (299)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCH
T ss_pred CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCH
Confidence 4 47889999999999999999999999988776655542110000 01135688
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCCCCCCCCCC
Q 030203 135 HVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQPSPTDMPL 179 (181)
Q Consensus 135 ~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~~~~~~~~~ 179 (181)
++.+|+.+||..||.+|||++|+++ ++|+++.+.+.++..+|.
T Consensus 255 ~~~dll~~~L~~dP~~R~sa~e~L~--Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 255 DLLDLIQGLFLFNPCARITATQALK--MKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTSSSCCCCSSSSCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhC--CHhhCCCCCCCCCCCCCC
Confidence 9999999999999999999999999 999998776666665554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=233.37 Aligned_cols=165 Identities=33% Similarity=0.638 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...... .......+++.|+|||.
T Consensus 107 ~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~ 184 (283)
T d1mqba_ 107 FSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184 (283)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHH
T ss_pred ccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHH
Confidence 678899999999999999999999 9999999999999999999999999997543321 12223456789999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++||||+|+++|+|++| .+++......++...+. .+.+.+.+..+++.+.+++.+||+.||.+|||+.++
T Consensus 185 l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp HHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence 9998999999999999999999985 55666667766666664 555667788899999999999999999999999999
Q ss_pred HHHHHHhhhCCC
Q 030203 158 MELLRPLIKSPT 169 (181)
Q Consensus 158 l~~L~~~~~~~~ 169 (181)
++.|+.+++.+.
T Consensus 264 l~~L~~l~~~p~ 275 (283)
T d1mqba_ 264 VSILDKLIRAPD 275 (283)
T ss_dssp HHHHHHHHHSGG
T ss_pred HHHHHHHhhCcc
Confidence 999999988643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-39 Score=235.90 Aligned_cols=163 Identities=29% Similarity=0.553 Sum_probs=142.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+|++|||+++...... .......+++.|+|||.
T Consensus 106 l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~ 183 (285)
T d1u59a_ 106 IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183 (285)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHH
Confidence 678999999999999999999999 9999999999999999999999999997543321 22234467789999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++||||+|+++|+|++ |+.||.+.+..++...+. .+.+.+.+..+++++.+|+.+||+.||.+|||+.++
T Consensus 184 ~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i 262 (285)
T d1u59a_ 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 262 (285)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 988889999999999999999998 899999988887777775 555677788999999999999999999999999999
Q ss_pred HHHHHHhhhC
Q 030203 158 MELLRPLIKS 167 (181)
Q Consensus 158 l~~L~~~~~~ 167 (181)
++.|+..+..
T Consensus 263 ~~~L~~~~~~ 272 (285)
T d1u59a_ 263 EQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999876653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=231.52 Aligned_cols=162 Identities=35% Similarity=0.639 Sum_probs=132.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
++++.++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...... .......+++.|+|||.+.
T Consensus 98 ~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 175 (263)
T d1sm2a_ 98 FAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175 (263)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhc
Confidence 678899999999999999999999 9999999999999999999999999987544332 2223456788999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++||||+|+++|+|++ |.+||.......+...+. ...+...+..+++++.+++.+||+.||.+|||++++++
T Consensus 176 ~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 254 (263)
T d1sm2a_ 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254 (263)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9899999999999999999998 577788778777777775 44555667888999999999999999999999999999
Q ss_pred HHHHhhh
Q 030203 160 LLRPLIK 166 (181)
Q Consensus 160 ~L~~~~~ 166 (181)
.|+++.+
T Consensus 255 ~L~~i~e 261 (263)
T d1sm2a_ 255 QLAEIAE 261 (263)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9998865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-39 Score=235.76 Aligned_cols=153 Identities=22% Similarity=0.446 Sum_probs=132.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.+|.++++|||+++..... ........|++.|+|||.+
T Consensus 105 l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~ 182 (288)
T d1uu3a_ 105 FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceee
Confidence 688999999999999999999999 999999999999999999999999999764432 2223445789999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+||++|+|++|+.||.+.+...+..++... ....+..+++++++||.+||+.||.+|||++|++
T Consensus 183 ~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 9988999999999999999999999999999888887777433 3456778999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-39 Score=235.11 Aligned_cols=164 Identities=35% Similarity=0.609 Sum_probs=139.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc-ccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF-LSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...... .......+++.|+|||.+.
T Consensus 112 ~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~ 189 (287)
T d1opja_ 112 VSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189 (287)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHc
Confidence 678899999999999999999999 9999999999999999999999999997644322 2223335677899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQ-PWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++||||+|+++|+|++|.. ++.+.+...+...+. .....+.+..+++.+.+|+.+||+.||.+|||++++++
T Consensus 190 ~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 8889999999999999999999655 556666666555554 55566778889999999999999999999999999999
Q ss_pred HHHHhhhCC
Q 030203 160 LLRPLIKSP 168 (181)
Q Consensus 160 ~L~~~~~~~ 168 (181)
.|+.+++..
T Consensus 269 ~L~~~~~~~ 277 (287)
T d1opja_ 269 AFETMFQES 277 (287)
T ss_dssp HHHHTTSSS
T ss_pred HHHHHHHhC
Confidence 999887653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-39 Score=234.10 Aligned_cols=163 Identities=31% Similarity=0.637 Sum_probs=134.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+|++|||+++..... ........+++.|+|||.+.
T Consensus 105 l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~ 182 (273)
T d1mp8a_ 105 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182 (273)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhc
Confidence 578999999999999999999999 999999999999999999999999998754332 22233456778999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++|+||+|+++|+|++ |..||.+....++..++. .....+.+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus 183 ~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~ 261 (273)
T d1mp8a_ 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261 (273)
T ss_dssp HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 8889999999999999999997 899999988888777775 45556778899999999999999999999999999999
Q ss_pred HHHHhhhC
Q 030203 160 LLRPLIKS 167 (181)
Q Consensus 160 ~L~~~~~~ 167 (181)
.|+.++++
T Consensus 262 ~L~~i~~~ 269 (273)
T d1mp8a_ 262 QLSTILEE 269 (273)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-38 Score=232.25 Aligned_cols=162 Identities=28% Similarity=0.441 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc---CCCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
+++.++..++.|++.||.|||++| ++||||||+||++. .++.++++|||+++...... ......|++.|+|||.
T Consensus 104 l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~GT~~y~APE~ 180 (307)
T d1a06a_ 104 YTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYVAPEV 180 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------------------CTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCC-eeeeeeeCccccCcHH
Confidence 689999999999999999999999 99999999999994 47899999999987544332 2234578999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
+.+..++.++|+||+||++|+|++|+.||.+.........+....... +....+|+++.+|+.+||+.||.+|||+++
T Consensus 181 ~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 999889999999999999999999999999998888777775444433 344678999999999999999999999999
Q ss_pred HHHHHHHhhhCC
Q 030203 157 IMELLRPLIKSP 168 (181)
Q Consensus 157 ~l~~L~~~~~~~ 168 (181)
+++ ++|+++.
T Consensus 261 il~--hp~~~~~ 270 (307)
T d1a06a_ 261 ALQ--HPWIAGD 270 (307)
T ss_dssp HHH--STTTTSS
T ss_pred Hhc--CHhhCCC
Confidence 999 8888754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.9e-38 Score=237.05 Aligned_cols=168 Identities=24% Similarity=0.370 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC--CCcEEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++. ++.+||+|||+++...... ......+++.|+|||.+
T Consensus 121 l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gT~~Y~aPEv~ 197 (350)
T d1koaa2 121 MSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVA 197 (350)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-CEEEECSCTTTCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccc-ccceecCcccccCHHHH
Confidence 689999999999999999999999 999999999999954 6789999999987544322 22345789999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..++.++|+||+||++|+|++|+.||.+.+..+....+....... .....+++++++||.+||..||.+|||++++
T Consensus 198 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei 277 (350)
T d1koaa2 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277 (350)
T ss_dssp HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99889999999999999999999999999998888777775443332 2335689999999999999999999999999
Q ss_pred HHHHHHhhhCCCCCCCC
Q 030203 158 MELLRPLIKSPTPQPSP 174 (181)
Q Consensus 158 l~~L~~~~~~~~~~~~~ 174 (181)
++ ++|++....+..+
T Consensus 278 l~--hp~~~~~~~~~~~ 292 (350)
T d1koaa2 278 LE--HPWLTPGNAPGRD 292 (350)
T ss_dssp HH--STTTSCTTCCSCC
T ss_pred hc--CcccCCCCCCCch
Confidence 99 8998865544333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-38 Score=236.68 Aligned_cols=157 Identities=24% Similarity=0.400 Sum_probs=138.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||+++ ++||||||+||+++.+|.+||+|||+++..... .....|++.|+|||.+.+
T Consensus 138 l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc---cccccCccccCCHHHHcC
Confidence 688999999999999999999999 999999999999999999999999999765432 234578899999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+||++|+|++|+.||.+.+......++.... ...+..+++++.++|.+||..||.+|+ |+++
T Consensus 213 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~e 290 (350)
T d1rdqe_ 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHH
T ss_pred CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHH
Confidence 889999999999999999999999999998888877775333 445678999999999999999999995 8999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ |+|++.
T Consensus 291 ll~--Hp~f~~ 299 (350)
T d1rdqe_ 291 IKN--HKWFAT 299 (350)
T ss_dssp HHT--SGGGTT
T ss_pred HHc--CccccC
Confidence 998 777653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=225.50 Aligned_cols=159 Identities=32% Similarity=0.598 Sum_probs=140.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc-cccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT-FLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+++++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++..... ........+++.|+|||.+.
T Consensus 97 ~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~ 174 (258)
T d1k2pa_ 97 FQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174 (258)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhc
Confidence 568899999999999999999999 999999999999999999999999998754332 22233456788999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..++.++||||+|+++|+|++ |+.||.+....++..++. ...+...+..+++.+.+|+.+||+.||.+|||++++++
T Consensus 175 ~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 253 (258)
T d1k2pa_ 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 253 (258)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8889999999999999999998 899999999988888876 45566778889999999999999999999999999999
Q ss_pred HHHH
Q 030203 160 LLRP 163 (181)
Q Consensus 160 ~L~~ 163 (181)
.|.+
T Consensus 254 ~L~d 257 (258)
T d1k2pa_ 254 NILD 257 (258)
T ss_dssp HHHC
T ss_pred HhhC
Confidence 8864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-38 Score=231.48 Aligned_cols=162 Identities=34% Similarity=0.617 Sum_probs=140.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..... ........+++.|+|||.+
T Consensus 137 l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (301)
T d1lufa_ 137 LSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH
Confidence 678899999999999999999999 999999999999999999999999998743322 1222345677899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++||||||+++|+|++|. .||.+.+..++...+. .+...+.+..+++++.+|+.+||+.||.+|||+.+++
T Consensus 215 ~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 215 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9989999999999999999999985 6899999888888876 4456667888999999999999999999999999999
Q ss_pred HHHHHhhh
Q 030203 159 ELLRPLIK 166 (181)
Q Consensus 159 ~~L~~~~~ 166 (181)
+.|+.+.+
T Consensus 294 ~~L~~i~~ 301 (301)
T d1lufa_ 294 RILQRMCE 301 (301)
T ss_dssp HHHHHTTC
T ss_pred HHHHHhcC
Confidence 99998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-38 Score=229.06 Aligned_cols=161 Identities=33% Similarity=0.589 Sum_probs=140.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||+++ ++||||+|+||+++.++.+|++|||+++...... .......++..|+|||.
T Consensus 108 l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 185 (273)
T d1u46a_ 108 FLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185 (273)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHH
Confidence 678899999999999999999999 9999999999999999999999999988643321 12233456778999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.....+.+.+..+++.+.+++.+||+.||.+|||+.++
T Consensus 186 ~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei 265 (273)
T d1u46a_ 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265 (273)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 998888999999999999999997 8999999999998888876777777788899999999999999999999999999
Q ss_pred HHHHHHh
Q 030203 158 MELLRPL 164 (181)
Q Consensus 158 l~~L~~~ 164 (181)
++.|++.
T Consensus 266 ~~~L~~~ 272 (273)
T d1u46a_ 266 RDFLLEA 272 (273)
T ss_dssp HHHHHHH
T ss_pred HHHHHhc
Confidence 9988864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-37 Score=231.09 Aligned_cols=157 Identities=26% Similarity=0.481 Sum_probs=139.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++.+|.+||+|||+++..... .....|++.|+|||.+.+
T Consensus 101 ~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 101 FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVST 175 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTT
T ss_pred ccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc---cccccCcccccCHHHHcC
Confidence 467888999999999999999999 999999999999999999999999998765443 234678999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCC-----CHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRP-----SFST 156 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ 156 (181)
..++.++|+||+||++|+|++|+.||.+.+......++... ....+..+++++.+++.+||..||.+|+ |+++
T Consensus 176 ~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~ 253 (316)
T d1fota_ 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 253 (316)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHH
T ss_pred CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHH
Confidence 88999999999999999999999999999988888777533 3456778999999999999999999996 8999
Q ss_pred HHHHHHHhhhC
Q 030203 157 IMELLRPLIKS 167 (181)
Q Consensus 157 ~l~~L~~~~~~ 167 (181)
+++ |+|+++
T Consensus 254 il~--Hp~f~~ 262 (316)
T d1fota_ 254 VKN--HPWFKE 262 (316)
T ss_dssp HHT--SGGGSS
T ss_pred HHc--Cccccc
Confidence 998 777654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-38 Score=234.23 Aligned_cols=163 Identities=31% Similarity=0.567 Sum_probs=139.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccc--cCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFL--SSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....... ......+++.|+|||.+
T Consensus 108 ~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 185 (317)
T d1xkka_ 108 IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHH
Confidence 678899999999999999999999 99999999999999999999999999875443221 22334678899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++||||+|+++|+|+| |..||.+....++...+. .+.+.+.+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 186 ~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil 264 (317)
T d1xkka_ 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264 (317)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHH
Confidence 98889999999999999999998 799999888777766664 4555677788999999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|..+.+.
T Consensus 265 ~~l~~~~~~ 273 (317)
T d1xkka_ 265 IEFSKMARD 273 (317)
T ss_dssp HHHHHHHHS
T ss_pred HHHHHHHhC
Confidence 998877543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=234.76 Aligned_cols=159 Identities=29% Similarity=0.509 Sum_probs=140.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||+++ ++||||||+||+++.++.++++|||+++.............|++.|+|||.+.+
T Consensus 100 ~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 177 (320)
T d1xjda_ 100 FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcC
Confidence 578999999999999999999999 999999999999999999999999999865554444555688999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHH-HHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFS-TIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~l~~ 160 (181)
..++.++|+||+||++|+|++|+.||.+.+...+..++... ....+..+|+++.+|+.+||..||.+||++. ++++
T Consensus 178 ~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~- 254 (320)
T d1xjda_ 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ- 254 (320)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG-
T ss_pred CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh-
Confidence 99999999999999999999999999999988888777533 3456778999999999999999999999995 7876
Q ss_pred HHHhhh
Q 030203 161 LRPLIK 166 (181)
Q Consensus 161 L~~~~~ 166 (181)
++|++
T Consensus 255 -hpff~ 259 (320)
T d1xjda_ 255 -HPLFR 259 (320)
T ss_dssp -SGGGT
T ss_pred -Cchhc
Confidence 55554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-37 Score=228.29 Aligned_cols=162 Identities=32% Similarity=0.628 Sum_probs=144.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+|++|||.+....... .......+++.|+|||.+
T Consensus 132 l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l 209 (299)
T d1fgka_ 132 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh
Confidence 688999999999999999999999 9999999999999999999999999987554332 223445677899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||||+++|+|++ |..||.+.....+...+. .+.....+..+++.+.+|+.+||+.||.+|||+.+++
T Consensus 210 ~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil 288 (299)
T d1fgka_ 210 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288 (299)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 98899999999999999999997 799999988888777765 5667778889999999999999999999999999999
Q ss_pred HHHHHhhh
Q 030203 159 ELLRPLIK 166 (181)
Q Consensus 159 ~~L~~~~~ 166 (181)
+.|+.++.
T Consensus 289 ~~L~~i~a 296 (299)
T d1fgka_ 289 EDLDRIVA 296 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 99998865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=232.10 Aligned_cols=160 Identities=26% Similarity=0.429 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~-~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|||++ | ++||||||+||+++.+|.+||+|||+++..... ...+..|++.|+|||.+.
T Consensus 101 l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~ 176 (322)
T d1s9ja_ 101 IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQ 176 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHc
Confidence 68899999999999999999974 8 999999999999999999999999998754432 233568999999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------------------------------------H
Q 030203 81 DEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVA------------------------------------------A 118 (181)
Q Consensus 81 ~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~------------------------------------------~ 118 (181)
+..++.++|+||+||++|+|++|+.||.+.+...... .
T Consensus 177 ~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (322)
T d1s9ja_ 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY 256 (322)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhh
Confidence 9999999999999999999999999997654322110 0
Q ss_pred HhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 119 VGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
+............+|+++.+|+.+||..||.+|||++++++ |+|++.
T Consensus 257 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~--Hpf~~~ 303 (322)
T d1s9ja_ 257 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR 303 (322)
T ss_dssp HHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHH
T ss_pred hhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh--CHhhCc
Confidence 00000001111346889999999999999999999999999 777764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-37 Score=226.65 Aligned_cols=163 Identities=23% Similarity=0.369 Sum_probs=138.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++++|||.+....... ......||+.|+|||.+.+
T Consensus 113 ~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~-~~~~~~gT~~Y~APE~~~~ 189 (305)
T d1blxa_ 113 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQ 189 (305)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhhhhcccc-cCCCcccChhhcCcchhcC
Confidence 678899999999999999999999 9999999999999999999999999987544332 3355688999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CC------------------------ccCCCCCCCHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GK------------------------RLEIPRNVNPHV 136 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~------------------------~~~~~~~~~~~~ 136 (181)
..++.++|+||+||++|+|++|+.||.+.+..+....+... +. .......+++.+
T Consensus 190 ~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 269 (305)
T d1blxa_ 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269 (305)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHH
T ss_pred CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHH
Confidence 99999999999999999999999999998877655544211 00 011334678899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 137 ASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 137 ~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
.+|+.+||+.||.+|||++|+++ ++|+++..
T Consensus 270 ~dli~~mL~~dP~~R~sa~e~L~--Hpff~~i~ 300 (305)
T d1blxa_ 270 KDLLLKCLTFNPAKRISAYSALS--HPYFQDLE 300 (305)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT--SGGGTTCC
T ss_pred HHHHHHHCcCChhHCcCHHHHhc--ChhhcCch
Confidence 99999999999999999999999 99998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-37 Score=233.94 Aligned_cols=162 Identities=25% Similarity=0.412 Sum_probs=140.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEc--CCCcEEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVD--KKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~--~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.+++.++.||+.||.|||++| ++||||||+||+++ .++.++|+|||++....... ......+++.|+|||.+
T Consensus 124 l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~ 200 (352)
T d1koba_ 124 MSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIV 200 (352)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-CEEEECSSGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC-ceeeccCcccccCHHHH
Confidence 689999999999999999999999 99999999999997 57899999999987654322 22345678899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--cCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..++.++|+||+||++|+|++|..||.+.+.......+...... ......+++++.+||.+||+.||.+|||+.++
T Consensus 201 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 280 (352)
T d1koba_ 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280 (352)
T ss_dssp TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 9988999999999999999999999999999888877777544433 33456799999999999999999999999999
Q ss_pred HHHHHHhhhCC
Q 030203 158 MELLRPLIKSP 168 (181)
Q Consensus 158 l~~L~~~~~~~ 168 (181)
++ ++|++..
T Consensus 281 l~--Hp~~~~~ 289 (352)
T d1koba_ 281 LE--HPWLKGD 289 (352)
T ss_dssp HT--STTTSSC
T ss_pred hc--CHhhCCC
Confidence 99 8888653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.5e-37 Score=231.50 Aligned_cols=160 Identities=25% Similarity=0.413 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++.+|.+||+|||+++..... ......|++.|+|||.+..
T Consensus 104 ~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~ 179 (364)
T d1omwa3 104 FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQK 179 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHST
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhc
Confidence 578899999999999999999999 999999999999999999999999998754433 2344578999999999864
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCC-----H
Q 030203 82 -EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKGKRLEIPRNVNPHVASIIEACWANEPWKRPS-----F 154 (181)
Q Consensus 82 -~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~ 154 (181)
..++.++|+||+||++|+|++|+.||.+.......... .........+..+++++++||.+||+.||.+||| +
T Consensus 180 ~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a 259 (364)
T d1omwa3 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259 (364)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTH
T ss_pred CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCH
Confidence 55889999999999999999999999876543322222 1234455567789999999999999999999998 7
Q ss_pred HHHHHHHHHhhhC
Q 030203 155 STIMELLRPLIKS 167 (181)
Q Consensus 155 ~~~l~~L~~~~~~ 167 (181)
+++++ ++|+++
T Consensus 260 ~eil~--Hp~f~~ 270 (364)
T d1omwa3 260 QEVKE--SPFFRS 270 (364)
T ss_dssp HHHHT--SGGGTT
T ss_pred HHHHc--CccccC
Confidence 99998 788764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7e-37 Score=223.57 Aligned_cols=161 Identities=24% Similarity=0.384 Sum_probs=137.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.||+.||.|||++| ++||||+|+||+++.++.+||+|||+++...... ......+++.|.+||.+.+
T Consensus 107 l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~ 183 (277)
T d1phka_ 107 LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIEC 183 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchheeEccCCC-ceeeeeccCCCCCHHHhhc
Confidence 689999999999999999999999 9999999999999999999999999997655432 2344678899999998853
Q ss_pred ------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCC
Q 030203 82 ------EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPS 153 (181)
Q Consensus 82 ------~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps 153 (181)
..++.++|+||+||++|+|++|+.||.+.+.......+........ ....+|+++++|+.+||+.||.+|||
T Consensus 184 ~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s 263 (277)
T d1phka_ 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT 263 (277)
T ss_dssp HHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred cccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC
Confidence 3357899999999999999999999999998887776654443322 33478999999999999999999999
Q ss_pred HHHHHHHHHHhhhC
Q 030203 154 FSTIMELLRPLIKS 167 (181)
Q Consensus 154 ~~~~l~~L~~~~~~ 167 (181)
++++++ ++|++.
T Consensus 264 ~~eil~--h~~~~~ 275 (277)
T d1phka_ 264 AEEALA--HPFFQQ 275 (277)
T ss_dssp HHHHTT--SGGGCT
T ss_pred HHHHHc--CHHHHH
Confidence 999999 888864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-37 Score=226.62 Aligned_cols=165 Identities=35% Similarity=0.673 Sum_probs=143.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++++++.|++.|+.|+|+++ ++||||+|+||+++.++.+||+|||+++...... ......++..|++||.+.+
T Consensus 124 l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~ 200 (309)
T d1fvra_ 124 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNY 200 (309)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCCCceEEccccccccccccc-cccceecCCcccchHHhcc
Confidence 678899999999999999999999 9999999999999999999999999987544332 2234467889999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELATLQ-QPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++||||||+++|+|++|. .||.+.+..++...+. .+.+.+.+..+++++.+|+.+||+.||++|||++++++.
T Consensus 201 ~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88999999999999999999964 6788888888888775 455667788899999999999999999999999999999
Q ss_pred HHHhhhCCCC
Q 030203 161 LRPLIKSPTP 170 (181)
Q Consensus 161 L~~~~~~~~~ 170 (181)
|+.+++....
T Consensus 280 L~~i~~~~~~ 289 (309)
T d1fvra_ 280 LNRMLEERKT 289 (309)
T ss_dssp HHHHHHSSSC
T ss_pred HHHHHhcCcC
Confidence 9999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-37 Score=225.76 Aligned_cols=165 Identities=28% Similarity=0.420 Sum_probs=139.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC----cEEEcccCCccccccccccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY----TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|||+++ ++||||||+||+++.++ .++++|||++....... ......+++.|+|||
T Consensus 110 l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~~t~~y~APE 186 (293)
T d1jksa_ 110 LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPE 186 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC-BCSCCCCCGGGCCHH
T ss_pred cchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhcCCCc-cccccCCCCcccCHH
Confidence 688999999999999999999999 99999999999998766 59999999987654332 234557888999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc--CCCCCCCHHHHHHHHHHhcCCCCCCCCHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL--EIPRNVNPHVASIIEACWANEPWKRPSFS 155 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 155 (181)
.+.+..++.++|+||+||++|+|++|+.||.+.+..+....+....... ..+..+|+.+++||.+||+.||.+|||++
T Consensus 187 ~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 266 (293)
T d1jksa_ 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266 (293)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred HHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 9998889999999999999999999999999998888777765433322 23467899999999999999999999999
Q ss_pred HHHHHHHHhhhCCCCC
Q 030203 156 TIMELLRPLIKSPTPQ 171 (181)
Q Consensus 156 ~~l~~L~~~~~~~~~~ 171 (181)
++++ ++|++....+
T Consensus 267 eil~--hp~~~~~~~~ 280 (293)
T d1jksa_ 267 DSLQ--HPWIKPKDTQ 280 (293)
T ss_dssp HHHH--STTTCC----
T ss_pred HHhc--CcccCCCChh
Confidence 9999 8998764433
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-36 Score=222.99 Aligned_cols=166 Identities=22% Similarity=0.309 Sum_probs=137.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.++.++++|||.++.............+++.|+|||....
T Consensus 99 l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 99 IPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhcc
Confidence 689999999999999999999999 999999999999999999999999999766555445556688999999998776
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCcc---------------C-----------CCCCCC
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GKRL---------------E-----------IPRNVN 133 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~---------------~-----------~~~~~~ 133 (181)
.. .+.++|+||+|+++|+|++|+.||.+.+......++... +... . ....++
T Consensus 177 ~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 256 (298)
T d1gz8a_ 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256 (298)
T ss_dssp CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCC
T ss_pred ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCC
Confidence 65 478999999999999999999999988776655443110 0000 0 112567
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTPQ 171 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~~ 171 (181)
+++.+|+.+||..||.+|||+.++++ ++|+++...+
T Consensus 257 ~~~~dll~~mL~~dP~~R~t~~ell~--H~ff~~~~~p 292 (298)
T d1gz8a_ 257 EDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKP 292 (298)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTCCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhC--CHhhccCCCC
Confidence 89999999999999999999999999 9999876444
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=220.82 Aligned_cols=159 Identities=35% Similarity=0.639 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++++|||+++..... .....++..|+|||.+.+
T Consensus 100 l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~ 174 (262)
T d1byga_ 100 LGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALRE 174 (262)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHH
T ss_pred CCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCCC---CccccccccCCChHHHhC
Confidence 578899999999999999999999 999999999999999999999999998754332 233456788999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 030203 82 EPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMEL 160 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 160 (181)
..++.++||||||+++|+|++ |+.||......++...+. ...+.+.+..+++.+.+++.+||+.||.+|||+.++++.
T Consensus 175 ~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 889999999999999999998 788999888888887775 456677788899999999999999999999999999999
Q ss_pred HHHhhh
Q 030203 161 LRPLIK 166 (181)
Q Consensus 161 L~~~~~ 166 (181)
|+.+.+
T Consensus 254 L~~i~~ 259 (262)
T d1byga_ 254 LEHIKT 259 (262)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 988754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-36 Score=221.44 Aligned_cols=162 Identities=23% Similarity=0.447 Sum_probs=131.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc---cccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT---FLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~~~pe~ 78 (181)
+++.+++.++.|++.||.|||++| ++||||||+||+++.++..+++|||.+...... ........|++.|+|||.
T Consensus 108 l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~ 185 (277)
T d1o6ya_ 108 MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHH
Confidence 678999999999999999999999 999999999999999999999999987643322 122344578999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc--cCCCCCCCHHHHHHHHHHhcCCCCCCC-CHH
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR--LEIPRNVNPHVASIIEACWANEPWKRP-SFS 155 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~ 155 (181)
+.+..++.++|+||+|+++|+|++|+.||.+.+..+...+....... ......+|+.+.++|.+||+.||.+|| |++
T Consensus 186 ~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~ 265 (277)
T d1o6ya_ 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 265 (277)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred HcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHH
Confidence 99888999999999999999999999999998887766655433332 234567999999999999999999999 899
Q ss_pred HHHHHHHHhh
Q 030203 156 TIMELLRPLI 165 (181)
Q Consensus 156 ~~l~~L~~~~ 165 (181)
+++..|..+.
T Consensus 266 ~l~~~l~r~~ 275 (277)
T d1o6ya_ 266 EMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9988877654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=227.20 Aligned_cols=164 Identities=28% Similarity=0.452 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCccccccccccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~ 78 (181)
|+|.++..++.|++.||.|||++| ++||||||+||+++. .+.++++|||+++...... ......|++.|+|||.
T Consensus 108 l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~ 184 (335)
T d2ozaa1 108 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEV 184 (335)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-CCCCCSCCCSSCCCCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcC--CccccccccccccccccccccccccccceeeeccCCC-ccccccCCcccCCcHH
Confidence 678999999999999999999999 999999999999975 5679999999987654432 2345678999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC--CccCCC----CCCCHHHHHHHHHHhcCCCCCCC
Q 030203 79 LRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG--KRLEIP----RNVNPHVASIIEACWANEPWKRP 152 (181)
Q Consensus 79 ~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp 152 (181)
+.+..++.++|+||+||++|+|++|+.||.+.+.......+.... .....+ ..+|+++.+||.+||+.||.+||
T Consensus 185 ~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 264 (335)
T d2ozaa1 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 264 (335)
T ss_dssp CCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC
T ss_pred HcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc
Confidence 998889999999999999999999999997765443333221111 111222 35789999999999999999999
Q ss_pred CHHHHHHHHHHhhhCCCC
Q 030203 153 SFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 153 s~~~~l~~L~~~~~~~~~ 170 (181)
|+.++++ ++|+.....
T Consensus 265 s~~eil~--hp~~~~~~~ 280 (335)
T d2ozaa1 265 TITEFMN--HPWIMQSTK 280 (335)
T ss_dssp CHHHHHH--SHHHHTTTS
T ss_pred CHHHHHc--CHHhhCCCC
Confidence 9999999 788765433
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-37 Score=224.07 Aligned_cols=154 Identities=23% Similarity=0.437 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-CCcEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++++++.++.|++.||.|||++| ++||||||+||+++. ++.++++|||+++..... ......|++.|+|||.+.
T Consensus 107 l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~ 182 (273)
T d1xwsa_ 107 LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIR 182 (273)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceecccc--cccccccCCCcCCHHHHc
Confidence 688999999999999999999999 999999999999985 579999999998754433 234467899999999987
Q ss_pred CCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 030203 81 DEPS-NEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIME 159 (181)
Q Consensus 81 ~~~~-~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 159 (181)
+..+ +.++|+||+||++|+|++|+.||.+.+ . + .......+..+|+++++|+.+||+.||.+|||++++++
T Consensus 183 ~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----I--IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----H--HHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCcccccccceeeehhHhhCCCCCCCch--H----H--hhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 7664 567899999999999999999997632 1 1 11233456779999999999999999999999999999
Q ss_pred HHHHhhhCCC
Q 030203 160 LLRPLIKSPT 169 (181)
Q Consensus 160 ~L~~~~~~~~ 169 (181)
++|+++..
T Consensus 255 --hp~~~~~~ 262 (273)
T d1xwsa_ 255 --HPWMQDVL 262 (273)
T ss_dssp --SGGGSSCC
T ss_pred --CHhhCCCC
Confidence 89998644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-36 Score=221.49 Aligned_cols=162 Identities=22% Similarity=0.309 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||+.+ ++||||||+||+++.++.++++|||.+..............+++.|.+||.+.+
T Consensus 97 l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~ 174 (286)
T d1ob3a_ 97 LESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174 (286)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTT
T ss_pred cchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhC
Confidence 689999999999999999999999 999999999999999999999999998766555444455678889999999876
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCc---------------------------cCCCCCCC
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKR---------------------------LEIPRNVN 133 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 133 (181)
.. ++.++|+||+|+++++|++|+.||.+.+..+...++...... ......++
T Consensus 175 ~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 254 (286)
T d1ob3a_ 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254 (286)
T ss_dssp CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCC
T ss_pred CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCC
Confidence 54 689999999999999999999999988876655543210000 11234578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 134 PHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 134 ~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
+.+.+|+.+||..||++|||++|+++ ++|+++
T Consensus 255 ~~~~dli~~~L~~dP~~R~s~~ell~--Hp~f~~ 286 (286)
T d1ob3a_ 255 ESGIDLLSKMLKLDPNQRITAKQALE--HAYFKE 286 (286)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGGC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc--CcccCc
Confidence 89999999999999999999999998 888864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=225.03 Aligned_cols=164 Identities=33% Similarity=0.627 Sum_probs=140.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccc--cccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANT--FLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++..++.|++.|+.|||+++ ++||||||+||+++.++.++++|||.++..... ........+++.|+|||.+
T Consensus 142 l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 219 (311)
T d1t46a_ 142 LDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh
Confidence 678899999999999999999999 999999999999999999999999998764432 2223345678899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++||||||+++|+|++ |.++|...+......++.....+...+..+++.+.+|+.+||+.||.+|||+.+++
T Consensus 220 ~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il 299 (311)
T d1t46a_ 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (311)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 98889999999999999999998 67777776665555444445666677788999999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
++|+..+.+
T Consensus 300 ~~L~~~i~~ 308 (311)
T d1t46a_ 300 QLIEKQISE 308 (311)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHhhcc
Confidence 999987765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-36 Score=221.59 Aligned_cols=166 Identities=33% Similarity=0.523 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc----ccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~pe 77 (181)
+++.+++.++.|++.||.|+|+.+ ++||||+|+||+++.++.+||+|||+++...... .......+++.|++||
T Consensus 127 ~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 204 (311)
T d1r0pa_ 127 PTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204 (311)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHH
T ss_pred chHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChH
Confidence 356788999999999999999999 9999999999999999999999999987543321 1222346788999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHH
Q 030203 78 VLRDEPSNEKSDIYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFST 156 (181)
Q Consensus 78 ~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 156 (181)
.+....++.++||||||+++|+|++|..||... +..++...+. .+.+...+..+++.+.+++.+||+.||.+||++.+
T Consensus 205 ~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence 998888999999999999999999977776554 3334444443 45566677889999999999999999999999999
Q ss_pred HHHHHHHhhhCCCC
Q 030203 157 IMELLRPLIKSPTP 170 (181)
Q Consensus 157 ~l~~L~~~~~~~~~ 170 (181)
+++.|+.+++.-..
T Consensus 284 i~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 284 LVSRISAIFSTFIG 297 (311)
T ss_dssp HHHHHHHHHHTCCS
T ss_pred HHHHHHHHHHhhhh
Confidence 99999999876444
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-36 Score=225.09 Aligned_cols=163 Identities=20% Similarity=0.363 Sum_probs=138.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCC--CcEEEcccCCccccccccccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKK--YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~--~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 79 (181)
++++++..++.||+.||.|||+.| ++||||+|+||+++.+ ..++++|||++....... ......+++.|++||..
T Consensus 99 l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-~~~~~~~t~~y~ape~~ 175 (321)
T d1tkia_ 99 LNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVH 175 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-EEEEEESCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC-cccccccccccccchhc
Confidence 689999999999999999999999 9999999999999754 479999999987544322 22334678899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCccC--CCCCCCHHHHHHHHHHhcCCCCCCCCHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRLE--IPRNVNPHVASIIEACWANEPWKRPSFSTI 157 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 157 (181)
.+..++.++|+||+||++|+|++|..||.+.+..+...++........ ....+|+++++|+.+||..||.+|||++++
T Consensus 176 ~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 255 (321)
T d1tkia_ 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255 (321)
T ss_dssp TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 888899999999999999999999999999998888777754433222 234689999999999999999999999999
Q ss_pred HHHHHHhhhCCC
Q 030203 158 MELLRPLIKSPT 169 (181)
Q Consensus 158 l~~L~~~~~~~~ 169 (181)
++ ++|++...
T Consensus 256 l~--hp~~~~~~ 265 (321)
T d1tkia_ 256 LQ--HPWLKQKI 265 (321)
T ss_dssp HH--SHHHHSCG
T ss_pred hc--CHhhccCc
Confidence 99 78887543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=219.29 Aligned_cols=163 Identities=36% Similarity=0.616 Sum_probs=141.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc--ccCCCCCCCCCccCCccc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF--LSSKSAAGTPEWMAPEVL 79 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~ 79 (181)
+++.++.+++.|++.||.|||+++ ++||||+|+||+++.++.+||+|||+++...... .......+++.|++||.+
T Consensus 130 ~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l 207 (308)
T d1p4oa_ 130 PSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 207 (308)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHH
Confidence 467889999999999999999999 9999999999999999999999999987543322 222344678899999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHH
Q 030203 80 RDEPSNEKSDIYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKGKRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIM 158 (181)
Q Consensus 80 ~~~~~~~~~Dv~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 158 (181)
.+..++.++|+||+|+++|+|++| ..||.+.+.......+. .+.....+..+++.+.+++.+||+.||.+|||+.+++
T Consensus 208 ~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il 286 (308)
T d1p4oa_ 208 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286 (308)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 988899999999999999999998 57899988888887775 5556667888999999999999999999999999999
Q ss_pred HHHHHhhhC
Q 030203 159 ELLRPLIKS 167 (181)
Q Consensus 159 ~~L~~~~~~ 167 (181)
+.|+..++.
T Consensus 287 ~~L~~~~~~ 295 (308)
T d1p4oa_ 287 SSIKEEMEP 295 (308)
T ss_dssp HHHGGGSCT
T ss_pred HHHHHhcCC
Confidence 999877553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=215.34 Aligned_cols=164 Identities=21% Similarity=0.256 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc----ccCCCCCCCCCccCCc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAGTPEWMAPE 77 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~~pe 77 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.++.++++|||++....... .......+++.|+|||
T Consensus 114 ~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 191 (318)
T d3blha1 114 FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHH
T ss_pred cccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHH
Confidence 568889999999999999999999 9999999999999999999999999986543221 1223456889999999
Q ss_pred ccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--ccCCCC------------------------
Q 030203 78 VLRDE-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK--RLEIPR------------------------ 130 (181)
Q Consensus 78 ~~~~~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~------------------------ 130 (181)
.+.+. .++.++|+||+||++++|++|+.||.+.........+..... ..+...
T Consensus 192 ~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (318)
T d3blha1 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 271 (318)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHH
T ss_pred HHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhh
Confidence 98765 578999999999999999999999998877665544322111 111000
Q ss_pred ----CCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 131 ----NVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 131 ----~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
..++.+.+|+.+||..||.+|||++|+++ ++||+..+
T Consensus 272 ~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~--Hpff~~~p 312 (318)
T d3blha1 272 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWSDP 312 (318)
T ss_dssp HHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGSSSS
T ss_pred hccccCCHHHHHHHHHHCcCChhHCcCHHHHHc--ChhhccCC
Confidence 13667889999999999999999999999 99999643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=217.72 Aligned_cols=162 Identities=20% Similarity=0.251 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++.++ .+||+|||++....... ......+++.|++||.+.
T Consensus 119 l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 195 (350)
T d1q5ka_ 119 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIF 195 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS-CCCSCCSCTTSCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhccCCc-ccccccccccccChHHhh
Confidence 688999999999999999999999 99999999999998765 89999999987544332 234457889999999876
Q ss_pred C-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-C----------------Cc----------cCCCCCC
Q 030203 81 D-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-G----------------KR----------LEIPRNV 132 (181)
Q Consensus 81 ~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~----------------~~----------~~~~~~~ 132 (181)
+ ..++.++|+||+||++|+|++|+.||...+..+....+... + .. ......+
T Consensus 196 ~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (350)
T d1q5ka_ 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275 (350)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTS
T ss_pred cccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCC
Confidence 5 45899999999999999999999999888766554443210 0 00 0112357
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
++++.+|+.+||..||.+|||+.|+++ ++|+++.
T Consensus 276 s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~ 309 (350)
T d1q5ka_ 276 PPEAIALCSRLLEYTPTARLTPLEACA--HSFFDEL 309 (350)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc--CHhhccc
Confidence 889999999999999999999999999 8887653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-34 Score=214.48 Aligned_cols=160 Identities=26% Similarity=0.375 Sum_probs=133.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++..+..++.|++.||.|||++| ++||||||+||+++.++.++++|||.++..... .....+++.|+|||.+.+
T Consensus 118 l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 118 LGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILN 192 (346)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHT
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceeccCCc---cccccccccccCHHHHcC
Confidence 688999999999999999999999 999999999999999999999999998765443 244678899999998876
Q ss_pred C-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-----------------------------CccCCCCC
Q 030203 82 E-PSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKG-----------------------------KRLEIPRN 131 (181)
Q Consensus 82 ~-~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 131 (181)
. .++.++|+||+||++|+|++|+.||.+.+............ ........
T Consensus 193 ~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (346)
T d1cm8a_ 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 272 (346)
T ss_dssp TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccC
Confidence 4 46889999999999999999999998887655443321100 00113346
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
+++.+.+||.+||..||.+|||++++++ ++|++..
T Consensus 273 ~s~~~~dli~~mL~~dP~~R~ta~eiL~--Hp~f~~~ 307 (346)
T d1cm8a_ 273 ASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFESL 307 (346)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTT
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhc--ChhhCcC
Confidence 7899999999999999999999999999 8998764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-34 Score=213.86 Aligned_cols=164 Identities=21% Similarity=0.338 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC---CCcEEEcccCCcccccccc-------ccCCCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK---KYTVKVCDFGLSRLKANTF-------LSSKSAAGTP 71 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~---~~~~~l~d~g~~~~~~~~~-------~~~~~~~~~~ 71 (181)
+++..+..++.|++.||.|||++| ++||||||+||+++. +..++++|||+++...... .......|++
T Consensus 100 ~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~ 177 (299)
T d1ckia_ 100 FSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCS
T ss_pred CcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCc
Confidence 678999999999999999999999 999999999999754 4569999999997644321 1234557899
Q ss_pred CccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------ccCCccCCCCCCCHHHHHHHHHHhc
Q 030203 72 EWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVG------FKGKRLEIPRNVNPHVASIIEACWA 145 (181)
Q Consensus 72 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~ 145 (181)
.|+|||.+.+..++.++|+||+||++|+|++|+.||...........+. ...........+|+++.+++.+|++
T Consensus 178 ~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~ 257 (299)
T d1ckia_ 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRS 257 (299)
T ss_dssp SSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHH
T ss_pred cccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHcc
Confidence 9999999999889999999999999999999999998765543222211 1111222345789999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhhhC
Q 030203 146 NEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 146 ~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
.||.+||++.++.+.|+.++..
T Consensus 258 ~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 258 LRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp SCTTCCCCHHHHHHHHHHHHHH
T ss_pred CChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999987653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-34 Score=215.23 Aligned_cols=163 Identities=23% Similarity=0.408 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc---ccCCCCCCCCCccCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF---LSSKSAAGTPEWMAPEV 78 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~pe~ 78 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++....... .......+++.|+|||.
T Consensus 106 l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~ 183 (345)
T d1pmea_ 106 LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHH
Confidence 688999999999999999999999 9999999999999999999999999987543322 12344568889999998
Q ss_pred cCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CC-----------------------c-----cCC
Q 030203 79 LRD-EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-GK-----------------------R-----LEI 128 (181)
Q Consensus 79 ~~~-~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~-~~-----------------------~-----~~~ 128 (181)
+.. ..++.++|+||+||++++|++|+.||.+....+........ .. . ...
T Consensus 184 l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (345)
T d1pmea_ 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 263 (345)
T ss_dssp TTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred hhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHh
Confidence 854 44688999999999999999999999887654433322110 00 0 012
Q ss_pred CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 129 PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
...+++++.+|+.+||..||.+|||+.++++ ++|++..
T Consensus 264 ~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~--hpf~~~~ 301 (345)
T d1pmea_ 264 FPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLEQY 301 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTTT
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhccC
Confidence 2457889999999999999999999999999 8888744
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-34 Score=209.03 Aligned_cols=165 Identities=23% Similarity=0.343 Sum_probs=133.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.|++.||.|||++| ++||||||+||+++.++.++++|||.+..............+++.|.+||.+..
T Consensus 98 ~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~ 175 (292)
T d1unla_ 98 LDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT
T ss_pred cchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhcc
Confidence 578899999999999999999999 999999999999999999999999999876655444455567788999998876
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhccC---------------------------CccCCCCCC
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKG---------------------------KRLEIPRNV 132 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~-~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~ 132 (181)
.. ++.++|+||+||++++|++|..|| .+.+..+...++.... ........+
T Consensus 176 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (292)
T d1unla_ 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255 (292)
T ss_dssp CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTC
T ss_pred CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccC
Confidence 55 588999999999999999998875 5555555444432110 011133457
Q ss_pred CHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCCC
Q 030203 133 NPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPTP 170 (181)
Q Consensus 133 ~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~~ 170 (181)
++.+.+|+.+||+.||.+|||++|+++ ++|+++-.+
T Consensus 256 s~~~~dll~~mL~~dP~~R~sa~e~L~--Hp~f~~~~~ 291 (292)
T d1unla_ 256 NATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCP 291 (292)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGSSCSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc--ChhhcCCCC
Confidence 889999999999999999999999999 899976443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-34 Score=211.64 Aligned_cols=162 Identities=24% Similarity=0.356 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCcccccc-ccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAN-TFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++..+..++.|++.||.|+|+++ ++||||+|+||+++.+|.++|+|||+++.... .........+++.|.+||.+.
T Consensus 126 ~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~ 203 (322)
T d1vzoa_ 126 FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhh
Confidence 568889999999999999999999 99999999999999999999999999875432 222334567888999999987
Q ss_pred CCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--cCCccCCCCCCCHHHHHHHHHHhcCCCCCCC----
Q 030203 81 DEP--SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGF--KGKRLEIPRNVNPHVASIIEACWANEPWKRP---- 152 (181)
Q Consensus 81 ~~~--~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---- 152 (181)
+.. ++.++||||+||++|+|++|+.||.+.........+.. .......+..+++++.+++.+||+.||.+||
T Consensus 204 ~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~ 283 (322)
T d1vzoa_ 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283 (322)
T ss_dssp TCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSST
T ss_pred cCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCc
Confidence 643 57789999999999999999999977644332222211 2234456678999999999999999999999
Q ss_pred -CHHHHHHHHHHhhhC
Q 030203 153 -SFSTIMELLRPLIKS 167 (181)
Q Consensus 153 -s~~~~l~~L~~~~~~ 167 (181)
+++|+++ ++|++.
T Consensus 284 ~t~~eil~--Hpff~~ 297 (322)
T d1vzoa_ 284 RDADEIKE--HLFFQK 297 (322)
T ss_dssp TTHHHHHT--SGGGTT
T ss_pred ccHHHHHc--CHhhcC
Confidence 4899988 777754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-33 Score=205.45 Aligned_cols=166 Identities=16% Similarity=0.280 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcC-----CCcEEEcccCCccccccc-------cccCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDK-----KYTVKVCDFGLSRLKANT-------FLSSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~-----~~~~~l~d~g~~~~~~~~-------~~~~~~~~~ 69 (181)
+++..+..++.|++.||.|||++| ++||||||+||+++. ++.++++|||+++..... ........|
T Consensus 98 ~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~G 175 (293)
T d1csna_ 98 FSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCS
T ss_pred hhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEE
Confidence 678899999999999999999999 999999999999964 578999999999754322 112334578
Q ss_pred CCCccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhc---cCCccCCCCCCCHHHHHHHHHH
Q 030203 70 TPEWMAPEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNP---AQVVAAVGF---KGKRLEIPRNVNPHVASIIEAC 143 (181)
Q Consensus 70 ~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~---~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~ 143 (181)
|+.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+... .....++.. .....+....+++++.+++..|
T Consensus 176 T~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~ 255 (293)
T d1csna_ 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYA 255 (293)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred chhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHH
Confidence 9999999999998899999999999999999999999976533 222222211 1112234467899999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 144 WANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 144 l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
+..+|.+||+++.+.+.|+++++...
T Consensus 256 ~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 256 RNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 99999999999999999999887543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-33 Score=209.49 Aligned_cols=161 Identities=24% Similarity=0.350 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++.+|.++++|||.+...... .....++..|+|||...+
T Consensus 118 l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~---~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 118 LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCTGG---GSSSCHHHHTSCHHHHTT
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccCcc---cccccccccccCchhhcC
Confidence 688999999999999999999999 999999999999999999999999998654433 244567789999998766
Q ss_pred CC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCcc---------------------C--------CCCC
Q 030203 82 EP-SNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGKRL---------------------E--------IPRN 131 (181)
Q Consensus 82 ~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------------------~--------~~~~ 131 (181)
.. ++.++|+||+||++|+|++|+.||.+.+.......+....... . ....
T Consensus 193 ~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (348)
T d2gfsa1 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272 (348)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTT
T ss_pred CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCC
Confidence 54 5789999999999999999999999887665544432111000 0 1135
Q ss_pred CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 132 VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 132 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
+++++.+||.+||..||.+|||++|+++ ++|+++..
T Consensus 273 ~s~~~~dli~~mL~~dP~~R~ta~elL~--Hp~f~~~~ 308 (348)
T d2gfsa1 273 ANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYH 308 (348)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTC
T ss_pred CCHHHHHHHHHHCcCChhhCcCHHHHhc--CHhhCCCC
Confidence 7889999999999999999999999999 89998643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-33 Score=208.15 Aligned_cols=165 Identities=30% Similarity=0.450 Sum_probs=125.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh--------CCCCceecCCCCCCEEEcCCCcEEEcccCCcccccccc----ccCCCCCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR--------RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF----LSSKSAAG 69 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~--------~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~ 69 (181)
+++.+++.++.|++.|+.|+|+ ++ ++|+||||+||+++.++.+||+|||++....... .......|
T Consensus 97 l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~g 174 (303)
T d1vjya_ 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174 (303)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceec
Confidence 5788999999999999999997 47 9999999999999999999999999987544322 12344678
Q ss_pred CCCccCCcccCCCC------CCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHhccCCccCC
Q 030203 70 TPEWMAPEVLRDEP------SNEKSDIYSFGVILWELATLQQPWGNL---------------NPAQVVAAVGFKGKRLEI 128 (181)
Q Consensus 70 ~~~~~~pe~~~~~~------~~~~~Dv~slG~~~~~ll~g~~p~~~~---------------~~~~~~~~~~~~~~~~~~ 128 (181)
++.|+|||.+.+.. ++.++|||||||++|+|++|..||... ........+.....+...
T Consensus 175 t~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 254 (303)
T d1vjya_ 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 254 (303)
T ss_dssp CGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred ccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCC
Confidence 99999999987643 356899999999999999998776331 222333333222222333
Q ss_pred CCC-----CCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 129 PRN-----VNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 129 ~~~-----~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
+.. ....+.+++.+||+.||.+|||+.++++.|+++.++.
T Consensus 255 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 255 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 222 2235889999999999999999999999999887653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-32 Score=205.59 Aligned_cols=162 Identities=19% Similarity=0.313 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCC-cEEEcccCCccccccccccCCCCCCCCCccCCcccC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLR 80 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 80 (181)
+++.++..++.||+.||.|||++| ++||||||+||+++.++ .++++|||.+....... ......+++.|+|||.+.
T Consensus 126 l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~ 202 (328)
T d3bqca1 126 LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLV 202 (328)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-CCCSCCSCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCC-cccccccCccccCccccc
Confidence 678999999999999999999999 99999999999998654 68999999987544332 234557788999999987
Q ss_pred CCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc-------------cC----------------------
Q 030203 81 DEP-SNEKSDIYSFGVILWELATLQQPWGNLNPA-QVVAAVGF-------------KG---------------------- 123 (181)
Q Consensus 81 ~~~-~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-~~~~~~~~-------------~~---------------------- 123 (181)
+.. ++.++|+||+||+++++++|..||...... .....+.. ..
T Consensus 203 ~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (328)
T d3bqca1 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282 (328)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGG
T ss_pred CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhc
Confidence 654 689999999999999999999999765432 11111100 00
Q ss_pred CccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCC
Q 030203 124 KRLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSP 168 (181)
Q Consensus 124 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~ 168 (181)
........+++++.+||.+||..||.+|||++++++ ++||+..
T Consensus 283 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~--Hp~F~~v 325 (328)
T d3bqca1 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYFYTV 325 (328)
T ss_dssp CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTS
T ss_pred ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCCC
Confidence 000112347889999999999999999999999999 9998764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.6e-33 Score=209.41 Aligned_cols=161 Identities=26% Similarity=0.369 Sum_probs=124.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccccccccCCCCCCCCCccCCcccCC
Q 030203 2 LDERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRD 81 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 81 (181)
+++.+++.++.|++.||.|||++| ++|+||||+||+++.++.++++|||++....... ......+++.|+|||.+.+
T Consensus 116 ~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~-~~~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 116 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG 192 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----------------CCTTCCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhcccccc-ccccccccccccChhhhcC
Confidence 678999999999999999999999 9999999999999999999999999876544432 2334567889999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC----------------------ccC------------
Q 030203 82 EPSNEKSDIYSFGVILWELATLQQPWGNLNPAQVVAAVGFKGK----------------------RLE------------ 127 (181)
Q Consensus 82 ~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~----------------------~~~------------ 127 (181)
..++.++|+||+||++++|++|+.||.+.+......++..... ...
T Consensus 193 ~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (355)
T d2b1pa1 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272 (355)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG
T ss_pred CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccc
Confidence 8899999999999999999999999998876655443311000 000
Q ss_pred C------CCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhC
Q 030203 128 I------PRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKS 167 (181)
Q Consensus 128 ~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~ 167 (181)
. ....++++.+|+.+||..||.+|||++|+++ ++|++.
T Consensus 273 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~--Hpw~~~ 316 (355)
T d2b1pa1 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYINV 316 (355)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTGG
T ss_pred ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccCC
Confidence 0 0123567899999999999999999999999 899875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=8.7e-31 Score=197.62 Aligned_cols=161 Identities=20% Similarity=0.362 Sum_probs=123.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCEEEcCCC------cEEEcccCCccccccccccCCCCCCCCCcc
Q 030203 2 LDERRRLNMAYDVAKGMNYLHR-RNPPIVHRDLKSPNLLVDKKY------TVKVCDFGLSRLKANTFLSSKSAAGTPEWM 74 (181)
Q Consensus 2 l~~~~~~~i~~ql~~~l~~lh~-~~~~~~h~~i~~~nil~~~~~------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 74 (181)
+++..+..++.|++.|+.|||+ .| ++||||||+||+++.++ .++++|||.+...... .....+++.|+
T Consensus 122 ~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~ 196 (362)
T d1q8ya_ 122 IPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYR 196 (362)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGC
T ss_pred CcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccceeeEeecccccccccc---ccccccccccc
Confidence 5678899999999999999998 88 99999999999997654 3899999998654332 24457888999
Q ss_pred CCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhccCC-----------------------
Q 030203 75 APEVLRDEPSNEKSDIYSFGVILWELATLQQPWGNLNPA-------QVVAAVGFKGK----------------------- 124 (181)
Q Consensus 75 ~pe~~~~~~~~~~~Dv~slG~~~~~ll~g~~p~~~~~~~-------~~~~~~~~~~~----------------------- 124 (181)
|||.+.+..++.++|+||+||++++|++|+.||...... .+...+...+.
T Consensus 197 aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~ 276 (362)
T d1q8ya_ 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 276 (362)
T ss_dssp CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS
T ss_pred ChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhh
Confidence 999999888999999999999999999999999754321 11111100000
Q ss_pred ----------------ccCCCCCCCHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhhhCCC
Q 030203 125 ----------------RLEIPRNVNPHVASIIEACWANEPWKRPSFSTIMELLRPLIKSPT 169 (181)
Q Consensus 125 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~L~~~~~~~~ 169 (181)
........++.+.+|+.+||..||.+|||++|+++ ++|+++..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~--Hp~f~~~~ 335 (362)
T d1q8ya_ 277 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN--HPWLKDTL 335 (362)
T ss_dssp SCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT--CGGGTTCT
T ss_pred ccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc--CcccCCCC
Confidence 00111234567999999999999999999999999 99998553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.25 E-value=2e-12 Score=88.10 Aligned_cols=53 Identities=23% Similarity=0.225 Sum_probs=45.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCEEEcCCCcEEEcccCCccccc
Q 030203 3 DERRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA 58 (181)
Q Consensus 3 ~~~~~~~i~~ql~~~l~~lh~~~~~~~h~~i~~~nil~~~~~~~~l~d~g~~~~~~ 58 (181)
++..+..++.|++.++.+||+.| ++|+||||+||+++++ .++++|||.+....
T Consensus 101 ~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 101 RVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred hhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence 34456789999999999999999 9999999999999975 48899999886543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.55 E-value=0.0056 Score=43.32 Aligned_cols=27 Identities=22% Similarity=0.310 Sum_probs=24.6
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+.+.||+++.++...++||+.+
T Consensus 185 iIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred cccCCcchhhhhcccccceeEeccccc
Confidence 899999999999998877789999875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=93.98 E-value=0.014 Score=39.74 Aligned_cols=27 Identities=30% Similarity=0.415 Sum_probs=23.5
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+.+.||+++.++...++||+.+
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred EEEeeccCcceeecCCceEEEeechhc
Confidence 789999999999998766679999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=93.10 E-value=0.018 Score=39.02 Aligned_cols=27 Identities=26% Similarity=0.354 Sum_probs=23.6
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLS 54 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~ 54 (181)
++|+|+.+.||+++.++.+.++||+.+
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhc
Confidence 799999999999998766779999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=92.36 E-value=0.096 Score=38.09 Aligned_cols=29 Identities=21% Similarity=0.359 Sum_probs=24.9
Q ss_pred CceecCCCCCCEEEcCCCcEEEcccCCccc
Q 030203 27 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 56 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~~~~~~l~d~g~~~~ 56 (181)
+++|||+.+.||+++.++ ++++||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 399999999999998764 89999987654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=84.61 E-value=0.15 Score=36.91 Aligned_cols=16 Identities=38% Similarity=0.648 Sum_probs=13.7
Q ss_pred CceecCCCCCCEEEcC
Q 030203 27 PIVHRDLKSPNLLVDK 42 (181)
Q Consensus 27 ~~~h~~i~~~nil~~~ 42 (181)
+++|+|+.+.||++..
T Consensus 219 v~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 219 TFCHNDLQEGNILLPK 234 (395)
T ss_dssp EEECSCCCGGGEEEEC
T ss_pred eEEecCCCcccEeecc
Confidence 3689999999999854
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=84.27 E-value=0.24 Score=34.78 Aligned_cols=26 Identities=23% Similarity=0.262 Sum_probs=21.5
Q ss_pred ceecCCCCCCEEEcCCCcEEEcccCCcc
Q 030203 28 IVHRDLKSPNLLVDKKYTVKVCDFGLSR 55 (181)
Q Consensus 28 ~~h~~i~~~nil~~~~~~~~l~d~g~~~ 55 (181)
++|+|+.+.||+++.+ ..++||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999743 4589998764
|